PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Reacher, MH; Shah, A; Livermore, DM; Wale, MCJ; Graham, C; Johnson, AP; Heine, H; Monnickendam, MA; Barker, KF; James, D; George, RC				Reacher, MH; Shah, A; Livermore, DM; Wale, MCJ; Graham, C; Johnson, AP; Heine, H; Monnickendam, MA; Barker, KF; James, D; George, RC			Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIMICROBIAL RESISTANCE; BLOOD	Objectives Determination of causes, trends, and antibiotic resistance in reports of bacterial pathogens isolated from blood in England and Wales from 1990 to 1998. Design Description of bacterial isolates from blood, judged to be clinically significant by microbiology staff, reported to the Communicable Disease Surveillance Centre. Setting Microbiology laboratories in England and Wales. Subjects Patients yielding clinically significant isolates from blood. Main outcome measures Frequency and Poisson regression analyses for trend of reported causes of bacteraemia and proportions of antibiotic resistant isolates. Results There was an upward trend in total numbers of reports of bacteraemia. The five most cited organisms accounted for over 60% of reports each year. There was a substantial increase in the proportion of reports of Staphylococcus aureus resistant to methicillin, Streptococcus pneumoniae resistance to penicillin and erythromycin, and Enterococcus faecalis and Enterococcus faecium resistance to vancomycin. No increase was seen in resistance of Escherichia coli to gentamicin. Conclusions Reports from laboratories provide Valuable information on trends and antibiotic resistance in bacteraemia and show a worrying increase in resistance to important antibiotics.	Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; PHLS Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England; PHLS Cent Publ Hlth Lab, Resp & Systemat Infect Lab, London NW9 5HT, England; Queens Med Ctr, PHLS Antimicrobial Susceptibil Surveillance Unit, Nottingham NG7 2UH, England; PHLS Stat Unit, London NW9 5EQ, England; PHLS Headquarters, London NW9 5DF, England; SmithKline Beecham Pharmaceut, Int Med Dept, Brentford TW8 9BD, Middx, England	Public Health England; University of Nottingham; GlaxoSmithKline	Reacher, MH (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.	mreacher@phls.nhs.uk	Reacher, Mark/Y-6979-2018; Johnson, Alan P/F-4420-2014	Reacher, Mark/0000-0001-6871-7903; 				*ASS MED MICR, 1998, AMM DIR MED MICR SER, P139; Ayliffe GAJ, 1998, J HOSP INFECT, V39, P253, DOI 10.1016/S0195-6701(98)90293-6; BANERJEE SN, 1991, AM J MED, V91, pS86, DOI 10.1016/0002-9343(91)90349-3; Cockerill FR, 1997, CLIN INFECT DIS, V24, P403, DOI 10.1093/clinids/24.3.403; Grant A D, 1993, Commun Dis Rep CDR Rev, V3, pR75; Hargreaves RM, 1996, BRIT MED J, V312, P160; Henry R., 1996, PHLS Microbiology Digest, V13, P26; *HOSP INF WORK GRO, 1995, HOSP INF CONTR GUID; Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522; Johnson AP, 1998, J HOSP INFECT, V40, P17, DOI 10.1016/S0195-6701(98)90020-2; Johnson AP, 1999, J ANTIMICROB CHEMOTH, V43, P160, DOI 10.1093/jac/43.1.160; Laurichesse H, 1998, Commun Dis Public Health, V1, P22; Livermore DM, 1998, BRIT MED J, V317, P614, DOI 10.1136/bmj.317.7159.614; LIVERMORE DM, INPRESS J ANTIMICROB; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Speller DCE, 1997, LANCET, V350, P323, DOI 10.1016/S0140-6736(97)12148-1; Standing Medical Advisory Committee: Sub-group on Antimicrobial Resistance, 1998, PATH LEAST RES; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Young L. S., 1995, PRINCIPLES PRACTICE, P690; 1999, COMMUN DIS REP CDR W, V9, P185; [No title captured]; [No title captured]; 1996, COMMUN DIS REPORT CD, V6, P83; 1997, COMMUN DIS REPORT CD, V7, P13	24	235	245	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2000	320	7229					213	216		10.1136/bmj.320.7229.213	http://dx.doi.org/10.1136/bmj.320.7229.213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642227	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085029600022
J	Stein, J				Stein, J			A fragile commodity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Stein, Joel/0000-0001-5527-025X					0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					305	306		10.1001/jama.283.3.305	http://dx.doi.org/10.1001/jama.283.3.305			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647782				2022-12-28	WOS:000084732400001
J	Mayor, S				Mayor, S			Cloned calves are grown from cultured cells	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					136	136		10.1136/bmj.320.7228.136	http://dx.doi.org/10.1136/bmj.320.7228.136			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634719	Green Published			2022-12-28	WOS:000084860300009
J	Britton-Davidian, J; Catalan, J; Ramalhinho, MD; Ganem, G; Auffray, JC; Capela, R; Biscoito, M; Searle, JB; Mathias, MD				Britton-Davidian, J; Catalan, J; Ramalhinho, MD; Ganem, G; Auffray, JC; Capela, R; Biscoito, M; Searle, JB; Mathias, MD			Environmental genetics - Rapid chromosomal evolution in island mice	NATURE			English	Article							MUS-MUSCULUS-DOMESTICUS		Univ Montpellier 2, ISEM, Lab Genet & Environm, CNRS,UMR 5554, F-34095 Montpellier 5, France; Museo Nacl Hist Nat, Ctr Biol Ambiental, P-1200 Lisbon, Portugal; Univ Madeira, Dept Biol, P-9000 Funchal, Madeira, Portugal; CITMA, P-9000 Funchal, Madeira, Portugal; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Lisbon, Fac Ciencias, Dept Zool & Anthropol, P-1700 Lisbon, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade da Madeira; University of York - UK; Universidade de Lisboa	Britton-Davidian, J (corresponding author), Univ Montpellier 2, ISEM, Lab Genet & Environm, CNRS,UMR 5554, F-34095 Montpellier 5, France.		da Luz Mathias, Maria/V-9931-2018; Ganem, Guila/AAC-1872-2022; Auffray, Jean-Christophe/AAW-1052-2020; Biscoito, Manuel/AAC-4390-2021; Auffray, jean-christophe/HCI-4881-2022; AUFFRAY, Jean-Christophe/H-1907-2011; Auffray, Jean-Christophe/AAH-6131-2019	da Luz Mathias, Maria/0000-0003-3876-958X; Ganem, Guila/0000-0002-5244-4979; Auffray, Jean-Christophe/0000-0002-5184-0507; Biscoito, Manuel/0000-0002-9347-0823; 				BAKER RJ, 1986, P NATL ACAD SCI USA, V83, P8245, DOI 10.1073/pnas.83.21.8245; GARAGNA S, 1997, NATURE, V390, P242; Grant PR, 1998, EVOLUTION ISLANDS; Hauffe HC, 1998, GENETICS, V150, P1143; HAUFFE HC, 1993, EVOLUTION, V47, P1374, DOI 10.1111/j.1558-5646.1993.tb02161.x; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MATHIAS MD, 1992, BIOL J LINN SOC, V46, P13, DOI 10.1111/j.1095-8312.1992.tb00846.x; NACHMAN MW, 1995, TRENDS ECOL EVOL, V10, P397, DOI 10.1016/S0169-5347(00)89155-7; Provine W.B., 1989, P43	9	130	135	1	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					158	158		10.1038/35003116	http://dx.doi.org/10.1038/35003116			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646592				2022-12-28	WOS:000084835300043
J	Murray, TJ				Murray, TJ			Personal time: The patient's experience	ANNALS OF INTERNAL MEDICINE			English	Article								When a life-threatening or chronic disease is diagnosed, patients may find that their sense of time, the passage of days, and their view of the future are altered. Most of the time, people live in a sense of linear time, or kronos. When illness strikes, they may begin to spend more time in kairos, a sense of soul-satisfying time, such as the feeling one gets when walking on the seashore with a grandchild, working in the garden, or talking with friends over good food and wine. This article comments on two patients, one who explores kairos through a diary that documents her positive attitude toward coping with multiple sclerosis, and one, a young artist with Hodgkin disease, who explores his condition through 96 paintings of his experience of the disease. Rather than "the devouring tyrant of linear time," life can be seen in a circular fashion, the eternal braid of Hofstadter. Patients begin to see life more in terms of cycles of daily events, routines, and the change of seasons. Illness brings one "close to the bone" of the soul's needs, with a reappraisal of the journey of life as a continuous line, to life spread out on a landscape that includes the past and the future.	Dalhousie Univ, Sch Med, Halifax, NS B3H 4H7, Canada	Dalhousie University	Murray, TJ (corresponding author), Dalhousie Univ, Sch Med, Sir Charles Tupper Med Bldg, Halifax, NS B3H 4H7, Canada.	jock.murray@dal.ca						AMIS M, 1998, TIMES ARROW; [Anonymous], ECCLESIASTES, V3; BOLEN JS, 1996, CLOSE BONE, P86; CAPPELLA B, 1977, PERCEPT MOTOR SKILL, V44, P787, DOI 10.2466/pms.1977.44.3.787; Dossey L., 1982, SPACE TIME MED; EDDINGTON AS, 1957, MATH THEORY RELATIVI, P23; Hofstadter D.R, 1979, GODEL ESCHER BACH ET; JANTSCH E, 1980, SELF ORG UNIVERSE SC, P97; McLuhan M., 1994, UNDERSTANDING MEDIA; Pope R, 1991, ILLNESS HEALING IMAG; Priestley J.B., 1978, MAN TIME; Shallis M., 1983, TIME INVESTIGATION S; SZAMOSI G, 1986, ORIGIN TIME MEDIEVAL, P33	13	14	14	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					58	62		10.7326/0003-4819-132-1-200001040-00010	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627253				2022-12-28	WOS:000084518600009
J	Duckett, S				Duckett, S			Ernest Duchesne and the concept of fungal antibiotic therapy	LANCET			English	Biographical-Item									Univ Paris 06, Hop La Pitie Salpetriere, Lab R Escourolle, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Duckett, S (corresponding author), 4 Rue Regnard,Pl Odeon, F-75006 Paris, France.							CAMELIN A, 1969, LYON MED, P177; CHAIN E, 1942, BR J EXP PATHOL, V29, P202; CHARRIN A, 1899, CR HEBD ACAD SCI, P764; Domsch K.H., 1980, COMPENDIUM SOIL FUNG, P564; DUCHESNE E, PUBLICATION LIST; FLOREY HW, 1946, YALE J BIOL MED, V19, P101; FLOREY HW, 1945, BRIT MED J, V4427, P635; FRASERMOODIE W, 1971, P ROY SOC MED, V64, P87, DOI 10.1177/003591577106400152; Koestler Arthur, 1964, ART CREATION; LEE KS, 1986, APPL ENVIRON MICROB, V52, P1046, DOI 10.1128/AEM.52.5.1046-1054.1986; MACFARLANE G, 1984, A FLEMING MAN MYTH, P136; MOSSE JR, 1852, LANCET, V2, P113; Pasteur L., 1877, B ACAD MED PARIS, V6, P781; Raistrick H, 1943, LANCET, V2, P625; RAPPER KB, 1949, MANUAL PENICILLINIA, P3; Roux Gabriel, 1892, PRECIS ANAL MICROBIO; SAILE M, 1974, PRECURSEUR LYONNAIS; SELWYN S, 1979, J ANTIMICROB CHEMOTH, V5, P249, DOI 10.1093/jac/5.3.249; STEIMAN R, 1989, MYCOPATHOLOGIA, V105, P129, DOI 10.1007/BF00437244; Veraldi G. B., 1972, PSYCHOL CREATION; WAKSMAN SA, 1941, BACTERIOL REV, P231; WAKSMAN SA, 1945, MICROBIAL ANTAGONISM, P124	22	10	11	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2068	2071		10.1016/S0140-6736(99)03162-1	http://dx.doi.org/10.1016/S0140-6736(99)03162-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636385				2022-12-28	WOS:000084183300045
J	Rice, N; Dixon, P; Lloyd, DCEF; Roberts, D				Rice, N; Dixon, P; Lloyd, DCEF; Roberts, D			Derivation of a needs based capitation formula for allocating prescribing budgets to health authorities and primary care groups in England: regression analysis	BRITISH MEDICAL JOURNAL			English	Article							SPECIFICATION	Objective To develop a weighted capitation formula for setting target allocations for prescribing expenditures for health authorities and primary care groups in England Design Regression analysis relating pl escribing costs to the demographic, morbidity, and mortality composition of practice lists. Setting 8500 general practices in England. Subjects: Data from the 1991 census were attributed to practice lists on the basis of the place of residence of the practice population. Main outcome measures Variation in age, ses, and temporary resident originated prescribing units (ASTRO(97)-PUs) adjusted net ingredient cost of general practices in England for 1997-8 modelled for the impact of health and social needs after controlling for differences in supply. Results A needs gradient based on the four variables: permanent sickness, percentage of dependents in no carer households, percentage of students, and percentage of births on practice lists. These, together with supply characteristics, explained 41% of variation in prescribing costs per ASTRO(97)-PU adjusted capita across practices. The latter alone explained about 35% of variation in total costs per head across practices. Conclusions The model has good statistical specification and contains intuitively plausible needs drivers of pr escribing expenditure. Together with adjustments made for differences in ASTRO(97)-PUs the model is capable of explaining 62% (35% + 0.65% (41%)) of variation in prescribing expenditure at practice level. The results of the study have formed the basis for setting target budgets for 1999-2000 allocations for prescribing expenditure for health authorities and primary care groups.	Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Prescribing Support Unit, Leeds LS2 7RJ, W Yorkshire, England	University of York - UK	Rice, N (corresponding author), Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England.							CARRHILL RA, 1994, BRIT MED J, V309, P1046, DOI 10.1136/bmj.309.6961.1046; Department of Health and Social Security, 1976, SHAR RES HLTH ENGL R; *EX NHS, 1997, LOC BUDG SETT FIN MA; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Jarman B., 1983, BRIT MED J, V286, P705; LLOYD DCE, 1997, BRIT J MED EC, V11, P81; LLOYD DCEF, 1995, BRIT MED J, V310, P165, DOI 10.1136/bmj.310.6973.165; *NHS EX, 1999, 15995 NHS EX RES ALL; RAMSEY JB, 1969, J ROY STAT SOC B, V31, P350; RICE N, 1997, J HLTH SERV RES POLI, V3, P154; RICE N, 1999, OCC PAP SER U YORK; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; *UK GOV, 1997, NEW NHS MOD DEP	14	33	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					284	287		10.1136/bmj.320.7230.284	http://dx.doi.org/10.1136/bmj.320.7230.284			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650026	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085132700022
J	Urano, F; Wang, XZ; Bertolotti, A; Zhang, YH; Chung, P; Harding, HP; Ron, D				Urano, F; Wang, XZ; Bertolotti, A; Zhang, YH; Chung, P; Harding, HP; Ron, D			Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1	SCIENCE			English	Article							NF-KAPPA-B; C-JUN; ENDOPLASMIC-RETICULUM; TERMINAL KINASE; TNF RECEPTOR-1; PATHWAY; TRAF2; NUCLEUS; PHOSPHORYLATION; REQUIRES	Malfolded proteins in the endoplasmic reticulum (ER) induce cellular stress and activate c-Jun amino-terminal kinases (JNKs or SAPKs), Mammalian homologs of yeast IRE1, which activate chaperone genes in response to ER stress, also activated INK, and IRE1 alpha(-/-) fibroblasts were impaired in JNK activation by ER stress. The cytoplasmic part of IRE1 bound TRAF2, an adaptor protein that couples plasma membrane receptors to JNK activation. Dominant-negative TRAF2 inhibited activation of JNK by IRE1. Activation of JNK by endogenous signals initiated in the ER proceeds by a pathway similar to that initiated by cell surface receptors in response to extracellular signals.	NYU, Sch Med, Skirball Inst Biomol Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, Dept Med, New York, NY 10016 USA	New York University; New York University	Ron, D (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dept Med, New York, NY 10016 USA.	ron@saturn.med.nyu.edu	Longo, Kenneth A/A-5631-2010; Urano, Fumihiko/AAF-4492-2020	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047119, R37DK047119, R01DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47119] Funding Source: Medline; NIEHS NIH HHS [ES08681] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Goberdhan DCI, 1998, BIOESSAYS, V20, P1009, DOI 10.1002/(SICI)1521-1878(199812)20:12<1009::AID-BIES7>3.0.CO;2-D; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MORI K, 1993, CELL, V74, P743; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Srivastava RK, 1999, MOL CELL BIOL, V19, P5659; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; YAN MH, 1994, NATURE, V372, P798; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681	33	2060	2130	10	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					664	666		10.1126/science.287.5453.664	http://dx.doi.org/10.1126/science.287.5453.664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10650002				2022-12-28	WOS:000084989400051
J	Greif, R; Akca, O; Horn, EP; Kurz, A; Sessler, DI				Greif, R; Akca, O; Horn, EP; Kurz, A; Sessler, DI		Outcomes Res Grp	Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTOPERATIVE-PATIENTS; RISK; COSTS; HOSPITALIZATION; NORMOTHERMIA; PERFUSION; COLLAGEN; TENSION; CHARGES; INDEX	Background Destruction by oxidation, or oxidative killing, is the most important defense against surgical pathogens and depends on the partial pressure of oxygen in contaminated tissue. An easy method of improving oxygen tension in adequately perfused tissue is to increase the concentration of inspired oxygen. We therefore tested the hypothesis that the supplemental administration of oxygen during the perioperative period decreases the incidence of wound infection. Methods We randomly assigned 500 patients undergoing colorectal resection to receive 30 percent or 80 percent inspired oxygen during the operation and for two hours afterward. Anesthetic treatment was standardized, and all patients received prophylactic antibiotic therapy. With use of a double-blind protocol, wounds were evaluated daily until the patient was discharged and then at a clinic visit two weeks after surgery. We considered wounds with culture-positive pus to be infected. The timing of suture removal and the date of discharge were determined by the surgeon, who did not know the patient's treatment-group assignment. Results Arterial oxygen saturation was normal in both groups; however, the arterial and subcutaneous partial pressure of oxygen was significantly higher in the patients given 80 percent oxygen than in those given 30 percent oxygen. Among the 250 patients who received 80 percent oxygen, 13 (5.2 percent; 95 percent confidence interval, 2.4 to 8.0 percent) had surgical-wound infections, as compared with 28 of the 250 patients given 30 percent oxygen (11.2 percent; 95 percent confidence interval, 7.3 to 15.1 percent; P=0.01). The absolute difference between groups was 6.0 percent (95 percent confidence interval, 1.2 to 10.8 percent). The duration of hospitalization was similar in the two groups. Conclusions The perioperative administration of supplemental oxygen is a practical method of reducing the incidence of surgical-wound infections. (N Engl J Med 2000;342:161-7.) (C) 2000, Massachusetts Medical Society.	Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; Washington Univ, Dept Anesthesiol, St Louis, MO USA; Univ Hosp Eppendorf, Dept Anesthesiol, Hamburg, Germany; Ludwig Boltzmann Inst Clin Anesthesia, Vienna, Austria; Univ Vienna, Vienna Gen Hosp, Dept Anesthesia & Gen Intens Care, Vienna, Austria; Univ Vienna, Donauspital, Dept Anesthesiol & Intens Care Med, Vienna, Austria	University of California System; University of California San Francisco; Washington University (WUSTL); University of Hamburg; University Medical Center Hamburg-Eppendorf; Ludwig Boltzmann Institute; University of Vienna; Donauspital; University of Vienna	Sessler, DI (corresponding author), Univ Calif San Francisco, Dept Anesthesia, Outcomes Res Grp, 374 Parnassus Ave,3rd Fl, San Francisco, CA 94143 USA.		Nagele, Peter/A-2922-2008; Akca, Ozan/I-8856-2019; Robert, Greif/O-6392-2016; Sessler, Daniel/D-3504-2011; Nagele, Peter/ABA-5189-2020	Nagele, Peter/0000-0001-8369-3858; Akca, Ozan/0000-0002-7275-1060; Robert, Greif/0000-0003-0160-2073; Sessler, Daniel/0000-0001-9932-3077; Kurz, Andrea/0000-0001-5887-3099; Hopf, Harriet/0000-0002-3603-5569; Roka, Sebastian/0000-0002-9888-5892	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM027345, R01GM058273] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27345, GM58273] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Akca O, 1999, ANESTHESIOLOGY, V91, P991, DOI 10.1097/00000542-199910000-00019; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BREMMELGAARD A, 1989, J HOSP INFECT, V13, P1, DOI 10.1016/0195-6701(89)90090-X; BURKE JF, 1961, SURGERY, V50, P161; BYRNE DJ, 1989, BIOMED PHARMACOTHER, V43, P669, DOI 10.1016/0753-3322(89)90085-1; CHANG N, 1983, ANN SURG, V197, P470, DOI 10.1097/00000658-198304000-00017; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; Fawcett A, 1996, GUT, V38, P714, DOI 10.1136/gut.38.5.714; FLECKENSTEIN W, 1984, ADV EXP MED BIOL, V169, P447; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014; HALEY RW, 1980, J INFECT DIS, V141, P248, DOI 10.1093/infdis/141.2.248; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; HARTMANN M, 1992, EUR J SURG, V158, P521; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; HUTTON JJ, 1967, ARCH BIOCHEM BIOPHYS, V118, P231, DOI 10.1016/0003-9861(67)90302-5; JONSSON K, 1987, BRIT J SURG, V74, P263, DOI 10.1002/bjs.1800740413; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; KURZ A, 1993, ANESTH ANALG, V77, P89; LINDBLAD WJ, 1984, ANAL BIOCHEM, V138, P390, DOI 10.1016/0003-2697(84)90827-3; Lynch W, 1992, Pharmacoeconomics, V2, P163, DOI 10.2165/00019053-199202020-00008; MEINERT CL, 1986, MONOGRAPHS EPIDEMIOL, V8; MILES AA, 1957, BRIT J EXP PATHOL, V38, P79; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; NIINIKOSKI J, 1973, AM J SURG, V126, P53, DOI 10.1016/S0002-9610(73)80094-7; POULSEN KB, 1994, EPIDEMIOL INFECT, V113, P283, DOI 10.1017/S0950268800051712; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; SHULKIN DJ, 1993, ARCH SURG-CHICAGO, V128, P449; Steinberg B, 1989, Anasth Intensivther Notfallmed, V24, P377; STOPINSKI J, 1993, J CHIR-PARIS, V130, P422; VANOSS CJ, 1980, J RETICULOENDOTH SOC, V27, P561; Zoutman D, 1998, INFECT CONT HOSP EP, V19, P254	35	699	725	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					161	167		10.1056/NEJM200001203420303	http://dx.doi.org/10.1056/NEJM200001203420303			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639541				2022-12-28	WOS:000084851700003
J	Del Mar, C				Del Mar, C			Evidence based case report - Asymptomatic haematuria ... in the doctor	BRITISH MEDICAL JOURNAL			English	Article							MICROHEMATURIA		Univ Queensland, Ctr Gen Practice, Inala, Qld 4077, Australia	University of Queensland	Del Mar, C (corresponding author), Univ Queensland, Ctr Gen Practice, Univ Gen Practice, Inala, Qld 4077, Australia.		Del Mar, Chris B/B-1136-2008	Del Mar, Chris B/0000-0003-3821-8163				DELMAR C, 1998, EVIDENCE BASED PRACT, P21; Denker BM, 1998, HARRISONS PRINCIPLES, P258; FROOM P, 1986, CLIN CHEM, V32, P2013; HIATT RA, 1994, CANCER EPIDEM BIOMAR, V3, P439; RITCHIE CD, 1986, BRIT MED J, V292, P581; SACKETT DL, 1997, EVIDENCE BASED MED; TIPCRAFT RC, 1995, BAILEY LOVES SHORT P, P904	7	14	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					165	166		10.1136/bmj.320.7228.165	http://dx.doi.org/10.1136/bmj.320.7228.165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634739	Green Published			2022-12-28	WOS:000084860300030
J	Wise, J				Wise, J			Breast cancer screening may not save lives, study finds	BRITISH MEDICAL JOURNAL			English	News Item																		Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					139	139		10.1136/bmj.320.7228.139	http://dx.doi.org/10.1136/bmj.320.7228.139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634727	Green Published			2022-12-28	WOS:000084860300016
J	Koskelainen, A; Ala-Laurila, P; Fyhrquist, N; Donner, K				Koskelainen, A; Ala-Laurila, P; Fyhrquist, N; Donner, K			Measurement of thermal contribution to photoreceptor sensitivity	NATURE			English	Article							FROG RETINA; NOISE; CONE; PIGMENTS; VISION	Activation of a visual pigment molecule to initiate phototransduction requires a minimum energy, E-a, that need not be wholly derived from a photon, but may be supplemented by heat(1), Theory(2,3) predicts that absorbance at very long wavelengths declines with the fraction of molecules that have a sufficient complement of thermal energy, and that E-a is inversely related to the wavelength of maximum absorbance (lambda(max)) of the pigment, Consistent with the first of these predictions, warming increases relative visual sensitivity to long wavelengths(4-8). Here we measure this effect in amphibian photoreceptors with different pigments to estimate E-a (refs 2, 5-7) and test experimentally the predictions of an inverse relation between E-a and lambda(max). For rods and 'red' cones in the adult frog retina, we find no significant difference in E-a between the two pigments involved, although their lambda(max) values are very different. We also determined E-a for the rhodopsin in toad retinal rods--spectrally similar to frog rhodopsin hut differing in amino-acid sequence-and found that it was significantly higher. In addition, we estimated E-a for two pigments whose lambda(max) difference was due only to a chromophore difference (A1 and A2 pigment, in adult and larval bag cones), Here E-a for A2 was lower than for Al. Our results refute the idea of a necessary relation between lambda(max) and E-a but show that the A1 --> A2 chromophore substitution decreases E-a.	Aalto Univ, Biomed Engn Lab, FIN-02015 Espoo, Finland; Univ Helsinki, Dept Biosci, Div Anim Physiol, FIN-00014 Helsinki, Finland	Aalto University; University of Helsinki	Koskelainen, A (corresponding author), Aalto Univ, Biomed Engn Lab, POB 2200, FIN-02015 Espoo, Finland.	ari.koskelainen@hut.fi	Ala-Laurila, Petri/AAE-1203-2019	Ala-Laurila, Petri/0000-0002-6139-6825; Fyhrquist, Nanna Theresia/0000-0002-5408-0005				BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BOWMAKER JK, 1994, VISION RES, V34, P591, DOI 10.1016/0042-6989(94)90015-9; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; DENTON EJ, 1954, J PHYSIOL-LONDON, V125, P181, DOI 10.1113/jphysiol.1954.sp005149; DONNER K, 1990, J PHYSIOL-LONDON, V428, P673, DOI 10.1113/jphysiol.1990.sp018234; Donner K, 1998, VISION RES, V38, P19, DOI 10.1016/S0042-6989(97)00144-2; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; FIRSOV ML, 1990, SENSORY SYSTEMS, V4, P25; Fyhrquist N, 1998, EXP EYE RES, V66, P295, DOI 10.1006/exer.1997.0430; Goldsmith T.H., 1989, P1; GOVARDOVSKII VI, IN PRESS VIS NEUROSC; KOSKELAINEN A, 1994, ACTA PHYSIOL SCAND, V152, P115, DOI 10.1111/j.1748-1716.1994.tb09790.x; KUNLIN J, 1948, CR HEBD ACAD SCI, V226, P357, DOI 10.1007/BF00369741; LAMB TD, 1977, J PHYSIOL-LONDON, V272, P435, DOI 10.1113/jphysiol.1977.sp012053; LAMB TD, 1984, J PHYSIOL-LONDON, V346, P557, DOI 10.1113/jphysiol.1984.sp015041; LEWIS PR, 1955, J PHYSIOL-LONDON, V130, P45, DOI 10.1113/jphysiol.1955.sp005391; LUTHGOE JN, 1988, SENSORY BIOL AQUATIC, P57; Lythgoe RJ, 1938, J PHYSIOL-LONDON, V93, P24, DOI 10.1113/jphysiol.1938.sp003622; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; Reuter T., 1969, Acta Zoologica Fennica, V122, P1; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SREBRO R, 1966, J PHYSIOL-LONDON, V187, P417, DOI 10.1113/jphysiol.1966.sp008099; STGEORGE RCC, 1952, J GEN PHYSIOL, V35, P495, DOI 10.1085/jgp.35.3.495; Stiles W. S., 1948, T OPTICAL CONVENTION, P97; WILLIAMS TP, 1968, VISION RES, V8, P359, DOI 10.1016/0042-6989(68)90105-3	30	31	33	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					220	223		10.1038/35003242	http://dx.doi.org/10.1038/35003242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646610				2022-12-28	WOS:000084835300061
J	Lipper, GM; Arndt, KA; Dover, JS				Lipper, GM; Arndt, KA; Dover, JS			Recent therapeutic advances in dermatology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; BURN CENTER; TOPICAL TACROLIMUS; IMIQUIMOD; INHIBITION; INTERFERON		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Dover, JS (corresponding author), Harvard Univ, Med Fac Phys, Cosmet Surg & Laser Ctr, Beth Israel Deaconess Med Ctr, 25 Boylston St,Suite 104, Chestnut Hill, MA 02167 USA.							Chaidemenos GC, 1997, INT J DERMATOL, V36, P218, DOI 10.1046/j.1365-4362.1997.00192.x; DEPAULIS A, 1992, J INVEST DERMATOL, V99, P723, DOI 10.1111/1523-1747.ep12614216; Edwards L, 1998, ARCH DERMATOL, V134, P25, DOI 10.1001/archderm.134.1.25; Egan CA, 1999, J AM ACAD DERMATOL, V40, P458, DOI 10.1016/S0190-9622(99)70497-4; HALEBIAN PH, 1986, ANN SURG, V204, P503, DOI 10.1097/00000658-198611000-00001; HENG MCY, 1991, J AM ACAD DERMATOL, V25, P778, DOI 10.1016/S0190-9622(08)80969-3; KELEMEN JJ, 1995, J AM COLL SURGEONS, V180, P273; McGee T, 1998, PLAST RECONSTR SURG, V102, P1018, DOI 10.1097/00006534-199809040-00014; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; Reich K, 1998, BRIT J DERMATOL, V139, P755; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; Ruzicka T, 1999, ARCH DERMATOL, V135, P574, DOI 10.1001/archderm.135.5.574; Rzany B, 1996, BRIT J DERMATOL, V135, P6; Rzany B, 1999, LANCET, V353, P2190, DOI 10.1016/S0140-6736(98)05418-X; SIDKY YA, 1992, CANCER RES, V52, P3528; STANLEY MA, 1999, PAPILLOMAVIRUS REP, V10, P23; Syed Tanweer A., 1998, Journal of Dermatology (Tokyo), V25, P309; Tyring SK, 1998, J INFECT DIS, V178, P551, DOI 10.1086/517472; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; WEEKS CE, 1994, J INTERFERON RES, V14, P81, DOI 10.1089/jir.1994.14.81; Wolkenstein P, 1998, LANCET, V352, P1586, DOI 10.1016/S0140-6736(98)02197-7; Zonneveld IM, 1998, ARCH DERMATOL, V134, P1101, DOI 10.1001/archderm.134.9.1101	23	14	21	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					175	177		10.1001/jama.283.2.175	http://dx.doi.org/10.1001/jama.283.2.175			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634322				2022-12-28	WOS:000084661400002
J	Lip, GYH; Gibbs, CR; Beevers, DG				Lip, GYH; Gibbs, CR; Beevers, DG			ABC of heart failure - Aetiology	BRITISH MEDICAL JOURNAL			English	Review									Univ Birmingham, City Hosp, Dept Med, Birmingham, W Midlands, England; Univ Birmingham, City Hosp, Dept Cardiol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Lip, GYH (corresponding author), Univ Birmingham, City Hosp, Dept Med, Birmingham, W Midlands, England.							Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Oakley C, 1997, BMJ-BRIT MED J, V315, P1520, DOI 10.1136/bmj.315.7121.1520; TEERLINK JR, 1991, AM HEART J, V121, P1852, DOI 10.1016/0002-8703(91)90072-P; WHEELDON NM, 1993, Q J MED, V86, P17	6	25	35	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 8	2000	320	7227					104	107		10.1136/bmj.320.7227.104	http://dx.doi.org/10.1136/bmj.320.7227.104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274CR	10625270	Green Published			2022-12-28	WOS:000084746600023
J	Hunter, T				Hunter, T			Signaling - 2000 and beyond	CELL			English	Review							TYROSINE KINASE DOMAIN; PROTEIN-KINASES; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; LIVING CELLS; RECEPTOR; TRANSDUCTION; PHOSPHORYLATION; PHOSPHATASE; SPECIFICITY		Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Hunter, T (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Adams PD, 1996, MOL CELL BIOL, V16, P6623; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Austin D J, 1994, Chem Biol, V1, P131, DOI 10.1016/1074-5521(94)90002-7; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; EICHEBLY M, 1999, SCIENCE, V283, P1544; Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fong TAT, 1999, CANCER RES, V59, P99; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Holland PM, 1999, CURR BIOL, V9, pR329, DOI 10.1016/S0960-9822(99)80205-X; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 1998, NAT GENET, V18, P303; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Johnson DL, 1998, BIOCHEMISTRY-US, V37, P3699, DOI 10.1021/bi971956y; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; Murad F, 1994, Adv Pharmacol, V26, P19, DOI 10.1016/S1054-3589(08)60049-6; Neet K, 1996, GENES CELLS, V1, P147, DOI 10.1046/j.1365-2443.1996.d01-234.x; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; Tian SS, 1998, SCIENCE, V281, P257, DOI 10.1126/science.281.5374.257; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yaffe MB, 1999, NATURE, V402, P30; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	88	2116	2229	8	206	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					113	127		10.1016/S0092-8674(00)81688-8	http://dx.doi.org/10.1016/S0092-8674(00)81688-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647936	Bronze			2022-12-28	WOS:000084722600010
J	Hong, K; Nishiyama, M; Henley, J; Tessier-Lavigne, M; Poo, MM				Hong, K; Nishiyama, M; Henley, J; Tessier-Lavigne, M; Poo, MM			Calcium signalling in the guidance of nerve growth by netrin-1	NATURE			English	Article							CONES; CELLS; INHIBITION; MODULATION; RECEPTOR; NEURONS; CA-2+	Pathfinding by growing axons in the developing nervous system is guided by diffusible or bound factors that attract or repel the axonal growth cone(1,2). The cytoplasmic signalling mechanisms that trigger the responses of the growth cone to guidance factors are mostly unknown(3). Previous studies have shown that the level and temporal patterns of cytoplasmic Ca2+ can regulate the rate of growth-cone extension in vitro(4-8) and in vivo(9). Here we report that Ca2+ also mediates the turning behaviour of the growth cones of cultured Xenopus neurons that are induced by an extracellular gradient of netrin-1, an established diffusible guidance factor in vivo(1,10). The netrin-1-induced turning response depends on Ca2+ influx through plasma membrane Ca2+ channels, as well as Ca2+-induced Ca2+ release from cytoplasmic stores(11). Reduction of Ca2+ signals by blocking either of these two Ca2+ sources converted the netrin-1-induced response from attraction to repulsion. Activation of Ca2+-induced Ca2+ release from internal stores with a gradient of ryanodine in the absence of netrin-1 was Sufficient to trigger either attractive or repulsive responses, depending on the ryanodine concentration used. These results support the model that cytoplasmic Ca2+ signals mediate growth-cone guidance by netrin-1, and different patterns of Ca2+ elevation trigger attractive and repulsive turning responses.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Henley, John/D-7171-2011	Henley, John/0000-0003-1846-5941				ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; KATER SB, 1988, TRENDS NEUROSCI, V11, P317; Lau PM, 1999, J CELL BIOL, V145, P1265, DOI 10.1083/jcb.145.6.1265; Leis HJ, 1996, BRIT J PHARMACOL, V117, P540, DOI 10.1111/j.1476-5381.1996.tb15224.x; Lin KD, 1999, BIOTECHNIQUES, V26, P318, DOI 10.2144/99262rr02; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MARCHETTI C, 1995, J NEUROPHYSIOL, V73, P1169, DOI 10.1152/jn.1995.73.3.1169; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zucchi R, 1997, PHARMACOL REV, V49, P1	30	299	307	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					93	98		10.1038/47507	http://dx.doi.org/10.1038/47507			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638760				2022-12-28	WOS:000084687400050
J	Huffman, PR; Brome, CR; Butterworth, JS; Coakley, KJ; Dewey, MS; Dzhosyuk, SN; Golub, R; Greene, GL; Habicht, K; Lamoreaux, SK; Mattoni, CEH; McKinsey, DN; Wietfeldt, FE; Doyle, JM				Huffman, PR; Brome, CR; Butterworth, JS; Coakley, KJ; Dewey, MS; Dzhosyuk, SN; Golub, R; Greene, GL; Habicht, K; Lamoreaux, SK; Mattoni, CEH; McKinsey, DN; Wietfeldt, FE; Doyle, JM			Magnetic trapping of neutrons	NATURE			English	Article							ULTRACOLD NEUTRONS; COLD NEUTRONS; SUPERFLUID-HELIUM; ATOMIC-HYDROGEN; LIFETIME; STORAGE; HE-4; UCN	Accurate measurement of the lifetime of the neutron (which is unstable to beta decay) is important for understanding the weak nuclear force(1) and the creation of matter during the Big Bang(2). Previous measurements of the neutron lifetime have mainly been limited by certain systematic errors(3); however, these could in principle be avoided by performing measurements on neutrons stored in a magnetic tray. Neutral-particle and charged-particle traps are widely used for studying both composite and elementary particles, because they allow long interaction times and isolation of particles from perturbing environments(4). Here,ve report the magnetic trapping of neutrons. The trapping region is filled with superfluid He-4, which is used to load neutrons into the trap and as a scintillator to detect their decay. Neutrons in the trap have a lifetime of 750(-200)(+330) seconds, mainly limited by their beta decay rather than trap losses. Our experiment verifies theoretical predictions regarding the loading process and magnetic trapping of neutrons. Further refinement of this method should lead to improved precision in the neutron lifetime measurement.	Harvard Univ, Cambridge, MA 02138 USA; Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Natl Inst Stand & Technol, Boulder, CO 80303 USA; Hahn Meitner Inst Kernforsch Berlin GmbH, D-14109 Berlin, Germany; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Harvard University; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); United States Department of Energy (DOE); Los Alamos National Laboratory	Huffman, PR (corresponding author), Harvard Univ, 17 Oxford St, Cambridge, MA 02138 USA.		Habicht, Klaus/K-3636-2013	Habicht, Klaus/0000-0002-9915-7221; Huffman, Paul/0000-0002-2562-1378				ABOV YG, 1983, SOV J NUCL PHYS+, V38, P70; Adams JS, 1998, J LOW TEMP PHYS, V113, P1121, DOI 10.1023/A:1022589325136; Butterworth JS, 1998, REV SCI INSTRUM, V69, P3998, DOI 10.1063/1.1149211; Byrne J, 1996, EUROPHYS LETT, V33, P187, DOI 10.1209/epl/i1996-00319-x; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x; CHU S, 1992, LASER MANIPULATION A, P239; DOYLE JM, 1994, EUROPHYS LETT, V26, P253, DOI 10.1209/0295-5075/26/4/003; DOYLE JM, 1995, PHYS REV A, V52, pR2515, DOI 10.1103/PhysRevA.52.R2515; Dubbers D., 1991, NUCL PHYS A, V527, P239; Golub R, 1996, REV MOD PHYS, V68, P329, DOI 10.1103/RevModPhys.68.329; GOLUB R, 1977, PHYS LETT A, V62, P337, DOI 10.1016/0375-9601(77)90434-0; GOLUB R, 1983, Z PHYS B CON MAT, V51, P187, DOI 10.1007/BF01307673; GOLUB R, 1994, PHYS REP, V237, P1, DOI 10.1016/0370-1573(94)90084-1; Golub R., 1991, ULTRACOLD NEUTRONS; Habicht K., 1998, THESIS TU BERLIN; HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169; HENDRY PC, 1987, CRYOGENICS, V27, P131, DOI 10.1016/0011-2275(87)90069-5; HESS HF, 1987, PHYS REV LETT, V59, P672, DOI 10.1103/PhysRevLett.59.672; KILVINGTON AI, 1987, PHYS LETT A, V125, P416, DOI 10.1016/0375-9601(87)90174-5; Lopez RE, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.103502; MAMPE W, 1989, PHYS REV LETT, V63, P593, DOI 10.1103/PhysRevLett.63.593; McKinsey DN, 1999, PHYS REV A, V59, P200, DOI 10.1103/PhysRevA.59.200; McKinsey DN, 1997, NUCL INSTRUM METH B, V132, P351, DOI 10.1016/S0168-583X(97)00409-6; Nesvizhevskii V. V., 1992, Soviet Physics - JETP, V75, P405; NIEHUES N, 1983, UNTERSUCHUNGEN EINER; PAUL W, 1989, Z PHYS C PART FIELDS, V45, P25, DOI 10.1007/BF01556667; Phillips W. D., 1992, LASER MANIPULATION A, P289; VANROIJEN R, 1988, PHYS REV LETT, V61, P931, DOI 10.1103/PhysRevLett.61.931; VLADIMIRSKII VV, 1961, SOV PHYS JETP-USSR, V12, P740; YOSHIKI H, 1992, PHYS REV LETT, V68, P1323, DOI 10.1103/PhysRevLett.68.1323	30	92	92	1	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					62	64		10.1038/47444	http://dx.doi.org/10.1038/47444			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638750	Green Submitted			2022-12-28	WOS:000084687400040
J	Kirby, SH				Kirby, SH			Earth science - Taking the temperature of slabs	NATURE			English	Editorial Material							FAULTS; ZONE		US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Kirby, SH (corresponding author), US Geol Survey, 345 Middlefield Rd,MS 977, Menlo Pk, CA 94025 USA.	skirby@isdmnl.wr.usgs.gov		Kirby, Stephen/0000-0001-8324-0971				Hyndman RD, 1997, ISL ARC, V6, P244, DOI 10.1111/j.1440-1738.1997.tb00175.x; Kirby S. H., 1996, GEOPHYS MONOGR SER, V96, P195, DOI DOI 10.1029/GM096P0195; Moore DE, 1997, J GEOPHYS RES-SOL EA, V102, P14787, DOI 10.1029/97JB00995; MOORE DE, 1997, T AGU FALL 1997 M EO, V78, pF732; Peacock SM, 1999, SCIENCE, V286, P937, DOI 10.1126/science.286.5441.937; Peacock SM, 1999, GEOPHYS RES LETT, V26, P2517, DOI 10.1029/1999GL900558; REINEN LA, 1994, PURE APPL GEOPHYS, V143, P317, DOI 10.1007/BF00874334; RUFF LJ, 1996, AM GEOPHYS UNION GEO, V96, P105; TICHELAAR BW, 1993, J GEOPHYS RES-SOL EA, V98, P2017, DOI 10.1029/92JB02045; WANG KL, 1995, TECTONOPHYSICS, V248, P53, DOI 10.1016/0040-1951(95)00028-L; ZHI Z, 1992, J GEOPHYS RES-SOL EA, V97, P537, DOI 10.1029/91JB02345	11	14	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					31	+		10.1038/47382	http://dx.doi.org/10.1038/47382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638737				2022-12-28	WOS:000084687400026
J	Zheng, JQ				Zheng, JQ			Turning of nerve growth cones induced by localized increases in intracellular calcium ions	NATURE			English	Article							SPINAL NEURONS; GUIDANCE; RESPONSES	Guidance of developing axons involves turning of the motile tip, the growth cone, in response to a variety of extracellular cues(1,2) Little is known about the intracellular mechanism by which the directional signal is transduced, Ca2+ is a key second messenger in growth cone extension(3,4) and has been implicated in growth-cone turning(5,6). Here I report that a direct, spatially restricted elevation of intracellular Ca2+ concentration ([Ca2+](i)) on one side of the growth cone by focal laser-induced photolysis (FLIP) of caged Ca2+ consistently induced turning of the growth cone to the side with elevated [Ca2+](i) (attraction). Furthermore, when the resting [Ca2+](i) at the growth cone was decreased by the removal of extracellular Ca2+, the same focal elevation of [Ca2+](i) by FLIP induced repulsion. These results provide direct evidence that a localized Ca2+ signal in the growth cone can provide the intracellular directional cue for extension and is sufficient to initiate both attraction and repulsion. By integrating local and global Ca2+ signals, a growth cone could thus generate different turning responses under different environmental conditions during guidance.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zheng, JQ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.							AHMED Z, 1988, CELL CALCIUM, V9, P57, DOI 10.1016/0143-4160(88)90025-5; BASHAW GJ, 1999, NEURON, V97, P917; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cb.04.110188.000355; CONNOR JA, 1984, CELL MOL NEUROBIOL, V4, P53, DOI 10.1007/BF00710942; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HONG K, 1999, NEURON, V97, P427; Ishihara A, 1997, BIOTECHNIQUES, V23, P268, DOI 10.2144/97232st01; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; KATER SB, 1991, J NEUROSCI, V11, P891; LANKFORD KL, 1991, CELL MOTIL CYTOSKEL, V20, P7, DOI 10.1002/cm.970200103; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 1997, J NEUROSCI, V17, P7860; SNOW DM, 1994, DEV BIOL, V166, P87, DOI 10.1006/dbio.1994.1298; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TABTI N, 1990, CULTURING NERVE CELL, P137; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TSIEN RY, 1988, TRENDS NEUROSCI, V11, P419, DOI 10.1016/0166-2236(88)90192-0; Wang Q, 1998, J NEUROSCI, V18, P4973; Zheng B, 1996, J CLIN IMMUNOL, V16, P1, DOI 10.1007/BF01540967; Zheng JQ, 1996, PERSPECT DEV NEUROBI, V4, P205; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	28	227	233	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					89	93		10.1038/47501	http://dx.doi.org/10.1038/47501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638759				2022-12-28	WOS:000084687400049
J	Henderson, SW				Henderson, SW			The unnatural nature of pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Illinois, Coll Med, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Henderson, SW (corresponding author), Univ Illinois, Coll Med, Chicago, IL 60680 USA.							BATES MS, 1993, PAIN, V52, P101, DOI 10.1016/0304-3959(93)90120-E; DANTE, DIVINE COMEDY, V1; France CR, 1999, PAIN, V81, P77, DOI 10.1016/S0304-3959(98)00272-3; HOOPER E, 1999, RIVER JOURNEY SOURCE, P151; MERSKEY H, 1980, PAIN, V9, P3, DOI 10.1016/0304-3959(80)90024-X; MILTON J, PARADISE LOST; Scarry Elaine, 1985, BODY PAIN MAKING UNM, P4; Shakespeare William, HAMLET; Sheiner EK, 1999, PAIN, V81, P299, DOI 10.1016/S0304-3959(99)00019-6	9	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					117	117		10.1001/jama.283.1.117	http://dx.doi.org/10.1001/jama.283.1.117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632294	hybrid			2022-12-28	WOS:000084514400039
J	Berger, A				Berger, A			How does herd immunity work?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		BEGG NT, 1997, TOPLEY WILSONS MICRO, V3; 1999, CDR WEEKLY, V9, P227	2	8	8	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 4	1999	319	7223					1466	1467						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263MV	10644148				2022-12-28	WOS:000084129200019
J	Nosanchuk, JD; Shoham, S; Fries, BC; Shapiro, DS; Levitz, SM; Casadevall, A				Nosanchuk, JD; Shoham, S; Fries, BC; Shapiro, DS; Levitz, SM; Casadevall, A			Evidence of zoonotic transmission Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient	ANNALS OF INTERNAL MEDICINE			English	Article							SEROTYPE-D; PIGEON EXCRETA; CR-NEOFORMANS; FECAL MATTER; BIRDS KEPT; DROPPINGS	Background: Although cryptococcosis has been associated with birds for almost 50 years, point sources for infection have not been identified. Objective: To document zoonotic transmission of Cryptococcus neoformans. Design: Case report. Setting: A:home in Boston, Massachusetts. Patient: A:72-year-old woman who received a diagnosis of cryptococcal meningitis in November 1998, The patient, who had been taking immunosuppressant drugs since undergoing renal transplantation in 1989, owned a pet cockatoo: Measurements: Cryptococcus neoformans was isolated from the feces of the cockatoo. Isolates from excreta and from the patient were compared by using biochemical profiles, monoclonal antibody binding patterns, restriction fragment length polymorphism analysis, and karyotyping. Results: The isolates from the patient and the cockatoo had identical biochemical profiles, the same monoclonal antibody immunofluorescence patterns, and indistinguishable patterns on restriction fragment length polymorphism analysis and karyotyping. Conclusions: The indistinguishable patient and cockatoo isolates strongly suggest that the patient's infection resulted from exposure to aerosolized cockatoo excreta. Although the incidence of cryptococcal infection due to such exposure is unknown, it may be prudent to advise immunocompromised patients to avoid pet birds and avian excreta.	Albert Einstein Coll Med, Bronx, NY 10461 USA; Boston Univ, Sch Med, Boston, MA 02118 USA	Yeshiva University; Albert Einstein College of Medicine; Boston University	Casadevall, A (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	casadeva@aecom.yu.edu	Nosanchuk, Joshua/AAS-7801-2021					ABOUGABAL M, 1978, SABOURAUDIA, V16, P63; CASADEVALL A, 1998, CYPTOCOCCUS NEOFORMA; CHEN FY, 1995, J CLIN MICROBIOL, V33, P2818, DOI 10.1128/JCM.33.11.2818-2822.1995; Cleare W, 1998, CLIN DIAGN LAB IMMUN, V5, P125, DOI 10.1128/CDLI.5.2.125-129.1998; CRISEO G, 1995, ZBL BAKT-INT J MED M, V282, P244, DOI 10.1016/S0934-8840(11)80124-6; CURRIE BP, 1994, J CLIN MICROBIOL, V32, P1188, DOI 10.1128/JCM.32.5.1188-1192.1994; Dromer F, 1996, CLIN INFECT DIS, V23, P91, DOI 10.1093/clinids/23.1.91; FENWICK B, 1985, J AM VET MED ASSOC, V187, P1218; Franzot SP, 1997, J CLIN MICROBIOL, V35, P2243, DOI 10.1128/JCM.35.9.2243-2251.1997; GarciaHermoso D, 1997, J CLIN MICROBIOL, V35, P2683, DOI 10.1128/JCM.35.10.2683-2685.1997; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; LITTMAN ML, 1968, MYCOPATH MYCOL APPL, V35, P329, DOI 10.1007/BF02050749; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; POWELL KE, 1972, J INFECT DIS, V125, P412, DOI 10.1093/infdis/125.4.412; SPITZER ED, 1992, J CLIN MICROBIOL, V30, P1094, DOI 10.1128/JCM.30.5.1094-1097.1992; STAIB F, 1984, ZBL BAKT MIK HYG B, V179, P179; STAIB F, 1985, ZBL BAKT MIK HYG B, V180, P567; WEBER A, 1991, BERL MUNCH TIERARZTL, V104, P419; YAMAMOTO Y, 1995, J CLIN MICROBIOL, V33, P3328, DOI 10.1128/JCM.33.12.3328-3332.1995	20	101	102	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					205	208		10.7326/0003-4819-132-3-200002010-00006	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651601				2022-12-28	WOS:000084903000005
J	Bedford, H; Elliman, D				Bedford, H; Elliman, D			Concerns about immunisation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CELL PERTUSSIS-VACCINE; ADVERSE EVENTS; MEASLES; OUTBREAK; 2-COMPONENT; ASTHMA; MUMPS; TRIAL		Univ London St Georges Hosp, Dept Child Hlth, London SW17 0QT, England; Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England	St Georges University London; University of London; University College London	Elliman, D (corresponding author), Univ London St Georges Hosp, Dept Child Hlth, London SW17 0QT, England.	DavidElliman@compuserve.com	Elliman, David/AAK-4595-2020					[Anonymous], 1951, Br Med J, V1, P1463; BEGG N, 1994, BRIT MED J, V309, P1073, DOI 10.1136/bmj.309.6961.1073; Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; *COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P37; *COMM DIS SURV CTR, 1994, COMMUN DIS REP CDR W, V4, P37; DESERRES G, 1995, EPIDEMIOL INFECT, V115, P315, DOI 10.1017/S0950268800058441; ENGLISH JM, 1987, BR HOMEOPATH J, V76, P61; ETKIND P, 1992, AM J DIS CHILD, V146, P173, DOI 10.1001/archpedi.1992.02160140039017; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Fisher P., 1990, BRIT HOME J, V79, P198; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; GAUBLOMME K, 1999, INT VACCINATION NEWS; GILBERG C, 1998, INT J RES PRACT, V2, P423; GILL E, 1998, IMMUNISATION RES SUM; HAHNEMANN S, 1982, ORGANON MED; HMSO, 1996, IMM INF DIS; Hutchins S, 1996, PEDIATR INFECT DIS J, V15, P31, DOI 10.1097/00006454-199601000-00007; KULENKAMPFF M, 1974, ARCH DIS CHILD, V49, P46, DOI 10.1136/adc.49.1.46; MCTAGGART L, 1998, VACCINATION BIBLE; MELLINGER AK, 1995, PEDIATR INFECT DIS J, V14, P573, DOI 10.1097/00006454-199507000-00004; MILLER CL, 1985, BRIT MED J, V290, P443, DOI 10.1136/bmj.290.6466.443; Nilsson L, 1996, JAMA-J AM MED ASSOC, V275, P760, DOI 10.1001/jama.275.10.760; ODENT MR, 1994, JAMA-J AM MED ASSOC, V272, P592, DOI 10.1001/jama.1994.03520080034035; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; OOSTVOGEL PM, 1994, LANCET, V344, P665, DOI 10.1016/S0140-6736(94)92091-5; Peltola H, 1998, LANCET, V351, P1327, DOI 10.1016/S0140-6736(98)24018-9; PLOTKIN SA, 1999, VACCINES; Ramsay M, 1994, Commun Dis Rep CDR Rev, V4, pR141; Schlegel M, 1999, BRIT MED J, V319, P352, DOI 10.1136/bmj.319.7206.352; SHEIBNER V, 1993, VACCINATION 100 YEAR; Simondon F, 1997, VACCINE, V15, P1606, DOI 10.1016/S0264-410X(97)00100-X; SIMPSON N, 1995, BRIT MED J, V310, P227; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; TAYLOR M, 1999, INFORMED PARENT; Wakefield AJ, 1998, LANCET, V351, P1356, DOI 10.1016/S0140-6736(05)79083-8	35	66	67	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2000	320	7229					240	243		10.1136/bmj.320.7229.240	http://dx.doi.org/10.1136/bmj.320.7229.240			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642238	Green Published			2022-12-28	WOS:000085029600036
J	Hampton, JR				Hampton, JR			Personal paper - Clinical trial safety committees: the devil's spoon	BRITISH MEDICAL JOURNAL			English	Article									Queens Med Ctr, Div Cardiovasc Med, Nottingham NG7 2UH, England	University of Nottingham	Hampton, JR (corresponding author), Queens Med Ctr, Div Cardiovasc Med, Nottingham NG7 2UH, England.								0	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					244	245		10.1136/bmj.320.7229.244	http://dx.doi.org/10.1136/bmj.320.7229.244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642241	Green Published			2022-12-28	WOS:000085029600037
J	Josefson, D				Josefson, D			Pain relief in US emergency rooms is related to patients' race	BRITISH MEDICAL JOURNAL			English	News Item																		Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0	1	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					139	139						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634728				2022-12-28	WOS:000084860300017
J	Wells, KB; Sherbourne, C; Schoenbaum, M; Duan, N; Meredith, L; Unutzer, J; Miranda, J; Carney, MF; Rubenstein, LV				Wells, KB; Sherbourne, C; Schoenbaum, M; Duan, N; Meredith, L; Unutzer, J; Miranda, J; Carney, MF; Rubenstein, LV			Impact of disseminating quality improvement programs for depression in managed primary care - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR DEPRESSION; MAPROTILINE; OUTPATIENTS; PAROXETINE; OUTCOMES	Context Care of patients with depression in managed primary care settings often fails to meet guideline standards, but the long-term impact of quality improvement (QI) programs for depression care in such settings is unknown. Objective To determine if QI programs in managed care practices for depressed primary care patients improve quality of care, health outcomes, and employment. Design Randomized controlled trial initiated from June 1996 to March 1997. Setting Forty-six primary care clinics in 6 US managed care organizations. Participants Of 27 332 consecutively screened patients, 1356 with current depressive symptoms and either 12-month, lifetime, or no depressive disorder were enrolled. Interventions Matched clinics were randomized to usual care (mailing of practice guidelines) or to 1 of 2 QI programs that involved institutional commitment to QI, training local experts and nurse specialists to provide clinician and patient education, identification of a pool of potentially depressed patients, and either nurses for medication follow-up or access to trained psychotherapists. Main Outcome Measures Process of care (use of antidepressant medication, mental health specialty counseling visits, medical visits for mental health problems, any medical visits), health outcomes (probable depression and health-related quality of life [HRQOL]), and employment at baseline and at 6- and 12-month follow-up. Results Patients in QI (n = 913) and control (n = 443) clinics did not differ significantly at baseline in service use, HRQOL, or employment after nonresponse weighting. At 6 months, 50.9% of QI patients and 39.7% of controls had counseling or used antidepressant medication at an appropriate dosage (P<.001), with a similar pattern at 12 months (59.2% vs 50.1%; P = .006). There were no differences in probability of having any medical visit at any point teach P greater than or equal to.21). At 6 months, 47.5% of QI patients and 36.6% of controls had a medical visit for mental health problems (P = .001), and QI patients were more likely to see a mental health specialist at 6 months (39.8% vs 27.2%; P<.001) and at 12 months (29.1% vs 22.7%; P = .03). At 6 months, 39.9% of QI patients and 49.9% of controls still met criteria for probable depressive disorder (P = .001), with a similar pattern at 12 months (41.6% vs 51.2%; P = .005). Initially employed QI patients were more likely to be working at 12 months relative to controls (P = .05). Conclusions When these managed primary care practices implemented QI programs that improve opportunities for depression treatment without mandating it, quality of care, mental health outcomes, and retention of employment of depressed patients improved over a year, while medical visits did not increase overall.	RAND Corp, Hlth Program, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA; Georgetown Univ, Med Ctr, Dept Psychiat, Washington, DC 20007 USA; VA Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Georgetown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Wells, KB (corresponding author), RAND Corp, Hlth Program, 1700 Main St, Santa Monica, CA 90407 USA.	kwells@ucla.edu	Unutzer, Jurgen/N-4048-2018; Schoenbaum, Michael/GRR-3988-2022	Duan, Naihua/0000-0001-9411-2924	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH054623, K05MH001170] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS08349] Funding Source: Medline; NIMH NIH HHS [MH01170-05, P50 MH54623] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1996, GLOBAL BURDEN DIS CO; ANTONUCCIO DO, 1995, PROF PSYCHOL-RES PR, V26, P574, DOI 10.1037/0735-7028.26.6.574; ATTIKSON CC, 1990, DEPRESSION PRIMARY C; Beck AT, 1987, COGNITIVE THERAPY DE; BROWN JB, 1995, JOINT COMM J QUAL IM, V21, P5, DOI 10.1016/S1070-3241(16)30123-7; *DEPR GID PAN, 1993, US PHS AG HLTH CAR P; *DEPR GUID PAN, 1993, US PHS AG HLTH CAR P; EVANS MD, 1992, ARCH GEN PSYCHIAT, V49, P802; HAMBLETON R, 1985, ITEM RESP THEORY PRI; *HAY GROUP, 1998, HLTH CAR PLAN DES CO; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Keller MB, 1998, JAMA-J AM MED ASSOC, V280, P1665, DOI 10.1001/jama.280.19.1665; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Lin EHB, 1997, MED CARE, V35, P831, DOI 10.1097/00005650-199708000-00008; Malt UF, 1999, BRIT MED J, V318, P1180; Miller, 1980, SIMULTANEOUS STAT IN; MINTZ J, 1992, ARCH GEN PSYCHIAT, V49, P761; MIRANDA J, 1994, PSYCHOSOM MED, V56, P136, DOI 10.1097/00006842-199403000-00009; Mittman B S, 1992, QRB Qual Rev Bull, V18, P413; Murray DM, 1998, DESIGN ANAL GROUP RA; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapaport MH, 1998, J AFFECT DISORDERS, V48, P227, DOI 10.1016/S0165-0327(97)00196-1; RUBENSTEIN LR, 1996, PARTNERS CARE GUIDEL; Rubenstein LV, 1999, HEALTH AFFAIR, V18, P89, DOI 10.1377/hlthaff.18.5.89; RUBENSTEIN LV, 1995, J GEN INTERN MED, V10, P607, DOI 10.1007/BF02602744; RUBENSTIEN LV, 1996, CLINICIAN GUIDE DEPR; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; SMITH JP, 1995, J CAN STUD, V30, P58, DOI 10.3138/jcs.30.2.58; STURM R, 1995, JAMA-J AM MED ASSOC, V273, P51; Szegedi A, 1997, J AFFECT DISORDERS, V45, P167, DOI 10.1016/S0165-0327(97)00072-4; Szegedi A, 1997, PHARMACOPSYCHIATRY, V30, P97, DOI 10.1055/s-2007-979490; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WARE J, 1995, SF12 SCORE SF12 PHYS; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS K, 1996, CARING DEPRESSION; WELLS KB, 1994, AM J PSYCHIAT, V151, P694; Wells KB, 1999, SOC PSYCH PSYCH EPID, V34, P20, DOI 10.1007/s001270050107; Wells KB, 1999, AM J PSYCHIAT, V156, P5, DOI 10.1176/ajp.156.1.5; Wells KB, 1999, ARCH FAM MED, V8, P529, DOI 10.1001/archfami.8.6.529; *WHO, 1995, COMP INT DIAGN INT C	45	829	830	0	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					212	220		10.1001/jama.283.2.212	http://dx.doi.org/10.1001/jama.283.2.212			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272QA	10634337	Bronze			2022-12-28	WOS:000084661400027
J	Fuchs, E; Segre, JA				Fuchs, E; Segre, JA			Stem cells: A new lease on life	CELL			English	Review							MOUSE INTESTINAL EPITHELIUM; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; IN-VITRO; BONE-MARROW; NEURAL CREST; MICE LACKING; PROGENITOR CELLS; GENE-EXPRESSION; TRANSGENIC MICE		Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago	Fuchs, E (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, Chicago, IL 60637 USA.	liptack@midway.uchicago.edu	Fuchs, Elaine/G-1565-2016					Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BEAULIEU JF, 1992, J CELL SCI, V102, P427; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bradley A, 1990, CURR OPIN CELL BIOL, V2, P1013, DOI 10.1016/0955-0674(90)90150-D; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Burt R K, 1998, Curr Opin Hematol, V5, P472, DOI 10.1097/00062752-199811000-00020; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COULSON RL, 1989, J MED PHILOS, V14, P109, DOI 10.1093/jmp/14.2.109; Dani C, 1997, J CELL SCI, V110, P1279; DASGUPTA R, 1999, IN PRESS DEVELOPMENT; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DOPINTO O, 1998, EMBO J, V19, P5744; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Firulli AB, 1997, TRENDS GENET, V13, P364, DOI 10.1016/S0168-9525(97)01171-2; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; GREEN H, 1991, Scientific American, V265, P96; Gumbiner BM, 1997, CURR BIOL, V7, pR443, DOI 10.1016/S0960-9822(06)00214-4; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Hidaka M, 1999, P NATL ACAD SCI USA, V96, P7370, DOI 10.1073/pnas.96.13.7370; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lahav R, 1998, P NATL ACAD SCI USA, V95, P14214, DOI 10.1073/pnas.95.24.14214; Lasky LA, 1996, CURR BIOL, V6, P1238, DOI 10.1016/S0960-9822(02)70705-7; LAVKER RM, 1991, ANN NY ACAD SCI, V642, P214; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Miller JB, 1999, CURR TOP DEV BIOL, V43, P191; Moles JP, 1997, J HISTOCHEM CYTOCHEM, V45, P867, DOI 10.1177/002215549704500611; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V15, P331; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Orkin SH, 1998, INT J DEV BIOL, V42, P927; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porter FD, 1997, DEVELOPMENT, V124, P2935; POTTEN CS, 1979, BIOCHIM BIOPHYS ACTA, V560, P281, DOI 10.1016/0304-419X(79)90022-2; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Weiss S, 1996, J NEUROSCI, V16, P7599; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; White PM, 1999, DEVELOPMENT, V126, P4351; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; YANG JS, 1993, J INVEST DERMATOL, V101, P652, DOI 10.1111/1523-1747.ep12371671; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	96	574	637	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					143	155		10.1016/S0092-8674(00)81691-8	http://dx.doi.org/10.1016/S0092-8674(00)81691-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647939	Bronze			2022-12-28	WOS:000084722600013
J	Scott, MP				Scott, MP			Development: The natural history of genes	CELL			English	Review							SEA-URCHIN EMBRYOS; CAENORHABDITIS-ELEGANS; EVOLUTIONARY CONSERVATION; SEQUENCE COMPLEXITY; SIGNALING PATHWAY; LIMB DEVELOPMENT; LIFE-SPAN; DROSOPHILA; YEAST; TRANSCRIPTION		Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Scott, MP (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; BEERMANN W, 1952, CHROMOSOMA, V5, P139; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Brand S., 1995, BUILDINGS LEARN WHAT; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Cedar H, 1999, CURR OPIN IMMUNOL, V11, P64, DOI 10.1016/S0952-7915(99)80012-0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan YM, 1999, CURR OPIN NEUROBIOL, V9, P582, DOI 10.1016/S0959-4388(99)00017-3; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; Darwin C., 1871, P475; Defossez PA, 1998, CURR OPIN MICROBIOL, V1, P707, DOI 10.1016/S1369-5274(98)80119-7; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Emmons SW, 1999, NATURE, V401, P339, DOI 10.1038/43810; Evans SM, 1999, SEMIN CELL DEV BIOL, V10, P73, DOI 10.1006/scdb.1999.0282; Firulli AB, 1997, TRENDS GENET, V13, P364, DOI 10.1016/S0168-9525(97)01171-2; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GALAU GA, 1974, CELL, V2, P9, DOI 10.1016/0092-8674(74)90003-8; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Goerke Heinz, 1973, LINNAEUS; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Greene E. L., 1909, Proceedings of the Washington Academy of Sciences, V11, P17; Guarente L, 1998, P NATL ACAD SCI USA, V95, P11034, DOI 10.1073/pnas.95.19.11034; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Hake S, 1998, CURR OPIN PLANT BIOL, V1, P9, DOI 10.1016/S1369-5266(98)80120-9; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hawkins N, 1998, GENE DEV, V12, P3625, DOI 10.1101/gad.12.23.3625; Hendrix R. W., 1983, LAMBDA 2, VII; Hodes RJ, 1999, J EXP MED, V190, P153, DOI 10.1084/jem.190.2.153; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Horder T. J., 1985, HIST EMBRYOLOGY; Horvitz HR, 1999, CANCER RES, V59, p1701S; HOUGH BR, 1975, CELL, V5, P291, DOI 10.1016/0092-8674(75)90104-X; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jacobs RE, 1999, TRENDS CELL BIOL, V9, P73, DOI 10.1016/S0962-8924(98)01435-4; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; KAYNE PS, 1995, CURR OPIN GENET DEV, V5, P38, DOI 10.1016/S0959-437X(95)90051-9; Kenyon C, 1996, CELL, V84, P501, DOI 10.1016/S0092-8674(00)81024-7; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levitan D, 1998, DEVELOPMENT, V125, P3599; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Linnaeus C., 1735, SYSTEMA NATURAE; LOUMAYE E, 1982, SCIENCE, V218, P1323, DOI 10.1126/science.6293058; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meister M, 1997, BIOESSAYS, V19, P1019, DOI 10.1002/bies.950191112; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Needham J., 1942, BIOCH MORPHOGENESIS; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OPPENHEIMER J, 1967, ESSAYS HIST EMBRYOLO; PERLASAMY A, 1999, METHOD CELL BIOL, V58, P293; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Pourquie O, 1998, CURR OPIN NEUROBIOL, V8, P665, DOI 10.1016/S0959-4388(98)80097-4; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; SANDER K, 1985, P363; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Teixeira SMR, 1998, BRAZ J MED BIOL RES, V31, P1503, DOI 10.1590/S0100-879X1998001200001; Tissenbaum HA, 1998, GENETICS, V148, P703; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Wakayama T, 1999, SEMIN CELL DEV BIOL, V10, P253, DOI 10.1006/scdb.1998.0267; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	87	44	45	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					27	40		10.1016/S0092-8674(00)81681-5	http://dx.doi.org/10.1016/S0092-8674(00)81681-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647929	Bronze			2022-12-28	WOS:000084722600003
J	Lee, TH; Cleeman, JI; Grundy, SM; Gillett, C; Pasternak, RC; Seidman, J; Sennett, C				Lee, TH; Cleeman, JI; Grundy, SM; Gillett, C; Pasternak, RC; Seidman, J; Sennett, C			Clinical coals and performance measures for cholesterol management in secondary prevention of coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERUM-CHOLESTEROL; LOWERING THERAPY; EVENTS; RISK; PRAVASTATIN; REDUCTION; PROGRAM; TRIAL; DEATH	Guidelines from the National Cholesterol Education Program (NCEP) recommend reduction of low-density lipoprotein cholesterol (LDL-C) to 100 mg/dL (2.59 mmol/l)or less in patients with established coronary heart disease (CHD), However, the National Committee for Quality Assurance (NCQA) is implementing a new performance measure as part of the Health Plan Employer and Data Information Set (HEDIS) that appears to endorse a different target. The new HEDIS measure will require managed care organizations seeking NCQA accreditation to measure and report the percentage of patients who have had major CHD events who achieve LDL-C levels less than 130 mg/dL (3.36 mmol/L) between 60 and 365 days after discharge. These different LDL-C thresholds emphasize the difference between a clinical goal for the management of individual patients (less than or equal to 100 mg/dL) and a performance measure used to evaluate the care of a population of patients (<130 mg/dL), This article discusses the rationale for each threshold and explains the use of 2 different thresholds for these 2 purposes. Both the NCQA and NCEP expect that the new HEDIS measure will encourage managed care organizations to develop systems that improve secondary prevention of CHD.	Partners Community HealthCare Inc, Boston, MA 02199 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; NHLBI, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Grp Hlth Cooperat Puget Sound, Clin Planning & Improvement, Seattle, WA 98121 USA; Natl Comm Qual Assurance, Washington, DC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Group Health Cooperative	Lee, TH (corresponding author), Partners Community HealthCare Inc, Prudential Tower,Suite 1150,800 Boylston St, Boston, MA 02199 USA.	thlee@partners.org						BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; BUCHWALD H, 1990, NEW ENGL J MED, V323, P946, DOI 10.1056/NEJM199010043231404; Campeau L, 1997, NEW ENGL J MED, V336, P153; Grundy SM, 1998, CIRCULATION, V97, P1436; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; McBride P, 1998, ARCH INTERN MED, V158, P1238, DOI 10.1001/archinte.158.11.1238; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1998, CIRCULATION, V97, P1446; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SMITH SC, 1995, CIRCULATION, V92, P2; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	16	36	37	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					94	98		10.1001/jama.283.1.94	http://dx.doi.org/10.1001/jama.283.1.94			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632286				2022-12-28	WOS:000084514400031
J	Johnson, AP; Livermore, DM				Johnson, AP; Livermore, DM			Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal	LANCET			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; VANCOMYCIN; BACTERIA		Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England	Public Health England	Johnson, AP (corresponding author), Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England.		Johnson, Alan P/F-4420-2014					Leclercq R, 1998, LANCET, V352, P591, DOI 10.1016/S0140-6736(05)79570-2; Low DE, 1997, J ANTIMICROB CHEMOTH, V39, P53, DOI 10.1093/jac/39.suppl_1.53; Moellering RC, 1999, J ANTIMICROB CHEMOTH, V44, P25, DOI 10.1093/jac/44.suppl_1.25; Moellering RC, 1999, J ANTIMICROB CHEMOTH, V44, P251, DOI 10.1093/jac/44.2.251; NADLER H, 1999, CLIN MICROBIOL NEWSL, V13, P103; Nichols RL, 1999, J ANTIMICROB CHEMOTH, V44, P19, DOI 10.1093/jac/44.suppl_1.19; Nichols RL, 1999, J ANTIMICROB CHEMOTH, V44, P263, DOI 10.1093/jac/44.2.263; Ploy MC, 1998, LANCET, V351, P1212, DOI 10.1016/S0140-6736(05)79166-2; Rubinstein E, 1999, J ANTIMICROB CHEMOTH, V44, P37, DOI 10.1093/jac/44.suppl_1.37; Tenover FC, 1998, J CLIN MICROBIOL, V36, P1020, DOI 10.1128/JCM.36.4.1020-1027.1998; Thal LA, 1999, J ANTIMICROB CHEMOTH, V43, P171, DOI 10.1093/jac/43.2.171; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725	12	28	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	1999	354	9195					2012	2013		10.1016/S0140-6736(99)00344-X	http://dx.doi.org/10.1016/S0140-6736(99)00344-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636359				2022-12-28	WOS:000084183300002
J	Houry, WA; Frishman, D; Eckerskorn, C; Lottspeich, F; Hartl, FU				Houry, WA; Frishman, D; Eckerskorn, C; Lottspeich, F; Hartl, FU			Identification of in vivo substrates of the chaperonin GroEL	NATURE			English	Article							COLI RNA-POLYMERASE; HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; POLYPEPTIDE BINDING; ATP HYDROLYSIS; GENE-PRODUCTS; IN-VIVO; SEQUENCE; DOMAIN	The chaperonin GroEL has an essential role in mediating protein folding in the cytosol of Escherichia coli. Here we show that GroEL interacts strongly with a well-defined set of approximately 300 newly translated polypeptides, including essential components of the transcription/translation machinery and metabolic enzymes. About one third of these proteins are structurally unstable and repeatedly return to GroEL for conformational maintenance. GroEL substrates consist preferentially of two or more domains with ap-folds, which contain a-helices and buried P-sheets with extensive hydrophobic surfaces. These proteins are expected to fold slowly and be prone to aggregation. The hydrophobic binding regions of GroEL may be well adapted to interact with the non-native states of ap-domain proteins.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Max Planck Inst Biochem, GSF Forschungszentrum Umwelt & Gesundheit, Munich Informat Ctr Prot Sequences, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany; Toplab GmbH, Proteom Div, D-82152 Martinsried, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hartl, F. Ulrich/Y-8206-2019; Frishman, Dmitrij/AAT-7815-2020					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 1998, NUCLEIC ACIDS RES, V26, P38, DOI 10.1093/nar/26.1.38; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Coyle JE, 1997, FOLD DES, V2, pR93, DOI 10.1016/S1359-0278(97)00046-1; EISENBERG D, 1986, J CELL BIOCHEM, V31, P11, DOI 10.1002/jcb.240310103; Ellis RJ, 1997, CURR BIOL, V7, pR531, DOI 10.1016/S0960-9822(06)00273-9; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; ELLIS RJ, 1994, CURR OPIN STRUC BIOL, V4, P117, DOI 10.1016/S0959-440X(94)90069-8; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fountoulakis M, 1997, ANAL BIOCHEM, V250, P153, DOI 10.1006/abio.1997.2213; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; GENTRY DR, 1986, GENE, V48, P33, DOI 10.1016/0378-1119(86)90349-5; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Hubbard TJP, 1999, NUCLEIC ACIDS RES, V27, P254, DOI 10.1093/nar/27.1.254; Huynen M, 1998, J MOL BIOL, V280, P323, DOI 10.1006/jmbi.1998.1884; Karp PD, 1998, NUCLEIC ACIDS RES, V26, P50, DOI 10.1093/nar/26.1.50; LABEDAN B, 1995, MOL BIOL EVOL, V12, P980; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; Meyer S.L., 1975, DATA ANAL SCI ENG; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orengo CA, 1999, NUCLEIC ACIDS RES, V27, P275, DOI 10.1093/nar/27.1.275; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Smith KE, 1998, J BIOL CHEM, V273, P28677, DOI 10.1074/jbc.273.44.28677; VANBOGELEN RA, 1992, ELECTROPHORESIS, V13, P1014, DOI 10.1002/elps.11501301203; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; VITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716; WADA M, 1987, J BACTERIOL, V169, P1102, DOI 10.1128/jb.169.3.1102-1106.1987; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xu D, 1998, FOLD DES, V3, P11, DOI 10.1016/S1359-0278(98)00004-2; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425	48	416	443	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					147	154		10.1038/45977	http://dx.doi.org/10.1038/45977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647006				2022-12-28	WOS:000083716400039
J	Reiner, DJ; Newton, EM; Tian, H; Thomas, JH				Reiner, DJ; Newton, EM; Tian, H; Thomas, JH			Diverse behavioural defects caused by mutations in Caenorhabditis elegans unc-43 CaM kinase II	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; C-ELEGANS; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; NERVOUS-SYSTEM; MUTANT MICE; CALMODULIN; DROSOPHILA; MICROSCOPY; FREQUENCY	Calcium/calmodulin-dependent serine/threonine kinase type II (CaMKII) is one of the most abundant proteins in the mammalian brain, where it is thought to regulate synaptic plasticity and other processes(1-3). Activation of the multisubunit kinase(4) by calcium is effectively cooperative and can persist long after transient calcium rises(1,5,6). Despite extensive biochemical characterization of CaMKII and identification of numerous in vitro kinase targets(1), little is known about its function in vivo. Here we report that unc-43 encodes the only Caenorhabditis elegans CaMKII. A gain-of-function unc-43 mutation reduces locomotory activity, alters excitation of three muscle types and lengthens the period of the motor output of a behavioural clock. Null unc-43 mutations cause phenotypes generally opposite to those of the gain-of-function mutation. Mutations in the unc-103 potassium channel gene suppress a gain-of-function phenotype of unc-43 in one tissue without affecting other tissues; thus, UNC-103 may be a tissue-specific target of CaMKII in vivo.	Univ Washington, Dept Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Thomas, JH (corresponding author), Univ Washington, Dept Genet, Box 357360, Seattle, WA 98195 USA.	jht@genetics.washington.edu		Reiner, David/0000-0002-0344-7161	NIGMS NIH HHS [R01 GM085309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085309] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BROCKE L, 1995, J NEUROSCI, V15, P6797; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; GRIFFITH LC, 1993, J NEUROCHEM, V61, P1534, DOI 10.1111/j.1471-4159.1993.tb13650.x; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; GUTAROY B, 1996, J NEUROCHEM, V66, P1282; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; LIU DWC, 1994, J NEUROSCI, V14, P1953; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Miller DM, 1995, METHOD CELL BIOL, V48, P365; PARK EC, 1986, GENETICS, V113, P821; REINER DJ, 1986, GENETICS, V113, P821; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHULMAN H, 1993, NEUROCHEM RES, V18, P65, DOI 10.1007/BF00966924; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; THOMAS JH, 1990, GENETICS, V124, P855; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	31	103	115	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	1999	402	6758					199	203		10.1038/46072	http://dx.doi.org/10.1038/46072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647014				2022-12-28	WOS:000083716400055
J	Li, LM; Lindquist, S				Li, LM; Lindquist, S			Creating a protein-based element of inheritance	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PRION-LIKE FACTOR; SUP35 GENE; GLUCOCORTICOID RECEPTOR; PSI; PROPAGATION; DETERMINANT; TRANSLATION; TERMINATION; URE3	Proteins capable of self-perpetuating changes in conformation and function (known as prions) can serve as genetic elements. To test whether novel prions could be created by recombinant methods, a yeast prion determinant was fused to the rat glucocorticoid receptor. The fusion protein existed in different heritable functional states, switched between states at a Low spontaneous rate, and could be induced to switch by experimental manipulations. The complete change in phenotype achieved by transferring a prion determinant from one protein to another confirms the protein-only nature of prion inheritance and establishes a mechanism for engineering heritable changes in phenotype that should be broadly applicable.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Lindquist, S (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 5841 S Maryland Ave MC 1028, Chicago, IL 60637 USA.							CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 1996, GENETICS, V144, P1375; GAMETCHU B, 1984, ENDOCRINOLOGY, V114, P274, DOI 10.1210/endo-114-1-274; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; KUSHNIROV VV, 1988, GENE, V66, P45, DOI 10.1016/0378-1119(88)90223-5; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Liu J., UNPUB; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; PATINO M, UNPUB; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; TUITE MF, 1981, GENETICS, V98, P691; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	23	146	151	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					661	664		10.1126/science.287.5453.661	http://dx.doi.org/10.1126/science.287.5453.661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10650001				2022-12-28	WOS:000084989400050
J	Dyer, C				Dyer, C			Pinochet's opponents call for medical evidence to be made public	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					204	204		10.1136/bmj.320.7229.204	http://dx.doi.org/10.1136/bmj.320.7229.204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642211	Green Published			2022-12-28	WOS:000085029600008
J	Majeed, A; Lehmann, P; Kirby, L; Knight, R; Coleman, M				Majeed, A; Lehmann, P; Kirby, L; Knight, R; Coleman, M			Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records	BRITISH MEDICAL JOURNAL			English	Article							PRION DISEASE; VARIANT; WALES	Objective To investigate the extent to which deaths from Creutzfeldt-Jakob,disease were misclassified during 1979-96. Design Structured review of clinical records based on predetermined criteria to determine whether death could have been due to sporadic or variant Creutzfeldt-Jakob disease. Setting 100 health authorities and 275 NHS trusts in England. Subjects 1485 people who died aged 15-44 years from selected neurological disorders in England during 1979-96. Main outcome measure Cause of death. Results The clinical records of 705 (48%) subjects were successfully traced. Tracing of clinical records was highest in subjects who died during 1990-6. There was sufficient information in the records of 640 (91%) of the 705 subjects to exclude Creutzfeldt-Jakob disease as a cause of death. In 61 (9%) subjects, there was insufficient information to reach any conclusion about the validity of the cause of death recorded on the death certificate. The clinical records of four subjects were examined further by the National Creutzfeldt-Jakob Disease Surveillance Unit; none was thought to have died from Creutzfeldt-Jakob disease. Conclusions No new cases of sporadic or variant Creutzfeldt-Jakob disease were detected in a sample of deaths most likely to have included misclassified cases. This suggests that the surveillance system is unlikely to have missed a significant number of cases among people aged 15-44 years. Hence, any rapid increase in the number of cases of variant Creutzfeldt-Jakob disease in this age group is likely to be real not artefactual.	Off Natl Stat, London SW1V 2QQ, England; Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Majeed, A (corresponding author), Off Natl Stat, London SW1V 2QQ, England.		Greiver, Michelle/N-8764-2015; Coleman, Michel/AAA-9543-2020	Greiver, Michelle/0000-0001-8957-0285; Coleman, Michel/0000-0001-8940-3807; Majeed, Azeem/0000-0002-2357-9858				AYLIN P, 1996, POPUL TRENDS, V85, P34; Baker HF, 1996, BRAIN RES BULL, V40, P237, DOI 10.1016/0361-9230(96)00162-1; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 1996, LANCET, V347, P916, DOI 10.1016/S0140-6736(96)91407-5; Cousens SN, 1997, BRIT MED J, V315, P389, DOI 10.1136/bmj.315.7105.389; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; Kirby L., 1998, POPULATION TRENDS, V92, P23; Majeed A, 1998, BRIT MED J, V317, P320, DOI 10.1136/bmj.317.7154.320; SOUTHWOOD R, 1989, REPORT WORKING PARTY; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; WILL RG, 1984, J NEUROL NEUROSUR PS, V47, P134, DOI 10.1136/jnnp.47.2.134; Will RG, 1999, LANCET, V353, P979, DOI 10.1016/S0140-6736(99)01160-5	12	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					145	147		10.1136/bmj.320.7228.145	http://dx.doi.org/10.1136/bmj.320.7228.145			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634732	Green Published, Green Submitted			2022-12-28	WOS:000084860300022
J	Ahmed, S; Hodgkin, J				Ahmed, S; Hodgkin, J			MRT-2 checkpoint protein is required for germline immortality and telomere replication in C-elegans	NATURE			English	Article							SCHIZOSACCHAROMYCES-POMBE RAD1(+); DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; ATAXIA-TELANGIECTASIA; YEAST TELOMERE; FISSION YEAST; MAINTENANCE; HOMOLOG; LENGTH	The germ line is an immortal cell lineage that is passed indefinitely from one generation to the next. To identify the genes that are required for germline immortality, we isolated Caenorhabditis elegans mutants with mortal germ lines-worms that can reproduce for several healthy generations but eventually become sterile. One of these mortal germline (mrt) mutants, mrt-2, exhibits progressive telomere shortening and accumulates end-to-end chromosome fusions in later generations, indicating that the MRT-2 protein is required for telomere replication. In addition, the germ line of mrt-2 is hypersensitive to X-rays and to transposon activity. Therefore, mrt-2 has defects in responding both to damaged DNA and to normal double-strand breaks present at telomeres. mrt-2 encodes a homologue of a checkpoint gene that is required to sense DMA damage in yeast. These results indicate that telomeres may be identified as a type of DNA damage and then repaired by the telomere-replication enzyme telomerase.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ahmed, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bluyssen HAR, 1998, GENOMICS, V54, P331, DOI 10.1006/geno.1998.5582; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Dahlen M, 1998, MOL BIOL CELL, V9, P611, DOI 10.1091/mbc.9.3.611; Dean FB, 1998, GENOMICS, V54, P424, DOI 10.1006/geno.1998.5587; di Fagagna FD, 1999, NAT GENET, V23, P76; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FANG GW, 1995, J CELL BIOL, V130, P243, DOI 10.1083/jcb.130.2.243; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HENDERSON E, 1995, TELOMERES, P35; HERMAN RK, 1982, GENETICS, V102, P379; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1979, GENETICS, V91, P67; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Marathi UK, 1998, GENOMICS, V54, P344, DOI 10.1006/geno.1998.5589; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Matsuura A, 1999, GENETICS, V152, P1501; McClintock B, 1941, GENETICS, V26, P234; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; PLASTERK RHA, 1997, TRANSPORSONS C ELEGA, V2, P97; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Sprung CN, 1997, MUTAT RES-FUND MOL M, V379, P177, DOI 10.1016/S0027-5107(97)00119-X; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; Sulston J., 1988, NEMATODE CAENORHABDI, P587; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; WEINERT TA, 1993, GENETICS, V134, P63; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wicky C, 1996, P NATL ACAD SCI USA, V93, P8983, DOI 10.1073/pnas.93.17.8983; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7	50	211	215	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					159	164		10.1038/35003120	http://dx.doi.org/10.1038/35003120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646593				2022-12-28	WOS:000084835300044
J	Jones, TF; Craig, AS; Hoy, D; Gunter, EW; Ashley, DL; Barr, DB; Brock, JW; Schaffner, W				Jones, TF; Craig, AS; Hoy, D; Gunter, EW; Ashley, DL; Barr, DB; Brock, JW; Schaffner, W			Mass psychogenic illness attributed to toxic exposure at a high school	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	37th Annual Meeting of the Infectious-Diseases-Society-of-America	NOV 18-21, 1999	PHILADELPHIA, PENNSYLVANIA	Infect Dis Soc Amer			EPIDEMIC HYSTERIA; ELEMENTARY-SCHOOL	Background: Mass psychogenic illness may be difficult to differentiate from illness caused by bioterrorism, rapidly spreading infection, or toxic substances. We investigated symptoms attributed to exposure to toxic gas at a high school in Tennessee. Methods: In November 1998, a teacher noticed a "gasoline-like'' smell in her classroom, and soon thereafter she had a headache, nausea, shortness of breath, and dizziness. The school was evacuated, and 80 students and 19 staff members went to the emergency room at the local hospital; 38 persons were hospitalized overnight. Five days later, after the school had reopened, another 71 persons went to the emergency room. An extensive investigation was performed by several government agencies. Results: We were unable to find a medical or environmental explanation for the reported illnesses. The persons who reported symptoms on the first day came from 36 classrooms scattered throughout the school. The most frequent symptoms (in this group and the group of people who reported symptoms five days later) were headache, dizziness, nausea, and drowsiness. Blood and urine specimens showed no evidence of carbon monoxide, volatile organic compounds, pesticides, polychlorinated biphenyls, paraquat, or mercury. There was no evidence of toxic compounds in the environment. A questionnaire administered a month later showed that the reported symptoms were significantly associated with female sex, seeing another ill person, knowing that a classmate was ill, and reporting an unusual odor at the school. Conclusions: This illness, attributed to toxic exposure, had features of mass psychogenic illness - notably, widespread subjective symptoms thought to be associated with environmental exposure to a toxic substance in the absence of objective evidence of an environmental cause. (N Engl J Med 2000;342:96-100.) (C) 2000, Massachusetts Medical Society.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Environm Hlth Labs, Natl Ctr Environm Hlth, Atlanta, GA USA; Tennessee Dept Hlth, CEDS, Nashville, TN 37247 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; Tennessee Dept Hlth, Cookeville, TN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Tennessee Department Health; Vanderbilt University; Tennessee Department Health	Jones, TF (corresponding author), Tennessee Dept Hlth, CEDS, 4th Fl,Cordell Hull Bldg,425 5th Ave N, Nashville, TN 37247 USA.		Barr, Dana B/E-6369-2011; Barr, Dana B/E-2276-2013					ALEXANDER RW, 1986, J OCCUP ENVIRON MED, V28, P42, DOI 10.1097/00043764-198601000-00011; ARAKI S, 1986, ARCH ENVIRON HEALTH, V41, P159, DOI 10.1080/00039896.1986.9935771; Boss LP, 1997, EPIDEMIOL REV, V19, P233, DOI 10.1093/oxfordjournals.epirev.a017955; CARTTER ML, 1989, AM J DIS CHILD, V143, P269, DOI 10.1001/archpedi.1989.02150150019001; *CTR ENV RES INF, 1999, COMP METH DET TOX OR; DAVID AS, 1995, J PSYCHOSOM RES, V39, P1, DOI 10.1016/0022-3999(94)00085-J; Dean A.G., 1994, EPI INFO VERSION 6 W; DICKER RC, 1996, FIELD EPIDEMIOLOGY, P92; HEFEZ A, 1985, AM J PSYCHIAT, V142, P833; LANDRIGAN PJ, 1983, LANCET, V2, P1474; Nitzkin J L, 1976, J Fla Med Assoc, V63, P357; *OFF SOL WAST EM R, 1986, SW846 EPA OFF SOL WA; PHILEN RM, 1989, LANCET, V2, P1372; ROBINSON P, 1984, ARCH INTERN MED, V144, P1959, DOI 10.1001/archinte.144.10.1959; SANDY, 1991, MED DETECTIVES, P317; SELDEN BS, 1989, ANN EMERG MED, V18, P892, DOI 10.1016/S0196-0644(89)80221-5; Small G W, 1994, Arch Fam Med, V3, P711, DOI 10.1001/archfami.3.8.711; WASON S, 1983, LANCET, V2, P731	18	94	100	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					96	100		10.1056/NEJM200001133420206	http://dx.doi.org/10.1056/NEJM200001133420206			5	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631279				2022-12-28	WOS:000084723900006
J	Ledwell, JR; Montgomery, ET; Polzin, KL; St Laurent, LC; Schmitt, RW; Toole, JM				Ledwell, JR; Montgomery, ET; Polzin, KL; St Laurent, LC; Schmitt, RW; Toole, JM			Evidence for enhanced mixing over rough topography in the abyssal ocean	NATURE			English	Article							DISSIPATION; TRACER	The overturning circulation of the ocean plays an important role in modulating the Earth's climate. But whereas the mechanisms for the vertical transport of water into the deep ocean-deep water formation at high latitudes-and horizontal transport in ocean currents have been largely identified, it is not dear how the compensating vertical transport of water from the depths to the surface is accomplished. Turbulent mixing across surfaces of constant density is the only viable mechanism for reducing the density of the water and enabling it to rise. However, measurements of the internal wave field, the main source of energy for mixing, and of turbulent dissipation rates, have typically implied diffusivities across surfaces of equal density of only similar to 0.1 cm(2) s(-1) too small to account for the return flow. Here we report measurements of tracer dispersion and turbulent energy dissipation in the Brazil basin that reveal diffusivities of 2-4 cm(2) s(-1) at a depth of 500 m above abyssal hills on the flank of the Mid-Atlantic Ridge, and approximately 10 cm(2) s(-1) nearer the bottom. This amount of mixing, probably driven by breaking internal waves that are generated by tidal currents flowing over the rough bathymetry, may be large enough to dose the buoyancy budget for the Brazil basin and suggests a mechanism for closing the global overturning circulation.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Ledwell, JR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.		Schmitt, Raymond W/B-7451-2011	Toole, John/0000-0003-2905-0637				BELL TH, 1975, J FLUID MECH, V67, P705, DOI 10.1017/S0022112075000560; BELL TH, 1975, J GEOPHYS RES, V80, P320, DOI 10.1029/JC080i003p00320; EGBERT GD, 1994, J GEOPHYS RES-OCEANS, V99, P24821, DOI 10.1029/94JC01894; GREGG MC, 1989, J GEOPHYS RES, V94, P9689; Hogg N, 1982, J MAR RES, V40, P231; LANGSETH MG, 1976, GEOPHYS RES LETT, V3, P241, DOI 10.1029/GL003i005p00241; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; LEDWELL JR, 1995, J GEOPHYS RES-OCEANS, V100, P20681, DOI 10.1029/95JC02164; MORRIS M, 1997, INT WOCE NEWSLETT, V28, P23; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; POLZIN KL, 1995, J PHYS OCEANOGR, V25, P306, DOI 10.1175/1520-0485(1995)025<0306:FPOTD>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; POLZIN KL, UNPUB J MAR RES; POLZIN KL, 1997, P MICR SENS WORKSH, P109; Schmitt R. W., 1988, Journal of Atmospheric and Oceanic Technology, V5, P484, DOI 10.1175/1520-0426(1988)005<0484:TDOAFA>2.0.CO;2; SMITH WHF, 1994, J GEOPHYS RES-SOL EA, V99, P21803, DOI 10.1029/94JB00988; TOOLE JM, 1994, SCIENCE, V264, P1120, DOI 10.1126/science.264.5162.1120	17	477	488	2	94	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					179	182		10.1038/35003164	http://dx.doi.org/10.1038/35003164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646599				2022-12-28	WOS:000084835300050
J	Schroeder, BC; Waldegger, S; Fehr, S; Bleich, M; Warth, R; Greger, R; Jentsch, TJ				Schroeder, BC; Waldegger, S; Fehr, S; Bleich, M; Warth, R; Greger, R; Jentsch, TJ			A constitutively open potassium channel formed by KCNQ1 and KCNE3	NATURE			English	Article							INHERITED CARDIAC-ARRHYTHMIAS; LONG QT SYNDROME; K+ CONDUCTANCE; CL SECRETION; RABBIT COLON; MUTATIONS; KVLQT1; GENE; CELLS; EPITHELIA	Mutations in all four known KCNQ potassium channel or-subunit genes lead to human diseases(1-6). KCNQ1 (KvLQT1)(1) interacts with the beta-subunit KCNE1 (IsK, minK)(7) to form the slow, depolarization-activated potassium current I-Ks(8,9) that is affected in some forms of cardiac arrhythmia. Here we show that the novel beta-subunit KCNE3 markedly changes KCNQ1 properties to yield currents that are nearly instantaneous and depend linearly on voltage, It also suppresses the currents of KCNQ4 and HERG potassium channels. In the intestine, KCNQ1 and KCNE3 messenger RNAs colocalized in crypt cells. This localization and the pharmacology, voltage-dependence and stimulation by cyclic AMP of KCNQ1/KCNE3 currents indicate that these proteins may assemble to form the potassium channel that is important for cyclic AMP-stimulated intestinal chloride secretion and that is involved in secretory diarrhoea and cystic fibrosis.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 85, D-20246 Hamburg, Germany.	Jentsch@plexus.uke.uni-hamburg.de	Warth, Richard/N-7119-2014; Bleich, Markus/A-2812-2010	Warth, Richard/0000-0001-6084-0659; Bleich, Markus/0000-0002-1745-2295; Jentsch, Thomas/0000-0002-3509-2553				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Busch AE, 1997, BRIT J PHARMACOL, V122, P187, DOI 10.1038/sj.bjp.0701434; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Devor DC, 1997, AM J PHYSIOL-CELL PH, V273, pC531, DOI 10.1152/ajpcell.1997.273.2.C531; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Diener M, 1996, BRIT J PHARMACOL, V118, P1477, DOI 10.1111/j.1476-5381.1996.tb15563.x; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; LOHRMANN E, 1995, PFLUG ARCH EUR J PHY, V429, P517, DOI 10.1007/BF00704157; MacVinish LJ, 1998, J PHYSIOL-LONDON, V510, P237, DOI 10.1111/j.1469-7793.1998.237bz.x; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; OFFNER FF, 1987, HEARING RES, V29, P117, DOI 10.1016/0378-5955(87)90160-2; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Suessbrich H, 1996, FEBS LETT, V396, P271, DOI 10.1016/0014-5793(96)01113-1; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Warth R, 1996, PFLUG ARCH EUR J PHY, V432, P81, DOI 10.1007/s004240050108; Wollnik B, 1997, HUM MOL GENET, V6, P1943, DOI 10.1093/hmg/6.11.1943; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	30	361	379	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					196	199		10.1038/35003200	http://dx.doi.org/10.1038/35003200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646604				2022-12-28	WOS:000084835300055
J	Kim, SK				Kim, SK			Biochemistry - Reading the worm genome	SCIENCE			English	Editorial Material									Stanford Univ, Med Ctr, Dept Dev Biol & Genet, Stanford, CA 94305 USA	Stanford University	Kim, SK (corresponding author), Stanford Univ, Med Ctr, Dept Dev Biol & Genet, 279 Campus Ds, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu						[Anonymous], 1997, NATURE, V387, pS; CAMPBELL A, 1913, BACTERIOPHAGE LAMBDA; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; GOFFEAU A, 1998, SCIENCE, V282, P2012; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	6	4	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2000	287	5450					52	53		10.1126/science.287.5450.52	http://dx.doi.org/10.1126/science.287.5450.52			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	271DG	10644223				2022-12-28	WOS:000084578400029
J	Kang, W; Stormer, HL; Pfeiffer, LN; Baldwin, KW; West, KW				Kang, W; Stormer, HL; Pfeiffer, LN; Baldwin, KW; West, KW			Tunnelling between the edges of two lateral quantum Hall systems	NATURE			English	Article							CARBON NANOTUBES; ELECTRON-GAS; BACKSCATTERING; CONDUCTANCE; CURRENTS; REGIME; CHARGE; WIRES	The edge of a two-dimensional electron system in a magnetic field consists of one-dimensional channels that arise from the confining electric field at the edge of the system(1-3). The crossed electric and magnetic fields cause electrons to drift parallel to the sample boundary, creating a chiral current that travels along the edge in only one direction. In an ideal two-dimensional electron system in the quantum Hall regime, all the current flows along the edge(4-6). Quantization of the Hall resistance arises from occupation of N one-dimensional edge channels, each contributing a conductance of e(2)/h (refs 7-11), Here we report differential conductance measurements, in the integer quantum Hall regime, of tunnelling between the edges of a pair of two-dimensional electron systems that are separated by an atomically precise, high-quality, tunnel barrier. The resultant interaction between the edge states leads to the formation of new energy gaps and an intriguing dispersion relation for electrons travelling along the barrier: for example, we see a persistent conductance peak at zero bias voltage and an absence of tunnelling features due to electron spin, These features are unexpected and are not consistent with a model of weakly interacting edge states, Remnant disorder along the barrier and charge screening may each play a role, although detailed numerical studies will be required to elucidate these effects.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys, New York, NY 10027 USA	University of Chicago; University of Chicago; Alcatel-Lucent; Lucent Technologies; AT&T; Columbia University; Columbia University	Kang, W (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.							APENKO SM, 1985, J PHYS C SOLID STATE, V18, P1197, DOI 10.1088/0022-3719/18/6/014; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Chang AM, 1996, PHYS REV LETT, V77, P2538, DOI 10.1103/PhysRevLett.77.2538; FONTEIN PF, 1991, PHYS REV B, V43, P12090, DOI 10.1103/PhysRevB.43.12090; GOLDMAN VJ, 1995, SCIENCE, V267, P1010, DOI 10.1126/science.267.5200.1010; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; HAUG RJ, 1988, PHYS REV LETT, V61, P2797, DOI 10.1103/PhysRevLett.61.2797; HO TL, 1994, PHYS REV B, V50, P4524, DOI 10.1103/PhysRevB.50.4524; Ishiguro T., 1998, ORGANIC SUPERCONDUCT, V2nd; JAIN JK, 1988, PHYS REV B, V37, P4276, DOI 10.1103/PhysRevB.37.4276; MACDONALD AH, 1984, PHYS REV B, V29, P1616, DOI 10.1103/PhysRevB.29.1616; McCormick KL, 1999, PHYS REV B, V59, P4654, DOI 10.1103/PhysRevB.59.4654; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; PFEIFFER L, 1990, APPL PHYS LETT, V56, P1697, DOI 10.1063/1.103121; PRANGE RE, 1980, QUANTUM HALL EFFECT; Sarma Sankar Das, 1997, PERSPECTIVES QUANTUM; STREDA P, 1987, PHYS REV LETT, V59, P1973, DOI 10.1103/PhysRevLett.59.1973; TARUCHA S, 1995, SOLID STATE COMMUN, V94, P413, DOI 10.1016/0038-1098(95)00102-6; Tessmer SH, 1998, NATURE, V392, P51, DOI 10.1038/32112; WASHBURN S, 1988, PHYS REV LETT, V61, P2801, DOI 10.1103/PhysRevLett.61.2801; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; WULF U, 1988, PHYS REV B, V38, P4218, DOI 10.1103/PhysRevB.38.4218; Yacoby A, 1996, PHYS REV LETT, V77, P4612, DOI 10.1103/PhysRevLett.77.4612	23	86	86	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					59	61		10.1038/47436	http://dx.doi.org/10.1038/47436			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638749	Green Submitted			2022-12-28	WOS:000084687400039
J	Strahl, BD; Allis, CD				Strahl, BD; Allis, CD			The language of covalent histone modifications	NATURE			English	Article							MITOTIC CHROMOSOME CONDENSATION; CHROMATIN STRUCTURE; LYSINE RESIDUES; ACETYLATION; H3; PHOSPHORYLATION; NUCLEOSOME; H4; HETEROCHROMATIN; TRANSCRIPTION	Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin. A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented. Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes. We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.	Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Allis, CD (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	allis@virginia.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259				ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; ANNUNZIATO AT, 1993, NUCLEUS, P31; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; CLARK D, 1993, COLD SPRING HARB SYM, V58, P1; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; DeRubertis F, 1996, NATURE, V384, P589; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kimura A, 1998, FEBS LETT, V431, P131, DOI 10.1016/S0014-5793(98)00752-2; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; LOIDL P, 1994, CHROMOSOMA, V103, P441; LOPEZRODAS G, 1993, FEBS LETT, V317, P175, DOI 10.1016/0014-5793(93)81271-Z; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; LUDUENA R F, 1992, Current Opinion in Cell Biology, V4, P53, DOI 10.1016/0955-0674(92)90058-K; Luduena RF, 1998, INT REV CYTOL, V178, P207; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mizzen C, 1998, COLD SPRING HARB SYM, V63, P469, DOI 10.1101/sqb.1998.63.469; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Roberts SM, 1997, GENETICS, V147, P451; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; ROTH SY, 1992, TRENDS BIOCHEM SCI, V17, P93, DOI 10.1016/0968-0004(92)90243-3; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Sternglanz R, 1999, P NATL ACAD SCI USA, V96, P8807, DOI 10.1073/pnas.96.16.8807; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; TORDERA V, 1993, EXPERIENTIA, V49, P780, DOI 10.1007/BF01923548; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; VANHOLDE KE, 1988, CHROMATIN, P111; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	69	6125	6418	10	791	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					41	45		10.1038/47412	http://dx.doi.org/10.1038/47412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638745				2022-12-28	WOS:000084687400035
J	Kelly, M; Bedell, R				Kelly, M; Bedell, R			Assessment of international medical evacuations in Macedonia	LANCET			English	Editorial Material									Med Sans Frontieres, NL-100 EA Amsterdam, Netherlands	Doctors Without Borders	Kelly, M (corresponding author), Med Sans Frontieres, Max Euwepl 40,POB 10014, NL-100 EA Amsterdam, Netherlands.		Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2076	2077		10.1016/S0140-6736(05)76814-8	http://dx.doi.org/10.1016/S0140-6736(05)76814-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636389				2022-12-28	WOS:000084183300049
J	Zollinger, PE; Tuinebreijer, WE; Kreis, RW; Breederveld, RS				Zollinger, PE; Tuinebreijer, WE; Kreis, RW; Breederveld, RS			Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial	LANCET			English	Article							ALPHA-TOCOPHEROL; ASCORBATE; ANTIOXIDANTS; OXIDATION	Background The pathogenesis of reflex sympathetic dystrophy (RSD) is not clear, nor is there a definitive treatment for this syndrome. The morbidity, costs in health care, and loss of work time justify the search for a means to prevent post-traumatic dystrophy. Although the role of toxic oxygen radicals has not yet been clarified, we investigated vitamin C (ascorbic acid) as a prophylactic antioxidant drug. Methods 123 adults with 127 conservatively treated wrist fractures were randomly allocated in a double-blind trial to take a capsule of 500 mg vitamin C or placebo daily for 50 days. Each participant's sex, age, side of fracture, dominance, fracture type, dislocation, reduction, and complaints with the plaster cast were recorded, and they were clinically scored for RSD. The follow-up lasted 1 year. Findings Eight patients were withdrawn after randomisation. 52 patients with 54 fractures (male 22%, female 78%; mean age 57 years) received vitamin C and 63 patients with 65 fractures (male 20%, female 80%; mean age 60 years) received placebo. RSD occurred in four (7%) wrists in the vitamin C group and 14 (22%) in the placebo group 15% (95% CI for differences 2-26). Other significant prognostic variables for the occurrence of RSD were complaints while wearing the cast (relative risk 0.17 [0.07-0.41]) and fracture type (0.37 [0.16-0.89]). Interpretation This prospective, double-blind study shows that vitamin C was associated with a lower risk of RSD after wrist fractures. Our hypothesis is that this beneficial effect of prophylaxis would be useful in other forms of trauma.	Leyenburg Hosp, Dept Orthopaed, NL-2504 LN The Hague, Netherlands; Red Cross Hosp, Dept Surg, Beverwijk, Netherlands; Free Univ Amsterdam Hosp, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Zollinger, PE (corresponding author), Buizerdstr 50, NL-2665 TG Bleiswijk, Netherlands.							ATKINS RM, 1990, J BONE JOINT SURG BR, V72, P105, DOI 10.1302/0301-620X.72B1.2298766; ATKINS RM, 1989, J HAND SURG-BRIT EUR, V14B, P161, DOI 10.1016/0266-7681(89)90118-6; BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775; BIELSKI BHJ, 1975, ANN NY ACAD SCI, V258, P231, DOI 10.1111/j.1749-6632.1975.tb29283.x; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Ciccone DS, 1997, PAIN, V71, P323, DOI 10.1016/S0304-3959(97)00009-2; FIELD J, 1994, J BONE JOINT SURG BR, V76B, P901, DOI 10.1302/0301-620X.76B6.7983115; Goris R J, 1987, Free Radic Res Commun, V3, P13, DOI 10.3109/10715768709069764; MATSUDA T, 1992, BURNS, V18, P127, DOI 10.1016/0305-4179(92)90009-J; Matsuda Takayoshi, 1993, Journal of Burn Care and Rehabilitation, V14, P624, DOI 10.1097/00004630-199311000-00007; Matsuda Takayoshi, 1992, Journal of Burn Care and Rehabilitation, V13, P560, DOI 10.1097/00004630-199209000-00009; Mitchell SW., 1864, GUNSHOT WOUNDS OTHER; Muller MENS., 1990, COMPREHENSIVE CLASSI, V1st ed; NIKI E, 1984, J BIOL CHEM, V259, P4177; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; OYEN WJG, 1993, PAIN, V55, P151, DOI 10.1016/0304-3959(93)90144-E; RENIER JC, 1994, SEM HOP PARIS, V70, P1049; SIES H, 1992, ANN NY ACAD SCI, V669, P7, DOI 10.1111/j.1749-6632.1992.tb17085.x; SUDECK P, 1900, ARCH KLIN CHIR, V62, P147; Tanaka Hideharu, 1992, Journal of Burn Care and Rehabilitation, V13, P567, DOI 10.1097/00004630-199209000-00010; TILMAN P B J, 1990, Micron and Microscopica Acta, V21, P271, DOI 10.1016/0739-6260(90)90143-4; URBAN T, 1995, ANN CHIR, V49, P427; van der Laan L, 1998, NEUROLOGY, V51, P20, DOI 10.1212/WNL.51.1.20; vanderLaan L, 1997, FREE RADICAL RES, V26, P363, DOI 10.3109/10715769709097816; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Ziegler TR, 1997, NUTRITION, V13, pS64, DOI 10.1016/S0899-9007(97)00208-6; Zuurmond WWA, 1996, ACTA ANAESTH SCAND, V40, P364, DOI 10.1111/j.1399-6576.1996.tb04446.x	28	183	189	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	1999	354	9195					2025	2028		10.1016/S0140-6736(99)03059-7	http://dx.doi.org/10.1016/S0140-6736(99)03059-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636366				2022-12-28	WOS:000084183300009
J	Bruce, MC; Donnelly, CA; Alpers, MP; Galinski, MR; Barnwell, JW; Walliker, D; Day, KP				Bruce, MC; Donnelly, CA; Alpers, MP; Galinski, MR; Barnwell, JW; Walliker, D; Day, KP			Cross-species interactions between malaria parasites in humans	SCIENCE			English	Article							PAPUA-NEW-GUINEA; PLASMODIUM-FALCIPARUM; DENSITY-DEPENDENCE; IMMUNITY; VIVAX; RESISTANCE; DYNAMICS; CHILDREN; MADANG; TESTS	The dynamics of multiple Plasmodium infections in asymptomatic children Living under intense malaria transmission pressure provide evidence for a density-dependent regulation that transcends species as well as genotype. This regulation, in combination with species- and genotype-specific immune responses, results in nonindependent, sequential episodes of infection with each species.	Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England; Papua New Guinea Inst Med Res, Madang, Papua N Guinea; Emory Univ, Sch Med, Emory Vaccine Ctr Yerkes, Dept Med,Div Infect Dis, Atlanta, GA 30329 USA; Ctr Dis Control & Prevent, Biol & Diagnost Branch, Div Parasit Dis, Atlanta, GA 30341 USA; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JN, Midlothian, Scotland	University of Oxford; PNG Institute Of Medical Research; Emory University; Centers for Disease Control & Prevention - USA; University of Edinburgh	Bruce, MC (corresponding author), Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England.		Day, Karen/F-3697-2015	Day, Karen/0000-0002-6115-6135; Donnelly, Christl/0000-0002-0195-2463	NIAID NIH HHS [AI24710, AI37545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI137545, R22AI024710, U01AI037545, R01AI024710] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABIKER H, 1994, T ROY SOC TROP MED H, V88, P328, DOI 10.1016/0035-9203(94)90103-1; BABIKER HA, 1991, T ROY SOC TROP MED H, V85, P578, DOI 10.1016/0035-9203(91)90349-4; Boyd M. F., 1937, American Journal of Tropical Medicine, V17, P855; BOYD MARK F., 1938, AMER JOUR TROP MED, V18, P521; BROWN KN, 1990, IMMUNOL LETT, V25, P97, DOI 10.1016/0165-2478(90)90098-B; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; BRUCE M, IN PRESS PARASITOLOG; Bruce MC, 1999, AM J TROP MED HYG, V61, P518, DOI 10.4269/ajtmh.1999.61.518; BULMER MG, 1975, BIOMETRICS, V31, P901, DOI 10.2307/2529815; BURKOT TR, 1987, B WORLD HEALTH ORGAN, V65, P375; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Ciuca M., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V27, P619, DOI 10.1016/S0035-9203(34)90111-5; COHEN JE, 1973, Q REV BIOL, V48, P467, DOI 10.1086/407705; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Farnert A, 1997, AM J TROP MED HYG, V56, P538, DOI 10.4269/ajtmh.1997.56.538; FOX DR, 1995, OECOLOGIA, V103, P435, DOI 10.1007/BF00328681; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; GUNEWARDENA DM, 1994, MEM I O CRUZ, V89, P61; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Karunaweera ND, 1998, AM J TROP MED HYG, V58, P204, DOI 10.4269/ajtmh.1998.58.204; KWIATKOWSKI D, 1995, PARASITOL TODAY, V11, P206, DOI 10.1016/0169-4758(95)80079-4; KYES S, 1993, EXP PARASITOL, V77, P473, DOI 10.1006/expr.1993.1108; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; MOLINEAUX L, 1980, AM J TROP MED HYG, V29, P725, DOI 10.4269/ajtmh.1980.29.725; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; RITCHIE TL, 1988, PARASITOLOGY, V96, P607; Staalsoe T, 1998, PARASITOL TODAY, V14, P177, DOI 10.1016/S0169-4758(98)01228-9; TALIAFERRO WH, 1939, MELARIOLOGY; WOLDA H, 1993, OECOLOGIA, V95, P581, DOI 10.1007/BF00317444	31	180	183	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					845	848		10.1126/science.287.5454.845	http://dx.doi.org/10.1126/science.287.5454.845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657296				2022-12-28	WOS:000085136400043
J	Yangco, BG; Von Bargen, JC; Moorman, AC; Holmberg, SD				Yangco, BG; Von Bargen, JC; Moorman, AC; Holmberg, SD		HIV Outpatient Study Investigators	Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection	ANNALS OF INTERNAL MEDICINE			English	Article								Background: HIV-infected patients with sustained immunologic improvement from antiretroviral therapy may be able to discontinue chemoprophylaxis against Pneumocystis carinii pneumonia (PCP). Objective: To compare PCP incidence in HIV-infected patients who had sustained CD4(+) lymphocyte counts greater than 200 cells/mm(3) and who either discontinued or continued PCP prophylaxis. Design: Nonrandomized prospective cohort study. Setting::10 HIV clinics in eight U.S, cities. Patients: 146 patients had follow-up visits for a mean of 18.2 months after discontinuation of PCP prophylaxis, and 345 patients who continued PCP prophylaxis had follow-up visits for a mean of 14.0 months. Measurements: Incidence of PCP. Results: Patients who discontinued PCP prophylaxis had higher maximum and minimum CD4(+) cell counts and lower vira I loads than patients who continued PCP prophylaxis. Pneumocystis carinii pneumonia did not develop in either group (upper 95% exact binomial confidence limit of incidence for those who discontinued PCP prophylaxis, 2.3/100 person-yea rs). Conclusions: Discontinuation of PCP chemoprophylaxis may be appropriate for some HIV-infected ambulatory patients.	Infect Dis Res Inst, Tampa, FL USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Yangco, BG (corresponding author), 4728 N Habana Ave,Suite 303, Tampa, FL 33614 USA.			Moorman, Anne/0000-0003-2411-2798	PHS HHS [U64/CCU5096889] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; GARCIAVAZQUEZ E, 1998, 38 INT C ANT AG CHEM; LOPEZ JC, 1999, 6 C RETR OPP INF 31; MARADONA JA, 1998, 38 INT C ANT AG CHEM; Moorman AC, 1998, J ACQ IMMUN DEF SYND, V19, P182, DOI 10.1097/00042560-199810010-00013; Moorman AC, 1999, ANN EPIDEMIOL, V9, P349, DOI 10.1016/S1047-2797(99)00005-8; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; RAVAUX I, 1998, 38 INT C ANT AG CHEM; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; Von Bargen J, 1998, JAMA-J AM MED ASSOC, V280, P29, DOI 10.1001/jama.280.1.29; 1999, MMWR MORB MORTAL WKL, V48, P4	11	37	38	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					201	205		10.7326/0003-4819-132-3-200002010-00005	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651600				2022-12-28	WOS:000084903000004
J	Cole, JE; Dunbar, RB; McClanahan, TR; Muthiga, NA				Cole, JE; Dunbar, RB; McClanahan, TR; Muthiga, NA			Tropical Pacific forcing of decadal SST variability in the western Indian Ocean over the past two centuries	SCIENCE			English	Article							SOUTH ASIAN MONSOON; INTERDECADAL VARIABILITY; NORTHERN-HEMISPHERE; CORAL RECORD; OSCILLATION; CLIMATE; RAINFALL; ENSO; PREDICTION; SIGNAL	A 194-year annual record of skeletal delta(18)O from a coral growing at Malindi, Kenya, preserves a history of sea surface temperature (SST) change that is coherent with instrumental and proxy records of tropical Pacific climate variability over interannual to decadal periods. This variability is superimposed on a warming of as much as 1.3 degrees C since the early 1800s. These results suggest that the tropical Pacific imparts substantial decadal climate variability to the western Indian Ocean and, by implication, may force decadal variability in other regions with strong El Nino-Southern Oscillation teleconnections.	Univ Colorado, Dept Geol Sci, Inst Arctic & Alpine Res, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA; Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; Wildlife Conservat Soc, Coral Reef Conservat Project, Mombasa, Kenya; Kenya Wildlife Serv, Mombasa, Kenya	University of Colorado System; University of Colorado Boulder; Stanford University	Cole, JE (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.		McClanahan, Tim/K-4998-2019; Cole, Julia/ABA-5759-2020	Cole, Julia/0000-0002-3389-7809; McClanahan, Timothy/0000-0001-5821-3584; Dunbar, Robert/0000-0002-9728-5609				Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; CLARK CO, IN PRESS J CLIM; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Crowley TJ, 1997, PALEOCEANOGRAPHY, V12, P633, DOI 10.1029/97PA01348; Davis J.C., 1986, STAT DATA ANAL GEOLO; EBBESMEYER CC, 1991, P 7 ANN PAC CLIM PAC, P120; Elliott WP, 1988, J CLIMATE, V1, P729, DOI 10.1175/1520-0442(1988)001<0729:EFCISO>2.0.CO;2; GAGAN MK, 1995, GEOPHYS RES LETT, V22, P1069, DOI 10.1029/95GL00607; GRAHAM NE, 1994, J CLIMATE, V7, P1416, DOI 10.1175/1520-0442(1994)007<1416:OTROTA>2.0.CO;2; GRAHAM NE, 1995, SCIENCE, V267, P686; HALPERT MS, 1992, J CLIMATE, V5, P577, DOI 10.1175/1520-0442(1992)005<0577:STPAWT>2.0.CO;2; HASTENRATH S, 1993, J GEOPHYS RES-OCEANS, V98, P20219, DOI 10.1029/93JC02330; HASTENRATH S, 1988, CLIMATE CIRCULATION; HULME M, 1992, INT J CLIMATOL, V12, P685, DOI 10.1002/joc.3370120703; HUTCHINSON P, 1992, J CLIMATE, V5, P525, DOI 10.1175/1520-0442(1992)005<0525:TSOAPO>2.0.CO;2; *INT AT EN AG WORL, 1998, GNIP DAT REL 2; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kiladis GN, 1989, J CLIMATE, V2, P1069, DOI 10.1175/1520-0442(1989)002<1069:GCAAWE>2.0.CO;2; LATIF M, 1994, SCIENCE, V266, P634, DOI 10.1126/science.266.5185.634; LEVITUS S, 1994, LEVITUS94 WORLD OCEA; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V209, P103, DOI 10.1016/S0022-0981(96)02663-9; MCCLANAHAN TR, UNPUB; MEEHL GA, 1994, SCIENCE, V266, P263, DOI 10.1126/science.266.5183.263; Meehl GA, 1997, J CLIMATE, V10, P1921, DOI 10.1175/1520-0442(1997)010<1921:TSAMAT>2.0.CO;2; NICHOLSON SE, 1986, ARCH METEOR GEOPHY A, V34, P311, DOI 10.1007/BF02257765; OGALLO LJ, 1987, J CLIMATOL, V7, P1; PARTHASARATHY B, 1992, METEOROL MAG, V121, P174; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; Shukla J., 1987, MONSOONS, P399; TERRAY P, 1995, J CLIMATE, V8, P2595, DOI 10.1175/1520-0442(1995)008<2595:STSOMI>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; TRENBERTH KE, 1987, MON WEATHER REV, V115, P3078, DOI 10.1175/1520-0493(1987)115<3078:OTEOTS>2.0.CO;2; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VERNEKAR AD, 1995, J CLIMATE, V8, P248, DOI 10.1175/1520-0442(1995)008<0248:TEOESC>2.0.CO;2; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; WILKINSON C, 1997 1998 MASS BLEAC; Zhang RH, 1998, NATURE, V391, P879, DOI 10.1038/36081; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	47	193	208	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					617	619		10.1126/science.287.5453.617	http://dx.doi.org/10.1126/science.287.5453.617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649987				2022-12-28	WOS:000084989400036
J	Izurieta, HS; Thompson, WW; Kramarz, P; Shay, DK; Davis, RL; DeStefano, F; Black, S; Shinefield, H; Fukuda, K				Izurieta, HS; Thompson, WW; Kramarz, P; Shay, DK; Davis, RL; DeStefano, F; Black, S; Shinefield, H; Fukuda, K			Influenza and the rates of hospitalization for respiratory disease among infants and young children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; MYCOPLASMA-PNEUMONIAE; SYNCYTIAL VIRUS; EPIDEMICS; VACCINE; IMPACT; PARAINFLUENZA; INFECTION	Background: Young children may be at increased risk for serious complications from influenzavirus infection. However, in population-based studies it has been difficult to separate the effects of influenzavirus from those of respiratory syncytial virus. Respiratory syncytial virus often circulates with influenzaviruses and is the most frequent cause of hospitalization for lower respiratory tract infections in infants and young children. We studied the rates of hospitalization for acute respiratory disease among infants and children during periods when the circulation of influenzaviruses predominated over the circulation of respiratory syncytial virus. Methods: For each season from October to May during the period from 1992 to 1997, we used local viral surveillance data to define periods in Washington State and northern California when the circulation of influenzaviruses predominated over that of respiratory syncytial virus. We calculated the rates of hospitalization for acute respiratory disease, excess rates attributable to influenzavirus, and incidence-rate ratios for all infants and children younger than 18 years of age who were enrolled in either the Kaiser Permanente Medical Care Program of Northern California or the Group Health Cooperative of Puget Sound. Results: The rates of hospitalization for acute respiratory disease among children who did not have conditions that put them at high risk for complications of influenza (e.g., asthma, cardiovascular diseases, or premature birth) and who were younger than two years of age were 231 per 100,000 person-months at Northern California Kaiser sites (from 1993 to 1997) and 193 per 100,000 person-months at Group Health Cooperative sites (from 1992 to 1997). These rates were approximately 12 times as high as the rates among children without high-risk conditions who were 5 to 17 years of age (19 per 100,000 person-months at Northern California Kaiser sites and 16 per 100,000 person-months at Group Health Cooperative sites) and approached the rates among children with chronic health conditions who were 5 to 17 years of age (386 per 100,000 person-months and 216 per 100,000 person-months, respectively). Conclusions: Infants and young children without chronic or serious medical conditions are at increased risk for hospitalization during influenza seasons. Routine influenza vaccination should be considered in these children. (N Engl J Med 2000;342:232-9.) (C)2000, Massachusetts Medical Society.	Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Influenza Branch, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Epidemiol & Surveillance Div, Atlanta, GA 30333 USA; Grp Hlth Cooperat, Seattle, WA USA; No Calif Kaiser Permanente, Oakland, CA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Group Health Cooperative; Kaiser Permanente	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Influenza Branch, Mailstop A 32,1600 Clifton Rd, Atlanta, GA 30333 USA.		Kramarz, Piotr/U-9442-2019	Fukuda, Keiji/0000-0002-9598-9565; Shay, David/0000-0001-9619-4820				*ADV COMM IMM PRAC, 1999, MMWR-MORBID MORTAL W, V4, P1; [Anonymous], 1997, MMWR RECOMM REP, V46, P1; AVILA M, 1990, REV INFECT DIS S, V8, P974; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; CAUL EO, 1976, J HYG-CAMBRIDGE, V77, P383, DOI 10.1017/S0022172400055765; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; COONEY MK, 1975, AM J EPIDEMIOL, V101, P532, DOI 10.1093/oxfordjournals.aje.a112125; *CYT SOFTW, 1995, STATX 3 WIND US MAN; *DEP HLTH HUM SERV, 1980, DHHS PUBL PHS; EICKHOFF TC, 1961, JAMA-J AM MED ASSOC, V176, P776, DOI 10.1001/jama.1961.03040220024005; Fishman PA, 1999, MED CARE, V37, P874, DOI 10.1097/00005650-199909000-00004; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GILCHRIST S, 1994, J INFECT DIS, V170, P986, DOI 10.1093/infdis/170.4.986; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GLEZEN WP, 1990, PEDIATR ANN, V19, P535, DOI 10.3928/0090-4481-19900901-09; GLEZEN WP, 1980, JAMA-J AM MED ASSOC, V243, P1345; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; HALL CB, 1998, TXB PEDIAT INFECT DI, V2, P2084; HAYDEN GF, 1995, PEDIATR INFECT DIS J, V14, P895, DOI 10.1097/00006454-199510000-00015; KILBOURNE ED, 1987, INFLUENZA; KRAMARZ P, 1998, PHARMACOEPIDEMIOL S2, V7, P113; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; MUFSON MA, 1970, AM J EPIDEMIOL, V91, P192, DOI 10.1093/oxfordjournals.aje.a121128; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; NOBLE GR, 1982, BASIC APPL INFLUENZA, P11; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; PETER G, 1997, 1997 RED BOOK REPORT, P307; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; SIMONSEN L, 1996, OPTIONS CONTROL INFL, V3, P26; 1996, MMWR MORB MORTAL WKL, V46, P173; 1995, MMWR MORB MORTAL WKL, V44, P292; 1996, MMWR MORB MORTAL WKL, V45, P326	36	761	806	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					232	239		10.1056/NEJM200001273420402	http://dx.doi.org/10.1056/NEJM200001273420402			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277PB	10648764				2022-12-28	WOS:000084941000002
J	Kikkawa, JM; Awschalom, DD				Kikkawa, JM; Awschalom, DD			All-optical magnetic resonance in semiconductors	SCIENCE			English	Article							HIGH-PURITY GAAS; QUANTUM-WELLS; ELECTRONIC STATES; GALLIUM-ARSENIDE; PUMPED NMR; SPIN	A scheme is proposed wherein nuclear magnetic resonance (NMR) can be induced and monitored using only optical fields. In analogy to radio-frequency fields used in traditional NMR, circularly polarized Light creates electron spins in semiconductors whose hyperfine coupling could tip nuclear moments. Time-resolved Faraday rotation experiments were performed in which the frequency of electron Larmor precession was used as a magnetometer of Local magnetic fields experienced by electrons in n-type gallium arsenide. Electron spin excitation by a periodic optical pulse train appears not only to prepare a hyperpolarized nuclear moment but also to destroy it resonantly at magnetic fields proportional to the pulse frequency. This resonant behavior is in many ways supportive of a simple model of optically induced NMR, but a curious discrepancy between one of the observed frequencies and classic NMR values suggests that this phenomenon is more complex.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	awsch@physics.ucsb.edu						ABRAGAM A, 1955, PHYS REV, V98, P1729, DOI 10.1103/PhysRev.98.1729; BERKOVITS VL, 1978, PHYS REV B, V18, P1767, DOI 10.1103/PhysRevB.18.1767; Cho H, 1998, PHYS REV LETT, V81, P2522, DOI 10.1103/PhysRevLett.81.2522; Crooker SA, 1996, PHYS REV LETT, V77, P2814, DOI 10.1103/PhysRevLett.77.2814; Dixon DC, 1997, PHYS REV B, V56, P4743, DOI 10.1103/PhysRevB.56.4743; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; FEHER G, 1959, PHYS REV, V114, P1219, DOI 10.1103/PhysRev.114.1219; KALEVICH VK, 1982, JETP LETT+, V35, P20; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kikkawa JM, 1997, SCIENCE, V277, P1284, DOI 10.1126/science.277.5330.1284; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Kronmuller S, 1999, PHYS REV LETT, V82, P4070, DOI 10.1103/PhysRevLett.82.4070; Kronmuller S, 1998, PHYS REV LETT, V81, P2526, DOI 10.1103/PhysRevLett.81.2526; Kuzma NN, 1998, SCIENCE, V281, P686, DOI 10.1126/science.281.5377.686; MAROHN JA, 1995, PHYS REV LETT, V75, P1364, DOI 10.1103/PhysRevLett.75.1364; OVERHAUSER AW, 1953, PHYS REV, V92, P411, DOI 10.1103/PhysRev.92.411; PAGET D, 1977, PHYS REV B, V15, P5780, DOI 10.1103/PhysRevB.15.5780; PAGET D, 1981, PHYS REV B, V24, P3776, DOI 10.1103/PhysRevB.24.3776; PAGET D, 1982, PHYS REV B, V25, P4444, DOI 10.1103/PhysRevB.25.4444; Seck M, 1997, PHYS REV B, V56, P7422, DOI 10.1103/PhysRevB.56.7422; TYCKO R, 1995, SCIENCE, V268, P1460, DOI 10.1126/science.7539550; ZAKHARCHENYA VP, 1974, JETP LETT+, V19, P378; [No title captured]; [No title captured]	24	207	211	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					473	476		10.1126/science.287.5452.473	http://dx.doi.org/10.1126/science.287.5452.473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642546				2022-12-28	WOS:000084929900044
J	Yang, PD; Wirnsberger, G; Huang, HC; Cordero, SR; McGehee, MD; Scott, B; Deng, T; Whitesides, GM; Chmelka, BF; Buratto, SK; Stucky, GD				Yang, PD; Wirnsberger, G; Huang, HC; Cordero, SR; McGehee, MD; Scott, B; Deng, T; Whitesides, GM; Chmelka, BF; Buratto, SK; Stucky, GD			Mirrorless lasing from mesostructured waveguides patterned by soft lithography	SCIENCE			English	Article							MESOPOROUS SILICA; GEL MATERIALS; EMISSION; FILMS; PORES	Mesostructured silica waveguide arrays were fabricated with a combination of acidic set-gel block copolymer templating chemistry and soft Lithography. Waveguiding was enabled by the use of a Low-refractive index (1.15) mesoporous silica thin film support. When the mesostructure was doped with the laser dye rhodamine 6G, amplified spontaneous emission was observed with a Low pumping threshold of 10 kilowatts per square centimeter, attributed to the mesostructure's ability to prevent aggregation of the dye molecules even at relatively high loadings within the organized high-surface area mesochannels of the waveguides. These highly processible, self-assembling mesostructured host media and claddings may have potential for the fabrication of integrated optical circuits.	Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Harvard Univ, Dept Chem, Cambridge, MA 02138 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University	Stucky, GD (corresponding author), Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA.		McGehee, Michael/ABA-8400-2020	McGehee, Michael/0000-0001-9609-9030				Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Dunn B, 1997, CHEM MATER, V9, P2280, DOI 10.1021/cm970270p; Ganschow M, 1999, J PORPHYR PHTHALOCYA, V3, P299, DOI 10.1002/(SICI)1099-1409(199904)3:4<299::AID-JPP134>3.0.CO;2-R; Hide F, 1996, SCIENCE, V273, P1833, DOI 10.1126/science.273.5283.1833; HUO QS, 1994, NATURE, V368, P317, DOI 10.1038/368317a0; HUO QS, 1994, CHEM MATER, V6, P1176, DOI 10.1021/cm00044a016; KNOBBE ET, 1990, APPL OPTICS, V29, P2729, DOI 10.1364/AO.29.002729; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Marlow F, 1999, ADV MATER, V11, P632, DOI 10.1002/(SICI)1521-4095(199906)11:8<632::AID-ADMA632>3.0.CO;2-Q; Marzolin C, 1998, ADV MATER, V10, P571, DOI 10.1002/(SICI)1521-4095(199805)10:8<571::AID-ADMA571>3.0.CO;2-P; McGehee MD, 1998, PHYS REV B, V58, P7035, DOI 10.1103/PhysRevB.58.7035; MCKIERNAN JM, 1990, J PHYS CHEM-US, V94, P5252; Melosh NA, 1999, MACROMOLECULES, V32, P4332, DOI 10.1021/ma9817323; QIAN SX, 1986, SCIENCE, V231, P486, DOI 10.1126/science.231.4737.486; SCHAFER FP, 1973, TOP APPL PHYS, V1, P158; Schueller OJA, 1999, ADV MATER, V11, P37, DOI 10.1002/(SICI)1521-4095(199901)11:1<37::AID-ADMA37>3.0.CO;2-0; Siegmann A. E., 1986, LASERS; Srdanov VI, 1998, J PHYS CHEM B, V102, P3341, DOI 10.1021/jp9729932; Trau M, 1997, NATURE, V390, P674, DOI 10.1038/37764; Vietze U, 1998, PHYS REV LETT, V81, P4628, DOI 10.1103/PhysRevLett.81.4628; WU CG, 1994, SCIENCE, V264, P1757, DOI 10.1126/science.264.5166.1757; Yanagi H, 1998, CHEM PHYS LETT, V292, P332, DOI 10.1016/S0009-2614(98)00675-7; Yang H, 1997, NATURE, V386, P692, DOI 10.1038/386692a0; Yang PD, 1998, CHEM MATER, V10, P2033, DOI 10.1021/cm980201q; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Zhao D, 1998, ADV MATER, V10, P1380, DOI 10.1002/(SICI)1521-4095(199811)10:16<1380::AID-ADMA1380>3.0.CO;2-8; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhao XM, 1997, APPL PHYS LETT, V71, P1017, DOI 10.1063/1.119713	28	486	498	10	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					465	467		10.1126/science.287.5452.465	http://dx.doi.org/10.1126/science.287.5452.465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642543				2022-12-28	WOS:000084929900041
J	Beecham, L				Beecham, L			Government to review generic drugs market	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					191	191						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634757				2022-12-28	WOS:000084860300066
J	Moustakas, AL; Baranger, HU; Balents, L; Sengupta, AM; Simon, SH				Moustakas, AL; Baranger, HU; Balents, L; Sengupta, AM; Simon, SH			Communication through a diffusive medium: Coherence and capacity	SCIENCE			English	Article								Coherent wave propagation in disordered media gives rise to many fascinating phenomena as diverse as universal conductance fluctuations in mesoscopic metals and speckle patterns in light scattering, Here, the theory of electromagnetic wave propagation in diffusive media is combined with information theory to show how interference affects the information transmission rate between antenna arrays. Nontrivial dependencies of the information capacity on the nature of the antenna arrays are found, such as the dimensionality of the arrays and their direction with respect to the local scattering medium. This approach provides a physical picture for understanding the importance of scattering in the transfer of information through wireless communications.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Duke Univ, Dept Phys, Durham, NC 27708 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Duke University; University of California System; University of California Santa Barbara	Moustakas, AL (corresponding author), Bell Labs, Lucent Technol, 700 Mt Ave, Murray Hill, NJ 07974 USA.	arislm@physics.bell-labs.com	Simon, Steven/AAS-9956-2021; Baranger, Harold U/O-2370-2013; Sengupta, Anirvan/G-2508-2012; Moustakas, Aris/AAD-7558-2019	Simon, Steven/0000-0001-7757-5978; Baranger, Harold U/0000-0002-1458-2756; 				AKKERMANS E., 1995, MESOSCOPIC QUANTUM P; Altshuler B. L., 1991, MESOSCOPIC PHENOMENA; Biglieri E, 1998, IEEE T INFORM THEORY, V44, P2619, DOI 10.1109/18.720551; Cover TM., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Foschini G. J., 1998, Wireless Personal Communications, V6, P311, DOI 10.1023/A:1008889222784; FOSCHINI JG, IN PRESS IEEE T COMM; KULLBACK S, 1959, INFORMATION THEORY S; Rappaport T. S., 1996, WIRELESS COMMUNICATI; Sengupta AM, 1999, PHYS REV E, V60, P3389, DOI 10.1103/PhysRevE.60.3389; SENGUPTA AM, 1111199031805 BELL L; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; STEPHEN MJ, 1986, PHYS REV B, V34, P7564, DOI 10.1103/PhysRevB.34.7564; STEPHEN MJ, 1991, MESOSCOPIC PHENOMENA, P81; TELATAR IE, IN PRESS EUR T TELEC; Ullmo D, 1999, IEEE T VEH TECHNOL, V48, P947, DOI 10.1109/25.765025; van Rossum MCW, 1999, REV MOD PHYS, V71, P313, DOI 10.1103/RevModPhys.71.313	16	161	162	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					287	290		10.1126/science.287.5451.287	http://dx.doi.org/10.1126/science.287.5451.287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634779	Green Submitted			2022-12-28	WOS:000084769600034
J	Rundle, HD; Nagel, L; Boughman, JW; Schluter, D				Rundle, HD; Nagel, L; Boughman, JW; Schluter, D			Natural selection and parallel speciation in sympatric sticklebacks	SCIENCE			English	Article							LAKE SPECIES PAIR; ADAPTIVE RADIATION; REPRODUCTIVE ISOLATION; MATE CHOICE; ENOS LAKE; GASTEROSTEUS-ACULEATUS; CHARACTER DISPLACEMENT; BRITISH-COLUMBIA; DARWIN FINCHES; DROSOPHILA	Natural selection plays a fundamental role in most theories of speciation, but empirical evidence from the wild has been lacking. Here the post-Pleistocene radiation of threespine sticklebacks was used to infer natural selection in the origin of species. Populations of sticklebacks that evolved under different ecological conditions show strong reproductive isolation, whereas populations that evolved independently under similar ecological conditions lack isolation. Speciation has proceeded in this adaptive radiation in a repeatable fashion, ultimately as a consequence of adaptation to alternative environments.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Rundle, HD (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	rundle@zoology.ubc.ca	Langerhans, R. Brian/A-7205-2009	Schluter, Dolph/0000-0003-1683-7836; Boughman, Janette/0000-0002-5731-7389; Rundle, Howard/0000-0002-8288-8888				BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Borland M., 1986, THESIS U BRIT COLUMB; CHRISTIE P, 1984, J HERED, V75, P510, DOI 10.1093/oxfordjournals.jhered.a110004; CLARKE B, 1975, GENETICS, V79, P101; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Dobzhansky T., 1951, COPEIA; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; DODD DMB, 1989, EVOLUTION, V43, P1308, DOI 10.1111/j.1558-5646.1989.tb02577.x; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Endler J.A., 1986, Monographs in Population Biology, pviii; FELSENSTEIN J, 1995, PHYLOGENY INFERENCE; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1996, EVOLUTION, V50, P2429, DOI 10.1111/j.1558-5646.1996.tb03629.x; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; KILIAS G, 1980, EVOLUTION, V34, P730, DOI 10.1111/j.1558-5646.1980.tb04012.x; LYNCH M, 1991, EVOLUTION, V45, P1065, DOI [10.2307/2409716, 10.1111/j.1558-5646.1991.tb04375.x]; LYNCH M, 1993, GENETICS, V135, P1197; MACNAIR MR, 1983, HEREDITY, V50, P295, DOI 10.1038/hdy.1983.31; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mayr E, 1942, SYSTEMATICS ORIGIN S; MCKINNON JS, UNPUB; MCPHAIL JD, 1984, CAN J ZOOL, V62, P1402, DOI 10.1139/z84-201; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; MCPHAIL JD, 1994, EVOLUTIONARY BIOL TH, P418; Muller HJ, 1942, BIOL S, V6, P71; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 1997, AM NAT, V149, P1156, DOI 10.1086/286044; PRICE TD, 1984, NATURE, V309, P787, DOI 10.1038/309787a0; RATCLIFFE LM, 1983, ANIM BEHAV, V31, P1139, DOI 10.1016/S0003-3472(83)80021-9; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; ROWLAND WJ, 1989, BEHAV ECOL SOCIOBIOL, V24, P433, DOI 10.1007/BF00293272; ROWLAND WJ, 1989, ANIM BEHAV, V38, P112, DOI 10.1016/S0003-3472(89)80070-3; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Saetre GP, 1997, NATURE, V387, P589; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D, 1996, AM NAT, V148, pS40, DOI 10.1086/285901; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Taylor EB, 1999, BIOL J LINN SOC, V66, P271, DOI 10.1111/j.1095-8312.1999.tb01891.x; TAYLOR EC, COMMUNICATION; Vamosi SM, 1999, EVOLUTION, V53, P874, DOI 10.1111/j.1558-5646.1999.tb05381.x	53	511	524	3	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					306	308		10.1126/science.287.5451.306	http://dx.doi.org/10.1126/science.287.5451.306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634785				2022-12-28	WOS:000084769600040
J	Maddox, J				Maddox, J			Positioning the goalposts - The best environmental policy depends on how you frame the question.	NATURE			English	Editorial Material																			0	6	6	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					139	139		10.1038/35003065	http://dx.doi.org/10.1038/35003065			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646578	Bronze			2022-12-28	WOS:000084835300028
J	McMillan, P				McMillan, P			Phase transitions - Jumping between liquid states	NATURE			English	Editorial Material							BIOPOLYMERS; GLASSES		Arizona State Univ, Ctr Solid State Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	McMillan, P (corresponding author), Arizona State Univ, Ctr Solid State Sci, Tempe, AZ 85287 USA.		McMillan, Paul/AAI-9067-2020					AASLAND S, 1994, NATURE, V369, P633, DOI 10.1038/369633a0; Angell CA, 1997, PHYSICA D, V107, P122, DOI 10.1016/S0167-2789(97)00077-8; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Brazhkin VV, 1997, HIGH PRESSURE RES, V15, P267, DOI 10.1080/08957959708240477; Katayama Y, 2000, NATURE, V403, P170, DOI 10.1038/35003143; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; PONYATOVSKY EG, 1992, MATER SCI REP, V8, P147, DOI 10.1016/0920-2307(92)90007-N; Poole PH, 1997, SCIENCE, V275, P322, DOI 10.1126/science.275.5298.322	8	53	57	0	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					151	152		10.1038/35003088	http://dx.doi.org/10.1038/35003088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646585				2022-12-28	WOS:000084835300034
J	Kirschner, M; Gerhart, J; Mitchison, T				Kirschner, M; Gerhart, J; Mitchison, T			Molecular "vitalism"	CELL			English	Review							MICROTUBULES; MODEL		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; University of California System; University of California Berkeley	Kirschner, M (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA.							Aufderheide KJ, 1999, EUR J PROTISTOL, V35, P81, DOI 10.1016/S0932-4739(99)80025-X; BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; BERG HC, 1988, COLD SPRING HARB SYM, V53, P1, DOI 10.1101/SQB.1988.053.01.003; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Darwin C, 1880, POWER MOVEMENT PLANT; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; ELINSON R, 1995, CURR TOP DEV BIOL, V30, P235; FANKHAUSER G, 1945, J EXP ZOOL, V100, P445, DOI 10.1002/jez.1401000310; Fankhauser G, 1972, Am Sci, V60, P46; FRANKEL J, 1993, J EUKARYOT MICROBIOL, V40, P1, DOI 10.1111/j.1550-7408.1993.tb04873.x; Frankel J, 2000, METHOD CELL BIOL, V62, P27; Frederickson RM, 1998, CURR OPIN BIOTECH, V9, P90, DOI 10.1016/S0958-1669(98)80090-6; GERHART J, 1989, DEVELOPMENT, V107, P37; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Henry ER, 1997, BIOCHEMISTRY-US, V36, P6511, DOI 10.1021/bi9619177; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; INOUE S, 1967, J GEN PHYSIOL, V50, P259, DOI 10.1085/jgp.50.6.259; Inoue S, 1982, DEV ORDER ITS ORIGIN, P35; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Oosawa F., 1975, THERMODYNAMICS POLYM; Prigogine I., 1955, INTRO THERMODYNAMICS; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SALMON ED, 1975, J CELL BIOL, V65, P603, DOI 10.1083/jcb.65.3.603; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPRATT NT, 1960, J EXP ZOOL, V145, P97, DOI 10.1002/jez.1401450202; Tartar V., 1961, BIOL STENTOR, DOI DOI 10.1016/C2013-0-01654-4; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Weinstein DC, 1999, ANNU REV CELL DEV BI, V15, P411, DOI 10.1146/annurev.cellbio.15.1.411; West-Eberhard MJ, 1998, P NATL ACAD SCI USA, V95, P8417, DOI 10.1073/pnas.95.15.8417	37	144	149	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 7	2000	100	1					79	88		10.1016/S0092-8674(00)81685-2	http://dx.doi.org/10.1016/S0092-8674(00)81685-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647933	Bronze			2022-12-28	WOS:000084722600007
J	Mellman, I; Warren, G				Mellman, I; Warren, G			The road taken: Past and future foundations of membrane traffic	CELL			English	Review							STOMATITIS-VIRUS GLYCOPROTEIN; EPIDERMAL GROWTH-FACTOR; GTP-BINDING-PROTEINS; TRANS-GOLGI NETWORK; ENDOPLASMIC-RETICULUM; COATED VESICLES; SECRETORY PATHWAY; VESICULAR TRANSPORT; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES		Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.		Mellman, Ira/ABG-5896-2020					Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bentivoglio M, 1998, TRENDS NEUROSCI, V21, P195, DOI 10.1016/S0166-2236(98)01229-6; BERGMANN JE, 1981, P NATL ACAD SCI-BIOL, V78, P1746, DOI 10.1073/pnas.78.3.1746; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BRETSCHER MS, 1975, NATURE, V258, P43, DOI 10.1038/258043a0; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; COHEN AR, 1998, J CELL BIOL, V142; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; DUVE CD, 1975, SCIENCE, V189, P186, DOI 10.1126/science.1138375; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; ENGELMAN DM, 1971, J MOL BIOL, V58, P153, DOI 10.1016/0022-2836(71)90238-5; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; FRYE LD, 1970, J CELL SCI, V7, P319; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GOLGI C, 1898, ARCH ITAL BIOL, V30, P60; Gorlich D, 1995, COLD SPRING HARB SYM, V60, P695, DOI 10.1101/SQB.1995.060.01.075; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Henry JM, 1998, NEUROSURGERY, V42, P143, DOI 10.1097/00006123-199801000-00031; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; JAMIESON JD, 1967, J CELL BIOL, V34, P597, DOI 10.1083/jcb.34.2.597; JAMIESON JD, 1971, J CELL BIOL, V48, P503, DOI 10.1083/jcb.48.3.503; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; KANASEKI T, 1969, J CELL BIOL, V42, P202, DOI 10.1083/jcb.42.1.202; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lodish H.F., 1981, International Review of Cytology Supplement, P247; Lyman SK, 1996, EXPERIENTIA, V52, P1042, DOI 10.1007/BF01952100; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MAYORGA LS, 1989, SCIENCE, V244, P1475, DOI 10.1126/science.2499930; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Merisko E M, 1986, Pancreas, V1, P95, DOI 10.1097/00006676-198603000-00001; Metchnikoff E., 1887, ANN I PASTEUR PARIS, V1, P321; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OPRINS A, 1993, J CELL BIOL, V121, P49, DOI 10.1083/jcb.121.1.49; ORCI L, 1984, CELL, V39, P39, DOI 10.1016/0092-8674(84)90189-2; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Simons K, 1993, Harvey Lect, V89, P125; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SLOT JW, 1983, J HISTOCHEM CYTOCHEM, V31, P1049, DOI 10.1177/31.8.6863900; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thiele C, 1998, SEMIN CELL DEV BIOL, V9, P511, DOI 10.1006/scdb.1998.0259; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; TOOZE J, 1986, J CELL BIOL, V103, P839, DOI 10.1083/jcb.103.3.839; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Warren G, 1999, CELL, V98, P125, DOI 10.1016/S0092-8674(00)81006-5; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITNEY JA, 1995, CELL, V83, P703; Wurmser AE, 1998, EMBO J, V17, P4930, DOI 10.1093/emboj/17.17.4930	106	349	354	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					99	112		10.1016/S0092-8674(00)81687-6	http://dx.doi.org/10.1016/S0092-8674(00)81687-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647935	Bronze			2022-12-28	WOS:000084722600009
J	Nurse, P				Nurse, P			A long twentieth century of the cell cycle and beyond	CELL			English	Review							DNA-REPLICATION; GENETIC-CONTROL; FISSION YEAST; S-PHASE; DIVISION; MITOSIS; CHROMOSOMES; INITIATION; MATURATION; COMPONENTS		Imperial Canc Res Fund, Cell Cycle Lab, London WC2A 3PX, England	Cancer Research UK	Nurse, P (corresponding author), Imperial Canc Res Fund, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.							BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BRADBURY EM, 1974, NATURE, V247, P257, DOI 10.1038/247257a0; BRUTLAG D, 1971, P NATL ACAD SCI USA, V68, P2826, DOI 10.1073/pnas.68.11.2826; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Darlington CD., 1958, EVOLUTION GENETIC SY; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; FLEMMING W, 1965, J CELL BIOL, V25, P1; HARIS P, 1961, J CELL BIOL, V11, P419; Harris H, 1999, BIRTH CELL; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1973, GENETICS, V74, P267; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Howard A, 1953, HEREDITY           S, V6, P261; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; KACSER H, 1987, TRENDS BIOCHEM SCI, V12, P5, DOI 10.1016/0968-0004(87)90005-3; KIEFER B, 1966, J MOL BIOL, V20, P75, DOI 10.1016/0022-2836(66)90118-5; KORNBERG A, 1956, BIOCHIM BIOPHYS ACTA, V21, P197, DOI 10.1016/0006-3002(56)90127-5; LEE P D K, 1987, Journal of Pediatric Endocrinology, V2, P31; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MAZIA D, 1961, CELL, V3, P77; MECHALI M, 1984, CELL, V38, P55, DOI 10.1016/0092-8674(84)90526-9; MITCHISON JM, 1971, BIOL CELL CYCLE; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORRIS CF, 1975, P NATL ACAD SCI USA, V72, P4800, DOI 10.1073/pnas.72.12.4800; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; MURRAY A, 1993, CELL CYCLE; Nasmyth K, 1999, TRENDS BIOCHEM SCI, V24, P98, DOI 10.1016/S0968-0004(99)01358-4; NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; ORNBERG A, 1992, DNA REPLICATION; SCHWANN T, 1857, MICROSCOPICAL RES AC; Sharp LW., 1921, INTRO CYTOLOGY; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; SWIFT H, 1950, P NATL ACAD SCI USA, V36, P643, DOI 10.1073/pnas.36.11.643; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vernos I, 1996, CURR OPIN CELL BIOL, V8, P4, DOI 10.1016/S0955-0674(96)80041-X; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	49	418	440	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					71	78		10.1016/S0092-8674(00)81684-0	http://dx.doi.org/10.1016/S0092-8674(00)81684-0			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647932	Bronze			2022-12-28	WOS:000084722600006
J	Feldman, M; McMahon, AT				Feldman, M; McMahon, AT			Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?	ANNALS OF INTERNAL MEDICINE			English	Review							PROSTAGLANDIN ENDOPEROXIDE SYNTHASES; MELOXICAM 15 MG; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; ANTIINFLAMMATORY DRUGS; ORAL MELOXICAM; ACUTE LUMBAGO; RAT STOMACH; EFFICACY; OSTEOARTHRITIS	Two forms of cyclooxygenase, cyclooxygenase-l (COX-1) and cyclooxygenase 2 (COX-2), act as rate-limiting enzymes in prostaglandin and thromboxane synthesis. Discovery of these compounds led to the development of drugs that selectively or specifically inhibit the COX-2 isoform. Although the COX-1 isoform is expressed at fairly constant levels in cells, including the gastrointestinal mucosa and platelets, expression of COX-2 varies greatly. In many cells, low expression of COX-2 can be upregulated by various stimuli, including inflammatory cytokines, bacterial toxins, and growth factors; this suggests that COX-2 plays a role in inflammation, infection, and cellular proliferation. It was thought that newly developed drugs designed to block COX-2 but not COX-1 would have anti-inflammatory properties and would avoid inhibiting the synthesis of gastrointestinal prostaglandins (thereby avoiding ulcers) and platelet thromboxane (thereby avoiding bleeding). Gastrointestinal ulcers and bleeding are side effects of traditional nonsteroidal anti-inflammatory drugs (NSAIDs) that block COX-1 and COX-2. Meloxicam and nimesulide, selective COX-2 inhibitors available outside the United States, are as effective as traditional NSAIDs but have similar gastrointestinal side effects. Celecoxib (Celebrex, C.D. Searle and Co., Chicago, Illinois) and rofecoxib (Vioxx, Merck and Co., Inc., West Point, Pennsylvania), selective COX-2 inhibitors approved in the United States in the past year, are also as effective as traditional NSAIDs. However, celecoxib and rofecoxib have no antiplatelet activity and lead to fewer endoscopically detected gastric and duodenal ulcers than traditional NSAIDs, such as ibuprofen or naproxen. Preliminary analyses of data pooled from several trials suggest that celecoxib and rofecoxib are associated with fewer clinically symptomatic ulcers and ulcer complications than traditional NSAIDs are. Postmarketing surveillance should help clarify the actual risk for serious ulcer complications with these new COX-2 inhibitors and reveal other potential nongastrointestinal toxic reactions that can result from their use.	Univ Texas, SW Med Ctr, Dallas, TX USA; Salix Pharmaceut Inc, Palo Alto, CA USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Feldman, M (corresponding author), Vet Affairs Med Ctr, Med Serv 111, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	mark.feldman@med.va.gov						[Anonymous], 1999, WALL STREET J; Bjarnason I, 1997, SCAND J GASTROENTERO, V32, P126, DOI 10.3109/00365529709000182; Bosch HC, 1997, CURR MED RES OPIN, V14, P29, DOI 10.1185/03007999709113340; Bourgeois P., 1994, European Journal of Rheumatology and Inflammation, V14, P39; Brideau C, 1996, INFLAMM RES, V45, P68, DOI 10.1007/BF02265118; Brown J, 1999, CLIN PHARMACOL THER, V65, P118, DOI 10.1016/S0009-9236(99)80004-6; Cannon G, 1998, ARTHRITIS RHEUM, V41, pS196; Carrabba M, 1995, CURR MED RES OPIN, V13, P343, DOI 10.1185/03007999509110494; Cheng HF, 1999, J CLIN INVEST, V103, P953, DOI 10.1172/JCI5505; Colberg K, 1996, CURR MED RES OPIN, V13, P363, DOI 10.1185/03007999609111556; Cryer B, 1999, GASTROENTEROLOGY, V116, pA141; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; CRYER B, 1996, AM J GASTROENTEROL, V91, P1907; Dreiser R L, 1993, Drugs, V46 Suppl 1, P191; Dreiser R L, 1993, Drugs, V46 Suppl 1, P183; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ehrich EW, 1999, CLIN PHARMACOL THER, V65, P336, DOI 10.1016/S0009-9236(99)70113-X; Fricke J, 1999, CLIN PHARMACOL THER, V65, P119, DOI 10.1016/S0009-9236(99)80007-1; FRIEDEL HA, 1993, DRUGS, V45, P131, DOI 10.2165/00003495-199345010-00009; Geis GS, 1998, ARTHRITIS RHEUM, V41, pS364; Geis GS, 1998, ARTHRITIS RHEUM, V41, pS316; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GLASER K, 1995, EUR J PHARMACOL, V281, P107, DOI 10.1016/0014-2999(95)00302-2; Goldstein JL, 1999, GASTROENTEROLOGY, V116, pA174; Gretzer B, 1998, BRIT J PHARMACOL, V123, P927, DOI 10.1038/sj.bjp.0701673; Gretzer B, 1998, GASTROENTEROLOGY, V114, pA139, DOI 10.1016/S0016-5085(98)80567-2; Harris RC, 1998, KIDNEY INT, V54, pS49, DOI 10.1046/j.1523-1755.1998.06710.x; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Hosie J, 1996, BRIT J RHEUMATOL, V35, P39; Hubbard R, 1998, ARTHRITIS RHEUM, V41, pS196; ISEKI S, 1995, HISTOCHEM J, V27, P323, DOI 10.1007/BF00398975; Kargman S, 1996, GASTROENTEROLOGY, V111, P445, DOI 10.1053/gast.1996.v111.pm8690211; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Laine L, 1999, GASTROENTEROLOGY, V116, pA229; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Lanza FL, 1999, ALIMENT PHARM THERAP, V13, P761, DOI 10.1046/j.1365-2036.1999.00529.x; Lecomte J, 1994, Eur J Rheumatol Inflamm, V14, P29; Lemmel EM, 1997, J RHEUMATOL, V24, P282; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Linden B, 1996, BRIT J RHEUMATOL, V35, P35; Lucker P W, 1994, Eur J Rheumatol Inflamm, V14, P29; Lund B, 1998, SCAND J RHEUMATOL, V27, P32; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Panara MR, 1998, CLIN PHARMACOL THER, V63, P672, DOI 10.1016/S0009-9236(98)90091-1; PANARA MR, 1995, BRIT J PHARMACOL, V116, P2429, DOI 10.1111/j.1476-5381.1995.tb15091.x; Patrignani P, 1997, J PHYSIOL PHARMACOL, V48, P623; Porto A, 1994, Eur J Rheumatol Inflamm, V14, P33; ROBERT A, 1983, AM J PHYSIOL, V245, pG113, DOI 10.1152/ajpgi.1983.245.1.G113; RODRIGUEZ LAG, 1998, AM J MED, V104, pS30, DOI DOI 10.1016/S0002-9343(97)00208-8; Rossat J, 1999, CLIN PHARMACOL THER, V66, P76, DOI 10.1016/S0009-9236(99)70056-1; Saag K, 1998, ARTHRITIS RHEUM, V41, pS196; Santini G, 1996, EUR J PHARMACOL, V316, P65, DOI 10.1016/S0014-2999(96)00640-1; SCHATTENKIRCHNER M, 1990, European Journal of Rheumatology and Inflammation, V10, P56; Schmassmann Adrian, 1998, American Journal of Medicine, V104, p43S, DOI 10.1016/S0002-9343(97)00211-8; Schwartz JI, 1999, CLIN PHARMACOL THER, V65, P653, DOI 10.1016/S0009-9236(99)90087-5; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Singh G, 1999, J RHEUMATOL, V26, P18; Takahashi S, 1998, AM J PHYSIOL-GASTR L, V275, pG1137, DOI 10.1152/ajpgi.1998.275.5.G1137; The HSG, 1997, OSTEOARTHR CARTILAGE, V5, P283; Tocco G, 1997, EXP NEUROL, V144, P339, DOI 10.1006/exnr.1997.6429; Wallace JL, 1998, GASTROENTEROLOGY, V115, P101, DOI 10.1016/S0016-5085(98)70370-1; Wojtulewski JA, 1996, BRIT J RHEUMATOL, V35, P22; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Zimmermann KC, 1998, MOL PHARMACOL, V54, P536, DOI 10.1124/mol.54.3.536; 1999, MED LETT DRUGS THER, V41, P59; 1998, CELEBREX PRODUCT LIT; 1999, ROFECOXIB PRODUCT LI; 1999, MED LETT DRUGS THER, V41, P11	72	127	139	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					134	143		10.7326/0003-4819-132-2-200001180-00008	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644275				2022-12-28	WOS:000084852300007
J	van Ginneken, VJT; van den Thillart, GEEJM				van Ginneken, VJT; van den Thillart, GEEJM			Physiology - Eel fat stores are enough to reach the Sargasso	NATURE			English	Article							SEA		Inst Ecol & Evolutionary Sci Integrat Zool, Van Der Klaauw Lab, NL-2300 RA Leiden, Netherlands		van Ginneken, VJT (corresponding author), Inst Ecol & Evolutionary Sci Integrat Zool, Van Der Klaauw Lab, POB 9511, NL-2300 RA Leiden, Netherlands.							BOETIUS I, 1980, Dana, V1, P1; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; ELLIOTT JM, 1975, OECOLOGIA, V19, P195, DOI 10.1007/BF00345305; FRICKE H, 1995, NATURWISSENSCHAFTEN, V82, P32, DOI 10.1007/s001140050136; MILLER MJ, 1994, J MAR RES, V52, P743, DOI 10.1357/0022240943076948; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Svedang H, 1997, J FISH BIOL, V50, P475, DOI 10.1111/j.1095-8649.1997.tb01943.x; Tesch F.-W., 1977, EEL BIOL MANAGEMENT; VANDIJK PLM, 1993, J FISH BIOL, V42, P661, DOI 10.1006/jfbi.1993.1075; Wootton RJ, 1979, S ZOOL SOC LOND, P133	11	97	108	0	26	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					156	157		10.1038/35003110	http://dx.doi.org/10.1038/35003110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646590				2022-12-28	WOS:000084835300041
J	Young, E				Young, E			Planetary science - Charon's first detailed spectra hold many surprises	SCIENCE			English	Editorial Material									SW Res Inst, Boulder, CO 80302 USA		Young, E (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	efy@boulder.swri.edu						BOCKELEEMORVAN D, IN PRESS ASTRON ASTR; Brown ME, 2000, SCIENCE, V287, P107, DOI 10.1126/science.287.5450.107; BUIE MW, 1987, NATURE, V329, P522, DOI 10.1038/329522a0; Gomes R, 1999, SCIENCE, V286, P1487, DOI 10.1126/science.286.5444.1487; Jenniskens P, 1998, ASTROPHYS SPACE SC L, V227, P139, DOI 10.1007/978-94-011-5252-5_7; LEWIS JS, 1997, PHYSICS CHEM SOLAR S; THOLEN DJ, 1997, PLUTO CHARON, P9; 1999, WORKSH ENT PLUT TRIT	8	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2000	287	5450					53	54		10.1126/science.287.5450.53	http://dx.doi.org/10.1126/science.287.5450.53			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	271DG	10644224				2022-12-28	WOS:000084578400030
J	Mulryan, K; Gitterman, DP; Lewis, CJ; Vial, C; Leckie, BJ; Cobb, AL; Brown, JE; Conley, EC; Buell, G; Pritchard, CA; Evans, RJ				Mulryan, K; Gitterman, DP; Lewis, CJ; Vial, C; Leckie, BJ; Cobb, AL; Brown, JE; Conley, EC; Buell, G; Pritchard, CA; Evans, RJ			Reduced vas deferens contraction and male infertility in mice lacking P2X(1) receptors	NATURE			English	Article							GATED ION CHANNELS; ALPHA,BETA-METHYLENE ATP; PURINE NUCLEOTIDES; GUINEA-PIG; RAT; MOUSE	P2X(1) receptors for ATP are ligand-gated cation channels, present on many excitable cells including vas deferens smooth muscle cells(1-5). A substantial component of the contractile response of the vas deferens to sympathetic nerve stimulation, which propels sperm into the ejaculate. is mediated through P2X receptors'. Here we show that male fertility is reduced by similar to 90% in mice with a targeted deletion of the P2X(1) receptor gene. Male mice copulate normally-reduced fertility results from a reduction of sperm in the ejaculate and not from sperm dysfunction. Female mice and heterozygote mice are unaffected. In P2X(1)-receptor-deficient mice, contraction of the vas deferens to sympathetic nerve stimulation is reduced by up to 60% and responses to P2X receptor agonists are abolished. These results show that P2X(1) receptors are essential for normal male reproductive function and suggest that the development of selective P2X(1) receptor antagonists may provide an effective non-hormonal male contraceptive pill. Also, agents that potentiate the actions of ATP at P2X(1) receptors may be useful in the treatment of male infertility.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Med, Transgen Unit, Biomed Serv, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Pathol, Leicester LE1 9HN, Leics, England; Univ Leicester, Ctr Mechanisms Human Tox, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; Glaxo Wellcome Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland	University of Leicester; University of Leicester; University of Leicester; University of Leicester; University of Leicester; GlaxoSmithKline	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg, Leicester LE1 9HN, Leics, England.			Pritchard, Catrin/0000-0003-1859-4487				ALLCORN RJ, 1986, BRIT J PHARMACOL, V89, P647, DOI 10.1111/j.1476-5381.1986.tb11169.x; ANDERSON RA, 1983, J REPROD FERTIL, V68, P1, DOI 10.1530/jrf.0.0680001; BRADING AF, 1990, BRIT J PHARMACOL, V99, P493, DOI 10.1111/j.1476-5381.1990.tb12956.x; BURNSTOCK G, 1961, J PHYSIOL-LONDON, V155, P115, DOI 10.1113/jphysiol.1961.sp006617; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Collo G, 1996, J NEUROSCI, V16, P2495; Costa SL, 1997, BIOL REPROD, V56, P985, DOI 10.1095/biolreprod56.4.985; Evans RJ, 1996, SEMIN NEUROSCI, V8, P217, DOI 10.1006/smns.1996.0028; HEDLUND H, 1985, J AUTON PHARMACOL, V5, P261, DOI 10.1111/j.1474-8673.1985.tb00127.x; HOFFMAN BB, 1996, PHARMACOL BASIS THER, V9, P199; HOGAN B, 1986, MANIPULATING MOUSE E; Jacobson KA, 1998, J MED CHEM, V41, P2201, DOI 10.1021/jm980183o; KENAKIN T, 1997, PHARM ANAL DRUG RECE, V3, P63; KHAKH BS, 1995, BRIT J PHARMACOL, V115, P177, DOI 10.1111/j.1476-5381.1995.tb16336.x; LEWIS C, 1998, BRIT J PHARMACOL, P1463; Ralevic V, 1998, PHARMACOL REV, V50, P413; SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VONKUGELGEN I, 1990, N-S ARCH PHARMACOL, V342, P198, DOI 10.1007/BF00166965; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; Yang LY, 1998, PHYSIOL BEHAV, V63, P675, DOI 10.1016/S0031-9384(97)00523-4	21	311	313	4	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					86	89		10.1038/47495	http://dx.doi.org/10.1038/47495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638758				2022-12-28	WOS:000084687400048
J	Brickner, ME; Hillis, LD; Lange, RA				Brickner, ME; Hillis, LD; Lange, RA			Congenital heart disease in adults - (Second of two parts).	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ARTERIAL SWITCH OPERATION; GREAT-ARTERIES; VENTRICULAR ARRHYTHMIAS; EISENMENGER-SYNDROME; POSTOPERATIVE TETRALOGY; SURGICAL REPAIR; PULMONARY VALVE; MUSTARD REPAIR; FALLOT; TRANSPOSITION		Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Rm CS7-102,5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Lange, Richard/AAM-9594-2021					ALLEN HD, 1991, CIRCULATION, V84, P2248, DOI 10.1161/01.CIR.84.5.2248; Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; ANDERSON KR, 1979, MAYO CLIN PROC, V54, P174; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Augustin N, 1997, ANN THORAC SURG, V63, P1650, DOI 10.1016/S0003-4975(97)00090-8; BAUM VC, 1993, ANESTH ANALG, V76, P1342, DOI 10.1213/00000539-199376060-00028; BERTRANOU EG, 1978, AM J CARDIOL, V42, P458, DOI 10.1016/0002-9149(78)90941-4; Cappato R, 1996, CIRCULATION, V94, P376, DOI 10.1161/01.CIR.94.3.376; Castaneda A R, 1990, Semin Thorac Cardiovasc Surg, V2, P70; CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170, DOI 10.1016/0735-1097(94)90516-9; CHANDAR JS, 1990, AM J CARDIOL, V65, P655, DOI 10.1016/0002-9149(90)91047-A; COLONOTERO G, 1987, MAYO CLIN PROC, V62, P379, DOI 10.1016/S0025-6196(12)65442-1; DABIZZI RP, 1990, EUR HEART J, V11, P692, DOI 10.1093/oxfordjournals.eurheartj.a059784; DIHMIS WC, 1993, BRIT HEART J, V69, P436; ELLIOTT LP, 1963, CIRCULATION, V27, P1105, DOI 10.1161/01.CIR.27.6.1105; Fallot ELA., 1888, MARSEILLE MEDICAL, V25, P403; FINCK SJ, 1988, ANN THORAC SURG, V45, P610, DOI 10.1016/S0003-4975(10)64760-1; Findlow D, 1997, BRIT J ANAESTH, V78, P416, DOI 10.1093/bja/78.4.416; FREED MD, 1981, CIRCULATION, V64, P899, DOI 10.1161/01.CIR.64.5.899; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; Gelatt M, 1997, J AM COLL CARDIOL, V29, P194, DOI 10.1016/S0735-1097(96)00424-X; GIULIANI ER, 1979, MAYO CLIN PROC, V54, P163; GRAHAM TP, 1982, PEDIATR CARDIOL, V2, P203, DOI 10.1007/BF02332111; GROH MA, 1991, CIRCULATION, V84, P206; GUSSENHOVEN EJ, 1984, AM J CARDIOL, V54, P172, DOI 10.1016/0002-9149(84)90324-2; GUTGESELL HP, 1994, AM J CARDIOL, V74, P959, DOI 10.1016/0002-9149(94)90598-3; Hartnell GG, 1996, CLIN RADIOL, V51, P851, DOI 10.1016/S0009-9260(96)80081-X; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; HENRIKSSON P, 1979, BRIT HEART J, V41, P23; HIRAISHI S, 1994, CIRCULATION, V89, P1306, DOI 10.1161/01.CIR.89.3.1306; HIRSCH R, 1994, CIRCULATION, V90, P2937, DOI 10.1161/01.CIR.90.6.2937; KASTOR JA, 1975, CIRCULATION, V52, P987, DOI 10.1161/01.CIR.52.6.987; KAVEY REW, 1984, J AM COLL CARDIOL, V4, P126, DOI 10.1016/S0735-1097(84)80329-0; Kiziltan HT, 1998, ANN THORAC SURG, V66, P1539, DOI 10.1016/S0003-4975(98)00961-8; LEV M, 1969, AM J CARDIOL, V23, P409, DOI 10.1016/0002-9149(69)90522-0; LINDERKAMP O, 1979, J PEDIATR-US, V95, P567, DOI 10.1016/S0022-3476(79)80770-2; MacLellanTobert SG, 1996, MAYO CLIN PROC, V71, P1071, DOI 10.4065/71.11.1071; MAHONY L, 1982, CIRCULATION, V66, P253, DOI 10.1161/01.CIR.66.2.253; MAIR DD, 1992, J AM COLL CARDIOL, V19, P1047, DOI 10.1016/0735-1097(92)90292-U; MCNAMARA DG, 1989, CURR PROB CARDIOLOGY, V14, P57, DOI 10.1016/S0146-2806(89)80001-5; MORGAN BC, 1965, CIRCULATION, V31, P66, DOI 10.1161/01.CIR.31.1.66; MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901; MUSTARD WT, 1964, J THORAC CARDIOVASC, V48, P899; OBERHOFFER R, 1992, BRIT HEART J, V68, P580; PAUL MH, 1995, MOSS ADAMS HEART DIS, P1154; PERLOFF JK, 1988, ANN INTERN MED, V109, P406, DOI 10.7326/0003-4819-109-5-406; PERLOFF JK, 1998, CONGENITAL HEART DIS, P199; Presbitero P, 1996, ANN THORAC SURG, V61, P1870, DOI 10.1016/0003-4975(96)00180-4; Puley G, 1999, AM J CARDIOL, V83, P1080, DOI 10.1016/S0002-9149(99)00019-3; Rammohan M, 1998, INT J CARDIOL, V63, P121, DOI 10.1016/S0167-5273(97)00279-9; RAO BNS, 1971, AM HEART J, V81, P361; Reich JD, 1998, J CARDIOVASC ELECTR, V9, P1370, DOI 10.1111/j.1540-8167.1998.tb00113.x; ROOSHESSELINK J, 1995, CIRCULATION, V91, P2214, DOI 10.1161/01.CIR.91.8.2214; ROSENTHAL A, 1984, ANN THORAC SURG, V38, P151, DOI 10.1016/S0003-4975(10)62224-2; Rosenzweig EB, 1999, CIRCULATION, V99, P1858, DOI 10.1161/01.CIR.99.14.1858; ROWE R D, 1955, Can Med Assoc J, V73, P23; ROWE SA, 1991, J AM COLL CARDIOL, V17, P461, DOI 10.1016/S0735-1097(10)80116-0; SAHA A, 1994, INT J CARDIOL, V45, P199, DOI 10.1016/0167-5273(94)90166-X; SERRAF A, 1993, J AM COLL CARDIOL, V22, P193, DOI 10.1016/0735-1097(93)90834-N; SEYBOLDEPTING W, 1977, ANN THORAC SURG, V24, P237, DOI 10.1016/S0003-4975(10)63749-6; SHIINA A, 1984, J AM COLL CARDIOL, V3, P356, DOI 10.1016/S0735-1097(84)80020-0; SLUYSMANS T, 1995, CIRCULATION, V91, P1506, DOI 10.1161/01.CIR.91.5.1506; Snider AR, 1997, ECHOCARDIOGRAPHY PED, P235; Soto B, 1990, Semin Thorac Cardiovasc Surg, V2, P12; TOUATI GD, 1990, J THORAC CARDIOV SUR, V99, P396; Tworetzky W, 1999, J AM COLL CARDIOL, V33, P228, DOI 10.1016/S0735-1097(98)00518-X; VAKSMANN G, 1990, AM J CARDIOL, V66, P346, DOI 10.1016/0002-9149(90)90847-T; van Son JAM, 1998, EUR J CARDIO-THORAC, V13, P280, DOI 10.1016/S1010-7940(98)00009-8; Vargas FJ, 1998, ANN THORAC SURG, V65, P1755, DOI 10.1016/S0003-4975(98)00290-2; VETTER VL, 1987, J AM COLL CARDIOL, V10, P1265, DOI 10.1016/S0735-1097(87)80129-8; Vongpatanasin W, 1998, ANN INTERN MED, V128, P745, DOI 10.7326/0003-4819-128-9-199805010-00008; Weiss BM, 1998, J AM COLL CARDIOL, V31, P1650, DOI 10.1016/S0735-1097(98)00162-4; WERNOVSKY G, 1995, J THORAC CARDIOV SUR, V109, P289, DOI 10.1016/S0022-5223(95)70391-8; Wilson NJ, 1998, J AM COLL CARDIOL, V32, P758, DOI 10.1016/S0735-1097(98)00309-X; WONG KY, 1988, BRIT HEART J, V60, P316; YOUNG D, 1971, AM J CARDIOL, V28, P658, DOI 10.1016/0002-9149(71)90054-3; ZAHKA KG, 1988, CIRCULATION, V78, P14	77	190	198	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					334	342		10.1056/NEJM200002033420507	http://dx.doi.org/10.1056/NEJM200002033420507			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655533				2022-12-28	WOS:000085070300007
J	Sharma, S; Dasroy, SK				Sharma, S; Dasroy, SK			Gingival hyperplasia induced by phenytoin.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Modern Med Inst, Raipur, Madhya Pradesh, India		Sharma, S (corresponding author), Modern Med Inst, Raipur, Madhya Pradesh, India.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					325	325		10.1056/NEJM200002033420505	http://dx.doi.org/10.1056/NEJM200002033420505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655531				2022-12-28	WOS:000085070300005
J	Naumburg, E; Bellocco, R; Cnattingius, S; Hall, P; Ekbom, A				Naumburg, E; Bellocco, R; Cnattingius, S; Hall, P; Ekbom, A			Prenatal ultrasound examinations and risk of childhood leukaemia: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY		Uppsala Univ, Paediat Sect, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden; Dept Med Epidemiol, S-17177 Stockholm, Sweden	Uppsala University	Naumburg, E (corresponding author), Uppsala Univ, Paediat Sect, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden.	Estelle.Namburg@pediatrik.uu.se	Bellocco, Rino/E-7674-2018; Naumburg, Estelle/B-8539-2018	Naumburg, Estelle/0000-0001-6090-494X				CARTWRIGHT RA, 1984, LANCET, V2, P999; DINNO MA, 1989, PHYS MED BIOL, V34, P1543, DOI 10.1088/0031-9155/34/11/003; *EUR COMM ULTR RAD, 1996, EUR J ULTRASOUND, V4, P69; Kieler H, 1998, OBSTET GYNECOL, V91, P750, DOI 10.1016/S0029-7844(98)00062-3; WILSON LMK, 1984, LANCET, V2, P997	5	15	18	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2000	320	7230					282	283		10.1136/bmj.320.7230.282	http://dx.doi.org/10.1136/bmj.320.7230.282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650024	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000085132700020
J	Daszak, P; Cunningham, AA; Hyatt, AD				Daszak, P; Cunningham, AA; Hyatt, AD			Wildlife ecology - Emerging infectious diseases of wildlife - Threats to biodiversity and human health	SCIENCE			English	Review							YELLOWSTONE-NATIONAL-PARK; UNITED-STATES; GEOGRAPHICAL SPREAD; POPULATION-DYNAMICS; NEWCASTLE-DISEASE; SARCOPTIC MANGE; LYME-DISEASE; VARIANT CJD; VIRUS; RABIES	Emerging infectious diseases (EIDs) of free-living wild animals can be classified into three major groups on the basis of key epizootiological criteria: (i) EIDs associated with "spill-over" from domestic animals to wildlife populations living in proximity; (ii) EIDs related directly to human intervention, via host or parasite translocations; and (iii) EIDs with no overt human or domestic animal involvement. These phenomena have two major biological implications: first, many wildlife species are reservoirs of pathogens that threaten domestic animal and human health; second, wildlife EIDs pose a substantial threat to the conservation of global biodiversity.	Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Ctr Dis Control & Prevent, Infect Dis & Pathol Act, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Zool Soc London, Inst Zool, London NW1 4RY, England; CSIRO, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Zoological Society of London; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Daszak, P (corresponding author), Univ Georgia, Inst Ecol, Athens, GA 30602 USA.	daszak@uga.edu	Cunningham, Andrew A/E-7536-2010; daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695				Alderman DJ, 1996, REV SCI TECH OIE, V15, P603, DOI 10.20506/rst.15.2.943; Alexander KA, 1996, J ZOO WILDLIFE MED, V27, P426; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Ault A, 1999, LANCET, V353, P2050, DOI 10.1016/S0140-6736(05)77880-6; AZIZ J, 1999, 11 INT C VIR 9 13 AU; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Baylis M, 1999, NATURE, V397, P574, DOI 10.1038/17512; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Bons N, 1999, P NATL ACAD SCI USA, V96, P4046, DOI 10.1073/pnas.96.7.4046; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Butynski Thomas M., 1998, P294, DOI 10.1002/9781444313598.ch12; CHEKE AS, 1987, STUDIES MASCARENE IS, pCH1; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Cleaveland S, 1995, PARASITOLOGY, V111, pS33, DOI 10.1017/S0031182000075806; Cleaveland S, 1998, T ROY SOC TROP MED H, V92, P131, DOI 10.1016/S0035-9203(98)90718-0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COOK GC, 1992, J ROY SOC MED, V85, P688; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CRANFIELD R, 1990, P AM ASS ZOO VET, P243; Cully JF, 1997, J WILDLIFE DIS, V33, P706, DOI 10.7589/0090-3558-33.4.706; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; CUNNINGHAM AA, 1992, J COMP PATHOL, V107, P207, DOI 10.1016/0021-9975(92)90037-U; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Cunningham AA, 1998, CONSERV BIOL, V12, P1139, DOI 10.1046/j.1523-1739.1998.97485.x; Cunningham Andrew A., 1997, Memoirs of the Museum of Victoria, V56, P647; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; DAVIDSON WR, IN PRESS INFECT DIS; Dobson A, 1996, ECOLOGY, V77, P1026, DOI 10.2307/2265573; DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1; DOBSON AP, 1986, CONSERVATION BIOL SC, pCH16; Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6; Ebel GD, 1999, EMERG INFECT DIS, V5, P570, DOI 10.3201/eid0504.990423; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; Epstein PR, 1998, LANCET, V351, P1737, DOI 10.1016/S0140-6736(05)77777-1; Fidler DP, 1996, EMERG INFECT DIS, V2, P77, DOI 10.3201/eid0202.960201; Fischer JR, 1997, EMERG INFECT DIS, V3, P69, DOI 10.3201/eid0301.970110; FRENKEL JK, 1989, AM ZOOL, V29, P455; *GAL CONS TRUST, 1996, S INV SPEC OC ISL; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gardner H, 1997, NATURE, V387, P245, DOI 10.1038/387245a0; GINSBERG JR, 1995, P ROY SOC B-BIOL SCI, V262, P221, DOI 10.1098/rspb.1995.0199; Gompper ME, 1998, CONSERV BIOL, V12, P730, DOI 10.1046/j.1523-1739.1998.97196.x; GOODALL J, 1988, SHADOW MAN, P214; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GRIFFITH B, 1993, J ZOO WILDLIFE MED, V24, P231; Griffiths JK, 1998, ADV PARASIT, V40, P37, DOI 10.1016/S0065-308X(08)60117-7; Hagmann M, 1999, SCIENCE, V286, P654, DOI 10.1126/science.286.5440.654; HARRIS EA, 1983, PARASITOLOGY, V87, pR29; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HEDRICK RP, 1995, VET RES, V26, P423; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; HIME JM, 1975, VET REC, V97, P392, DOI 10.1136/vr.97.20.392-a; Hooper PT, 1999, AUST VET J, V77, P529, DOI 10.1111/j.1751-0813.1999.tb12127.x; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Hyatt AD, 1997, DIS AQUAT ORGAN, V28, P17, DOI 10.3354/dao028017; JACOBSON ER, 1993, J ZOO WILDLIFE MED, V24, P245; Jancovich JK, 1997, DIS AQUAT ORGAN, V31, P161, DOI 10.3354/dao031161; KAT PW, 1995, P ROY SOC B-BIOL SCI, V262, P229, DOI 10.1098/rspb.1995.0200; KERRY K, 1999, DIS ANTARCTIC WILDLI; Kirkwood JK, 1998, VET REC, V142, P468; KIRKWOOD JK, 1992, P AM ASS ZOO VET OAK, P26; KIRKWOOD JK, 1999, WORLD VET C 23 26 SE; KIRKWOOD JK, 1999, ZOO WILD ANIMAL MED, V4, P662; KLENK HD, 1999, CURR TOP MICROBIOL I, V235; KRAUSE RM, 1994, J INFECT DIS, V170, P265, DOI 10.1093/infdis/170.2.265; Laurenson K, 1998, ANIM CONSERV, V1, P273, DOI 10.1111/j.1469-1795.1998.tb00038.x; Lederberg J., 1992, I MED US COMMITTEE; Leirs H, 1999, J INFECT DIS, V179, pS155, DOI 10.1086/514299; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; LYLES AM, 1993, J ZOO WILDLIFE MED, V24, P315; MACDONALD DW, 1992, NATURE, V360, P633, DOI 10.1038/360633b0; MACPHEE RDE, 1997, NATURAL CHANGE HUMAN, pCH7; Maes E, 1998, CLIN THER, V20, P993, DOI 10.1016/S0149-2918(98)80081-7; MAHY BWJ, 1997, TOPLEY WILSONS MICRO, V1, pCH47; MAY R M, 1988, Conservation Biology, V2, P28, DOI 10.1111/j.1523-1739.1988.tb00332.x; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; MCCANDLISH I, 1979, VET REC, V105, P180; McCurry J, 1997, LANCET, V350, P1825, DOI 10.1016/S0140-6736(97)23051-5; McMichael AJ, 1999, BIOSCIENCE, V49, P205, DOI 10.2307/1313510; McSweegan E, 1996, EMERG INFECT DIS, V2, P103, DOI 10.3201/eid0202.960204; MELLOR PS, 1995, ANN TROP MED PARASIT, V89, P1; MELTZER DGA, 1993, J ZOO WILDLIFE MED, V24, P237; Meteyer CU, 1997, AVIAN DIS, V41, P171, DOI 10.2307/1592457; MEYER ME, 1995, J WILDLIFE DIS, V31, P579, DOI 10.7589/0090-3558-31.4.579; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; MONTALI RJ, 1995, AM J PATHOL, V147, P1441; Morell V, 1999, SCIENCE, V284, P728, DOI 10.1126/science.284.5415.728; MORSE SS, 1993, EMERGING VIRUSES, pCH2; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Nettles VF, 1996, ASM NEWS, V62, P589; NETTLES VF, 1997, WORLD ANIMAL HLTH 19; Noah DL, 1996, AM J PUBLIC HEALTH, V86, P1149, DOI 10.2105/AJPH.86.8_Pt_1.1149; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; Pennycott TW, 1998, VET REC, V143, P155, DOI 10.1136/vr.143.6.155; Pertz C, 1997, J ZOO WILDLIFE MED, V28, P491; Pimentel D, 1997, BIOSCIENCE, V47, P747, DOI 10.2307/1313097; PIMENTEL D, 1996, REV SCI TECH OIE, V15, P387; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Plowright W., 1982, Symposia of the Zoological Society of London, V50, P1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Real LA, 1996, BIOSCIENCE, V46, P88, DOI 10.2307/1312811; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Rodda GH, 1997, BIOSCIENCE, V47, P565, DOI 10.2307/1313163; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; RUPPRECHT CE, 1995, EMERG INFECT DIS, V1, P107, DOI 10.3201/eid0104.950401; Sainsbury AW, 1997, CONSERVATION RED SQU, P105; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; Skerratt LF, 1998, AUST VET J, V76, P408, DOI 10.1111/j.1751-0813.1998.tb12389.x; Spratt D, 1998, INT J PARASITOL, V28, P925; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; STORK NE, 1993, NATURE, V366, P307, DOI 10.1038/366307a0; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Telford SR, 1996, P NATL ACAD SCI USA, V93, P6209, DOI 10.1073/pnas.93.12.6209; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209; THORNE E T, 1988, Conservation Biology, V2, P66, DOI 10.1111/j.1523-1739.1988.tb00336.x; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VIGGERS KL, 1993, WILDLIFE RES, V20, P687, DOI 10.1071/WR9930687; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Whittington RJ, 1996, AUST VET J, V73, P112, DOI 10.1111/j.1751-0813.1996.tb09992.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WINDSOR DA, 1990, NATURE, V348, P104, DOI 10.1038/348104c0; WOBESER G, 1993, CAN VET J, V34, P353; WOODFORD MH, 1993, J ZOO WILDLIFE MED, V24, P265; Woodroffe R, 1999, ANIM CONSERV, V2, P185, DOI 10.1111/j.1469-1795.1999.tb00064.x; 1998, VET REC, V143, P378	140	2693	2826	30	1175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					443	449		10.1126/science.287.5452.443	http://dx.doi.org/10.1126/science.287.5452.443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642539				2022-12-28	WOS:000084929900034
J	Mead, DG; Ramberg, FB; Besselsen, DG; Mare, CJ				Mead, DG; Ramberg, FB; Besselsen, DG; Mare, CJ			Transmission of vesicular stomatitis virus from infected to noninfected black flies co-feeding on nonviremic deer mice	SCIENCE			English	Article							NEW-JERSEY; SIMULIUM-VITTATUM; DIPTERA; DISEASE; PSYCHODIDAE; WILDLIFE; HAMSTERS; HOSTS; RNA	Vesicular stomatitis is an economically important arboviral disease of Livestock, Viremia is absent in infected mammalian hosts, and the mechanism by which insects become infected with the causative agents, vesicular stomatitis viruses, remains unknown. Because infected and noninfected insects potentially feed on the same host in nature, infected and noninfected black flies were allowed to feed on the same host. Viremia was not detected in the host after infection by a black fly bite, but because noninfected black flies acquired the virus while co-feeding on the same host with infected black flies, it is concluded that a viremic host is not necessary for an insect to be infected with the virus. Thus co-feeding is a mechanism of infection for an insect-transmitted virus.	Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ 85721 USA	University of Arizona	Mead, DG (corresponding author), Univ Arizona, Dept Vet Sci & Microbiol, 1117 E Lowell, Tucson, AZ 85721 USA.	dmead@u.arizona.edu	Mead, Daniel/F-7501-2013					AGUIRRE AA, 1992, J WILDLIFE DIS, V28, P435, DOI 10.7589/0090-3558-28.3.435; ANDERSON J. R., 1961, ANN ENT SOC AMER, V54, P716, DOI 10.1093/aesa/54.5.716; ANDERSON JOHN R., 1963, MOSQUITO NEWS, V23, P126; Barrera JD, 1996, VIROLOGY, V219, P453, DOI 10.1006/viro.1996.0271; BERNARDO MJ, 1986, ANN ENTOMOL SOC AM, V79, P610, DOI 10.1093/aesa/79.4.610; CAVE DR, 1984, J VIROL, V50, P86, DOI 10.1128/JVI.50.1.86-91.1984; COMER JA, 1995, J MED ENTOMOL, V32, P738, DOI 10.1093/jmedent/32.5.738; COTTON WE, 1926, JAVMA, V70, P168; CUPP EW, 1992, J MED ENTOMOL, V29, P137, DOI 10.1093/jmedent/29.2.137; Cupp EW, 1997, J MED ENTOMOL, V34, P87, DOI 10.1093/jmedent/34.2.87; DAVIES DOUGLAS M., 1956, CANADIAN JOUR ZOOL, V34, P615, DOI 10.1139/z56-064; FRANCY DB, 1988, J MED ENTOMOL, V25, P343, DOI 10.1093/jmedent/25.5.343; FULTZ PN, 1982, J GEN VIROL, V63, P493, DOI 10.1099/0022-1317-63-2-493; FULTZ PN, 1985, VIRUS RES, V3, P129, DOI 10.1016/0168-1702(85)90003-6; GREEN SL, 1993, VET CLIN N AM-EQUINE, V9, P349, DOI 10.1016/S0749-0739(17)30401-7; Jenney E. W., 1972, Proceedings of the United States Animal Health Association, V76, P183; Jimenez AE, 1996, J WILDLIFE DIS, V32, P274, DOI 10.7589/0090-3558-32.2.274; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; KARSTAD L, 1957, AM J VET RES, V18, P162; Knowlton GF, 1935, J ECON ENTOMOL, V28, P824, DOI 10.1093/jee/28.5.824; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; MARE CJ, 1973, INFECT IMMUN, V8, P118; MARE CJ, 1991, P US ANIM HLTH ASS, V19, P179; MULLER MJ, 1987, J MED ENTOMOL, V24, P206, DOI 10.1093/jmedent/24.2.206; MURPHY FA, 1975, EXP MOL PATHOL, V23, P426, DOI 10.1016/0014-4800(75)90035-0; MURPHY FA, 1994, VIRUS TAXONOMY CLASS; PATTERSON WC, 1955, P US LIVESTOCK SANIT, V59, P368; PETERSON B. V., 1959, CANADIAN ENT, V91, P147; REDELMAN D, 1989, VET IMMUNOL IMMUNOP, V20, P345, DOI 10.1016/0165-2427(89)90080-9; RYCKMAN RE, 1961, J PARASITOL, V47, P405, DOI 10.2307/3275364; Stallknecht DE, 1999, AM J VET RES, V60, P43; TESH RB, 1970, AM J EPIDEMIOL, V91, P216, DOI 10.1093/oxfordjournals.aje.a121130; THORNE ET, 1983, P US ANIMAL HLTH ASS, V87, P638; THURMOND MC, 1987, J AM VET MED ASSOC, V191, P965; TITUS RG, 1990, PARASITOL TODAY, V6, P157, DOI 10.1016/0169-4758(90)90338-5; WEBB PA, 1987, J WILDLIFE DIS, V23, P192, DOI 10.7589/0090-3558-23.2.192; *WHO, 1967, TECH REP SER, V369, P9; *WHO, 1985, TECH REP SER, V719, P36; Wikel SK, 1999, BIOSCIENCE, V49, P311, DOI 10.2307/1313614; YOUNG DG, 1984, MOSQ NEWS, V44, P263; Yuill T. M., 1981, CRC handbook series in zoonoses. Section B: viral zoonoses. Volume I, P125	41	98	103	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					485	487		10.1126/science.287.5452.485	http://dx.doi.org/10.1126/science.287.5452.485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642550				2022-12-28	WOS:000084929900048
J	Gillick, MR				Gillick, MR			Sounding board - Rethinking the role of tube feeding in patients with advanced dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; NURSING-HOME RESIDENTS; LIFE-SUSTAINING TREATMENTS; TERMINALLY ILL PATIENTS; CARDIOPULMONARY-RESUSCITATION; ARTIFICIAL NUTRITION; SUPREME-COURT; CARE; PREFERENCES; DECISIONS		Hebrew Rehabil Ctr Aged, Boston, MA 02131 USA		Gillick, MR (corresponding author), Hebrew Rehabil Ctr Aged, Boston, MA 02131 USA.							Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Callahan CM, 1999, J AM GERIATR SOC, V47, P1105, DOI 10.1111/j.1532-5415.1999.tb05235.x; Callahan Daniel, 1993, TROUBLED DREAM LIFE; COSTA PT, 1996, AHCPR PUBLICATION; EVANS LK, 1989, J AM GERIATR SOC, V37, P65, DOI 10.1111/j.1532-5415.1989.tb01571.x; Fainsinger RL, 1997, SUPPORT CARE CANCER, V5, P205, DOI 10.1007/s005200050061; FEINBERG MJ, 1992, RADIOLOGY, V183, P811, DOI 10.1148/radiology.183.3.1584939; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; FINUCANE TE, 1997, LANCET, V349, P364; Fischer GS, 1997, ARCH INTERN MED, V157, P801, DOI 10.1001/archinte.157.7.801; Grant MD, 1998, JAMA-J AM MED ASSOC, V279, P1973, DOI 10.1001/jama.279.24.1973; HODGES MO, 1994, CLIN GERIATR MED, V10, P475, DOI 10.1016/S0749-0690(18)30334-3; Kane RS, 1997, J AM GERIATR SOC, V45, P154, DOI 10.1111/j.1532-5415.1997.tb04500.x; KAW M, 1994, DIGEST DIS SCI, V39, P738, DOI 10.1007/BF02087416; LO B, 1984, NEW ENGL J MED, V311, P402, DOI 10.1056/NEJM198408093110611; LO B, 1991, ANN INTERN MED, V114, P895, DOI 10.7326/0003-4819-114-10-895; LYNN J, 1986, BY NO EXTRORDINARY M, P47; MCCANN RM, 1994, JAMA-J AM MED ASSOC, V272, P1263, DOI 10.1001/jama.272.16.1263; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 1999, CAN MED ASSOC J, V160, P1705; Mitchell SL, 1998, J GERONTOL A-BIOL, V53, pM207, DOI 10.1093/gerona/53A.3.M207; Morris J, 1997, MEASUREMENT ELDERLY, P130; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; *NAT C CATH BISH, 1995, ETH REL DIR CATH HLT; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; OBrien LA, 1997, J GEN INTERN MED, V12, P364, DOI 10.1046/j.1525-1497.1997.00061.x; OUSLANDER JG, 1993, J AM GERIATR SOC, V41, P70, DOI 10.1111/j.1532-5415.1993.tb05951.x; PECK A, 1990, J AM GERIATR SOC, V38, P1195, DOI 10.1111/j.1532-5415.1990.tb01498.x; Petersen TI, 1997, EUR J SURG, V163, P351; PHILLIPS PA, 1984, NEW ENGL J MED, V311, P753, DOI 10.1056/NEJM198409203111202; Post SG, 1995, MORAL CHALLENGE ALZH; Rabeneck L, 1997, LANCET, V349, P496, DOI 10.1016/S0140-6736(96)07369-2; Rabeneck L, 1996, J GEN INTERN MED, V11, P287, DOI 10.1007/BF02598270; Rosin AJ, 1998, J MED ETHICS, V24, P44, DOI 10.1136/jme.24.1.44; Sachs GA, 1998, J AM GERIATR SOC, V46, P782, DOI 10.1111/j.1532-5415.1998.tb03818.x; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; SCHOSTAK RZ, 1994, J MED ETHICS, V20, P93, DOI 10.1136/jme.20.2.93; SHAILESH LTC, 1992, AM J SURG, V164, P114, DOI 10.1016/S0002-9610(05)80367-8; Sheiman SL, 1996, J AM GERIATR SOC, V44, P1268, DOI 10.1111/j.1532-5415.1996.tb01384.x; SIEGLER M, 1985, ARCH INTERN MED, V145, P129, DOI 10.1001/archinte.145.1.129; SLOMKA J, 1995, ARCH INTERN MED, V155, P1258, DOI 10.1001/archinte.155.12.1258; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14; STEINBROOK R, 1988, NEW ENGL J MED, V318, P286, DOI 10.1056/NEJM198802043180505; SULLIVAN RJ, 1993, J GEN INTERN MED, V8, P220, DOI 10.1007/BF02599271; Sullivan-Marx EM, 1999, J AM GERIATR SOC, V47, P342, DOI 10.1111/j.1532-5415.1999.tb02999.x; TAYLOR CA, 1992, MAYO CLIN PROC, V67, P1042, DOI 10.1016/S0025-6196(12)61118-5; Thomasma D., 1992, DEMENTIA AGING ETHIC, P101; VOLICER L, 1986, JAMA-J AM MED ASSOC, V256, P2210, DOI 10.1001/jama.256.16.2210; WEIR RF, 1990, JAMA-J AM MED ASSOC, V264, P1846, DOI 10.1001/jama.264.14.1846	50	335	343	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					206	210		10.1056/NEJM200001203420312	http://dx.doi.org/10.1056/NEJM200001203420312			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275ZT	10639550				2022-12-28	WOS:000084851700012
J	Edelman, JM; Turpin, JA; Bronsky, EA; Grossman, J; Kemp, JP; Ghannam, AF; DeLucca, PT; Gormley, GJ; Pearlman, DS				Edelman, JM; Turpin, JA; Bronsky, EA; Grossman, J; Kemp, JP; Ghannam, AF; DeLucca, PT; Gormley, GJ; Pearlman, DS		Exercise Study Grp	Oral Montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction - A randomized, double-blind trial	ANNALS OF INTERNAL MEDICINE			English	Article							LEUKOTRIENE-RECEPTOR ANTAGONIST; INDUCED ASTHMA; INDUCED BRONCHOSPASM; PROTECTION; CHILDREN; SUBSENSITIVITY; SALBUTAMOL; TOLERANCE; MILD	Background: Montelukast, an oral, once-daily leukotriene receptor antagonist, provides protection against exercise-induced bronchoconstriction. Objective: To evaluate the effect of 8 weeks of therapy with salmeterol aerosol or montelukast on exercise-induced bronchoconstriction in adults with asthma. Design: 8-week multicenter, randomized, double-blind study. Setting: 17 asthma treatment centers in the United States. Patients: 191 adults with asthma who had documented exercise-induced bronchoconstriction. Intervention: qualified patients were randomly assigned to double-blind treatment with montelukast (10 mg once in the evening) or salmeterol (50 mu g [2 puffs] twice daily). Measurements: Changes in pre-exercise and postexercise challenge values; percentage inhibition in the maximal percentage decrease in FEV,; the area above the FEV1-time curve; and time to recovery of FEV, at days 1 to 3, week 4, and week 8 of treatment. Results: By day 3, similar and statistically significant reductions in maximal percentage decrease in FEV, were seen with both therapies. Sustained improvement occurred in the montelukast group at weeks 4 and 8; at these time points, the bronchoprotective effect of salmeterol decreased significantly. At week 8, the percentage inhibition in the maximal percentage decrease in FEV, was 57.2% in the montelukast group and 33.0% in the salmeterol group (P = 0,002), By week 8, 67% of patients receiving montelukast and 46% of patients receiving salmeterol had a maximal percentage decrease in FEV, of less than 20%, Conclusions: The bronchoprotective effect of montelukast was maintained throughout 8 weeks of study. In contrast, significant loss of bronchoprotection at weeks 4 and was seen with salmeterol. Long-term administration of montelukast provided consistent inhibition of exercise- induced bronchoconstriction at the end of the 8-week dosing interval without tolerance.	Merck & Co Inc, West Point, PA 19486 USA; Intermt Clin Res, Salt Lake City, UT USA; VIVRA Res Partners, Tucson, AZ USA; Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA; Colorado Allergy & Asthma Clin PC, Aurora, CO USA	Merck & Company	Edelman, JM (corresponding author), Merck & Co Inc, Box 4,HM-220, West Point, PA 19486 USA.							BARNES NC, 1984, THORAX, V39, P500, DOI 10.1136/thx.39.7.500; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Bronsky EA, 1997, CLIN PHARMACOL THER, V62, P556, DOI 10.1016/S0009-9236(97)90051-5; CYPCAR D, 1994, CLIN CHEST MED, V15, P351; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; EGGLESTON PA, 1976, J ALLERGY CLIN IMMUN, V58, P414, DOI 10.1016/0091-6749(76)90122-6; FINNERTY JP, 1992, AM REV RESPIR DIS, V145, P746, DOI 10.1164/ajrccm/145.4_Pt_1.746; FREEZER NJ, 1995, EUR RESPIR J, V8, P1488; GREEN CP, 1992, ARCH DIS CHILD, V67, P1014, DOI 10.1136/adc.67.8.1014; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Inman MD, 1996, AM J RESP CRIT CARE, V153, P65, DOI 10.1164/ajrccm.153.1.8542164; ISRAEL E, 1994, ANN ALLERGY, V72, P279; KEMP JP, 1994, AM J RESP CRIT CARE, V150, P1612, DOI 10.1164/ajrccm.150.6.7952623; Kemp JP, 1998, J PEDIATR-US, V133, P424, DOI 10.1016/S0022-3476(98)70281-1; KIKAWA Y, 1992, J ALLERGY CLIN IMMUN, V89, P1111, DOI 10.1016/0091-6749(92)90294-C; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; Nelson JA, 1998, NEW ENGL J MED, V339, P141, DOI 10.1056/NEJM199807163390301; NEWNHAM DM, 1993, RESP MED, V87, P439, DOI 10.1016/0954-6111(93)90070-G; RAMAGE L, 1994, RESP MED, V88, P363, DOI 10.1016/0954-6111(94)90042-6; Reiss TF, 1997, THORAX, V52, P1030, DOI 10.1136/thx.52.12.1030; Reiss TF, 1997, THORAX, V52, P45, DOI 10.1136/thx.52.1.45; Simons FER, 1997, PEDIATRICS, V99, P655, DOI 10.1542/peds.99.5.655; SMITH LJ, 1985, AM REV RESPIR DIS, V131, P368; SMYTH ET, 1993, BRIT MED J, V306, P543, DOI 10.1136/bmj.306.6877.543; 1995, AM J RESPIR CRIT CAR, V152, P1107; 1998, POCKET GUIDE PHYSICA; 1996, H ALLERGY CLIN IMMUN, V98, P475; 1997, NATL ASTHMA ED PREVE	30	145	149	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					97	104		10.7326/0003-4819-132-2-200001180-00002	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644288				2022-12-28	WOS:000084852300001
J	Chan, AWS; Dominko, T; Luetjens, CM; Neuber, E; Martinovich, C; Hewitson, L; Simerly, CR; Schatten, GP				Chan, AWS; Dominko, T; Luetjens, CM; Neuber, E; Martinovich, C; Hewitson, L; Simerly, CR; Schatten, GP			Clonal propagation of primate offspring by embryo splitting	SCIENCE			English	Article							CELLS; FETAL; MOUSE; ADULT	Primates that are identical in both nuclear and cytoplasmic components have not been produced by current cloning strategies, yet such identicals represent the ideal model for investigations of human diseases. Here, genetically identical nonhuman embryos were produced as twin and larger sets by separation and reaggregation of blastomeres of cleavage-stage embryos. A total of 368 multiples were created by the splitting of 107 rhesus embryos with four pregnancies established after 13 embryo transfers (31% versus 53% in vitro fertilization controls). The birth of Tetra, a healthy female cloned from a quarter of an embryo, proves that this approach can result in live offspring.	Oregon Reg Primate Res Ctr, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University	Schatten, GP (corresponding author), Oregon Reg Primate Res Ctr, Beaverton, OR 97006 USA.	schatten@ohsu.edu	simerly, Calvin/AAC-9564-2021; Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782				Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; COHEN J, 1992, HUM REPROD, V7, P685, DOI 10.1093/oxfordjournals.humrep.a137720; Evans MJ, 1999, NAT GENET, V23, P90, DOI 10.1038/12696; Gardner RL, 1997, DEVELOPMENT, V124, P289; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hewitson L, 1998, HUM REPROD, V13, P3449, DOI 10.1093/humrep/13.12.3449; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Heyman Y, 1998, REPROD NUTR DEV, V38, P595, DOI 10.1051/rnd:19980602; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; KOLBERG R, 1993, SCIENCE, V262, P652, DOI 10.1126/science.8235583; Leese HJ, 1998, HUM REPROD, V13, P184, DOI 10.1093/humrep/13.suppl_4.184; Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977; PAPAIOANNOU VE, 1989, DEVELOPMENT, V106, P817; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; SEIKE N, 1990, JPN J VET RES, V38, P1; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; TARANTAL AF, 1988, AM J PRIMATOL, V15, P309, DOI 10.1002/ajp.1350150405; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wells DN, 1998, REPROD FERT DEVELOP, V10, P369, DOI 10.1071/R98109; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf DP, 1999, BIOL REPROD, V60, P199, DOI 10.1095/biolreprod60.2.199; Wu GJ, 1996, BIOL REPROD, V55, P260, DOI 10.1095/biolreprod55.2.260	28	92	101	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					317	319		10.1126/science.287.5451.317	http://dx.doi.org/10.1126/science.287.5451.317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634789				2022-12-28	WOS:000084769600044
J	Nauta, K; Miller, RE				Nauta, K; Miller, RE			Formation of cyclic water hexamer in liquid helium: The smallest piece of ice	SCIENCE			English	Article							AB-INITIO; VIBRATIONAL SPECTROSCOPY; CAGE FORM; CLUSTERS; SPECTRA; MOLECULES; COMPLEXES; (H2O)(N); TETRAMER; ENERGIES	The cyclic water hexamer, a higher energy isomer than the cage structure previously characterized in the gas phase, was formed in liquid helium droplets and studied with infrared spectroscopy. This isomer is formed selectively as a result of unique cluster growth processes in liquid helium. The experimental results indicate that the cyclic hexamer is formed by insertion of water molecules into smaller preformed cyclic complexes and that the rapid quenching provided by the liquid helium inhibits its rearrangement to the more stable cage structure.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Miller, RE (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.							Behrens M, 1999, J CHEM PHYS, V111, P2436, DOI 10.1063/1.479521; BELCH AC, 1987, J CHEM PHYS, V86, P5676, DOI 10.1063/1.452545; Brown MG, 1998, J CHEM PHYS, V109, P9645, DOI 10.1063/1.477630; Brudermann J, 1999, J CHEM PHYS, V110, P10649, DOI 10.1063/1.479008; Buck U, 1998, PHYS REV LETT, V80, P2578, DOI 10.1103/PhysRevLett.80.2578; Cruzan JD, 1996, SCIENCE, V271, P59, DOI 10.1126/science.271.5245.59; Frochtenicht R, 1996, J CHEM PHYS, V105, P6128, DOI 10.1063/1.472472; HARTMANN M, 1995, PHYS REV LETT, V75, P1566, DOI 10.1103/PhysRevLett.75.1566; Huisken F, 1996, J CHEM PHYS, V104, P17, DOI 10.1063/1.470871; Kim J, 1999, J CHEM PHYS, V110, P9128, DOI 10.1063/1.478834; Kim J, 1998, J CHEM PHYS, V109, P5886, DOI 10.1063/1.477211; KOFRANEK M, 1987, CHEM PHYS, V113, P53, DOI 10.1016/0301-0104(87)80219-7; Liu K, 1997, J PHYS CHEM A, V101, P8995, DOI 10.1021/jp9707807; Liu K, 1996, NATURE, V381, P501, DOI 10.1038/381501a0; MHIN BJ, 1991, CHEM PHYS LETT, V176, P41, DOI 10.1016/0009-2614(91)90007-V; MILLER RE, 1988, SCIENCE, V240, P447, DOI 10.1126/science.240.4851.447; Nauta K, 1999, SCIENCE, V283, P1895, DOI 10.1126/science.283.5409.1895; Nauta K, 1999, J CHEM PHYS, V111, P3426, DOI 10.1063/1.479627; Pedulla JM, 1998, CHEM PHYS LETT, V291, P78, DOI 10.1016/S0009-2614(98)00582-X; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; Remacle F, 1998, INT J QUANTUM CHEM, V67, P85, DOI 10.1002/(SICI)1097-461X(1998)67:2<85::AID-QUA3>3.0.CO;2-U; SPEEDY RJ, 1987, J PHYS CHEM-US, V91, P909, DOI 10.1021/j100288a029; TSAI CJ, 1993, CHEM PHYS LETT, V213, P181, DOI 10.1016/0009-2614(93)85438-T; TSAI CJ, 1993, J PHYS CHEM-US, V97, P11227, DOI 10.1021/j100145a019; Viant MR, 1999, J CHEM PHYS, V110, P4369, DOI 10.1063/1.478319; Wales DJ, 1997, J CHEM PHYS, V106, P7193, DOI 10.1063/1.473681; Xantheas SS, 1996, PHILOS MAG B, V73, P107, DOI 10.1080/13642819608239116; XANTHEAS SS, 1993, J CHEM PHYS, V99, P8774, DOI 10.1063/1.465599; XANTHEAS SS, 1995, J CHEM PHYS, V102, P4505, DOI 10.1063/1.469499	29	554	561	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					293	295		10.1126/science.287.5451.293	http://dx.doi.org/10.1126/science.287.5451.293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634781				2022-12-28	WOS:000084769600036
J	Legler, B; Moore, G				Legler, B; Moore, G			East German academics faced unfair hurdles	NATURE			English	Letter											Legler, B (corresponding author), Erfenschlager Str 150, D-09125 Chemnitz, Germany.							REICH J, 1999, NATURE, V401, P637	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					130	130		10.1038/35003044	http://dx.doi.org/10.1038/35003044			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646576	Bronze			2022-12-28	WOS:000084835300021
J	Havlir, DV; Hellmann, NS; Petropoulos, CJ; Whitcomb, JM; Collier, AC; Hirsch, MS; Tebas, P; Sommadossi, JP; Richman, DD				Havlir, DV; Hellmann, NS; Petropoulos, CJ; Whitcomb, JM; Collier, AC; Hirsch, MS; Tebas, P; Sommadossi, JP; Richman, DD			Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 RNA LOAD; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; IN-VIVO; TREATED PATIENTS; RESISTANCE; ZIDOVUDINE; MUTATIONS	Context Loss of viral suppression in patients infected with human immunodeficiency virus (HIV), who,are receiving potent antiretroviral therapy, has been attributed to outgrowth of drug-resistant virus; however, resistance patterns are not well characterized in patients whose protease inhibitor combination therapy fails after achieving viral suppression. Objective To characterize drug susceptibility of virus from HIV-infected patients who are failing to sustain suppression while taking an indinavir-containing antiretroviral regimen. Design and Setting Substudy of the AIDS Clinical Trials Group 343, a multicenter clinical research trial conducted between February 1997 and October 1998. Patients Twenty-six:subjects who experienced rebound (HIV RNA level greater than or equal to 200 copies/mL) during indinavir monotherapy (n = 9) or triple-drug therapy (indinavir, lamivudine, and zidovudine; n = 17) after initially achieving suppression while receiving all 3 drugs, and 10 control subjects who had viral suppression while receiving triple-drug therapy. Main Outcome Measure: Drug susceptibility, determined by a phenotypic assay and genotypic evidence of resistance assessed by nucleotide sequencing of protease and reverse transcriptase; compared: among the 3 patient groups. Results Indinavir resistance was not detected in the 9 subjects with viral rebound during indinavir monotherapy, or in the 17 subjects with rebound during triple-drug therapy, despite plasma HIV RNA levels ranging from 10(2) to 10(5) copies/mL. In contrast, lamivudine resistance was detected by phenotypic assay in rebound isolates from 14 of 17 subjects receiving triple-drug therapy, and genotypic analyses sh owed chan ges at codon 184 of reverse transcriptase in these 14 isolates. Mean random plasma indinavir concentrations in the 2 groups with rebound were similar to those of a control group with sustained viral suppression, although levels below 50 ng/mL were more frequent in the triple-drug group than in the control group (P = .03). Conclusions Loss of viral suppression may be due to suboptimal antiviral potency, and selection of a predominantly indinavir-resistant virus population may be delayed for months even in the presence of ongoing indinavir therapy. The results suggest possible value in assessing strategies using drug components of failing regimens evaluated with resistance testing.	Univ Calif San Diego, San Diego, CA 92103 USA; San Diego Vet Affairs Med Ctr, San Diego, CA USA; ViroLog Inc, San Francisco, CA USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Washington, Sch Med, Seattle, WA USA; Washington Univ, St Louis, MO USA; Univ Alabama Birmingham, Birmingham, AL USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Havlir, DV (corresponding author), Univ Calif San Diego, 2760 5th Ave,Suite 300, San Diego, CA 92103 USA.	dhavlir@ucsd.edu	Tebas, Pablo/A-7061-2008	Tebas, Pablo/0000-0001-5345-7942	NIAID NIH HHS [AI27670, AI36214, AI38858] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, U01AI038858, U01AI027670] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BACHELER L, 1998, 12 WORLD AIDS C JUN; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; deJong MD, 1996, P NATL ACAD SCI USA, V93, P5501, DOI 10.1073/pnas.93.11.5501; DESCAMPS D, 1999, 6 C RETR OPP INF JAN; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; GULNIK SV, 1995, BIOCHEMISTRY-US, V34, P9282, DOI 10.1021/bi00029a002; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; HELIMANN N, 1999, 3 INT WORKSH DRUG RE; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HO DD, 1994, J VIROL, V68, P2016, DOI 10.1128/JVI.68.3.2016-2020.1994; HOLDER DJ, 1999, 6 C RETR OPP INF JAN; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; LARDER B, 1996, ANTIVIRAL DRUG RESIS, P169; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; MARKOWITZ M, 1996, ANTIVIRAL DRUG RESIS, P261; MAYERS D, 1997, INT WORKSH HIV DRUG; MCLEAN AR, 1992, AIDS, V6, P71, DOI 10.1097/00002030-199201000-00009; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; NIJHUIS M, 1997, INT WORKSH HIV DRUG; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Shafer RW, 1998, ANN INTERN MED, V128, P906, DOI 10.7326/0003-4819-128-11-199806010-00008; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wein LM, 1998, J THEOR BIOL, V192, P81, DOI 10.1006/jtbi.1997.0622; Young B, 1998, J INFECT DIS, V178, P1497, DOI 10.1086/314437; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998	37	223	224	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					229	234		10.1001/jama.283.2.229	http://dx.doi.org/10.1001/jama.283.2.229			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634339				2022-12-28	WOS:000084661400029
J	Shapiro, L; Losick, R				Shapiro, L; Losick, R			Dynamic spatial regulation in the bacterial cell	CELL			English	Review							DEVELOPMENTAL TRANSCRIPTION FACTOR; DIVISION PROTEIN FTSZ; COLI F-PLASMID; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; POLAR LOCALIZATION; SUBCELLULAR-LOCALIZATION; CHROMOSOME SEGREGATION; PROTEOLYTIC ACTIVATION		Stanford Univ, Sch Med, Beckman Ctr, Dept Dev Biol, Stanford, CA 94305 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Stanford University; Harvard University	Shapiro, L (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Dev Biol, Stanford, CA 94305 USA.							ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; ALLEY MRK, 1993, SCIENCE, V259, P1754, DOI 10.1126/science.8456303; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Cervin MA, 1998, MOL MICROBIOL, V29, P85, DOI 10.1046/j.1365-2958.1998.00905.x; CUTTING S, 1991, GENE DEV, V5, P456, DOI 10.1101/gad.5.3.456; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; ELY B, 1984, GENETICS, V108, P523; Fawcett P, 1998, MOL MICROBIOL, V28, P931, DOI 10.1046/j.1365-2958.1998.00849.x; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Feucht A, 1999, MOL MICROBIOL, V33, P1015, DOI 10.1046/j.1365-2958.1999.01543.x; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; GOMEZ M, 1995, J BACTERIOL, V177, P4825, DOI 10.1128/jb.177.16.4825-4827.1995; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hanai R, 1996, J BIOL CHEM, V271, P17469, DOI 10.1074/jbc.271.29.17469; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hofmeister A, 1998, J BACTERIOL, V180, P2426, DOI 10.1128/JB.180.9.2426-2433.1998; HOFMEISTER AEM, 1995, CELL, V83, P219, DOI 10.1016/0092-8674(95)90163-9; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jacobs C, 1998, CURR OPIN GENET DEV, V8, P386, DOI 10.1016/S0959-437X(98)80107-X; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; JU J, 1999, J BACTERIOL, V18; Ju JL, 1997, J BACTERIOL, V179, P4888, DOI 10.1128/jb.179.15.4888-4893.1997; KAROW ML, 1995, P NATL ACAD SCI USA, V92, P2012, DOI 10.1073/pnas.92.6.2012; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Kim SK, 1999, P NATL ACAD SCI USA, V96, P8557, DOI 10.1073/pnas.96.15.8557; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 2000, PROKARYOTIC DEVELOPMENT, P167; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lewis AP, 1999, PROTEIN SCI, V8, P439; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; LONDONOVALLEJO JA, 1995, GENE DEV, V9, P503, DOI 10.1101/gad.9.4.503; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; LU SJ, 1990, P NATL ACAD SCI USA, V87, P9722, DOI 10.1073/pnas.87.24.9722; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Niki H, 1998, GENE DEV, V12, P1036, DOI 10.1101/gad.12.7.1036; Niki H, 1997, CELL, V90, P951, DOI 10.1016/S0092-8674(00)80359-1; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Resnekov O, 1996, GENES CELLS, V1, P529, DOI 10.1046/j.1365-2443.1996.d01-262.x; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; SHAZAND K, 1995, EMBO J, V14, P1439, DOI 10.1002/j.1460-2075.1995.tb07130.x; SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989; SOMMER JM, 1991, GENETICS, V129, P623; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; Wheeler RT, 1998, CURR OPIN MICROBIOL, V1, P636, DOI 10.1016/S1369-5274(98)80108-2; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973; Zhang B, 1998, J BACTERIOL, V180, P2434, DOI 10.1128/JB.180.9.2434-2441.1998	84	103	104	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					89	98		10.1016/S0092-8674(00)81686-4	http://dx.doi.org/10.1016/S0092-8674(00)81686-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647934	Bronze			2022-12-28	WOS:000084722600008
J	Scholin, CA; Gulland, F; Doucette, GJ; Benson, S; Busman, M; Chavez, FP; Cordaro, J; DeLong, R; De Vogelaere, A; Harvey, J; Haulena, M; Lefebvre, K; Lipscomb, T; Loscutoff, S; Lowenstine, LJ; Marin, R; Miller, PE; McLellan, WA; Moeller, PDR; Powell, CL; Rowles, T; Silvagni, P; Silver, M; Spraker, T; Trainer, V; Van Dolah, FM				Scholin, CA; Gulland, F; Doucette, GJ; Benson, S; Busman, M; Chavez, FP; Cordaro, J; DeLong, R; De Vogelaere, A; Harvey, J; Haulena, M; Lefebvre, K; Lipscomb, T; Loscutoff, S; Lowenstine, LJ; Marin, R; Miller, PE; McLellan, WA; Moeller, PDR; Powell, CL; Rowles, T; Silvagni, P; Silver, M; Spraker, T; Trainer, V; Van Dolah, FM			Mortality of sea lions along the central California coast linked to a toxic diatom bloom	NATURE			English	Article							DOMOIC ACID; HIPPOCAMPAL DAMAGE; PROBES; MICE	Over 400 California sea lions (Zalophus californianus) died and many others displayed signs of neurological dysfunction along the central California coast during May and June 1998. A bloom of Pseudo-nitzschia australis (diatom) was observed in the Monterey Bay region during the same period. This bloom was associated with production of domoic acid (DA), a neurotoxin(1) that was also detected in planktivorous fish, including the northern anchovy (Engraulis mordax), and in sea lion body fluids. These and other concurrent observations demonstrate the trophic transfer of DA resulting in marine mammal mortality. In contrast to fish, blue mussels (Mytilus edulus) collected during the DA outbreak contained no DA or only trace amounts. Such findings reveal that monitoring of mussel toxicity alone does not necessarily provide adequate warning of DA entering the food web at levels sufficient to harm marine wildlife and perhaps humans.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Marin Headlands, Marine Mammal Ctr, Sausalito, CA 94965 USA; Natl Ocean Serv, Marine Biotoxins Program, NOAA, Charleston, SC 29412 USA; Moss Landing Marine Labs, Moss Landing, CA 95039 USA; Natl Marine Fisheries Serv, Long Beach, CA 90802 USA; Natl Marine Mammal Lab, Seattle, WA 98115 USA; Monterey Bay Natl Marine Sanctuary, Monterey, CA 93940 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Armed Forces Inst Pathol, Washington, DC 20306 USA; Calif Dept Hlth Serv, Food & Drug Branch, Sacramento, CA 94234 USA; Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; Univ N Carolina, Wilmington, NC 28403 USA; Natl Marine Fisheries Serv, Silver Spring, MD 20910 USA; Colorado State Univ, Coll Vet Med, Ft Collins, CO 80523 USA; Natl Marine Fisheries Serv, NOAA, ECD, Seattle, WA 98112 USA	Monterey Bay Aquarium Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Moss Landing Marine Laboratories; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; United States Department of Defense; California Department of Health Care Services; University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington; National Oceanic Atmospheric Admin (NOAA) - USA; Colorado State University; National Oceanic Atmospheric Admin (NOAA) - USA	Scholin, CA (corresponding author), Monterey Bay Aquarium Res Inst, 770 Sandholdt Rd, Moss Landing, CA 95039 USA.	scholin@mbari.org	Doucette, Gregory/M-3283-2013; Busman, Mark/AFM-0629-2022; Trainer, Vera/AAE-9306-2022; Busman, Mark/AAH-3042-2022	Busman, Mark/0000-0001-9750-064X				ANDERSON DM, 1993, 9302 WOODS HOL OC I; ANTONELIS GA, 1984, FISH B-NOAA, V82, P67; Bates S. S., 1998, PHYSL ECOLOGY HARMFU, P405; Bates S.S., 1998, PHYSL ECOLOGY HARMFU, P267; Beltran AS, 1997, TOXICON, V35, P447, DOI 10.1016/S0041-0101(96)00140-7; BOESCH DF, 1997, NOAA COASTAL OCEAN P, V10; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; CHAVEZ FP, 1991, J GEOPHYS RES-OCEANS, V96, P14833, DOI 10.1029/91JC01163; DAKSHINAMURTI K, 1993, J NEUROSCI, V13, P4486; GERACI JR, 1989, CAN J FISH AQUAT SCI, V46, P1895, DOI 10.1139/f89-238; Gulland F, 1999, NMFSOPR8 NOAA; Harwood J, 1998, NATURE, V393, P17, DOI 10.1038/29877; Hatfield Christine L., 1994, Natural Toxins, V2, P206, DOI 10.1002/nt.2620020409; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; McClain CR, 1998, SEA TECHNOL, V39, P10; Miller PE, 1998, J PHYCOL, V34, P371, DOI 10.1046/j.1529-8817.1998.340371.x; Ochoa JI, 1998, J SHELLFISH RES, V17, P1671; PARSONS TR, 1984, BIOL OCEANOGRAPHIC P, P39; QUILLIAM MA, 1995, J AOAC INT, V78, P543; Sakamoto CM, 1990, 902 MBARI; Scholin C, 1997, LIMNOL OCEANOGR, V42, P1265, DOI 10.4319/lo.1997.42.5_part_2.1265; SCHOLIN CA, IN PRESS J PHYCOL; STRAIN SM, 1991, NEUROSCIENCE, V44, P343, DOI 10.1016/0306-4522(91)90059-W; SUTHERLAND RJ, 1990, NEUROSCI LETT, V120, P221, DOI 10.1016/0304-3940(90)90043-9; VanDolah FM, 1997, ANAL BIOCHEM, V245, P102, DOI 10.1006/abio.1996.9889; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54; WRIGHT JLC, 1995, MANUAL HARMFUL MARIN, P113	27	587	612	2	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					80	84		10.1038/47481	http://dx.doi.org/10.1038/47481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638756				2022-12-28	WOS:000084687400046
J	Scott, HD; Bell, J; Geller, S; Thomas, M				Scott, HD; Bell, J; Geller, S; Thomas, M			Physicians helping the underserved - The Reach Out program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-INSURANCE	In the current health care environment of competition and market forces, concern has arisen that the classic principle of serving disadvantaged persons may not be fulfilled due to pressures from managed care. Reach Out, a $12 million national program of the Robert Wood Johnson Foundation, was developed to recruit leaders from among practicing physicians to organize projects to care for the uninsured and underserved, Physician volunteerism was a key component of all projects. Thirty-nine Reach Out projects were implemented and carried out across the United States, with average funding per project of $300 000 distributed over a period of 4 years. Seven model types emerged, the most common of which, the free clinic and the referral network, accounted for two thirds of the total. At the program's conclusion, 199 584 patients were enrolled and 11 252 physicians recruited. Project execution was more complex than initially supposed, and major progress commonly was not evident until the third or fourth year, but at least two thirds of the projects are likely to continue with local support. With strong physician leadership and a funded administrative core, organized community efforts can develop and sustain an effective program. Programs such as Reach Out cannot solve the national problem of access to health care, but they can make a small but important impact on the number of uninsured and underserved persons without access to health care.	Brown Univ, Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, Pawtucket, RI 02860 USA	Brown University	Scott, HD (corresponding author), Brown Univ, Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, 111 Brewster St,Wood 5, Pawtucket, RI 02860 USA.							BURSTIN HR, 1993, JAMA-J AM MED ASSOC, V270, P1697, DOI 10.1001/jama.270.14.1697; Campbell J., 1999, HLTH INSURANCE COVER; Carrasquillo O, 1999, AM J PUBLIC HEALTH, V89, P36, DOI 10.2105/AJPH.89.1.36; Cunningham PJ, 1999, JAMA-J AM MED ASSOC, V281, P1087, DOI 10.1001/jama.281.12.1087; Donelan K, 1996, JAMA-J AM MED ASSOC, V276, P1346, DOI 10.1001/jama.276.16.1346; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; Kuttner R, 1999, NEW ENGL J MED, V340, P163, DOI 10.1056/NEJM199901143400226; MORRIS GS, 1998, J AM CITIZENSHIP POL, V89, P45; Wielawski I, 1997, Mod Healthc, V27, P56; WIELAWSKI I, 1994, LA TIMES        0930, pB7; WIELAWSKI IM, 1995, BOSTON GLOBE MA 1015, P34; WIELAWSKI IM, 1998, ADVANCES S, P1; WIELAWSKI IM, 1995, BOSTON GLOBE MA 1015, P26; Wielawski IM, 1997, IMPROVE HLTH HLTH CA, P1; WIELAWSKI IM, 1995, BOSTON GLOBE MA 1015, P12	16	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					99	104		10.1001/jama.283.1.99	http://dx.doi.org/10.1001/jama.283.1.99			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632287	Bronze			2022-12-28	WOS:000084514400032
J	Spanagel, R				Spanagel, R			Is there a pharmacological basis for therapy with rapid opioid detoxification?	LANCET			English	Editorial Material							RECEPTOR BLOCKADE; ADDICTED PATIENTS; ANESTHESIA		Max Planck Inst Psychiat, Dept Psychopharmacol, D-80804 Munich, Germany	Max Planck Society	Spanagel, R (corresponding author), Max Planck Inst Psychiat, Dept Psychopharmacol, D-80804 Munich, Germany.							Bell JR, 1999, MED J AUSTRALIA, V171, P26, DOI 10.5694/j.1326-5377.1999.tb123493.x; Kienbaum P, 1998, ANESTHESIOLOGY, V88, P1154, DOI 10.1097/00000542-199805000-00004; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Maldonado R, 1996, NEUROBIOLOGICAL MECH; Miotto K, 1997, DRUG ALCOHOL DEPEN, V45, P131, DOI 10.1016/S0376-8716(97)01348-3; MORRIS BJ, 1988, J PHARMACOL EXP THER, V247, P729; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; O'Connor PG, 1998, JAMA-J AM MED ASSOC, V279, P229, DOI 10.1001/jama.279.3.229; Rabinowitz J, 1997, DRUG ALCOHOL DEPEN, V47, P77, DOI 10.1016/S0376-8716(97)00073-2; Roizen MF, 1998, ANESTHESIOLOGY, V88, P1142, DOI 10.1097/00000542-199805000-00002; Seoane A, 1997, BRIT J PSYCHIAT, V171, P340, DOI 10.1192/bjp.171.4.340; Spanagel R, 1998, DRUG ALCOHOL DEPEN, V52, P251, DOI 10.1016/S0376-8716(98)00106-9; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	13	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2017	2018		10.1016/S0140-6736(99)90248-9	http://dx.doi.org/10.1016/S0140-6736(99)90248-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636363				2022-12-28	WOS:000084183300006
J	Smyth, MG; Hoult, J				Smyth, MG; Hoult, J			The home treatment enigma	BRITISH MEDICAL JOURNAL			English	Article							MENTAL-ILLNESS; COMMUNITY CARE; PSYCHIATRY; HOSPITALS; SERVICE; PEOPLE; TRIAL; MODEL		No Birmingham Mental Hlth NHS Trust, Dept Psychiat, Birmingham B23 6AL, W Midlands, England		Smyth, MG (corresponding author), No Birmingham Mental Hlth NHS Trust, Dept Psychiat, Birmingham B23 6AL, W Midlands, England.							AUDINI B, 1994, BRIT J PSYCHIAT, V165, P204, DOI 10.1192/bjp.165.2.204; BRAUN P, 1981, AM J PSYCHIAT, V138, P736; COID J, 1994, BRIT MED J, V308, P805, DOI 10.1136/bmj.308.6932.805a; Deahl M, 1997, BRIT J PSYCHIAT, V171, P6, DOI 10.1192/bjp.171.1.6; DEAN C, 1993, BRIT MED J, V307, P473, DOI 10.1136/bmj.307.6902.473; DEDMAN P, 1993, BRIT MED J, V306, P1359, DOI 10.1136/bmj.306.6889.1359; Department of Health, 1998, MOD MENT HLTH SERV; FENTON FR, 1979, ARCH GEN PSYCHIAT, V36, P1073; HOULT J, 1986, BRIT J PSYCHIAT, V149, P137, DOI 10.1192/bjp.149.2.137; JOY CB, 1998, COCHRANE LIB; KIESLER CA, 1982, AM PSYCHOL, V37, P349, DOI 10.1037/0003-066X.37.4.349; Kleinman A., 1988, ILLNESS NARRATIVES; KLIUTER H, 1997, CURR OPIN PSYCHIATR, V10, P160; Marshall M, 1997, BRIT MED J, V314, P246; MARSON DC, 1988, AM J PSYCHIAT, V145, P918; Minghella E, 1998, OPEN ALL HOURS 24 HO; *MON INN LOND MENT, 1995, PSYCHIAT B, V19, P276; MOSHER LR, 1983, NEW ENGL J MED, V309, P1579, DOI 10.1056/NEJM198312223092512; MUIJEN M, 1992, BRIT MED J, V304, P749, DOI 10.1136/bmj.304.6829.749; Pasaminick B, 1967, SCHIZOPHRENIA COMMUN; POLAK PR, 1976, J NERV MENT DIS, V162, P13, DOI 10.1097/00005053-197601000-00003; POLAK PR, 1967, SOC PSYCHIATR, V2, P150, DOI 10.1007/BF00578050; QUERIDO A, 1968, BRIT J PSYCHIAT, V114, P293, DOI 10.1192/bjp.114.508.293; RABINOWITZ J, 1995, PSYCHIATR SERV, V46, P712; SCOTT RD, 1980, HLTH TRENDS, V12, P65; SMYTH M, 1994, PSYCHIAT B, V18, P408; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Szmukler GI, 1990, CURR OPIN PSYCHIATR, V3, P273; YOUNG L, 1980, EVALUATION SELECTED	29	52	53	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					305	308		10.1136/bmj.320.7230.305	http://dx.doi.org/10.1136/bmj.320.7230.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	280ZB	10650032	Green Published			2022-12-28	WOS:000085132700034
J	Weeks, ER; Crocker, JC; Levitt, AC; Schofield, A; Weitz, DA				Weeks, ER; Crocker, JC; Levitt, AC; Schofield, A; Weitz, DA			Three-dimensional direct imaging of structural relaxation near the colloidal glass transition	SCIENCE			English	Article							INTERMEDIATE SCATTERING FUNCTION; SUPERCOOLED ORTHO-TERPHENYL; DIGITAL VIDEO MICROSCOPY; LIQUIDS; SUSPENSIONS; SPHERES; HETEROGENEITIES; DIFFUSION; PARTICLES; NMR	Confocal microscopy was used to directly observe three-dimensional dynamics of particles in colloidal supercooled fluids and colloidal glasses. The fastest particles moved cooperatively; connected clusters of these mobile particles could be identified: and the cluster size distribution, structure, and dynamics were investigated. The characteristic cluster size grew markedly in the supercooled fluid as the glass transition was approached, in agreement with computer simulations; at the glass transition, however, there was a sudden drop in their size. The clusters of fast-moving particles were largest near the alpha-relaxation time scale for supercooled colloidal fluids, but were also present, albeit with a markedly different nature, at shorter beta-relaxation time scales, in both supercooled fluid and glass colloidal phases.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	Harvard University; Harvard University; University of Pennsylvania; University of Edinburgh	Weeks, ER (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	weeks@deas.harvard.edu	Schofield, Andrew Bruce/AAV-4862-2020; Weeks, Eric R/I-8960-2019; Crocker, John C/D-4991-2012	Schofield, Andrew Bruce/0000-0002-8741-856X; Weeks, Eric R/0000-0003-1503-3633; Crocker, John C/0000-0001-6239-6010				ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ANGELL CA, 1988, J PHYS CHEM SOLIDS, V49, P863, DOI 10.1016/0022-3697(88)90002-9; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; ANTL L, 1986, COLLOID SURFACE, V17, P67, DOI 10.1016/0166-6622(86)80187-1; BARTSCH E, 1993, PHYSICA A, V201, P363, DOI 10.1016/0378-4371(93)90433-5; Bohmer R, 1996, EUROPHYS LETT, V36, P55, DOI 10.1209/epl/i1996-00186-5; CICERONE MT, 1995, J CHEM PHYS, V103, P5684, DOI 10.1063/1.470551; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Doliwa B, 1999, J PHYS-CONDENS MAT, V11, pA277, DOI 10.1088/0953-8984/11/10A/025; Donati C, 1999, PHYS REV E, V60, P3107, DOI 10.1103/PhysRevE.60.3107; Donati C, 1998, PHYS REV LETT, V80, P2338, DOI 10.1103/PhysRevLett.80.2338; Donati C, 1999, PHYS REV LETT, V82, P5064, DOI 10.1103/PhysRevLett.82.5064; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; Kasper A, 1998, LANGMUIR, V14, P5004, DOI 10.1021/la971089y; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; KIVELSON SA, 1994, J CHEM PHYS, V101, P2391, DOI 10.1063/1.468414; Kob W, 1997, PHYS REV LETT, V79, P2827, DOI 10.1103/PhysRevLett.79.2827; Marcus AH, 1999, PHYS REV E, V60, P5725, DOI 10.1103/PhysRevE.60.5725; Parisi G, 1999, J PHYS CHEM B, V103, P4128, DOI 10.1021/jp983967m; Preparata F.P., 1985, COMPUTATIONAL GEOMET; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; RAHMAN A, 1964, PHYS REV, V136, pA405, DOI 10.1103/PhysRev.136.A405; Schiener B, 1996, SCIENCE, V274, P752, DOI 10.1126/science.274.5288.752; SCHMIDT-ROHR K, 1991, PHYS REV LETT, V66, P3020, DOI 10.1103/PhysRevLett.66.3020; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; TOKUYAMA M, 1994, PHYS REV E, V50, pR16, DOI 10.1103/PhysRevE.50.R16; Tracht U, 1998, PHYS REV LETT, V81, P2727, DOI 10.1103/PhysRevLett.81.2727; van Megen W, 1998, PHYS REV E, V58, P6073, DOI 10.1103/PhysRevE.58.6073; VANBLAADEREN A, 1995, SCIENCE, V270, P1177, DOI 10.1126/science.270.5239.1177; VANMEGEN W, 1994, PHYS REV E, V49, P4206, DOI 10.1103/PhysRevE.49.4206; Yamamoto R, 1998, PHYS REV LETT, V81, P4915, DOI 10.1103/PhysRevLett.81.4915	32	1488	1502	9	331	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					627	631		10.1126/science.287.5453.627	http://dx.doi.org/10.1126/science.287.5453.627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649991				2022-12-28	WOS:000084989400040
J	Bass, D				Bass, D			Surfacing after burnout	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					259	259		10.1136/bmj.320.7229.259	http://dx.doi.org/10.1136/bmj.320.7229.259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642257	Green Published			2022-12-28	WOS:000085029600071
J	Wazana, A				Wazana, A			Physicians and the pharmaceutical industry - Is a gift ever just a gift?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POINTS-OF-VIEW; SALES REPRESENTATIVES; DRUG COMPANIES; FREE LUNCH; RESIDENCY PROGRAMS; COMMERCIAL SOURCES; MEDICINE FACULTY; CLINICAL-TRIALS; ATTITUDES; INFORMATION	Context Controversy exists over the fact that physicians have regular contact with the pharmaceutical industry and its sales representatives, who spend a large sum of money each year promoting to them by way of gifts, free meals, travel subsidies, sponsored teachings, and symposia. Objective To identify the extent of and attitudes toward the relationship between physicians and the pharmaceutical industry and its representatives and its impact on the knowledge, attitudes, and behavior of physicians, Data Sources A MEDLINE search was conducted for English-language articles published from 1994 to present, with review of reference lists from retrieved articles; in addition, an Internet database was searched and 5 key informants were interviewed. Study Selection A total of 538 studies that provided data on any of the study questions were targeted for retrieval, 29 of which were included in the analysis. Data Extraction Data were extracted by 1 author. Articles using an analytic design were considered to be of higher methodological quality, Data Synthesis Physician interactions with pharmaceutical representatives were generally endorsed, began in medical school, and continued at a rate of about 4 times per month. Meetings with pharmaceutical representatives were associated with requests by physicians for adding the drugs to the hospital formulary and changes in prescribing practice. Drug company-sponsored continuing medical education (CME) preferentially highlighted the sponsor's drug(s) compared with other CME programs. Attending sponsored CME events and accepting funding for travel or lodging for educational symposia were associated with increased prescription rates of the sponsor's medication. Attending presentations given by pharmaceutical representative speakers was also associated with nonrational prescribing. Conclusion The present extent of physician-industry interactions appears to affect prescribing and professional behavior and should be further addressed at the level of policy and education.	McGill Univ, Montreal, PQ, Canada	McGill University	Wazana, A (corresponding author), Psychiat Postgrad Educ, McGill Res & Training Bldg,1033 Pine St W, Montreal, PQ H3A 1A1, Canada.		Fahimifar, Sepideh/M-5303-2019					Anastasio GD, 1996, PHARMACOTHERAPY, V16, P103; ANDALEEB SS, 1995, HEALTH CARE MANAGE R, V20, P68; ANDERSON JJ, 1991, ARTHRITIS RHEUM-US, V34, P1304, DOI 10.1002/art.1780341015; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BANKS JW, 1992, ACAD MED, V67, P610, DOI 10.1097/00001888-199209000-00017; BERINGS D, 1994, EUR J CLIN PHARMACOL, V46, P501; BICKELL NA, 1995, J GEN INTERN MED, V10, P392, DOI 10.1007/BF02599839; BOWER AD, 1987, J FAM PRACTICE, V24, P612; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; BOWMAN MA, 1986, MOBIUS, V6, P66; BROTZMAN GL, 1993, J GEN INTERN MED, V8, P130, DOI 10.1007/BF02599757; BROTZMAN GL, 1992, J FAM PRACTICE, V34, P54; BUCCI KK, 1992, J FAM PRACTICE, V34, P49; *CAN MED ASS, 1994, CMAJ, V150, pA256; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; DANIEL EE, 1966, J MED EDUC, V41, P49; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; Drake D, 1993, MAKING MED MAKING MO; EROLA JA, 1994, CAN MED ASSOC J, V150, P955; FERGUSON RP, 1989, JAMA-J AM MED ASSOC, V261, P992; Gibbons RV, 1998, J GEN INTERN MED, V13, P151, DOI 10.1046/j.1525-1497.1998.00048.x; GUYATT G, 1994, CAN MED ASSOC J, V150, P951; HAAYER F, 1982, SOC SCI MED, V16, P2017, DOI 10.1016/0277-9536(82)90158-7; HEMMINKI E, 1977, MED EDUC, V11, P210, DOI 10.1111/j.1365-2923.1977.tb00595.x; HEMMINKI E, 1975, SOC SCI MED, V9, P111, DOI 10.1016/0037-7856(75)90103-1; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HODGES B, 1995, CAN MED ASSOC J, V153, P553; Hopper JA, 1997, J GEN INTERN MED, V12, P639, DOI 10.1046/j.1525-1497.1997.07126.x; KEIM SM, 1993, ANN EMERG MED, V22, P1576, DOI 10.1016/S0196-0644(05)81262-4; Landefeld CS, 1996, J GEN INTERN MED, V11, P642, DOI 10.1007/BF02599035; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; LICHSTEIN PR, 1992, ARCH INTERN MED, V152, P1009, DOI 10.1001/archinte.152.5.1009; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Mahood S, 1997, CAN FAM PHYSICIAN, V43, P1947; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; *MED LOBB APPR MAR, 1999, BIBL PHARM PROM; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V265, P501; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; PALMISANO P, 1980, J MED EDUC, V55, P453; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; POIRIER TI, 1994, AM J HOSP PHARM, V51, P378, DOI 10.1093/ajhp/51.3.378; RANDALL T, 1991, JAMA-J AM MED ASSOC, V265, P440, DOI 10.1001/jama.265.4.440; RANDALL T, 1991, JAMA-J AM MED ASSOC, V265, P442; Reeder M, 1993, ANN EMERG MED, V22, P105; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; *ROYAL COLL PHYS S, 1999, GUID SUPP CONT MED E; Sandberg WS, 1997, ACAD MED, V72, P916, DOI 10.1097/00001888-199710000-00018; Sergeant MD, 1996, CAN MED ASSOC J, V155, P1243; Shear NH, 1996, CAN J CLIN PHARM, V3, P175; SMITH MC, 1977, AM J HOSP PHARM, V34, P1208, DOI 10.1093/ajhp/34.11.1208; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; Spingarn RW, 1996, ACAD MED, V71, P86, DOI 10.1097/00001888-199601000-00022; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Strang D, 1996, Ann R Coll Physicians Surg Can, V29, P474; THOMSON AN, 1994, BRIT J GEN PRACT, V44, P220; WADE VA, 1989, LANCET, V2, P1261; WAUD DR, 1992, NEW ENGL J MED, V327, P351, DOI 10.1056/NEJM199207303270511; WHITE LJ, 1990, ANN INTERN MED, V112, P624, DOI 10.7326/0003-4819-112-8-624; Wolfe SM, 1996, J GEN INTERN MED, V11, P637, DOI 10.1007/BF02599033; WOOLLARD RF, 1993, CAN MED ASSOC J, V149, P403; WOOSLEY RL, 1994, CLIN PHARMACOL THER, V55, P249, DOI 10.1038/clpt.1994.24; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296; 1992, ACAD MED, V67, P615	65	975	1003	1	127	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					373	380		10.1001/jama.283.3.373	http://dx.doi.org/10.1001/jama.283.3.373			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	273WM	10647801				2022-12-28	WOS:000084732400030
J	Martina, M; Vida, I; Jonas, P				Martina, M; Vida, I; Jonas, P			Distal initiation and active propagation of action potentials in interneuron dendrites	SCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPUS IN-VITRO; RAT HIPPOCAMPUS; INHIBITORY NEURONS; CELL DENDRITES; MITRAL CELLS; SODIUM; ACTIVATION; SYNAPSES; CHANNELS	Fast and reliable activation of inhibitory interneurons is critical for the stability of cortical neuronal networks. Active conductances in dendrites may facilitate interneuron activation, but direct experimental evidence was unavailable. Patch-clamp recordings from dendrites of hippocampal oriens-alveus interneurons revealed high densities of voltage-gated sodium and potassium ion channels. Simultaneous recordings from dendrites and somata suggested that action potential initiation occurs preferentially in the axon with long threshold stimuli, but can be shifted to somatodendritic sites when brief stimuli are applied. After initiation, action potentials propagate over the somatodendritic domain with constant amplitude, high velocity, and reliability, even during high-frequency trains.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Univ Freiburg, Inst Anat, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Jonas, P (corresponding author), Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany.		Vida, Imre/F-8275-2012	Vida, Imre/0000-0003-3214-2233; Jonas, Peter/0000-0001-5001-4804; martina, marco/0000-0002-9648-2918				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; COLQUHOUN D, 1995, SINGLE CHANNEL RECOR, pCH19; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1999, HDB EXPT PHARM, V141, pCH11; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; KOSAKA T, 1983, BRAIN RES, V271, P157, DOI 10.1016/0006-8993(83)91377-X; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; PEREZ Y, 1999, 29 M SOC NEUR MIAM B; SAKMANN B, 1995, SINGLE CHANNEL RECOR, pCH21; SIK A, 1995, J NEUROSCI, V15, P6651; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P249, DOI 10.1177/33.3.2579124; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; ZILBERTER Y, 1999, 29 M SOC NEUR MIAM B	46	250	253	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					295	300		10.1126/science.287.5451.295	http://dx.doi.org/10.1126/science.287.5451.295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634782				2022-12-28	WOS:000084769600037
J	Pawlowski, B; Dunbar, RIM; Lipowicz, A				Pawlowski, B; Dunbar, RIM; Lipowicz, A			Evolutionary fitness - Tall men have more reproductive success	NATURE			English	Article							SHORT STATURE; ATTRACTIVENESS		Univ Wroclaw, Dept Anthropol, PL-50138 Wroclaw, Poland; Univ Liverpool, Sch Biol Sci, ESRC Res Ctr Econ Learning & Social Evolut, Liverpool L69 3BX, Merseyside, England; Polish Acad Sci, Inst Anthropol, PL-50951 Wroclaw, Poland	University of Wroclaw; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Liverpool; Polish Academy of Sciences	Pawlowski, B (corresponding author), Univ Wroclaw, Dept Anthropol, Ul Kuznicza 35, PL-50138 Wroclaw, Poland.	rimd@liv.ac.uk	Lipowicz, Anna M/A-1730-2017; Pawlowski, Boguslaw/C-1088-2013	Lipowicz, Anna M/0000-0002-9182-6953; Pawlowski, Boguslaw/0000-0002-7418-475X				BARKER DJP, 1990, ANN HUM BIOL, V17, P1, DOI 10.1080/03014469000000732; Bielicki T, 1999, J BIOSOC SCI, V31, P525, DOI 10.1017/S0021932099005258; Bogin Barry, 1988, PATTERNS HUMAN GROWT; HEBERT PR, 1993, CIRCULATION, V88, P1437, DOI 10.1161/01.CIR.88.4.1437; HOLL RW, 1991, DEUT MED WOCHENSCHR, V116, P928, DOI 10.1055/s-2008-1063699; Kee F, 1997, INT J EPIDEMIOL, V26, P748, DOI 10.1093/ije/26.4.748; Komlos J, 1994, STATURE LIVING STAND; MACINTYRE S, 1991, SOCIOL HEALTH ILL, V13, P149, DOI 10.1111/1467-9566.ep11340769; *MIEJSK URS STAT W, 1971, ROCZNIK STAT MIAST W; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; SCHUMACHER A, 1982, J HUM EVOL, V11, P697, DOI 10.1016/S0047-2484(82)80058-4; TEASDALE TW, 1991, HUM BIOL, V63, P19	12	233	236	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					156	156		10.1038/35003107	http://dx.doi.org/10.1038/35003107			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275TB	10646589	Bronze			2022-12-28	WOS:000084835300040
J	Descamps, D; Flandre, P; Calvez, V; Peytavin, G; Meiffredy, V; Collin, G; Delaugerre, C; Robert-Delmas, S; Bazin, B; Aboulker, JP; Pialoux, G; Raffi, F; Brun-Vezinet, F				Descamps, D; Flandre, P; Calvez, V; Peytavin, G; Meiffredy, V; Collin, G; Delaugerre, C; Robert-Delmas, S; Bazin, B; Aboulker, JP; Pialoux, G; Raffi, F; Brun-Vezinet, F		Trilege Study Team	Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTEASE-INHIBITOR; DRUG-THERAPY; RESISTANCE; INDINAVIR; PLASMA; LAMIVUDINE; ZIDOVUDINE; MUTATIONS; RNA	Context In the Trilege trial, following induction with a zidovudine, lamivudine, and indinavir regimen, human immunodeficiency virus (HIV) replication was less sup pressed by 2-drug maintenance therapy than by triple-drug therapy. Objective To identify mechanisms, of virologic failure in the 3 arms of the Trilege trial. Design Case-control study conducted from February to October 1998. Setting Three urban hospitals in Paris, France. Patients Fify-eight case patients with virologic failure (HIV RNA rebound to >500 copies/mL in 2 consecutive samples) randomized to 3 therapy groups: triple drug (zidovudine, lamivudine, and:indinavir), 8; zidovudine-lamivudine, 29; and zidovudine-indinavir, 21, the case patients were randomly matched with 58 control patients with sustained viral suppression. Main Outcome Measures At virologic failure (S1 sample) and 6 weeks later (S2 sample), assessment of protease and reverse transcriptase gene mutations, plasma indinavir level, and degree:of viral load rebound pill count during induction and maintenance periods. Results Only 1 primary resistance mutation, M184V, was detected in S1 plasma samples from 4 of 6 patients in the triple-drug and in all 22 in the zidovudine-lamivudine therapy groups and in S2 plasma samples from 3 of 6 in the triple-drug and 20 of 21 in the zidovudine-lamivudine groups. Of controls, M184V was detected in 11 of 13 S1 plasma samples and in 10 of 11 S2 plasma samples. Indinavir levels were undetectable in all S1 samples but 2 in 7 triple-drug cases tested and in the expected range in 1 1 of 18 S1 and 5 of 12 S2 zidovudine-indinavir case plasma samples tested. Maintenance adherence rates were lower for cases vs controls for zidovudine (P = .05) and indinavir (P = .05). Low indinavir levels, lower adherence rates for zidovudine (P =.04) and lamivudine (P = .03), and rebound to near-baseline values suggested adherence as cause of early failure for 4 of 8 triple-drug cases; In the zidovudine-lamivudine arm, for which case and control adherence rates did not differ significantly (P = .96), most failures occurred late with low rebound, suggesting suboptimal drug potency. In the zidovudine-indinavir arm, virologic failures may be related to both mechanisms. Conclusions During the maintenance phase early and late virologic failures appeared to be related more to problems of adherence and antiretroviral treatment potency, respectively, than to selection of resistant mutant viruses.	Hop Bichat Claude Bernard, Virol Lab, F-75018 Paris, France; Hop La Pitie Salpetriere, Paris, France; Hop Rothschild, F-75571 Paris, France; INSERM, Serv Commun 10, Villejuif, France; Hop Hotel Dieu, Nantes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Brun-Vezinet, F (corresponding author), Hop Bichat Claude Bernard, Virol Lab, 46 Rue Henri Huchard, F-75018 Paris, France.		Flandre, Philippe/N-6314-2017	Flandre, Philippe/0000-0002-2612-3522				BRUNVEZINET F, 1998, 12 INT C AIDS JUN 28; CALVEZ V, 1998, INT C DISC CLIN DEV; CLUMECK N, 1999, 6 C RETR OPP INFECT; Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996; DEPASQUALE MP, 1998, 2 INT WORKSH HIV DRU; Drusano GL, 1998, J INFECT DIS, V178, P360, DOI 10.1086/515631; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; HAVLIR DV, 1998, 2 INT WORKSH HIV DRU; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoetelmans RMW, 1998, AIDS, V12, pF111, DOI 10.1097/00002030-199811000-00002; JOHNSON VA, 1997, ANTIVIR THER S, V2, P72; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; MAYERS DL, 1997, ANTIVIR THER S, V2, P72; Nijhuis M, 1998, P NATL ACAD SCI USA, V95, P14441, DOI 10.1073/pnas.95.24.14441; NIJHUIS M, 1995, BIOTECHNIQUES, V19, P178; Paes AHP, 1998, PHARM WORLD SCI, V20, P73, DOI 10.1023/A:1008663215166; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; SOUSSAN P, 1997, 4 C RETR OPP INF WAS; Stuyver L, 1997, ANTIMICROB AGENTS CH, V41, P284, DOI 10.1128/AAC.41.2.284; WOOLF E, 1995, J CHROMATOGR A, V692, P45, DOI 10.1016/0021-9673(94)00608-C; Young B, 1998, J INFECT DIS, V178, P1497, DOI 10.1086/314437	24	305	313	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					205	211		10.1001/jama.283.2.205	http://dx.doi.org/10.1001/jama.283.2.205			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634336	Bronze			2022-12-28	WOS:000084661400026
J	Fraser, SE; Harland, RM				Fraser, SE; Harland, RM			The molecular metamorphosis of experimental embryology	CELL			English	Review							C-ELEGANS; DROSOPHILA EMBRYO; CAENORHABDITIS-ELEGANS; CELL LINEAGE; THRESHOLD RESPONSES; CORTICAL ROTATION; PATTERN-FORMATION; DORSAL GRADIENT; GENE-EXPRESSION; FATE		CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	California Institute of Technology; California Institute of Technology; University of California System; University of California Berkeley	Fraser, SE (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.		Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bergmann D, 1997, DEV BIOL, V186, pS56; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; Boveri T., 1907, JENA Z NATURW, V43, P1; Boveri T., 1904, ERGEBNISSE KONSTITUT; Bronchain OJ, 1999, CURR BIOL, V9, P1195, DOI 10.1016/S0960-9822(00)80025-1; BRYANT PJ, 1988, DEV BIOL, V127, P197, DOI 10.1016/0012-1606(88)90201-1; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P589; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Davidson EH, 1998, DEVELOPMENT, V125, P3269; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DiLeone RJ, 1998, GENETICS, V148, P401; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; FRASER SE, 1992, SEMIN NEUROSCI, V4, P337; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; GERHART J, 1989, DEVELOPMENT, V107, P37; GERHART J, 1991, BOD MAR LAB, P57; GOLDSTEIN B, 1993, DEVELOPMENT, V118, P1267; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Hamburger V, 1988, HERITAGE EXPT EMBRYO; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HORSTADIUS S, 1939, BIOL REV, V14, P251; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; Jacobs RE, 1999, TRENDS CELL BIOL, V9, P73, DOI 10.1016/S0962-8924(98)01435-4; JACOBS RE, 1994, SCIENCE, V263, P681, DOI 10.1126/science.7508143; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Kimelman D, 1998, CELL, V94, P419, DOI 10.1016/S0092-8674(00)81582-2; Lane MC, 1999, DEVELOPMENT, V126, P423; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Marcelle C, 1997, DEVELOPMENT, V124, P3955; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; MEINHARDT H, 1993, DEV BIOL, V157, P321, DOI 10.1006/dbio.1993.1138; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P115; MILLER J, 1995, DEVELOPMENT, V121, P2501; Moats RA, 1997, ANGEW CHEM INT EDIT, V36, P726, DOI 10.1002/anie.199707261; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Moskowitz IPG, 1996, DEVELOPMENT, V122, P4105; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; Nishida H, 1997, SEMIN CELL DEV BIOL, V8, P359, DOI 10.1006/scdb.1997.0160; NOETGEN H, 1999, DEVELOPMENT, V126, P815; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pfeiffer S, 1999, SEMIN CELL DEV BIOL, V10, P303, DOI 10.1006/scdb.1999.0306; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; Satoh N., 1994, DEV BIOL ASCIDIANS; Saunders JW, 1998, J EXP ZOOL, V282, P669, DOI 10.1002/(SICI)1097-010X(19981215)282:6<669::AID-JEZ3>3.0.CO;2-D; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Skarnes WC, 1999, DEV BIOL, V210, P206; SLACK JMW, 1998, EGG EGO ALMOST TRUE; Spemann H., 1938, EMBRYONIC DEV INDUCT; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; STJOHNSTON D, 1992, CELL, V68, P201; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Vogt TF, 1999, CELL, V99, P563, DOI 10.1016/S0092-8674(00)81545-7; WHITTAKER JR, 1987, AM ZOOL, V27, P607; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; WITKOWSKI J, 1985, TRENDS BIOCHEM SCI, V10, P379, DOI 10.1016/0968-0004(85)90058-1; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254; Wood W. B., 1988, NEMATODE CAENOHABDIT; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5	84	42	42	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2000	100	1					41	55		10.1016/S0092-8674(00)81682-7	http://dx.doi.org/10.1016/S0092-8674(00)81682-7			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647930	Bronze			2022-12-28	WOS:000084722600004
J	Knoppers, BM; Hirtle, M; Glass, KC				Knoppers, BM; Hirtle, M; Glass, KC			Policy forum: Genetic technologies - Commercialization of genetic research and public policy	SCIENCE			English	Article									Univ Montreal, Ctr Publ Law, Genet & Soc Project, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Knoppers, BM (corresponding author), Univ Montreal, Ctr Publ Law, Genet & Soc Project, Montreal, PQ H3C 3J7, Canada.							BULGER RE, 1993, ETHICAL DIMENSIONS B; Council of Europe, 1997, CONV PROT HUM RIGHTS; *EUR COMM, 1998, DIR LEG PROT BIOT IN; Greely HT, 1998, SCIENCE, V282, P625, DOI 10.1126/science.282.5389.625; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; *HUGO, 1995, STAT PAT DNA SEQ; *INT ETH COMM, 1998, STAT DNA SAMPL CONTR; Knoppers BM, 1999, NAT GENET, V22, P23, DOI 10.1038/8735; Knoppers BM, 1998, GENOMICS, V50, P385, DOI 10.1006/geno.1998.5287; *NAT BIOT ADV COMM, 1999, RES INV HUM BIOL MAT; Nelkin D, 1998, HASTINGS CENT REP, V28, P30, DOI 10.2307/3528230; *UNESCO, 1997, UN DECL HUM GEN HUM	12	37	37	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	1999	286	5448					2277	2278		10.1126/science.286.5448.2277	http://dx.doi.org/10.1126/science.286.5448.2277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266UK	10636788				2022-12-28	WOS:000084318500032
J	Herrmann, BG; Koschorz, B; Wertz, K; McLaughlin, KJ; Kispert, A				Herrmann, BG; Koschorz, B; Wertz, K; McLaughlin, KJ; Kispert, A			A protein kinase encoded by the t complex responder gene causes non-mendelian inheritance	NATURE			English	Article							TRANSMISSION RATIO DISTORTION; DYNEIN LIGHT-CHAIN; TERT-HAPLOTYPES; TRANSGENIC MICE; SPERM MOTILITY; MEIOTIC DRIVE; MOUSE; LOCUS; IDENTIFICATION; FAMILY	Males heterozygous for the t-haplotype form of mouse chromosome 17 preferentially transmit the t-chromosome to their progeny. Several distorter/sterility loci carried on the t-haplotype together impair flagellar function in all spermatozoa whereas the responder, Tcr, rescues t-sperm but not wild-type sperm. Thus, t-sperm have an advantage over wild-type sperm in fertilizing egg cells. We have isolated Tcr by positional cloning and show that it is a member of a novel protein kinase gene family, designated Smok, which is expressed late during spermiogenesis, Smok kinases are components of a signal cascade which may control sperm motility, Tcr has a reduced kinase activity, which may allow it to counterbalance a signalling impairment caused by the distorter/sterility loci, Tcr transgene constructs cause non-mendelian transmission of chromosomes on which they are carried, which leads to sex-ratio distortion when Tcr cosegregates with the Y chromosome.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Max Planck Society	Herrmann, BG (corresponding author), Max Planck Inst Immunbiol, Stubeweg 51, D-79108 Freiburg, Germany.		McLaughlin, Kenneth/E-3648-2011					Albanesi C, 1996, DEVELOPMENT, V122, P1291; BENNETT D, 1983, GENET RES, V41, P29, DOI 10.1017/S0016672300021042; Bracho GE, 1998, BIOCHEM BIOPH RES CO, V242, P231, DOI 10.1006/bbrc.1997.7937; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; BULLARD DC, 1992, MAMM GENOME, V3, P579, DOI 10.1007/BF00350625; Carrera A, 1996, DEV BIOL, V180, P284, DOI 10.1006/dbio.1996.0301; Cosson J, 1996, CELL BIOL INT, V20, P83, DOI 10.1006/cbir.1996.0012; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ewulonu UK, 1996, GENETICS, V144, P785; FOX HS, 1985, CELL, V40, P63, DOI 10.1016/0092-8674(85)90309-5; Fraser LR, 1999, BIOESSAYS, V21, P304, DOI 10.1002/(SICI)1521-1878(199904)21:4<304::AID-BIES6>3.0.CO;2-H; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; HUW LY, 1995, DEV BIOL, V170, P183, DOI 10.1006/dbio.1995.1206; Kispert A, 1999, MAMM GENOME, V10, P794, DOI 10.1007/s003359901094; LADER E, 1989, CELL, V58, P969, DOI 10.1016/0092-8674(89)90948-3; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; LYON MF, 1990, GENET RES, V55, P13, DOI 10.1017/S0016672300025143; LYON MF, 1987, GENET RES, V50, P29, DOI 10.1017/S0016672300023302; LYON MF, 1986, CELL, V44, P357, DOI 10.1016/0092-8674(86)90770-1; LYON MF, 1984, CELL, V37, P621, DOI 10.1016/0092-8674(84)90393-3; MAZARAKIS N, 1909, DEVELOPMENT, V111, P561; OLDSCLARKE P, 1993, DEV BIOL, V155, P14, DOI 10.1006/dbio.1993.1002; PatelKing RS, 1997, J CELL BIOL, V137, P1081, DOI 10.1083/jcb.137.5.1081; PESCHON JJ, 1987, P NATL ACAD SCI USA, V84, P5316, DOI 10.1073/pnas.84.15.5316; ROSEN LL, 1990, GENOMICS, V8, P134, DOI 10.1016/0888-7543(90)90235-M; ROSSI P, 1992, DEV BIOL, V152, P203, DOI 10.1016/0012-1606(92)90172-D; Rugh R, 1990, MOUSE ITS REPROD DEV; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIMENTI J, 1987, J MOL BIOL, V194, P583, DOI 10.1016/0022-2836(87)90235-X; SCHIMENTI J, 1988, CELL, V55, P71, DOI 10.1016/0092-8674(88)90010-4; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; SILVER LM, 1987, GENET RES, V49, P51, DOI 10.1017/S0016672300026720; TASH JS, 1988, J CELL BIOL, V106, P1625, DOI 10.1083/jcb.106.5.1625; TASH JS, 1984, CELL, V38, P551, DOI 10.1016/0092-8674(84)90509-9; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO; WILLISON K, 1987, TRENDS GENET, V3, P351, DOI 10.1016/0168-9525(87)90296-4	38	128	139	4	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					141	146		10.1038/45970	http://dx.doi.org/10.1038/45970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647005				2022-12-28	WOS:000083716400038
J	Yasui, M; Hazama, A; Kwon, TH; Nielsen, S; Guggino, WB; Agre, P				Yasui, M; Hazama, A; Kwon, TH; Nielsen, S; Guggino, WB; Agre, P			Rapid gating and anion permeability of an intracellular aquaporin	NATURE			English	Article							MAJOR INTRINSIC PROTEIN; CD WATER CHANNELS; KIDNEY; MEMBRANE; CLONING; CONDUCTANCE; CHIP28; PUMP; LENS	Aquaporin (AQP) water-channel proteins are freely permeated by water but not bg ions or charged solutes(1), Although mammalian aquaporins were believed to be located in plasma membranes, rat AQP6 is restricted to intracellular vesicles in renal epithelia(2). Here we show that AQP6 is functionally distinct from other known aquaporins. When expressed in Xenopus laevis oocytes, AQP6 exhibits low basal water permeability; however, when treated with the known water channel inhibitor, Hg2+, the water permeability of AQP6 oocytes rapidly rises up to tenfold and is accompanied by ion conductance. AQP6 colocalizes with H+-ATPase in intracellular vesicles of acid-secreting alpha-intercalated cells in renal collecting duct. At pH less than 5.5, anion conductance is rapidly and reversibly activated in AQP6 oocytes. Site-directed mutation of lysine to glutamate at position 72 in the cytoplasmic mouth of the pore changes the cation/anion selectivity: but leaves low pH activation intact, Our results demonstrate unusual biophysical properties of an aquaporin, and indicate that anion-channel function may now be explored in a protein with known structure.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Aarhus Univ, Inst Anat, Dept Cell Biol, DK-8000 Aarhus, Denmark	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Aarhus University	Agre, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Kwon, Tae-Hwan/ABA-1981-2020; Yasui, Masato/L-3312-2013					Agre P, 1997, SCIENCE, V275, P1490, DOI 10.1126/science.275.5305.1490; Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; Jena BP, 1997, P NATL ACAD SCI USA, V94, P13317, DOI 10.1073/pnas.94.24.13317; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Ma TH, 1996, GENOMICS, V35, P543, DOI 10.1006/geno.1996.0396; MA TH, 1993, BIOCHEM BIOPH RES CO, V197, P654, DOI 10.1006/bbrc.1993.2529; MITSUOKA K, IN PRESS J STRUCT BI; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; SCHWARTZ GJ, 1986, ANNU REV PHYSIOL, V48, P153; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yasui M, 1999, P NATL ACAD SCI USA, V96, P5808, DOI 10.1073/pnas.96.10.5808; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216	23	371	378	0	50	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					184	187		10.1038/46045	http://dx.doi.org/10.1038/46045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647010				2022-12-28	WOS:000083716400051
J	[Anonymous]				[Anonymous]			The increasing opacity of gene therapy	NATURE			English	Editorial Material																		1996, NATURE, V384, P297; 1999, NATURE, V401, P517; 1999, NATURE, V402, P6	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	1999	402	6758					107	107						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10646989				2022-12-28	WOS:000083716400001
J	Nuorti, JP; Butler, JC; Gelling, L; Kool, JL; Reingold, AL; Vugia, DJ				Nuorti, JP; Butler, JC; Gelling, L; Kool, JL; Reingold, AL; Vugia, DJ			Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	35th Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 07-16, 1997	SAN FRANCISCO, CA	Infect Dis Soc Amer			HUMAN-IMMUNODEFICIENCY-VIRUS; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL PNEUMONIA; ANTIBODY-RESPONSES; UNITED-STATES; BACTEREMIA; INFECTION; VACCINE; POPULATION; INFLUENZA	Background: Patients with AIDS have a high incidence of invasive pneumococcal disease, but no population-based data are available on secular trends or rates of this disease in specific demographic groups. Objective: To compare clinical characteristics, rates, and trends of pneumococcal disease in HIV-infected and non-HIV-infected persons. Design: Population-based laboratory surveillance and chart review. Setting: All of the 13 microbiology laboratories in San Francisco County, California. Patients: Persons who had a sterile site culture that was positive for Streptococcus pneumoniae between October 1994 and June 1997. Measurements: Stratified incidence rates and adjusted rate ratios, serotyping of isolates, and comparison of secular trends and rates according to census tract by Poisson regression. Results: Persons infected with HIV accounted for 54.2% of 399 patients 18 to 64 years of age who had pneumococcal disease. The incidence of pneumococcal disease per 100 000 person-years was 35.0 cases overall and 802.9 cases in patients with AIDS. Compared with persons who were not known to be HIV-infected, the rate ratio for patients with AIDS was 46.0 (95% CI, 36.0 to 58.9); 55.2% of cases were attributable to HIV. In HIV-infected patients, 82.5% of isolates were serotypes that are included in the pneumococcal polysaccharide vaccine. The incidence of pneumococcal disease in black patients with AIDS (2384.6 cases per 100 000 person-years) was 5.4 times that in nonblack patients with AIDS. Rates by census tract were inversely associated with income (P < 0.001). During the study period, the incidence of pneumococcal disease decreased from 10.6 cases per 1000 person-years to 4.2 cases per 1000 person-years in patients with AIDS (P = 0.004, Poisson regression). Conclusions: In a community with a high prevalence of HIV infection, much of the burden of pneumococcal disease was attributable to AIDS. High incidence rates were seen in young adults and especially in black persons. Efforts to increase pneumococcal vaccination rates should target HIV-infected adults, particularly those living in poor urban areas.	Calif Dept Hlth Serv, Calif Emerging Infect Program, Berkeley, CA USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA	California Department of Health Care Services; California Emerging Infections Program; University of California System; University of California Berkeley; Centers for Disease Control & Prevention - USA	Nuorti, JP (corresponding author), Natl Publ Hlth Inst, Dept Infect Dis Epidemiol, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	pekka.nuorti@ktl.fi		Kool, Jacob/0000-0002-9605-2918				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; BENNETT NM, 1992, AM J PUBLIC HEALTH, V82, P1513, DOI 10.2105/AJPH.82.11.1513; Bloch KC, 1998, ANN INTERN MED, V129, P698, DOI 10.7326/0003-4819-129-9-199811010-00004; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; Chan CY, 1996, J INFECT DIS, V173, P256, DOI 10.1093/infdis/173.1.256; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; Facklam RR, 1991, MANUAL CLIN MICROBIO, P238; Frankel RE, 1996, CLIN INFECT DIS, V23, P577, DOI 10.1093/clinids/23.3.577; GARCIALEONI ME, 1992, ARCH INTERN MED, V152, P1808, DOI 10.1001/archinte.152.9.1808; Gebo KA, 1996, J INFECT DIS, V173, P857, DOI 10.1093/infdis/173.4.857; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; GLASER JB, 1991, J INFECT DIS, V164, P761, DOI 10.1093/infdis/164.4.761; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; HUANG KL, 1987, JAMA-J AM MED ASSOC, V257, P2047, DOI 10.1001/jama.257.15.2047; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; JANOFF EN, 1993, J INFECT DIS, V167, P49, DOI 10.1093/infdis/167.1.49; KELLER DW, 1995, CLIN INFECT DIS, V21, pS77, DOI 10.1093/clinids/21.Supplement_1.S77; KLEINBAUM DG, 1998, APPL REGRESSION ANAL, P687; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; REDD SC, 1990, J INFECT DIS, V162, P1012, DOI 10.1093/infdis/162.5.1012; RODRIGUEZBARRADAS MC, 1992, J INFECT DIS, V165, P553, DOI 10.1093/infdis/165.3.553; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P267; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SCHUCHAT A, 1991, JAMA-J AM MED ASSOC, V265, P3275, DOI 10.1001/jama.265.24.3275; Schwarcz SK, 1999, AIDS, V13, P1109, DOI 10.1097/00002030-199906180-00015; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; WORTLEY PM, 1994, AIDS, V8, P941, DOI 10.1097/00002030-199407000-00010; 1997, MMWR MORB MORTAL WKL, V46, P861; 1997, MMWR MORB WKLY REP, V46, P1; 1997, DIVISION HIV AIDS, V9, P6	34	156	158	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					182	190		10.7326/0003-4819-132-3-200002010-00003	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	276XE	10651598				2022-12-28	WOS:000084903000002
J	Kong, J; Franklin, NR; Zhou, CW; Chapline, MG; Peng, S; Cho, KJ; Dai, HJ				Kong, J; Franklin, NR; Zhou, CW; Chapline, MG; Peng, S; Cho, KJ; Dai, HJ			Nanotube molecular wires as chemical sensors	SCIENCE			English	Article							CARBON NANOTUBE; GAS SENSORS	Chemical sensors based on individual single-walled carbon nanotubes (SWNTs) are demonstrated. Upon exposure to gaseous molecules such as NO2 or NH3, the electrical resistance of a semiconducting SWNT is found to dramatically increase or decrease. This serves as the basis for nanotube molecular sensors. The nanotube sensors exhibit a fast response and a substantially higher sensitivity than that of existing solid-state sensors at room temperature. Sensor reversibility is achieved by slow recovery under ambient conditions or by heating to high temperatures. The interactions between molecular species and SWNTs and the mechanisms of molecular sensing with nanotube molecular wires are investigated.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@chem.stanford.edu	Dai, Hongjie/ABC-4574-2021; Zhou, Chongwu/F-7483-2010					Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Capone S, 1999, LANGMUIR, V15, P1748, DOI 10.1021/la980608+; CHENG A, 1990, J CHEM PHYS, V92, P3867, DOI 10.1063/1.457843; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Grigorian L, 1998, PHYS REV LETT, V80, P5560, DOI 10.1103/PhysRevLett.80.5560; Hair M.L., 1967, INFRARED SPECTROSCOP; HEINEY PA, 1992, J PHYS CHEM SOLIDS, V53, P1333, DOI 10.1016/0022-3697(92)90231-2; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; Lee RS, 1997, NATURE, V388, P255, DOI 10.1038/40822; Lonergan MC, 1996, CHEM MATER, V8, P2298, DOI 10.1021/cm960036j; MANDELIS A, 1993, PHYSICS CHEM TECHNOL; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; MIASIK JJ, 1986, J CHEM SOC FARAD T 1, V82, P1117, DOI 10.1039/f19868201117; *MRS, 1999, MRS B, V24; Peng S., UNPUB; ROWNTREE P, 1990, J CHEM PHYS, V92, P3853, DOI 10.1063/1.457842; SBERVEGLIERI G, 1991, SENSOR ACTUAT B-CHEM, V4, P457, DOI 10.1016/0925-4005(91)80151-9; Shimizu Y, 1999, MRS BULL, V24, P18, DOI 10.1557/S0883769400052465; SJOVALL P, 1990, CHEM PHYS LETT, V172, P125, DOI 10.1016/0009-2614(90)87284-X; Soh HT, 1999, APPL PHYS LETT, V75, P627, DOI 10.1063/1.124462; TAKAO Y, 1994, J ELECTROCHEM SOC, V141, P1028, DOI 10.1149/1.2054836; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; ZHOU CS, UNPUB	27	5464	5831	45	1966	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					622	625		10.1126/science.287.5453.622	http://dx.doi.org/10.1126/science.287.5453.622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649989				2022-12-28	WOS:000084989400038
J	Sanci, LA; Coffey, CMM; Veit, FCM; Carr-Gregg, M; Patton, GC; Day, E; Bowes, G				Sanci, LA; Coffey, CMM; Veit, FCM; Carr-Gregg, M; Patton, GC; Day, E; Bowes, G			Evaluation of the effectiveness of an educational intervention for general practitioners in adolescent health care: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CONTINUING MEDICAL-EDUCATION; PHYSICIAN PERFORMANCE; SIMULATED PATIENTS; CONSULTATION; COMPETENCE	Objective To evaluate the effectiveness of an educational intervention in adolescent health designed for general practitioners in accordance with evidence based practice in continuing medical education. Design Randomised controlled trial with baseline testing and follow up at seven and 13 months. Setting Local communities in metropolitan Melbourne, Australia. Participants 108 self selected general practitioners. Intervention A multifaceted educational programme for 2.5 hours a week over six weeks on the principles of adolescent health care followed six weeks later by a two hour session of case discussion and debriefing. Outcome measures Objective ratings of consultations with standardised adolescent patients recorded on videotape. Questionnaires completed by the general practitioners were used to measure their knowledge, skill, and self perceived competency, satisfaction with the programme, and self reported change in practice. Results 103 of 108 (95%) doctors completed all phases of the intervention and evaluation protocol. The intervention group showed significantly greater improvements in all outcomes than the control group at the seven month follow up except for the rapport and satisfaction rating by the standardised patients. 104 (96%) participants found the programme appropriate and relevant At the 13 month follow up most improvements were sustained, the confidentiality rating by the standardised patients decreased slightly, and the objective assessment of competence further improved. 106 (98%) participants reported a change in practice attributable ts the intervention. Conclusions General practitioners were willing to complete continuing medical education in adolescent health care and its evaluation, The design of the intervention using evidence based educational strategies proved an effective and quick way to achieve sustainable and large improvements in knowledge, skill, and self perceived competency.	Monash Univ, Fac Business Econ, Ctr Hlth Program Evaluat, Clayton, Vic 3168, Australia; Univ Melbourne, Dept Paediat, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia	Monash University; University of Melbourne	Sanci, LA (corresponding author), Univ Melbourne, Dept Paediat, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia.		Patton, George C/B-5246-2013; Day, Emma/GZM-2074-2022; Ribeiro, Ana Cristina/HHN-7466-2022	Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376				BEARINGER LH, 1993, J PAEDIATR CHILD H, V29, pS10, DOI 10.1111/j.1440-1754.1993.tb02253.x; BENNETT DL, 1984, ADOLESCENT HLTH AUST; BLUM R, 1987, J MED EDUC, V62, P401; BLUM RW, 1990, J ADOLESCENT HEALTH, V11, P289, DOI 10.1016/0197-0070(90)90037-3; Bridges-Webb Charles, 1992, Medical Journal of Australia, V157, pS1; *CAMPB RES CONS, 1997, GEN PRACT PROF STUD; Caracelli V.J, 1997, ADV MIXED METHOD EVA, DOI DOI 10.1002/EV.1069; Colliver J A, 1997, JAMA, V278, P790, DOI 10.1001/jama.278.9.790; Colliver JA, 1995, ACAD MED, V70, P1062; DAVIS D, 1994, PHYSICIAN LEARNER LI; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; Donovan C, 1997, BRIT J GEN PRACT, V47, P715; Ginsburg Kenneth R., 1996, Current Opinion in Pediatrics, V8, P333, DOI 10.1097/00008480-199608000-00006; HAYS RB, 1995, MED EDUC, V29, P317, DOI 10.1111/j.1365-2923.1995.tb02855.x; Knowles M., 1990, ADULT LEARNER NEGLEC; Masters G. N., 1990, COMPETENCY BASED ASS; McPherson A, 1996, BRIT J GEN PRACT, V46, P627; Norman G.R., 1985, ASSESSING CLIN COMPE, P15; NORMAN GR, 1985, J MED EDUC, V60, P925; OppongOdiseng ACK, 1997, ARCH DIS CHILD, V77, P115, DOI 10.1136/adc.77.2.115; OWEN JM, 1993, PROGRAM EVALUATION F; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; PIETERS HM, 1994, MED EDUC, V28, P226, DOI 10.1111/j.1365-2923.1994.tb02703.x; RESNICK MD, 1986, PEDIATR ANN, V15, P799, DOI 10.3928/0090-4481-19861101-09; RETHANS JJ, 1991, BRIT MED J, V303, P1377, DOI 10.1136/bmj.303.6814.1377; ROSEN D, 1995, ADOLESCENT MED RESID, P1; *ROYAL AUSTR COLL, 1996, ROYAL AUSTR COLL GEN; Veit FCM, 1996, MED J AUSTRALIA, V165, P131, DOI 10.5694/j.1326-5377.1996.tb124885.x; VEIT FCM, 1995, MED J AUSTRALIA, V163, P16, DOI 10.5694/j.1326-5377.1995.tb126081.x; WARD J, 1988, MED J AUSTRALIA, V148, P77, DOI 10.5694/j.1326-5377.1988.tb104512.x; WOODWARD CA, 1985, MED CARE, V23, P1019, DOI 10.1097/00005650-198508000-00009	32	143	149	1	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					224	229		10.1136/bmj.320.7229.224	http://dx.doi.org/10.1136/bmj.320.7229.224			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642233	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000085029600027
J	Tenery, RM				Tenery, RM			Interactions between physicians and the health care technology industry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FREE LUNCH; REPRESENTATIVES; GIFTS; FIRMS		Amer Med Assoc, Council Eth & Judicial Affairs, Chicago, IL 60610 USA	American Medical Association	Tenery, RM (corresponding author), Amer Med Assoc, Council Eth & Judicial Affairs, 515 N State St, Chicago, IL 60610 USA.							*ACCR COUNC CONT M, 1999, STAND COMM SUPP CONT; *AM MED ASS COUNC, 1998, OP 8 061 GIFTS PHYS; *AM MED ASS COUNC, OP 9 011 CONT MED ED; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Beary JF, 1996, J GEN INTERN MED, V11, P635, DOI 10.1007/BF02599032; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; GIANELLI DM, 1998, AM MED NEWS     0112, P8; GRAVES J, 1987, NEW ENGL J MED, V317, P252; HERMAN CM, 1976, J MED EDUC, V51, P189; HIZENBATH DS, 1998, WASHINGTON POST 0512; LICHSTEIN PR, 1992, ARCH INTERN MED, V152, P1009, DOI 10.1001/archinte.152.5.1009; LIEBMAN M, 1998, MED MARKETING ME JUL, P38; RANDALL T, 1991, JAMA-J AM MED ASSOC, V265, P440, DOI 10.1001/jama.265.4.440; RANDALL T, 1991, JAMA-J AM MED ASSOC, V265, P442; Roughead EE, 1998, AUST NZ J MED, V28, P306, DOI 10.1111/j.1445-5994.1998.tb01953.x; Sandberg WS, 1997, ACAD MED, V72, P916, DOI 10.1097/00001888-199710000-00018; SMITH MC, 1977, AM J HOSP PHARM, V34, P1208, DOI 10.1093/ajhp/34.11.1208; STOLBERG SG, 1998, NY TIMES        0401; WAUD DR, 1992, NEW ENGL J MED, V327, P351, DOI 10.1056/NEJM199207303270511; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Worthen D B, 1973, Br J Med Educ, V7, P109; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	22	28	29	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					391	393		10.1001/jama.283.3.391	http://dx.doi.org/10.1001/jama.283.3.391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647803				2022-12-28	WOS:000084732400032
J	Meyer, J				Meyer, J			Qualitative research in health care - Using qualitative methods in health related action research	BMJ-BRITISH MEDICAL JOURNAL			English	Article									City Univ London, St Bartholomews Sch Nursing & Midwifery, London, England	City University London	Meyer, J (corresponding author), City Univ London, St Bartholomews Sch Nursing & Midwifery, London, England.			Meyer, Julienne/0000-0001-5378-2761				BROOKING JI, 1986, THESIS U LONDON LOND; CAREY LM, 1993, ARCH PHYS MED REHAB, V74, P602, DOI 10.1016/0003-9993(93)90158-7; Carr W., 1986, BECOMING CRITICAL ED; East L, 1994, J Clin Nurs, V3, P57, DOI 10.1111/j.1365-2702.1994.tb00359.x; Hart E., 1995, ACTION RES HLTH SOCI; Hicks C, 1997, J ADV NURS, V25, P595, DOI 10.1046/j.1365-2648.1997.1997025595.x; LYON J, 1999, NURSE RES, V6, P39; MEYER J, 1998, ACTION RES STUDY ORG; Meyer J., 1993, J INTERPROF CARE, V7, P57; MEYER J, 1993, RES HLTH PROMOTION N, P86; MEYER JE, 1993, J ADV NURS, V18, P1066, DOI 10.1046/j.1365-2648.1993.18071066.x; Miller E, 1998, BRIT MED J, V316, P875, DOI 10.1136/bmj.316.7135.875; ONG BN, 1996, RAPID APPRAISAL HLTH; Reason P., 1981, HUMAN INQUIRY SOURCE; Rolfe G., 1998, EXPANDING NURSING KN; Sackett D. L., 1997, EVIDENCE BASED MED P; *SECR STAT HLTH, 1997, CMND3807; STARK S, 1994, J ADV NURS, V19, P579, DOI 10.1111/j.1365-2648.1994.tb01124.x; STREET A, 1995, J CLIN NURS, V4, P349, DOI 10.1111/j.1365-2702.1995.tb00036.x; TITCHEN A, 1993, J ADV NURS, V18, P1054, DOI 10.1046/j.1365-2648.1993.18071054.x; TITCHEN A, 1993, J CLIN NURS, V2, P219; Walshe K, 1995, Health Serv J, V105, P28; WEBB C, 1989, J ADV NURS, V14, P403, DOI 10.1111/j.1365-2648.1989.tb01548.x	23	286	297	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2000	320	7228					178	181		10.1136/bmj.320.7228.178	http://dx.doi.org/10.1136/bmj.320.7228.178			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	276DL	10634744	Green Published			2022-12-28	WOS:000084860300035
J	Rudnick, RL; Barth, M; Horn, I; McDonough, WF				Rudnick, RL; Barth, M; Horn, I; McDonough, WF			Rutile-bearing refractory eclogites: Missing link between continents and depleted mantle	SCIENCE			English	Article							ISLAND-ARC BASALTS; TRACE-ELEMENTS; CHEMICAL-COMPOSITION; DIAMOND INCLUSIONS; OCEANIC-CRUST; GEOCHEMISTRY; CONSTRAINTS; KIMBERLITE; EARTH; CLINOPYROXENE	A mass imbalance exists in Earth for Nb, Ta, and possibly Ti: continental crust and depleted mantle both have subchondritic Nb/Ta, Nb/La, and Ti/Zr, which requires the existence of an additional reservoir with superchondritic ratios, such as refractory eclogite produced by slab melting. Trace element compositions of minerals in xenolithic eclogites derived from cratonic lithospheric mantle show that rutile dominates the budget of Nb and Ta in the eclogites and imparts a superchondritic Nb/Ta, Nb/La, and Ti/Zr to the whole rocks. About 1 to 6 percent by weight of eclogite is required to solve the mass imbalance in the silicate Earth, and this reservoir must have an Nb concentration greater than or equal to 2 parts per million, Nb/La greater than or equal to 1.2, and Nb/Ta between 19 and 37-values that overlap those of the xenolithic eclogites. As the mass of eclogite in the continental lithosphere is significantly lower than this, much of this material may reside in the lower mantle, perhaps as deep as the core-mantle boundary.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Rudnick, RL (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.		McDonough, William F/I-7720-2012; McDonough, William F/C-4791-2009; Barth, Matthias G/B-1928-2008; Rudnick, Roberta Lyn/J-2398-2013	McDonough, William F/0000-0001-9154-3673; McDonough, William F/0000-0001-9154-3673; Barth, Matthias G/0000-0002-0876-0544; Rudnick, Roberta Lyn/0000-0003-1559-7463				ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; BARTH MG, IN PRESS CHEM GEOL; BARTH MG, 1999, EOS, V80, pF1192; Beard BL, 1996, CONTRIB MINERAL PETR, V125, P293, DOI 10.1007/s004100050223; BRENAN JM, 1994, EARTH PLANET SC LETT, V128, P327, DOI 10.1016/0012-821X(94)90154-6; Eggins SM, 1997, CHEM GEOL, V134, P311, DOI 10.1016/S0009-2541(96)00100-3; Elliott T, 1997, J GEOPHYS RES-SOL EA, V102, P14991, DOI 10.1029/97JB00788; FREY FA, 1985, GEOCHIM COSMOCHIM AC, V49, P2469, DOI 10.1016/0016-7037(85)90247-9; Halliday AN, 1999, NATURE, V399, P733, DOI 10.1038/21533; HILLS DV, 1989, CONTRIB MINERAL PETR, V103, P397, DOI 10.1007/BF01041749; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Hofmann AW, 1996, J GEOPHYS RES-SOL EA, V101, P11831, DOI 10.1029/95JB03701; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HORN I, IN PRESS CHEM GEOL; IRELAND TR, 1994, EARTH PLANET SC LETT, V128, P199, DOI 10.1016/0012-821X(94)90145-7; JAGOUTZ E, 1984, P 25 LUN PLAN SCI C, P395; JERDE EA, 1993, CONTRIB MINERAL PETR, V114, P189, DOI 10.1007/BF00307755; Jochum K. P., 1997, EOS, V78, pF805; Jochum KP, 1997, FRESEN J ANAL CHEM, V359, P385, DOI 10.1007/s002160050593; JOCHUM KP, 1997, METEORITICS PLAN S67, V32; JOCHUM KP, 1996, EOS T AGU, V77, pF785; Kaneshima S, 1999, SCIENCE, V283, P1888, DOI 10.1126/science.283.5409.1888; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Lundstrom CC, 1998, GEOCHIM COSMOCHIM AC, V62, P2849, DOI 10.1016/S0016-7037(98)00197-5; MARTIN H, 1986, GEOLOGY, V14, P753, DOI 10.1130/0091-7613(1986)14<753:EOSAGG>2.0.CO;2; MCDONOUGH WF, 1990, EARTH PLANET SC LETT, V101, P1, DOI 10.1016/0012-821X(90)90119-I; MCDONOUGH WF, 1991, PHILOS T ROY SOC A, V335, P407, DOI 10.1098/rsta.1991.0055; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MUETNER O, 1997, THESIS SWISS FEDERAL; Munker C, 1998, CHEM GEOL, V144, P23, DOI 10.1016/S0009-2541(97)00105-8; NEAL CR, 1990, EARTH PLANET SC LETT, V99, P362, DOI 10.1016/0012-821X(90)90140-S; Niu YL, 1997, EARTH PLANET SC LETT, V148, P471, DOI 10.1016/S0012-821X(97)00048-4; NIXON PH, 1989, MANTLE XENOLITHS; PEARSON DG, 1995, NATURE, V374, P711, DOI 10.1038/374711a0; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; PLANK T, 1995, EOS T AM GEOPHYS UN, V76, pF655; Rollinson H, 1997, NATURE, V389, P173, DOI 10.1038/38266; Rudnick R. L., 1995, 6 INT KIMB C, P473; RUDNICK RL, 1999, P 7 INT KIMB C CAP T; RUDNICK RL, 1995, REV GEOPHYS, V33, P3; RYERSON FJ, 1987, EARTH PLANET SC LETT, V86, P225, DOI 10.1016/0012-821X(87)90223-8; SCHULZE DJ, 1989, J GEOPHYS RES-SOLID, V94, P4205, DOI 10.1029/JB094iB04p04205; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sobolev NV, 1998, GEOLOGY, V26, P971, DOI 10.1130/0091-7613(1998)026<0971:UUMBGG>2.3.CO;2; Stalder R, 1998, GEOCHIM COSMOCHIM AC, V62, P1781, DOI 10.1016/S0016-7037(98)00101-X; Stolz AJ, 1996, GEOLOGY, V24, P587, DOI 10.1130/0091-7613(1996)024<0587:FAMREI>2.3.CO;2; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; TAKAZAWA E, 1996, THESIS MIT CAMBRIDGE; TAYLOR SR, 1985, CONTINENTAL CRUST IT, P67; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; WEAVER BL, 1984, NATURE, V310, P575, DOI 10.1038/310575a0; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	53	429	494	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					278	281		10.1126/science.287.5451.278	http://dx.doi.org/10.1126/science.287.5451.278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634776				2022-12-28	WOS:000084769600031
J	Jensen, DM; Machicado, GA; Jutabha, R; Kovacs, TOG				Jensen, DM; Machicado, GA; Jutabha, R; Kovacs, TOG			Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLEEDING COLONIC DIVERTICULA; ENDOSCOPIC HEMOSTASIS; INJECTION; THERAPY; VESSEL	Background: Although endoscopy is often used to diagnose and treat acute upper gastrointestinal bleeding, its role in the management of diverticulosis and lower gastrointestinal bleeding is uncertain. Methods: We studied the role of urgent colonoscopy in the diagnosis and treatment of 121 patients with severe hematochezia and diverticulosis. All patients were hospitalized, received blood transfusions as needed, and received a purge to rid the colon of clots, stool, and blood. Colonoscopy was performed within 6 to 12 hours after hospitalization or the diagnosis of hematochezia. Among the first 73 patients, those with continued diverticular bleeding underwent hemicolectomy. For the subsequent 48 patients, those requiring treatment received therapy, such as epinephrine injections or bipolar coagulation, through the colonoscope. Results: Of the first 73 patients, 17 (23 percent) had definite signs of diverticular hemorrhage (active bleeding in 6, nonbleeding visible vessels in 4, and adherent clots in 7). Nine of the 17 had additional bleeding after colonoscopy, and 6 of these required hemicolectomy. Of the subsequent 48 patients, 10 (21 percent) had definite signs of diverticular hemorrhage (active bleeding in 5, nonbleeding visible vessels in 2, and adherent clots in 3). An additional 14 patients in this group (29 percent) were presumed to have diverticular bleeding because although they had no stigmata of diverticular hemorrhage, no other source of bleeding was identified. The other 24 patients (50 percent) had other identified sources of bleeding. All 10 patients with definite diverticular hemorrhage were treated endoscopically; none had recurrent bleeding or required surgery. Conclusions: Among patients with severe hematochezia and diverticulosis, at least one fifth have definite diverticular hemorrhage. Colonoscopic treatment of such patients with epinephrine injections, bipolar coagulation, or both may prevent recurrent bleeding and decrease the need for surgery. (N Engl J Med 2000;342:78-82.) (C) 2000, Massachusetts Medical Society.	VA GLAHS, CURE, Digest Dis Res Ctr, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Ctr Ulcer Res & Educ,Div Digest Dis, Hemostasis Res Unit,Digest Dis Res Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles	Jensen, DM (corresponding author), VA GLAHS, CURE, Digest Dis Res Ctr, 11301 Wilshire Blvd,Bldg 115,Rm 318, Los Angeles, CA 90073 USA.				PHS HHS [41301, R01 33273] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDRESS HJ, 1993, ENDOSCOPY, V25, P193, DOI 10.1055/s-2007-1010286; BAILAR JC, 1992, MED USES STAT, P183; BERTONI G, 1990, ENDOSCOPY, V22, P202, DOI 10.1055/s-2007-1012847; BERTONI G, 1990, ENDOSCOPY, V22, P154, DOI 10.1055/s-2007-1012827; Hokama A, 1997, AM J GASTROENTEROL, V92, P543; HYMAN N, 1991, GASTROINTEST ENDOSC, V37, P56, DOI 10.1016/S0016-5107(91)70622-6; Jensen Dennis M., 1994, P201; JENSEN DM, 1988, GASTROENTEROLOGY, V95, P1569, DOI 10.1016/S0016-5085(88)80079-9; JENSEN DM, 1999, TXB GASTROENTEROLOGY, P2857; JENSEN DM, 1990, MED LASER ENDOSCOPY, P45; JENSEN DM, 1995, COLONOSCOPY PRINCIPL, P317; JENSEN DM, 1996, GASTROINTEST ENDOSC, V43, P297; JOHNSTON J, 1986, GASTROINTEST ENDOSC, V32, P160; KIM YI, 1993, J CLIN GASTROENTEROL, V17, P46, DOI 10.1097/00004836-199307000-00013; KNIGHT CD, 1957, SURGERY, V42, P853; MCGUIRE HH, 1972, ANN SURG, V175, P847, DOI 10.1097/00000658-197206010-00004; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; Ramirez FC, 1996, GASTROINTEST ENDOSC, V43, P167, DOI 10.1016/S0016-5107(06)80126-4; SAVIDES TJ, 1994, GASTROINTEST ENDOSC, V40, P70, DOI 10.1016/S0016-5107(94)70014-1; SWAIN CP, 1986, GASTROENTEROLOGY, V90, P595, DOI 10.1016/0016-5085(86)91113-3	20	427	444	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					78	82		10.1056/NEJM200001133420202	http://dx.doi.org/10.1056/NEJM200001133420202			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631275				2022-12-28	WOS:000084723900002
J	Galy, V; Olivo-Marin, JC; Scherthan, H; Doye, V; Rascalou, N; Nehrbass, U				Galy, V; Olivo-Marin, JC; Scherthan, H; Doye, V; Rascalou, N; Nehrbass, U			Nuclear pore complexes in the organization of silent telomeric chromatin	NATURE			English	Article							DOUBLE-STRAND BREAKS; END-JOINING REPAIR; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; YEAST KU; PROTEINS; LENGTH; GENE; MAINTENANCE; REPRESSION	The functional regulation of chromatin is closely related to its spatial organization within the nucleus. In yeast, perinuclear chromatin domains constitute areas of transcriptional repression(1-3). These 'silent' domains are defined by the presence of perinuclear telomere clusters(4). The only protein found to be involved in the peripheral localization of telomeres is Yku70/Yku80 (ref. 5). This conserved heterodimer(6) can bind telomeres(7) and functions in both repair of DNA double-strand breaks(8-11) and telomere maintenance(7,12-15) These findings, however, do not address the underlying structural basis of perinuclear silent domains. Here we show that nuclear-pore-complex extensions formed by the conserved TpR(16,17) homologues Mlp1 and Mlp2(18,19) are responsible for the structural and functional organization of perinuclear chromatin. Loss of MLP2 results in a severe deficiency in the repair of double-strand breaks. Furthermore, double deletion of MLP1 and MLP2 disrupts the clustering of perinuclear telomeres and releases telomeric gene repression. These effects are probably mediated through the interaction with Yku70. Mlp2 physically tethers Yku70 to the nuclear periphery, thus forming a link between chramatin and the nuclear envelope. We show, moreover, that this structural link is docked to nuclear-pore complexes through a cleavable nucleoporin, Nup145(20). We propose that, through these interactions, nuclear-pore complexes organize a nuclear subdomain that is intimately involved in the regulation of chromatin metabolism.	Inst Pasteur, Lab Biol Cellulaire Noyau, CNRS, URA 1773, F-75724 Paris 15, France; Inst Pasteur, Lab Anal & Images Quantitat, CNRS, URA 1947, F-75724 Paris 15, France; Univ Kaiserslautern, Abt Humanbiol, D-67653 Kaiserslautern, Germany; Univ Kaiserslautern, Abt Zellbiol, D-67653 Kaiserslautern, Germany; Inst Curie, CNRS, UMR144, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Kaiserslautern; University of Kaiserslautern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Nehrbass, U (corresponding author), Inst Pasteur, Lab Biol Cellulaire Noyau, CNRS, URA 1773, 25 Rue Docteur Roux, F-75724 Paris 15, France.		Olivo-Marin, Jean-Christophe/K-4428-2015	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Nehrbass, Ulf/0000-0002-7028-8076				Andrulis ED, 1998, NATURE, V395, P525, DOI 10.1038/26795; ARIS JP, 1989, J CELL BIOL, V108, P2059, DOI 10.1083/jcb.108.6.2059; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KOLLING R, 1993, MOL GEN GENET, V237, P359; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Mages GJ, 1996, J BIOL CHEM, V271, P7910, DOI 10.1074/jbc.271.14.7910; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Olivo JC, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL I, P311, DOI 10.1109/ICIP.1996.559495; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Shore D, 1997, BIOL CHEM, V378, P591; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Teixeira MT, 1999, J BIOL CHEM, V274, P32439, DOI 10.1074/jbc.274.45.32439; Trelles-Sticken E, 1999, J CELL SCI, V112, P651	30	252	259	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					108	112		10.1038/47528	http://dx.doi.org/10.1038/47528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638763				2022-12-28	WOS:000084687400053
J	Muller-Navarra, DC; Brett, MT; Liston, AM; Goldman, CR				Muller-Navarra, DC; Brett, MT; Liston, AM; Goldman, CR			A highly unsaturated fatty acid predicts carbon transfer between primary producers and consumers	NATURE			English	Article							DAPHNIA GROWTH; LIMITATION; ZOOPLANKTON; MICROALGAE; QUALITY	The factors that regulate energy transfer between primary producers and consumers in aquatic ecosystems have been investigated for more than 50 years (refs 1-3). Among all levels of the food web (plants, herbivores, carnivores), the plant-animal interface is the most variable and least predictable link(4-6). In hypereutrophic lakes, for example, biomass and energy transfer is often inhibited at the phytoplankton-zooplankton link(4), resulting in an accumulation of phytoplankton biomass instead of sustaining production at higher trophic levels, such as fish. Accumulation of phytoplankton (especially cyanobacteria) results in severe deterioration of water quality, with detrimental effects on the health of humans and domestic animals, and diminished recreational value of water bodies(7,8). We show here that low transfer efficiencies between primary producers and consumers during cyanobacteria bloom conditions are related to low relative eicosapentaenoic acid (20:5 omega 3) content of the primary producer community. Zooplankton growth and egg production were strongly related to the primary producer 20:5 omega 3 to carbon ratio. This indicates that limitation of zooplankton production by this essential fatty acid is of central importance at the pelagic producer-consumer interface.	Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of California System; University of California Davis; University of Washington; University of Washington Seattle	Muller-Navarra, DC (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.		Brett, Michael T/A-2066-2010					AHLGREN G, 1992, J PHYCOL, V28, P37, DOI 10.1111/j.0022-3646.1992.00037.x; ARNOLD DE, 1971, LIMNOL OCEANOGR, V16, P906, DOI 10.4319/lo.1971.16.6.0906; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brett MT, 1997, SCIENCE, V275, P384, DOI 10.1126/science.275.5298.384; COBELAS MA, 1989, GRASAS ACEITES, V40, P118; Greenberg AE, 1995, STANDARD METHODS EXA; GULATI RD, 1990, BIOMANIPULATION TOOL, V200, P29; GULATI RD, 1997, FRESHWAT BIOL, V38; KATTNER G, 1986, J CHROMATOGR, V361, P263, DOI 10.1016/S0021-9673(01)86914-4; LAMPERT W, 1977, Archiv fuer Hydrobiologie Supplement, V48, P310; LAMPERT W, 1988, B MAR SCI, V43, P620; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; LAMPERT W, 1985, ARCH HYDROBIOL BEIH, V21, pR5; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Marker A. F. H., 1980, ARCH HYDROBIOL S, V14, P52; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; MULLERNAVARRA D, 1995, ARCH HYDROBIOL, V132, P297; MullerNavarra D, 1996, J PLANKTON RES, V18, P1137, DOI 10.1093/plankt/18.7.1137; PORTER KG, 1987, EVOLUTION ECOLOGY ZO, P268; STERNER RW, 1993, ECOLOGY, V74, P2351, DOI 10.2307/1939587; URABE J, 1992, LIMNOL OCEANOGR, V37, P244, DOI 10.4319/lo.1992.37.2.0244; VINCENT WF, 1987, NZ J MAR FRESHWAT RE, V221; Wood B.J.B., 1974, ALGAL PHYSL BIOCH, P236; [No title captured]	25	568	586	13	249	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					74	77		10.1038/47469	http://dx.doi.org/10.1038/47469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638754				2022-12-28	WOS:000084687400044
J	Mundinger, MO; Kane, RL; Lenz, ER; Totten, AM; Tsai, WY; Cleary, PD; Friedewald, WT; Siu, AL; Shelanski, ML				Mundinger, MO; Kane, RL; Lenz, ER; Totten, AM; Tsai, WY; Cleary, PD; Friedewald, WT; Siu, AL; Shelanski, ML			Primary care outcomes in patients treated by nurse practitioners or physicians - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONICALLY ILL PATIENTS; HEALTH SURVEY SF-36; PREVENTABLE HOSPITALIZATIONS; MEDICAL OUTCOMES; FAMILY-PRACTICE; URBAN	Context Studies have suggested that the quality of primary care delivered by nurse practitioners is equal to that of physicians. However, these studies did not measure nurse practitioner practices that had the same degree of independence as the comparison physician practices, nor did previous studies provide direct comparison of outcomes for patients with nurse practitioner or physician providers. Objective To compare outcomes for patients randomly assigned to nurse practitioners or physicians for primary care follow-up and ongoing care after an emergency department or urgent care visit. Design Randomized trial conducted between August 1995 and October 1997, with patient interviews at 6 months after initial appointment and health services utilization data recorded at 6 months and 1 year after initial appointment. Setting Four community-based primary care clinics (17 physicians) and 1 primary care clinic (7 nurse practitioners) at an urban academic medical center. Patients Of 3397 adults originally screened, 1316 patients (mean age, 45.9 years; 76.8% female, 90.3% Hispanic) who had no regular source of care and kept their initial primary care appointment were enrolled and randomized with either a nurse practitioner (n = 806) or physician (n = 510), Main Outcome Measures Patient satisfaction after initial appointment (based on 15-item questionnaire); health status (Medical Outcomes Study Short-Form 36), satisfaction, and physiologic test results 6 months later; and service utilization (obtained from computer records) for 1 year after initial appointment, compared by type of provider. Results No significant differences were found in patients' health status (nurse practitioners vs physicians) at 6 months (P = .92). Physiologic test results for patients with diabetes (P = .82) or asthma (P = .77) were not different. For patients with hypertension, the diastolic value was statistically significantly lower for nurse practitioner patients (82 vs 85 mm Hg; P = .04). No significant differences were found in health services utilization after either 6 months or 1 year. There were no differences in satisfaction ratings following the initial appointment (P = .88 for overall satisfaction). Satisfaction ratings at 6 months differed for 1 of 4 dimensions measured (provider attributes), with physicians rated higher (4.2 vs 4.1 on a scale where 5 = excellent; P = .05), Conclusions In an ambulatory care situation in which patients were randomly assigned to either nurse practitioners or physicians, and where nurse practitioners had the same authority, responsibilities, productivity and administrative requirements, and patient population as primary care physicians, patients' outcomes were comparable.	Columbia Univ, Sch Nursing, New York, NY 10032 USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Metropolitan Life Insurance Co, New York, NY USA; Mt Sinai Med Ctr, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Mundinger, MO (corresponding author), Columbia Univ, Sch Nursing, 630 W 168th St, New York, NY 10032 USA.	mm44@columbia.edu	Friedewald, William T/C-8034-2011; Totten, Annette/P-7909-2019; Cleary, Paul/AAF-7048-2019	Totten, Annette/0000-0002-9100-8678; 				Bertakis KD, 1998, MED CARE, V36, P879, DOI 10.1097/00005650-199806000-00011; Billings J, 1996, HEALTH AFFAIR, V15, P239, DOI 10.1377/hlthaff.15.3.239; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Brown SA, 1995, NURS RES, V44, P332; DEYO RA, 1980, MED CARE, V18, P1146, DOI 10.1097/00005650-198011000-00006; DOCKERTY JD, 1992, NEW ZEAL MED J, V105, P147; GARFIELD R, 1995, ACAD MED, V70, P405, DOI 10.1097/00001888-199505000-00017; Garratt A M, 1994, Qual Health Care, V3, P186, DOI 10.1136/qshc.3.4.186; Kopjar B, 1996, Inj Prev, V2, P135, DOI 10.1136/ip.2.2.135; Kusek JW, 1996, CONTROL CLIN TRIALS, V17, pS40, DOI 10.1016/S0197-2456(97)82681-5; Mangione CM, 1997, J GEN INTERN MED, V12, P686, DOI 10.1046/j.1525-1497.1997.07142.x; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MUNDINGER MO, 1994, NEW ENGL J MED, V330, P211, DOI 10.1056/NEJM199401203300314; Pearson L J, 1999, Nurse Pract, V24, P16; PEARSON LJ, 1999, NURSE PRACT, V24, P23; PEARSON LJ, 1999, NURSE PRACT, V24, P27; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; Safriet B.J., 1992, YALE J REGUL, V9; Sherbourne CD, 1996, ARCH GEN PSYCHIAT, V53, P889; Shiely JC., 1996, SF 36 HLTH SURVEY AN; SPITZER WO, 1974, NEW ENGL J MED, V290, P251, DOI 10.1056/NEJM197401312900506; TEMPLE PC, 1995, J AM COLL SURGEONS, V181, P17; TSAI C, 1997, SF 36 SURVEY ANNOTAT; VIKANDER T, 1986, J FAM PRACTICE, V22, P263; Ware J.E, 1994, PHYS MENTAL HLTH SUM; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; [No title captured]	29	588	591	3	62	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					59	68		10.1001/jama.283.1.59	http://dx.doi.org/10.1001/jama.283.1.59			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	270AZ	10632281	Bronze			2022-12-28	WOS:000084514400026
J	Wright, TC; Denny, L; Kuhn, L; Pollack, A; Lorincz, A				Wright, TC; Denny, L; Kuhn, L; Pollack, A; Lorincz, A			HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; SWABS; WOMEN	Context More than half of the women diagnosed as having cervical cancer in the United States have not been screened within the last 3 years, despite many having had contact with the health care system. In many other regions of the world, there is only limited access to cervical cancer screening. Objective To determine whether testing of self-collected vaginal swabs for human papillomavirus (HPV) DNA can be used to screen for cervical disease in women aged 35 years and older. Design Cross-sectional observational study comparing Papanicolaou smears with HPV DNA testing of self-collected vaginal swabs. Setting Outpatient clinics in a periurban settlement outside of Cape Town, South Africa, between January 1998 and April 1999, Participants Screening was performed on 1415 previously unscreened black South African women aged 35 to 65 years. Intervention Women self-collected a vaginal swab for HPV testing in the clinic and were then screened using 4 different tests: Papanicolaou smear, direct visual inspection of the cervix after the application of 5% acetic acid, cervicography, and HPV DNA testing of a clinician-obtained cervical sample. Women with abnormal results on any of the screening tests were referred for colposcopy. Main Outcome Measure Biopsy-confirmed high-grade cervical squamous intraepithelial lesions or invasive cancer. Results High-grade squamous intraepithelial lesions were identified in 47 (3.4%) of 1365 women adequately assessed, and there were 9 cases of invasive cancer. Of women with high-grade disease, 66.1% (95% confidence interval [CI], 52.1%-77.8%) had high risk for HPV detected in self-collected vaginal samples, and 67.9% (95% CI, 53.9%-79.4%) had an abnormal Papanicolaou smear (P = .78). The false-positive rates for HPV DNA testing of self-collected vaginal samples and Papanicolaou smears were 17.1% (95% CI, 15.1%-19.3%) and 12.3% (95% CI, 10.5% -14.2%), respectively (P<.001), A high-risk type of HPV DNA was detected in 83.9% (95% CI, 71.2%-91.9%) of women with high-grade disease and 15.5% (95% CI, 13.6%-17.7%) of women with no evidence of cervical disease using a clinician-obtained cervical sample. Conclusions These results indicate that HPV testing of self-collected vaginal swabs is less specific than but as sensitive as Papanicolaou smears for detecting high-grade cervical disease in women aged 35 years and older, and HPV testing offers an important new way to increase screening in settings where cytology is not readily performed.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; Columbia Univ, Div Epidemiol, New York, NY 10032 USA; AVSC Int, New York, NY USA; Univ Cape Town, Dept Obstet & Gynecol, ZA-7925 Cape Town, South Africa; Digene Corp, Beltsville, MD USA	Columbia University; Columbia University; Columbia University; University of Cape Town	Wright, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Room 16-428,630 W 168th St, New York, NY 10032 USA.	tcw1@columbia.edu						ABRAMS J, 1990, AM J GYNECOL HLTH, V4, P37; *AM CANC SOC, 1999, 1999 CANC FACTS FIG; Burack RC, 1998, CANCER, V82, P2391, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2391::AID-CNCR13>3.0.CO;2-K; *CDCP, 1999, BEH RISK FACT SURV S; *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P659; Chock C, 1997, J CLIN EPIDEMIOL, V50, P1211, DOI 10.1016/S0895-4356(97)00122-4; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; DENNY L, IN PRESS AM J OBSTET; Gray RH, 1998, SEX TRANSM DIS, V25, P450, DOI 10.1097/00007435-199809000-00014; HAKAMA M, 1985, BRIT J CANCER, V52, P669, DOI 10.1038/bjc.1985.241; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Kinney W, 1998, GYNECOL ONCOL, V71, P428, DOI 10.1006/gyno.1998.5135; LUFF RD, 1992, HUM PATHOL, V23, P719, DOI 10.1016/0046-8177(92)90338-4; Megevand E, 1996, OBSTET GYNECOL, V88, P383, DOI 10.1016/0029-7844(96)00189-5; Meijer C J, 1992, IARC Sci Publ, P271; Meijer CJ., 1992, CERVIX, V10, P101; MILLER AB, 1995, AM J PUBLIC HEALTH, V85, P761, DOI 10.2105/AJPH.85.6.761; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Polaneczky M, 1998, OBSTET GYNECOL, V91, P375, DOI 10.1016/S0029-7844(97)00674-1; REID R, 1990, PREMALIGNANT LESIONS, P87; RICHART RM, 1995, CANCER, V76, P1919, DOI 10.1002/1097-0142(19951115)76:10+<1919::AID-CNCR2820761308>3.0.CO;2-9; Rozendaal L, 1996, INT J CANCER, V68, P766, DOI 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z; Sankaranarayanan R, 1998, CANCER-AM CANCER SOC, V83, P2150, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S; SCHATZKIN A, 1987, AM J EPIDEMIOL, V125, P672, DOI 10.1093/oxfordjournals.aje.a114580; Schneider A, 1996, AM J OBSTET GYNECOL, V174, P1534, DOI 10.1016/S0002-9378(96)70602-6; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Sewankambo N, 1997, LANCET, V350, P1036; Solomon D, 1998, ACTA CYTOL, V42, P16, DOI 10.1159/000331531; WAWER MJ, 1995, LANCET, V345, P131, DOI 10.1016/S0140-6736(95)90100-0	29	321	346	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					81	86		10.1001/jama.283.1.81	http://dx.doi.org/10.1001/jama.283.1.81			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632284	Bronze			2022-12-28	WOS:000084514400029
J	Reiser, SJ				Reiser, SJ			The technologies of time measurement: Implications at the bedside and the bench	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL RECORD; MEDICINE	This essay explores how chronologically linked indices of health and illness, such as variation in body temperature, achieved clinical and scientific significance. It shows why time has been a potent concept through which key associations among the data of medicine are ordered and revealed, and it examines the graphical and case reporting methods of organizing evidence that made such associations possible.	Univ Texas, Hlth Sci Ctr, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Reiser, SJ (corresponding author), Univ Texas, Hlth Sci Ctr, Box 20708, Houston, TX 77225 USA.	sreiser@heart.med.uth.tmc.edu						ADAMS F, 1886, GENUINE WORKS HIPPOC, V1, P313; Bolton H., 1900, EVOLUTION THERMOMETE; DAVIS AB, 1981, MED ITS TECHNOLOGY I, P73; FRANK RG, 1988, INVESTIGATIVE ENTERP, P211; HIPPOCRATES, 1923, HIPPOCRATES, V1, P71; Marey E. J., 1860, RECHERCHES POULS MOY; MAREY EJ, 1876, BMJ-BRIT MED J, V1, P1; MAREY EJ, 1876, BMJ-BRIT MED J, V1, P65; MITCHELL SW, 1892, EARLY HIST INSTRUMEN, V13; PEARL R, 1923, INTRO MED BIOMETRY S, P105; REISER SJ, 1991, ANN INTERN MED, V114, P980, DOI 10.7326/0003-4819-114-11-980; REISER SJ, 1991, ANN INTERN MED, V114, P902, DOI 10.7326/0003-4819-114-10-902; Reiser SJ., 1978, MED REIGN TECHNOLOGY, P91; TUFTE ER, 1983, VISUAL DISPLAY QUANT, P28; WARNER JH, 1986, THERAPEUTIC PERSPECT, P157; WOOD A, 1954, T YOUNG NATURAL PHIL, P136; Wunderlich CA., 1871, TEMPERATURE DIS MANU; WUNDERLICH CA, 1871, TEMPERATURE DIS MANU, P78; WUNDERLICH CA, 1871, TEMPERATURE DIS MANU, P288; Zerubavel Eviatar., 1979, PATTERNS TIME HOSP L	20	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					31	36		10.7326/0003-4819-132-1-200001040-00006	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627249				2022-12-28	WOS:000084518600005
J	O'Hollaren, MT				O'Hollaren, MT			Update in allergy and immunology	ANNALS OF INTERNAL MEDICINE			English	Review							ASTHMA; IMMUNOTHERAPY; MANAGEMENT; GUIDELINES; CHILDREN		Allergy Clin, Portland, OR 97205 USA		O'Hollaren, MT (corresponding author), Allergy Clin, 511 SW 10th Ave,Suite 1301, Portland, OR 97205 USA.							Balon J, 1998, NEW ENGL J MED, V339, P1013, DOI 10.1056/NEJM199810083391501; Bousquet J., 1998, Allergy (Copenhagen), V53, P1; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Cote J, 1998, CHEST, V113, P968, DOI 10.1378/chest.113.4.968; Craig TJ, 1998, J ALLERGY CLIN IMMUN, V101, P633, DOI 10.1016/S0091-6749(98)70171-X; Devalia JL, 1998, ALLERGY, V53, P335, DOI 10.1111/j.1398-9995.1998.tb03903.x; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Evans DJ, 1997, NEW ENGL J MED, V337, P1412, DOI 10.1056/NEJM199711133372002; Garbe E, 1998, JAMA-J AM MED ASSOC, V280, P539, DOI 10.1001/jama.280.6.539; Golden DBK, 1998, J ALLERGY CLIN IMMUN, V101, P298, DOI 10.1016/S0091-6749(98)70239-8; Jatulis DE, 1998, ANN ALLERG ASTHMA IM, V81, P82, DOI 10.1016/S1081-1206(10)63113-4; Legorreta AP, 1998, ARCH INTERN MED, V158, P457, DOI 10.1001/archinte.158.5.457; McFadden ER, 1998, AM J MED, V105, P12, DOI 10.1016/S0002-9343(98)00132-6; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Simons FER, 1998, J ALLERGY CLIN IMMUN, V101, P33, DOI 10.1016/S0091-6749(98)70190-3; Teeter JG, 1998, CHEST, V113, P272, DOI 10.1378/chest.113.2.272	17	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					219	226		10.7326/0003-4819-132-3-200002010-00008	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651603				2022-12-28	WOS:000084903000007
J	Rathbun, SW; Raskob, GE; Whitsett, TL				Rathbun, SW; Raskob, GE; Whitsett, TL			Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: A systematic review	ANNALS OF INTERNAL MEDICINE			English	Review							VENTILATION-PERFUSION SCINTIGRAPHY; SPIRAL CT ANGIOGRAPHY; DEEP-VEIN THROMBOSIS; OPINION RESPONSE; LUNG-SCAN; OBSERVER AGREEMENT; MEDICAL LITERATURE; USERS GUIDES; VENOGRAPHY; ULTRASONOGRAPHY	Purpose: To determine the sensitivity and specificity of helical computed tomography (CT) for the diagnosis of pulmonary embolism and to determine the safety of withholding anticoagulant therapy in patients who have clinically suspected pulmonary embolism and negative results on helical CT. Data Sources: The MEDLINE database was searched for all reports published from 1986 to October 1999 that evaluated the use of helical CT for the diagnosis of pulmonary embolism. Bibliographies of the retrieved articles were cross-checked to identify additional studies. Study Selection: All prospective English-language studies were selected. Retrospective studies, review articles, and case reports were excluded, and 5 of the 20 identified articles were excluded. The scientific validity of the remaining 15 articles was assessed. Data Extraction: Two of the authors used a priori, predefined criteria to independently assess each study. A third author resolved disagreements by adjudication. The predefined criteria were inclusion of a consecutive series of all patients with suspected pulmonary embolism, inclusion of patients with and those without pulmonary embolism, a broad spectrum of patient characteristics, performance of helical CT and pulmonary angiography (or an appropriate reference test) in all patients, and independent interpretation of the CT scan and pulmonary angiogram (or reference test). Specific data on sensitivity and specificity and the associated 95% Cls were recorded when available. Data Synthesis: No study met all of the predefined criteria for adequately evaluating sensitivity and specificity. The reported sensitivity of helical CT ranged from 53% to 100%,;and specificity ranged from 81% to 100%. In no prospective study was anticoagulant therapy withheld without further testing for venous thromboembolism in consecutive patients with suspected pulmonary embolism. One prospective study reported the outcome of selected patients with negative results on helical CT who did not receive anticoagulant therapy. Conclusions: Use of helical CT in the diagnosis of pulmonary embolism has not been adequately evaluated. The safety of withholding anticoagulant treatment in patients with negative results on helical CT is uncertain. Definitive large, prospective studies should be done to evaluate the sensitivity, specificity, and safety of helical CT for diagnosis of suspected pulmonary embolism.	Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Rathbun, SW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, WP 3120,POB 26901, Oklahoma City, OK 73190 USA.							BLUM AG, 1994, AM J CARDIOL, V74, P96, DOI 10.1016/0002-9149(94)90502-9; Coche EE, 1998, RADIOLOGY, V207, P753, DOI 10.1148/radiology.207.3.9609900; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Cross JJL, 1998, CLIN RADIOL, V53, P177, DOI 10.1016/S0009-9260(98)80097-4; DALEN JE, 1971, AM HEART J, V81, P175, DOI 10.1016/0002-8703(71)90128-1; Dresel S, 1995, NUCL MED COMMUN, V16, P1009, DOI 10.1097/00006231-199512000-00004; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; Garg K, 1998, RADIOLOGY, V208, P201, DOI 10.1148/radiology.208.1.9646814; Garg K, 1999, AM J ROENTGENOL, V172, P1627, DOI 10.2214/ajr.172.6.10350303; Gefter WB, 1997, J THORAC IMAG, V12, P97, DOI 10.1097/00005382-199704000-00007; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369, DOI 10.2214/ajr.164.6.7754875; Goodman LR, 1996, RADIOLOGY, V199, P25, DOI 10.1148/radiology.199.1.8633154; GOODMAN LR, 1994, RADIOLOGY, V193, P262; Herold CJ, 1998, RADIOLOGY, V209P, P299; HULL RD, 1985, CHEST, V88, P819, DOI 10.1378/chest.88.6.819; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; HULL RD, 1995, ARCH INTERN MED, V155, P1845; Hyers TM, 1999, AM J RESP CRIT CARE, V159, P1; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; Layish D T, 1997, Curr Opin Pulm Med, V3, P280, DOI 10.1097/00063198-199707000-00008; LENSING AWA, 1992, THROMB HAEMOSTASIS, V68, P245; LENSING AWA, 1992, THROMB HAEMOSTASIS, V67, P8; Lomis NNT, 1999, J VASC INTERV RADIOL, V10, P707, DOI 10.1016/S1051-0443(99)70104-1; Loud PA, 1998, AM J ROENTGENOL, V170, P951, DOI 10.2214/ajr.170.4.9530042; Mayo JR, 1997, RADIOLOGY, V205, P447, DOI 10.1148/radiology.205.2.9356627; Mayo JR, 1997, J THORAC IMAG, V12, P95, DOI 10.1097/00005382-199704000-00006; Meade MO, 1997, ANN INTERN MED, V127, P531, DOI 10.7326/0003-4819-127-7-199710010-00005; MILLS SR, 1980, RADIOLOGY, V136, P295, DOI 10.1148/radiology.136.2.7403500; Miniati M, 1999, AM J RESP CRIT CARE, V159, P864, DOI 10.1164/ajrccm.159.3.9806130; Miniati M, 1996, AM J RESP CRIT CARE, V154, P1387, DOI 10.1164/ajrccm.154.5.8912753; NOVELLINE RA, 1978, RADIOLOGY, V126, P561, DOI 10.1148/126.3.561; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Remy-Jardin M, 1998, EUR RADIOL, V8, P1376, DOI 10.1007/s003300050557; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; RemyJardin M, 1997, J THORAC IMAG, V12, P92, DOI 10.1097/00005382-199704000-00005; REMYJARDIN MJ, 1995, RADIOLOGY, V197, P303; Robinson PJA, 1997, BRIT J RADIOL, V70, P1085, DOI 10.1259/bjr.70.839.9536897; ROSSUM AV, 1994, RADIOLOGY, V193, P262; Rubin GD, 1997, J THORAC IMAG, V12, P81, DOI 10.1097/00005382-199704000-00001; Russi TJ, 1997, CLIN IMAG, V21, P175, DOI 10.1016/S0899-7071(96)00014-9; Siegle RL, 1998, ACAD RADIOL, V5, P148, DOI 10.1016/S1076-6332(98)80277-8; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sostman HD, 1996, JMRI-J MAGN RESON IM, V6, P275, DOI 10.1002/jmri.1880060203; SOSTMAN HD, 1995, RADIOLOGY, V197, P303; Sostman HD, 1997, J THORAC IMAG, V12, P89, DOI 10.1097/00005382-199704000-00004; STEIN PD, 1991, AM J CARDIOL, V68, P1723, DOI 10.1016/0002-9149(91)90339-M; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Stein PD, 1997, J THORAC IMAG, V12, P86, DOI 10.1097/00005382-199704000-00003; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; van Rossum AB, 1998, EUR RADIOL, V8, P90, DOI 10.1007/s003300050345; vanRossum AB, 1996, THORAX, V51, P23, DOI 10.1136/thx.51.1.23; vanRossum AB, 1996, RADIOLOGY, V201, P467, DOI 10.1148/radiology.201.2.8888242; VANROSSUM AB, 1995, RADIOLOGY, V197, P303; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; 1990, JAMA, V263, P2753	63	299	319	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					227	232		10.7326/0003-4819-132-3-200002010-00009	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651604				2022-12-28	WOS:000084903000008
J	Scott, CH				Scott, CH			Cardiology textbooks on disk	ANNALS OF INTERNAL MEDICINE			English	Article									Hosp Univ Penn, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Scott, CH (corresponding author), Hosp Univ Penn, 9023 E Gates Pavillion,3400 Spruce St, Philadelphia, PA 19104 USA.							TOPOL EJ, 1998, CARDIOVASCULAR MED E; 1998, CARDIOLOGY BASED TXB; [No title captured]	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					248	251		10.7326/0003-4819-132-3-200002010-00025	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651616				2022-12-28	WOS:000084903000024
J	Lee, HL; Carini, JP; Baxter, DV; Henderson, W; Gruner, G				Lee, HL; Carini, JP; Baxter, DV; Henderson, W; Gruner, G			Quantum-critical conductivity scaling for a metal-insulator transition	SCIENCE			English	Article							DISORDERED-SYSTEMS	Temperature (T)- and frequency (omega)-dependent conductivity measurements are reported here in amorphous niobium-silicon alloys with compositions (x) near the zero-temperature metal-insulator transition. There is a one-to-one correspondence between the frequency- and temperature-dependent conductivity on both sides of the critical concentration, thus establishing the quantum-critical nature of the transition. The analysis of the conductivity leads to a universal scaling function and establishes the critical exponents. This scaling can be described by an x-, T-, and omega-dependent characteristic length, the form of which is derived by experiment.	Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Univ Calif Los Angeles, Dept Phys, Los Angeles, CA 90095 USA	Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles	Carini, JP (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	jcarini@indiana.edu	Baxter, David V/D-3769-2013	Baxter, David V/0000-0003-2812-0904; Carini, John P/0000-0001-6535-3390				Abrahams E, 1996, SCIENCE, V274, P1853, DOI 10.1126/science.274.5294.1853; Aeppli G, 1997, SCIENCE, V278, P1432, DOI 10.1126/science.278.5342.1432; Balaban NQ, 1998, PHYS REV LETT, V81, P4967, DOI 10.1103/PhysRevLett.81.4967; BELITZ D, 1994, REV MOD PHYS, V66, P261, DOI 10.1103/RevModPhys.66.261; BISHOP DJ, 1985, SOLID STATE ELECTRON, V28, P73, DOI 10.1016/0038-1101(85)90212-6; Efros A. L., 1985, ELECT ELECT INTERACT; ENGEL LW, 1993, PHYS REV LETT, V71, P2638, DOI 10.1103/PhysRevLett.71.2638; GRUNER G, 1998, TOPICS APPL PHYSICS; HERTEL G, 1983, PHYS REV LETT, V50, P743, DOI 10.1103/PhysRevLett.50.743; HOFSTETTER E, 1993, EUROPHYS LETT, V21, P933, DOI 10.1209/0295-5075/21/9/010; Husmann S, 1996, SCIENCE, V274, P1874, DOI 10.1126/science.274.5294.1874; Lee HL, 1998, PHYS REV LETT, V80, P4261, DOI 10.1103/PhysRevLett.80.4261; Sachdev S., 1999, QUANTUM PHASE TRANSI; SCHWARTZ A, 1995, REV SCI INSTRUM, V66, P2943, DOI 10.1063/1.1145581; Sondhi SL, 1997, REV MOD PHYS, V69, P315, DOI 10.1103/RevModPhys.69.315; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; WEGNER FJ, 1976, Z PHYS B CON MAT, V25, P327, DOI 10.1007/BF01315248	17	44	45	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					633	636		10.1126/science.287.5453.633	http://dx.doi.org/10.1126/science.287.5453.633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649993				2022-12-28	WOS:000084989400042
J	Bruce, CJ; Breen, JF				Bruce, CJ; Breen, JF			Aortic coarctation and bicuspid aortic valve	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Bruce, CJ (corresponding author), Mayo Clin, Rochester, MN 55905 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					249	249		10.1056/NEJM200001273420405	http://dx.doi.org/10.1056/NEJM200001273420405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277PB	10648767				2022-12-28	WOS:000084941000005
J	Neuzil, KM; Mellen, BG; Wright, PF; Mitchel, EF; Griffin, MR				Neuzil, KM; Mellen, BG; Wright, PF; Mitchel, EF; Griffin, MR			The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNCYTIAL VIRUS-INFECTION; RESPIRATORY-DISEASE; YOUNG-CHILDREN; OTITIS-MEDIA; A-VIRUS; IMPACT; VACCINE; EPIDEMIOLOGY; MORTALITY; AGE	Background: Despite high annual rates of influenza in children, influenza vaccines are given to children infrequently. We measured the disease burden of influenza in a large cohort of healthy children in the Tennessee Medicaid program who were younger than 15 years of age. Methods: We determined the rates of hospitalization for acute cardiopulmonary conditions, outpatient visits, and courses of antibiotics over a period of 19 consecutive years. Using the differences in the rates of these events when influenzavirus was circulating and the rates from November through April when there was no influenza in the community, we calculated morbidity attributable to influenza. There was a total of 2,035,143 person-years of observation. Results: During periods when influenzavirus was circulating, the average number of hospitalizations for cardiopulmonary conditions in excess of the expected number was 104 per 10,000 children per year for children younger than 6 months of age, 50 per 10,000 per year for those 6 months to less than 12 months, 19 per 10,000 per year for those 1 year to less than 3 years, 9 per 10,000 per year for those 3 years to less than 5 years, and 4 per 10,000 per year for those 5 years to less than 15 years. For every 100 children, an annual average of 6 to 15 outpatient visits and 3 to 9 courses of antibiotics were attributable to influenza. In winter, 10 to 30 percent of the excess number of courses of antibiotics occurred during periods when influenzavirus was circulating. Conclusions: Healthy children younger than one year of age are hospitalized for illness attributable to influenza at rates similar to those for adults at high risk for influenza. The rate of hospitalization decreases markedly with age. Influenza accounts for a substantial number of outpatient visits and courses of antibiotics in children of all ages. (N Engl J Med 2000; 342:225-31.) (C)2000, Massachusetts Medical Society.	Dept Vet Affairs, Puget Sound Hlth Care Syst, Div Infect Dis 111, Seattle, WA 98108 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University; Vanderbilt University	Neuzil, KM (corresponding author), Dept Vet Affairs, Puget Sound Hlth Care Syst, Div Infect Dis 111, 1660 S Columbian Way, Seattle, WA 98108 USA.	kneuzil@u.washington.edu			PHS HHS [U50/CCU41398-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; BRANDT CD, 1973, AM J EPIDEMIOL, V98, P355, DOI 10.1093/oxfordjournals.aje.a121565; CLEMENTS DA, 1995, ARCH PEDIAT ADOL MED, V149, P1113, DOI 10.1001/archpedi.1995.02170230067009; Clements ML, 1996, J INFECT DIS, V173, P44, DOI 10.1093/infdis/173.1.44; COUCH RB, 1986, J INFECT DIS, V153, P431, DOI 10.1093/infdis/153.3.431; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Fisher RG, 1997, PEDIATRICS, V99, pE71, DOI 10.1542/peds.99.2.e7; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; FOY HM, 1973, AM J EPIDEMIOL, V97, P93, DOI 10.1093/oxfordjournals.aje.a121493; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; GLEZEN WP, 1980, JAMA-J AM MED ASSOC, V243, P1345; GLEZEN WP, 1987, J INFECT DIS, V155, P1119, DOI 10.1093/infdis/155.6.1119; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; GLEZEN WP, 1973, NEW ENGL J MED, V288, P498, DOI 10.1056/NEJM197303082881005; GLEZEN WP, 1982, J INFECT DIS, V146, P313, DOI 10.1093/infdis/146.3.313; HEIKKINEN T, 1991, AM J DIS CHILD, V145, P445, DOI 10.1001/archpedi.1991.02160040103017; KARRON RA, 1995, PEDIATR INFECT DIS J, V14, P10, DOI 10.1097/00006454-199501000-00002; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; KIM HW, 1973, AM J EPIDEMIOL, V98, P216, DOI 10.1093/oxfordjournals.aje.a121550; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; MONTO AS, 1971, AM J EPIDEMIOL, V94, P280, DOI 10.1093/oxfordjournals.aje.a121321; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; *NAT CTR HLTH STAT, 1995, VIT HLTH STAT 10, V193; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; PERROTTA DM, 1985, AM J EPIDEMIOL, V122, P468, DOI 10.1093/oxfordjournals.aje.a114128; Piper J M, 1991, Paediatr Perinat Epidemiol, V5, P402, DOI 10.1111/j.1365-3016.1991.tb00726.x; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Rothman K., 1998, MODERN EPIDEMIOLOGY; Simonsen L, 1997, EPIDEMIOLOGY, V8, P390, DOI 10.1097/00001648-199707000-00007; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; WRIGHT PF, 1980, AM J EPIDEMIOL, V112, P814, DOI 10.1093/oxfordjournals.aje.a113053; WRIGHT PF, 1977, NEW ENGL J MED, V296, P829, DOI 10.1056/NEJM197704142961501	36	830	868	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					225	231		10.1056/NEJM200001273420401	http://dx.doi.org/10.1056/NEJM200001273420401			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277PB	10648763				2022-12-28	WOS:000084941000001
J	Barry, M				Barry, M			Effect of the US embargo and economic decline on health in Cuba	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICINE; IMPACT	This article describes the ways in which economic crisis and the U.S. embargo have affected Cuba's health care system during the past 15 years. With the demise of subsidized trade, the absence of aid from the former Soviet Union, and the progressive tightening of U.S. sanctions, Cuba's model health care system has become threatened by serious shortages of medical supplies. Several public health catastrophes have occurred, including an epidemic of blindness that was partially attributed to a dramatic decrease in access to nutrients; an outbreak of the Guillain-Barre syndrome caused by lack of chlorination chemicals; and an epidemic of lye ingestion in toddlers due to severe shortages of soap. The policy of mandatory quarantine for HIV-infected Cubans has evolved into a less rigid system. Although the prevalence of HIV infection in Cuba is low compared with that in the United States and other Caribbean nations, it is threatened by prostitution, which has increased along with tourism. In general, economic sanctions may have an unintended but profound effect on the health and nutrition of vulnerable populations.	Yale Univ, Sch Med, Int Hlth Off, New Haven, CT 06520 USA	Yale University	Barry, M (corresponding author), Yale Univ, Sch Med, Int Hlth Off, 333 Cedar St, New Haven, CT 06520 USA.							BAYER R, 1989, NEW ENGL J MED, V320, P1022, DOI 10.1056/NEJM198904133201529; Eisenberg L, 1997, NEW ENGL J MED, V336, P1248, DOI 10.1056/NEJM199704243361711; Garfield R, 1997, AM J PUBLIC HEALTH, V87, P15, DOI 10.2105/AJPH.87.1.15; Garfield R, 1997, J Am Med Womens Assoc (1972), V52, P181; HANSON H, IN PRESS MED ANTHROP; Kirkpatrick AF, 1996, LANCET, V348, P1489, DOI 10.1016/S0140-6736(96)07376-X; KUNTZ D, 1994, INT J HEALTH SERV, V24, P161, DOI 10.2190/L6VN-57RR-AFLK-XW90; UBELL RN, 1983, NEW ENGL J MED, V309, P1468, DOI 10.1056/NEJM198312083092334; 1997, DENIAL FOOD MED; 1995, N ENEN ENGL J MED, V333, P1176	10	40	44	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					151	154		10.7326/0003-4819-132-2-200001180-00010	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275ZZ	10644277				2022-12-28	WOS:000084852300009
J	Wernick, R; Campbell, SM				Wernick, R; Campbell, SM			Update in rheumatology	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLACEBO-CONTROLLED TRIAL; HELICOBACTER-PYLORI; DOUBLE-BLIND; FOLLOW-UP; ARTHRITIS; THERAPY; MISOPROSTOL; COST		Providence Portland Med Ctr, Portland, OR 97213 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA	Providence Portland Medical Center; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Wernick, R (corresponding author), Providence Portland Med Ctr, 4805 NE Glisan, Portland, OR 97213 USA.							Adachi JD, 1997, NEW ENGL J MED, V337, P382, DOI 10.1056/NEJM199708073370603; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Buckley LM, 1996, ANN INTERN MED, V125, P961, DOI 10.7326/0003-4819-125-12-199612150-00004; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; Geis GS, 1998, ARTHRITIS RHEUM, V41, pS364; Geis GS, 1998, ARTHRITIS RHEUM, V41, pS316; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Lipsky LPE, 1998, J RHEUMATOL, V25, P2298; Maetzel A, 1998, ARTHRITIS RHEUM, V41, P16, DOI 10.1002/1529-0131(199801)41:1<16::AID-ART3>3.3.CO;2-W; Marshall B, 1998, LANCET, V352, P1001, DOI 10.1016/S0140-6736(05)60069-4; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Skargren EI, 1997, SPINE, V22, P2167, DOI 10.1097/00007632-199709150-00015; van den Hoogen HJM, 1998, ANN RHEUM DIS, V57, P13, DOI 10.1136/ard.57.1.13; van Poppel MNM, 1998, JAMA-J AM MED ASSOC, V279, P1789, DOI 10.1001/jama.279.22.1789; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; 1998, MED LETT DRUGS THER, V40, P110	17	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					125	133		10.7326/0003-4819-132-2-200001180-00007	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644274				2022-12-28	WOS:000084852300006
J	Hasan, A; Pozzi, M; Hamilton, JRL				Hasan, A; Pozzi, M; Hamilton, JRL			New surgical procedures: can we minimise the learning curve?	BRITISH MEDICAL JOURNAL			English	Article							AORTIC-VALVE DISEASE; PULMONARY AUTOGRAFT; EXPERIENCE; CHILDREN		Freeman Rd Hosp, Dept Cardiothorac Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Royal Liverpool Childrens Hosp, Dept Surg, Liverpool L12 2AP, Merseyside, England	Newcastle Freeman Hospital; Newcastle University - UK; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Hasan, A (corresponding author), Freeman Rd Hosp, Dept Cardiothorac Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.							ELKINS RC, 1994, ANN THORAC SURG, V57, P1387, DOI 10.1016/0003-4975(94)90089-2; GULA G, 1979, ANN THORAC SURG, V28, P392, DOI 10.1016/S0003-4975(10)63140-2; KOUCHOUKOS NT, 1994, NEW ENGL J MED, V330, P1, DOI 10.1056/NEJM199401063300101; *ROSS PROC INT REG, 1998, 5 ANN ROSS C BOST RO; *SEN SURG, 1998, RESP GEN MED COUNC D; Stelzer P, 1998, J THORAC CARDIOV SUR, V115, P1091, DOI 10.1016/S0022-5223(98)70409-X; STELZER P, 1987, J CARDIOVASC SURG, V37, P429	7	65	66	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					171	173		10.1136/bmj.320.7228.171	http://dx.doi.org/10.1136/bmj.320.7228.171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634741	Green Published			2022-12-28	WOS:000084860300032
J	Ye, XD; Al-Babili, S; Kloti, A; Zhang, J; Lucca, P; Beyer, P; Potrykus, I				Ye, XD; Al-Babili, S; Kloti, A; Zhang, J; Lucca, P; Beyer, P; Potrykus, I			Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm	SCIENCE			English	Article							VITAMIN-A-DEFICIENCY; NARCISSUS-PSEUDONARCISSUS; FUNCTIONAL EXPRESSION; PLANT TRANSFORMATION; PHYTOENE SYNTHASE; VECTORS	Rice (Oryza sativa), a major staple food, is usually milled to remove the oil-rich aleurone layer that turns rancid upon storage, especially in tropical areas. The remaining edible part of rice grains, the endosperm, Lacks several essential nutrients, such as provitamin A. Thus, predominant rice consumption promotes vitamin A deficiency, a serious public health problem in at least 26 countries, including highly populated areas of Asia, Africa, and Latin America. Recombinant DNA technology was used to improve its nutritional value in this respect. A combination of transgenes enabled biosynthesis of provitamin A in the endosperm.	Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; Univ Freiburg, Ctr Appl Biosci, D-79104 Freiburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg	Beyer, P (corresponding author), Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland.			Al-Babili, Salim/0000-0003-4823-2882				Al-Babili S., 1996, PLANT PHYSIOL, V112, P1398; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Bonk M, 1997, EUR J BIOCHEM, V247, P942, DOI 10.1111/j.1432-1033.1997.00942.x; Burkhardt PK, 1997, PLANT J, V11, P1071, DOI 10.1046/j.1365-313X.1997.11051071.x; GRANT JP, 1991, STATE WORLDS CHILDRE; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; HUMPHREY JH, 1992, B WORLD HEALTH ORGAN, V70, P225; Landrum JT, 1997, EXP EYE RES, V65, P57, DOI 10.1006/exer.1997.0309; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; PIRIE A, 1983, P NUTR SOC, V42, P53, DOI 10.1079/PNS19830007; Schledz M, 1996, PLANT J, V10, P781, DOI 10.1046/j.1365-313X.1996.10050781.x; SOMMER A, 1989, J NUTR, V119, P96, DOI 10.1093/jn/119.1.96; SOMMER A, 1989, ELEVATED DOSAGES VIT, P37; Uze M, 1997, PLANT SCI, V130, P87, DOI 10.1016/S0168-9452(97)00211-2; WEST KP, 1989, ANNU REV NUTR, V9, P63, DOI 10.1146/annurev.nu.09.070189.000431; WUENN J, 1996, BIOTECHNOLOGY, V14, P171; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	18	1458	1703	19	628	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					303	305		10.1126/science.287.5451.303	http://dx.doi.org/10.1126/science.287.5451.303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634784				2022-12-28	WOS:000084769600039
J	Parasnis, D				Parasnis, D			Proteins and the naked truth about e-commerce	NATURE			English	Letter											Parasnis, D (corresponding author), Gnejsstigen 6, S-97753 Lulea, Sweden.							Kalyanaraman V, 1999, NATURE, V402, P118, DOI 10.1038/45912	1	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					129	130		10.1038/35003036	http://dx.doi.org/10.1038/35003036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646573	Bronze			2022-12-28	WOS:000084835300017
J	Teeling, EC; Scally, M; Kao, DJ; Romagnoli, ML; Springer, MS; Stanhope, MJ				Teeling, EC; Scally, M; Kao, DJ; Romagnoli, ML; Springer, MS; Stanhope, MJ			Molecular evidence regarding the origin of echolocation and flight in bats	NATURE			English	Article							MAMMALS; COST	Bats (order Chiroptera) are one of the few orders of mammals that echolocate and the only group with the capacity for powered flight. The order is subdivided into Microchiroptera and Megachiroptera, with an array of characteristics defining each group(1), including complex laryngeal echolocation systems in microbats and enhanced visual acuity in megabats. The respective monophylies of the two suborders have been tacitly assumed, although microbat monophyly is uncorroborated by molecular data, Here we present a phylogenetic analysis of bat relationships using DNA sequence data from four nuclear genes and three mitochondrial genes (total of 8,230 base pairs), indicating that microbat families in the superfamily Rhinolophoidea are more closely related to megabats than they are to other microbats, This implies that echolocation systems either evolved independently in rhinolophoids and other microbats or were lost in the evolution of megabats, Our data also reject flying lemur (order Dermoptera) as the bat sister group, indicating that presumed shared derived characters for flying lemurs and bats(2) are convergent features that evolved in association with gliding and flight, respectively.	Queens Univ Belfast, Belfast BT9 7BL, Antrim, North Ireland; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Queens University Belfast; University of California System; University of California Riverside	Springer, MS (corresponding author), Queens Univ Belfast, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	mark.springer@ucr.edu; Michael_J_Stanhope@sbphrd.com		Teeling, Emma/0000-0002-3309-1346				Altringham JD, 1996, BATS BIOL BEHAV; Beard K. C., 1993, PRIMATES THEIR RELAT, P63, DOI DOI 10.1007/978-1-4899-2388-2; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; FORSMAN KA, 1988, J ZOOL, V216, P655, DOI 10.1111/j.1469-7998.1988.tb02463.x; GOULD EDWIN, 1965, PROC AMER PHIL SOC, V109, P352; Hill J., 1984, BATS NATURAL HIST; Hutcheon JM, 1998, PHILOS T R SOC B, V353, P607, DOI 10.1098/rstb.1998.0229; KALKO EKV, 1994, FOLIA ZOOL, V43, P363; KISHINO H, J MOL EVOL, V29, P170; LyonsWeiler J, 1996, MOL BIOL EVOL, V13, P749, DOI 10.1093/oxfordjournals.molbev.a025635; Miller Jr G.S., 1907, B US NAT MUS, V57, P1; NOVACEK M J, 1986, Cladistics, V2, P257, DOI 10.1111/j.1096-0031.1986.tb00463.x; NOVACEK MJ, 1980, P 5 INT BAT RES C, P317; Pumo DE, 1998, J MOL EVOL, V47, P709, DOI 10.1007/PL00006430; RAYNER JMV, 1991, NATURE, V350, P383, DOI 10.1038/350383a0; Simmons NB, 1998, B AM MUS NAT HIST, P1; Simmons NB, 1995, SYM ZOOL S, P27; SPEAKMAN JR, 1991, NATURE, V350, P421, DOI 10.1038/350421a0; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Swofford David L., 1996, P407; SWOFFORD DL, 1998, PAUP PHYLOGENEITC AN; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; TOMASI TE, 1979, J MAMMAL, V60, P751, DOI 10.2307/1380190; Woodburne M.O., 1995, GEOCHRONOLGY TIME SC, V54, P335, DOI DOI 10.2110/PEC.95.04.0335)	26	210	213	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					188	192		10.1038/35003188	http://dx.doi.org/10.1038/35003188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646602				2022-12-28	WOS:000084835300053
J	Bennett, MJ; Lebron, JA; Bjorkman, PJ				Bennett, MJ; Lebron, JA; Bjorkman, PJ			Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor	NATURE			English	Article							HEMOCHROMATOSIS GENE-PRODUCT; CELL-SURFACE EXPRESSION; INSULIN-RECEPTOR; LIGAND-BINDING; IRON RELEASE; HLA-H; ASSOCIATION; PROGRAM; BETA(2)-MICROGLOBULIN; REFINEMENT	HFE is related to major histocompatibility complex (MHC) class I proteins and is mutated in the iron-overload disease hereditary haemochromatosis. HFE binds to the transferrin receptor (TfR), a receptor by which cells acquire iron-loaded transferrin. The 2.8 Angstrom crystal structure of a complex between the extracellular portions of HFE and TfR shows two HFE molecules which grasp each side of a twofold symmetric TfR dimer. On a cell membrane containing both proteins, HFE would 'lie down' parallel to the membrane, such that the HFE helices that delineate the counterpart of the MHC peptide-binding groove make extensive contacts with helices in the TfR dimerization domain. The structures of TfR alone and complexed with HFE differ in their domain arrangement and dimer interfaces, providing a mechanism for communicating binding events between TfR chains. The HFE-TfR complex suggests a binding site for transferrin on TfR and sheds light upon the function of HFE in regulating iron homeostasis.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Bjorkman, PJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	bjorkman@cco.caltech.edu						Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; Andrews NC, 1998, BLOOD, V92, P1845, DOI 10.1182/blood.V92.6.1845.418k35_1845_1851; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; BALI PK, 1991, BIOCHEMISTRY-US, V30, P324, DOI 10.1021/bi00216a003; Barton JC, 1999, BLOOD CELL MOL DIS, V25, P146; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchegger F, 1996, EUR J BIOCHEM, V235, P9, DOI 10.1111/j.1432-1033.1996.0009u.x; Creighton T. E., 1993, PROTEINS STRUCTURES; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dubljevic V, 1999, BIOCHEM J, V341, P11, DOI 10.1042/0264-6021:3410011; EGAN TJ, 1993, BIOCHEMISTRY-US, V32, P8162, DOI 10.1021/bi00083a016; ENNS CA, 1981, J BIOL CHEM, V256, P9820; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fuchs H, 1998, STRUCTURE, V6, P1235, DOI 10.1016/S0969-2126(98)00124-5; FUJINAGA M, 1993, J MOL BIOL, V234, P222, DOI 10.1006/jmbi.1993.1576; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Henry J.B, 1996, CLIN DIAGNOSIS MANAG, V9th; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Lebron JA, 1999, J MOL BIOL, V289, P1109, DOI 10.1006/jmbi.1999.2842; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; SIPE DM, 1991, J BIOL CHEM, V266, P8002; STAGSTED J, 1990, CELL, V62, P297, DOI 10.1016/0092-8674(90)90367-N; TURKEWITZ AP, 1988, J BIOL CHEM, V263, P16309; VERLAND S, 1989, J IMMUNOL, V143, P945; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; Wilson IA, 1998, CURR OPIN IMMUNOL, V10, P67, DOI 10.1016/S0952-7915(98)80034-4; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	47	275	283	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					46	53		10.1038/47417	http://dx.doi.org/10.1038/47417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638746				2022-12-28	WOS:000084687400036
J	Heilbron, JL; Bynum, WF				Heilbron, JL; Bynum, WF			Millennial highlights ... from Gerbert d'Aurillac to Watson and Crick.	NATURE			English	Editorial Material									Univ Oxford Worcester Coll, Oxford OX1 2HB, England; Wellcome Inst Hist Med Sci, London NW1 2BE, England	University of Oxford; University of London; University College London	Heilbron, JL (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.							ARISTOTLE, LIBRI NAT; DARWIN, 1859, ANNUS MIRABILIS; DEWOLF H, 1945, ATOMIC ENERGY MILITA; Euclid, ELEMENTS; GALILEO, DIALOGUE 2 CHIEF WOR; Galileo, 1610, SIDEREUS NUNCIUS; Kepler J., 1609, ASTRONOMIA NOVA; Lamarck, 1809, PHILOS ZOOLOGIQUE; LAPLACE, 1796, SYSTEME MONDE; LAVOISIER, 1789, TRAITE ELEMENTAIRE C; NEWTON, 1704, OPTICKS; Newton, 1687, PRINCIPIA; NEWTON, 1706, OPTICKS; PTOLEMY, ALMAGEST; RUTHERFORD, 1905, RADIO ACTIVITY; RUTHERFORD, 1904, RADIO ACTIVITY; RUTHERFORD, 1912, RADIO ACTIVITY; SAINTALBERT, VEGITABILIBUS PLANTI; [No title captured]	20	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					13	16		10.1038/47347	http://dx.doi.org/10.1038/47347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638731				2022-12-28	WOS:000084687400014
J	Kern, S				Kern, S			Time and medicine (Reprinted from The Culture of Time and Space, 1983)	ANNALS OF INTERNAL MEDICINE			English	Reprint								Although historians work with the record of events in public time, they have not developed an explicit understanding of lived time. To set the stage for the other essays in th is issue of Annals, th is introductory essay explores how an understanding of lived or "private" time began to emerge in the early 20th century in the works of that era's major thinkers: Henri Bergson's philosophy of duration, Emile Durkheim's social time, Sigmund Freud's five psychoanalytic temporal narratives, and Eugene Minkowski's exploration of lived time. This essay then considers the reaction against the burden of history that began with the great 19th-century historicizers: Comte, Hegel, Marx, Darwin, and Spencer. It reflects on the effort, beginning in those years, of modern artists and intellectuals to focus on the personal past in place of the overbearing burden of the historical past. New ways of experiencing the present, made possible by new communication technologies, including the telephone and telegraph,have centered on the experience of simultaneity. Norbert Wiener's cybernetics, Marshall McLuhan's globalism, and the Internet have further transformed how both the medical and lay communities experience past, present, and future, as well as near and far. The discussion concludes with consideration of Eurotransplant, an Internet-based information and action network used by physicians to coordinate organ transplantation; it is a system that integrates cybernetics, globalism, and the Internet in an everyday, real drama of the electronic age of simultaneity.	No Illinois Univ, De Kalb, IL 60115 USA	Northern Illinois University	Kern, S (corresponding author), 39W793 Reindeer Trail, St Charles, IL 60175 USA.							BERGMAN P, 1962, MODERNOLALTRIA SIMUL, V10; BERGSON H, 1955, INTRO METAPHYSICS, P23; Dilthey W., 1978, CRITIQUE HIST REASON; DURKHEIM E, 1965, ELEMENTARY FORMS REL, P22; FREUD S, 1955, STANDARD EDITION COM, V18, P28; Heidegger Martin, 1962, SEIN ZEIT; Janelle Donald, 1991, COLLAPSING SPACE TIM, P49; KERN S, 1970, THESIS COLUMBIA U NE; Kern Stephen, 2003, CULTURE TIME SPACE 1; MARUYAMA M, 1985, TECHNOL FORECAST SOC, V28, P351, DOI 10.1016/0040-1625(85)90036-8; MCLUHAN M, 1964, UNDERST MEDIA, P19; MINKOWSKI E, 1967, EXISTENCE NEW DIMENS, P127; ROCHLIN GI, 1997, TRAPPED NET UNANTICA, P70; Weiner N., 1948, CYBERNETICS	14	5	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					3	9		10.7326/0003-4819-132-1-200001040-00002	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627248				2022-12-28	WOS:000084518600001
J	Sikorski, R; Peters, R				Sikorski, R; Peters, R			Cell biology - Sorting on silicon	SCIENCE			English	Article																		Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	1999	286	5448					2293	2294						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266UK	10636792				2022-12-28	WOS:000084318500044
J	Onishi, A; Koike, S; Ida, M; Imai, H; Shichida, Y; Takenaka, O; Hanazawa, A; Konatsu, H; Mikami, A; Goto, S; Suryobroto, B; Kitahara, K; Yamamori, T				Onishi, A; Koike, S; Ida, M; Imai, H; Shichida, Y; Takenaka, O; Hanazawa, A; Konatsu, H; Mikami, A; Goto, S; Suryobroto, B; Kitahara, K; Yamamori, T			Vision - Dichromatism in macaque monkeys	NATURE			English	Article							VISUAL PIGMENT GENES; LINKED COLOR-VISION; MOLECULAR-GENETICS; OLD; EVOLUTION; ANCESTRY; PRIMATE; DEFECTS; GREEN; BLUE		Natl Inst Basic Biol, Lab Speciat Mechanisms J, Okazaki, Aichi 4448585, Japan; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Tokyo Metropolitan Inst Neurosci, Dept Microbiol & Immunol, Tokyo 1838526, Japan; Primate Res Inst, Dept Cellular & Mol Biol, Aichi 4848506, Japan; Primate Res Inst, Dept Behav & Brain Sci, Aichi 4848506, Japan; Primate Res Inst, Ctr Appl Primatol & Human Evolutionary Modelling, Aichi 4848506, Japan; Natl Inst Physiol Sci, Neural Control Lab, Okazaki, Aichi 4448585, Japan; Bogor Agr Univ, Dept Biol, Bogor 16143, Indonesia; Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, Tokyo 1050003, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Bogor Agricultural University; Jikei University	Onishi, A (corresponding author), Natl Inst Basic Biol, Lab Speciat Mechanisms J, 38 Myodaijicho, Okazaki, Aichi 4448585, Japan.		Yamamori, Tetsuo/N-6536-2015	Yamamori, Tetsuo/0000-0001-5016-0078; Imai, Hiroo/0000-0003-0729-0322; Suryobroto, Bambang/0000-0002-9393-4085				BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P131, DOI 10.1113/jphysiol.1980.sp013071; DEEB SS, 1992, AM J HUM GENET, V51, P687; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; DULAI KS, 1994, VISION RES, V34, P2483, DOI 10.1016/0042-6989(94)90233-X; Fletcher R., 1985, DEFECTIVE COLOUR VIS; Jacobs GH, 1997, VISUAL NEUROSCI, V14, P921, DOI 10.1017/S0952523800011639; JACOBS GH, 1989, AM J PRIMATOL, V18, P35, DOI 10.1002/ajp.1350180104; JORGENSEN AL, 1990, P NATL ACAD SCI USA, V87, P6512, DOI 10.1073/pnas.87.17.6512; Kojima D, 1996, BIOCHEMISTRY-US, V35, P2625, DOI 10.1021/bi9511548; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; TOVEE MJ, 1994, TRENDS NEUROSCI, V17, P30, DOI 10.1016/0166-2236(94)90032-9; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827	14	55	56	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					139	140		10.1038/45966	http://dx.doi.org/10.1038/45966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647004				2022-12-28	WOS:000083716400037
J	Schauser, L; Roussis, A; Stiller, J; Stougaard, J				Schauser, L; Roussis, A; Stiller, J; Stougaard, J			A plant regulator controlling development of symbiotic root nodules	NATURE			English	Article							LIPO-OLIGOSACCHARIDE SIGNALS; LOTUS-JAPONICUS; LEUCINE ZIPPER; RHIZOBIUM-LOTI; DNA; IDENTIFICATION; CHLAMYDOMONAS; GENES; TRANSCRIPTION; NODULATION	Symbiotic nitrogen-fixing root nodules on legumes are founded by root cortical cells that de-differentiate and restart cell division to establish nodule primordia. Bacterial microsymbionts invade these primordia through infection threads laid down by the plant and, after endocytosis, membrane-enclosed bacteroids occupy cells in the nitrogen-fixing tissue of functional nodules, The bacteria excrete lipochitin oligosaccharides(1,2), triggering a developmental process that is controlled by the plant and can be suppressed, Nodule inception initially relies on cell competence in a narrow infection zone located just behind the growing root tip. Older nodules then regulate the number of nodules on a root system by suppressing the development of nodule primordia(3), To identify the regulatory components that act early in nodule induction, ive characterized a transposon-tagged Lotus japonicus mutant, nin (for nodule inception), arrested at the stage of bacterial recognition. We show that rlin is required for the formation of infection threads and the initiation of primordia, NlN protein has regional similarity to transcription factors, and the predicted DNA-binding/dimerization domain identifies and typifies a consensus motif conserved in plant proteins with a function in nitrogen-controlled development.	Aarhus Univ, Dept Mol & Struct Biol, Lab Gene Express, DK-8000 Aarhus C, Denmark	Aarhus University	Stougaard, J (corresponding author), Aarhus Univ, Dept Mol & Struct Biol, Lab Gene Express, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.		Stiller, Jiri/E-1564-2012; Roussis, Andreas/AAZ-2468-2021	Stougaard, Jens/0000-0002-9312-2685; Roussis, Andreas/0000-0003-2346-7132				Beck CF, 1996, INT REV CYTOL, V168, P259, DOI 10.1016/S0074-7696(08)60886-4; BOIVIN C, 1990, PLANT CELL, V2, P1157, DOI 10.1105/tpc.2.12.1157; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CAETANOANOLLES G, 1991, ANNU REV MICROBIOL, V45, P345, DOI 10.1146/annurev.mi.45.100191.002021; EARP DJ, 1990, NUCLEIC ACIDS RES, V18, P3271, DOI 10.1093/nar/18.11.3271; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Ferris PJ, 1997, GENETICS, V146, P859; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEHMBECK J, 1986, PLANT MOL BIOL, V7, P3, DOI 10.1007/BF00020126; LOPEZLARA IM, 1995, MOL MICROBIOL, V15, P627, DOI 10.1111/j.1365-2958.1995.tb02372.x; Papadopoulou K, 1996, PLANT MOL BIOL, V30, P403, DOI 10.1007/BF00049320; PLANO GV, 1991, J BACTERIOL, V173, P3389, DOI 10.1128/jb.173.11.3389-3396.1991; PUYET A, 1993, J BIOL CHEM, V268, P25402; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; SPAINK HP, 1996, PLANT CELL, V8, P1885; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; THYKJAER T, 1995, PLANT MOL BIOL, V27, P981, DOI 10.1007/BF00037025; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	25	601	643	5	122	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					191	195		10.1038/46058	http://dx.doi.org/10.1038/46058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647012				2022-12-28	WOS:000083716400053
J	Sager, WW; Koppers, AAP				Sager, WW; Koppers, AAP			Late cretaceous polar wander of the Pacific plate: Evidence of a rapid true polar wander event	SCIENCE			English	Article							EARLY TERTIARY; LINE ISLANDS; SEAMOUNT MAGNETISM; GEOMAGNETIC-FIELD; HOTSPOT VOLCANISM; HOT SPOT; PALEOMAGNETISM; MOTIONS; MAGNETIZATION; ATLANTIC	We reexamined the Late Cretaceous-early Tertiary apparent polar wander path for the Pacific plate using 27 paleomagnetic poles from seamounts dated by 40Ar/39Ar geochronology. The path shows little motion from 120 to 90 million years ago (Ma), northward motion from 79 to 39 Ma, and two groups of poles separated by 16 to 21 degrees with indistinguishable mean ages of 84 +/- 2 Ma. The latter phenomenon may represent a rapid polar wander episode (3 to 10 degrees per million years) whose timing is not adequately resolved with existing data. Similar features in other polar wander paths imply that the event was a rapid shift of the spin axis relative to the mantle (true polar wander), which may have been related to global changes in plate motion, large igneous province eruptions, and a shift in magnetic field polarity state.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; Scripps Institution of Oceanography	Sager, WW (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	wsager@ocean.tarnu.edu		Koppers, Anthony/0000-0002-8136-5372				ABDELMONEM A, 1967, EARTH PLANET SC LETT, V2, P415, DOI 10.1016/0012-821X(67)90182-3; ACTON GD, 1994, SCIENCE, V263, P1246, DOI 10.1126/science.263.5151.1246; ATWATER T, 1989, E PACIFIC OCEAN HAWA, P21, DOI DOI 10.1130/DNAG-GNA-N.21; BESSE J, 1991, J GEOPHYS RES-SOLID, V96, P4029, DOI 10.1029/90JB01916; BRYAN P, 1993, MESOZOIC PACIFIC GEO, P387; CANDE SC, 1992, J GEOPHYS RES-SOL EA, V97, P13917, DOI 10.1029/92JB01202; Clague D. A., 1989, GEOLOGY N AM, VN, P187; DIEHL JF, 1991, J GEOPHYS RES-SOLID, V96, P9887, DOI 10.1029/91JB00959; Duncan R.A., 1984, EOS T AM GEOPHYS UN, V65, P1076; DUNCAN RA, 1992, SYNTHESIS RESULTS SC, P91; EPP D, 1984, J GEOPHYS RES, V89, P1273, DOI 10.1029/JB089iB13p11273; FLECK RJ, 1977, GEOCHIM COSMOCHIM AC, V41, P15, DOI 10.1016/0016-7037(77)90184-3; FRANCHETEAU J, 1970, J GEOPHYS RES, V75, P2035, DOI 10.1029/JB075i011p02035; GEE J, 1993, J GEOPHYS RES-SOL EA, V98, P11743, DOI 10.1029/93JB00932; Gee J, 1995, P OCEAN DRILL PROGRA, V144, P615, DOI DOI 10.2973/0DP.PR0C.SR.144.020.1995; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; GORDON RG, 1980, GEOPHYS J ROY ASTR S, V63, P619, DOI 10.1111/j.1365-246X.1980.tb02642.x; GORDON RG, 1983, GEOPHYS RES LETT, V10, P709, DOI 10.1029/GL010i008p00709; GORDON RG, 1987, ANNU REV EARTH PL SC, V15, P567; HARRISON CGA, 1975, GEOPHYS J ROY ASTR S, V42, P859, DOI 10.1111/j.1365-246X.1975.tb06455.x; HARRISON CGA, 1982, NATURE, V300, P251, DOI 10.1038/300251a0; HILDE TWC, 1977, TECTONOPHYSICS, V38, P145, DOI 10.1016/0040-1951(77)90205-0; HILDEBRAND JA, 1987, J GEOPHYS RES-SOLID, V92, P12695, DOI 10.1029/JB092iB12p12695; Kerr A., 1997, GEOPH MONOG SERIES, P123; Kirschvink JL, 1997, SCIENCE, V277, P541, DOI 10.1126/science.277.5325.541; Klitgord K. D., 1986, GEOLOGY N AM, P351, DOI DOI 10.1130/DNAG-GNA-M.351; Koppers AAP, 1998, EARTH PLANET SC LETT, V163, P53, DOI 10.1016/S0012-821X(98)00175-7; KOPPERS AAP, 1998, THESIS FREE U AMSTER; KOPPERS AAP, IN PRESS CHEM GEOL; LIVERMORE RA, 1984, GEOPHYS J ROY ASTR S, V79, P939, DOI 10.1111/j.1365-246X.1984.tb02878.x; MCFADDEN PL, 1981, GEOPHYS J ROY ASTR S, V67, P19, DOI 10.1111/j.1365-246X.1981.tb02729.x; MORGAN JP, 1995, J GEOPHYS RES-SOL EA, V100, P8045, DOI 10.1029/94JB02887; MULLER RD, 1993, GEOLOGY, V21, P275, DOI 10.1130/0091-7613(1993)021<0275:RPMRTT>2.3.CO;2; PARKER RL, 1987, REV GEOPHYS, V25, P17, DOI 10.1029/RG025i001p00017; PARKER RL, 1991, J GEOPHYS RES-SOL EA, V96, P16101, DOI 10.1029/91JB01497; PARKER RL, 1988, J GEOPHYS RES-SOLID, V93, P3105, DOI 10.1029/JB093iB04p03105; Petronotis KE, 1999, GEOPHYS J INT, V139, P227, DOI 10.1046/j.1365-246X.1999.00901.x; Pringle M. S., 1993, MESOZOIC PACIFIC, V77, P263, DOI [10.1029/gm077p0263, DOI 10.1029/GM077P0263]; PRINGLE MS, 1991, GEOLOGY, V19, P364, DOI 10.1130/0091-7613(1991)019<0364:JSSMYO>2.3.CO;2; PRINGLE MS, 1997, EOS T AM GEOPHYS U S, V78, pF728; PRINGLE MS, 1993, MESOZOIC PACIFIC GEO, P187; PRINGLE MS, 1995, P OCEAN DRILL PROGRA, V144, P547, DOI DOI 10.2973/ODP.PROC.SR.144.033.1995; RICHARDS ML, 1967, GEOPHYSICS, V32, P678, DOI 10.1190/1.1439883; ROYER JY, 1988, TECTONOPHYSICS, V155, P235, DOI 10.1016/0040-1951(88)90268-5; Sager W.W., 1993, MESOZOIC PACIFIC GEO, V77, P401, DOI [10.1029/GM077p0401, DOI 10.1029/GM077P0401]; SAGER WW, 1984, J GEOPHYS RES, V89, P1135, DOI 10.1029/JB089iB13p11135; SAGER WW, 1984, J GEOPHYS RES, V89, P6271, DOI 10.1029/JB089iB07p06271; SAGER WW, 1988, J GEOPHYS RES-SOLID, V93, P11753, DOI 10.1029/JB093iB10p11753; SAGER WW, 1987, NATURE, V326, P488, DOI 10.1038/326488a0; SAGER WW, 1992, GEOLOGY OFSHORE MINE, P21; SAGER WW, 1987, AM GEOPHYS UNION GEO, V43, P133, DOI DOI 10.1029/GM043P0133; SAGER WW, 1983, THESIS U HAWAII; SAITO K, 1977, EARTH PLANET SC LETT, V33, P353, DOI 10.1016/0012-821X(77)90087-5; SCHLANGER SO, 1984, J GEOPHYS RES, V89, P1261, DOI 10.1029/JB089iB13p11261; STEIN M, 1994, NATURE, V372, P63, DOI 10.1038/372063a0; TAKIGAMI Y, 1989, PALAEOGEOGR PALAEOCL, V71, P71, DOI 10.1016/0031-0182(89)90030-8; Tarduno JA, 1997, EARTH PLANET SC LETT, V153, P171, DOI 10.1016/S0012-821X(97)00169-6; TARDUNO JA, 1995, NATURE, V378, P477, DOI 10.1038/378477a0; Tejada MLG, 1996, J PETROL, V37, P361, DOI 10.1093/petrology/37.2.361; UEDA Y, 1985, J GEOMAGN GEOELECTR, V49, P1481; VASAS SM, 1994, EOS T AM GEOPHYS UN, V75, P203; Wessel P, 1997, NATURE, V387, P365, DOI 10.1038/387365a0; Wessel P, 1997, SCIENCE, V277, P802, DOI 10.1126/science.277.5327.802; WINTERER EL, 1993, MESOZOIC PACIFIC GEO, P307	64	52	55	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					455	459		10.1126/science.287.5452.455	http://dx.doi.org/10.1126/science.287.5452.455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642540				2022-12-28	WOS:000084929900038
J	Folks, TM				Folks, TM			Chimpanzees as original source for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IDENTIFICATION	The human AIDS viruses human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) represent cross-species (zoonotic) infections. Although the primate reservoir of HIV-2 has been clearly identified as the sooty mangabey (Cercocebus atys), the origin of HIV-1 remains uncertain. Viruses related to HIV-1 have been isolated from the common chimpanzee (Pan troglodytes), but only three such SIVcpz infections have been documented, one of which involved a virus so divergent that it might represent a different primate lentiviral lineage. In a search for the HIV-1 reservoir, we have now sequenced the genome of a new SIVcpz strain (SIVcpzUS) and have determined, by mitochondrial DNA analysis, the subspecies identity of all known SIVcpz-infected chimpanzees. We find that two chimpanzee subspecies in Africa, the central P, t, troglodytes and the eastern P, t, schweinfurthii, harbour SIVcpz and that their respective viruses form two highly divergent (but subspecies-specific) phylogenetic lineages. All HIV-1 strains known to infect man, including HIV-1 groups M, N and O, are closely related to just one of these SIVcpz lineages, that found in P, t, troglodytes. Moreover, we find that HIV-1 group N is a mosaic of SIVcpzUS- and HIV-1-related sequences, indicating an ancestral recombination event in a chimpanzee host. These results, together with the observation that the natural range of P, t. troglodytes coincides uniquely with areas of HIV-1 group M, N and O endemicity, indicate that P, t. troglodytes is the primary reservoir for HIV-1 and has been the source of at least three independent introductions of SIVcpz into the human population.	Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div HIV AIDS, HIV & Retrovirol Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Folks, TM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div HIV AIDS, HIV & Retrovirol Branch, Atlanta, GA 30333 USA.							Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; SHARP PM, 1994, AIDS, V8, P527; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					310	310		10.1001/jama.283.3.310	http://dx.doi.org/10.1001/jama.283.3.310			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647783				2022-12-28	WOS:000084732400002
J	Jackson, G; Gibbs, CR; Davies, MK; Lip, GYH				Jackson, G; Gibbs, CR; Davies, MK; Lip, GYH			ABC of heart failure - Pathophysiology	BRITISH MEDICAL JOURNAL			English	Article							DYSFUNCTION		Guys & St Thomas Hosp, Dept Cardiol, London, England; Univ Birmingham, City Hosp, Dept Med, Birmingham, W Midlands, England; City Hosp, Dept Cardiol, Birmingham, W Midlands, England; Selly Oak Hosp, Dept Cardiol, Birmingham, W Midlands, England	Guy's & St Thomas' NHS Foundation Trust; University of Birmingham; University of Birmingham	Jackson, G (corresponding author), Guys & St Thomas Hosp, Dept Cardiol, London, England.							GROSSMAN W, 1991, NEW ENGL J MED, V325, P1557; Love MP, 1997, HEART, V77, P93, DOI 10.1136/hrt.77.2.93; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; RAHIMTOOLA SH, 1989, AM HEART J, V117, P211, DOI 10.1016/0002-8703(89)90685-6; Wilkins MR, 1997, LANCET, V349, P1307, DOI 10.1016/S0140-6736(96)07424-7	6	89	91	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					167	170		10.1136/bmj.320.7228.167	http://dx.doi.org/10.1136/bmj.320.7228.167			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634740	Green Published			2022-12-28	WOS:000084860300031
J	Young, RK				Young, RK			How to have your first mammogram	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					171	171		10.1001/jama.283.2.171	http://dx.doi.org/10.1001/jama.283.2.171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634321				2022-12-28	WOS:000084661400001
J	Dudman, NPB				Dudman, NPB			An alternative view of homocysteine	LANCET			English	Editorial Material							PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; RISK; STROKE		Univ New S Wales, Prince Wales Hosp, Fac Med, Ctr Thrombosis & Vasc Res, Randwick, NSW, Australia	University of New South Wales Sydney	Dudman, NPB (corresponding author), Care of Chesterman C, Univ New S Wales, Prince Wales Hosp, Ctr Thrombosis & Vasc Res, Barker St, Randwick, NSW 2031, Australia.							ANDERSSON A, 1992, CLIN CHEM, V38, P1311; BLOM HJ, 1992, J INHERIT METAB DIS, V15, P419, DOI 10.1007/BF02435993; Dudman N. P. B., 1998, Netherlands Journal of Medicine, V52, pS22; Dudman NPB, 1999, CIRC RES, V84, P409, DOI 10.1161/01.RES.84.4.409; DUDMAN NPB, 1993, ARTERIOSCLER THROMB, V13, P512, DOI 10.1161/01.ATV.13.4.512; DUDMAN NPB, 1993, ARTERIOSCLER THROMB, V13, P1253, DOI 10.1161/01.ATV.13.9.1253; Dudman NPB, 1997, DEV CARDIOVASC MED, P267; DURAND P, 1997, FASEB J, V11, P1; Egerton W, 1996, AM J CARDIOL, V77, P759, DOI 10.1016/S0002-9149(97)89213-2; Gudnason V, 1998, ATHEROSCLEROSIS, V136, P347, DOI 10.1016/S0021-9150(97)00237-2; Guo X. W., 1998, Netherlands Journal of Medicine, V52, pS58; HULTBERG B, 1993, ALCOHOL CLIN EXP RES, V17, P687, DOI 10.1111/j.1530-0277.1993.tb00820.x; Jacobsen D. W., 1998, Netherlands Journal of Medicine, V52, pS1; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Lai KN, 1996, CLIN IMMUNOL IMMUNOP, V80, P47, DOI 10.1006/clin.1996.0093; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; Mann N. J., 1998, Netherlands Journal of Medicine, V52, pS10; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; REDDY GSR, 1982, METABOLISM, V31, P778, DOI 10.1016/0026-0495(82)90075-0; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; REICHENBACH D, 1991, CARDIOVASC PATHOL, P61; Tosetto A, 1997, BRIT J HAEMATOL, V97, P804, DOI 10.1046/j.1365-2141.1997.1422957.x; UELAND PM, 1993, CLIN CHEM, V39, P1764; Wang Hong, 1998, Netherlands Journal of Medicine, V52, pS8; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236; Wilcken DEL, 1996, ARTERIOSCL THROM VAS, V16, P878, DOI 10.1161/01.ATV.16.7.878; Wilcken DEL, 1992, MOL GENETICS CORONAR, P311	27	129	131	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2072	2074		10.1016/S0140-6736(99)03383-8	http://dx.doi.org/10.1016/S0140-6736(99)03383-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636386				2022-12-28	WOS:000084183300046
J	Onyango, AW; Esrey, SA; Kramer, MS				Onyango, AW; Esrey, SA; Kramer, MS			Continued breastfeeding and child growth in the second year of life: a prospective cohort study in western Kenya	LANCET			English	Article							NUTRITIONAL-STATUS; PERUVIAN TODDLERS; BREAST-MILK; WATER; MALNUTRITION; INFANTS; ASSOCIATION; HEALTH; FOODS; AGE	Background The value of postinfancy breastfeeding for growth and nutritional status is debated. We have investigated this issue in a longitudinal study. Methods We prospectively followed up a cohort of 264 children in western Kenya for 6 months (mean age 14 months [range 9-18] at baseline) to investigate the nature of the association between breastfeeding and growth. Only 14 (5.3%) children had been weaned at baseline, and 173 (65.5%) were still breastfed at follow-up. For analysis, children were classified into three groups of breastfeeding duration as a proportion Of the total follow-up period (0-49%, n=42; 50-99%, n=49; and 100%, n=173). Findings In general linear models multivariate analysis, children in the longest-duration breastfeeding group gained 3.4 cm (p=0.0001) and 370 g (p=0.005) more than those in the shortest duration group, and 0.6 cm (p=0.0015) and 230 g (p=0.038) more than children in the intermediate group. The strongest association between breastfeeding and linear growth was observed in households that had no latrine and daily water use of less than 10 L per person. Interpretation Our findings support WHO's recommendation to continue breastfeeding for at least 2 years, especially in settings with poor sanitation and inadequate water supply.	WHO, Dept Nutr, CH-1211 Geneva 27, Switzerland; UNICEF, New York, NY USA; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	World Health Organization; UNICEF; McGill University; McGill University	Onyango, AW (corresponding author), WHO, Dept Nutr, CH-1211 Geneva 27, Switzerland.							ADAIR L, 1993, EUR J CLIN NUTR, V47, P42; BUTZ WP, 1984, AM J EPIDEMIOL, V119, P516, DOI 10.1093/oxfordjournals.aje.a113769; CAIRNCROSS S, 1987, T ROY SOC TROP MED H, V81, P51, DOI 10.1016/0035-9203(87)90280-X; Caulfield LE, 1996, INT J EPIDEMIOL, V25, P693, DOI 10.1093/ije/25.4.693; COHEN RJ, 1994, LANCET, V344, P288, DOI 10.1016/S0140-6736(94)91337-4; ESREY SA, 1992, AM J EPIDEMIOL, V135, P659, DOI 10.1093/oxfordjournals.aje.a116345; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608, DOI 10.1093/oxfordjournals.aje.a008791; *FAO WHO, 1992, INT C NUTR WORLD DEC; Fawzi WW, 1998, INT J EPIDEMIOL, V27, P255, DOI 10.1093/ije/27.2.255; GRUMMERSTRAWN LM, 1993, PEDIATRICS, V91, P766; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; Marquis GS, 1997, INT J EPIDEMIOL, V26, P349, DOI 10.1093/ije/26.2.349; Marquis GS, 1997, AM J CLIN NUTR, V66, P1102, DOI 10.1093/ajcn/66.5.1102; MARTINES JC, 1994, J NUTR, V124, P1189, DOI 10.1093/jn/124.8.1189; MARTORELL R, 1988, NESTLE NUTRITION WOR, V14, P57; Molbak K, 1997, INT J EPIDEMIOL, V26, P458, DOI 10.1093/ije/26.2.458; NGANDU NH, 1990, J EPIDEMIOL COMMUN H, V44, P281, DOI 10.1136/jech.44.4.281; Nube M, 1996, EUR J CLIN NUTR, V50, P171; SAULS HS, 1979, PEDIATRICS, V64, P523; Simondon KB, 1998, INT J EPIDEMIOL, V27, P490, DOI 10.1093/ije/27.3.490; TAREN D, 1993, AM J CLIN NUTR, V58, P862, DOI 10.1093/ajcn/58.6.862; Victora C G, 1991, Epidemiology, V2, P175, DOI 10.1097/00001648-199105000-00003; VICTORA CG, 1984, AM J CLIN NUTR, V39, P307, DOI 10.1093/ajcn/39.2.307; WHO, 1995, WEEKLY EPIDEMIOLOGIC, V70, P119; *WHO UNICEF, 1990, WHO UNICEF POL MAK M	25	51	54	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2041	2045		10.1016/S0140-6736(99)02168-6	http://dx.doi.org/10.1016/S0140-6736(99)02168-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636370				2022-12-28	WOS:000084183300013
J	Pelrine, R; Kornbluh, R; Pei, QB; Joseph, J				Pelrine, R; Kornbluh, R; Pei, QB; Joseph, J			High-speed electrically actuated elastomers with strain greater than 100%	SCIENCE			English	Article							ELECTROSTRICTION; POLYMERS; BEHAVIOR	Electrical actuators were made from films of dielectric elastomers (such as silicones) coated on both sides with compliant electrode material. When voltage was applied, the resulting electrostatic forces compressed the film in thickness and expanded it in area, producing strains up to 30 to 40%. It is now shown that prestraining the film further improves the performance of these devices. Actuated strains up to 117% were demonstrated with silicone elastomers, and up to 215% with acrylic elastomers using biaxially and uniaxially prestrained films. The strain, pressure, and response time of silicone exceeded those of natural muscle; specific energy densities greatly exceeded those of other field-actuated materials. Because the actuation mechanism is faster than in other high-strain electroactive polymers, this technology may be suitable for diverse applications.	SRI Int, Menlo Pk, CA 94025 USA	SRI International	Pelrine, R (corresponding author), SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pelrine@erg.sri.com	Pei, Qibing/N-7497-2015	Pei, Qibing/0000-0003-1669-1734				Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; FURUKAWA T, 1990, JPN J APPL PHYS 1, V29, P675, DOI 10.1143/JJAP.29.675; Heydt R, 1998, J SOUND VIB, V215, P297, DOI 10.1006/jsvi.1998.1642; HEYDT R, IN PRESS J ACOUST SO; Joseph J., 1995, P 3 IASTED INT C ROB, P1; Kornbluh R, 1999, PROC SPIE, V3669, P149, DOI 10.1117/12.349672; Kornbluh R, 1998, IEEE INT CONF ROBOT, P2147, DOI 10.1109/ROBOT.1998.680638; OGURO K, 1992, J MICROMACHINE SOC, V5, P27; Otero TF, 1999, PROC SPIE, V3669, P98, DOI 10.1117/12.349668; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Pelrine RE, 1998, SENSOR ACTUAT A-PHYS, V64, P77, DOI 10.1016/S0924-4247(97)01657-9; Schreyer HB, 1999, P SOC PHOTO-OPT INS, V3669, P192, DOI 10.1117/12.349676; Smela E, 1999, ADV MATER, V11, P953; SMELA E, 1995, SCIENCE, V268, P1735, DOI 10.1126/science.268.5218.1735; TAMAGAWA H, 1999, P SOC PHOTO-OPT INS, V3669, P24; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZHENYL M, 1994, J POLYM SCI POL PHYS, V32, P2721, DOI 10.1002/polb.1994.090321618	17	2512	2632	71	926	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2000	287	5454					836	839		10.1126/science.287.5454.836	http://dx.doi.org/10.1126/science.287.5454.836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657293				2022-12-28	WOS:000085136400040
J	Marshall, T				Marshall, T			Exploring a fiscal food policy: the case of diet and ischaemic heart disease	BRITISH MEDICAL JOURNAL			English	Article							SERUM-CHOLESTEROL; REDUCTION; SYSTEMS; SMOKING; TRIALS; HEALTH; DEMAND; RISK		Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Marshall, T (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.			Marshall, Tom/0000-0001-9277-5214				Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Gregory J., 1990, DIETARY NUTR SURVEY; HOLME I, 1990, CIRCULATION, V82, P1916, DOI 10.1161/01.CIR.82.6.1916; James WPT, 1997, BMJ-BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545; Jousilahti P, 1998, CIRCULATION, V97, P1087, DOI 10.1161/01.CIR.97.11.1087; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; MOSCHINI G, 1994, AM J AGR ECON, V76, P61, DOI 10.2307/1243921; *OFF NAT STAT, 1998, MORT STAT CAUS ENGL; Tang JL, 1998, BMJ-BRIT MED J, V316, P1213, DOI 10.1136/bmj.316.7139.1213; TOWNSEND J, 1993, ADDICTION, V88, P37; TOWNSEND J, 1994, BMJ-BRIT MED J, V309, P923, DOI 10.1136/bmj.309.6959.923; TUNSTALLPEDOE H, 1998, BRIT MED J, V317, P102; VanDriel H, 1997, J APPL ECONOM, V12, P509, DOI 10.1002/(SICI)1099-1255(199709/10)12:5<509::AID-JAE451>3.3.CO;2-G	15	86	86	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					301	304		10.1136/bmj.320.7230.301	http://dx.doi.org/10.1136/bmj.320.7230.301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	280ZB	10650031	Green Published			2022-12-28	WOS:000085132700032
J	Shakespeare, J; Neve, E; Hodder, K				Shakespeare, J; Neve, E; Hodder, K			Is norethisterone a lifestyle drug? Results of database analysis	BRITISH MEDICAL JOURNAL			English	Article									Summertown Hlth Ctr, Oxford OX2 7BS, England; Oxfordshire Hlth Author, Oxford OX3 9LG, England		Shakespeare, J (corresponding author), Summertown Hlth Ctr, 160 Banbury Rd, Oxford OX2 7BS, England.							[Anonymous], 1999, CONCISE OXFORD DICT; COULTER A, 1995, INT J TECHNOL ASSESS, V11, P456, DOI 10.1017/S0266462300008679; *NHS CTR REV DISS, 1995, EFF HLTH CAR, V9; *ROYAL COLL OBST G, 1998, IN MAN MEN EV BAS CL, V1; *STAT OFF, 1999, DRUG TAR	5	24	25	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					291	291		10.1136/bmj.320.7230.291	http://dx.doi.org/10.1136/bmj.320.7230.291			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650028	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085132700025
J	Ahn, J; Weinacht, TC; Bucksbaum, PH				Ahn, J; Weinacht, TC; Bucksbaum, PH			Information storage and retrieval through quantum phase	SCIENCE			English	Article							IMPLEMENTATION; COMPUTER; STATES; PULSES	Information was stored as quantum phase in an N-state Rydberg atom data register. One or more flipped states stored in an eight-state atomic wave packet could be retrieved in a single operation, in agreement with a recent proposal by Grover.	Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bucksbaum, PH (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.		Ahn, Jaewook/C-1637-2011	Bucksbaum, Philip/0000-0003-1258-5571				BENNETT CH, 1995, PHYS TODAY, V48, P24, DOI 10.1063/1.881452; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; GALLAGHER TF, 1977, PHYS REV A, V16, P1098, DOI 10.1103/PhysRevA.16.1098; Grover LK, 1997, PHYS REV LETT, V79, P4709, DOI 10.1103/PhysRevLett.79.4709; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Jones JA, 1998, NATURE, V393, P344, DOI 10.1038/30687; KWIAT PG, 1999, QUANTPH9905086 LOS A; LLOYD S, 1999, QUANTPH9903057 LOS A; SCHUMACHER B, 1995, PHYS REV A, V51, P2738, DOI 10.1103/PhysRevA.51.2738; STRICKLAND D, 1985, OPT COMMUN, V55, P447, DOI 10.1016/0030-4018(85)90151-8; TIELKING NE, 1995, PHYS REV A, V52, P1371, DOI 10.1103/PhysRevA.52.1371; TULL JX, 1997, ADV MAGN OPT RES, V20, P1; Weinacht TC, 1998, PHYS REV LETT, V80, P5508, DOI 10.1103/PhysRevLett.80.5508	14	239	251	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					463	465		10.1126/science.287.5452.463	http://dx.doi.org/10.1126/science.287.5452.463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642542				2022-12-28	WOS:000084929900040
J	Murakami, Y; Tsuyama, M; Kobayashi, Y; Kodama, H; Iba, K				Murakami, Y; Tsuyama, M; Kobayashi, Y; Kodama, H; Iba, K			Trienoic fatty acids and plant tolerance of high temperature	SCIENCE			English	Article							CHLOROPLAST OMEGA-3-FATTY-ACID DESATURASE; ENHANCED THERMAL TOLERANCE; ARABIDOPSIS DEFICIENT; GROWTH TEMPERATURE; MUTANT; LIPIDS; PHOTOSYNTHESIS; ACCLIMATION; STABILITY; MEMBRANES	The chloroplast membrane of higher plants contains an unusually high concentration of trienoic fatty acids. Plants grown in colder temperatures have a higher content of trienoic fatty acids. Transgenic tobacco plants in which the gene encoding chloroplast omega-3 fatty acid desaturase, which synthesizes trienoic fatty acids, was silenced contained a lower level of trienoic fatty acids than wild-type plants and were better able to acclimate to higher temperatures.	Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Kyushu Univ, Dept Forestry, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Iba, K (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan.	koibascb@mbox.nc.kyushu-u.ac.jp						BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; HUGLY S, 1992, PLANT PHYSIOL, V99, P197, DOI 10.1104/pp.99.1.197; HUGLY S, 1989, PLANT PHYSIOL, V90, P1134, DOI 10.1104/pp.90.3.1134; IBA K, 1993, J BIOL CHEM, V268, P24099; KOBAYASHI Y, 1994, PHOTOSYNTH RES, V41, P419, DOI 10.1007/BF02183044; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; KUNST L, 1989, PLANT PHYSIOL, V91, P401, DOI 10.1104/pp.91.1.401; LEE JH, 1995, PLANT J, V8, P603, DOI 10.1046/j.1365-313X.1995.8040603.x; LEMIEUX B, 1990, THEOR APPL GENET, V80, P234, DOI 10.1007/BF00224392; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; MCCONN M, 1994, PLANT PHYSIOL, V106, P1609, DOI 10.1104/pp.106.4.1609; MURAKAMI Y, UNPUB; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; PEARCY RW, 1978, PLANT PHYSIOL, V61, P484, DOI 10.1104/pp.61.4.484; RAISON JK, 1982, BIOCHIM BIOPHYS ACTA, V688, P218, DOI 10.1016/0005-2736(82)90597-1; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; THOMAS PG, 1986, BIOCHIM BIOPHYS ACTA, V849, P131, DOI 10.1016/0005-2728(86)90104-0; WEIS E, 1988, SYM SOC EXP BIOL, V42, P329	21	295	352	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					476	479		10.1126/science.287.5452.476	http://dx.doi.org/10.1126/science.287.5452.476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642547				2022-12-28	WOS:000084929900045
J	Bellentani, S; Saccoccio, G; Masutti, F; Croce, LS; Brandi, G; Sasso, F; Cristanini, G; Tiribelli, C				Bellentani, S; Saccoccio, G; Masutti, F; Croce, LS; Brandi, G; Sasso, F; Cristanini, G; Tiribelli, C			Prevalence of and risk factors for hepatic steatosis in northern Italy	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	33rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver	APR 15-18, 1998	LISBON, PORTUGAL	European Assoc Study Liver			ALCOHOLIC LIVER-DISEASE; JEJUNOILEAL BYPASS; OBESE SUBJECTS; FATTY LIVER; WEIGHT-LOSS; ABNORMALITIES; FIBROSIS	Background: Although hepatic steatosis is seen with increasing frequency in clinical practice, its prevalence and risk factors are unknown. Objective: To investigate the prevalence of and risk factors for hepatic steatosis, such as alcohol consumption and obesity. Design: Cross-sectional, observational study. Setting: Participants in the Dionysos Study. Patients: 257 participants assigned to one of four categories (67 controls, 66 obese persons, 69 heavy drinkers, and 55 obese heavy drinkers). Measurements: Ethanol intake, assessed by a validated questionnaire and expressed as daily (g/d) and lifetime (kg) consumption, and body mass, expressed as body mass index. Biochemical tests of liver and metabolic function and hepatic ultrasonography were done. Results: The prevalence of steatosis was increased in heavy drinkers (46.4% [95% CI, 34% to 59%]) and obese persons (75.8% [CI, 63% to 85%]) compared with controls (16.4% [CI, 8% to 25%]). Steatosis was found in 94.5% (CI, 85% to 99%) of obese heavy drinkers. Compared with controls, the risk for steatosis was higher by 2.8-fold (CI, 1.4-fold to 7.1-fold) in heavy drinkers, 4.6-fold (CI, 2.5-fold to 11.0-fold) in obese persons, and 5.8-fold (CI, 3.2-fold to 12.3-fold) in persons who were obese and drank heavily. In heavy drinkers, obesity increased the risk for steatosis by twofold (CI, 1.5-fold to 3.0-fold) (P < 0.001), but heavy drinking was associated with only a 1.3-fold (CI, 1.02-fold to 1.6-fold) increase in risk in obese persons (P = 0.0053). Elevated alanine aminotransferase and triglyceride levels are the most reliable markers of steatosis. Conclusions: Steatosis is frequently encountered in healthy persons and is almost always present in obese persons who drink more than 60 g of alcohol per day. Steatosis is more strongly associated with obesity than with heavy drinking, suggesting a greater role of overweight than alcohol consumption in accumulation of fat in the liver.	Univ Trieste, Ctr Studi Fegato, Dept Biochem Biophys & Chem Macromol, I-34100 Trieste, Italy; Fondo Studio Malattie Fegato, Trieste, Italy	University of Trieste	Tiribelli, C (corresponding author), Univ Trieste, Ctr Studi Fegato, Dept Biochem Biophys & Chem Macromol, Via Giorgieri 1, I-34100 Trieste, Italy.	liver@fmc.univ.trieste.it	croce', lory saveria l/E-2565-2011; Brandi, Giovanni/AAD-6327-2021; Bellentani, Stefano/L-3600-2019; Tiribelli, Claudio/A-4716-2014	croce', lory saveria l/0000-0001-9890-7011; Brandi, Giovanni/0000-0003-0013-2858; Tiribelli, Claudio/0000-0001-6596-7595; Bellentani, Stefano/0000-0003-2836-8870				ADLER M, 1979, AM J MED, V67, P811, DOI 10.1016/0002-9343(79)90740-X; ANDERSEN T, 1991, J HEPATOL, V12, P224, DOI 10.1016/0168-8278(91)90942-5; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BOULTON R, 1995, GASTROENTEROLOGY, V109, P1324, DOI 10.1016/0016-5085(95)90595-2; BRAILLON A, 1985, GUT, V26, P133, DOI 10.1136/gut.26.2.133; CONTE D, 1995, ITAL J GASTROENTEROL, V27, P363; CUBEAU J, 1980, REV EPIDEMIOL SANTE, V28, P367; DAY CP, 1994, BBA-LIPID LIPID MET, V1215, P33, DOI 10.1016/0005-2760(94)90089-2; FLEISS JL, 1981, STAT METHODS RATES P, P83; GODDARD CJR, 1992, DIGEST DIS, V10, P218, DOI 10.1159/000171360; HAINES NW, 1981, HEPATOLOGY, V1, P161, DOI 10.1002/hep.1840010212; HOSMER DW, 1989, APPL LOGISTIC; IKAI E, 1995, J HUM HYPERTENS, V9, P101; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; LELBACH WK, 1976, PROGR LIVER DIS, P434; Luyckx FH, 1998, INT J OBESITY, V22, P222, DOI 10.1038/sj.ijo.0800571; MARUBBIO AT, 1976, AM J CLIN PATHOL, V66, P684; Matsuura K, 1995, Nihon Shokakibyo Gakkai Zasshi, V92, P1743; MEIER P, 1988, ANAL CLIN MED, P7; Mezey E, 1998, HEPATOLOGY, V28, P901, DOI 10.1002/hep.510280401; MIDANIK L, 1982, BRIT J ADDICT, V77, P357; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; NOMURA H, 1988, JPN J MED, V27, P142, DOI 10.2169/internalmedicine1962.27.142; PATON A, 1981, BRIT MED J, V283, P1248, DOI 10.1136/bmj.283.6301.1248; Perry IJ, 1998, DIABETES CARE, V21, P732, DOI 10.2337/diacare.21.5.732; PETERS RL, 1977, AM J CLIN NUTR, V30, P53, DOI 10.1093/ajcn/30.1.53; Ricci C, 1997, J HEPATOL, V27, P108, DOI 10.1016/S0168-8278(97)80288-7; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; TIETZ NW, 1987, DUNDAMENTALS CLIN CH; VANTHIEL DH, 1985, CURR CONCEPTS GASTRO, V10, P3	33	949	995	2	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					112	117		10.7326/0003-4819-132-2-200001180-00004	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00004			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	275ZZ	10644271				2022-12-28	WOS:000084852300003
J	Gupta, A; Wang, Y; Markram, H				Gupta, A; Wang, Y; Markram, H			Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex	SCIENCE			English	Article							RAT FRONTAL-CORTEX; CAT VISUAL-CORTEX; SYNAPTIC CONNECTIONS; NONPYRAMIDAL CELLS; PYRAMIDAL NEURONS; BASKET CELL; FACILITATION; CIRCUITS	A puzzling feature of the neocortex is the rich array of inhibitory interneurons. Multiple neuron recordings revealed numerous electrophysiological-anatomical subclasses of neocortical gamma-aminobutyric acid-ergic (GABAergic) interneurons and three types of GABAergic synapses. The type of synapse used by each interneuron to influence its neighbors follows three functional organizing principles. These principles suggest that inhibitory synapses could shape the impact of different interneurons according to their specific spatiotemporal patterns of activity and that GABAergic interneuron and synapse diversity may enable: combinatorial inhibitory effects in the neocortex.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Markram, H (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, 828-HSE, San Francisco, CA 94143 USA.							CAJAL SRY, 1911, HISTOLOGY DUE SYSTEM, V2; Cauli B, 1997, J NEUROSCI, V17, P3894; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DEFELIPE J, 1982, BRAIN RES, V244, P9, DOI 10.1016/0006-8993(82)90898-8; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; FLEIDERVISH IA, 1995, J NEUROPHYSIOL, V73, P2591, DOI 10.1152/jn.1995.73.6.2591; GUPTA A, UNPUB; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KAWAGUCHI Y, 1997, CEREB CORTEX, V7, P47; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Martinotti C, 1889, ANN FRENIATR SCI AFF, V1, P314; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SHOLL DA, 1953, J ANAT, V87, P387; Siegel M.R., 1988, NONPARAMETRIC STAT B; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; White E.L., 1989, CORTICAL CIRCUITS SY; White EL, 1997, SOMATOSENS MOT RES, V14, P34, DOI 10.1080/08990229771204	27	774	780	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					273	278		10.1126/science.287.5451.273	http://dx.doi.org/10.1126/science.287.5451.273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634775				2022-12-28	WOS:000084769600030
J	Gleiche, M; Chi, LF; Fuchs, H				Gleiche, M; Chi, LF; Fuchs, H			Nanoscopic channel lattices with controlled anisotropic wetting	NATURE			English	Article							SELF-ASSEMBLED MONOLAYERS; THIN-FILMS; SURFACES; POLYMER; SUBSTRATE	Engineered microscopic surface structures allow local control of physical surface properties such as adhesion, friction and wettability. These properties are related both to molecular interactions and the surface topology(1,2)-for example, selective adsorption and molecular recognition capabilities(3) require controlled anisotropy in the surface properties. Chemistry with extremely small amounts of material has become possible using liquid-guiding channels of sub-micrometre dimensions(4-6) Laterally structured surfaces with differing wettabilities may be produced using various techniques, such as microcontact printing(7-9), micromachining(10), photolithography(11,12) and vapour deposition(13). Another strategy(14) for introducing anisotropic texture is based on the use of the intrinsic material properties of stretched ultrathin polymer coatings. Here we present a fast and simple method to generate extended patterned surfaces with controlled wetting properties on the nanometre scale, without any lithographic processes. The technique utilizes wetting instabilities that occur when monomolecular layers are transferred onto a solid substrate. The modified surfaces can be used as templates for patterning a wide variety of molecules and nanoclusters into approximately parallel channels, with a spatial density of up to 20,000 cm(-1). We demonstrate the transport properties of these channels for attolitre quantities of liquid.	Univ Munster, Inst Phys, D-48149 Munster, Germany	University of Munster	Chi, LF (corresponding author), Univ Munster, Inst Phys, D-48149 Munster, Germany.		Chi, Lifeng/A-1419-2015; Fuchs, Harald/AAW-6196-2020					ABOTT NL, 1992, SCIENCE, V257, P1380; Anczykowski B, 1999, APPL SURF SCI, V140, P376, DOI 10.1016/S0169-4332(98)00558-3; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; BIEBUYCK HA, 1994, LANGMUIR, V10, P2790, DOI 10.1021/la00020a047; Boltau M, 1998, NATURE, V391, P877, DOI 10.1038/36075; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; CALVERT JM, 1993, J VAC SCI TECHNOL B, V11, P2155, DOI 10.1116/1.586449; CHUNBO Y, 1996, SURF SCI, V366, pL729; Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779; Eriksson LGT, 1997, THIN SOLID FILMS, V300, P240, DOI 10.1016/S0040-6090(96)09547-8; EVANS SD, 1995, LANGMUIR, V11, P3811, DOI 10.1021/la00010a035; GALLARDO BS, 1999, NATURE, V283, P57; Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0; Kuhn H., 1972, PHYSICAL TECHNIQU 3B, V1, P577; KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030; LNAGER JS, 1992, PHYS TODAY, P24; MASKE HA, 1997, NATURE, V386, P379; NEUMANN AW, 1972, ADV COLLOID INTERFAC, V59, P105; PETROV JG, 1980, J COLLOID INTERF SCI, V73, P66, DOI 10.1016/0021-9797(80)90123-X; RIEGLER H, 1992, THIN SOLID FILMS, V210, P9, DOI 10.1016/0040-6090(92)90153-3; SPRATTE K, 1994, EUROPHYS LETT, V25, P211, DOI 10.1209/0295-5075/25/3/010; Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; WEIS RM, 1985, J PHYS CHEM-US, V89, P4453, DOI 10.1021/j100267a011; WITTMANN JC, 1991, NATURE, V352, P414, DOI 10.1038/352414a0; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xia YN, 1997, LANGMUIR, V13, P2059, DOI 10.1021/la960936e; ZASADZINSKI JAN, 1987, J PHYS-PARIS, V48, P2001, DOI 10.1051/jphys:0198700480110200100	30	399	412	4	217	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					173	175		10.1038/35003149	http://dx.doi.org/10.1038/35003149			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646597				2022-12-28	WOS:000084835300048
J	Weissman, IL				Weissman, IL			Stem cells: Units of development, units of regeneration, and units in evolution	CELL			English	Review							COLONY-STIMULATING FACTOR; CENTRAL-NERVOUS-SYSTEM; BONE-MARROW; IN-VIVO; BOTRYLLUS-SCHLOSSERI; HEMATOPOIETIC PROGENITORS; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS; ADULT MICE; DIFFERENTIATION		Stanford Univ, Med Ctr, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Weissman, IL (corresponding author), Stanford Univ, Med Ctr, Sch Med, Dept Pathol, Stanford, CA 94305 USA.							AKASHI K, 1999, IN PRESS COLD SPRING; ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; Archimbaud E., 1997, Blood, V90, p394A; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BANCROFT FW, 1903, CALIF ACAD SCI, V31, P137; Baroffio A, 1996, DIFFERENTIATION, V60, P47, DOI 10.1046/j.1432-0436.1996.6010047.x; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Berrill NJ, 1941, BIOL BULL-US, V80, P185, DOI 10.2307/1537596; BILLINGHAM RE, 1954, PROC R SOC SER B-BIO, V143, P58, DOI 10.1098/rspb.1954.0054; BJOMSON CR, 1999, SCIENCE, V283, P534; Bradford GB, 1997, EXP HEMATOL, V25, P445; Brill S, 1999, DIGEST DIS SCI, V44, P364, DOI 10.1023/A:1026666820422; Buss LW, 1999, P NATL ACAD SCI USA, V96, P8801, DOI 10.1073/pnas.96.16.8801; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CAMPBELL KHS, 1993, BIOL REPROD, V49, P933, DOI 10.1095/biolreprod49.5.933; CHADWICKFURMAN NE, 1995, P ROY SOC B-BIOL SCI, V262, P157, DOI 10.1098/rspb.1995.0190; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Choi K, 1998, DEVELOPMENT, V125, P725; CUMANO A, 1995, C R SEANCES SOC BIOL, V1889, P617; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; EZINE S, 1987, J IMMUNOL, V139, P2195; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Gandy KL, 1998, TRANSPLANTATION, V65, P295, DOI 10.1097/00007890-199802150-00001; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GAZITT Y, 1995, BLOOD, V86, P381, DOI 10.1182/blood.V86.1.381.bloodjournal861381; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Harrison D E, 1980, Adv Pathobiol, V7, P187; HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jones EM, 1997, HORM METAB RES, V29, P308, DOI 10.1055/s-2007-979041; KAY HEM, 1965, LANCET, V2, P418; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LAUZON RJ, 1993, CELL TISSUE RES, V272, P115, DOI 10.1007/BF00323577; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Magor BG, 1999, IMMUNOL REV, V167, P69, DOI 10.1111/j.1600-065X.1999.tb01383.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Metcalf D., 1971, HEMATOPOIETIC CELLS; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MOLINEUX G, 1990, BLOOD, V76, P2153; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Overturf K, 1997, AM J PATHOL, V151, P1273; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; PANCER Z, 1995, BIOL BULL, V189, P106, DOI 10.2307/1542460; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHMAN CM, 1976, BLOOD, V47, P1031; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; SHIZURU JA, 1999, HEMATOPOIETIC CELL T, P63; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STEINBECK J, 1955, LOG SEA CORTEZ; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; THOMAS ED, 1991, BLOOD CELLS, V17, P259; TILL J, 1961, RADIAT RES, V14, P1419; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uchida N, 1996, EXP HEMATOL, V24, P649; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; UCHIDA N, 1992, THESIS STANFORD U ST; UCHIDA N, 1999, J NEUROSCI, V25, P1767; VANBEKKUM DW, 1962, ANN NY ACAD SCI, V99, P550; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; WATKINS DI, 1990, J IMMUNOL, V144, P3726; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; WEISSMAN IL, 1991, HARVEY LECT, V85, P43; WEISSMANN A, 1992, KEIMPLASMA THEORIE V; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029	110	1263	1386	4	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					157	168		10.1016/S0092-8674(00)81692-X	http://dx.doi.org/10.1016/S0092-8674(00)81692-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647940	Bronze			2022-12-28	WOS:000084722600014
J	Hansen, B				Hansen, B			Astronomy - A bright future for dark matter	NATURE			English	Editorial Material									Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Princeton University	Hansen, B (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.							Alcock C, 1999, ASTROPHYS J, V518, P44, DOI 10.1086/307265; Alcock C, 1997, ASTROPHYS J, V486, P697, DOI 10.1086/304535; BENNETT DP, 1996, NUCL PHYS B S, V51, P131; Hansen BMS, 1998, NATURE, V394, P860, DOI 10.1038/29710; Hodgkin ST, 2000, NATURE, V403, P57, DOI 10.1038/47431; Ibata RA, 1999, ASTROPHYS J, V524, pL95, DOI 10.1086/312310; Saumon D, 1999, ASTROPHYS J, V511, pL107, DOI 10.1086/311851	7	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					30	31		10.1038/47380	http://dx.doi.org/10.1038/47380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638736				2022-12-28	WOS:000084687400025
J	Hodgkin, ST; Oppenheimer, BR; Hambly, NC; Jameson, RF; Smartt, SJ; Steele, IA				Hodgkin, ST; Oppenheimer, BR; Hambly, NC; Jameson, RF; Smartt, SJ; Steele, IA			Infrared spectrum of an extremely cool white-dwarf star	NATURE			English	Article							HUBBLE DEEP FIELD; LUMINOSITY FUNCTION; GALACTIC DISK; AGE; HALO; DEGENERATE; UNIVERSE	White dwarfs are the remnant cores of stars that initially had masses of less than 8 solar masses. They cool gradually over billions of years, and have been suggested(1,2) to make up much of the 'dark matter' in the halo of the Milky way. But extremely cool white dwarfs have proved difficult to detect, owing to both their faintness and their anticipated similarity in colour to other classes of dwarf stars. Recent improved models(3-5) indicate that white dwarfs are much more blue than previously supposed, suggesting that the earlier searches may have been looking for the wrong kinds of objects. Here we report an infrared spectrum of an extremely cool white dwarf that is consistent with the new models. We determine the star's temperature to be 3,500 +/- 200 K, making it the coolest known white dwarf. The kinematics of this star indicate that it is in the halo of the Milky Way, and the density of such objects implied by the serendipitous discovery of this star is consistent with white dwarfs dominating the dark matter in the halo.	Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Univ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; Isaac Newton Grp Telescopes, La Palma 38770, Islas Canarias, Spain; Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead L41 1LD, Merseyside, England; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Leicester; University of California System; University of California Berkeley; University of Edinburgh; Isaac Newton Group of Telescopes; Liverpool John Moores University; University of Cambridge	Hodgkin, ST (corresponding author), Univ Leicester, Dept Phys & Astron, Univ Rd, Leicester LE1 7RH, Leics, England.	sth@ast.cam.ac.uk		Oppenheimer, Rebecca/0000-0001-7130-7681				Alcock C, 1997, ASTROPHYS J, V486, P697, DOI 10.1086/304535; Borysow A, 1997, ASTRON ASTROPHYS, V324, P185; Chabrier G, 1996, ASTROPHYS J, V468, pL21, DOI 10.1086/310229; Dahn C. C., 1995, Bottom of the Main Sequence - and Beyond. Proceedings of the ESO Workshop, P239; Elson RAW, 1997, NEW ASTRON, V1, P1; Festin L, 1998, ASTRON ASTROPHYS, V336, P883; Flynn C, 1996, ASTROPHYS J, V466, pL55, DOI 10.1086/310174; Gizis JE, 1999, ASTRON J, V117, P508, DOI 10.1086/300709; Graff DS, 1998, ASTROPHYS J, V499, P7, DOI 10.1086/305602; Hambly NC, 1997, ASTROPHYS J, V489, pL157, DOI 10.1086/316797; Hambly NC, 1999, MON NOT R ASTRON SOC, V309, pL33, DOI 10.1046/j.1365-8711.1999.03085.x; Hansen BMS, 1999, ASTROPHYS J, V520, P680, DOI 10.1086/307476; Hansen BMS, 1998, NATURE, V394, P860, DOI 10.1038/29710; Harris HC, 1999, ASTROPHYS J, V524, P1000, DOI 10.1086/307856; Knox RA, 1999, MON NOT R ASTRON SOC, V306, P736, DOI 10.1046/j.1365-8711.1999.02625.x; Leggett SK, 1998, ASTROPHYS J, V497, P294, DOI 10.1086/305463; LIEBERT J, 1988, ASTROPHYS J, V332, P891, DOI 10.1086/166699; LUYTEN WJ, 1979, NLTT CATALOG; Matthews K., 1994, EXP ASTRON, V3, P77; Mendez RA, 1996, MON NOT R ASTRON SOC, V283, P666, DOI 10.1093/mnras/283.2.666; Oswalt TD, 1996, NATURE, V382, P692, DOI 10.1038/382692a0; RICHER HB, IN PRESS ASTROPHYS J; Ruiz MT, 1996, ASTRON J, V111, P1267, DOI 10.1086/117871; RUIZ MT, 1995, ASTROPHYS J, V455, pL159, DOI 10.1086/309845; RYAN SG, 1991, ASTRON J, V101, P1835, DOI 10.1086/115811; Saumon D, 1999, ASTROPHYS J, V511, pL107, DOI 10.1086/311851; TAMANAHA CM, 1990, ASTROPHYS J, V358, P164, DOI 10.1086/168971; WINGET DE, 1987, ASTROPHYS J, V315, pL77, DOI 10.1086/184864; Wood M. A., 1995, White Dwarfs. Proceedings of the 9th European Workshop on White Dwarfs, P41; WOOD MA, 1992, ASTROPHYS J, V386, P539, DOI 10.1086/171038	30	64	64	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					57	59		10.1038/47431	http://dx.doi.org/10.1038/47431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638748				2022-12-28	WOS:000084687400038
J	Foley, K				Foley, K			Dismantling the barriers: Providing palliative and pain care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSISTED SUICIDE; CANCER PAIN; ATTITUDES		Cornell Univ, Coll Med, New York, NY 10021 USA	Cornell University	Foley, K (corresponding author), Cornell Univ, Coll Med, New York, NY 10021 USA.							Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Carron A T, 1999, Ann Intern Med, V130, P82; Foley Kathleen M., 1997, P2807; FOLEY KM, 1995, PAIN FORUM, V4, P163; *GALL I, 1997, SPIR BEL DYING PROC; *I MED DIV HLTH CA, 1997, APPROACHING DEATH IM; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LEVIN DN, 1985, CANCER, V56, P2337, DOI 10.1002/1097-0142(19851101)56:9<2337::AID-CNCR2820560935>3.0.CO;2-W; MEIER DE, 1997, ANN INTERN MED, V127, P3; Mount B, 1996, J PALLIAT CARE, V12, P31, DOI 10.1177/082585979601200405; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; World Health Organization, 1990, CANC PAIN REL PALL C	12	19	19	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					115	115		10.1001/jama.283.1.115	http://dx.doi.org/10.1001/jama.283.1.115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632292	hybrid			2022-12-28	WOS:000084514400037
J	Sulkowski, MS; Thomas, DL; Chaisson, RE; Moore, RD				Sulkowski, MS; Thomas, DL; Chaisson, RE; Moore, RD			Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV PROTEASE INHIBITORS; CD4 CELL COUNTS; COMBINATION THERAPY; CUBIC MILLIMETER; CONTROLLED TRIAL; ADVERSE EVENTS; DRUG-THERAPY; RITONAVIR; DISEASE; INDINAVIR	Context Use of antiretroviral drugs, including protease inhibitors, for treatment of human immunodeficiency virus (HIV) infection has been anecdotally associated with hepatotoxicity, particularly in persons coinfected with hepatitis C or B virus. Objectives To ascertain if incidence of severe hepatotoxicity during antiretroviral therapy is similar for ail antiretroviral drug combinations, and to define the role of chronic viral hepatitis in its development. Design Prospective cohort study. Setting University-based urban HIV clinic. Patients A total of 298 patients who were prescribed new antiretroviral therapies between January 1996 and January 1998, 211 (71%) of whom received protease inhibitors as part of combination therapy (median follow-up, 182 days) and 87 (29%) of whom received dual nucleoside analog regimens (median follow-up, 167 days). Chronic hepatitis C and B virus infection was present in 154 (52%) and 8 (2.7%) patients, respectively. Main Outcome Measure Severe hepatotoxicity, defined as a grade 3 or 4 change in levels of serum alanine aminotransferase and aspartate aminotransferase, evaluated before and during therapy. Results Severe hepatotoxicity was observed in 31 (10.4%) of 298 patients (95% confidence interval [CI], 7.2%-14.4%). Ritonavir use was associated with a higher incidence of toxicity (30%; 95% CI, 17.9%-44.6%). However, no significant difference was detected in hepatotoxicity incidence in other treatment groups, ie, nucleoside analogs (5.7%; 95% CI, 1.2%-12.9%), nelfinavir (5.9%; 95% CI, 1.2%-16.2%), saquinavir (5.9%; 95% Cl, 0.15%-28.7%), and indinavir (6.8%; 95% CI, 3.0%-13.1%). Although chronic viral hepatitis was associated with an increased risk of severe hepatotoxicity among patients prescribed nonritonavir regimens (relative risk, 3.7; 95% CI, 1.0-11.8), most patients with chronic hepatitis C or B virus infection (88%) did not experience significant toxic effects. Rate of severe toxicity with use of any protease inhibitor in patients with hepatitis C infection was 12.2% (13/107; 95% CI, 6.6%-19.9%). In multivariate logistic regression, only ritonavir (adjusted odds ratio [AOR], 8.6; 95% CI, 3.0-24.6) and a CD4 cell count increase of more than 0.05 x 10(9)/L (AOR, 3.6; 95% CI, 1.0-12.9) were associated with severe hepatotoxicity. No irreversible outcomes were seen in patients with severe hepatotoxicity. Conclusions Our data indicate that use of ritonavir may increase risk of severe hepatotoxicity. Although hepatotoxicity may be more common in persons with chronic viral hepatitis, these data do not support withholding protease inhibitor therapy from persons coinfected with hepatitis B or C virus.	Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sulkowski, MS (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 E Monument St,Suite 450 C, Baltimore, MD 21287 USA.	msulkows@jhmi.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS007809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602] Funding Source: NIH RePORTER; AHRQ HHS [HS-07809] Funding Source: Medline; NIDA NIH HHS [DA-11602] Funding Source: Medline; FDA HHS [FD-U-000977] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); FDA HHS		*AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV; [Anonymous], 1996, Lancet, V348, P283; Arribas JR, 1998, AIDS, V12, P1722; Bangsberg D, 1997, JAMA-J AM MED ASSOC, V278, P63, DOI 10.1001/jama.278.1.63; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Brau N, 1997, LANCET, V349, P924, DOI 10.1016/S0140-6736(05)62700-6; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; CAMERON DW, 1998, 5 C RETR OPP INF FEB; Carroll DS, 1998, PALLIATIVE MED, V12, P51, DOI 10.1191/026921698666041220; CHAISSON RE, 1995, NEW ENGL J MED, V333, P751, DOI 10.1056/NEJM199509213331202; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3; DANNER SA, 1995, NEW ENGL J MED, V333, P1528, DOI 10.1056/NEJM199512073332303; DELMAS C, 1998, 12 WORLD AIDS C JUN; Gill MJ, 1998, AIDS, V12, P1400; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; John M, 1998, AIDS, V12, P2289, DOI 10.1097/00002030-199817000-00010; Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423; LEE BL, 1992, CLIN INFECT DIS, V14, P773, DOI 10.1093/clinids/14.3.773-a; LEE C, IN PRESS J ACQUIR IM; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Markowitz M, 1998, J INFECT DIS, V177, P1533, DOI 10.1086/515312; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; Matsuda J, 1997, LANCET, V350, P364, DOI 10.1016/S0140-6736(05)63416-2; Miwa LJ, 1997, ARCH INTERN MED, V157, P2129, DOI 10.1001/archinte.157.18.2129; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; Moore RD, 1996, AM J MED, V101, P34, DOI 10.1016/S0002-9343(96)00077-0; PERRILLO RP, 1986, ANN INTERN MED, V105, P382, DOI 10.7326/0003-4819-105-3-382; Rodriguez-Rosado R, 1998, AIDS, V12, P1256, DOI 10.1097/00002030-199810000-00025; Rutschmann OT, 1998, J INFECT DIS, V177, P783, DOI 10.1086/517808; Thomas DL, 1998, HEPATOLOGY, V28, p568A; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Vento S, 1998, AIDS, V12, P116; VERDON R, 1998, 38 INT C ANT AG CHEM; Zylberberg H, 1996, CLIN INFECT DIS, V23, P1117, DOI 10.1093/clinids/23.5.1117; Zylberberg H, 1998, CLIN INFECT DIS, V26, P1104, DOI 10.1086/520281; 1998, MMWR MORB MORTAL WKL, V47, P38	39	690	710	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					74	80		10.1001/jama.283.1.74	http://dx.doi.org/10.1001/jama.283.1.74			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632283				2022-12-28	WOS:000084514400028
J	Charon, R				Charon, R			Medicine, the novel, and the passage of time	ANNALS OF INTERNAL MEDICINE			English	Article								Doctors and patients move together through time, humble in the face of its dictates. Novelists allow their characters to enter time, revealing in the characters' particular, ongoing lives some universal truths about living. Both the medical chart and the novel capture individual human lives as they change and as they age, finding some meaning in the random events that happen in them. Literary critics who write about the novel provide useful frameworks for doctors who reflect on their practice. In this essay, I examine the medical charts of two of my patients in detail and describe the experiences I shared with them. As a repository of detail not only about the patients but about the doctors and nurses who cared for them, the charts provide rich and powerful evidence about the insides of practice and the meanings that clinical relationships accrue. Doctors might discover underlying meaning in their practices that would otherwise elude them by reading their patients' charts as if they were novels, looking for patterns and movements throughout a patient's life, and recognizing the deep connections woven between their patients and themselves. By placing great novels-by Henry James, Virginia Woolf, and Thomas Mann-side by side with actual medical charts, I suggest the usefulness of close readings of medicine's texts. The juxtaposition suggests the utility of brooding about the seasons of our relationships with patients. Perhaps not a luxury but a necessity for effective care, reflection such as this on our patients may restore to medicine some of its passion, its meaning,and its joy.	Columbia Univ Coll Phys & Surg, Program Humanities & Med, New York, NY 10032 USA	Columbia University	Charon, R (corresponding author), Columbia Univ Coll Phys & Surg, Program Humanities & Med, 630 W 168th St, New York, NY 10032 USA.							CHARON R, IN PRESS CLIN GERIAT; DuPlessis R.B., 1985, WRITING ENDING NARRA; FORSTER EM, 1985, ASPECTS NOVEL, P27; JAMES H, 1909, NOVELS TALES H JAMES, V19, P160; JAMES H, 1909, NOVELS TALES H JAMES, V20, P214; Kermode F., 2000, SENSE ENDING STUDIES; Laqueur Thomas, 1989, NEW CULTURAL HIST, P176, DOI DOI 10.1525/J.CTT1PPFH6; LUKACS G, 1971, THEORY NOVEL, P121; MANN T, 1969, MAGIC MOUNTAIN, P66; MANN T, 1969, MAGIC MOUNTAIN, P112; RICOEUR P, 1985, TIME NARRATIVE, V2, P61; Said Edward, 1985, BEGINNINGS INTENTION; Watt Ian, 1957, RISE NOVEL, P13; WEIL S, 1973, WAITING GOD, P115; WEINBERG RB, 1995, ANN INTERN MED, V123, P804, DOI 10.7326/0003-4819-123-10-199511150-00011; WOOLF V, 1927, LIGHTHOUSE, P189; WOOLF V, 1927, LIGHTHOUSE, P73	17	21	22	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					63	68		10.7326/0003-4819-132-1-200001040-00011	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627254				2022-12-28	WOS:000084518600010
J	Eskola, J; Ward, J; Dagan, R; Goldblatt, D; Zepp, F; Siegrist, C				Eskola, J; Ward, J; Dagan, R; Goldblatt, D; Zepp, F; Siegrist, C			Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis	LANCET			English	Review							CAPSULAR POLYSACCHARIDE ANTIBODIES; SERUM ANTIBODIES; OROPHARYNGEAL CARRIAGE; IMMUNOLOGICAL RESPONSE; PROTECTIVE LEVEL; INFANTS; VACCINES; IMMUNOGENICITY; IMMUNIZATION; CHILDREN	After the introduction of effective Haemophilus influenzae type b (Hib) conjugate vaccines, clinical practice has driven the development of combination vaccines comprising Hib conjugates with the infant diphtheria-tetanus-pertussis (DTP) vaccines. However, when such combinations contain an acellular pertussis component (Pa), the antibody response to Hib is lower than that with separate injections and doubts have been raised about their efficacy. We believe that such concerns are unwarranted, since the serological correlates of efficacy previously applied for Hib polysaccharide vaccines seem inappropriate for Hib conjugates. Furthermore, our own studies have shown that the lower antibody responses are not associated with impaired function of the antibodies induced, nor, and possibly more importantly, with the induction of immune memory against Hib. Therefore, with the proviso that careful clinical surveillance of Hib disease is maintained, we encourage the introduction of DTPa-Hib combinations to facilitate the inclusion of Hib into the already crowded childhood immunisation schedule.	Natl Publ Hlth Inst, FIN-00300 Helsinki, Finland; Univ Calif Los Angeles, Ctr Vaccine Res, Torrance, CA USA; Soroka Univ, Med Ctr, Paediat Infect Dis Unit, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Inst Child Hlth, Immunobiol Unit, London, England; Univ Hosp, Mainz, Germany; Univ Geneva, WHO, Collaborating Ctr Vaccinol & Neonatal Immunol, Geneva, Switzerland	Finland National Institute for Health & Welfare; University of California System; University of California Los Angeles; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of London; University College London; University Hospital Mainz; University of Geneva; World Health Organization	Eskola, J (corresponding author), Natl Publ Hlth Inst, FIN-00300 Helsinki, Finland.		Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242				Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; AMBROSINO DM, 1986, J INFECT DIS, V153, P1, DOI 10.1093/infdis/153.1.1; AMIR J, 1990, J INFECT DIS, V162, P163, DOI 10.1093/infdis/162.1.163; ANDERSON P, 1984, J INFECT DIS, V149, P1034, DOI 10.1093/infdis/149.6.1034; Aristegui J, 1998, VACCINE, V16, P1976, DOI 10.1016/S0264-410X(98)00114-5; AVENDANO A, 1993, PEDIATR INFECT DIS J, V12, P638, DOI 10.1097/00006454-199308000-00003; Barbour ML, 1996, EMERG INFECT DIS, V2, P176, DOI 10.3201/eid0203.960303; Booy R, 1997, LANCET, V349, P1197, DOI 10.1016/S0140-6736(96)06392-1; CLEMENS J, 1995, ANN NY ACAD SCI, V754, P255, DOI 10.1111/j.1749-6632.1995.tb44458.x; CLEMENTS DA, 1986, PEDIATR RES, V20, pA307; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1113, DOI 10.1097/00006454-199712000-00004; Dagan R, 1998, INFECT IMMUN, V66, P2093, DOI 10.1128/IAI.66.5.2093-2098.1998; DECKER MD, 1992, J PEDIATR-US, V120, P184, DOI 10.1016/S0022-3476(05)80424-X; Eskola J, 1996, LANCET, V348, P1688, DOI 10.1016/S0140-6736(96)04356-5; FERRECCIO C, 1991, PEDIATR INFECT DIS J, V10, P764, DOI 10.1097/00006454-199110000-00009; FRASCH CE, 1995, CLIN IMMUNOTHER, V4, P376, DOI 10.1007/BF03259300; Galil K, 1999, J INFECT DIS, V179, P101, DOI 10.1086/314569; Goldblatt D, 1998, BMJ-BRIT MED J, V316, P1570, DOI 10.1136/bmj.316.7144.1569; GRANOFF DM, 1993, J INFECT DIS, V168, P663, DOI 10.1093/infdis/168.3.663; KAUPPI M, 1993, J INFECT DIS, V167, P365, DOI 10.1093/infdis/167.2.365; KAUPPI M, 1995, PEDIATR INFECT DIS J, V14, P286, DOI 10.1097/00006454-199504000-00008; KAYHTY H, 1984, PEDIATRICS, V74, P857; KAYHTY H, 1983, J INFECT DIS, V147, P1100; KAYHTY H, 1995, 35 INT C ANT AG CHEM; KAYHTY H, 1992, J INFECT DIS S1, V165, P165; LUCAS AH, 1995, J IMMUNOL, V154, P4195; MADORE DV, 1990, PEDIATRICS, V86, P527; MILLER MA, 1995, PEDIATRICS, V95, P522; Mills E, 1998, VACCINE, V16, P576, DOI 10.1016/S0264-410X(97)00241-7; PELTOLA H, 1984, NEW ENGL J MED, V310, P1561, DOI 10.1056/NEJM198406143102404; PELTOLA H, 1977, PEDIATRICS, V60, P730; Pichichero ME, 1997, PEDIATR INFECT DIS J, V16, P863, DOI 10.1097/00006454-199709000-00009; Pichichero ME, 1997, CLIN INFECT DIS, V25, P1378, DOI 10.1086/516154; PUANG HF, 1997, PEDIATR RES, V41, P47; ROBBINS JB, 1973, PEDIATR RES, V7, P103, DOI 10.1203/00006450-197303000-00001; SCHLESINGER Y, 1992, JAMA-J AM MED ASSOC, V267, P1489, DOI 10.1001/jama.267.11.1489; Schmitt HJ, 1998, EUR J PEDIATR, V157, P208, DOI 10.1007/s004310050797; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361; TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982; Zepp F, 1997, EUR J PEDIATR, V156, P18	41	164	175	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2063	2068		10.1016/S0140-6736(99)04377-9	http://dx.doi.org/10.1016/S0140-6736(99)04377-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636384				2022-12-28	WOS:000084183300044
J	Chua, K; Reed, R				Chua, K; Reed, R			The RNA splicing factor hSlu7 is required for correct 3 ' splice-site choice	NATURE			English	Article							2ND CATALYTIC STEP; U5 SNRNA LOOP-1; CROSS-LINKING; YEAST; PROTEIN; 3'-SPLICE-SITE; MUTATIONS; SELECTION; SUGGEST; SLU7	The production of correctly spliced messenger RNA requires two catalytic splicing steps(1-3). During step II, exon 1 attacks an adenine-guanine (AG) dinucleotide at the 3' splice site. This AG is usually located between 18 and 40 nucleotides downstream from the branch site, and closer AGs are skipped in favour of AGs located more optimally downstream(4-6). At present, little is understood about how the correct AG is distinguished from other AGs. Here we describe a metazoan splicing factor (hSlu7) that is required for selection of the correct AG. In the absence of hSlu7, use of the correct AG is suppressed and incorrect AGs are activated. We investigated this loss of fidelity by analysing spliceosomes assembled in the absence of hSlu7. These studies reveal that exon 1 is loosely associated with these spliceosomes. Thus, the improperly held exon cannot access the correct AG, but can attack other AGs indiscriminately. We conclude that hSlu7 is required to hold exon 1 tightly within the spliceosome for attack on a prespecified AG.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Brys A, 1996, RNA, V2, P707; Burge CB, 1999, RNA WORLD, P525; Chiara MD, 1997, EMBO J, V16, P4746, DOI 10.1093/emboj/16.15.4746; Chua K, 1999, GENE DEV, V13, P841, DOI 10.1101/gad.13.7.841; CORTES JJ, 1993, EMBO J, V12, P5181, DOI 10.1002/j.1460-2075.1993.tb06213.x; DAS R, IN PRESS RNA; FRANK D, 1992, MOL CELL BIOL, V12, P5197, DOI 10.1128/MCB.12.11.5197; FRANK D, 1992, GENE DEV, V6, P2112, DOI 10.1101/gad.6.11.2112; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Horowitz DS, 1997, GENE DEV, V11, P139, DOI 10.1101/gad.11.1.139; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; MOORE MJ, 1993, RNA WORLD, P306; Newman AJ, 1995, RNA, V1, P968; Newman AJ, 1997, EMBO J, V16, P5797, DOI 10.1093/emboj/16.19.5797; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; O'Keefe RT, 1998, EMBO J, V17, P565, DOI 10.1093/emboj/17.2.565; OKeefe RT, 1996, CELL, V86, P679, DOI 10.1016/S0092-8674(00)80140-3; REED R, 1997, EUKARYOTIC MRNA PROC, P103; Segault V, 1999, MOL CELL BIOL, V19, P2782; SMITH CW, 1993, MOL CELL BIOL, V13, P4949; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TEIGELKAMP S, 1995, EMBO J, V14, P2602, DOI 10.1002/j.1460-2075.1995.tb07258.x; Umen JG, 1996, GENETICS, V143, P723; UMEN JG, 1995, GENE DEV, V9, P855, DOI 10.1101/gad.9.7.855; Umen JG, 1995, RNA, V1, P869; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542	27	76	78	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					207	210		10.1038/46086	http://dx.doi.org/10.1038/46086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647016				2022-12-28	WOS:000083716400057
J	Block, SD				Block, SD		ACP ASIM End Life Care Consensus P	Assessing and managing depression in the terminally ill patient	ANNALS OF INTERNAL MEDICINE			English	Article							STRUCTURED PSYCHIATRIC INTERVENTION; CANCER PAIN RELIEF; MEDICAL ILLNESS; PSYCHOLOGICAL SYMPTOMS; BREAST-CANCER; DISORDERS; ANTIDEPRESSANTS; SUICIDE; PREVALENCE; THERAPY				Block, SD (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.				NCI NIH HHS [CA66818-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA066818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHLES TA, 1983, PAIN, V17, P277, DOI 10.1016/0304-3959(83)90100-8; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANGRIST B, 1992, J CLIN PSYCHOPHARM, V12, P268; Balint M., 1964, DOCTOR HIS PATIENT I; BLAZER DG, 1986, J AM GERIATR SOC, V34, P519, DOI 10.1111/j.1532-5415.1986.tb04244.x; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; BOLUND C, 1985, J PSYCHOSOC ONCOL, V3, P17; Bolund C., 1985, J PSYCHOSOC ONCOL, V3, P31; BREITBART W, 1995, J PAIN SYMPTOM MANAG, V10, P131, DOI 10.1016/0885-3924(94)00075-V; Breitbart W, 1987, Oncology (Williston Park), V1, P49; BREITBART W, 1990, ADV PAIN RES THERAPY; BREITBART W, 1998, PSYCHOONCOLOGY; BROWN JT, 1983, JAMA-J AM MED ASSOC, V250, P378, DOI 10.1001/jama.250.3.378; BRUERA E, 1992, PAIN, V50, P75, DOI 10.1016/0304-3959(92)90114-Q; BUKBERG J, 1984, PSYCHOSOM MED, V46, P199, DOI 10.1097/00006842-198405000-00002; Burt, 1979, TAKING CARE STRANGER; Byock I, 1997, DYING WELL PROSPECT; CASSEM EH, 1995, PSYCHOSOMATICS, V36, pS2, DOI 10.1016/S0033-3182(95)71698-X; Chaturvedi SK, 1994, PSYCHO-ONCOLOGY, V3, P57; Chochinov HM, 1997, AM J PSYCHIAT, V154, P674; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; CLAYTON PJ, 1974, CAN PSYCHIAT ASSOC J, V19, P309, DOI 10.1177/070674377401900312; CLEELAND CS, 1984, CANCER, V54, P235; COMAROFF J, 1981, SOC SCI MED-MED ANTH, V15, P115, DOI 10.1016/0160-7987(81)90034-X; DEAN C, 1987, J PSYCHOSOM RES, V31, P385, DOI 10.1016/0022-3999(87)90059-6; DeFlorio M, 1995, DEPRESSION, V3, P66; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; DEROGATIS LR, 1979, CANCER, V44, P1919, DOI 10.1002/1097-0142(197911)44:5<1919::AID-CNCR2820440555>3.0.CO;2-T; Elliott AJ, 1998, AM J PSYCHIAT, V155, P367; ENDICOTT J, 1984, CANCER, V53, P2243; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; Farberow N. L., 1971, SUICIDE LIFE-THREAT, V1, P184; FAWZY FI, 1990, ARCH GEN PSYCHIAT, V47, P729; FAWZY FI, 1990, ARCH GEN PSYCHIAT, V47, P720; FERNANDEZ F, 1988, PSYCHOSOMATICS, V29, P38, DOI 10.1016/S0033-3182(88)72420-2; FERNANDEZ F, 1987, PSYCHOSOMATICS, V28, P455, DOI 10.1016/S0033-3182(87)72476-1; FORREST WH, 1977, NEW ENGL J MED, V296, P712, DOI 10.1056/NEJM197703312961303; FRANCE RD, 1987, PSYCHOPATHOLOGY, V20, P99, DOI 10.1159/000284529; GANZINI L, 1994, AM J PSYCHIAT, V151, P1631; GERETY MB, 1994, J AM GERIATR SOC, V42, P1103, DOI 10.1111/j.1532-5415.1994.tb06217.x; GOLDBERG RJ, 1983, PSYCHOTHER PSYCHOSOM, V39, P180, DOI 10.1159/000287739; GREER S, 1992, BRIT MED J, V304, P675, DOI 10.1136/bmj.304.6828.675; GROND S, 1991, J PAIN SYMPTOM MANAG, V6, P411, DOI 10.1016/0885-3924(91)90039-7; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; HELIG S, 1988, SAN FRANCISCO MED, V61, P24; HOLLAND JC, 1986, AM J PSYCHIAT, V143, P982; JAEGER H, 1985, GEN HOSP PSYCHIAT, V7, P353, DOI 10.1016/0163-8343(85)90051-9; KAASA S, 1993, RADIOTHER ONCOL, V27, P193, DOI 10.1016/0167-8140(93)90073-H; Kasper S, 1992, Drugs, V43 Suppl 2, P11; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; KATON W, 1990, Journal of Clinical Psychiatry, V51, P3; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOENIG HG, 1992, INT J PSYCHIAT MED, V22, P183, DOI 10.2190/M1F5-F40P-C4KD-YPA3; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; LEVINE PM, 1978, CANCER, V42, P1385, DOI 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0; LEWISFERNANDEZ R, 1995, PSYCHIAT CLIN N AM, V18, P433, DOI 10.1016/S0193-953X(18)30033-9; LIEBOWITZ MR, 1993, J CLIN PSYCHIAT, V54, P4; Lindemann E, 1944, AM J PSYCHIAT, V101, P141, DOI 10.1176/ajp.101.2.141; MACKENZIE TB, 1987, INT J PSYCHIAT MED, V17, P3; MAGUIRE P, 1984, INT REV APPL PSYCHOL, V33, P479; MAGUIRE P, 1985, ACTA PSYCHIAT SCAND, V72, P81, DOI 10.1111/j.1600-0447.1985.tb08080.x; MALTSBERGER JT, 1974, ARCH GEN PSYCHIAT, V30, P625; MARZUK PM, 1988, JAMA-J AM MED ASSOC, V259, P1333, DOI 10.1001/jama.259.9.1333; MASAND P, 1991, PSYCHOSOMATICS, V32, P203, DOI 10.1016/S0033-3182(91)72093-8; Masand PS, 1996, PSYCHIAT CLIN N AM, V19, P515, DOI 10.1016/S0193-953X(05)70304-X; MASSIE MJ, 1990, J CLIN PSYCHIAT, V51, P12; MASSIE MJ, 1987, MED CLIN N AM, V71, P243, DOI 10.1016/S0025-7125(16)30868-9; MCCARTNEY CF, 1989, AM J PSYCHIAT, V146, P898; MENDELS J, 1987, J CLIN PSYCHIAT, V48, P26; PLUMB M, 1981, PSYCHOSOM MED, V43, P243, DOI 10.1097/00006842-198106000-00006; PLUMB MM, 1977, PSYCHOSOM MED, V39, P264, DOI 10.1097/00006842-197707000-00007; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; PORTENOY RK, 1992, LANCET, V339, P1026, DOI 10.1016/0140-6736(92)90545-E; PRESKORN SH, 1993, AM J MED, V94, pS2; PRESKORN SH, 1992, J CLIN PSYCHIAT, V53, P5; PRESKORN SH, 1990, J CLIN PSYCHOPHARM, V10, P88, DOI 10.1097/00004714-199004000-00003; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; RABINS PV, 1992, J AM GERIATR SOC, V40, P727, DOI 10.1111/j.1532-5415.1992.tb01968.x; RIFKIN A, 1985, J CLIN PSYCHIAT, V46, P4; Roose SP, 1998, JAMA-J AM MED ASSOC, V279, P287, DOI 10.1001/jama.279.4.287; SILVERSTONE T, 1983, PSYCHOL MED, V13, P251, DOI 10.1017/S0033291700050856; SPIEGEL D, 1994, CANCER, V74, P2570, DOI 10.1002/1097-0142(19941101)74:9<2570::AID-CNCR2820740927>3.0.CO;2-3; SPIEGEL D, 1989, LANCET, V2, P888; SPIEGEL D, 1981, ARCH GEN PSYCHIAT, V38, P527; STIEFEL FC, 1990, CANCER, V65, P1048, DOI 10.1002/1097-0142(19900215)65:4<1048::AID-CNCR2820650434>3.0.CO;2-N; Twycross RG, 1983, SYMPTOM CONTROL FAR; VACHON MLS, 1998, OXFORD TXB PALLIATIV; VENTAFRIDDA V, 1987, CANCER, V59, P850, DOI 10.1002/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1; Weisman AD., 1972, DYING DENYING PSYCHI; WEISMAN AD, 1976, CANC BEHAV DIMENSION; WOODFORD.JM, 1970, J PSYCHOSOM RES, V14, P365, DOI 10.1016/0022-3999(70)90002-4; WOODS SW, 1986, J CLIN PSYCHIAT, V47, P12; ZINBARG RE, 1991, CHRONIC ANXIETY GENE, P136	94	238	242	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					209	218		10.7326/0003-4819-132-3-200002010-00007	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	276XE	10651602				2022-12-28	WOS:000084903000006
J	Wei, QH; Bechinger, C; Leiderer, P				Wei, QH; Bechinger, C; Leiderer, P			Single-file diffusion of colloids in one-dimensional channels	SCIENCE			English	Article							MEAN-SQUARE DISPLACEMENT; LONG-TIME LIMIT; MOLECULAR-SIEVE; PORE; PARTICLES; TRANSPORT; SYSTEMS	Single-file diffusion, prevalent in many processes, refers to the restricted motion of interacting particles in narrow micropores with the mutual passage excluded. A single-filing system was developed by confining colloidal spheres in one-dimensional circular channels of micrometer scale. Optical video microscopy study shows evidence that the particle self-diffusion is non-Fickian for long periods of time. In particular, the distribution of particle displacement is a Gaussian function.	Univ Konstanz, Fac Phys, D-78457 Constance, Germany	University of Konstanz	Wei, QH (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.		Wei, Qi-Huo/C-1475-2010; Wei, Qi-Huo/M-5448-2019; Wei, Qi-Huo/AAS-6041-2020	Wei, Qi-Huo/0000-0003-3316-8988; Wei, Qi-Huo/0000-0003-3316-8988				Alberts B., 1994, MOL BIOL CELL; ALEXANDER S, 1978, PHYS REV B, V18, P2011, DOI 10.1103/PhysRevB.18.2011; ARRATIA R, 1983, ANN PROBAB, V11, P362, DOI 10.1214/aop/1176993602; Chen NY., 1994, MOL TRANSPORT REACTI; Chou T, 1999, PHYS REV LETT, V82, P3552, DOI 10.1103/PhysRevLett.82.3552; DRABER S, 1991, J MEMBRANE BIOL, V123, P183, DOI 10.1007/BF01998088; Gupta V, 1995, CHEM PHYS LETT, V247, P596, DOI 10.1016/S0009-2614(95)01246-X; HAHN K, 1995, J PHYS A-MATH GEN, V28, P3061, DOI 10.1088/0305-4470/28/11/010; Hahn K, 1998, J PHYS CHEM B, V102, P5766, DOI 10.1021/jp981039h; HALPINHEALY T, 1995, PHYS REP, V254, P215, DOI 10.1016/0370-1573(94)00087-J; HARRIS EJ, 1960, TRANSPORT ACCUMULATI; HERNANDEZ JA, 1992, J GEN PHYSIOL, V99, P645, DOI 10.1085/jgp.99.4.645; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Jobic H, 1997, J PHYS CHEM B, V101, P5834, DOI 10.1021/jp970773i; KARGER J, 1992, PHYS REV A, V45, P4173, DOI 10.1103/PhysRevA.45.4173; KARGER J, 1993, PHYS REV E, V47, P1427, DOI 10.1103/PhysRevE.47.1427; Karger J., 1992, DIFFUSION ZEOLITES O; Kukla V, 1996, SCIENCE, V272, P702, DOI 10.1126/science.272.5262.702; LEA EJA, 1963, J THEOR BIOL, V5, P102, DOI 10.1016/0022-5193(63)90038-9; LEVITT DG, 1974, BIOCHIM BIOPHYS ACTA, V373, P115, DOI 10.1016/0005-2736(74)90111-4; NAGLE G, 1996, PHYS REP, V272, P215; NIVARTHI SS, 1994, CHEM PHYS LETT, V229, P197; QIU X, 1988, J PHYS-PARIS, V49, P1043; Radhakrishnan R, 1997, PHYS REV LETT, V79, P2847, DOI 10.1103/PhysRevLett.79.2847; RICHARDS PM, 1977, PHYS REV B, V16, P1393, DOI 10.1103/PhysRevB.16.1393; RICKERT H, 1964, Z PHYS CHEM NEUE FOL, V43, P129, DOI 10.1524/zpch.1964.43.3_4.129; ROSENBERG PA, 1978, J GEN PHYSIOL, V72, P341, DOI 10.1085/jgp.72.3.341; Sholl DS, 1997, PHYS REV LETT, V79, P3569, DOI 10.1103/PhysRevLett.79.3569; VANBEIJEREN H, 1983, PHYS REV B, V28, P5711, DOI 10.1103/PhysRevB.28.5711; VANBLAADEREN A, 1992, J CHEM PHYS, V96, P4591, DOI 10.1063/1.462795; ZAHN K, 1997, THESIS U STRASBOURG	31	383	392	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					625	627		10.1126/science.287.5453.625	http://dx.doi.org/10.1126/science.287.5453.625			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649990	Green Submitted			2022-12-28	WOS:000084989400039
J	Moy, E; Griner, PF; Challoner, DR; Perry, DR				Moy, E; Griner, PF; Challoner, DR; Perry, DR			Distribution of research awards from the National Institutes of Health among medical schools	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL RESEARCH; PHYSICIAN-SCIENTISTS; MANAGED CARE; CRISIS	Background: Previous studies have demonstrated that a small number of the 125 medical schools in the United States receive a disproportionately large share of the research awards granted by the National Institutes of Health (NIH). We assessed whether the distribution of NIH research awards to medical schools changed between 1986 and 1997. Methods: We used NIH data to rank medical schools in each year from 1986 to 1997 according to the number of awards each school received (as a measure of each school's activity in research, also referred to as research intensity). The proportion of awards received by schools ranked 1 to 10, 11 to 30, 31 to 50, and 51 or lower in research activity was then calculated, and changes over time were examined. We also examined changes in the distribution of awards and changes in award amounts according to the type of department, the type of academic degree held by the principal investigator, and the awarding institute. Results: Between 1986 and 1997, the proportion of research awards granted by the NIH to the 10 most research-intensive medical schools increased slightly (from 24.6 percent of all awards to 27.1 percent), whereas the 75 least research-intensive medical schools (those ranked 51 or lower) received proportionately fewer awards (declining from 24.3 percent to 21.8 percent). The increased proportion of awards to top-10 schools consisted primarily of increases in awards to clinical departments, awards to physicians, and awards from highly competitive NIH institutes. Basic-science departments received a smaller proportion of awards than clinical departments, both in 1986 and in 1997. Conclusions: Research funded by the NIH is becoming more concentrated in the medical schools that are most active in research. (N Engl J Med 2000;342:250-5.) (C)2000, Massachusetts Medical Society.	Assoc Amer Med Coll, Ctr Assessment & Management Change Acad Med, Washington, DC 20037 USA; Univ Florida, Inst Sci & Hlth Policy, Gainesville, FL USA; Univ N Carolina, Sch Med, Deans Off, Chapel Hill, NC USA	Association of American Medical Colleges; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Moy, E (corresponding author), Assoc Amer Med Coll, Ctr Assessment & Management Change Acad Med, 2450 N St NW, Washington, DC 20037 USA.							Burnett DA, 1996, HEALTH AFFAIR, V15, P90, DOI 10.1377/hlthaff.15.3.90; CADMAN EC, 1994, ANN INTERN MED, V120, P401, DOI 10.7326/0003-4819-120-5-199403010-00009; Crowley WF, 1996, ACAD MED, V71, P1154, DOI 10.1097/00001888-199611000-00013; CULLITON BJ, 1995, NAT MED, V1, P281, DOI 10.1038/nm0495-281; DAVIS M, 1999, PRESIDENTS FY 2000 B; GEIGER R, 1995, J HIGH EDUC, V66, P336, DOI 10.2307/2943895; Jones RF, 1998, JAMA-J AM MED ASSOC, V280, P813, DOI 10.1001/jama.280.9.813; Mechanic RE, 1996, HEALTH AFFAIR, V15, P72, DOI 10.1377/hlthaff.15.3.72; Meyer RE, 1998, P ASSOC AM PHYSICIAN, V110, P513; *MIT COLL, 1999, AN IMP FY 2000 FED R; MOVSESIAN MA, 1990, NEW ENGL J MED, V322, P1602, DOI 10.1056/NEJM199005313222211; Moy E, 1997, JAMA-J AM MED ASSOC, V278, P217, DOI 10.1001/jama.278.3.217; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; NEELY SK, 1998, WHAT AM SAY NATIONS; Neilson EG, 1995, J INVEST MED, V43, P534; *NIH, 1999, BRDPI DEF; *NIH, 1999, NIH EXTR DAT FISC YE; *NIH, 1997, NIH DIR PAN CLIN RES; *NIH, 1999, FY 1970 1998 NIH PRE; *NIH FY, 1998, 1997 EXTR AW MED SCH; *OFF EXTR RES, 1998, ACC REV UNS APPL REQ; *OFF EXTR RES, 1998, SAL LIM GRANTS COOP; PERRY DR, 1981, NEW ENGL J MED, V305, P320, DOI 10.1056/NEJM198108063050605; Rockey DC, 1999, J INVEST MED, V47, P25; Schechter AN, 1998, JAMA-J AM MED ASSOC, V280, P1440, DOI 10.1001/jama.280.16.1440; Schrier RW, 1997, ACAD MED, V72, P589, DOI 10.1097/00001888-199707000-00010; Shine KI, 1998, JAMA-J AM MED ASSOC, V280, P1442, DOI 10.1001/jama.280.16.1442; Shine KI, 1997, JAMA-J AM MED ASSOC, V278, P245, DOI 10.1001/jama.278.3.245; Shulman LE, 1996, ACAD MED, V71, P362, DOI 10.1097/00001888-199604000-00013; SHULMAN LE, 1996, ACAD MED, V71, P398; Thompson JN, 1997, JAMA-J AM MED ASSOC, V278, P388; Weissman JS, 1999, JAMA-J AM MED ASSOC, V281, P1093, DOI 10.1001/jama.281.12.1093; 1995, CENTERWATCH, V2, P1	33	33	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					250	255		10.1056/NEJM200001273420406	http://dx.doi.org/10.1056/NEJM200001273420406			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	277PB	10648768				2022-12-28	WOS:000084941000006
J	Murphy, AM; Kogler, H; Georgakopoulos, D; McDonough, JL; Kass, DA; Van Eyk, JE; Marban, E				Murphy, AM; Kogler, H; Georgakopoulos, D; McDonough, JL; Kass, DA; Van Eyk, JE; Marban, E			Transgenic mouse model of stunned myocardium	SCIENCE			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TROPONIN-I; CELLULAR MECHANISMS; THIN FILAMENT; MUSCLE; CA2+; MUTATIONS; PROTEINS; CALCIUM; HEART	Stunned myocardium is a syndrome of reversible contractile failure that frequently complicates coronary artery disease. Cardiac excitation is uncoupled from contraction at the level of the myofilaments, Selective proteolysis of the thin filament protein troponin I has been correlated with stunned myocardium. Here, transgenic mice expressing the major degradation product of troponin I (TnI(1-193)) in the heart were found to develop ventricular dilatation, diminished contractility, and reduced myofilament calcium responsiveness, recapitulating the phenotype of stunned myocardium. Proteolysis of troponin I also occurs in ischemic human cardiac muscle. Thus, troponin I proteolysis underlies the pathogenesis of a common acquired form of heart failure.	Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Mol Cardiobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Queens Univ, Dept Biochem, Kingston, ON K7L 3W6, Canada; Queens Univ, Dept Physiol, Kingston, ON K7L 3W6, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Queens University - Canada; Queens University - Canada	Murphy, AM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Ross Bldg 1144,720 Rutland Ave, Baltimore, MD 21205 USA.		Marban, Eduardo/GWC-8514-2022		NHLBI NIH HHS [HL 63038, HL 44065] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044065, R56HL063038, R01HL063038] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; BECKER LC, 1986, J AM COLL CARDIOL, V7, P580, DOI 10.1016/S0735-1097(86)80468-5; Bolli R, 1999, PHYSIOL REV, V79, P609, DOI 10.1152/physrev.1999.79.2.609; BOLLI R, 1985, AM J CARDIOL, V56, P964, DOI 10.1016/0002-9149(85)90413-8; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; Foster DB, 1999, CIRC RES, V85, P470, DOI 10.1161/01.RES.85.5.470; Gao WD, 1996, CIRC RES, V78, P455; Gao WD, 1998, J PHYSIOL-LONDON, V507, P175, DOI 10.1111/j.1469-7793.1998.175bu.x; Gao WD, 1999, J CLIN INVEST, V103, P661, DOI 10.1172/JCI5220; GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036; GAO WD, 1997, CIRC RES, V80, P383; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; GEORGAKOPOULOS D, 1998, AM J PHYSIOL-HEART C, V274, P1416; HUNKELER NM, 1991, CIRC RES, V69, P1409, DOI 10.1161/01.RES.69.5.1409; James J, 1999, CIRCULATION, V100, P276; James J., UNPUB; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; KUSUOKA H, 1992, ANNU REV PHYSIOL, V54, P243, DOI 10.1146/annurev.ph.54.030192.001331; LEHRER SS, 1994, J MUSCLE RES CELL M, V15, P232; McDonald KS, 1998, J MOL CELL CARDIOL, V30, P285, DOI 10.1006/jmcc.1997.0603; McDonough JL, 1999, CIRCULATION, V100, P767; McDonough JL, 1999, CIRC RES, V84, P9; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Palmiter KA, 1997, BASIC RES CARDIOL, V92, P63, DOI 10.1007/BF00794070; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Shen YT, 1996, AM J PHYSIOL-HEART C, V270, pH1312, DOI 10.1152/ajpheart.1996.270.4.H1312; Solaro RJ, 1996, J MOL CELL CARDIOL, V28, P217; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; Thomas SA, 1999, CIRC RES, V85, P446, DOI 10.1161/01.RES.85.5.446; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Van Eyk JE, 1998, CIRC RES, V82, P261	37	203	214	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					488	491		10.1126/science.287.5452.488	http://dx.doi.org/10.1126/science.287.5452.488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642551				2022-12-28	WOS:000084929900049
J	Beecham, L				Beecham, L			GPs given better protection against violence	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					191	191						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634757				2022-12-28	WOS:000084860300065
J	Lear, CH; Elderfield, H; Wilson, PA				Lear, CH; Elderfield, H; Wilson, PA			Cenozoic deep-sea temperatures and global ice volumes from Mg/Ca in benthic foraminiferal calcite	SCIENCE			English	Article							SHEET DEVELOPMENT; MAGNESIUM; SEAWATER; OXYGEN; OCEAN; PALEOCEANOGRAPHY; CIRCULATION; TRANSITION; CARBONATE; PALEOGENE	A deep-sea temperature record for the past 50 million years has been produced from the magnesium/calcium ratio (Mg/Ca) in benthic foraminiferal calcite. The record is strikingly similar in form to the corresponding benthic oxygen isotope (delta(18)O) record and defines an overall cooling of about 12 degrees C in the deep oceans with four main cooling periods. Used in conjunction with the benthic delta(18)O record, the magnesium temperature record indicates that the first major accumulation of Antarctic ice occurred rapidly in the earliest Oligocene (34 million years ago) and was not accompanied by a decrease in deep-sea temperatures.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Lear, CH (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.		Lear, Caroline/D-2582-2009	Wilson, Paul/0000-0001-6425-8906; Lear, Caroline/0000-0002-7533-4430				BARKER PF, 1988, P ODP INIT REP, V113, P89, DOI DOI 10.2973/ODP.PROC.IR.113.106.1988; BARTEK LR, 1992, EOCENE OLIGOCENE CLI, P131; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Browning JV, 1996, GEOLOGY, V24, P639, DOI 10.1130/0091-7613(1996)024<0639:GIOLTM>2.3.CO;2; BURTON EA, 1991, GEOCHIM COSMOCHIM AC, V55, P777, DOI 10.1016/0016-7037(91)90341-2; Drever J., 1988, CHEM CYCLES EVOLUTIO, P17; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; EHRMANN WU, 1992, PALAEOGEOGR PALAEOCL, V93, P85, DOI 10.1016/0031-0182(92)90185-8; Elderfield H, 1996, EARTH PLANET SC LETT, V142, P409, DOI 10.1016/0012-821X(96)00105-7; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; FLOWER BP, 1995, PALEOCEANOGRAPHY, V10, P1095, DOI 10.1029/95PA02022; Gieskes J.M., 1983, CHEM OCEANOGR, V8, P221, DOI 10.1016/S0012-821X(01)00496-4; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hartley G, 1996, GEOCHIM COSMOCHIM AC, V60, P315, DOI 10.1016/0016-7037(95)00388-6; Hastings DW, 1998, PALEOCEANOGRAPHY, V13, P161, DOI 10.1029/97PA03147; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; HINE AC, 1999, EOS, V80, P521; HSU KJ, 1984, INITIAL REP DEEP SEA, V73, P187; KATZ A, 1973, GEOCHIM COSMOCHIM AC, V37, P1563, DOI 10.1016/0016-7037(73)90091-4; Kennett J.P., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P937; KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; KOIZUMI I, 1990, PALAEOGEOGR PALAEOCL, V77, P181, DOI 10.1016/0031-0182(90)90175-7; MARTIN PA, 1998, 6 INT C PAL LISB 23; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; MATTHEWS RK, 1980, GEOLOGY, V8, P501, DOI 10.1130/0091-7613(1980)8<501:TORAGS>2.0.CO;2; MAYER L, 1985, INITIAL REP DEEP SEA, V85, P137; MCGOWRAN B, 1989, GEOLOGY, V17, P857, DOI 10.1130/0091-7613(1989)017<0857:SBITEO>2.3.CO;2; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; Prothero D.R., 1994, EOCENE OLIGOCENE TRA; Rosenthal Y, 1997, GEOCHIM COSMOCHIM AC, V61, P3633, DOI 10.1016/S0016-7037(97)00181-6; Shackleton N.J., 1974, Colloques int Cent natn Res Scient, VNo. 219,1974, P203; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; SHACKLETON NJ, 1986, PALAEOGEOGR PALAEOCL, V57, P91, DOI 10.1016/0031-0182(86)90008-8; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; SHACKLETON NJ, 1995, P OCEAN DRILL PROGRA, V154, P153; Thomas Ellen, 1992, P245; Thomas Ellen, 1992, Antarctic Research Series, V56, P141; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; Wolfe J.A., 1985, GEOPHYS MONOGR SER, V32, P357, DOI DOI 10.1029/GM032P0357; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	45	798	831	4	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					269	272		10.1126/science.287.5451.269	http://dx.doi.org/10.1126/science.287.5451.269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634774				2022-12-28	WOS:000084769600029
J	Gottfried, K				Gottfried, K			Sowing nuclear misconceptions	NATURE			English	Editorial Material									Cornell Univ, Nucl Studies Lab, Ithaca, NY 14853 USA	Cornell University	Gottfried, K (corresponding author), Cornell Univ, Nucl Studies Lab, Ithaca, NY 14853 USA.							DRELL S, 1995, JSR953200 MITRE CORP; JOHNSON K, 1996, SAND95751UCUC700; KIDDER R, 1987, UCRL53820; Kidder RE, 1997, NATURE, V386, P645, DOI 10.1038/386645a0; LEDOGAR SJ, 1999, COMMUNICATION   1007; Mikhailov V.N., 1999, CATALOG WORLDWIDE NU, P113; Perkovich G., 1999, INDIAS NUCL BOMB IMP; Richards PG, 1997, NATURE, V389, P781, DOI 10.1038/39720; Wallace T. C., 1998, SEISMOL RES LETT, V69, P386	9	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					131	133		10.1038/35003046	http://dx.doi.org/10.1038/35003046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646577				2022-12-28	WOS:000084835300022
J	Orentlicher, D; Caplan, A				Orentlicher, D; Caplan, A			The Pain Relief Promotion Act of 1999 - A serious threat to palliative care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSISTED SUICIDE; SUPREME-COURT	Recent educational efforts in the US medical community have begun to address the critical issue bf palliative care for terminally ill patients. However, a newly introduced bill in; Congress, the Pain Relief Promotion Act of 1999 (PRPA), could dramatically hinder these efforts if enacted. The act criminally punishes the use of controlled substances to cause-or assist in causing-a patient's death. The primary purposes of PRPA are to override the physician-assisted suicide law currently in effect in Oregon and prohibit other states from enacting similar laws, The act also includes valuable provisions for better research and education in palliative care, but the benefits of those provisions are outweighed by the punitive sections of the act. Under PRPA, the quality of palliative care in the United States could be compromised when physicians, fearing criminal prosecution, err on the side of caution rather than risk their patients' deaths by using highly aggressive pain treatments. Furthermore,PRPA would put Drug Enforcement Administration officials, who have no medical expertise, in the position of regulating medical decisions. The act also would interfere with individual states' long-standing authority over medical practice. Finally, PRPA would discourage physicians from engaging in experimentation and innovation in palliative care, again out of concern for crossing the line between relief of suffering and physician-assisted suicide. Other bills have been introduced that go much further than PRPA to encourage palliative care, without its problematic provisions. Regardless of the controversy surrounding physician-assisted suicide in the United States, the need for quality end-of-life care will be far better sewed if Congress enacts one of these bills rather than PRPA.	Indiana Univ, Sch Law, Ctr Law & Hlth, Indianapolis, IN 46202 USA; Univ Penn Hlth Syst, Ctr Bioeth, Philadelphia, PA USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Pennsylvania Medicine	Orentlicher, D (corresponding author), Indiana Univ, Sch Law, Ctr Law & Hlth, 735 W New York St, Indianapolis, IN 46202 USA.							Alpers A, 1998, J LAW MED ETHICS, V26, P308, DOI 10.1111/j.1748-720X.1998.tb01678.x; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; *BNA, 1999, BNA HLTH LAW RE 0624, V8, P1027; Brody H, 1998, J Palliat Med, V1, P329, DOI 10.1089/jpm.1998.1.329; Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Fohr S A, 1998, J Palliat Med, V1, P315, DOI 10.1089/jpm.1998.1.315; IGLEHART JK, 1992, NEW ENGL J MED, V326, P962, DOI 10.1056/NEJM199204023261426; Johnson SH, 1996, J LAW MED ETHICS, V24, P319, DOI 10.1111/j.1748-720X.1996.tb01874.x; JORANSON DE, 1994, PSYCHIAT PRACTICE FI, P173; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Meisel A, 1999, ARCH INTERN MED, V159, P1089, DOI 10.1001/archinte.159.10.1089; Noble Holcomb B, 1999, N Y Times Web, pA13; Orentlicher D, 1997, NEW ENGL J MED, V337, P1236, DOI 10.1056/NEJM199710233371713; Quill T E, 1998, J Palliat Med, V1, P333, DOI 10.1089/jpm.1998.1.333	14	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					255	258		10.1001/jama.283.2.255	http://dx.doi.org/10.1001/jama.283.2.255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634344				2022-12-28	WOS:000084661400034
J	Bernhard, JM; Buck, KR; Farmer, MA; Bowser, SS				Bernhard, JM; Buck, KR; Farmer, MA; Bowser, SS			The Santa Barbara Basin is a symbiosis oasis	NATURE			English	Article							SEDIMENTS; SEA; HYPOTHESIS; DIVERSITY; BACTERIA; PATTERNS; PROTOZOA; WATER	It is generally agreed that the origin and initial diversification of Eucarya occurred in the late Archaean or Proterozoic Eons when atmospheric oxygen levels were low(1) and the risk of DNA damage due to ultraviolet radiation was high(2). Because deep water provides refuge against ultraviolet radiation(3) and early eukaryotes may have been aerotolerant anaerobes(1,4,5), deep-water dysoxic environments are likely settings for primeval eukaryotic diversification. Fossil evidence shows that deep-sea microbial mats, possibly of sulphur bacteria similar to Beggiatoa, existed during that time(6). Here we report on the eukaryotic community of a modern analogue, the Santa Barbara Basin (California, USA). The Beggiatoa mats of these severely dysoxic and sulphidic sediments support a surprisingly abundant protistan and metazoan meiofaunal community, most members of which harbour prokaryotic symbionts, Many of these taxa are new to science, and both microaerophilic and anaerobic taxa appear to be represented. Compared with nearby aerated sites, the Santa Barbara Basin is a 'symbiosis oasis' offering a new source of organisms for testing symbiosis hypotheses of eukaryogenesis.	Univ S Carolina, Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC 29208 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Monterey Bay Aquarium Research Institute; University System of Georgia; University of Georgia; State University of New York (SUNY) System; Wadsworth Center	Bernhard, JM (corresponding author), Univ S Carolina, Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC 29208 USA.		Bernhard, Joan/M-3260-2013	Bernhard, Joan/0000-0003-2121-625X				ALONGI DM, 1987, DEEP-SEA RES, V34, P1245, DOI 10.1016/0198-0149(87)90074-4; ANDERSON OR, 1992, SYMBIOSIS, V12, P237; Baldauf J. G., 1995, P OC DRILL PROGR S 2, V146; Bernard C, 1995, MAR ECOL PROG SER, V128, P171, DOI 10.3354/meps128171; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; Bernhard Joan M., 1996, Revue de Paleobiologie, V15, P261; BROENKOW WW, 1969, LIMNOL OCEANOGR, V14, P450, DOI 10.4319/lo.1969.14.3.0450; Buck KR, 1998, CAH BIOL MAR, V39, P333; Cockell CS, 1998, J THEOR BIOL, V193, P717, DOI 10.1006/jtbi.1998.0738; Desbruyeres D, 1998, DEEP-SEA RES PT II, V45, P383, DOI 10.1016/S0967-0645(97)00083-0; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Epstein SS, 1995, AQUAT MICROB ECOL, V9, P219, DOI 10.3354/ame009219; Esteban G, 1995, ARCH PROTISTENKD, V146, P137; FENCHEL T, 1995, OPHELIA, V43, P45, DOI 10.1080/00785326.1995.10430576; FENCHEL T, 1995, ECOLOGY EVOLUTION AN; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KNOLL AH, 1995, EFFECTS PAST GLOBAL, P21; Kuwabara JS, 1999, GEOCHIM COSMOCHIM AC, V63, P2199, DOI 10.1016/S0016-7037(99)00084-8; Lee J.J., 1991, BIOL FORAMINIFERA; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; OTT JA, 1991, PSZNI MAR ECOL, V12, P261; Reimers CE, 1996, GEOCHIM COSMOCHIM AC, V60, P4037, DOI 10.1016/S0016-7037(96)00231-1; Richardson SL, 1999, SYMBIOSIS, V26, P299; Saphonov MV, 1997, OPHELIA, V47, P215, DOI 10.1080/00785236.1997.10428672; Simonson BM, 1999, PALAIOS, V14, P13, DOI 10.2307/3515358; Simpson AGB, 1997, ARCH PROTISTENKD, V147, P213, DOI 10.1016/S0003-9365(97)80049-8; SOUTAR A, 1977, GEOL SOC AM BULL, V88, P1161, DOI 10.1130/0016-7606(1977)88<1161:SACPIT>2.0.CO;2; STARINK M, 1994, APPL ENVIRON MICROB, V60, P167, DOI 10.1128/AEM.60.1.167-173.1994; STOLZ JF, 1986, NATURE, V321, P849, DOI 10.1038/321849a0	30	183	196	1	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					77	80		10.1038/47476	http://dx.doi.org/10.1038/47476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638755				2022-12-28	WOS:000084687400045
J	di Bernardo, D; Murray, A				di Bernardo, D; Murray, A			Medical physics - Explaining the T-wave shape in the ECG	NATURE			English	Article							REPOLARIZATION; MODEL		Newcastle Univ, Freeman Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	di Bernardo, D (corresponding author), Newcastle Univ, Freeman Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.		di Bernardo, Diego/AAF-5881-2021; di Bernardo, Diego/I-9440-2012	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Murray, Alan/0000-0003-2621-4632				BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; CONOVER MB, 1992, UNDERSTANDING ELECTR; COWAN JC, 1988, BRIT HEART J, V60, P424; FRANZ MR, 1987, CIRCULATION, V75, P379, DOI 10.1161/01.CIR.75.2.379; GELERNTER HL, 1964, BIOPHYS J, V4, P285, DOI 10.1016/S0006-3495(64)86783-7; HIGUCHI T, 1984, AM HEART J, V108, P290, DOI 10.1016/0002-8703(84)90614-8; MERRI M, 1989, CIRCULATION, V80, P1301, DOI 10.1161/01.CIR.80.5.1301; MURRAY A, 1994, BRIT HEART J, V71, P386; NOBLE D, 1978, CARDIOVASC RES, V12, P13, DOI 10.1093/cvr/12.1.13; SIMMS HD, 1995, J CARDIOVASC ELECTR, V6, P522, DOI 10.1111/j.1540-8167.1995.tb00425.x; WOHLFART B, 1987, EUR HEART J, V8, P409, DOI 10.1093/oxfordjournals.eurheartj.a062295; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928	12	38	38	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					40	40		10.1038/47409	http://dx.doi.org/10.1038/47409			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638744	Bronze			2022-12-28	WOS:000084687400034
J	Shahar, Y				Shahar, Y			Dimension of time in illness: An objective view	ANNALS OF INTERNAL MEDICINE			English	Article							TEMPORAL ABSTRACTION; FRAMEWORK	It is almost impossible to try to represent acid analyze clinical data in the absence of a temporal dimension. The temporal aspect is especially important when automated decision support is used for patient care over substantial periods. This paper emphasizes the crucial role that tasks of temporal reasoning and temporal maintenance play in modern medical information and decision support systems; it also discusses the implications of providing automated support to clinicians who must perform such tasks as part of broader clinical tasks (for example, monitoring and therapy). Temporal reasoning tasks mainly involve intelligent analysis of time-oriented clinical data, and temporal maintenance tasks focus on effective storage and retrieval of these data. Both types of tasks, however, are highly relevant for such applications as patient monitoring, proper use of therapeutic guidelines, assessment of the quality of guideline use, and visualization and exploration of time-oriented biomedical data. Scientists in medical informatics should view the integration of these two areas as a major research and development goal. This paper demonstrates one approach to integration by presenting the concept of a temporal mediator, which combines temporal reasoning and temporal maintenance. Use of the temporal mediator in several clinical tasks is also presented and discussed.	Stanford Univ, Stanford Med Informat, Stanford, CA 94305 USA	Stanford University	Shahar, Y (corresponding author), Stanford Univ, Stanford Med Informat, Med Sch Off Bldg X215,251 Campus Dr, Stanford, CA 94305 USA.	shahar@smi.stanford.edu	Shahar, Yuval/P-5185-2019	Shahar, Yuval/0000-0003-0328-2333	NLM NIH HHS [LM06245] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R29LM006245] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Cousins S. B., 1991, Artificial Intelligence in Medicine, V3, P341, DOI 10.1016/0933-3657(91)90005-V; DAS AK, 1994, METHOD INFORM MED, V33, P358; Keravnou E. T., 1990, Artificial Intelligence in Medicine, V2, P239, DOI 10.1016/0933-3657(90)90001-8; Musen MA, 1996, J AM MED INFORM ASSN, V3, P367, DOI 10.1136/jamia.1996.97084511; Nguyen JH, 1999, J INTELL INF SYST, V13, P121, DOI 10.1023/A:1008711006591; Russ T. A., 1989, Proceedings: The Thirteenth Annual Symposium on Computer Applications in Medical Care (Cat. No.89TH0286-5), P38; Shahar Y, 1999, J AM MED INFORM ASSN, V6, P494, DOI 10.1136/jamia.1999.0060494; Shahar Y, 1996, ARTIF INTELL MED, V8, P267, DOI 10.1016/0933-3657(95)00036-4; Shahar Y, 1998, ANN MATH ARTIF INTEL, V22, P159, DOI 10.1023/A:1018998326167; Shahar Y, 1997, ARTIF INTELL, V90, P79, DOI 10.1016/S0004-3702(96)00025-2; Shahar Y, 1998, ARTIF INTELL MED, V14, P29, DOI 10.1016/S0933-3657(98)00015-3; SHAHAR Y, TOPICS HLTH INFORMAT, V20, P15; Snodgrass R., 1986, IEEE COMPUT, V19, P3542; [No title captured]; [No title captured]	15	20	20	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					45	53		10.7326/0003-4819-132-1-200001040-00008	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627251				2022-12-28	WOS:000084518600007
J	Lutter, R				Lutter, R			Policy forum: Food safety - Food irradiation - The neglected solution to food-borne illness	SCIENCE			English	Article									Amer Enterprise Inst Publ Policy Res, Brookings Joint Ctr Regulatory Studies, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Lutter, R (corresponding author), Amer Enterprise Inst Publ Policy Res, Brookings Joint Ctr Regulatory Studies, 1150 17th St NW, Washington, DC 20036 USA.	rlutter@aei.org						ALTEKURSE S, 1997, EMERG INFECT DIS, V3, P3; BUZBY JC, 1996, 741 USDA; CARLTON J, 1999, WALL STREET J   0715, pA1; *CONS UN, 1998, TMD94002 NAT ORG PRO; Fox JA, 1998, RADIAT PHYS CHEM, V52, P63, DOI 10.1016/S0969-806X(98)00075-9; LUTTER R, 1999, AEI BROOKINGS JOINT, V992; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; OSTERHOLM M, 1997, US TODAY        1104, pD4; *PUBL VOIC FOOD HL, 1998, ID ADDR OV CONS CON; *US CDC, 1999, MMWR-MORBID MORTAL W, V48, P189; *US GEN ACC OFF, 1996, GAORCED9696; *USDA, 1999, IRR MEAT MEAT PROD R; *WHO, 1997, WHO68; WHO, 1981, WHO TECH REP SER, V659; WILKINSON VM, 1996, FOOD IRRADIATION; 1994, FED REG, V164, P43838; 1997, FED REG, V232, P64107; 1999, FED REG, V36, P9089; 1996, MENDOCINO ENV C 0922; 1990, FED REG, V85, P18539	20	27	32	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	1999	286	5448					2275	2276		10.1126/science.286.5448.2275	http://dx.doi.org/10.1126/science.286.5448.2275			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266UK	10636787				2022-12-28	WOS:000084318500031
J	Duffy, SJ; Gokce, N; Holbrook, M; Huang, A; Frei, B; Keaney, JF; Vita, JA				Duffy, SJ; Gokce, N; Holbrook, M; Huang, A; Frei, B; Keaney, JF; Vita, JA			Treatment of hypertension with ascorbic acid	LANCET			English	Article								In a randomised, double-blind, placebo-controlled study we showed that treatment of hypertensive patients with ascorbic acid lowers blood pressure. Further studies of ascorbic add to treat hypertension, with clinical endpoints, are warranted.	Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA	Boston University; Boston University; Oregon State University	Vita, JA (corresponding author), Boston Med Ctr, 88 E Newton St, Boston, MA 02118 USA.			Vita, Joseph/0000-0001-5607-1797; Gokce, Noyan/0000-0003-2920-3445; Keaney, John/0000-0002-0866-1837	NHLBI NIH HHS [HL59346, HL55993, HL53398] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055993, R01HL053398, R01HL059346] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ENSTROM JE, 1992, EPIDEMIOLOGY, V3, P194, DOI 10.1097/00001648-199205000-00003; Galley HF, 1997, CLIN SCI, V92, P361, DOI 10.1042/cs0920361; NAKAZONO K, 1991, P NATL ACAD SCI USA, V88, P10045, DOI 10.1073/pnas.88.22.10045; SALONEN JT, 1988, AM J CLIN NUTR, V48, P1226, DOI 10.1093/ajcn/48.5.1226; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222	5	236	245	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2048	2049		10.1016/S0140-6736(99)04410-4	http://dx.doi.org/10.1016/S0140-6736(99)04410-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636373	hybrid			2022-12-28	WOS:000084183300016
J	Moreno, CG				Moreno, CG			WHO recommendations put women first	LANCET			English	Editorial Material									WHO, Global Program Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland	World Health Organization	Moreno, CG (corresponding author), WHO, Global Program Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland.		Moreno, Claudia/GRJ-1036-2022						0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2075	2076		10.1016/S0140-6736(05)76813-6	http://dx.doi.org/10.1016/S0140-6736(05)76813-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636388				2022-12-28	WOS:000084183300048
J	Horton, B				Horton, B			From bench to bedside ... research makes the translational transition	NATURE			English	Article																			0	14	15	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					213	215		10.1038/46097	http://dx.doi.org/10.1038/46097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647017				2022-12-28	WOS:000083716400058
J	Shirayama, M; Toth, A; Galova, M; Nasmyth, K				Shirayama, M; Toth, A; Galova, M; Nasmyth, K			APC(Cdc20) promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; S-PHASE; COMPLEX; PROTEOLYSIS; TRANSITION; PROTEIN; KINASE; APC; UBIQUITINATION	Ubiquitin-mediated proteolysis due to the anaphase-promoting complex/cyclosome (APC/C) is essential for separation of sister chromatids, requiring degradation of the anaphase inhibitor Pds1, and for exit from mitosis, requiring inactivation of cyclin B Cdk1 kinases(1). Exit from mitosis in yeast involves accumulation of the cyclin kinase inhibitor Sic1 as well as cyclin proteolysis mediated by APC/C bound by the activating subunit Cdh1/Hct1 (ApC(Cdh1))(2,3). Both processes require the Cdc(14) phosphatase, whose release from the nucleolus during anaphase causes dephosphorylation and thereby activation of Cdh1 and accumulation of another protein, Sic1 (refs 4-7). We do not know what determines the release of Cdc14 and enables it to promote Cdk1 inactivation, but it is known to be dependent on APC/C bound by Cdc20 (ApC(Cdc20)) (ref. 4). Here we show that ApC(Cdc20) allows activation of Cdc 14 and promotes exit from mitosis by mediating proteolysis of Pds1 and the S phase cyclin Clb5 in the yeast Saccharomyces cerevisiae. Degradation of Pds1 is necessary for release of Cdc14 from the nucleolus, whereas degradation of Clb5 is crucial if Cdc14 is to overwhelm Cdk1 and activate its foes (Cdh1 and Sic1). Remarkably, cells lacking both Pds1 and Clb5 can proliferate in the complete absence of Cdc20.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Toth, Attila/C-9624-2013	Toth, Attila/0000-0001-5744-3847; Nasmyth, Kim/0000-0001-7030-4403				BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; DEBEUS E, 1994, J CELL BIOL, V127, P1799, DOI 10.1083/jcb.127.6.1799; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Novak B, 1999, J THEOR BIOL, V199, P223, DOI 10.1006/jtbi.1999.0956; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	288	292	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					203	207		10.1038/46080	http://dx.doi.org/10.1038/46080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647015				2022-12-28	WOS:000083716400056
J	Osterbacka, R; An, CP; Jiang, XM; Vardeny, ZV				Osterbacka, R; An, CP; Jiang, XM; Vardeny, ZV			Two-dimensional electronic excitations in self-assembled conjugated polymer nanocrystals	SCIENCE			English	Article							ORGANIC LINEAR CONDUCTORS; ALPHA-SEXITHIOPHENE; CHARGE-TRANSFER; OPTICAL-ABSORPTION; INFRARED ACTIVITY; SOLID-STATE; THIN-FILMS; POLYACETYLENE; SPECTROSCOPY; POLY(3-ALKYLTHIOPHENES)	Several spectroscopic methods were applied to study the characteristic properties of the electronic excitations in thin films of regioregular and regiorandom polythiophene polymers. In the regioregular polymers, which form two-dimensional lamellar structures, increased interchain coupling strongly influences the traditional one-dimensional electronic properties of the polymer chains. The photogenerated charge excitations (polarons) show two-dimensional delocalization that results in a relatively small polaronic energy, multiple absorption bands in the gap where the Lowest energy band becomes dominant, and associated infrared active vibrations with reverse absorption bands caused by electron-vibration interferences. The relatively weak absorption bands of the delocalized polaron in the visible and near-infrared spectral ranges may help to achieve Laser action in nanocrystalline polymer devices using current injection.	Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Vardeny, ZV (corresponding author), Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA.		Österbacka, Ronald/I-9161-2012; Österbacka, Ronald/N-7773-2019	Österbacka, Ronald/0000-0003-0656-2592; Österbacka, Ronald/0000-0003-0656-2592				BAERISWYL D, 1991, SYNTHETIC MET, V41, P3585; Bao Z, 1996, APPL PHYS LETT, V69, P4108, DOI 10.1063/1.117834; BISCARINI F, 1995, PHYS REV B, V52, P14868, DOI 10.1103/PhysRevB.52.14868; BLACKMAN JA, 1993, PHYS REV B, V47, P15437, DOI 10.1103/PhysRevB.47.15437; BLINOV LM, 1995, CHEM PHYS LETT, V232, P401, DOI 10.1016/0009-2614(94)01368-6; CHEN TA, 1995, J AM CHEM SOC, V117, P233, DOI 10.1021/ja00106a027; DEUSSEN M, 1993, SYNTHETIC MET, V54, P49, DOI 10.1016/0379-6779(93)91044-3; Dodabalapur A, 1998, APPL PHYS LETT, V73, P142, DOI 10.1063/1.121736; EHRENFREUND E, 1987, PHYS REV B, V36, P1535, DOI 10.1103/PhysRevB.36.1535; EMIN D, 1986, PHYS REV B, V33, P3973, DOI 10.1103/PhysRevB.33.3973; FESSER K, 1983, PHYS REV B, V27, P4804, DOI 10.1103/PhysRevB.27.4804; Fichou D, 1996, ADV MATER, V8, P500, DOI 10.1002/adma.19960080610; GARSTEIN YN, 1989, SYNTHETIC MET, V28, pD501; GARSTEIN YN, 1987, SOLID STATE COMMUN, V62, P213; GARSTEIN YN, 1987, J MOL ELECTRON, V3, P163; GARSTEIN YN, 1986, SOLID STATE COMMUN, V60, P105; GARTSTEIN YN, 1991, SYNTHETIC MET, V41, P3649; HARRISON MG, 1994, SYNTHETIC MET, V67, P215, DOI 10.1016/0379-6779(94)90044-2; HOROVITZ B, 1982, SOLID STATE COMMUN, V41, P729, DOI 10.1016/0038-1098(82)91126-7; HOROVITZ B, 1978, PHYS REV B, V17, P2796, DOI 10.1103/PhysRevB.17.2796; Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U; Lane PA, 1996, CHEM PHYS, V210, P229, DOI 10.1016/0301-0104(96)00075-4; Lane PA, 1998, CHEM PHYS, V227, P57, DOI 10.1016/S0301-0104(97)00303-0; Lanzani G, 1997, PHYS REV LETT, V79, P3066, DOI 10.1103/PhysRevLett.79.3066; Liess M, 1997, PHYS REV B, V56, P15712, DOI 10.1103/PhysRevB.56.15712; McCullough RD, 1998, ADV MATER, V10, P93, DOI 10.1002/(SICI)1521-4095(199801)10:2<93::AID-ADMA93>3.0.CO;2-F; MIZES HA, 1994, PHYS REV B, V50, P11243, DOI 10.1103/PhysRevB.50.11243; MIZES HA, 1993, PHYS REV LETT, V70, P1505, DOI 10.1103/PhysRevLett.70.1505; PENG XZ, 1990, APPL PHYS LETT, V57, P2013, DOI 10.1063/1.103994; PORZIO W, 1993, ACTA POLYM, V44, P266, DOI 10.1002/actp.1993.010440602; Prosa TJ, 1996, MACROMOLECULES, V29, P3654, DOI 10.1021/ma951510u; RICE MJ, 1976, PHYS REV LETT, V37, P36, DOI 10.1103/PhysRevLett.37.36; SEBASTIAN L, 1981, PHYS REV LETT, V46, P1156, DOI 10.1103/PhysRevLett.46.1156; SERBET B, 1993, ADV MATER, V5, P461; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741; VARDENY ZV, 1997, HDB CONDUCTING POLYM, pCH22; VOGL P, 1989, PHYS REV LETT, V62, P2012, DOI 10.1103/PhysRevLett.62.2012	38	588	597	2	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					839	842		10.1126/science.287.5454.839	http://dx.doi.org/10.1126/science.287.5454.839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657294				2022-12-28	WOS:000085136400041
J	Mooren, FC; Lerch, MM; Ullerich, H; Burger, H; Domschke, W				Mooren, FC; Lerch, MM; Ullerich, H; Burger, H; Domschke, W			Drug points - Systemic granulomatous disease after intravesical BCG instillation	BRITISH MEDICAL JOURNAL			English	Article							CALMETTE-GUERIN; BLADDER		Univ Munster, Dept Med B, D-4400 Munster, Germany; Univ Munster, Dept Pathol, D-4400 Munster, Germany	University of Munster; University of Munster	Mooren, FC (corresponding author), Univ Munster, Dept Med B, D-4400 Munster, Germany.		Lerch, Markus M./E-2206-2016	Lerch, Markus M./0000-0002-9643-8263				LAMM DL, 1991, NEW ENGL J MED, V325, P1205, DOI 10.1056/NEJM199110243251703; LAMM DL, 1992, J UROLOGY, V147, P596, DOI 10.1016/S0022-5347(17)37316-0; Lotte A, 1984, Adv Tuberc Res, V21, P107; Zumla A, 1998, BRIT MED J, V316, P1962, DOI 10.1136/bmj.316.7149.1962	4	9	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					219	219		10.1136/bmj.320.7229.219	http://dx.doi.org/10.1136/bmj.320.7229.219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642231	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000085029600025
J	Morin, K; Miles, SH				Morin, K; Miles, SH		Ethics Human Rights Comm	The health effects of economic sanctions and embargoes: The role of health professionals	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICINE; IMPACT; IRAQ	As a widely used tool of foreign policy, economic sanctions take many forms. They include mandating trade restrictions (for example, limiting imports from or exports to a sanctioned nation), freezing bank accounts, limiting international travel to and from an area, imposing additional tariffs, and exerting other pressures that are intended to slow key economic activities. Since the end of the Cold War, as the global market has expanded, many countries and the United Nations have increasingly used economic sanctions instead of military intervention to compel nations to end civil or extraterritorial war or to reduce abuse of human rights. Similarly, the United States has attempted to influence international governments' domestic policies by using other economic means, such as relating "most favored nation" trading status to a country's human rights record or prohibiting the import of goods from countries in which illegal child labor is widespread. Repercussions from these measures influence a country's economic development and, therefore, can also affect the overall welfare of a nation's population. In contrast to war's easily observable casualties, the apparently nonviolent consequences of economic intervention seem like an acceptable alternative. However, recent reports suggest that economic sanctions can seriously harm the health of persons who live in targeted nations. For this reason, the American College of Physicians-American Society of Internal Medicine has undertaken this examination of physicians' roles in addressing the health effects of economic sanctions.	Care of Synder L, Amer Coll Phys, Ctr Eth & Professionalism, Amer Soc Internal Med, Philadelphia, PA 19106 USA	American College of Physicians	Morin, K (corresponding author), Care of Synder L, Amer Coll Phys, Ctr Eth & Professionalism, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							*AM ASS WORLD HLTH, 1997, DEN FOOD MED; *AM COLL PHYS, 1998, ETH MAN, V128, P576; [Anonymous], 1986, 1 INT C HLTH PROM OT; [Anonymous], 1966, INT COVENANT EC SOCI; [Anonymous], 1948, GEN ASSEMBLY RESOLUT; ASCHERIO A, 1992, NEW ENGL J MED, V327, P931, DOI 10.1056/NEJM199209243271306; BERN C, 1995, NEW ENGL J MED, V333, P1176; BOUTROSGHALI B, 1995, 50 ANN UN NAT GEN AS; CASSEL C, 1982, ANN INTERN MED, V97, P426, DOI 10.7326/0003-4819-97-3-426; CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Cole TB, 1998, JAMA-J AM MED ASSOC, V280, P468, DOI 10.1001/jama.280.5.468; COTTON P, 1993, JAMA-J AM MED ASSOC, V270, P421, DOI 10.1001/jama.270.4.421; Doswald-Beck L, 1993, INT REV RED CROSS, V293, P94; Eisenberg L, 1997, NEW ENGL J MED, V336, P1248, DOI 10.1056/NEJM199704243361711; FOEGE WH, 1991, JAMA-J AM MED ASSOC, V266, P702, DOI 10.1001/jama.266.5.702; Garfield R, 1997, AM J PUBLIC HEALTH, V87, P15, DOI 10.2105/AJPH.87.1.15; Garfield R, 1997, BMJ-BRIT MED J, V315, P1474, DOI 10.1136/bmj.315.7120.1474; Garfield R, 1995, B NEW YORK ACAD MED, V72, P454; GRODEN MA, 1976, JAMA-J AM MED ASSOC, V276, P1682; Hufbauer Gary C., 2009, EC SANCTIONS RECONSI, VThird; Kirkpatrick AF, 1997, CAN MED ASSOC J, V157, P281; Leary Virginia A, 1994, Health Hum Rights, V1, P24, DOI 10.2307/4065261; LOPEZ GA, 1997, INT J HUMAN RIGHTS, V1, P1; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Pellegrino ED, 1997, ANN INTERN MED, V127, P307, DOI 10.7326/0003-4819-127-4-199708150-00010; ZAIDI S, 1995, LANCET, V346, P1485, DOI 10.1016/S0140-6736(95)92499-X; 1977, DIPL C REAFF DEV INT; 1991, N ENGL J MED, V325, P977; 1995, N NEGL J MED, V333, P1176; 1993, INVESTING HLTH; 1949, RELATIVE PROTECTION	31	21	21	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					158	161		10.7326/0003-4819-132-2-200001180-00013	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644279				2022-12-28	WOS:000084852300011
J	Macilwain, C				Macilwain, C			Bell Labs win superconductivity patent	NATURE			English	News Item																			0	15	15	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					121	122		10.1038/35003008	http://dx.doi.org/10.1038/35003008			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646568	Bronze			2022-12-28	WOS:000084835300007
J	Meigs, JB; Mittleman, MA; Nathan, DM; Tofler, GH; Singer, DE; Murphy-Sheehy, PM; Lipinsky, I; D'Angostino, R; Wilson, PWF				Meigs, JB; Mittleman, MA; Nathan, DM; Tofler, GH; Singer, DE; Murphy-Sheehy, PM; Lipinsky, I; D'Angostino, R; Wilson, PWF			Hyperinsulinemia, hyperglucemia, and impaired hemostasis - The Framingham offspring study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; INSULIN-RESISTANCE SYNDROME; CORONARY-HEART-DISEASE; LINKED IMMUNOSORBENT-ASSAY; VON-WILLEBRAND-FACTOR; RISK FACTOR; VASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; OBESE SUBJECTS; MYOCARDIAL-INFARCTION	Context Increased risk for cardiovascular disease in persons with glucose intolerance (impaired glucose tolerance and type 2 diabetes mellitus) is not fully explained by concomitant elevations in traditional atherosclerosis risk factors. Hyperinsulinemia associated with glucose intolerance may increase risk directly, or its effect could be mediated through impaired hemostatic function. Objective To evaluate associations between fasting insulin levels and hemostatic factors in subjects with normal and impaired glucose homeostasis. Design Cross-sectional analysis conducted between January 1991 and June 1995. Setting The population-based Framingham Offspring Study. Subjects A total of 1331 men and 1631 women aged 26 to 82 years, without diagnosed diabetes or cardiovascular disease and classified as having normal glucose tolerance (80.2%) or glucose intolerance (impaired glucose tolerance and impaired fasting glucose combined, 15.2%; previously undiagnosed diabetes, 4.7%) using an oral glucose tolerance test. Main Outcome Measures Trends across quintiles of fasting insulin in levels of plasminogen activator inhibitor 1 (PAI-1) antigen, tissue-type plasminogen activator (tPA) antigen, von Willebrand factor (VWF) antigen, factor VII antigen, fibrinogen, and plasma viscosity. We stratified analyses by sex and glucose tolerance status and adjusted hemostatic factor levels for obesity, lipid levels, and traditional cardiovascular disease risk factors. Results Mean levels of all hemostatic factors (except for fibrinogen in men) increased across fasting insulin quintiles among subjects with normal glucose tolerance (P<.001 for trend). Levels of PAI-1 and tPA antigens, but not other hemostatic factors, were higher comparing subjects with glucose intolerance with those with normal glucose tolerance (P<.001). Among subjects with glucose intolerance, levels of PAI-1 and tPA antigen in men and women (P<.01 for trend) and VWF antigen in men (P<.05 for trend) increased significantly across insulin quintiles, but levels of factor VII antigen, fibrinogen, and plasma viscosity did not increase. Conclusions Elevated levels of fasting insulin are associated with impaired fibrinolysis and hypercoagulability in subjects with normal glucose tolerance. Hyperinsulinemia is associated primarily with impaired fibrinolysis in subjects with glucose intolerance. Excess risk for cardiovascular disease associated with hyperinsulinemia and glucose intolerance may be mediated in part by enhanced potential for acute thrombosis.	Massachusetts Gen Hosp, Gen Internal Med Unit S50 9, Div Gen Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Inst Prevent & Cardiovasc Dis, Cardiovasc Div,Beth Israel Deaconess Med Ctr, Boston, MA USA; Boston Univ, Dept Math, Stat & Consulting Unit, Boston, MA 02215 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Framingham Heart Dis Epidemiol Study, Framingham, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Boston University; Framingham Heart Study	Meigs, JB (corresponding author), Massachusetts Gen Hosp, Gen Internal Med Unit S50 9, Div Gen Med, Boston, MA 02114 USA.	jmeigs@partners.org	Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657; Mittleman, Murray/0000-0001-9788-7274	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048157] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38083, R01 HL48157] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; ALESSI MC, 1988, THROMB HAEMOSTASIS, V60, P491; Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; ANDERSON RL, 1995, AM J EPIDEMIOL, V142, P724, DOI 10.1093/aje/142.7.724; [Anonymous], 1985, ANN INTERN MED, V103, P1073, DOI 10.7326/0003-4819-103-6-1073; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; ASPLUNDCARLSON A, 1993, DIABETOLOGIA, V36, P817, DOI 10.1007/BF00400356; BarrettConnor E, 1997, DIABETES CARE, V20, P1620, DOI 10.2337/diacare.20.10.1620; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Calles-Escandon J, 1998, DIABETES, V47, P290, DOI 10.2337/diabetes.47.2.290; CIGOLINI M, 1994, ATHEROSCLEROSIS, V106, P139, DOI 10.1016/0021-9150(94)90119-8; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; CUPPLES LA, 1988, FRAMINGHAM STUDY EPI; DECLERCK PJ, 1988, BLOOD, V71, P220; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; DONAHUE RP, 1987, DIABETES, V36, P689, DOI 10.2337/diabetes.36.6.689; Eliasson M, 1997, DIABETES CARE, V20, P1252, DOI 10.2337/diacare.20.8.1252; ELIASSON M, 1994, METABOLISM, V43, P1579, DOI 10.1016/0026-0495(94)90020-5; Emanuele N, 1998, ARCH INTERN MED, V158, P2485, DOI 10.1001/archinte.158.22.2485; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FULLER JH, 1979, BMJ-BRIT MED J, V2, P964, DOI 10.1136/bmj.2.6196.964; GANDA OP, 1992, DIABETES CARE, V15, P1245, DOI 10.2337/diacare.15.10.1245; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; GRANT PJ, 1990, CLIN SCI, V79, P513, DOI 10.1042/cs0790513; Haffner SM, 1998, STROKE, V29, P1498, DOI 10.1161/01.STR.29.8.1498; HAFFNER SM, 1994, J CLIN ENDOCR METAB, V79, P1806, DOI 10.1210/jc.79.6.1806; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; JUHANVAGUE I, 1991, DIABETOLOGIA, V34, P457, DOI 10.1007/BF00403280; JUHANVAGUE I, 1993, ARTERIOSCLER THROMB, V13, P1865, DOI 10.1161/01.ATV.13.12.1865; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KNATTERUD GL, 1978, JAMA-J AM MED ASSOC, V240, P37, DOI 10.1001/jama.240.1.37; LATRON Y, 1991, ARTERIOSCLER THROMB, V11, P1821, DOI 10.1161/01.ATV.11.6.1821; Lindahl B, 1996, INT J EPIDEMIOL, V25, P291, DOI 10.1093/ije/25.2.291; Mansfield MW, 1996, CIRCULATION, V94, P2171, DOI 10.1161/01.CIR.94.9.2171; MCGILL JB, 1994, DIABETES, V43, P104, DOI 10.2337/diabetes.43.1.104; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MEDVESCEK M, 1990, FIBRINOLYSIS, V4, P89, DOI 10.1016/0268-9499(90)90371-P; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Missov RM, 1996, DIABETES CARE, V19, P157, DOI 10.2337/diacare.19.2.157; MORRISH NJ, 1990, DIABETOLOGIA, V33, P538, DOI 10.1007/BF00404141; MYKKANEN L, 1994, ARTERIOSCLER THROMB, V14, P1264, DOI 10.1161/01.ATV.14.8.1264; MYKKANEN L, 1997, DIABETES S1, V46, pA72; Nagi DK, 1996, DIABETIC MED, V13, P59, DOI 10.1002/(SICI)1096-9136(199601)13:1<59::AID-DIA2>3.0.CO;2-Z; NAGI DK, 1993, DIABETES CARE, V16, P621, DOI 10.2337/diacare.16.4.621; NATHAN DM, 1981, CLIN CHEM, V27, P1261; NORDT TK, 1994, CIRCULATION, V89, P321, DOI 10.1161/01.CIR.89.1.321; Pandolfi A, 1996, DIABETOLOGIA, V39, P1425, DOI 10.1007/s001250050594; PENNY WF, 1991, CIRCULATION, V83, P1630, DOI 10.1161/01.CIR.83.5.1630; Pyorala M, 1998, CIRCULATION, V98, P398, DOI 10.1161/01.CIR.98.5.398; RANBY M, 1986, CLIN CHEM, V32, P2160; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REWERS M, 1996, DIABETES S2, V45, pA52; RIDKER PM, 1994, LANCET, V343, P940, DOI 10.1016/S0140-6736(94)90064-7; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K., 1998, MODERN EPIDEMIOLOGY; SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284; SAS Institute Inc, 1989, SAS STAT US GUID, V2; Savage PJ, 1996, ANN INTERN MED, V124, P123, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00008; SCHNEIDER DJ, 1993, DIABETES, V42, P1, DOI 10.2337/diabetes.42.1.1; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SINGER DE, 1992, DIABETES, V41, P202, DOI 10.2337/diabetes.41.2.202; Sobel BE, 1999, CIRCULATION, V99, P2496, DOI 10.1161/01.CIR.99.19.2496; STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabetes Study Group, 1996, ANN INTERN MED, V124, P136; VAGUE P, 1986, METABOLISM, V35, P250, DOI 10.1016/0026-0495(86)90209-X; VERHEUGT FWA, 1987, AM J CARDIOL, V59, P1075, DOI 10.1016/0002-9149(87)90851-4; VUORINENMARKKOLA H, 1992, THROMB HAEMOSTASIS, V67, P117; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WINGARD DL, 1995, DIABETES CARE, V18, P1299, DOI 10.2337/diacare.18.9.1299; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	77	423	451	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					221	228		10.1001/jama.283.2.221	http://dx.doi.org/10.1001/jama.283.2.221			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634338	Bronze			2022-12-28	WOS:000084661400028
J	Somerville, C				Somerville, C			The twentieth century trajectory of plant biology	CELL			English	Review							ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; PLASMID; DNA; CELLS; TUMEFACIENS; REGULATORS; SEQUENCES; GROWTH; GENOME		Carnegie Inst Sci, Stanford, CA 94305 USA	Carnegie Institution for Science	Somerville, C (corresponding author), Carnegie Inst Sci, 290 Panama St, Stanford, CA 94305 USA.		Somerville, Christopher R/A-4048-2009	Somerville, Christopher R/0000-0003-4647-0094				ADDICOTT FT, 1998, DISCOVERIES PLANT BI, V1, P33; Allard R.W., 1960, S REPORT; [Anonymous], 1945, PHOTOSYNTHESIS RELAT; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Bawden FC, 1938, NATURE, V141, P513, DOI 10.1038/141513b0; BEEVERS H, 1974, PLANT PHYSIOL, V54, P437, DOI 10.1104/pp.54.4.437; BENSON AA, 1998, DISCOVERIES PLANT BI, V1, P197; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Bonner J, 1938, PLANT PHYSIOL, V13, P331, DOI 10.1104/pp.13.2.331; BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P662, DOI 10.1073/pnas.38.8.662; BRAKKE MK, 1988, ANNU REV PHYTOPATHOL, V26, P331, DOI 10.1146/annurev.py.26.090188.001555; BRAUN AC, 1958, P NATL ACAD SCI USA, V44, P344, DOI 10.1073/pnas.44.4.344; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; CHEN CM, 1998, DISCOVERIES PLANT BI, V1, P1; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; CLAUSEN J, 1940, CARNEGIE I WASH PUB, V520; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Creelman RA, 1997, PLANT CELL, V9, P1211, DOI 10.1105/tpc.9.7.1211; D'Agostino IB, 1999, CURR OPIN PLANT BIOL, V2, P359, DOI 10.1016/S1369-5266(99)00005-9; Darwin C., 1897, POWER MOVEMENT PLANT; DEISENHOFER J, 1991, ANNU REV CELL BIOL, V7, P1; EMERSON R. A., 1932, Proceedings 6th Int. Congr. Genet., V1, P141; FEDEROFF N, 1998, DISCOVERIES PLANT BI, V1, P89; FEDEROFF N, 1992, B MCCLINTOCKS IDEAS; FEDOROFF N, 1983, CELL, V35, P235, DOI 10.1016/0092-8674(83)90226-X; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Franssen HJ, 1998, CURR OPIN PLANT BIOL, V1, P384, DOI 10.1016/S1369-5266(98)80260-4; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Gaffron H., 1963, BACTERIAL PHOTOSYNTH, P3; GALSTON AW, 1974, PLANT PHYSIOL, V54, P427, DOI 10.1104/pp.54.4.427; GORDON MP, 1998, DISCOVERIES PLANT BI, V1, P111; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Hamner KC, 1938, BOT GAZ, V100, P388, DOI 10.1086/334793; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; Hill R, 1940, NATURE, V146, P61, DOI 10.1038/146061a0; Hill R., 1937, NATURE, V139, P881, DOI [10.1038/139881a0, DOI 10.1038/139881A0]; HOAGLAND DR, 1938, 347 U CAL AG EXP STA; Hogness TR, 1937, J PHYS CHEM-US, V41, P379, DOI 10.1021/j150381a005; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; JAGENDORF A. T., 1966, BROOKHAVEN SYMP BIOL, V19, P215; Judson HF., 1979, 8 DAY CREATION; KELMAN A, 1994, HIST PERSPECTIVES PL, P89; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; KORTSCHAK HP, 1965, PLANT PHYSIOL, V40, P209, DOI 10.1104/pp.40.2.209; KRAMER PJ, 1974, PLANT PHYSIOL, V54, P463, DOI 10.1104/pp.54.4.463; LANG A, 1957, P NATL ACAD SCI USA, V43, P709, DOI 10.1073/pnas.43.8.709; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MATTHEWS REF, 1981, PLANT VIROLOGY; McClintock B., 1949, CARNEGIE I WASHINGTO, V48, P142; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; MEYEROWITZ EM, 1994, ARABIDOPSIS, P1; MYERS J, 1974, PLANT PHYSIOL, V54, P420, DOI 10.1104/pp.54.4.420; Nagy F, 1999, TRENDS PLANT SCI, V4, P125, DOI 10.1016/S1360-1385(99)01394-1; OGREN WL, 1971, NATURE-NEW BIOL, V230, P159, DOI 10.1038/newbio230159a0; OSTERHOUT WJV, 1922, NATURE LIFE; PALEG LG, 1960, PLANT PHYSIOL, V35, P293, DOI 10.1104/pp.35.3.293; PARKER MW, 1945, SCIENCE, V102, P152, DOI 10.1126/science.102.2641.152; POIRIER Y, 1992, SCIENCE, V256, P520, DOI 10.1126/science.256.5056.520; Reed JW, 1999, CURR OPIN PLANT BIOL, V2, P393, DOI 10.1016/S1369-5266(99)00011-4; RUBEN SAMUEL, 1941, JOUR AMER CHEM SOC, V63, P877, DOI 10.1021/ja01848a512; Sage LC., 1992, PIGMENT IMAGINATION; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; SHADE RE, 1994, BIO-TECHNOL, V12, P793, DOI 10.1038/nbt0894-793; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Slack C., 1998, DISCOVERIES PLANT BI, VI, P175; Somerville C, 1999, SCIENCE, V285, P380, DOI 10.1126/science.285.5426.380; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; STEBBINS L, 1994, HIST PERSPECTIVES PL, P3; Takahashi N., 1998, DISCOVERIES PLANT BI, P17; THIMANN KV, 1974, PLANT PHYSIOL, V54, P450, DOI 10.1104/pp.54.4.450; Thimann KV, 1938, PLANT PHYSIOL, V13, P437, DOI 10.1104/pp.13.3.437; THIMANN KV, 1935, ANNU REV BIOCHEM, V4, P545; THOMASHOW MF, 1980, CELL, V19, P729, DOI 10.1016/S0092-8674(80)80049-3; TOOLE EH, 1953, P INT SEED TEST ASSN, V18, P267; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; VISHWANATH R, 1999, SCIENCE, V283, P835; WENT FW, 1974, ANNU REV PLANT PHYS, V25, P1, DOI 10.1146/annurev.pp.25.060174.000245; WHITE P. R., 1942, Annual Review of Biochemistry, V11, P615, DOI 10.1146/annurev.bi.11.070142.003151; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; ZIMMERMANN MH, 1974, PLANT PHYSIOL, V54, P472, DOI 10.1104/pp.54.4.472	84	21	22	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					13	25		10.1016/S0092-8674(00)81680-3	http://dx.doi.org/10.1016/S0092-8674(00)81680-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647928	Bronze			2022-12-28	WOS:000084722600002
J	Hein, L; Altman, JD; Kobilka, BK				Hein, L; Altman, JD; Kobilka, BK			Two functionally distinct alpha(2)-adrenergic receptors regulate sympathetic neurotransmission	NATURE			English	Article							PRESYNAPTIC ALPHA(2)-AUTORECEPTORS; HEART-FAILURE; ALPHA(2A)-ADRENERGIC RECEPTOR; SUBTYPE; RAT; BRAIN; MICE; GENE; INHIBITION; ALPHA(2D)	The sympathetic nervous system regulates cardiovascular function by activating adrenergic receptors in the heart, blood vessels and kidney(1), alpha(2)-Adrenergic receptors are known to have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system(2-5); however, the individual roles of the three highly homologous alpha(2)-adrenergic-receptor subtypes (alpha(2A), alpha(2B), alpha(2C)) in this process are not known. We have now studied neurotransmitter release in mice in which the genes encoding the three alpha(z)-adrenergic-receptor subtypes were disrupted. Here we show that both the alpha(2A)- and alpha(2C)-subtypes are required for normal presynaptic control of transmitter release from sympathetic nerves in the heart and from central noradrenergic neurons. alpha(2A)-Adrenergic receptors inhibit transmitter release at high stimulation frequencies, whereas the a,c-subtype modulates neurotransmission at lower levels of nerve activity. Both low- and high-frequency regulation seem to be physiologically important, as mice lacking both alpha(2A)- and alpha(2C)-receptor subtypes have elevated plasma noradrenaline concentrations and develop cardiac hypertrophy with decreased left ventricular contractility by four months of age.	Stanford Univ, Beckman Ctr B157, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Univ Wurzburg, Dept Pharmacol & Toxicol, D-97078 Wurzburg, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Wurzburg	Kobilka, BK (corresponding author), Stanford Univ, Beckman Ctr B157, Howard Hughes Med Inst, Stanford, CA 94305 USA.			Kobilka, Brian/0000-0001-5958-3990				Altman JD, 1999, MOL PHARMACOL, V56, P154, DOI 10.1124/mol.56.1.154; BYLUND DB, 1994, PHARMACOL REV, V46, P121; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Graefe KH, 1997, N-S ARCH PHARMACOL, V356, P115, DOI 10.1007/PL00005018; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; LIMBERGER N, 1995, N-S ARCH PHARMACOL, V352, P43; LINK R, 1992, MOL PHARMACOL, V42, P16; LINK RE, 1995, MOL PHARMACOL, V48, P48; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; McLachlan EM, 1997, J PHYSIOL-LONDON, V501, P165, DOI 10.1111/j.1469-7793.1997.165bo.x; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; MOLDERINGS GJ, 1995, N-S ARCH PHARMACOL, V352, P483; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Sallinen J, 1997, MOL PHARMACOL, V51, P36, DOI 10.1124/mol.51.1.36; Sallinen J, 1998, J NEUROSCI, V18, P3035; SINGER EA, 1988, TRENDS PHARMACOL SCI, V9, P274, DOI 10.1016/0165-6147(88)90004-1; SMITH K, 1995, BRIT J PHARMACOL, V115, P316, DOI 10.1111/j.1476-5381.1995.tb15879.x; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; STJARNE L, 1989, REV PHYSL BIOCH PHAR, V112, P4; TAUBE HD, 1977, N-S ARCH PHARMACOL, V299, P123, DOI 10.1007/BF00498554; TAYLOR AA, 1994, J CLIN PHARMACOL, V34, P363, DOI 10.1002/j.1552-4604.1994.tb04976.x; Trendelenburg AU, 1997, N-S ARCH PHARMACOL, V356, P721, DOI 10.1007/PL00005111; TRENDELENBURG AU, 1993, N-S ARCH PHARMACOL, V348, P35, DOI 10.1007/BF00168534; Wahl CA, 1996, N-S ARCH PHARMACOL, V354, P253	30	396	412	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					181	184		10.1038/46040	http://dx.doi.org/10.1038/46040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647009				2022-12-28	WOS:000083716400050
J	Smulyan, H; Safar, ME				Smulyan, H; Safar, ME			The diastolic blood pressure in systolic hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; HUMAN AORTA; CARDIOVASCULAR MORTALITY; PULSE PRESSURE; PREDICTOR; STROKE	Because antihypertensive therapy is effective in elderly patients with isolated systolic hypertension, attention has been focused on the systolic blood pressure as a predictor of cardiovascular risk. However, it is a normal diastolic pressure that separates patients with isolated systolic hypertension from those with essential hypertension. The normal diastolic and elevated systolic pressures are largely due to age-related stiffening of the aorta, An indistensible aorta causes the pressure pulse to travel faster than normal, where it is quickly reflected off the peripheral resistance. The reflected wave then returns to the centra I aorta in systole rather than diastole. This augments the systolic pressure further, increasing cardiac work while reducing the diastolic pressure, on which coronary flow is dependent. The potential harm of further reducing the diastolic pressure with antihypertensive therapy, especially in patients with coronary heart disease, underlies the controversial "J curve." By decreasing the blood pressure, all antihypertensive agents improve aortic distensibility, but no agents do so directly; the nitrates come the closest. Such an agent would be useful because any therapeutic increase in aortic distensibility would decrease systolic pressure without greatly reducing diastolic pressure. The problem is complicated by the suspected inaccuracy of the cuff technique in predicting the aortic diastolic pressure. New noninvasive methods to predict the aortic diastolic pressure may help in the future. At present, the combination of a high systolic and normal diastolic pressure-a widened pulse pressure-seems to be the best predictor of cardiovascular risk in patients with hypertension or heart disease. Patients with isolated systolic hypertension should be treated, but marked diastolic hypotension should be avoided.	SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA; Hop Broussais, F-75674 Paris, France	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Smulyan, H (corresponding author), SUNY Hlth Sci Ctr, 750 E Adams St, Syracuse, NY 13210 USA.	smulyanh@mailbox.hscsyr.edu						ADAMOPOULOS PN, 1975, AM J CARDIOL, V36, P697, DOI 10.1016/0002-9149(75)90171-X; ANDERSON TW, 1978, LANCET, V2, P1139; Benetos A, 1996, CIRCULATION, V94, P698, DOI 10.1161/01.CIR.94.4.698; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; BERNE RM, 1997, CARDIOVASCULAR PHYSL, P137; BLACK HR, 1993, HYPERTENSION, V21, P335; Chen CH, 1997, CIRCULATION, V95, P1827; COLANDREA MA, 1970, CIRCULATION, V41, P239, DOI 10.1161/01.CIR.41.2.239; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; CRUICKSHANK JM, 1987, LANCET, V1, P581; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; DUCHIER J, 1987, AM J CARDIOL, V60, P99, DOI 10.1016/0002-9149(87)90993-3; FANG J, 1995, J HYPERTENS, V13, P413; Fineberg MH, 1927, AM J MED SCI, V173, P835; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; GUBNER RS, 1962, AM J CARDIOL, V9, P773, DOI 10.1016/0002-9149(62)90139-X; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; KANNEL WB, 1980, CIRCULATION, V61, P1179, DOI 10.1161/01.CIR.61.6.1179; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Kelly R, 1989, J VASC MED BIOL, V1, P241; LANG RM, 1994, CIRCULATION, V90, P1875, DOI 10.1161/01.CIR.90.4.1875; LATHAM RD, 1985, CIRCULATION, V72, P1257, DOI 10.1161/01.CIR.72.6.1257; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mitchell GF, 1997, CIRCULATION, V96, P4254; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; NICHOLS WW, 1985, AM J CARDIOL, V55, P1179, DOI 10.1016/0002-9149(85)90659-9; NICHOLS WW, 1992, J HYPERTENS, V10, pS73; O'Rourke, 1982, ARTERIAL FUNCTION HL; OMALLEY K, 1980, JAMA-J AM MED ASSOC, V302, P1397; SAFAR ME, 1994, AM J MED SCI, V307, pS3; SAFAR ME, 1987, ANGIOLOGY, V38, P287, DOI 10.1177/000331978703800402; Somes GW, 1999, ARCH INTERN MED, V159, P2004, DOI 10.1001/archinte.159.17.2004; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STEFANADIS C, 1995, CIRCULATION, V92, P2210, DOI 10.1161/01.CIR.92.8.2210; STEWART IMG, 1979, LANCET, V1, P861; VARDAN S, 1983, ARCH INTERN MED, V143, P935, DOI 10.1001/archinte.143.5.935; VARDAN S, 1983, JAMA-J AM MED ASSOC, V250, P2807, DOI 10.1001/jama.250.20.2807; ZWEIFLER AJ, 1993, J HYPERTENS, V11, P1, DOI 10.1097/00004872-199301000-00001	39	73	81	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					233	237		10.7326/0003-4819-132-3-200002010-00010	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651605				2022-12-28	WOS:000084903000009
J	Reid, S; Chalder, T; Cleare, A; Hotopf, M; Wessely, S				Reid, S; Chalder, T; Cleare, A; Hotopf, M; Wessely, S			Extracts from "clinical evidence" - Chronic fatigue syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; GRADED-EXERCISE; CELL MAGNESIUM; PREVALENCE; FLUOXETINE; EFFICACY		Guys Kings & St Thomas Sch Med & Inst Psychiat, London SE5 8AZ, England	University of London; King's College London	Reid, S (corresponding author), Guys Kings & St Thomas Sch Med & Inst Psychiat, London SE5 8AZ, England.	steve.reid@kcl.ac.uk	Chalder, Trudie/A-5717-2011; Hotopf, Matthew/E-4971-2010; Cleare, Anthony J/B-4506-2008; Wessely, Simon C/A-8713-2008; Cleare, Anthony/AAN-5418-2021	Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929; Chalder, Trudie/0000-0003-0775-1045				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BEHAN PO, 1990, ACTA NEUROL SCAND, V82, P209, DOI 10.1111/j.1600-0404.1990.tb04490.x; BEHAN PO, 1995, J IMMUNOL IMMUNOPHAR, V15, P66; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; CLAGUE JE, 1992, LANCET, V340, P124, DOI 10.1016/0140-6736(92)90455-C; Cleare AJ, 1999, LANCET, V353, P455, DOI 10.1016/S0140-6736(98)04074-4; COX IM, 1991, LANCET, V337, P757, DOI 10.1016/0140-6736(91)91371-Z; DALRYMPLE W, 1964, Postgrad Med, V35, P345; Deale A, 1997, AM J PSYCHIAT, V154, P408; DEMITRACK MA, 1991, J CLIN ENDOCR METAB, V73, P1224, DOI 10.1210/jcem-73-6-1224; Forsyth LM, 1999, ANN ALLERG ASTHMA IM, V82, P185, DOI 10.1016/S1081-1206(10)62595-1; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; HINDS G, 1994, ANN CLIN BIOCHEM, V31, P459, DOI 10.1177/000456329403100506; Joyce J, 1997, QJM-MON J ASSOC PHYS, V90, P223, DOI 10.1093/qjmed/90.3.223; Karnofsky D., 1949, CLIN EVALUATION CHEM, P191; LAWRIE SM, 1995, BRIT J PSYCHIAT, V166, P793, DOI 10.1192/bjp.166.6.793; LLOYD A, 1990, AM J MED, V89, P561, DOI 10.1016/0002-9343(90)90173-B; LLOYD AR, 1993, AM J MED, V94, P197, DOI 10.1016/0002-9343(93)90183-P; McKenzie R, 1998, JAMA-J AM MED ASSOC, V280, P1061, DOI 10.1001/jama.280.12.1061; Natelson BH, 1996, PSYCHOPHARMACOLOGY, V124, P226, DOI 10.1007/BF02246661; PETERSON PK, 1990, AM J MED, V89, P554, DOI 10.1016/0002-9343(90)90172-A; Peterson PK, 1998, ARCH INTERN MED, V158, P908, DOI 10.1001/archinte.158.8.908; PRICE JR, 1998, COCHRANE LIB; Rowe KS, 1997, J PSYCHIAT RES, V31, P133, DOI 10.1016/S0022-3956(96)00047-7; Sandler H., 1986, INACTIVITY PHYSL EFF; See DM, 1996, IMMUNOL INVEST, V25, P153, DOI 10.3109/08820139609059298; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Steele Lea, 1998, American Journal of Medicine, V105, p83S, DOI 10.1016/S0002-9343(98)00158-2; Steinberg P, 1996, J ALLERGY CLIN IMMUN, V97, P119, DOI 10.1016/S0091-6749(96)70290-7; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; SWANINK CMA, 1995, J INTERN MED, V237, P499, DOI 10.1111/j.1365-2796.1995.tb00876.x; Vercoulen JHMM, 1996, LANCET, V347, P858, DOI 10.1016/S0140-6736(96)91345-8; VollmerConna U, 1997, AM J MED, V103, P38, DOI 10.1016/S0002-9343(97)90045-0; Warren G, 1999, ACTA NEUROL SCAND, V99, P112, DOI 10.1111/j.1600-0404.1999.tb00667.x; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485; WESSELY S, 1995, EPIDEMIOL REV, V17, P139, DOI 10.1093/oxfordjournals.epirev.a036170; Wessely S, 1997, AM J PUBLIC HEALTH, V87, P1449, DOI 10.2105/AJPH.87.9.1449	40	97	101	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2000	320	7230					292	296		10.1136/bmj.320.7230.292	http://dx.doi.org/10.1136/bmj.320.7230.292			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	280ZB	10650029	Green Published			2022-12-28	WOS:000085132700026
J	Earn, DJD; Rohani, P; Bolker, BM; Grenfell, BT				Earn, DJD; Rohani, P; Bolker, BM; Grenfell, BT			A simple model for complex dynamical transitions in epidemics	SCIENCE			English	Article							MEASLES DYNAMICS; METAPOPULATION DYNAMICS; CHAOS; VACCINATION; PERSISTENCE; PREDICTABILITY; PERIODICITY; DISEASES; ENGLAND; IMPACT	Dramatic changes in patterns of epidemics have been observed throughout this century. For childhood infectious diseases such as measles, the major transitions are between regular cycles and irregular, possibly chaotic epidemics, and from regionally synchronized oscillations to complex, spatially incoherent epidemics. A simple model can explain both kinds of transitions as the consequences of changes in birth and vaccination rates. Measles is a natural ecological system that exhibits different dynamical transitions at different times and places, yet all of these transitions can be predicted as bifurcations of a single nonlinear model.	McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Florida, Dept Zool, Gainesville, FL 32611 USA	McMaster University; University of Cambridge; State University System of Florida; University of Florida	Earn, DJD (corresponding author), McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada.	earn@math.mcmaster.ca		Earn, David/0000-0002-7562-1341; rohani, pejman/0000-0002-7221-3801; Bolker, Benjamin/0000-0002-2127-0443				ANDERSON R M, 1991; Anderson R.M., 1982, POPULATION DYNAMICS; ARON JL, 1990, THEOR POPUL BIOL, V38, P58, DOI 10.1016/0040-5809(90)90003-E; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; EARN DJD, UNPUB; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; ENGBERT R, 1994, PREDICTABILITY AND NONLINEAR MODELLING IN NATURAL SCIENCES AND ECONOMICS, P204; FERGUSON NM, 1997, MONOGRAPHS POPULATIO, V30, P137; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Glendinning P, 1997, J MATH BIOL, V35, P359, DOI 10.1007/s002850050056; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; GRENFELL BT, 1992, J ROY STAT SOC B MET, V54, P383; GRENFELL BT, 1994, PHILOS T R SOC A, V348, P515, DOI 10.1098/rsta.1994.0108; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; May R.M., 1986, Biomathematics (Berlin), V17, P405; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; MOLLISON D, 1993, MATH BIOSCI, V117, P155, DOI 10.1016/0025-5564(93)90021-2; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; OLSEN LF, 1990, SCIENCE, V249, P499, DOI 10.1126/science.2382131; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Schaffer W M, 1985, IMA J Math Appl Med Biol, V2, P221; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; SCHAFFER WM, 1993, IMA J MATH APPL MED, V10, P227; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; SCHWARTZ IB, 1985, J MATH BIOL, V21, P347, DOI 10.1007/BF00276232; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Turchin P, 1999, SCIENCE, V285, P1068, DOI 10.1126/science.285.5430.1068; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	39	484	501	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					667	670		10.1126/science.287.5453.667	http://dx.doi.org/10.1126/science.287.5453.667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10650003				2022-12-28	WOS:000084989400052
J	Giuliani, G; Chaussidon, M; Schubnel, HJ; Piat, DH; Rollion-Bard, C; France-Lanord, C; Giard, D; de Narvaez, D; Rondeau, B				Giuliani, G; Chaussidon, M; Schubnel, HJ; Piat, DH; Rollion-Bard, C; France-Lanord, C; Giard, D; de Narvaez, D; Rondeau, B			Oxygen isotopes and emerald trade routes since antiquity	SCIENCE			English	Article								Oxygen isotopic compositions of historical emerald artifacts from the Gallo-Roman period to the 18th century indicate that during historical times, artisans worked emeralds originating from deposits supposedly discovered in the 20th century. In antiquity, Pakistani and Egyptian emeralds were traded by way of the Silk Route. Together with Austrian stones, they were the only source of gem-quality emeralds. Immediately after the discovery of the Colombian mines by Spaniards in the 16th century, a new trade route was established, first via Spain to Europe and India and then directly via the Philippines to India. Since then, Colombian emeralds have dominated the emerald trade, and most of the high-quality emeralds cut in the 18th century in India originated from Colombia.	CNRS, Inst Rech Dev, F-54501 Vandoeuvre Nancy, France; CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Nancy, France; Museum Natl Hist Nat, Lab Mineral, F-75005 Paris, France; Assoc Francaise Gemmol, F-75009 Paris, France; Compania Mineira Rio Dulce, Bogota, Colombia	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Museum National d'Histoire Naturelle (MNHN)	Giuliani, G (corresponding author), CNRS, Inst Rech Dev, Boite Postale 20, F-54501 Vandoeuvre Nancy, France.		Rollion-Bard, Claire/E-8864-2017; Chaussidon, Marc/E-7067-2017; France-Lanord, Christian/F-8848-2010	France-Lanord, Christian/0000-0002-4873-5546				BARIAND P, 1985, LAROUSSE PIERRES PRE, P133; BEURDELEY C, 1985, ROUTES SOIE, P14; DOMINGUEZ R, 1965, HIST ESMERALDAS COLO, P131; FORESTIER FH, 1998, EMERAUDE, P139; Giuliani G, 1998, MINER DEPOSITA, V33, P513, DOI 10.1007/s001260050166; Gonthier E., 1998, EMERAUDE, P27; KANE RE, 1989, GEMS GEMOL, V25, P196; LYON E, 1976, NATL GEOGR, V149, P786; LYON E, 1982, NATL GEOGR, V161, P228; NWE YY, 1990, LITHOS, V25, P281, DOI 10.1016/0024-4937(90)90027-X; SCHWARZ D, 1987, ESMERALDAS INCLUSOES, P304; Ward F., 1993, EMERALDS; Zwaan J., 1997, GEMS GEMOL, V33, P80	13	56	56	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					631	633		10.1126/science.287.5453.631	http://dx.doi.org/10.1126/science.287.5453.631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649992				2022-12-28	WOS:000084989400041
J	Oghalai, JS; Zhao, HB; Kutz, JW; Brownell, WE				Oghalai, JS; Zhao, HB; Kutz, JW; Brownell, WE			Voltage- and tension-dependent lipid mobility in the outer hair cell plasma membrane	SCIENCE			English	Article							ERYTHROCYTE-MEMBRANE; BIOLOGICAL-MEMBRANES; LATERAL MOBILITY; BILAYER COUPLES; SHAPE CHANGES; MOTILITY; ELECTROMOTILITY; CHOLESTEROL; CAPACITANCE; COCHLEA	The mechanism responsible for electromotility of outer hair cells in the ear is unknown but is thought to reside within the plasma membrane. Lipid Lateral diffusion in the outer hair fell plasma membrane is a sigmoidal function of transmembrane potential and bathing media osmolality. Cell depolarization or hyposmotic challenge shorten the cell and reduce membrane fluidity by half. Changing the membrane tension with amphipathic drugs results in similar reductions. These dynamic changes in membrane fluidity represent the modulation of membrane tension by lipid-protein interactions. The voltage dependence may be associated with the force-generating motors that contribute to the exquisite sensitivity of mammalian hearing.	Baylor Coll Med, Dept Otolaryngol & Commun Sci, Houston, TX 77030 USA	Baylor College of Medicine	Brownell, WE (corresponding author), Baylor Coll Med, Dept Otolaryngol & Commun Sci, 1 Baylor Plaza, Houston, TX 77030 USA.		Kutz, Joe/ABF-4855-2020		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000354] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC000354] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adachi M, 1999, P NATL ACAD SCI USA, V96, P7244, DOI 10.1073/pnas.96.13.7244; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BLOOM JA, 1983, BIOPHYS J, V42, P295, DOI 10.1016/S0006-3495(83)84397-5; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DALLOS P, 1992, J NEUROSCI, V12, P4575; DERZKO Z, 1980, BIOCHEMISTRY-US, V19, P6050, DOI 10.1021/bi00567a016; DEUTICKE B, 1968, BIOCHIM BIOPHYS ACTA, V163, P494, DOI 10.1016/0005-2736(68)90078-3; Gale JE, 1997, NATURE, V389, P63, DOI 10.1038/37968; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; GOLAN DE, 1984, BIOCHEMISTRY-US, V23, P332, DOI 10.1021/bi00297a024; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; HOLLEY MC, 1996, SPR HDB AUD, V8, P386; HUANG GJ, 1994, P NATL ACAD SCI USA, V91, P12268, DOI 10.1073/pnas.91.25.12268; IWASA KH, 1992, J ACOUST SOC AM, V92, P3169, DOI 10.1121/1.404194; IWASA KH, 1994, J ACOUST SOC AM, V96, P2216, DOI 10.1121/1.410094; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; KAPITZA HG, 1980, BIOCHIM BIOPHYS ACTA, V595, P56, DOI 10.1016/0005-2736(80)90247-3; MONTANA V, 1989, BIOCHEMISTRY-US, V28, P4536, DOI 10.1021/bi00437a003; Oghalai JS, 1999, HEARING RES, V135, P19, DOI 10.1016/S0378-5955(99)00077-5; Oghalai JS, 1998, J NEUROSCI, V18, P48; Oghalai JS, 1998, J NEUROPHYSIOL, V79, P2235, DOI 10.1152/jn.1998.79.4.2235; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; SERVUSS RM, 1976, BIOCHIM BIOPHYS ACTA, V436, P900, DOI 10.1016/0005-2736(76)90422-3; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Sit PS, 1997, BIOPHYS J, V72, P2812, DOI 10.1016/S0006-3495(97)78923-9; SMITH CA, 1968, ANN OTO RHINOL LARYN, V77, P629, DOI 10.1177/000348946807700404; THOMPSON NL, 1980, BIOCHIM BIOPHYS ACTA, V597, P155, DOI 10.1016/0005-2736(80)90159-5; VAZ WLC, 1982, MEMBRANE RECONSTITUT, P83; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686	35	90	95	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					658	661		10.1126/science.287.5453.658	http://dx.doi.org/10.1126/science.287.5453.658			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10650000	Green Accepted			2022-12-28	WOS:000084989400049
J	O'Donnell, HC; Rosand, J; Knudsen, KA; Furie, KL; Segal, AZ; Chiu, RI; Ikeda, D; Greenberg, SM				O'Donnell, HC; Rosand, J; Knudsen, KA; Furie, KL; Segal, AZ; Chiu, RI; Ikeda, D; Greenberg, SM			Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; E EPSILON-4 ALLELE; ALZHEIMERS-DISEASE; HIGH-FREQUENCY; STROKE; HEMATOMAS; ONSET	Background: Recurrent lobar intracerebral hemorrhage is the hallmark of cerebral amyloid angiopathy. The factors that predispose patients to early recurrence of lobar hemorrhage are unknown. One candidate is the apolipoprotein E gene, since both the epsilon 2 and the epsilon 4 alleles of apolipoprotein E appear to be associated with the severity of amyloid angiopathy. Methods: We performed a prospective, longitudinal study of consecutive elderly patients who survived a lobar intracerebral hemorrhage. The patients were followed for recurrent hemorrhagic stroke by interviews at six-month intervals and reviews of medical records and computed tomographic scans. Results: Nineteen of 71 enrolled patients had recurrent hemorrhages during a mean (+/-SD) follow-up period of 23.9+/-14.8 months, yielding a 2-year cumulative rate of recurrence of 21 percent. The apolipoprotein E genotype was significantly associated with the risk of recurrence. Carriers of the epsilon 2 or epsilon 4 allele had a two-year rate of recurrence of 28 percent, as compared with only 10 percent for patients with the common apolipoprotein E epsilon 3/epsilon 3 genotype (risk ratio, 3.8; 95 percent confidence interval, 1.2 to 11.6; P=0.01). Early recurrence occurred in eight patients, four of whom had the uncommon epsilon 2/epsilon 4 genotype. Also at increased risk for recurrence were patients with a history of hemorrhagic stroke before entry into the study (two-year recurrence, 61 percent; risk ratio, 6.4; 95 percent confidence interval, 2.2 to 18.5; P<0.001). Conclusions: The apolipoprotein E genotype can identify patients with lobar intracerebral hemorrhage who are at highest risk for early recurrence. This finding makes possible both the provision of prognostic information to patients with lobar hemorrhage and a method of targeting and assessing potential strategies for prevention. (N Engl J Med 2000;342:240-5.) (C)2000, Massachusetts Medical Society.	Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Greenberg, SM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Wang ACC 836, Boston, MA 02114 USA.		Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789	NIA NIH HHS [AG00725] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alonzo NC, 1998, J NEUROPATH EXP NEUR, V57, P353, DOI 10.1097/00005072-199804000-00008; Arakawa S, 1998, STROKE, V29, P1806, DOI 10.1161/01.STR.29.9.1806; BRODERICK J, 1993, STROKE, V24, P49, DOI 10.1161/01.STR.24.1.49; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; COUNSELL C, 1995, CEREBROVASC DIS, V5, P26, DOI 10.1159/000107814; GILLES C, 1984, NEUROLOGY, V34, P730, DOI 10.1212/WNL.34.6.730; GomezIsla T, 1996, ANN NEUROL, V39, P62, DOI 10.1002/ana.410390110; GRAY F, 1985, ANN NEUROL, V18, P54, DOI 10.1002/ana.410180110; Greenberg SM, 1998, NEUROLOGY, V51, P690, DOI 10.1212/WNL.51.3.690; GREENBERG SM, 1993, NEUROLOGY, V43, P2073, DOI 10.1212/WNL.43.10.2073; Greenberg SM, 1999, NEUROLOGY, V53, P1135, DOI 10.1212/WNL.53.5.1135; Greenberg SM, 1998, NEUROLOGY, V50, P961, DOI 10.1212/WNL.50.4.961; Greenberg SM, 1996, NEUROLOGY, V46, P1751, DOI 10.1212/WNL.46.6.1751; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Greenberg SM, 1996, STROKE, V27, P1333, DOI 10.1161/01.STR.27.8.1333; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; KASE CS, 1982, NEUROLOGY, V32, P1146, DOI 10.1212/WNL.32.10.1146; Kurz A, 1996, NEUROLOGY, V47, P440, DOI 10.1212/WNL.47.2.440; MASSARO AR, 1991, NEUROLOGY, V41, P1881, DOI 10.1212/WNL.41.12.1881; Mayeux R, 1998, NEW ENGL J MED, V338, P1325; McCarron MO, 1998, NEUROSCI LETT, V247, P45, DOI 10.1016/S0304-3940(98)00286-9; McCarron MO, 1999, J NEUROPATH EXP NEUR, V58, P711, DOI 10.1097/00005072-199907000-00005; Neau JP, 1997, NEUROLOGY, V49, P106, DOI 10.1212/WNL.49.1.106; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; Offenbacher H, 1996, AM J NEURORADIOL, V17, P573; Olichney JM, 1996, NEUROLOGY, V47, P190, DOI 10.1212/WNL.47.1.190; PASSERO S, 1995, STROKE, V26, P1189, DOI 10.1161/01.STR.26.7.1189; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Stern Y, 1997, ANN NEUROL, V41, P615, DOI 10.1002/ana.410410510; TATEMICHI TK, 1994, NEUROLOGY, V44, P1885, DOI 10.1212/WNL.44.10.1885; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666	33	348	359	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					240	245		10.1056/NEJM200001273420403	http://dx.doi.org/10.1056/NEJM200001273420403			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277PB	10648765				2022-12-28	WOS:000084941000003
J	Gottlieb, S				Gottlieb, S			Non-compliance often the cause when AIDS drugs "fail"	BRITISH MEDICAL JOURNAL			English	News Item																		Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229	2	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					208	208						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642225				2022-12-28	WOS:000085029600020
J	McMurry, MT; Krangel, MS				McMurry, MT; Krangel, MS			A role for histone acetylation in the developmental regulation of V(D)J recombination	SCIENCE			English	Article							DELTA-GENE REARRANGEMENT; IN-VITRO; ALPHA/DELTA LOCUS; NUCLEOSOMAL DNA; ALPHA-ENHANCER; RECEPTOR; TRANSCRIPTION; ACCESSIBILITY; CHROMATIN; BETA	V(D)J recombination is developmentally regulated in vivo by enhancer-dependent changes in the accessibility of chromosomal recombination signal sequences to the recombinase, but the molecular nature of these changes is unknown. Here histone H3 acetylation was measured along versions of a transgenic V(D)J recombination reporter and the endogenous T cell receptor alpha/delta Locus. Enhancer activity was shown to impart Long-range, developmentally regulated changes in H3 acetylation, and H3 acetylation status was tightly Linked to V(D)J recombination. H3 hyperacetylation is proposed as a molecular mechanism coupling enhancer activity to accessibility for V(D)J recombination.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Krangel, MS (corresponding author), Duke Univ, Med Ctr, Dept Immunol, POB 3010, Durham, NC 27710 USA.		McMurry-Heath, Michelle/AAB-5420-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052, R01GM041052] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 41052] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; HernandezMunain C, 1996, J EXP MED, V183, P289, DOI 10.1084/jem.183.1.289; Krangel MS, 1998, IMMUNOL REV, V165, P131, DOI 10.1111/j.1600-065X.1998.tb01236.x; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Lauzurica P, 1997, J EXP MED, V185, P1193, DOI 10.1084/jem.185.7.1193; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281; McMurry M. T, UNPUB; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Monroe RJ, 1999, IMMUNITY, V10, P503, DOI 10.1016/S1074-7613(00)80050-3; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Schatz D G, 1997, Semin Immunol, V9, P149, DOI 10.1006/smim.1997.0068; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Wolffe AP, 1997, GENES CELLS, V2, P291, DOI 10.1046/j.1365-2443.1997.1260323.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219	33	239	241	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					495	498		10.1126/science.287.5452.495	http://dx.doi.org/10.1126/science.287.5452.495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642553				2022-12-28	WOS:000084929900051
J	Gaist, D; Vaeth, M; Tsiropoulos, I; Christensen, K; Corder, E; Olsen, J; Sorensen, HT				Gaist, D; Vaeth, M; Tsiropoulos, I; Christensen, K; Corder, E; Olsen, J; Sorensen, HT			Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark	BRITISH MEDICAL JOURNAL			English	Article							FAMILIAL INTRACRANIAL ANEURYSMS; CASE-FATALITY; HEMORRHAGE; REGION; CANADA	Objective To estimate the risk of occurrence of subarachnoid haemorrhage in first degree relatives (parents, siblings, children) of patients with subarachnoid haemorrhage. Design Population based cohort study using data from the Danish National Discharge Registry and the Central Person Registry. Subjects Incident cases of subarachnoid haemorrhage admitted to hospital from 1977 to 1995 (9367 patients) and their first degree relatives (14781). Main outcome measures The incidence rate of subarachnoid haemorrhage was determined for the relatives and compared with that of the entire population, standardised for age, sex, and calendar period. This process was repeated for patients discharged from neurosurgery units, as diagnoses from these wards had high validity (93%). Results 18 patients had a total of 19 first degree relatives with subarachnoid haemorrhage during the study period, corresponding to a standardised incidence ratio of 2.9 (95% confidence interval 1.9 to 4.6). Patients discharged from neurosurgery wards had a higher standardised incidence ratio (4.5, 2.7 to 7.3). Conclusions First degree relatives of patients with subarachnoid haemorrhage have a threefold to fivefold increased risk of subarachnoid haemorrhage compared with the general population.	Odense Univ, Univ So Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark; Aarhus Univ, Dept Biostat, DK-8000 Aarhus, Denmark; Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark; Univ Aarhus, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark; Univ Aarhus, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Univ Aarhus, Inst Epidemiol & Social Med, Aalborg Univ Hosp, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University; Aarhus University; Aalborg University; Aarhus University	Gaist, D (corresponding author), Odense Univ, Univ So Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark.		Christensen, Kaare/C-2360-2009; Gaist, David/I-4397-2014; Sorensen, Henrik Toft/Z-6181-2019; Vaeth, Michael/T-6882-2017	Christensen, Kaare/0000-0002-5429-5292; Gaist, David/0000-0001-5205-7007; Sorensen, Henrik Toft/0000-0003-4299-7040; Vaeth, Michael/0000-0002-0134-5006				Breslow NE, 1987, STAT METHODS CANC RE; BROMBERG JEC, 1995, BRIT MED J, V311, P288, DOI 10.1136/bmj.311.7000.288; BROMBERG JEC, 1995, STROKE, V26, P961, DOI 10.1161/01.STR.26.6.961; CHRISTENSEN K, 1995, NEW ENGL J MED, V333, P161, DOI 10.1056/NEJM199507203330305; DeBraekeleer M, 1996, ANN HUM GENET, V60, P99, DOI 10.1111/j.1469-1809.1996.tb01181.x; LEBLANC R, 1995, NEUROSURGERY, V37, P633, DOI 10.1227/00006123-199510000-00005; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Menghini VV, 1998, NEUROLOGY, V51, P405, DOI 10.1212/WNL.51.2.405; NORRGARD O, 1987, NEUROSURGERY, V20, P236, DOI 10.1227/00006123-198702000-00006; Ostbye T, 1997, STROKE, V28, P793, DOI 10.1161/01.STR.28.4.793; RONKAINEN A, 1995, NEUROSURGERY, V37, P43, DOI 10.1227/00006123-199507000-00006; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; Schievink WI, 1996, STROKE, V27, P340; SCHIEVINK WI, 1995, J NEUROSURG, V83, P426, DOI 10.3171/jns.1995.83.3.0426; Schievink WI, 1996, NEUROSURGERY, V39, P685, DOI 10.1097/00006123-199610000-00006; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001; *STAT DENM, 1998, STAT YB 1998; *SUNDH, 1981, AKT SYG 1979; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; Truelsen T, 1998, STROKE, V29, P2298, DOI 10.1161/01.STR.29.11.2298; WANG PS, 1995, ARCH NEUROL-CHICAGO, V52, P202, DOI 10.1001/archneur.1995.00540260108026	23	62	63	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					141	145		10.1136/bmj.320.7228.141	http://dx.doi.org/10.1136/bmj.320.7228.141			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634731	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000084860300021
J	Munchau, A; Bhatia, KP				Munchau, A; Bhatia, KP			Regular review - Uses of botulinum toxin injection in medicine today	BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; SPASMODIC TORTICOLLIS; A TOXIN; DYSTONIA		Univ London, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England	University of London; University College London	Bhatia, KP (corresponding author), Univ London, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England.							ANDERSON TJ, 1992, J ROY SOC MED, V85, P524; Bakheit AMO, 1997, J NEUROL NEUROSUR PS, V62, P198, DOI 10.1136/jnnp.62.2.198; Bhatia KP, 1999, J NEUROL NEUROSUR PS, V67, P90, DOI 10.1136/jnnp.67.1.90; Bhatia KP, 1999, J NEUROL NEUROSUR PS, V67, P697, DOI 10.1136/jnnp.67.5.697; Boyd R, 1997, EUR J NEUROL, V4, pS15; Brin M F, 1998, Adv Neurol, V78, P237; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; Cherington M, 1998, MUSCLE NERVE, V21, P701, DOI 10.1002/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B; Cuilliere C, 1997, GUT, V41, P87, DOI 10.1136/gut.41.1.87; DOLLYJO, 1997, EUR J NEUROL S12, V4, pS5; DRESSLER D, 1998, BOTULINUM TOXIN THER; ERBGUTH F, 1993, J NEUROL NEUROSUR PS, V56, P1235, DOI 10.1136/jnnp.56.11.1235; FAHN S, 1998, ADV NEUROLOGY DYSTON; GLANZMAN RL, 1990, NEUROLOGY, V40, P1143, DOI 10.1212/WNL.40.7.1143; Houser MK, 1998, J NEUROL NEUROSUR PS, V64, P577, DOI 10.1136/jnnp.64.5.577; JANKOVIC J, 1997, MUSCLE NERVE S6, V20, pS129; JANKOVIC J, 1994, THERAPY BOTULINUM TO; Jitpimolmard S, 1998, J NEUROL NEUROSUR PS, V64, P751, DOI 10.1136/jnnp.64.6.751; KERNER J, 1817, TUBINGER BLATT NATUR, P1; Latimer PR, 1998, EYE, V12, P51, DOI 10.1038/eye.1998.9; LEPORE V, 1995, MOVEMENT DISORD, V10, P525, DOI 10.1002/mds.870100425; Maria G, 1998, NEW ENGL J MED, V338, P217, DOI 10.1056/NEJM199801223380402; MOORE P, 1995, HDB BOTULINUM TOXIN; Naumann M, 1997, ANN NEUROL, V42, P973; Odergren T, 1998, J NEUROL NEUROSUR PS, V64, P6, DOI 10.1136/jnnp.64.1.6; PRIORI A, 1995, BRAIN, V118, P801, DOI 10.1093/brain/118.3.801; SCHNIDER P, 1993, LANCET, V342, P811, DOI 10.1016/0140-6736(93)91580-F; Scott A B, 1981, Trans Am Ophthalmol Soc, V79, P734; SCOTT AB, 1990, OPHTHALMOLOGY, V97, P1434; SHEEAN GL, 1998, SPASTICITY REHABILIT, P109; Shelley WB, 1998, J AM ACAD DERMATOL, V38, P227, DOI 10.1016/S0190-9622(98)70242-7; SIMPSON DM, 1997, MUSCLE NERVE S6, V20, pS169; TROSCH RM, 1994, MOVEMENT DISORD, V9, P601, DOI 10.1002/mds.870090604; TSUI JKC, 1986, LANCET, V2, P245; TSUI JKC, 1993, NEUROLOGY, V43, P183, DOI 10.1212/WNL.43.1_Part_1.183; van Ermengem E., 1897, Z HYG INFEKTIONSKR, V26, P1, DOI [10.1007/BF02220526, DOI 10.1007/BF02220526]; [No title captured]	37	106	118	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					161	165		10.1136/bmj.320.7228.161	http://dx.doi.org/10.1136/bmj.320.7228.161			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634738	Green Published			2022-12-28	WOS:000084860300029
J	Bachmaier, K; Krawczyk, C; Kozieradzki, I; Kong, YY; Sasaki, T; Oliveira-dos-Santos, A; Mariathasan, S; Bouchard, D; Wakeham, A; Itie, A; Le, J; Ohashi, PS; Sarosi, I; Nishina, H; Lipkowitz, S; Penninger, JM				Bachmaier, K; Krawczyk, C; Kozieradzki, I; Kong, YY; Sasaki, T; Oliveira-dos-Santos, A; Mariathasan, S; Bouchard, D; Wakeham, A; Itie, A; Le, J; Ohashi, PS; Sarosi, I; Nishina, H; Lipkowitz, S; Penninger, JM			Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b	NATURE			English	Article							T-CELL RECEPTOR; PROTEIN; MICE; PROTOONCOGENE; TOLERANCE; ANTIGENS; KINASE; TISSUE; BINDS; VAV	The signalling thresholds of antigen receptors and co-stimulatory receptors determine immunity or tolerance to self molecules(1). Changes in co-stimulatory pathways can lead to enhanced activation of lymphocytes and autoimmunity, or the induction of clonal anergy(2). The molecular mechanisms that maintain immunotolerance in vivo and integrate co-stimulatory signals with antigen receptor signals in T and B lymphocytes are poorly understood. Members of the Cbl/Sli family of molecular adaptors function downstream from growth factor and antigen receptors(3-5). Here we show that gene-targeted mice lacking the adaptor Cbl-b develop spontaneous autoimmunity characterized by auto-antibody production, infiltration of activated T and B lymphocytes into multiple organs, and parenchymal damage. Resting cbl-b(-/-) lymphocytes hyperproliferate upon antigen receptor stimulation, and cbl-b(-/-) T cells display specific: hyperproduction of the T-celI growth factor interleukin-2, hut not interferon-gamma or tumour necrosis factor-alpha. Mutation of Cbl-b uncouples T-cell proliferation, interleukin-2 production and phosphorylation of the GDP/GTP exchange factor Vav1 from the requirement for CD28 costimulation. Cbl-b is thus a key regulator of activation thresholds in mature lymphocytes and immunological tolerance and autoimmunity.	Univ Toronto, Amgen Inst, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Amgen Inst, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2M9, Canada; Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA; NCI, Med Branch, Dept Genet, Naval Hosp, Bethesda, MD 20889 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Amgen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy	Penninger, JM (corresponding author), Univ Toronto, Amgen Inst, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada.		Penninger, Josef M/I-6860-2013; Bachmaier, Kurt/B-6331-2014; Bachmaier, Kurt/AHC-5491-2022	Penninger, Josef M/0000-0002-8194-3777; Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Sasaki, Takehiko/0000-0003-1837-3748; Ohashi, Pamela S./0000-0003-2915-9317	NATIONAL CANCER INSTITUTE [Z01SC007263, ZIASC007263] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach JF, 1997, TRENDS ENDOCRIN MET, V8, P71, DOI 10.1016/S1043-2760(96)00271-8; BOUSSIOTIS VA, 1994, CURR OPIN IMMUNOL, V6, P797, DOI 10.1016/0952-7915(94)90087-6; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; CELLS E, 1992, EUR J IMMUNOL, V22, P3127; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CORY GOC, 1995, J EXP MED, V182, P611, DOI 10.1084/jem.182.2.611; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; KEANE MM, 1995, ONCOGENE, V10, P2367; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; RADVANYI LG, 1993, J IMMUNOL, V150, P5704; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Sawasdikosol S, 1996, J IMMUNOL, V157, P110; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Zhang ZH, 1999, CURR BIOL, V9, P203, DOI 10.1016/S0960-9822(99)80090-6	23	526	566	1	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					211	216		10.1038/35003228	http://dx.doi.org/10.1038/35003228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646608				2022-12-28	WOS:000084835300059
J	Barsbold, R; Currie, PJ; Myhrvold, NP; Osmolska, H; Tsogtbaatar, K; Watabe, M				Barsbold, R; Currie, PJ; Myhrvold, NP; Osmolska, H; Tsogtbaatar, K; Watabe, M			A pygostyle from a non-avian theropod - The independent evolution of a bird-like tail has been discovered in an oviraptorosaur.	NATURE			English	Article							NORTH-AMERICA		Mongolian Acad Sci, Inst Geol, Ulan Bator 210351, Mongolia; Royal Tyrrell Museum Palaeontol, Drumheller, AB T0J 0Y0, Canada; Microsoft Corp, Redmond, WA 98052 USA; Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland; Hayashibara Museum Nat Sci, Okayama 7000907, Japan	Mongolian Academy of Sciences; Microsoft; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Barsbold, R (corresponding author), Mongolian Acad Sci, Inst Geol, Ulan Bator 210351, Mongolia.		Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Myhrvold, Nathan/0000-0003-3994-5143				Barsbold R., 1997, ENCY DINOSAURS, P505; BAUMEL JJ, 1988, ADV ANAT EMBRYOL CEL, V110, P1; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Parker WK, 1888, P R SOC LOND, V43, P465; PECK JI, 1889, J MORPHOL, V3, P127; STEINER H, 1938, NATURF GESELL ZURICH, V83, P279; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; van Oort E, 1904, TIJDSCHRIFT NEDERLAN, V9, P1; [No title captured]	11	34	38	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					155	156		10.1038/35003103	http://dx.doi.org/10.1038/35003103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646588				2022-12-28	WOS:000084835300039
J	Tellides, G; Tereb, DA; Kirkiles-Smith, NC; Kim, RW; Wilson, JH; Schechner, JS; Lorber, MI; Pober, JS				Tellides, G; Tereb, DA; Kirkiles-Smith, NC; Kim, RW; Wilson, JH; Schechner, JS; Lorber, MI; Pober, JS			Interferon-gamma elicits arteriosclerosis in the absence of leukocytes	NATURE			English	Article							SMOOTH-MUSCLE CELLS; TRANSPLANTED MOUSE HEARTS; CORONARY ARTERIOSCLEROSIS; IMMUNE INTERFERON; INHIBITS PROLIFERATION; GENE-EXPRESSION; GROWTH-FACTORS; ATHEROSCLEROSIS; INVIVO; INJURY	Atherosclerosis and post-transplant graft arteriosclerosis are both characterized by expansion of the arterial intima as a result of the infiltration of mononuclear leukocytes, the proliferation of vascular smooth muscle cells (VSMCs) and the accumulation of extracellular matrix(1-3). They are also associated with the presence of the immunomodulatory cytokine interferon-gamma (IFN-gamma)(2,3). Moreover, in mouse models of atheroma formation or allogeneic transplantation, the serological neutralization(4) or genetic absence(5-8) of IFN-gamma markedly reduces the extent of intimal expansion. However, other studies have found that exogenous IFN-gamma inhibits Cultured VSMC proliferation(9-14) and matrix synthesis(15), and reduces intimal expansion in response to mechanical injury(16-18). This discrepancy is generally explained by the idea that IFN-gamma either directly activates macrophages, or, by increasing antigen presentation, indirectly activates T cells within the lesions of atherosclerosis and graft arteriosclerosis. These activated leukocytes are thought to express the VSMC-activating cytokines(1-3) and cell-surface molecules(19) that cause the observed arteriosclerotic responses. Here we have inserted pig and human arteries into the aorta of immunodeficient immunodeficient mice, and we show that IFN-gamma can induce arteriosclerotic changes in the absence of detectable immunocytes by acting on VSMCs to potentiate growth-factor-induced mitogenesis.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Interdepartmental Program Vasc Biol & Transplanta, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Tellides, G (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Interdepartmental Program Vasc Biol & Transplanta, 333 Cedar St, New Haven, CT 06510 USA.							AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; BENNETT MR, 1994, CIRC RES, V74, P525, DOI 10.1161/01.RES.74.3.525; BRINCKERHOFF CE, 1985, J IMMUNOL, V134, P3142; Castronuovo J J Jr, 1995, Cardiovasc Surg, V3, P463, DOI 10.1016/0967-2109(95)94442-Y; Goes N, 1996, TRANSPLANTATION, V62, P1889, DOI 10.1097/00007890-199612270-00036; GROENEWEGEN G, 1985, NATURE, V316, P361, DOI 10.1038/316361a0; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; HANSSON GK, 1991, CIRCULATION, V84, P1266, DOI 10.1161/01.CIR.84.3.1266; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; HANSSON GK, 1989, J EXP MED, V170, P1595, DOI 10.1084/jem.170.5.1595; HUNNINGHAKE GW, 1986, AM REV RESPIR DIS, V134, P1025, DOI 10.1164/arrd.1986.134.5.1025; LIBBY P, 1989, TRANSPLANT P, V21, P3677; Lorber MI, 1999, TRANSPLANTATION, V67, P897, DOI 10.1097/00007890-199903270-00018; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Marra F, 1996, J CLIN INVEST, V98, P1218, DOI 10.1172/JCI118905; Mensink A, 1996, EUR J PHARMACOL, V310, P73, DOI 10.1016/0014-2999(96)00368-8; Nagano H, 1997, J CLIN INVEST, V100, P550, DOI 10.1172/JCI119564; Nagano H, 1998, AM J PATHOL, V152, P1187; NUNOKAWA Y, 1992, BIOCHEM BIOPH RES CO, V188, P409, DOI 10.1016/0006-291X(92)92400-R; Raisanen-Sokolowski A, 1998, AM J PATHOL, V152, P359; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUSSELL PS, 1994, TRANSPLANTATION, V57, P1367, DOI 10.1097/00007890-199405150-00014; SHIMOKADO K, 1990, ANN NY ACAD SCI, V598, P544, DOI 10.1111/j.1749-6632.1990.tb42340.x; Sultan P, 1997, P NATL ACAD SCI USA, V94, P8767, DOI 10.1073/pnas.94.16.8767; SUZUKI H, 1989, AM J PATHOL, V134, P35; WARNER SJC, 1989, J CLIN INVEST, V83, P1174, DOI 10.1172/JCI113998; YOKOTA T, 1992, ARTERIOSCLER THROMB, V12, P1393, DOI 10.1161/01.ATV.12.12.1393; YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016	30	324	331	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					207	211		10.1038/35003221	http://dx.doi.org/10.1038/35003221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646607				2022-12-28	WOS:000084835300058
J	Weir, EC				Weir, EC			The sharp end of the dural puncture	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	25	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 8	2000	320	7227					127	127		10.1136/bmj.320.7227.127	http://dx.doi.org/10.1136/bmj.320.7227.127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274CR	10625287	Green Published			2022-12-28	WOS:000084746600057
J	Schlag, J; Cai, RH; Dorfman, A; Mohempour, A; Schlag-Rey, M				Schlag, J; Cai, RH; Dorfman, A; Mohempour, A; Schlag-Rey, M			Neuroscience - Extrapolating movement without retinal motion	NATURE			English	Article							LATENCY		Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schlag, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.							Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Gegenfurtner K, 1999, NATURE, V398, P291, DOI 10.1038/18563; Nijhawan R, 1997, NATURE, V386, P66, DOI 10.1038/386066a0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659	6	36	36	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					38	39		10.1038/47402	http://dx.doi.org/10.1038/47402			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638742				2022-12-28	WOS:000084687400032
J	Gundestrup, M; Storm, HH				Gundestrup, M; Storm, HH			Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: a population-based cohort study	LANCET			English	Article							MORTALITY; PILOTS; RISK; EXPOSURE	Background Cockpit crews receive cosmic radiation during flight operations. The increasing total accumulated dose over the years might be expected to cause increased frequency of radiation-induced cancer. The rate should increase with number of flight hours per year, number of years of flying, and higher flight altitude. If the cumulative radiation exposure during flights is of concern, we would expect an increased cancer risk to be present among those crew members flying jets. Methods Cockpit-crew medical records (pilots and flight engineers) from 1946 onwards, holding information on the individual, flight hours, aircraft type, and date of commercial certification and decertification, were linked to the population-based Danish Cancer Registry, the central population registry, and the National Death Index. Findings Altogether 3877 cockpit crew members could be traced for follow-up, accruing 61 095 person-years at risk in 3790 men and 661 in 87 women. The total number of cancers observed was 169 whereas 153.1 were expected (standardised incidence ratio 1.1 [95% CI 0.94-1.28]). Significantly increased risks of acute myeloid leukaemia (5.1 [1.03-14.91]), skin cancer, excluding melanoma (3.0 [2.12-4.23]), and total cancer (1.2 [1.00-1.53]) were observed among Danish male jet cockpit crew members flying more than 5000 h. Increased risk of malignant melanoma irrespective of aircraft type was also found among those flying more than 5000 h. Interpretation Both malignant melanoma and skin cancer were found in excess in cockpit crew members with a long flying history, probably attributable to sun exposure during leisure time at holiday destinations. We cannot confirm previously reported increased risk of brain and rectal cancers in pilots. The study shows that male cockpit crew members in jets flying more than 5000 h have significantly increased frequency of acute myeloid leukaemia.	Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Natl Clin Aviat Med, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Rigshospitalet; University of Copenhagen	Storm, HH (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49, DK-2100 Copenhagen, Denmark.			Storm, Hans/0000-0001-7223-8198				BAND PR, 1990, AVIAT SPACE ENVIR MD, V61, P299; Band PR, 1996, AM J EPIDEMIOL, V143, P137; Blettner M, 1998, RADIAT ENVIRON BIOPH, V37, P75, DOI 10.1007/s004110050097; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; FRIEDBERG W, 1989, AVIAT SPACE ENVIR MD, V60, P1104; Grayson JK, 1996, AVIAT SPACE ENVIR MD, V67, P101; IRVINE D, 1992, AVIAT SPACE ENVIR MD, V63, P276; KAJI M, 1993, AVIAT SPACE ENVIR MD, V64, P748; OBRIEN K, 1972, HEALTH PHYS, V22, P225, DOI 10.1097/00004032-197203000-00002; PARETZKE HG, 1993, RADIAT PROT DOSIM, V48, P33; PUKKALA E, 1995, BRIT MED J, V311, P349; PUKKALA E, 1995, CONTR EPIDE, V7, P1; SALISBURY DA, 1991, AVIAT SPACE ENVIR MD, V62, P351	13	114	119	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2029	2031		10.1016/S0140-6736(99)05093-X	http://dx.doi.org/10.1016/S0140-6736(99)05093-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636367				2022-12-28	WOS:000084183300010
J	Kinsley, CH; Madonia, L; Gifford, GW; Tureski, K; Griffin, GR; Lowry, C; Williams, J; Collins, J; McLearie, H; Lambert, KG				Kinsley, CH; Madonia, L; Gifford, GW; Tureski, K; Griffin, GR; Lowry, C; Williams, J; Collins, J; McLearie, H; Lambert, KG			Motherhood improves learning and memory - Neural activity in rats is enhanced by pregnancy and the demands of rearing offspring.	NATURE			English	Article							HIPPOCAMPAL		Univ Richmond, Dept Psychol, Richmond, VA 23173 USA; Randolph Macon Coll, Dept Psychol, Ashland, VA 23005 USA	University of Richmond	Kinsley, CH (corresponding author), Univ Richmond, Dept Psychol, Richmond, VA 23173 USA.	ckinsley@richmond.edu		Lambert, Kelly/0000-0003-1626-5129				Daniel JM, 1999, PHYSIOL BEHAV, V66, P11, DOI 10.1016/S0031-9384(98)00272-8; Diamond M C, 1971, Int J Neurosci, V2, P171, DOI 10.3109/00207457109146999; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; JACOBS LF, 1990, P NATL ACAD SCI USA, V87, P6349, DOI 10.1073/pnas.87.16.6349; KESNER RP, 1995, PSYCHOPHARMACOLOGY, V120, P203, DOI 10.1007/BF02246194; Kinsley C. H., 1998, Society for Neuroscience Abstracts, V24, P952; LOY R, 1988, BRAIN RES, V467, P248; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MODNEY BK, 1990, MAMMALIAN PARENTING, P305; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; [No title captured]	12	218	225	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	1999	402	6758					137	138		10.1038/45957	http://dx.doi.org/10.1038/45957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647003				2022-12-28	WOS:000083716400034
J	Sterling, B				Sterling, B			Homo sapiens declared extinct	NATURE			English	Editorial Material																			0	2	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					125	125		10.1038/45932	http://dx.doi.org/10.1038/45932			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10646998	Bronze			2022-12-28	WOS:000083716400024
J	Flesch, LM; Holt, WE; Haines, AJ; Shen-Tu, BM				Flesch, LM; Holt, WE; Haines, AJ; Shen-Tu, BM			Dynamics of the Pacific-North American plate boundary in the western United States	SCIENCE			English	Article							SAN-ANDREAS FAULT; ACTIVE DEFORMATION; RANGE PROVINCE; UPPER-MANTLE; EARTHQUAKE; MOTIONS; STRESS; BASIN; FLOW; LITHOSPHERE	The vertically averaged deviatoric stress tensor field within the western United States was determined with topographic data, geoid data, recent global positioning system observations, and strain rate magnitudes and styles from Quaternary faults. Gravitational potential energy differences control the large fault-normal compression on the California coast. Deformation in the Basin and Range is driven, in part, by gravitational potential energy differences, but extension directions there are modified by plate interaction stresses, The California shear zone has relatively low vertically averaged viscosity of about 10(21) pascal seconds, whereas the Basin and Range has a higher vertically averaged viscosity of 10(22) pascal seconds.	SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Cambridge, Bullard Labs, Cambridge CB3 0EZ, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Cambridge	Flesch, LM (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	flesch@stillwater.ess.sunysb.edu		Holt, William/0000-0002-0267-5306				Atwater T., 1970, GEOL SOC AM BULL, V81, P3513, DOI [DOI 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2, 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2]; Bennett RA, 1999, GEOLOGY, V27, P371, DOI 10.1130/0091-7613(1999)027<0371:PDPOCD>2.3.CO;2; BILLS BG, 1994, J GEOPHYS RES-SOL EA, V99, P22059, DOI 10.1029/94JB01192; BILLS BG, 1995, EOS, V76, P608; BOHANNON RG, 1995, GEOL SOC AM BULL, V107, P937, DOI 10.1130/0016-7606(1995)107<0937:TIOPMP>2.3.CO;2; COBLENTZ DD, 1994, TECTONICS, V13, P929, DOI 10.1029/94TC01033; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Deng JS, 1998, SCIENCE, V282, P1689, DOI 10.1126/science.282.5394.1689; ENGLAND P, 1982, GEOPHYS J ROY ASTR S, V70, P295, DOI 10.1111/j.1365-246X.1982.tb04969.x; England P, 1997, SCIENCE, V278, P647, DOI 10.1126/science.278.5338.647; FLEITOUT L, 1982, TECTONICS, V1, P21, DOI 10.1029/TC001i001p00021; FLESCH LM, UNPUB; GILBERT LE, 1994, J GEOPHYS RES-SOL EA, V99, P23975, DOI 10.1029/94JB01558; HAGER BH, 1985, NATURE, V313, P541, DOI 10.1038/313541a0; HAINES AJ, 1993, J GEOPHYS RES-SOL EA, V98, P12057, DOI 10.1029/93JB00892; HUMPHREYS ED, 1994, J GEOPHYS RES-SOL EA, V99, P9635, DOI 10.1029/93JB02640; JENNINGS CW, 1994, FAULT ACTIVITY MAP C; Jones CH, 1996, NATURE, V381, P37, DOI 10.1038/381037a0; LACHENBRUCH AH, 1992, J GEOPHYS RES-SOL EA, V97, P4995, DOI 10.1029/91JB01506; Liu M, 1998, GEOLOGY, V26, P299, DOI 10.1130/0091-7613(1998)026<0299:SNUADL>2.3.CO;2; Liu M, 1998, TECTONICS, V17, P311, DOI 10.1029/98TC00313; MA C, 1998, NASA SPACE GEODESY P; MCKENZIE DP, 1969, GEOPHYS J ROY ASTR S, V18, P1, DOI 10.1111/j.1365-246X.1969.tb00259.x; MORSE PM, 1953, METHODS THEORETICAL, P275; MOUNT VS, 1987, GEOLOGY, V15, P1143, DOI 10.1130/0091-7613(1987)15<1143:SOSNTS>2.0.CO;2; PETERSEN MD, 1994, B SEISMOL SOC AM, V84, P1608; POLLITZ FF, 1998, EOS, V79, pF601; SHEEHAN AF, 1991, J GEOPHYS RES-SOL EA, V96, P19981, DOI 10.1029/91JB01988; Shen-Tu B, 1998, J GEOPHYS RES-SOL EA, V103, P18087, DOI 10.1029/98JB01669; Shen-Tu BM, 1999, J GEOPHYS RES-SOL EA, V104, P28927, DOI 10.1029/1999JB900293; Smith DA, 1999, J GEODESY, V73, P219, DOI 10.1007/s001900050239; Sonder LJ, 1999, ANNU REV EARTH PL SC, V27, P417, DOI 10.1146/annurev.earth.27.1.417; STOCK J, 1988, TECTONICS, V7, P1339, DOI 10.1029/TC007i006p01339; Thatcher W, 1999, SCIENCE, V283, P1714, DOI 10.1126/science.283.5408.1714; TOVISH A, 1978, J GEOPHYS RES, V83, P5892, DOI 10.1029/JB083iB12p05892; WDOWINSKI S, 1991, J GEOPHYS RES-SOLID, V96, P12245, DOI 10.1029/91JB01196; Wernicke B., 1992, CORDILLERAN OROGEN C, P553, DOI DOI 10.1130/DNAG-GNA-G3.553; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105; ZOBACK ML, 1989, J GEOPHYS RES-SOLID, V94, P7105, DOI 10.1029/JB094iB06p07105; ZOBACK ML, 1992, J GEOPHYS RES-SOL EA, V97, P11703, DOI 10.1029/92JB00221	40	181	188	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2000	287	5454					834	836		10.1126/science.287.5454.834	http://dx.doi.org/10.1126/science.287.5454.834			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657292				2022-12-28	WOS:000085136400039
J	Blower, SM; Gershengorn, HB; Grant, RM				Blower, SM; Gershengorn, HB; Grant, RM			A tale of two futures: HIV and antiretroviral therapy in San Francisco	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTRINSIC TRANSMISSION DYNAMICS; SENSITIVITY ANALYSIS; TUBERCULOSIS EPIDEMICS; REVERSE-TRANSCRIPTASE; COMPUTER-MODELS; RESISTANCE; INFECTION; PROTEASE; MEN	The effect of antiretroviral therapy (ART) in preventing human immunodeficiency virus (HIV) infections and averting acquired immunodeficiency syndrome (AIDS) deaths in the San Francisco gay community over the next 10 years was predicted. A transmission model was coupled with a statistical approach that enabled inclusion of a high degree of uncertainty in the potential treatment effects of ART (in terms of infectivity and survival), increase in risky behavior, and rate of emergence of drug resistance. Increasing the usage of ART in San Francisco would decrease the AIDS death rate and could substantially reduce the incidence rate.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Blower, SM (corresponding author), Univ Calif San Francisco, Dept Med, 513 Parnassus,Box 0414, San Francisco, CA 94143 USA.			Grant, Robert/0000-0002-0851-7085	NIAID NIH HHS [AI41935, AI42923] Funding Source: Medline; NIMH NIH HHS [P30-MH59037] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON RM, 1991, NATURE, V350, P356, DOI 10.1038/350356a0; Blower S, 1999, NAT MED, V5, P358, DOI 10.1038/7328; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 1998, NAT MED, V4, P673, DOI 10.1038/nm0698-673; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Cavert W, 1997, SCIENCE, V276, P960, DOI 10.1126/science.276.5314.960; CONDRA J, 1995, 4 INT WORKSH HIV DRU; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; DEEKS S, 1999, ANTIVIR THER, V4, P92; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Eron JJ, 1998, AIDS, V12, pF181, DOI 10.1097/00002030-199815000-00003; Fiscus SA, 1998, AIDS RES HUM RETROV, V14, pS27; GRANT RM, 1987, J INFECT DIS, V156, P189, DOI 10.1093/infdis/156.1.189; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; GUPTA S, 1993, SIAM REV, V35, P1, DOI 10.1137/1035001; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; HSIEH YH, 1995, BIOSYSTEMS, V35, P75, DOI 10.1016/0303-2647(94)01482-M; IMAN RL, 1981, J QUAL TECHNOL, V13, P232, DOI 10.1080/00224065.1981.11978763; IMAN RL, 1981, J QUAL TECHNOL, V13, P174, DOI 10.1080/00224065.1981.11978748; LAND S, 1992, J INFECT DIS, V166, P1139, DOI 10.1093/infdis/166.5.1139; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; PAGESHAFER KA, 1999, MMWR-MORBID MORTAL W, V48, P45; PALTIEL AD, 1991, J ACQ IMMUN DEF SYND, V4, P795; POLLACK L, COMMUNICATION; Porco TC, 1998, INTERFACES, V28, P167, DOI 10.1287/inte.28.3.167; Porco TC, 1998, THEOR POPUL BIOL, V54, P117, DOI 10.1006/tpbi.1998.1366; *SAN FRANC DEP PUB, 1999, Q AIDS SURV REP JUN; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; STALL R, UNPUB; Staprans S, 1999, AIDS, V13, P1051, DOI 10.1097/00002030-199906180-00008; VELASCOHERNANDE.JX, UNPUB; VelascoHernandez JX, 1996, IMA J MATH APPL MED, V13, P175; VELASCOHERNANDEZ JX, 1994, J MATH BIOL, V32, P233, DOI 10.1007/BF00163880; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	47	292	298	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					650	654		10.1126/science.287.5453.650	http://dx.doi.org/10.1126/science.287.5453.650			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649998				2022-12-28	WOS:000084989400047
J	Sterling, TR; Pope, DS; Bishai, WR; Harrington, S; Gershon, RR; Chaisson, RE				Sterling, TR; Pope, DS; Bishai, WR; Harrington, S; Gershon, RR; Chaisson, RE			Transmission of Mycobacterium tuberculosis from a cadaver to an embalmer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDENTIFICATION; RISK		Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Baltimore City Hlth Dept, Eastern Chest Clin, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sterling, TR (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 E Monument St,Rm 444, Baltimore, MD 21287 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040605] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40605] Funding Source: Medline; PHS HHS [U300466-10] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1994, MMWR-MORBID MORTAL W, V43, P1; Behr MA, 1997, CLIN INFECT DIS, V25, P806, DOI 10.1086/515550; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P1140, DOI 10.1164/ajrccm.155.3.9117000; Gershon RRM, 1998, J OCCUP ENVIRON MED, V40, P497, DOI 10.1097/00043764-199805000-00014; KANTOR HS, 1988, AM J MED, V84, P833, DOI 10.1016/0002-9343(88)90060-5; McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591; MEADE GM, 1949, AM REV TUBERC PULM, V59, P429; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; *OSHA CPL, 1996, 2106 OSHA CPL; TEMPLETON GL, 1995, ANN INTERN MED, V122, P922, DOI 10.7326/0003-4819-122-12-199506150-00005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WEED LA, 1951, AM J CLIN PATHOL, V21, P1114	13	52	57	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					246	248		10.1056/NEJM200001273420404	http://dx.doi.org/10.1056/NEJM200001273420404			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277PB	10648766	Bronze			2022-12-28	WOS:000084941000004
J	Weeks, DL; Eskandari, S; Scott, DR; Sachs, G				Weeks, DL; Eskandari, S; Scott, DR; Sachs, G			A H+-gated urea channel: The link between Helicobacter pylori urease and gastric colonization	SCIENCE			English	Article							PROTEIN; PH; TRANSPORTER; METABOLISM; MEMBRANES; ACID	Acidic media trigger cytoplasmic urease activity of the unique human gastric pathogen Helicobacter pylori. Deletion of urel prevents this activation of cytoplasmic urease that is essential for bacterial acid resistance. Urel is an inner membrane protein with six transmembrane segments as shown by in vitro transcription/translation and membrane separation. Expression of Urel in Xenopus oocytes results in acid-stimulated urea uptake, with a pH profile similar to activation of cytoplasmic urease, Mutation of periplasmic histidine 123 abolishes stimulation. Urel-mediated transport is urea specific, passive, nonsaturable, nonelectrogenic, and temperature independent. Urel functions as a H+-gated urea channel regulating cytoplasmic urease that is essential for gastric survival and colonization.	VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sachs, G (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046917, P30DK041301, S15DK043462] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46917, DK43462, DK41301] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bayle D, 1997, J BIOL CHEM, V272, P19697, DOI 10.1074/jbc.272.32.19697; BODE G, 1993, MED MICROBIOL IMMUN, V182, P223; Chebrou H, 1996, GENE, V182, P215, DOI 10.1016/S0378-1119(96)00478-7; CHEN BW, 1994, BIOTECHNIQUES, V17, P657; CUSSAC V, 1992, J BACTERIOL, V174, P2466, DOI 10.1128/jb.174.8.2466-2473.1992; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; HU LT, 1992, INFECT IMMUN, V60, P2657, DOI 10.1128/IAI.60.7.2657-2666.1992; KATAYAMA Y, 1991, J PHYSIOL-LONDON, V443, P587, DOI 10.1113/jphysiol.1991.sp018853; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; McGowan CC, 1996, GASTROENTEROLOGY, V110, P926, DOI 10.1053/gast.1996.v110.pm8608904; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; ORBACH E, 1980, J GEN PHYSIOL, V75, P427, DOI 10.1085/jgp.75.4.427; Phadnis SH, 1996, INFECT IMMUN, V64, P905, DOI 10.1128/IAI.64.3.905-912.1996; Rektorschek M, 1998, GASTROENTEROLOGY, V115, P628, DOI 10.1016/S0016-5085(98)70142-8; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; Shayakul C, 1996, J CLIN INVEST, V98, P2580, DOI 10.1172/JCI119077; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; TAYLOR MB, 1988, FEMS MICROBIOL LETT, V55, P259, DOI 10.1016/0378-1097(88)90034-1; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; TUDOR JJ, 1994, J BACTERIOL, V176, P948, DOI 10.1128/JB.176.4.948-952.1994; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631	22	335	359	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					482	485		10.1126/science.287.5452.482	http://dx.doi.org/10.1126/science.287.5452.482			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642549				2022-12-28	WOS:000084929900047
J	Braden, B; Teuber, G; Dietrich, CF; Caspary, WF; Lembcke, B				Braden, B; Teuber, G; Dietrich, CF; Caspary, WF; Lembcke, B			Comparison of new faecal antigen test with C-13-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation	BRITISH MEDICAL JOURNAL			English	Article									Univ Hosp Frankfurt, Dept Med 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Braden, B (corresponding author), Univ Hosp Frankfurt, Dept Med 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.		Braden, Barbara/AAH-8693-2021; Braden, Barbara/AAI-7869-2020; Dietrich, Christoph/AAB-7514-2020	Braden, Barbara/0000-0002-8534-6873; 				BRADEN B, 1994, Z GASTROENTEROL, V32, P198; GRAHAM DY, 1987, LANCET, V2, P174; PerezPerez GI, 1997, CLIN INFECT DIS, V25, P1038, DOI 10.1086/516089; SCHURMANN D, 1988, BLUT, V56, P27, DOI 10.1007/BF00321056; Vaira D, 1999, LANCET, V354, P30, DOI 10.1016/S0140-6736(98)08103-3	5	56	57	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					148	148		10.1136/bmj.320.7228.148	http://dx.doi.org/10.1136/bmj.320.7228.148			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634733	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000084860300023
J	Zwart, S; Sachs, APE; Ruijs, GJHM; Gubbels, JW; Hoes, AW; de Melker, RA				Zwart, S; Sachs, APE; Ruijs, GJHM; Gubbels, JW; Hoes, AW; de Melker, RA			Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults	BRITISH MEDICAL JOURNAL			English	Article							BETA-HEMOLYTIC STREPTOCOCCI; GROUP-A STREPTOCOCCI; CONTROLLED CLINICAL-TRIAL; DUTCH GENERAL-PRACTICE; PRESCRIBING STRATEGIES; COLLEGE-STUDENTS; PHARYNGITIS; ANTIBIOTICS; PHARYNGOTONSILLITIS; MANAGEMENT	Objective To assess whether treatment with penicillin for three days and the traditional treatment for seven days were equally as effective at accelerating resolution of symptoms in patients with sore throat compared with placebo. Design Randomised double blind placebo controlled trial. Setting 43 family practices in the Netherlands. Participants 561 patients, aged 15-60 years, with sore throat for less than seven days and at least three of four Center criteria-that is, history of fever, absence of cough, swollen tender anterior cervical lymph nodes, and tonsillar exudate. 142 patients were excluded for medical reasons and 73 needed penicillin. Interventions Patients were randomly assigned to penicillin V for seven days, penicillin V for three days followed by placebo for four days, or placebo for seven days. Main outcome measures Resolution of symptoms in the first week, eradication of bacteria after two weeks, and recurrences of sore throat after two, four, and six months. Results Symptoms resolved 1.9 and 1.7 days earlier patients taking penicillin for seven days than in those taking penicillin for three days or placebo Symptoms resolved 2.5 days earlier in patients with group A streptococci and 1.3 days earlier in patients with high colony counts of non-group A streptococci. 23 (13%) of the placebo group had to be given antibiotics later in the week because of clinical deterioration; three developed a peritonsillar abscess. The eradication rate for group A streptococci was 72% in the seven day penicillin group, 41% in the three day penicillin group, and 7% in the placebo group. Sore throat recurred more often in the three day penicillin group than in the seven day penicillin or placebo groups. Conclusion Penicillin treatment for seven days was superior to treatment for three days or placebo in resolving symptoms of sore throat in patients with group A streptococcal pharyngitis and, possibly, in those with non-group A streptococcal pharyngitis.	Univ Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, NL-3584 CG Utrecht, Netherlands; Isala Clin, Lab Microbiol & Infect Dis, Zwolle, Netherlands; Org Advice Res & Policymaking, Grave, Netherlands	Utrecht University; Utrecht University Medical Center; Isala Clinics	Zwart, S (corresponding author), Univ Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, NL-3584 CG Utrecht, Netherlands.							Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; CHAPPLE PAL, 1956, BMJ-BRIT MED J, V1, P705, DOI 10.1136/bmj.1.4969.705; CIMOLAI N, 1988, REV INFECT DIS, V10, P587; DAGNELIE CF, 1993, FAM PRACT, V10, P371, DOI 10.1093/fampra/10.4.371; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DELMAR CB, 1999, COCHRANE LIB; DEMELKER RA, 1991, BRIT J GEN PRACT, V41, P504; deMelker RA, 1997, INT J ANTIMICROB AG, V9, P43, DOI 10.1016/S0924-8579(97)00025-3; DEMEYERE M, 1992, EUR J CLIN PHARMACOL, V43, P581, DOI 10.1007/BF02284954; Falck G, 1997, SCAND J INFECT DIS, V29, P239, DOI 10.3109/00365549709019035; GERBER MA, 1987, AM J DIS CHILD, V141, P224, DOI 10.1001/archpedi.1987.04460020114043; Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365; Howe RW, 1997, BRIT J GEN PRACT, V47, P280; Kaplan EL, 1997, CLIN INFECT DIS, V24, pS89, DOI 10.1093/clinids/24.Supplement_1.S89; KELLOGG JA, 1986, JAMA-J AM MED ASSOC, V255, P2638, DOI 10.1001/jama.255.19.2638; Kolmos HJ, 1999, BRIT MED J, V318, P799, DOI 10.1136/bmj.318.7186.799; Kozyrskyj AL, 1998, JAMA-J AM MED ASSOC, V279, P1736, DOI 10.1001/jama.279.21.1736; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Marlow R A, 1989, Fam Med, V21, P425; MELAND E, 1993, SCAND J INFECT DIS, V25, P177, DOI 10.3109/00365549309008482; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Petersen K, 1997, J GEN INTERN MED, V12, P95, DOI 10.1046/j.1525-1497.1997.00013.x; SCHROCK CG, 1992, J FAM PRACTICE, V35, P622; SCHWARTZ RH, 1981, JAMA-J AM MED ASSOC, V246, P1790, DOI 10.1001/jama.246.16.1790; STROMBERG A, 1988, SCAND J INFECT DIS, V20, P37, DOI 10.3109/00365548809117215; Turner JC, 1997, J CLIN MICROBIOL, V35, P1; TURNER JC, 1990, JAMA-J AM MED ASSOC, V264, P2644, DOI 10.1001/jama.264.20.2644; WHITFIELD MJ, 1981, PRACTITIONER, V225, P236; WILLIAMS JW, 1995, JAMA-J AM MED ASSOC, V273, P1015, DOI 10.1001/jama.273.13.1015	32	125	129	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					150	154		10.1136/bmj.320.7228.150	http://dx.doi.org/10.1136/bmj.320.7228.150			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634735	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000084860300025
J	Gryfe, R; Kim, H; Hsieh, ETK; Aronson, MD; Holowaty, EJ; Bull, SB; Redston, M; Gallinger, S				Gryfe, R; Kim, H; Hsieh, ETK; Aronson, MD; Holowaty, EJ; Bull, SB; Redston, M; Gallinger, S			Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLON-CANCER; DNA-REPLICATION ERRORS; GENETIC INSTABILITY; MUTATIONS; HOMOLOG; HMLH1; CARCINOGENESIS; EXPRESSION; SEQUENCES; POLYPOSIS	Background: Colorectal cancer can arise through two distinct mutational pathways: microsatellite instability or chromosomal instability. We tested the hypothesis that colorectal cancers arising from the microsatellite-instability pathway have distinctive clinical attributes that affect clinical outcome. Methods: We tested specimens of colorectal cancer from a population-based series of 607 patients (50 years of age or younger at diagnosis) for microsatellite instability. We compared the clinical features and survival of patients who had colorectal cancer characterized by high-frequency microsatellite instability with these characteristics in patients who had colorectal cancers with microsatellite stability. Results: We found high-frequency microsatellite instability in 17 percent of the colorectal cancers in 607 patients, and in a multivariate analysis, microsatellite instability was associated with a significant survival advantage independently of all standard prognostic factors, including tumor stage (hazard ratio, 0.42; 95 percent confidence interval, 0.27 to 0.67; P<0.001). Furthermore, regardless of the depth of tumor invasion, colorectal cancers with high-frequency microsatellite instability had a decreased likelihood of metastasizing to regional lymph nodes (odds ratio, 0.33; 95 percent confidence interval, 0.21 to 0.53; P<0.001) or distant organs (odds ratio, 0.49; 95 percent confidence interval, 0.27 to 0.89; P=0.02). Conclusions: High-frequency microsatellite instability in colorectal cancer is independently predictive of a relatively favorable outcome and, in addition, reduces the likelihood of metastases. (N Engl J Med 2000;342:69-77.) (C) 2000, Massachusetts Medical Society.	Samuel Lunenfeld Res Inst, Ctr Canc Genet, Toronto, ON, Canada; Samuel Lunenfeld Res Inst, Div Clin Epidemiol, Toronto, ON, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Gallinger, S (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Suite 1225, Toronto, ON M5G 1X5, Canada.		Bull, Shelley B/A-1920-2013; Gryfe, Robert/AAF-1870-2021; Gallinger, Steven/E-4575-2013					AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; *AM JOINT COMM CAN, 1997, AJCC CANC STAG MAN; Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931; Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Bubb VJ, 1996, ONCOGENE, V12, P2641; Claij N, 1999, EXP CELL RES, V246, P1, DOI 10.1006/excr.1998.4299; COX DR, 1972, J R STAT SOC B, V34, P187; Dietmaier W, 1997, CANCER RES, V57, P4749; Fielding LP, 1995, ARCH PATHOL LAB MED, V119, P1115; FISHEL R, 1994, CELL, V77, P167; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Holowaty E, 1995, CANC INCIDENCE ONTAR; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jass JR, 1989, WHO INT HISTOLOGICAL, V2nd; Johannsdottir JT, 1999, ANTICANCER RES, V19, P1821; Kane MF, 1997, CANCER RES, V57, P808; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KIM HG, 1994, AM J PATHOL, V145, P148; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Ko JMY, 1999, INT J CANCER, V84, P404, DOI 10.1002/(SICI)1097-0215(19990820)84:4&lt;404::AID-IJC13&gt;3.0.CO;2-L; Konishi M, 1996, GASTROENTEROLOGY, V111, P307, DOI 10.1053/gast.1996.v111.pm8690195; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; LOEB LA, 1991, CANCER RES, V51, P3075; LOEB LA, 1974, CANCER RES, V34, P2311; LOTHE RA, 1993, CANCER RES, V53, P5849; Lukish JR, 1998, ANN SURG, V227, P51, DOI 10.1097/00000658-199801000-00008; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Messerini L, 1999, HUM PATHOL, V30, P629, DOI 10.1016/S0046-8177(99)90086-2; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; *NAT CANC I CAN, 1999, CAN CANC STAT 1999; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Salahshor S, 1999, BRIT J CANCER, V81, P190, DOI 10.1038/sj.bjc.6690676; Sparks AB, 1998, CANCER RES, V58, P1130; STRAND M, 1994, NATURE, V368, P569, DOI 10.1038/368569a0; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	48	1027	1063	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					69	77		10.1056/NEJM200001133420201	http://dx.doi.org/10.1056/NEJM200001133420201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631274				2022-12-28	WOS:000084723900001
J	Imamizu, H; Miyauchi, S; Tamada, T; Sasaki, Y; Takino, R; Putz, B; Yoshioka, T; Kawato, M				Imamizu, H; Miyauchi, S; Tamada, T; Sasaki, Y; Takino, R; Putz, B; Yoshioka, T; Kawato, M			Human cerebellar activity reflecting an acquired internal model of a new tool	NATURE			English	Article							OCULAR FOLLOWING RESPONSES; TEMPORAL FIRING PATTERNS; PURKINJE-CELLS; VENTRAL PARAFLOCCULUS; COMPLEX SPIKES; HUMAN BRAIN; ACTIVATION; MOVEMENT; MONKEYS; ADAPTATION	Theories of motor control postulate that the brain uses internal models of the body to control movements accurately. Internal models are neural representations of how, for instance, the arm would respond to a neural command, given its current position and velocity(1-6), Previous studies have shown that the cerebellar cortex can acquire internal models through motor learning(7-11). Because the human cerebellum is involved in higher cognitive function(12-15) as well as in motor control, we propose a coherent computational theory in which the phylogenetically newer part of the cerebellum similarly acquires internal models of objects in the external world. While human subjects learned to use a new tool (a computer mouse with a novel rotational transformation), cerebellar activity was measured by functional magnetic resonance imaging, As predicted by our theory, two types of activity were observed. One was spread over wide areas of the cerebellum and was precisely proportional to the error signal that guides the acquisition of internal models during learning. The other was confined to the area near the posterior superior fissure and remained even after learning, when the error levels had been equalized, thus probably reflecting an acquired internal model of the new tool.	JST ERATO Kawato Dynam brain Project, Seika, Kyoto 6190288, Japan; Commun Res Lab, Nishi Ku, Kobe, Hyogo 6512401, Japan; Shiraume Gakuen Coll, Kodaira, Tokyo 1878570, Japan; ATR Human Informat Proc Res Labs, Seika, Kyoto 6190288, Japan	Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan	Imamizu, H (corresponding author), JST ERATO Kawato Dynam brain Project, 2-2 Hikaridai, Seika, Kyoto 6190288, Japan.		Pütz, Benno/P-2630-2016; Imamizu, Hiroshi/AAK-6059-2020	Pütz, Benno/0000-0002-2208-209X; Imamizu, Hiroshi/0000-0003-1024-0051; Sasaki, Yuka/0000-0002-0061-0250				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Flament D, 1996, HUM BRAIN MAPP, V4, P210, DOI 10.1002/hbm.460040302; FRISTON KJ, 1992, P ROY SOC B-BIOL SCI, V248, P223, DOI 10.1098/rspb.1992.0065; Gomi H, 1998, J NEUROPHYSIOL, V80, P818, DOI 10.1152/jn.1998.80.2.818; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Grafton S T, 1994, Hum Brain Mapp, V1, P221, DOI 10.1002/hbm.460010307; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P1174, DOI 10.1037/0096-1523.21.5.1174; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KAWATO M, 1992, BIOL CYBERN, V68, P95, DOI 10.1007/BF00201431; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Kobayashi Y, 1998, J NEUROPHYSIOL, V80, P832, DOI 10.1152/jn.1998.80.2.832; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; ROLAND PE, 1988, EUR J NEUROSCI, V1, P3; SASAKI K, 1977, EXP BRAIN RES, V29, P419; SEITZ RJ, 1994, NEUROREPORT, V5, P2541, DOI 10.1097/00001756-199412000-00034; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Tamada T, 1999, NEUROREPORT, V10, P325, DOI 10.1097/00001756-199902050-00022; Thach W. T., 1996, Behavioral and Brain Sciences, V19, P411; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	30	678	682	1	39	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					192	195		10.1038/35003194	http://dx.doi.org/10.1038/35003194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275TB	10646603				2022-12-28	WOS:000084835300054
J	Miller, ST; Sleeper, LA; Pegelow, CH; Enos, LE; Wang, WC; Weiner, SJ; Wethers, DL; Smith, J; Kinney, TR				Miller, ST; Sleeper, LA; Pegelow, CH; Enos, LE; Wang, WC; Weiner, SJ; Wethers, DL; Smith, J; Kinney, TR			Prediction of adverse outcomes in children with sickle cell disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-CLUSTER HAPLOTYPES; RISK-FACTORS; FETAL HEMOGLOBIN; ANEMIA; MORTALITY; DISORDERS; MORBIDITY; FAILURE; COHORT; RATES	Background: The ability to identify infants with sickle cell anemia who are likely to have severe complications later in life would permit accurate prognostication and tailoring of therapy to match disease-related risks and facilitate planning of clinical trials. We attempted to define the features of such babies by following the clinical course of 392 children with sickle cell disease from infancy to about the age of 10 years. Methods: We analyzed the records of 392 infants who received the diagnosis of homozygous sickle cell anemia or sickle cell-beta(0)-thalassemia before the age of six months and for whom comprehensive clinical and laboratory data were recorded prospectively; data were available for a mean (+/-SD) of 10.0+/-4.8 years. Results obtained before the age of two years were evaluated to determine whether they predicted the outcome later in life. Results: Of the 392 infants in the cohort, 70 (18 percent) subsequently had an adverse outcome, defined as death (18 patients [26 percent]), stroke (25 [36 percent]), frequent pain (17 [24 percent]), or recurrent acute chest syndrome (10 [14 percent]). Using multivariate analysis, we found three statistically significant predictors of an adverse outcome: an episode of dactylitis (defined as pain and tenderness in the hands or feet) before the age of one year (relative risk of an adverse outcome, 2.55; 95 percent confidence interval, 1.39 to 4.67), a hemoglobin level of less than 7 g per deciliter (relative risk, 2.47; 95 percent confidence interval, 1.14 to 5.33), and leukocytosis in the absence of infection (relative risk, 1.80; 95 percent confidence interval, 1.05 to 3.09). Conclusions: Three easily identifiable manifestations of sickle cell disease that may appear in the first two years of life (dactylitis, severe anemia, and leukocytosis) can help to predict the possibility of severe sickle cell disease later in life. (N Engl J Med 2000;342:83-9.) (C) 2000, Massachusetts Medical Society.	Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; New England Res Inst, Watertown, MA 02172 USA; Univ Miami, Miami, FL 33152 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; St Lukes Roosevelt Hosp, New York, NY USA; Harlem Hosp Med Ctr, New York, NY USA; Duke Univ, Med Ctr, Durham, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; HealthCore, Inc; University of Miami; St Jude Children's Research Hospital; Mount Sinai St. Luke's; Mount Sinai West; Duke University	Miller, ST (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,Box 49, Brooklyn, NY 11203 USA.	stmseelig@aol.com			NHLBI NIH HHS [N01-HB-47110] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB047110] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams Junius G. Iii, 1994, P457; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; Bratt J, 1997, J IMMUNOL, V159, P912; BRAY GL, 1994, AM J PEDIAT HEMATOL, V16, P50; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; COX DR, 1972, J R STAT SOC B, V34, P187; Efron B., 1993, INTRO BOOTSTRAP, P141; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; GASTON M, 1987, CONTROL CLIN TRIALS, V8, pS131; GASTON M, 1982, AM J PEDIAT HEMATOL, V4, P197; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; KOSHY M, 1989, BLOOD, V74, P1403; Koshy M, 1990, J Assoc Acad Minor Phys, V1, P71; LANE PA, 1995, BLOOD, V85, P2238, DOI 10.1182/blood.V85.8.2238.bloodjournal8582238; LEIKIN SL, 1989, PEDIATRICS, V84, P500; MILNER PF, 1991, NEW ENGL J MED, V325, P1476, DOI 10.1056/NEJM199111213252104; Moser FG, 1996, AM J NEURORADIOL, V17, P965; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pass KA, 1994, NEWBORN SCREENING SI, P29; PEARSON HA, 1985, PEDIATRICS, V76, P392; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1988, MEDICINE, V67, P66, DOI 10.1097/00005792-198801000-00005; POWARS DR, 1991, HEMATOL ONCOL CLIN N, V5, P475, DOI 10.1016/S0889-8588(18)30426-X; POWARS DR, 1991, SEMIN HEMATOL, V28, P202; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; REID CD, 1995, NIH PUBLICATION; Walters MC, 1996, NEW ENGL J MED, V335, P369, DOI 10.1056/NEJM199608083350601; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEST MS, 1992, J CLIN EPIDEMIOL, V45, P893; WRIGHTSTONE RN, 1974, AM J CLIN PATHOL, V61, P375; ZARKOWSKY HS, 1986, J PEDIATR-US, V109, P579, DOI 10.1016/S0022-3476(86)80216-5	37	320	329	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					83	89		10.1056/NEJM200001133420203	http://dx.doi.org/10.1056/NEJM200001133420203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631276				2022-12-28	WOS:000084723900003
J	Parker, MJ				Parker, MJ			Evidence based case report - Managing an elderly patient with a fractured femur	BRITISH MEDICAL JOURNAL			English	Review									Peterborough Dist Gen Hosp, Dept Orthopaed, Peterborough PE3 6DA, England		Parker, MJ (corresponding author), Peterborough Dist Gen Hosp, Dept Orthopaed, Peterborough PE3 6DA, England.							*AM COLL PHYS, 1998, BEST EV, V2; AVENELL A, 1999, COCHRANE LIB; CAMERON I, 1999, COCHRANE LIB; *COCHR COLL, 1997, COCHR LIB DAT DISK C; GILLESPIE WJ, 1999, COCHRANE LIB; HANDOLL HHG, 1999, COCHRANE LIB; PARKER MJ, 1999, COCHRANE LIB; *SCOTT INT GUID NE, 1995, PROPH VEN THROMB; *SCOTT INT GUID NE, 1997, MAN ELD PEOPL FRACT; SHEPPERD S, 1999, COCHRANE LIB; *U YORK NHS CTR RE, 1995, 2 NHS CDR U YORK CTR; 1996, EFFECTIVE HLTH CARE, V4; 1997, BANDOLIER, V37	13	9	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 8	2000	320	7227					102	103		10.1136/bmj.320.7227.102	http://dx.doi.org/10.1136/bmj.320.7227.102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274CR	10625268	Green Published			2022-12-28	WOS:000084746600022
J	Abbas, AK; Janeway, CA				Abbas, AK; Janeway, CA			Immunology: Improving on nature in the twenty-first century	CELL			English	Review							T-CELL RECEPTOR; IMMUNE-SYSTEM; ANTIGEN; LYMPHOCYTES; ACTIVATION; RECOGNITION; MOLECULES; COMPLEX; PEPTIDE; SELF		Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94123 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	University of California System; University of California San Francisco; Yale University	Abbas, AK (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94123 USA.							Abbas A K, 2003, CELL MOL IMMUNOL, P115; Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bjorkman PJ, 1997, CELL, V89, P167, DOI 10.1016/S0092-8674(00)80195-6; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HENDRICK SM, 1984, NATURE, V308, P149; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Janeway C.A., 1999, IMMUNOBIOLOGY IMMUNE; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jenner E, 1798, INQUIRY CAUSES EFFEC; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KATZ DH, 1973, J EXP MED, V138, P734, DOI 10.1084/jem.138.3.734; Kenyon NS, 1999, P NATL ACAD SCI USA, V96, P8132, DOI 10.1073/pnas.96.14.8132; KIM J, 1985, J EXP MED, V162, P188, DOI 10.1084/jem.162.1.188; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Libby P, 1999, CIRCULATION, V100, P1148, DOI 10.1161/01.CIR.100.11.1148; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; Metchnikoff E., 1893, LECT COMP PATHOLOGY; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PAUL WE, 1999, FUNDAMENTAL IMMUNOLO, P1589; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Rose N, 1998, AUTOIMMUNE DIS; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TONEGAWA S, 1976, COLD SPRING HARB SYM, V41, P877; Van Parijs L, 1998, SCIENCE, V280, P243; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	65	63	73	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					129	138		10.1016/S0092-8674(00)81689-X	http://dx.doi.org/10.1016/S0092-8674(00)81689-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647937	Bronze			2022-12-28	WOS:000084722600011
J	Brent, R				Brent, R			Genomic biology	CELL			English	Review							GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; BACTERIOPHAGE-LAMBDA; RIGHT OPERATOR; SINGLE-CELL; DNA; HYBRIDIZATION; PROTEIN; YEAST; RNA		Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Brent, R (corresponding author), Inst Mol Sci, 2168 Shattuck Ave, Berkeley, CA 94704 USA.							Abler R.F., 1987, INT J GEOGR INF SYST, V1, P303, DOI [10.1080/02693798708927819, DOI 10.1080/02693798708927819]; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bacon Francis, 1901, NOVUM ORGANUM; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradnam KR, 1999, MOL BIOL EVOL, V16, P666, DOI 10.1093/oxfordjournals.molbev.a026149; Carey M. J., 1995, Proceedings RIDE-DOM '95. Fifth International Workshop on Research Issues in Data Engineering-Distributed Object Management (Cat.No.95TH8039), P124, DOI 10.1109/RIDE.1995.378736; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CODD EF, 1970, COMMUN ACM, V13, P377, DOI 10.1145/357980.358007; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; DAMELIN M, 2000, IN PRESS MOL CELL, V5; DATE CJ, 1994, INTRO DATABASE SYSTE; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DELBRUCK M, 1945, J BACTERIOL, V50, P131; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; EDWARDS MD, 1987, GENETICS, V116, P113; Eichelbaum M, 1996, CLIN EXP PHARMACOL P, V23, P983, DOI 10.1111/j.1440-1681.1996.tb01154.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ELOWITZ MB, 2000, IN PRESS NATURE; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; FORESMAN TW, 1980, HIST GEOGRAPHIC INFO; Geyer CR, 1999, P NATL ACAD SCI USA, V96, P8567, DOI 10.1073/pnas.96.15.8567; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haas LM, 1997, PROCEEDINGS OF THE TWENTY-THIRD INTERNATIONAL CONFERENCE ON VERY LARGE DATABASES, P276; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horn F, 1998, RECEPTOR CHANNEL, V5, P305; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KELLY K, 1993, WIRED, V1, P100; Keogh RS, 1998, YEAST, V14, P443, DOI 10.1002/(SICI)1097-0061(19980330)14:5<443::AID-YEA243>3.0.CO;2-L; KHINAI, 1957, MATH FDN INFROMATION; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kuipers B., 1994, QUALITATIVE REASONIN; LANDER ES, 1989, GENETICS, V121, P185; LEWIS A, 1925, ARROWSMITH; Link AJ, 1997, ELECTROPHORESIS, V18, P1314, DOI 10.1002/elps.1150180808; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Maniatis T., 1982, MOL CLONING; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McCalla W. J., 1988, FUNDAMENTALS COMPUTE; MELTON DA, 1985, P NATL ACAD SCI USA, V82, P144, DOI 10.1073/pnas.82.1.144; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Owens K, 1999, SCIENCE, V286, P451, DOI 10.1126/science.286.5439.451; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peckol EL, 1999, DEVELOPMENT, V126, P1891; REICHARDT LF, 1975, J MOL BIOL, V93, P267, DOI 10.1016/0022-2836(75)90132-1; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sax K, 1923, GENETICS, V8, P552; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; STENT GS, 1968, SCIENCE, V160, P390, DOI 10.1126/science.160.3826.390; STENT GS, 1985, CELL, V40, P1, DOI 10.1016/0092-8674(85)90299-5; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; THOMAS JH, 1993, GENETICS, V134, P1105; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; Venkatesh B, 1997, P NATL ACAD SCI USA, V94, P12462, DOI 10.1073/pnas.94.23.12462; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; WEINSTEIN JN, 1994, STEM CELLS, V12, P13, DOI 10.1002/stem.5530120106; Weinstein JN, 1998, SCIENCE, V282, P628; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Xu CW, 1997, P NATL ACAD SCI USA, V94, P12473, DOI 10.1073/pnas.94.23.12473; YOSHIDA M, 1995, TRANSGENIC RES, V4, P277, DOI 10.1007/BF01969122; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	99	120	133	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					169	183		10.1016/S0092-8674(00)81693-1	http://dx.doi.org/10.1016/S0092-8674(00)81693-1			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647941	Bronze			2022-12-28	WOS:000084722600015
J	Cox, PA				Cox, PA			Will tribal knowledge survive the millennium?	SCIENCE			English	Editorial Material									Natl Trop Bot Garden, Kauai, HI 96765 USA		Cox, PA (corresponding author), Natl Trop Bot Garden, POB 340, Kauai, HI 96765 USA.								0	153	168	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 7	2000	287	5450					44	45		10.1126/science.287.5450.44	http://dx.doi.org/10.1126/science.287.5450.44			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	271DG	10644221				2022-12-28	WOS:000084578400023
J	Oldstone, MBA; Levine, AJ				Oldstone, MBA; Levine, AJ			Virology in the next millennium	CELL			English	Review							T-CELL LEUKEMIA; DEPENDENT DNA POLYMERASE; SV40-TRANSFORMED CELLS; VIRUS; RETROVIRUS; ANTIGEN; RESOLUTION; VIRIONS; VACCINE; PATIENT		Scripps Res Inst, La Jolla, CA 92037 USA; Rockefeller Inst, New York, NY 10021 USA	Scripps Research Institute; Rockefeller University	Oldstone, MBA (corresponding author), Scripps Res Inst, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.							AGRAMONTE A, 1903, J AM MED ASS, V40; ARBER W, 1978, NOBEL LECT; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Beijerinck M. W., 1898, VERHANDELINGEN KONIN, V6, P3; BENZER S, 1961, P NATL ACAD SCI USA, V47, P1025, DOI 10.1073/pnas.47.7.1025; BLUMBERG BS, 1967, ANN INTERN MED, V66, P924, DOI 10.7326/0003-4819-66-5-924; Carrel A, 1923, J EXP MED, V38, P407, DOI 10.1084/jem.38.4.407; COHEN SS, 1948, J BIOL CHEM, V174, P281; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; DUBLECCO R, 1953, COLD SPRING HARB SYM, V18, P273; DUESBERG PH, 1970, P NATL ACAD SCI USA, V67, P1673, DOI 10.1073/pnas.67.4.1673; EAGLE H, 1955, J EXP MED, V102, P37, DOI 10.1084/jem.102.1.37; Ellerman V., 1908, ZBL BAKT, V46, P595; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; ENDERS JF, 1980, REV INFECT DIS, V2, P493; ENDERS JF, 1949, SCIENCE, V109, P85, DOI 10.1126/science.109.2822.85; ENDERS JF, 1954, P SOC EXP BIOL MED, V86, P277, DOI 10.3181/00379727-86-21073; Frosch P., 1898, ZTBL BAKT PARASITKDE, V23, P371; FURTH J., 1931, JOUR EXP MED, V53, P715, DOI 10.1084/jem.53.5.715; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; Gallo RC, 1999, P ASSOC AM PHYSICIAN, V111, P560, DOI 10.1046/j.1525-1381.1999.99992.x; GARD S, 1954, NOBEL AWARD PHYSL ME; GOODPASTURE ERNEST W., 1929, MEDICINE, V8, P223, DOI 10.1097/00005792-192905000-00004; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; HAUSEN HZ, 1991, SCIENCE, V254, P1167, DOI 10.1126/science.1659743; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; IVANOVSKI DI, 1899, ZENTRALBL BAKTERIO 2, V5, P250; IVEROFSKY DI, 1892, ST PETERSBERG ACAD I, V35, P67; KAUSCHE GH, 1993, NATURWISSENSCHAFTEN, V27, P292; KOPROWSKI H, 1996, MICROBE HUNTERS THEN, P141; KRUGMAN S, 1962, AM J DIS CHILD, V103, P353, DOI 10.1001/archpedi.1962.02080020365035; Landsteiner K, 1909, CR SOC BIOL, V67, P592; Landsteiner K., 1909, Z IMMUNITATSFORSCH, V2, P377; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Luria SE, 1942, P NATL ACAD SCI USA, V28, P127, DOI 10.1073/pnas.28.4.127; LURIA SE, 1945, GENETICS, V30, P84; Maitland HB, 1928, LANCET, V2, P596; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; MONOD J, 1947, ANN I PASTEUR PARIS, V73, P937; Oldstone M.B.A., 1998, VIRUSES PLAGUES HIST; Oldstone MBA, 1996, CELL, V87, P799, DOI 10.1016/S0092-8674(00)81987-X; POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PURSINER S, 1997, NOBEL LECT; REED W, 1902, AM MED, V3; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rous P, 1936, J EXP MED, V64, P401, DOI 10.1084/jem.64.3.401; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; ROWE WP, 1954, 0050481401 NM NAV ME; SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420; SALK J, 1988, VACCINES PLOTKIN MOR, P205; SHARP PA, 1993, NOBEL LEUREATE MED; SIGURDSSON BJORN, 1954, BRIT VET JOUR, V110, P341; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; STANLEY W. M., 1935, SCIENCE, V81, P644, DOI 10.1126/science.81.2113.644; Stanley Wendell M., 1946, NOBEL LECT; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; THEILER M, 1951, NOBEL PRIZE PHYSL ME; THEILER M, 1937, J EXP MED, V65; Twort FW, 1949, SCI NEWS, V14, P33; Valiee, 1904, CR HEBD ACAD SCI, V139, P331; VARMUS HT, 1989, NOBEL LECT; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; *WHO, 1980, 4 INT PUBL HLTH; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Woodruff AM, 1931, AM J PATHOL, V7, P209; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; ZINKERNAGEL RM, 1996, NOBEL LEUREATE MED	77	6	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					139	142		10.1016/S0092-8674(00)81690-6	http://dx.doi.org/10.1016/S0092-8674(00)81690-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647938	Bronze			2022-12-28	WOS:000084722600012
J	Channell, R; Lomolino, MV				Channell, R; Lomolino, MV			Dynamic biogeography and conservation of endangered species	NATURE			English	Article							EXTINCTION; PATTERNS; TRANSLOCATION; ABUNDANCE; AUSTRALIA; BIRDS	As one moves from the core to the periphery of a species' geographical range, populations occupy less favourable habitats and exhibit lower and more variable densities(1-4). Populations along the periphery of the range tend to be more fragmented and, as a result, are less likely to receive immigrants from other populations. A population's probability of extinction is directly correlated with its variability and inversely correlated with density and immigration rate(5-9). This has led to the prediction that, when a species becomes endangered, its geographical range should contract inwards, with the core populations persisting until the final stages of decline(2,10). Convinced by these logical but untested deductions, conservation biologists and wildlife managers have been instructed to avoid the range periphery when planning conservation strategies or allocating resources for endangered species(11-13). We have analysed range contraction in 245 species from a broad range of taxonomic groups and geographical regions, Here we report that observed patterns of range contraction do not support the above predictions and that most species examined persist in the periphery of their historical geographical ranges.	Ft Hays State Univ, Dept Biol Sci, Hays, KS 67601 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Oklahoma Nat Heritage Inventory, Oklahoma Biol Survey, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Channell, R (corresponding author), Ft Hays State Univ, Dept Biol Sci, Hays, KS 67601 USA.	Rchannel@FHSU.edu						BIBBY CJ, 1994, PHILOS T R SOC B, V344, P35, DOI 10.1098/rstb.1994.0048; Brown J.H., 1995, MACROECOLOGY; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; CHANNELL R, 1998, THESIS U OKLAHOMA; Diamond J.M., 1984, P824; Eastman J. R., 1995, IDRISI WINDOWS VERSI; FRANKLIN J, 1991, CONSERV BIOL, V5, P506, DOI 10.1111/j.1523-1739.1991.tb00358.x; GASTON KJ, 1990, BIOL REV, V65, P105, DOI 10.1111/j.1469-185X.1990.tb01185.x; Goel N., 1974, STOCHASTIC MODELS BI; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Lawton John H., 1995, P147; MAC ARTHUR ROBERT H., 1967; Martin P.S., 1984, P354; Pearl Mary, 1992, P297; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; SHORT J, 1992, BIOL CONSERV, V62, P189, DOI 10.1016/0006-3207(92)91047-V; STEVENS G, 1992, SYSTEMATICS, ECOLOGY, AND THE BIODIVERSITY CRISIS, P40; TOWNS DR, 1994, NEW ZEAL J ZOOL, V21, P325, DOI 10.1080/03014223.1994.9518003; TRACY CR, 1992, AM NAT, V139, P102, DOI 10.1086/285315; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x	23	438	461	3	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					84	86		10.1038/47487	http://dx.doi.org/10.1038/47487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638757				2022-12-28	WOS:000084687400047
J	Wikelski, M; Thom, C				Wikelski, M; Thom, C			Marine iguanas shrink to survive El Nino - Changes in bone metabolism enable these adult lizards to reversibly alter their length.	NATURE			English	Article							AMBLYRHYNCHUS-CRISTATUS; BODY-SIZE; GALAPAGOS	Changes in bone metabolism enable these adult lizards to reversibly alter their length.	Univ Illinois, Dept Ecol Ethol & Evolut, Urbana, IL 61801 USA; Max Planck Inst Behav Physiol, D-82319 Seewiesen, Germany; Univ Bielefeld, D-33501 Bielefeld, Germany; Univ Wurzburg, Dept Biol, D-97072 Wurzburg, Germany	University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society; University of Bielefeld; University of Wurzburg	Wikelski, M (corresponding author), Univ Illinois, Dept Ecol Ethol & Evolut, 515 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA.							Andrews R.M., 1982, Biology of Reptilia, V13, P273; COOPER JE, 1987, J COMP PATHOL, V97, P129, DOI 10.1016/0021-9975(87)90032-6; Enlow D. H., 1969, pUnpaginated; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Grigoriev A I, 1998, Aviakosm Ekolog Med, V32, P21; Jarman P.J., 1979, SERENGETI DYNAMICS E, P130, DOI DOI 10.1086/284321; LAURIE WA, 1990, J ANIM ECOL, V59, P545, DOI 10.2307/4880; LAURIE WA, 1989, GLOBAL ECOLOGICAL CO, P121; MUNDY GR, 1994, NATURE, V367, P216, DOI 10.1038/367216a0; Strollo F, 1998, AVIAT SPACE ENVIR MD, V69, P777; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; WIKELSKI M, 1994, BEHAVIOUR, V128, P255, DOI 10.1163/156853994X00280; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; WRONSKI TJ, 1982, METAB BONE DIS RELAT, V4, P69, DOI 10.1016/0221-8747(82)90011-X	15	157	162	1	129	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					37	38		10.1038/47396	http://dx.doi.org/10.1038/47396			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638740				2022-12-28	WOS:000084687400030
J	Servan-Schreiber, D				Servan-Schreiber, D			For what purpose?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					18	19		10.1001/jama.283.1.18	http://dx.doi.org/10.1001/jama.283.1.18			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632265				2022-12-28	WOS:000084514400001
J	Hall, WJ				Hall, WJ			The doctors of time	ANNALS OF INTERNAL MEDICINE			English	Article							HARTFORD-FOUNDATION; ELDERLY PATIENTS; UNITED-STATES; MEDICINE; GERIATRICS; SENESCENCE; CANCER; TRENDS	Throughout human history, we have sought to understand the changes we observe in ourselves and in others with the passage of time. Does this so-called aging process have some purpose, and to what extent can we control what are otherwise inexorable consequences? Although various philosophical traditions have offered different interpretations of the relation between age and time, a more unified concept of human aging may be developing. Ancient philosophical concepts are converging with insights from developmental genetics, molecular biology, and clinical research. This new approach suggests that aging is a continuum of human growth and development, full of potential and highly modifiable by a combination of personal responsibility and appropriate medical care. In providing this care to older adults, skillful physicians use time as a key diagnostic and therapeutic tool to interpret symptoms properly and to place treatment choices in the context of human values that may change with age. We who care for older adults are the doctors of time. Sadly, in our contemporary system of medical care, time is one of the least understood and most poorly used tools. A medical care system that is increasingly oriented toward minimizing the time spent caring for older adults cannot possibly increase the quality of life for the rapidly growing elderly population. With the potential for substantial life extension within our grasp, we must develop attitudes and skills that are more compatible with the value systems of our older patients.	Univ Rochester, Sch Med & Dent, Rochester, NY USA	University of Rochester	Hall, WJ (corresponding author), Box MED GMU,601 Elmwood Ave, Rochester, NY 14642 USA.				NATIONAL INSTITUTE ON AGING [P60AG010463] Funding Source: NIH RePORTER; NIA NIH HHS [P60-AG10463] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams F, 1929, GENUINE WORKS HIPPOC; Bortz WM, 1997, WESTERN J MED, V166, P313; Brass LM, 1998, ARCH INTERN MED, V158, P2093, DOI 10.1001/archinte.158.19.2093; Butler R. N., 1975, WHY SURVIVE BEING OL; Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x; Cole Thomas R., 1992, JOURNEY LIFE CULTURA; Dawkins Richard, 1976, SELFISH GENE; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fentiman IS, 1996, ANN ONCOL, V7, P657; GRANT RL, 1963, PERSPECT BIOL MED, V6, P443; Havranek EP, 1998, ARCH INTERN MED, V158, P2024, DOI 10.1001/archinte.158.18.2024; Hazzard WR, 1997, J AM GERIATR SOC, V45, P638, DOI 10.1111/j.1532-5415.1997.tb03102.x; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Obeid LM, 1997, J AM GERIATR SOC, V45, P361, DOI 10.1111/j.1532-5415.1997.tb00954.x; OSLER W, 1979, FIXED PERIOD CONTROV; Panofsky E., 1972, STUDIES ICONOLOGY HU; Regenstreif DI, 1998, MED CARE, V36, P1521, DOI 10.1097/00005650-199811000-00001; Revel J.-F., 1999, MONK PHILOS FATHER S; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; SHAKESPEARE W, 1999, SHAKESPEARE SONNETS; Trollope Anthony, 1882, FIXED PERIOD; VIJG J, 1995, J AM GERIATR SOC, V43, P426, DOI 10.1111/j.1532-5415.1995.tb05819.x; 1996, HUANG TI NEI CHING S	24	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					18	24		10.7326/0003-4819-132-1-200001040-00004	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	270CV	10627246				2022-12-28	WOS:000084518600003
J	Hardin, PE; Glossop, NRJ				Hardin, PE; Glossop, NRJ			Neurobiology - The CRYs of flies and mice	SCIENCE			English	Editorial Material							DROSOPHILA CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; PHOTIC REGULATION; PERIOD HOMOLOGS; LIGHT; CRYPTOCHROME; ENTRAINMENT; MECHANISM; TIMELESS; MPER1		Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Houston, Biol Clocks Program, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Hardin, PE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.			Hardin, Paul/0000-0002-3370-9011				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	29	20	21	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 24	1999	286	5449					2460	2461		10.1126/science.286.5449.2460	http://dx.doi.org/10.1126/science.286.5449.2460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268RQ	10636810				2022-12-28	WOS:000084429700033
J	Poulton, J; Lyall, H; Taylor, G; Williams, GT				Poulton, J; Lyall, H; Taylor, G; Williams, GT			HIV-1 therapy and fetal mitochondrial dysfunction	LANCET			English	Letter							DNA		John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; St Marys Hosp, Imperial Coll Sch Med, London, England	University of Oxford; Imperial College London	Poulton, J (corresponding author), John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.		Poulton, Joanna/AAB-4828-2021	Poulton, Joanna/0000-0002-2460-5587				ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V176, P87, DOI 10.1016/0006-291X(91)90893-C	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2081	2082		10.1016/S0140-6736(05)76823-9	http://dx.doi.org/10.1016/S0140-6736(05)76823-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636397				2022-12-28	WOS:000084183300059
J	Ramsay, S				Ramsay, S			Breaking the silence surrounding rape	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Ramsay, S (corresponding author), The Lancet, London WC1X 8RR, England.							MILNER H, 1999, BRIT COUNCIL NEW OCT; Robertson M, OVERVIEW RAPE S AFRI; Sibomana Andre, 1999, HOPE RWANDA CONVERSA; *UN DIV ADV WOM, 1998, WOM 2000	4	2	3	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2018	2018		10.1016/S0140-6736(99)00455-9	http://dx.doi.org/10.1016/S0140-6736(99)00455-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636364				2022-12-28	WOS:000084183300007
J	Hermann, T; Patel, DJ				Hermann, T; Patel, DJ			Biochemistry - Adaptive recognition by nucleic acid aptamers	SCIENCE			English	Review							IN-VITRO SELECTION; 16S RIBOSOMAL-RNA; DNA APTAMER; HAMMERHEAD RIBOZYME; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; ALPHA-HELIX; AMINO-ACID; L-ARGININE; TAR RNA	Nucleic acid molecules play crucial roles in diverse biological processes including the storage, transport, processing, and expression of the genetic information. Nucleic acid aptamers are selected in vitro from Libraries containing random sequences of up to a few hundred nucleotides. Selection is based on the ability to bind ligand molecules with high affinity and specificity. Three-dimensional structures have been determined at high resolution for a number of aptamers in complex with their cognate ligands. Structures of aptamer complexes reveal the key molecular interactions conferring specificity to the aptamer-ligand association, including the precise stacking of flat moieties, specific hydrogen bonding, and molecular shape complementarity. These basic principles of discriminatory molecular interactions in aptamer complexes parallel recognition events central to many cellular processes involving nucleic acids.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Hermann, T (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	thermann@sbnmr1.ski.mskcc; pateld@mskcc.org	Hermann, Thomas/L-4311-2019	Hermann, Thomas/0000-0002-9855-1593	NATIONAL CANCER INSTITUTE [R01CA046778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054777] Funding Source: NIH RePORTER; NCI NIH HHS [CA-46778] Funding Source: Medline; NIGMS NIH HHS [GM-54777] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baskerville S, 1999, J VIROL, V73, P4962, DOI 10.1128/JVI.73.6.4962-4971.1999; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Blind M, 1999, P NATL ACAD SCI USA, V96, P3606, DOI 10.1073/pnas.96.7.3606; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; BORER PN, 1995, BIOCHEMISTRY-US, V34, P6488, DOI 10.1021/bi00019a030; Bruno JG, 1999, BIOSENS BIOELECTRON, V14, P457, DOI 10.1016/S0956-5663(99)00028-7; BURGSTALLER P, 1994, ANGEW CHEM INT EDIT, V33, P1084, DOI 10.1002/anie.199410841; Cai ZP, 1998, NAT STRUCT BIOL, V5, P203, DOI 10.1038/nsb0398-203; CLOUETDORVAL B, 1995, BIOCHEMISTRY-US, V34, P11186, DOI 10.1021/bi00035a025; CONNELL GJ, 1993, BIOCHEMISTRY-US, V32, P5497, DOI 10.1021/bi00072a002; Convery MA, 1998, NAT STRUCT BIOL, V5, P133, DOI 10.1038/nsb0298-133; Dieckmann T, 1996, RNA, V2, P628; Eaton BE, 1997, CURR OPIN CHEM BIOL, V1, P10, DOI 10.1016/S1367-5931(97)80103-2; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Famulok M, 1996, BIOCHEMISTRY-US, V35, P4265, DOI 10.1021/bi952479r; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; Fan P, 1996, J MOL BIOL, V258, P480, DOI 10.1006/jmbi.1996.0263; Feigon J, 1996, CHEM BIOL, V3, P611, DOI 10.1016/S1074-5521(96)90127-1; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; GIVER L, 1993, NUCLEIC ACIDS RES, V21, P5509, DOI 10.1093/nar/21.23.5509; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Hager AJ, 1997, CHEM BIOL, V4, P607, DOI 10.1016/S1074-5521(97)90246-5; HARADA K, 1995, EMBO J, V14, P5798, DOI 10.1002/j.1460-2075.1995.tb00268.x; Hermann T, 1999, J MED CHEM, V42, P1250, DOI 10.1021/jm981108g; Hermann T, 1999, CHEM BIOL, V6, pR335, DOI 10.1016/S1074-5521(00)80003-4; Hermann T, 1998, BIOPOLYMERS, V48, P155, DOI 10.1002/(SICI)1097-0282(1998)48:2<155::AID-BIP5>3.0.CO;2-I; Hermann T, 1998, CURR OPIN BIOTECH, V9, P66, DOI 10.1016/S0958-1669(98)80086-4; Hermann T, 1999, J MOL BIOL, V294, P829, DOI 10.1006/jmbi.1999.3312; Hermann T, 1998, J MOL BIOL, V276, P903, DOI 10.1006/jmbi.1997.1590; HERMANN T, IN PRESS ANGEW CHEM; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; HUIZENGA DE, 1995, BIOCHEMISTRY-US, V34, P656, DOI 10.1021/bi00002a033; Jayasena SD, 1999, CLIN CHEM, V45, P1628; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Jiang F, 1999, STRUCT FOLD DES, V7, P1461, DOI 10.1016/S0969-2126(00)88337-9; Jiang F, 1996, NATURE, V382, P183, DOI 10.1038/382183a0; Jiang LC, 1999, STRUCTURE, V7, P817, DOI 10.1016/S0969-2126(99)80105-1; Jiang LC, 1998, NAT STRUCT BIOL, V5, P769, DOI 10.1038/1804; Jiang LC, 1997, CHEM BIOL, V4, P35, DOI 10.1016/S1074-5521(97)90235-0; JOYCE GF, 1994, CURR OPIN STRUC BIOL, V4, P331, DOI 10.1016/S0959-440X(94)90100-7; Kelly JA, 1996, J MOL BIOL, V256, P417, DOI 10.1006/jmbi.1996.0097; LATO SM, 1995, CHEM BIOL, V2, P291, DOI 10.1016/1074-5521(95)90048-9; Lee SW, 1997, NAT BIOTECHNOL, V15, P41, DOI 10.1038/nbt0197-41; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Li YF, 1999, CURR OPIN STRUC BIOL, V9, P315, DOI 10.1016/S0959-440X(99)80042-6; Lin CH, 1998, CHEM BIOL, V5, P555, DOI 10.1016/S1074-5521(98)90114-4; Lin CH, 1997, CHEM BIOL, V4, P817, DOI 10.1016/S1074-5521(97)90115-0; Lin CH, 1996, NAT STRUCT BIOL, V3, P1046, DOI 10.1038/nsb1296-1046; Lorsch JR, 1996, ACCOUNTS CHEM RES, V29, P103, DOI 10.1021/ar9501378; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Marshall KA, 1997, STRUCTURE, V5, P729, DOI 10.1016/S0969-2126(97)00227-X; Michel F, 1996, SCIENCE, V273, P1676, DOI 10.1126/science.273.5282.1676; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; Pan T, 1997, CURR OPIN CHEM BIOL, V1, P17, DOI 10.1016/S1367-5931(97)80104-4; Patel Dinshaw J., 1999, Current Opinion in Structural Biology, V9, P74, DOI 10.1016/S0959-440X(99)80010-4; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; PRUDENT JR, 1994, SCIENCE, V264, P1924; PUGLISI JD, 1993, P NATL ACAD SCI USA, V90, P3680, DOI 10.1073/pnas.90.8.3680; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; PUGLISI JD, 1999, RNA WORLD, P403; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Rogers J, 1996, J MOL BIOL, V259, P916, DOI 10.1006/jmbi.1996.0369; Rowsell S, 1998, NAT STRUCT BIOL, V5, P970, DOI 10.1038/2946; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Shi H, 1999, P NATL ACAD SCI USA, V96, P10033, DOI 10.1073/pnas.96.18.10033; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; STAGE TK, 1995, RNA, V1, P95; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; Tao JS, 1996, BIOCHEMISTRY-US, V35, P2229, DOI 10.1021/bi951844b; TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723; Tarasow TM, 1997, NATURE, V389, P54, DOI 10.1038/37950; Tor Y, 1998, CHEM BIOL, V5, pR277, DOI 10.1016/S1074-5521(98)90286-1; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; Valegard K, 1997, J MOL BIOL, V270, P724, DOI 10.1006/jmbi.1997.1144; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; Wallace ST, 1998, RNA, V4, P112; WALLIS MG, 1995, CHEM BIOL, V2, P543, DOI 10.1016/1074-5521(95)90188-4; Wang H, 1998, ANGEW CHEM INT EDIT, V37, P109, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<109::AID-ANIE109>3.0.CO;2-0; WANG KY, 1993, BIOCHEMISTRY-US, V32, P1899, DOI 10.1021/bi00059a003; WANG Y, 1995, CHEM BIOL, V2, P281, DOI 10.1016/1074-5521(95)90047-0; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; Yang YS, 1996, SCIENCE, V272, P1343, DOI 10.1126/science.272.5266.1343; Ye XM, 1999, CHEM BIOL, V6, P657, DOI 10.1016/S1074-5521(99)80117-3; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6; Ye XM, 1996, NAT STRUCT BIOL, V3, P1026, DOI 10.1038/nsb1296-1026; Yoshizawa S, 1998, EMBO J, V17, P6437, DOI 10.1093/emboj/17.22.6437; Zimmermann GR, 1997, NAT STRUCT BIOL, V4, P644, DOI 10.1038/nsb0897-644	107	1244	1432	34	960	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2000	287	5454					820	825		10.1126/science.287.5454.820	http://dx.doi.org/10.1126/science.287.5454.820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657289				2022-12-28	WOS:000085136400036
J	Hadzic, N; Pagliuca, A; Rela, M; Portmann, B; Jones, A; Veys, P; Heaton, ND; Mufti, GJ; Mieli-Vergani, G				Hadzic, N; Pagliuca, A; Rela, M; Portmann, B; Jones, A; Veys, P; Heaton, ND; Mufti, GJ; Mieli-Vergani, G			Correction of the Hyper-IgM syndrome after liver and bone marrow transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STEM-CELL TRANSPLANTATION; SCLEROSING CHOLANGITIS; CD40L GENE; CRYPTOSPORIDIOSIS; AZITHROMYCIN; PAROMOMYCIN; THERAPY; INFECTION; DEFECTS		Kings Coll Hosp London, Dept Child Hlth, London SE5 9RJ, England; Kings Coll Hosp London, Dept Haematol Med, London, England; Kings Coll Hosp London, Dept Transplant Surg, London, England; Kings Coll Hosp London, Inst Liver Studies, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Hadzic, N (corresponding author), Kings Coll Hosp London, Dept Child Hlth, Denmark Hill, London SE5 9RJ, England.	nedim.hadzic@kcl.ac.uk	pagliuca, antonio/F-8886-2013; Hadzic, Nedim/H-7574-2019; Heaton, Nigel/AAK-8363-2020; Mieli-Vergani, Giorgina/G-5616-2011	pagliuca, antonio/0000-0003-2519-0333; Hadzic, Nedim/0000-0002-5493-3418; Mieli-Vergani, Giorgina/0000-0002-8215-4489				ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARMITAGE K, 1992, ARCH INTERN MED, V152, P2497, DOI 10.1001/archinte.152.12.2497; Blanshard C, 1997, INT J STD AIDS, V8, P124, DOI 10.1258/0956462971919543; DAVIS JJ, 1987, AM J GASTROENTEROL, V82, P1196; Fuleihan RL, 1998, SEMIN HEMATOL, V35, P321; Giralt S, 1997, BLOOD, V89, P4531, DOI 10.1182/blood.V89.12.4531; Grewal IS, 1997, CURR OPIN IMMUNOL, V9, P491, DOI 10.1016/S0952-7915(97)80100-8; Hadzic N, 1998, HEPATOLOGY, V28, p446A; Hayward AR, 1997, J IMMUNOL, V158, P977; Hicks P, 1996, J PEDIATR-US, V129, P297, DOI 10.1016/S0022-3476(96)70258-5; Ibanez VM, 1997, TRANSPL P, V29, P432, DOI 10.1016/S0041-1345(96)00172-8; Kapoor N, 1998, SEMIN HEMATOL, V35, P346; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Nachbaur D, 1997, BONE MARROW TRANSPL, V19, P1261, DOI 10.1038/sj.bmt.1700826; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Notarangelo LD, 1996, IMMUNOL TODAY, V17, P511, DOI 10.1016/0167-5699(96)30059-5; PETERSEN C, 1992, CLIN INFECT DIS, V15, P903, DOI 10.1093/clind/15.6.903; POL S, 1993, NEW ENGL J MED, V328, P95, DOI 10.1056/NEJM199301143280204; Rosen H R, 1996, Liver Transpl Surg, V2, P225, DOI 10.1002/lt.500020308; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763; THOMAS C, 1995, NEW ENGL J MED, V333, P426, DOI 10.1056/NEJM199508173330705; VILLA A, 1994, P NATL ACAD SCI USA, V91, P2110, DOI 10.1073/pnas.91.6.2110; *WHO SCI GROUP, 1995, CLIN EXP IMMUNOL  S1, V99, P2	24	74	77	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					320	324		10.1056/NEJM200002033420504	http://dx.doi.org/10.1056/NEJM200002033420504			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655530	Bronze			2022-12-28	WOS:000085070300004
J	Dai, SD; Schwendtmayer, C; Schurmann, P; Ramaswamy, S; Eklund, H				Dai, SD; Schwendtmayer, C; Schurmann, P; Ramaswamy, S; Eklund, H			Redox signaling in chloroplasts: Cleavage of disulfides by an iron-sulfur cluster	SCIENCE			English	Article							FERREDOXIN-THIOREDOXIN REDUCTASE; SPINACH FERREDOXIN; PROTEIN MODELS; PHOTOSYSTEM-I; CRYSTALLOGRAPHY; POTENTIALS; RESOLUTION; REFINEMENT; DOMAINS; PEPTIDE	Light generates reducing equivalents in chloroplasts that are used not only for carbon reduction, but also for the regulation of the activity of chloroplast enzymes by reduction of regulatory disulfides via the ferredoxin:thioredoxin reductase (FTR) system, FTR, the key electron/thiol transducer enzyme in this pathway, is unique in that it can reduce disulfides by an iron-sulfur cluster, a property that is explained by the tight contact of its active-site disulfide and the iron-sulfur center. The thin, flat FTR molecule makes the two-electron reduction possible by forming on one side a mixed disulfide with thioredoxin and by providing on the opposite side access to ferredoxin for delivering electrons.	Swedish Univ Agr Sci, Dept Mol Biol, Ctr Biomed, S-75124 Uppsala, Sweden; Univ Neuchatel, Lab Biochim Vegetale, CH-2007 Neuchatel, Switzerland	Swedish University of Agricultural Sciences; University of Neuchatel	Eklund, H (corresponding author), Swedish Univ Agr Sci, Dept Mol Biol, Ctr Biomed, Box 590, S-75124 Uppsala, Sweden.	hasse@xray.bmc.uu.se	Subramanian, Ramaswamy/Q-8671-2019	Subramanian, Ramaswamy/0000-0002-6709-190X				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; BACKES G, 1991, J AM CHEM SOC, V113, P2055, DOI 10.1021/ja00006a027; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; BUCHANAN BB, 1991, ARCH BIOCHEM BIOPHYS, V288, P1, DOI 10.1016/0003-9861(91)90157-E; BUCHANAN BB, 1994, ARCH BIOCHEM BIOPHYS, V314, P257, DOI 10.1006/abbi.1994.1439; Capitani G, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1939; Carr PD, 1999, STRUCTURE, V7, P461, DOI 10.1016/S0969-2126(99)80058-6; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; CIURLI S, 1990, J AM CHEM SOC, V112, P2654, DOI 10.1021/ja00163a028; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FALZONE CJ, 1994, BIOCHEMISTRY-US, V33, P6052, DOI 10.1021/bi00186a004; Hampton MB, 1998, BIOFACTORS, V8, P1, DOI 10.1002/biof.5520080101; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; HIRASAWA M, 1998, BIOCHIM BIOPHYS ACTA, V935, P1; HOWARD JB, 1991, ADV PROTEIN CHEM, V42, P199; JACOBSON BL, 1993, BIOCHEMISTRY-US, V32, P6788, DOI 10.1021/bi00077a033; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; Johansson K, 1999, BIOCHEMISTRY-US, V38, P4319, DOI 10.1021/bi982876c; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klukas O, 1999, J BIOL CHEM, V274, P7351, DOI 10.1074/jbc.274.11.7351; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LANGEN R, 1992, J BIOL CHEM, V267, P25625; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAUBLE H, 1994, J MOL BIOL, V237, P437, DOI 10.1006/jmbi.1994.1246; LEVINGS CS, 1995, SCIENCE, V268, P695, DOI 10.1126/science.268.5211.695; Mayer KL, 1999, BIOCHEMISTRY-US, V38, P13736, DOI 10.1021/bi9910373; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; SALAMON Z, 1995, BBA-BIOENERGETICS, V1230, P114, DOI 10.1016/0005-2728(95)00042-H; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Schwendtmayer C, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1927; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Staples CR, 1996, BIOCHEMISTRY-US, V35, P11425, DOI 10.1021/bi961007p; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; Stout CD, 1998, J MOL BIOL, V278, P629, DOI 10.1006/jmbi.1998.1732; van Thor JJ, 1999, BIOCHEMISTRY-US, V38, P12735, DOI 10.1021/bi9903502; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23	45	161	169	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					655	658		10.1126/science.287.5453.655	http://dx.doi.org/10.1126/science.287.5453.655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649999	Green Submitted			2022-12-28	WOS:000084989400048
J	Holgate, ST				Holgate, ST			Science, medicine, and the future - Allergic disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MONOCLONAL-ANTIBODY; INHIBITION; IMMUNOTHERAPY; RESPONSES; RHINITIS; IL-4; IGE		Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Holgate, ST (corresponding author), Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	sth@soton.ac.uk						Borish LC, 1998, J ALLERGY CLIN IMMUN, V101, pS8; Casale TB, 1997, J ALLERGY CLIN IMMUN, V100, P110, DOI 10.1016/S0091-6749(97)70202-1; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Clavel R, 1998, ALLERGY, V53, P493, DOI 10.1111/j.1398-9995.1998.tb04086.x; DAERON M, 1997, IMMUNOLOGIST, V5, P79; Danzig M, 1997, ALLERGY, V52, P787, DOI 10.1111/j.1398-9995.1997.tb02149.x; Durham SR, 1998, J ALLERGY CLIN IMMUN, V102, P157, DOI 10.1016/S0091-6749(98)70079-X; Grunewald SM, 1998, J IMMUNOL, V160, P4004; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; HOPKIN JM, 1998, THORAX S4, V53, pA16; Jung T, 1999, CLIN EXP ALLERGY, V29, P912; Leckie MJ, 1999, AM J RESP CRIT CARE, V159, pA624; MARTINEZ FD, 1999, LANCET S, V2, P354; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Palmer EM, 1997, J IMMUNOL, V158, P2654; Patalano F, 1999, ALLERGY, V54, P103; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; Renz H, 1996, INT ARCH ALLERGY IMM, V109, P167, DOI 10.1159/000237216; ROMAN GC, 1995, J PUBLIC HEALTH POL, V16, P5, DOI 10.2307/3342974; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Rudolf MP, 1998, J IMMUNOL, V160, P3315; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; STANWORTH DR, 1990, LANCET, V336, P1279, DOI 10.1016/0140-6736(90)92963-I; Teran LM, 1999, CLIN EXP ALLERGY, V29, P287; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; Wagner H, 1999, ADV IMMUNOL, V73, P329, DOI 10.1016/S0065-2776(08)60790-7; Wang CC, 1998, IMMUNOLOGY, V93, P307; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	29	19	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2000	320	7229					231	234		10.1136/bmj.320.7229.231	http://dx.doi.org/10.1136/bmj.320.7229.231			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642235	Green Published			2022-12-28	WOS:000085029600029
J	Lyons, J; Khot, A				Lyons, J; Khot, A			Infopoints - Managing information overload: developing an electronic directory	BRITISH MEDICAL JOURNAL			English	Editorial Material									Primary Care Informat Serv, Portslade BN41 1XY, England		Lyons, J (corresponding author), Primary Care Informat Serv, POB 11, Portslade BN41 1XY, England.							Fraser HSF, 1997, BRIT MED J, V314, P1600, DOI 10.1136/bmj.314.7094.1600; Hibble A, 1998, BRIT MED J, V317, P862, DOI 10.1136/bmj.317.7162.862; Smith R, 1996, BRIT MED J, V313, P1062	3	3	3	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					160	160		10.1136/bmj.320.7228.160	http://dx.doi.org/10.1136/bmj.320.7228.160			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634737	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000084860300028
J	Basden, AM; Young, GC; Coates, MI; Ritchie, A				Basden, AM; Young, GC; Coates, MI; Ritchie, A			The most primitive osteichthyan braincase?	NATURE			English	Article							FISHES	Most living vertebrates, from teleosts to tetrapods, are osteichthyans (bony fishes)(1), but the origin of this major group is poorly understood(2). The actinopterygians (ray-finned bony fishes) are the most successful living vertebrates in terms of diversity. They appear in the fossil record in the Late Silurian but are poorly known before the Late Devonian. Here we report the discovery of the oldest and most primitive actinopterygian-like osteichthyan braincase known, from 400-million-year-old limestone in southeastern Australia. This specimen displays previously unknown primitive conditions, in particular, an opening for a cartilaginous eyestalk. It provides an important and unique counterpart to the similarly aged and recently described Psarolepis from China and Vietnam(3,4). The contrasting features of these specimens, and the unusual anatomy of the new specimen in particular, provide new insights into anatomical conditions close to the evolutionary radiation of all modern osteichthyan groups.	Macquarie Univ, Dept Earth & Planetary Sci, Ctr Ecostratig & Palaeobiol, N Ryde, NSW 2109, Australia; Australian Natl Univ, Dept Geol, Canberra, ACT 0200, Australia; UCL, Dept Biol Sci, London WC1E 6BT, England; Australian Museum, Sydney S, NSW 2000, Australia	Macquarie University; Australian National University; University of London; University College London; Australian Museum	Basden, AM (corresponding author), Macquarie Univ, Dept Earth & Planetary Sci, Ctr Ecostratig & Palaeobiol, N Ryde, NSW 2109, Australia.	abasden@laurel.ocs.mq.edu.au	Coates, Michael/AAO-3810-2020	Coates, Michael/0000-0003-2843-1075				Ahlberg PE, 1999, NATURE, V397, P564, DOI 10.1038/17484; [Anonymous], THESIS U STOCKHOLM; BASDEN AM, IN PRESS COUR FORSCH; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; de Beer G., 1937, DEV VERTEBRATE SKULL; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner B.G., 1984, Journal of Vertebrate Paleontology, V4, P379; Gardiner B.G., 1977, PROBLEMS EARLY VERTE, P227; Goujet D, 1982, GEOBIOS MEMOIRE SPEC, V15, P27; Goujet D.F., 1984, Proceedings of the Linnean Society of New South Wales, V107, P211; Gross W., 1937, Senckenbergiana Frankfurt a M, V19, P80; Janvier P, 1996, OXFORD MONOGRAPHS GE, V33; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; PATTERSON C, 1975, PHILOS T R SOC B, V269, P275, DOI 10.1098/rstb.1975.0001; SCHAEFFER B, 1937, AM MUS NOVIT, P1; SCHULTZE H-P, 1968, Bulletin of the British Museum (Natural History) Geology, V16, P343; Swofford D., 1998, PAUP PHYLOGENETIC AN; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; YOUNG GC, 1979, Z J LINN SOC, V66, P307; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594	22	59	63	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					185	188		10.1038/35003183	http://dx.doi.org/10.1038/35003183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646601				2022-12-28	WOS:000084835300052
J	Rabinowitz, D; Helin, E; Lawrence, K; Pravdo, S				Rabinowitz, D; Helin, E; Lawrence, K; Pravdo, S			A reduced estimate of the number of kilometre-sized near-Earth asteroids	NATURE			English	Article								Near-Earth asteroids are small (diameters < 10 km), rocky bodies with orbits that approach that of the Earth (they come within 1.3 AU Of the Sun). Most have a chance of approximately 0.5% of colliding with the Earth in the next million years. The total number of such bodies with diameters > 1 km has been estimated to be in the range 1,000-2,000, which translates to an approximately 1% chance of a catastrophic collision with the Earth in the next millennium(1,2). These numbers are, however, poorly constrained because of the limitations of previous searches using photographic plates. (One kilometre is below the size of a body whose impact on the Earth would produce global effects(3).) Here we report an analysis of our survey for near-Earth asteroids that uses improved detection technologies. We find that the total number of asteroids with diameters > 1 km is about half the earlier estimates. At the current rate of discovery of near-Earth asteroids, 90% will probably have been detected within the next 20 years.	Yale Univ, Dept Phys, New Haven, CT 06511 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Yale University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Rabinowitz, D (corresponding author), Yale Univ, Dept Phys, 266 Whitney Ave,JWG 552, New Haven, CT 06511 USA.	david.rabinowitz@yale.edu						Bowell E., 1994, HAZARDS DUE COMETS A, P149; Bowell E., 1989, ASTEROIDS, VII, P524; GEHRELS T, 1991, SPACE SCI REV, V58, P347, DOI 10.1007/BF01206004; HARRIS AW, IN PRESS COLLISIONAL; Helin E. F., 1990, Vistas in Astronomy, V33, P21, DOI 10.1016/0083-6656(90)90030-C; HELIN EF, 1979, ICARUS, V40, P321, DOI 10.1016/0019-1035(79)90021-6; MARSDEN BG, ELECT LISTING MINOR; MCFADDEN LA, 1989, ASTEROIDS, V2, P442; Pravdo SH, 1999, ASTRON J, V117, P1616, DOI 10.1086/300769; RABINOWITZ DL, 1994, ICARUS, V111, P364, DOI 10.1006/icar.1994.1150; RABINOWITZ DL, 1993, ASTROPHYS J, V407, P412, DOI 10.1086/172524; SHOEMAKER EM, 1990, GEOL S AM S, V247, P155; [No title captured]	13	103	105	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					165	166		10.1038/35003128	http://dx.doi.org/10.1038/35003128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646594				2022-12-28	WOS:000084835300045
J	Ragazzoni, R; Marchetti, E; Valente, G				Ragazzoni, R; Marchetti, E; Valente, G			Adaptive-optics corrections available for the whole sky	NATURE			English	Article							ITALIAN-NATIONAL-TELESCOPE; ATMOSPHERIC-TURBULENCE; GALILEO; COMPENSATION; IMAGE	Adaptive-optics systems can in principle allow a telescope to achieve performance at its theoretical maximum (Limited only by diffraction), by correcting in real time for the distortion of starlight by atmospheric turbulence(1). For such a system installed on an 8-m-class telescope(2,3), the spatial resolution and sensitivity could be up to 100 times better than conventional imaging(4,5). Adaptive-optics corrections have hitherto been achieved only for regions of the sky within a few arcseconds of a bright reference source. But it has been proposed theoretically that by using multiple guide stars, the tomography of atmospheric turbulence could be probed and used to extend adaptive-optics corrections to the whole sky(6,7). Here we report the experimental verification of such tomographic(8) corrections, using three off-axis reference stars similar to 15 arcsec from the central star. We used the observations of the off-axis stars to calculate the deformations of the wavefront of the central star, and then compare them with the real measured values. This tomographic approach is found to reduce variations in the wavefront by similar to 92%. Our result demonstrates that a serious barrier to achieving diffraction-limited seeing over the whole sky has been removed.	Astron Observ Padova, I-35122 Padua, Italy; Ctr Galileo Galilei, E-38700 Santa Cruz De La Palma, Spain; Univ Padua, Dept Phys, I-35131 Padua, Italy; Univ Padua, Ist Nazl Fis Nucl, Sez PD, I-35131 Padua, Italy	University of Padua; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua	Ragazzoni, R (corresponding author), Astron Observ Padova, Vicolo Osservatorio 5, I-35122 Padua, Italy.			Ragazzoni, Roberto/0000-0002-7697-5555				Barbieri C, 1997, P SOC PHOTO-OPT INS, V2871, P244, DOI 10.1117/12.269046; BECKERS JM, 1993, ANNU REV ASTRON ASTR, V31, P13, DOI 10.1146/annurev.aa.31.090193.000305; BECKERS JM, 1989, P SOC PHOTO-OPT INS, V1114, P215, DOI 10.1117/12.960826; Bortoletto F, 1996, P SOC PHOTO-OPT INS, V2654, P248, DOI 10.1117/12.236107; Bortoletto F, 1998, P SOC PHOTO-OPT INS, V3352, P91, DOI 10.1117/12.319258; CHRISTOU JC, 1995, ASTROPHYS J, V450, P369, DOI 10.1086/176147; Giacconi R, 1999, ASTRON ASTROPHYS, V343, pL1; Gilmozzi R, 1998, P SOC PHOTO-OPT INS, V3352, P778, DOI 10.1117/12.319284; HAPPER W, 1994, J OPT SOC AM A, V11, P263, DOI 10.1364/JOSAA.11.000263; HICKSON P, 1994, J OPT SOC AM A, V11, P1667, DOI 10.1364/JOSAA.11.001667; HICKSON P, 1994, P SOC PHOTO-OPT INS, V2201, P549, DOI 10.1117/12.176090; Mountain CM, 1998, P SOC PHOTO-OPT INS, V3352, P2, DOI 10.1117/12.319254; MOUNTAIN CM, 1997, P SOC PHOTO-OPT INS, V2871, P579; MURPHY DV, 1991, OPT LETT, V16, P1797, DOI 10.1364/OL.16.001797; NOLL RJ, 1976, J OPT SOC AM, V66, P207, DOI 10.1364/JOSA.66.000207; Ragazzoni R, 1999, ASTRON ASTROPHYS, V342, pL53; Ragazzoni R, 1999, ASTRON ASTROPHYS SUP, V136, P205, DOI 10.1051/aas:1999207; Ragazzoni R, 1999, ASTRON ASTROPHYS, V350, pL23; RAGAZZONI R, 1995, ATMOS OCEAN OPT, V8, P174; RAGAZZONI R, 1994, TELESCOPIC NAZL GALI, V39, P1; Ribak EN, 1995, P SOC PHOTO-OPT INS, V2580, P166, DOI 10.1117/12.228480; RODDIER F, 1991, APPL OPTICS, V30, P1325, DOI 10.1364/AO.30.001325; Roddier F, 1998, PUBL ASTRON SOC PAC, V110, P837, DOI 10.1086/316194; SINNOTT RW, 1999, SKY TELESC       MAR, P100; TALLON M, 1990, ASTRON ASTROPHYS, V235, P549; Tyson R. K., 1991, PRINCIPLES ADAPTIVE	26	135	139	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					54	56		10.1038/47425	http://dx.doi.org/10.1038/47425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638747				2022-12-28	WOS:000084687400037
J	Zarur, AJ; Ying, JY				Zarur, AJ; Ying, JY			Reverse microemulsion synthesis of nanostructured complex oxides for catalytic combustion	NATURE			English	Article							MAGNESIUM-OXIDE; TEMPERATURE	Catalysts play an important role in many industrial processes, but their use in high-temperature applications-such as energy generation through natural gas combustion, steam reforming and the partial oxidation of hydrocarbons to produce feedstock chemicals-is problematic. The need for catalytic materials that remain stable and active over long periods at high operation temperatures, often in the presence of deactivating or even poisoning compounds, presents a challenge. For example, catalytic methane combustion, which generates power with reduced greenhouse-gas and nitrogen-oxide emissions(1-3), is limited by the availability of catalysts that are sufficiently active at low temperatures for start-up and are then able to sustain activity and mechanical integrity at flame temperatures as high as 1,3000 degrees C. Here we use sol-gel processing in reverse microemulsions to produce discrete barium hexaaluminate nanoparticles that display excellent methane combustion activity, owing to their high surface area, high thermal stability and the ultrahigh dispersion of cerium oxide on the their surfaces. Our synthesis method provides a general route to the production of a wide range of thermally stable nanostructured composite materials with large surface-to-volume ratios(4-6) and an ultrahigh component dispersion that gives rise to synergistic chemical and electronic effects(7,8), thus paving the way to the development of catalysts suitable for high-temperature industrial applications.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ying, JY (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.		Ying, Jackie Y./A-8402-2012	Ying, Jackie Y./0000-0001-6938-2113				BERG M, 1994, APPL CATAL A-GEN, V114, P227, DOI 10.1016/0926-860X(94)80176-2; GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0921-5093(89)90083-X; GROPPI G, 1993, APPL CATAL A-GEN, V104, P101, DOI 10.1016/0926-860X(93)85092-4; KARCH J, 1987, NATURE, V330, P556, DOI 10.1038/330556a0; Linan A., 1993, FUNDAMENTAL ASPECTS; MACHIDA M, 1988, B CHEM SOC JPN, V61, P3659, DOI 10.1246/bcsj.61.3659; MACHIDA M, 1989, J CATAL, V120, P377, DOI 10.1016/0021-9517(89)90277-7; MATSUURA I, 1991, APPL CATAL, V74, P273; McCarty JG, 1995, CATAL TODAY, V26, P283, DOI 10.1016/0920-5861(95)00150-7; Park JG, 1996, J SOLID STATE CHEM, V121, P278, DOI 10.1006/jssc.1996.0039; PFEFFERLE LD, 1987, CATAL REV, V29, P219, DOI 10.1080/01614948708078071; SCHERER GW, 1990, SOL GEL SCI PHYSICS; SIEGEL RW, 1991, ANNU REV MATER SCI, V21, P559; Trimm DL, 1995, CATAL TODAY, V26, P231, DOI 10.1016/0920-5861(95)00144-1; Ying JY, 1996, CHEM ENG J, V64, P225, DOI 10.1016/S0923-0467(96)03142-9; Ying JY, 1995, NANOSTRUCT MATER, V6, P237, DOI 10.1016/0965-9773(95)00047-X; ZWINKELS MFM, 1993, CATAL REV, V35, P319, DOI 10.1080/01614949308013910	17	503	558	10	325	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					65	67		10.1038/47450	http://dx.doi.org/10.1038/47450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638751				2022-12-28	WOS:000084687400041
J	Stein, D; Ayotte, B				Stein, D; Ayotte, B			East Timor: extreme deprivation of health and human rights	LANCET			English	Editorial Material									Phys Human Rights, Boston, MA 02116 USA; Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Sch Publ Hyg & Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Stein, D (corresponding author), Phys Human Rights, 100 Boylston St,Suite 702, Boston, MA 02116 USA.								0	5	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2075	2075		10.1016/S0140-6736(99)10124-7	http://dx.doi.org/10.1016/S0140-6736(99)10124-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636387				2022-12-28	WOS:000084183300047
J	Baysal, BE; Ferrell, RE; Willett-Brozick, JE; Lawrence, EC; Myssiorek, D; Bosch, A; van der Mey, A; Taschner, PEM; Rubinstein, WS; Myers, EN; Richard, CW; Cornelisse, CJ; Devilee, P; Devlin, B				Baysal, BE; Ferrell, RE; Willett-Brozick, JE; Lawrence, EC; Myssiorek, D; Bosch, A; van der Mey, A; Taschner, PEM; Rubinstein, WS; Myers, EN; Richard, CW; Cornelisse, CJ; Devilee, P; Devlin, B			Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma	SCIENCE			English	Article							SUCCINATE-UBIQUINONE OXIDOREDUCTASE; CAROTID-BODY CHEMORECEPTORS; CHROMOSOME 11Q23; ESCHERICHIA-COLI; HIGH-ALTITUDES; NECK REGION; HYPOXIA; CELLS; HEAD; HYPERPLASIA	Hereditary paraganglioma (PGL) is characterized by the development of benign, vascularized tumors in the head and neck. The most common tumor site is the carotid body (CB), a chemoreceptive organ that senses oxygen Levels in the blood. Analysis of families carrying the PGL1 gene, described here, revealed germ line mutations in the SDHD gene on chromosome 11q23. SDHD encodes a mitochondrial respiratory chain protein-the small subunit of cytochrome b in succinate-ubiquinone oxidoreductase (cybS). In contrast to expectations based on the inheritance pattern of PGL, the SDHD gene showed no evidence of imprinting. These findings indicate that mitochondria play an important role in the pathogenesis of certain tumors and that cybS plays a role in normal CB physiology.	Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Human Genet, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA 15213 USA; Long Isl Jewish Med Ctr, Dept Otolaryngol & Communicat Disorders, New York, NY 11040 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Otolaryngol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RA Leiden, Netherlands; Wyeth Ayerst Res, Genet Inst, Cambridge, MA 02140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwell Health; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pfizer	Baysal, BE (corresponding author), Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA.	baysalbe@msx.upmc.edu	DEVILEE, PETER/ABR-2140-2022; Taschner, Peter/J-8853-2014; Brozick, Joan/AAA-5785-2019	Taschner, Peter/0000-0001-9621-465X; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57881] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARIASSTELLA J, 1976, ARCH PATHOL LAB MED, V100, P636; ARIASSTELLA J, 1976, HUM PATHOL, V7, P361, DOI 10.1016/S0046-8177(76)80052-4; Baysal BE, 1997, AM J HUM GENET, V60, P121; Baysal BE, 1998, GENE, V217, P107, DOI 10.1016/S0378-1119(98)00350-3; Baysal BE, 1999, HUM GENET, V104, P219, DOI 10.1007/s004390050939; Baysal BE, 1997, GENOMICS, V44, P214, DOI 10.1006/geno.1997.4880; BAYSAL BE, UNPUB; BEE D, 1986, ACTA ANAT, V126, P226; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEVILEE P, 1994, GENE CHROMOSOME CANC, V11, P71, DOI 10.1002/gcc.2870110202; EDWARDS C, 1971, J PATHOL, V104, P231, DOI 10.1002/path.1711040404; Farr JE, 1999, AM J HUM GENET, V65, pA271; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Heutink Peter, 1994, European Journal of Human Genetics, V2, P148; Hirawake H, 1997, CYTOGENET CELL GENET, V79, P132, DOI 10.1159/000134700; Koreth J, 1999, J PATHOL, V187, P28, DOI 10.1002/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R; LACK EE, 1979, HUM PATHOL, V10, P191, DOI 10.1016/S0046-8177(79)80008-8; LACK EE, 1985, AM J PATHOL, V119, P301; LACK EE, 1978, AM J PATHOL, V91, P497; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Milunsky J, 1997, AM J MED GENET, V72, P66, DOI 10.1002/(SICI)1096-8628(19971003)72:1<66::AID-AJMG14>3.0.CO;2-S; MORELLI L, 1994, SCI TOTAL ENVIRON, V150, P215, DOI 10.1016/0048-9697(94)90153-8; Morison IM, 1998, HUM MOL GENET, V7, P1599, DOI 10.1093/hmg/7.10.1599; Nakamura K, 1996, J BIOL CHEM, V271, P521, DOI 10.1074/jbc.271.1.521; Nurse CA, 1997, DEV BIOL, V184, P197, DOI 10.1006/dbio.1997.8539; SALDANA MJ, 1973, HUM PATHOL, V4, P251, DOI 10.1016/S0046-8177(73)80012-7; Scheffler IE, 1998, PROG NUCLEIC ACID RE, V60, P267, DOI 10.1016/S0079-6603(08)60895-8; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Shenoy SK, 1999, J BIOL CHEM, V274, P8717, DOI 10.1074/jbc.274.13.8717; STILLER D, 1975, VIRCHOWS ARCH A, V365, P163, DOI 10.1007/BF00432387; van Schothorst EM, 1998, AM J HUM GENET, V63, P468, DOI 10.1086/301951; van Schothorst EM, 1998, HUM PATHOL, V29, P1045, DOI 10.1016/S0046-8177(98)90411-7; VANDERMEY AGL, 1989, LANCET, V2, P1291; Vaupel P, 1998, STRAHLENTHER ONKOL, V174, P6; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Zhu H, 1999, RESP PHYSIOL, V115, P239, DOI 10.1016/S0034-5687(99)00024-9	41	1231	1271	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2000	287	5454					848	851		10.1126/science.287.5454.848	http://dx.doi.org/10.1126/science.287.5454.848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657297				2022-12-28	WOS:000085136400044
J	Davies, MK; Gibbs, CR				Davies, MK; Gibbs, CR			ABC of heart failure - Investigation	BRITISH MEDICAL JOURNAL			English	Review									Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England; Univ Birmingham, City Hosp, Dept Med, Birmingham, W Midlands, England; Univ Birmingham, City Hosp, Dept Cardiol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Davies, MK (corresponding author), Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England.							Cheesman MG, 1998, HEART, V80, pS1, DOI 10.1136/hrt.80.2008.1S; DARGIE HJ, 1994, BMJ-BRIT MED J, V308, P321, DOI 10.1136/bmj.308.6924.321; Schiller NB, 1996, HEART, V75, P17, DOI 10.1136/hrt.75.6_Suppl_2.17	3	7	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					297	300		10.1136/bmj.320.7230.297	http://dx.doi.org/10.1136/bmj.320.7230.297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650030	Green Published			2022-12-28	WOS:000085132700031
J	Caldeira, K; Duffy, PB				Caldeira, K; Duffy, PB			The role of the Southern Ocean in uptake and storage of anthropogenic carbon dioxide	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; SEA-ICE FORMATION; MIXED LAYER; CO2; SENSITIVITY; SIMULATION; BUDGET; WATER; SALT	An ocean-climate model that shows high fluxes of anthropogenic carbon dioxide into the Southern Ocean, but very Low storage of anthropogenic carbon there, agrees with observation-based estimates of ocean storage of anthropogenic carbon dioxide. This low simulated storage indicates a subordinate role for deep convection in the present-day Southern Ocean. The primary mechanism transporting anthropogenic carbon out of the Southern Ocean is isopycnal transport. These results imply that if global climate change reduces the density of surface waters in the Southern Ocean, isopycnal surfaces that now outcrop may become isolated from the atmosphere, tending to diminish Southern Ocean carbon uptake.	Univ Calif Lawrence Livermore Natl Lab, Climate Syst Modeling Grp, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System	Caldeira, K (corresponding author), Univ Calif Lawrence Livermore Natl Lab, Climate Syst Modeling Grp, Livermore, CA 94550 USA.		Caldeira, Ken/E-7914-2011	Caldeira, Ken/0000-0002-4591-643X				Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; BRYAN K, 1984, J PHYS OCEANOGR, V14, P666, DOI 10.1175/1520-0485(1984)014<0666:ATCTEO>2.0.CO;2; Caldeira K, 1998, GEOPHYS RES LETT, V25, P1003, DOI 10.1029/98GL00336; Duffy PB, 1997, GEOPHYS RES LETT, V24, P1323, DOI 10.1029/97GL01294; Duffy PB, 1999, GEOPHYS RES LETT, V26, P1739, DOI 10.1029/1999GL900286; Gruber N, 1998, GLOBAL BIOGEOCHEM CY, V12, P165, DOI 10.1029/97GB03658; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Joos F, 1999, SCIENCE, V284, P464, DOI 10.1126/science.284.5413.464; KEELING CD, 1989, GEOPHYS MONOGR SER, V55, P305, DOI DOI 10.1029/GM055P0305; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; MAIERREIMER E, 1987, CLIM DYNAM, V2, P63, DOI 10.1007/BF01054491; MARTINSON DG, 1990, J GEOPHYS RES-OCEANS, V95, P11641, DOI 10.1029/JC095iC07p11641; Matear RJ, 1999, TELLUS B, V51, P722, DOI 10.1034/j.1600-0889.1999.t01-1-00012.x; MURPHY PP, 1991, MAR CHEM, V35, P77, DOI 10.1016/S0304-4203(09)90009-3; OBERHUBER JM, 1993, J PHYS OCEANOGR, V23, P808, DOI 10.1175/1520-0485(1993)023<0808:SOTACW>2.0.CO;2; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; PACANOWSKI R, 1991, 2 NOAA GEOPH FLUID D; POISSON A, 1987, DEEP-SEA RES, V34, P1255, DOI 10.1016/0198-0149(87)90075-6; Sabine CL, 1999, GLOBAL BIOGEOCHEM CY, V13, P179, DOI 10.1029/1998GB900022; SARMIENTO JL, 1992, NATURE, V356, P589, DOI 10.1038/356589a0; SARMIENTO JL, 1995, GLOBAL BIOGEOCHEM CY, V9, P121, DOI 10.1029/94GB01779; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Watson AJ, 1999, NATURE, V401, P902, DOI 10.1038/44807	27	156	192	10	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					620	622		10.1126/science.287.5453.620	http://dx.doi.org/10.1126/science.287.5453.620			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649988				2022-12-28	WOS:000084989400037
J	Vellinga, A; Van Damme, P; Joossens, E; Goossens, H				Vellinga, A; Van Damme, P; Joossens, E; Goossens, H			Response to diphtheria booster vaccination in healthy adults: vaccine trial	BRITISH MEDICAL JOURNAL			English	Article							CONTROL STRATEGIES		Univ Antwerp, Ctr Evaluat Vaccinat, Dept Epidemiol & Community Med, B-2610 Wilrijk, Belgium; Univ Antwerp, Microbiol Lab, B-2610 Wilrijk, Belgium	University of Antwerp; University of Antwerp	Van Damme, P (corresponding author), Univ Antwerp, Ctr Evaluat Vaccinat, Dept Epidemiol & Community Med, B-2610 Wilrijk, Belgium.		van damme, pierre/I-4846-2013; Vellinga, Akke/H-2130-2011	Vellinga, Akke/0000-0002-6583-4300				DIXON JMS, 1990, TOPLEY WILSONS PRINC, P56; Galazka AM, 1996, VACCINE, V14, P845, DOI 10.1016/0264-410X(96)00021-7; Hardy IRB, 1996, LANCET, V347, P1739, DOI 10.1016/S0140-6736(96)90811-9; Mathei C, 1997, EUR J CLIN MICROBIOL, V16, P631, DOI 10.1007/BF01708551; Prospero E, 1997, EUR J EPIDEMIOL, V13, P527, DOI 10.1023/A:1007305205763	5	10	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					217	217		10.1136/bmj.320.7229.217	http://dx.doi.org/10.1136/bmj.320.7229.217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642229	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000085029600023
J	Kaindl, RA; Woerner, M; Elsaesser, T; Smith, DC; Ryan, JF; Farnan, GA; McCurry, MP; Walmsley, DG				Kaindl, RA; Woerner, M; Elsaesser, T; Smith, DC; Ryan, JF; Farnan, GA; McCurry, MP; Walmsley, DG			Ultrafast mid-infrared response of YRa2Cu3O7-delta	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTIVITY; T-C SUPERCONDUCTORS; THIN-FILMS; YBA2CU3O7-DELTA; SPECTROSCOPY; ABSORPTION	Optical spectra of high-transition-temperature superconductors in the midinfrared display a gap of in-plane conductivity whose role for superconductivity remains unresolved. Femtosecond measurements of the mid-infrared reflectivity of YBa2Cu3O7-delta after nonequilibrium optical excitation are used to demonstrate the ultrafast fill-in of this gap and reveal two gap constituents: a picosecond recovery of the superconducting condensate in underdoped and optimally doped material and, in underdoped YBa2Cu3O7-delta, an additional subpicosecond component related to pseudogap correlations. The temperature-dependent amplitudes of both contributions correlate with the antiferromagnetic 41-millielectronvolt peak in neutron scattering, supporting the coupling between charges and spin excitations.	Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Queens Univ Belfast, Dept Pure & Appl Phys, Belfast BT7 1NN, Antrim, North Ireland	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; University of Oxford; Queens University Belfast	Elsaesser, T (corresponding author), Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany.		Elsaesser, Thomas/P-7608-2014; Smith, David C/B-1485-2010	Elsaesser, Thomas/0000-0003-3056-6665; Smith, David C/0000-0003-0931-3874				Blumberg G, 1997, SCIENCE, V278, P1427, DOI 10.1126/science.278.5342.1427; BRORSON SD, 1990, PHYS REV LETT, V64, P2172, DOI 10.1103/PhysRevLett.64.2172; Carbotte JP, 1999, NATURE, V401, P354, DOI 10.1038/43843; CHWALEK JM, 1990, APPL PHYS LETT, V57, P1696, DOI 10.1063/1.104140; Dai PC, 1999, SCIENCE, V284, P1344, DOI 10.1126/science.284.5418.1344; Demler E, 1998, NATURE, V396, P733, DOI 10.1038/25482; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; FARNAN GA, UNPUB; HAN SG, 1990, PHYS REV LETT, V65, P2708, DOI 10.1103/PhysRevLett.65.2708; Kaindl RA, 1999, APPL PHYS LETT, V75, P1060, DOI 10.1063/1.124596; Munzar D, 1999, PHYSICA C, V312, P121, DOI 10.1016/S0921-4534(98)00659-5; ORENSTEIN J, 1990, PHYS REV B, V42, P6342, DOI 10.1103/PhysRevB.42.6342; Pines D, 1997, Z PHYS B CON MAT, V103, P129, DOI 10.1007/s002570050346; Puchkov AV, 1996, J PHYS-CONDENS MAT, V8, P10049, DOI 10.1088/0953-8984/8/48/023; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; SAKEEK HF, 1991, J APPL PHYS, V70, P2455, DOI 10.1063/1.349398; SCHLESINGER Z, 1994, PHYSICA C, V235, P49, DOI 10.1016/0921-4534(94)91311-0; Shen ZX, 1997, PHYS REV LETT, V78, P1771, DOI 10.1103/PhysRevLett.78.1771; Siders JLW, 1998, SPRINGER SERIES CHEM, V63, P365; Stevens CJ, 1997, PHYS REV LETT, V78, P2212, DOI 10.1103/PhysRevLett.78.2212; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Yamaguchi S, 1996, J MOL STRUCT, V379, P87, DOI 10.1016/0022-2860(95)09178-5	22	158	159	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					470	473		10.1126/science.287.5452.470	http://dx.doi.org/10.1126/science.287.5452.470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642545				2022-12-28	WOS:000084929900043
J	Jamieson, DJ; Meikle, SF; Hillis, SD; Mtsuko, D; Mawji, S; Duerr, A				Jamieson, DJ; Meikle, SF; Hillis, SD; Mtsuko, D; Mawji, S; Duerr, A			An evaluation of poor pregnancy outcomes among Burundian refugees in Tanzania	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; LOW-BIRTH-WEIGHT; MALAWI; RISK; PREVENTION; MORTALITY; MALARIA; INFANT; WOMEN	Context Little is known about pregnancy outcomes among the approximately 11 million refugees worldwide, 25% of whom are women of reproductive age. Objective To estimate incidence of and determine risk factors for poor pregnancy outcomes and to calculate the contribution of mortality from neonatal and maternal deaths to overall mortality in a refugee camp. Design Cross-sectional review of records and survey, conducted in February and March 1998, Setting Mtendeli refugee camp, Tanzania, Participants For the overall assessment, 664 Burundi women who had a pregnancy outcome during a recent 5-month period (September 1, 1997-January 31, 1998) and their 679 infants; 538 women (81%) completed the survey. Main Outcome Measures Incidence of fetal death (fetus born greater than or equal to 500 g or greater than or equal to 22 weeks' gestation with no signs of life), low birth weight (<2500 g), neonatal death (death <28 days of life), and maternal death (deaths during or within 42 days of pregnancy from any cause related to or aggravated by the pregnancy or its management). Results The fetal death rate was 45.6 per 1000 births, the neonatal mortality rate was 29.3 per 1000 live births, and 22.4% of all live births were low birth weight. Compared with women without poor pregnancy outcome, those with poor pregnancy outcome were more likely to report prior high socioeconomic status (adjusted odds ratio [OR], 1.6; 95 % confidence interval [CI], 1.1-2.4), having a first or second pregnancy (OR, 2.2; 95% CI, 1.4-3.4), and having 3 or more episodes of malaria during pregnancy (OR, 2.0; 95% CI, 1.4-3.1). Neonatal and maternal deaths accounted for 16% of all deaths during the period studied. Conclusions Poor pregnancy outcomes were common in this refugee setting, and neonatal and maternal deaths, 2 important components of reproductive health-related deaths, contributed substantially to overall mortality.	Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30341 USA; Int Rescue Comm, New York, NY USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Jamieson, DJ (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,Mailstop K 34, Atlanta, GA 30341 USA.			Jamieson, Denise/0000-0003-2597-1201				Abouzahr Carla, 1996, World Health Statistics Quarterly, V49, P77; ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; Basso O, 1997, BRIT MED J, V315, P1498, DOI 10.1136/bmj.315.7121.1498; *CDCP, 1991, EP APPR REPR HLTH; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P705; DALLABETTA GA, 1993, J INFECT DIS, V167, P36, DOI 10.1093/infdis/167.1.36; *M STOP INT, 1998, REPR HLTH CAR REF SE; *MAT HLTH SAF MOTH, 1992, LOW BIRTH WEIGHT TAB; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Sachs L, 1997, Afr Health, V19, P24; SCHULZ KF, 1987, GENITOURIN MED, V63, P320; SEIDMAN DS, 1988, OBSTET GYNECOL, V72, P158; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; TAHA TE, 1995, INT J EPIDEMIOL, V24, P1022, DOI 10.1093/ije/24.5.1022; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; *UN HIGH COMM REF, 1999, REG OTH CONC UNHCR 1; *UN HIGH COMM REF, 1995, REPR HLTH REF SIT IN; VANDERSTUYFT P, 1993, ANN SOC BELG MED TR, V73, P81; *WOM COMM REF WOM, 1996, FACT SHEET; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	20	37	37	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					397	402		10.1001/jama.283.3.397	http://dx.doi.org/10.1001/jama.283.3.397			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647805				2022-12-28	WOS:000084732400034
J	Crowley, MP; Fahrer, AM; Baumgarth, N; Hampl, J; Gutgemann, I; Teyton, L; Chien, YH				Crowley, MP; Fahrer, AM; Baumgarth, N; Hampl, J; Gutgemann, I; Teyton, L; Chien, YH			A population of murine gamma delta T cells that recognize an inducible MHC class lb molecule	SCIENCE			English	Article							LYMPHOCYTES; ACTIVATION; ANTIGEN; GAMMA/DELTA; DEFICIENT; INFECTION; INDUCTION; TOLERANCE; RESPONSES; PRODUCT	Although gamma delta T cells are implicated in regulating immune responses, gamma delta T cell-ligand pairs that could mediate such regulatory functions have not been identified. Here, the expression of the major histocompatibility complex (MHC) class Ib T22 and the closely related T10 molecules is shown to be activation-induced, and they confer specificity to about 0.4% of the gamma delta T cells in normal mice. Thus, the increased expression of T22 and/or T'10 might trigger immunoregulatory gamma delta T cells during immune responses. Furthermore, the fast on-rates and slow off-rates that characterize this receptor/ligand interaction would compensate for the low ligand stability and suggest a high threshold for gamma delta T cell activation.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Stanford University; Stanford University; Stanford University; Scripps Research Institute	Chien, YH (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	chien@leland.stanford.edu	Gütgemann, Ines/ABH-6426-2020; Fahrer, Aude M/C-9318-2009; Baumgarth, Nicole/AAI-6949-2020	Fahrer, Aude/0000-0001-8556-0223	NIAID NIH HHS [AI42267, AI34762-34, AI33431] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034762, R21AI142267, R01AI042267, R01AI033431] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BAUMGARTH N, UNPUB; Bigos A, 1999, CYTOMETRY, V36, P36; Born W, 1999, Adv Immunol, V71, P77; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; CROWLEY MP, UNPUB; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; EMOTO M, 1995, INFECT IMMUN, V63, P3736, DOI 10.1128/IAI.63.9.3736-3738.1995; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; GUTGEMANN I, UNPUB; HOULDEN BA, 1989, COLD SH Q B, V54, P45; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; KAUFMANN SHE, 1993, P NATL ACAD SCI USA, V90, P9620, DOI 10.1073/pnas.90.20.9620; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Ke Y, 1997, J IMMUNOL, V158, P3610; MAVADDAT N, 1995, THESIS U W AUSTR NED; MCKEARN TJ, 1979, TRANSPLANT P, V11, P932; MCMENAMIN C, 1995, J IMMUNOL, V154, P4390; Ogg GS, 1998, CURR OPIN IMMUNOL, V10, P393, DOI 10.1016/S0952-7915(98)80110-6; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; SPANER D, 1995, J IMMUNOL, V155, P3866; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; WEINTRAUB BC, 1994, J IMMUNOL, V153, P3051; Wingren C, 2000, SCIENCE, V287, P310, DOI 10.1126/science.287.5451.310; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	29	150	150	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					314	316		10.1126/science.287.5451.314	http://dx.doi.org/10.1126/science.287.5451.314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634788				2022-12-28	WOS:000084769600043
J	Loder, N				Loder, N			UK discussed ban on foreign job ads in 1960s	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					121	121		10.1038/35003005	http://dx.doi.org/10.1038/35003005			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646567	Bronze			2022-12-28	WOS:000084835300006
J	Macilwain, C				Macilwain, C			Inadequate optics 'threat to US laser facility'	NATURE			English	News Item																			0	5	5	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					120	120		10.1038/35003273	http://dx.doi.org/10.1038/35003273			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646566	Bronze			2022-12-28	WOS:000084835300005
J	Tomson, CRV				Tomson, CRV			Recent advances - Nephrology	BRITISH MEDICAL JOURNAL			English	Review							POLYCYSTIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; DIABETIC NEPHROPATHY; FAILURE PATIENTS; HEART-FAILURE; HYPERTENSION; PROGRESSION; RECEPTOR; IDENTIFICATION; ANGIOPLASTY		Southmead Gen Hosp, Richard Bright Renal Unit, N Bristol NHS Trust, Bristol BS10 5NB, Avon, England	North Bristol NHS Trust; Southmead Hospital	Tomson, CRV (corresponding author), Southmead Gen Hosp, Richard Bright Renal Unit, N Bristol NHS Trust, Westbury Trym, Bristol BS10 5NB, Avon, England.			Tomson, Charles/0000-0002-0224-8726				Allen A, 1997, BIOCHEM SOC T, V25, P486, DOI 10.1042/bst0250486; Allen AC, 1998, NEPHROL DIAL TRANSPL, V13, P930, DOI 10.1093/ndt/13.4.930; Brown EM, 1996, KIDNEY INT, V49, P1042, DOI 10.1038/ki.1996.152; Connolly DL, 1996, LANCET, V347, P210, DOI 10.1016/S0140-6736(96)90399-2; Cusi D, 1998, KIDNEY INT, V54, P328, DOI 10.1046/j.1523-1755.1998.00007.x; DEVOY MAB, 1992, J INTERN MED, V232, P493, DOI 10.1111/j.1365-2796.1992.tb00622.x; Donadio JV, 1997, J AM SOC NEPHROL, V8, P1324; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Geberth S, 1995, J AM SOC NEPHROL, V6, P1643; Giatras I, 1997, ANN INTERN MED, V127, P337, DOI 10.7326/0003-4819-127-5-199709010-00001; HARRIS PC, 1995, J AM SOC NEPHROL, V6, P1125; Harris PC, 1997, NEPHROL DIAL TRANSPL, V12, P1089, DOI 10.1093/ndt/12.6.1089; Hebert SC, 1996, KIDNEY INT, V50, P2129, DOI 10.1038/ki.1996.539; Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Ismail N, 1998, NEPHROL DIAL TRANSPL, V13, P246, DOI 10.1093/ndt/13.2.246; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; KASISKE BL, 1993, ANN INTERN MED, V118, P129, DOI 10.7326/0003-4819-118-2-199301150-00009; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; KHAN IH, 1995, AM J KIDNEY DIS, V25, P276, DOI 10.1016/0272-6386(95)90009-8; KLAHR S, 1995, J AM SOC NEPHROL, V5, P2037; Krumholz HM, 1998, LANCET, V352, P3, DOI 10.1016/S0140-6736(05)79504-0; Kunz R, 1998, J AM SOC NEPHROL, V9, P1653; Kurtz I, 1998, KIDNEY INT, V54, P1396, DOI 10.1046/j.1523-1755.1998.00124.x; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Mikhail A, 1997, LANCET, V349, P926, DOI 10.1016/S0140-6736(05)62702-X; MISSOURIS CG, 1993, LANCET, V341, P1521, DOI 10.1016/0140-6736(93)90645-W; NEMETH EF, 1988, NEPHROL DIAL TRANSPL, V13, P1923; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Preston RA, 1997, J HYPERTENS, V15, P1365, DOI 10.1097/00004872-199715120-00001; RAMSAY LE, 1990, BRIT MED J, V300, P569, DOI 10.1136/bmj.300.6724.569; Rhodes JM, 1996, LANCET, V347, P1641, DOI 10.1016/S0140-6736(96)91482-8; RIMMER JM, 1993, ANN INTERN MED, V118, P712, DOI 10.7326/0003-4819-118-9-199305010-00010; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1998, BRIT MED J, V316, P504, DOI 10.1136/bmj.316.7130.504; Sawicki PT, 1998, DIABETOLOGIA, V41, P598, DOI 10.1007/s001250050953; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Stearne MR, 1998, BRIT MED J, V317, P713; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; VANDERKLEIJ FGH, 1998, KIDNEY INT S63, V53, P23; VIDT DG, 1988, CLEV CLIN J MED, V56, P407; WEIDMANN P, 1992, J HUM HYPERTENS S2, V6, P523	43	16	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 8	2000	320	7227					98	101		10.1136/bmj.320.7227.98	http://dx.doi.org/10.1136/bmj.320.7227.98			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274CR	10625267	Green Published			2022-12-28	WOS:000084746600021
J	Samet, JM				Samet, JM			Concepts of time in clinical research	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MULTICENTER AIDS COHORT; HIV-INFECTION; LUNG-CANCER; SEROCONVERSION; MODELS; PERIOD; AGE; INTERMEDIATE; INCUBATION	The study of events in time is fundamental to biomedical research and public health surveillance. Clinicians have an intuitive appreciation for the relevance of time to health and disease, and patients invariably ask questions relating to time for which clinicians need answers. An appreciation of the picture of health and disease over time is equally fundamental to public health. Research designs that incorporate time have long been in use; the cohort study, which involves follow-up of persons over time, is the fundamental design. Analysis of longitudinal data, generated by cohort studies and related approaches, has been enhanced by new statistical methods that are appropriate to data collected over time from repeated observations. In the next millennium, new and increasingly complex questions will undoubtedly require investigation. The research designs and analytic methods used to address clinical questions in time will continue to evolve and will provide better, sharper answers.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University	Samet, JM (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, 615 N Wolfe St,Suite 6041, Baltimore, MD 21205 USA.							*ACT SOC AM, 1903, SPEC MORT INV; ANDVORD K. F., 1930, Norsk Magazin for Laegevidenskaben, V91, P642; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; BROWN L, 1904, AM MED, V8, P879; CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; *COMM HLTH RISKS E, 1998, BEIR, V5; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; COX DR, 1972, J R STAT SOC B, V34, P187; Dawber TR, 1980, FRAMINGHAM STUDY EPI, P1; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Diggle PJ, 1994, ANAL LONGITUDINAL DA; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Enger C, 1996, JAMA-J AM MED ASSOC, V275, P1329, DOI 10.1001/jama.275.17.1329; EYLER JM, 1978, TIMES PLACES PERSONS, P1; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Frost WH, 1939, AM J HYG, V30, P91, DOI 10.1093/oxfordjournals.aje.a118570; Gange SJ, 1996, STAT MED, V15, P2323, DOI 10.1002/(SICI)1097-0258(19961115)15:21<2323::AID-SIM451>3.0.CO;2-P; GANGE SJ, 1997, J ACQ IMMUN DEF SYND, V15, pS5; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hu FB, 1999, JAMA-J AM MED ASSOC, V281, P1387, DOI 10.1001/jama.281.15.1387; JACOBSON LP, 1993, AM J EPIDEMIOL, V138, P952, DOI 10.1093/oxfordjournals.aje.a116815; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KINGSLEY LA, 1991, AM J EPIDEMIOL, V134, P331, DOI 10.1093/oxfordjournals.aje.a116094; LAST JM, 1995, DICT EPIDEMIOLOGY; LUNDIN FD, 1979, P WORK GROUP 2 C SOC, P243; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Miller R. G., 1981, SURVIVAL ANAL; Munoz A, 1998, EPIDEMIOL REV, V20, P29, DOI 10.1093/oxfordjournals.epirev.a017970; MUNOZ A, 1992, STAT MED, V11, P939, DOI 10.1002/sim.4780110711; MUNOZ A, 1995, J ACQ IMMUN DEF SYND, V8, P496, DOI 10.1097/00042560-199504120-00010; Munoz A, 1996, STAT MED, V15, P2459, DOI 10.1002/(SICI)1097-0258(19961130)15:22<2459::AID-SIM464>3.0.CO;2-Q; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; Munoz A, 1997, AIDS, V11, pS69; MUNOZ A, 1993, AM J EPIDEMIOL, V137, P423, DOI 10.1093/oxfordjournals.aje.a116691; MUNOZ A, 1995, USE COHORT STUDIES E, P423; *NCI, 1998, SEER CANC STAT REV 1; Nieto FJ, 1998, AM J EPIDEMIOL, V148, P937, DOI 10.1093/oxfordjournals.aje.a009570; Pearl R, 1938, SCIENCE, V87, P216, DOI 10.1126/science.87.2253.216; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Samet JM, 1998, EPIDEMIOL REV, V20, P1; SARTWELL PE, 1951, AM REV TUBERC PULM, V63, P608; SCHULL WJ, 1995, EFFECTS ATOMIC RAD H, P1; Singer R B, 1985, Natl Cancer Inst Monogr, V67, P15; Speizer F E, 1979, Epidemiol Rev, V1, P124; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; TAYLOR JMG, 1990, STAT MED, V9, P505, DOI 10.1002/sim.4780090504; Thomas D, 1998, EPIDEMIOL REV, V20, P122, DOI 10.1093/oxfordjournals.epirev.a017967; *US DHEW, 1964, DHEW PUBL, V1103; Vogelstein B., 1998, GENETIC BASIS HUMAN; WHITE C, 1990, YALE J BIOL MED, V63, P29; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; Wynder EL, 1997, AM J EPIDEMIOL, V146, P687	61	8	8	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					37	44		10.7326/0003-4819-132-1-200001040-00007	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627250				2022-12-28	WOS:000084518600006
J	Lamont, D; Parker, L; White, M; Unwin, N; Bennett, SMA; Cohen, M; Richardson, D; Dickinson, HO; Adamson, A; Alberti, KGMM; Craft, AW				Lamont, D; Parker, L; White, M; Unwin, N; Bennett, SMA; Cohen, M; Richardson, D; Dickinson, HO; Adamson, A; Alberti, KGMM; Craft, AW			Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; B-MODE ULTRASOUND; FETAL GROWTH; MYOCARDIAL-INFARCTION; PERIPHERAL ARTERIES; WALL THICKNESS; FOLLOW-UP; CHILDHOOD; WOMEN; ATHEROSCLEROSIS	Objective To quantify the direct and indirect effects of fetal life, childhood, and adult life on risk of cardiovascular disease at age 49-51 years. Design Follow up study of the "Newcastle thousand families" birth cohort established in 1947. Participants 154 men and 193 women who completed a health and lifestyle questionnaire and attended for clinical examination between October 1996 and December 1998. Main outcome measures Correlations between mean intima-media thickness of the carotid artery (carotid intima-media thickness) and family history, birth weight, and socioeconomic position around birth; socioeconomic position, growth, illness, and adverse Life events in childhood; and adult socioeconomic position, lifestyle, and biological risk markers. Proportions of variance in carotid intima-media thickness that were accounted for by each stage of the lifecourse. Results Socioeconomic position at birth and birth weight were negatively associated with carotid intima-media thickness, although only social class at birth in women was a statistically significant covariate independent of adult lifestyle. These early life variables accounted directly for 2.2% of total variance in men and 2.0% in women. More variation in carotid intima-media thickness was explained by adult socioeconomic position and lifestyle, which accounted directly and indirectly for 3.4% of variance in men (95% confidence interval 0.5% to 6.2%) and 7.6% in women (2.1% to 13.0%). Biological risk markers measured in adulthood independently accounted for a further 9.5% of variance in men (2.4% to 14.2%) and 4.9% in women (1.6% to 7.4%). Conclusions Adult lifestyle and biological risk markers were the most important determinants of the cardiovascular health of the study members of the Newcastle thousand families cohort at age 49-51 years. The limited overall effect of early life factors may reflect the postwar birth year of this cohort.	Newcastle Univ, Royal Victoria Infirm, Dept Child Hlth, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Newcastle Univ, Sch Med, Sch Hlth Care Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE1 4HH, Tyne & Wear, England; Newcastle Univ, Sch Med, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Royal Victoria Infirm, Dept Radiol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Lamont, D (corresponding author), Newcastle Univ, Royal Victoria Infirm, Dept Child Hlth, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	d.w.lamont@ncl.ac.uk	White, Martin J. R./G-2410-2010	Unwin, Nigel/0000-0002-1368-1648; Adamson, Ashley/0000-0003-3735-2846; PARKER, LOUISE/0000-0002-5188-8113	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barker DJP, 1998, MOTHERS BABIES HLTH; Ben Shlomo, 1997, LIFECOURSE APPROACH; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; *DEP HLTH, 1992, 41 DEP HLTH; Dubuisson JT, 1998, DIABETES CARE, V21, P1790, DOI 10.2337/diacare.21.11.1790; EBRAHIM S, 1994, BRIT HEART J, V72, P501; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GAIRDNER D, 1971, ARCH DIS CHILD, V46, P783, DOI 10.1136/adc.46.250.783; GLIKSMAN MD, 1995, J EPIDEMIOL COMMUN H, V49, P10, DOI 10.1136/jech.49.1.10; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HOLLINGSWORTH D, 1991, ENGLISHMANS FOOD 5 C, P429; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; KUH DJL, 1992, J EPIDEMIOL COMMUN H, V46, P114, DOI 10.1136/jech.46.2.114; Lamont DW, 1998, PUBLIC HEALTH, V112, P85, DOI 10.1016/S0033-3506(98)00591-5; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Little R. J. A., 1987, STAT ANAL MISSING DA; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; Njolstad I, 1996, CIRCULATION, V93, P450; PETRIE JC, 1990, RECOMMENDATIONS BLOO; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Power C, 1998, LANCET, V352, P877, DOI 10.1016/S0140-6736(98)23937-7; Prineas R.J, 1982, MINNESOTA MANUAL ELE; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Williams S, 1999, BRIT MED J, V318, P897, DOI 10.1136/bmj.318.7188.897; World Health Organisation, 1990, MONICA MAN 3	33	134	138	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2000	320	7230					273	278		10.1136/bmj.320.7230.273	http://dx.doi.org/10.1136/bmj.320.7230.273			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650022	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000085132700018
J	Hazuda, DJ; Felock, P; Witmer, M; Wolfe, A; Stillmock, K; Grobler, JA; Espeseth, A; Gabryelski, L; Schleif, W; Blau, C; Miller, MD				Hazuda, DJ; Felock, P; Witmer, M; Wolfe, A; Stillmock, K; Grobler, JA; Espeseth, A; Gabryelski, L; Schleif, W; Blau, C; Miller, MD			Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 INTEGRASE; VIRAL-DNA; PREINTEGRATION COMPLEXES; STABLE COMPLEX; PROTEIN; INVITRO; IDENTIFICATION; GENE; SITE	Integrase is essential for human immunodeficiency virus-type 1 (HIV-1) replication; however, potent inhibition of the isolated enzyme in biochemical assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration. In this report, we describe diketo acid inhibitors of HIV-1 integrase that manifest antiviral activity as a consequence of their effect on integration. The antiviral activity of these compounds is due exclusively to inhibition of one of the two catalytic functions of integrase, strand transfer.	Merck Sharp & Dohme Res Labs, Dept Antiviral Res, W Point, PA 19486 USA	Merck & Company	Hazuda, DJ (corresponding author), Merck Sharp & Dohme Res Labs, Dept Antiviral Res, W Point, PA 19486 USA.							CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; ESPESETH A, UNPUB; Farnet CM, 1996, P NATL ACAD SCI USA, V93, P9742, DOI 10.1073/pnas.93.18.9742; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; GOLDMAN ME, 1991, P NATL ACAD SCI USA, V88, P6863, DOI 10.1073/pnas.88.15.6863; Hazuda D, 1997, Drug Des Discov, V15, P17; Hazuda DJ, 1997, J VIROL, V71, P7005, DOI 10.1128/JVI.71.9.7005-7011.1997; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; Miller M. M., UNPUB; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Neamati N, 1998, J MED CHEM, V41, P3202, DOI 10.1021/jm9801760; Pommier Y, 1999, ADV VIRUS RES, V52, P427, DOI 10.1016/S0065-3527(08)60310-3; Richman D.D, 1996, ANTIVIRAL DRUG RESIS; TADDEO B, 1994, J VIROL, V68, P8401, DOI 10.1128/JVI.68.12.8401-8405.1994; VANGENT DC, 1992, P NATL ACAD SCI USA, V89, P9598, DOI 10.1073/pnas.89.20.9598; VINK C, 1994, NUCLEIC ACIDS RES, V22, P4103, DOI 10.1093/nar/22.20.4103; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; WITMER M, UNPUB; Wolfe AL, 1996, J VIROL, V70, P1424, DOI 10.1128/JVI.70.3.1424-1432.1996	26	967	1028	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					646	650		10.1126/science.287.5453.646	http://dx.doi.org/10.1126/science.287.5453.646			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649997				2022-12-28	WOS:000084989400046
J	Berger, A				Berger, A			Scientists make rats' torn nerves regenerate	BRITISH MEDICAL JOURNAL			English	News Item																		Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					204	204						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642212				2022-12-28	WOS:000085029600009
J	Eisert, F; Gurka, M; Legant, A; Buck, M; Grunze, M				Eisert, F; Gurka, M; Legant, A; Buck, M; Grunze, M			Detection of molecular alignment in confined films	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; OPTICAL 2ND-HARMONIC GENERATION; FORCE MICROSCOPY; SURFACE; SPECTROSCOPY; SIMULATIONS; COMPRESSION; TRANSITION; CONTACTS	Optical second harmonic generation was used to study the in-plane alignment of self-assembled silane monolayers attached to a glass surface under mechanical Loading. The measurements allow correlation of the macroscopic forces acting on the monolayer with the average orientation and the azimuthal molecular alignment of the terminal molecular entity. Compression and shear forces Lead to an alignment of the initially randomly oriented molecules on a macroscopic length scale. The change in azimuthal alignment of molecules under mechanical stress was found to be irreversible on the time scale of 12 hours, whereas changes of the molecular tilt angle were reversible.	Lehrstuhl Angew Phys Chem, D-69120 Heidelberg, Germany		Buck, M (corresponding author), Lehrstuhl Angew Phys Chem, Neuenheimer Feld 253, D-69120 Heidelberg, Germany.	cv6@ix.urz.uni-heidelberg.de	Grunze, Michael H/H-1600-2013; Gurka, Martin/J-1464-2012; Grunze, Michael/O-2912-2019; Buck, Manfred/G-5508-2017	Buck, Manfred/0000-0003-1225-7607; Gurka, Martin/0000-0002-6359-5756				Bain CD, 1999, SURF SCI SERIES, V83, P335; Berman A, 1998, TRIBOL LETT, V4, P43, DOI 10.1023/A:1019134617374; BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; BIERBAUM K, 1995, LANGMUIR, V11, P512, DOI 10.1021/la00002a025; CANN PM, 1991, TRIBOL T, V34, P248, DOI 10.1080/10402009108982033; Chemla D. S., 1987, NONLINEAR OPTICAL PR, V1; CORN RM, 1994, CHEM REV, V94, P107, DOI 10.1021/cr00025a004; DU Q, 1995, PHYS REV B, V51, P7456, DOI 10.1103/PhysRevB.51.7456; FELDERHOF BU, 1993, J OPT SOC AM B, V10, P1824, DOI 10.1364/JOSAB.10.001824; Fraenkel R, 1998, J AM CHEM SOC, V120, P203, DOI 10.1021/ja972679l; HARRISON JA, 1998, MRS B            JUN, P27; Henda R, 1998, TRIBOL LETT, V5, P191, DOI 10.1023/A:1019141708230; IDZIAK SHJ, 1994, SCIENCE, V264, P1915, DOI 10.1126/science.264.5167.1915; ISRAELACHVILI J, 1992, J VAC SCI TECHNOL A, V10, P2961, DOI 10.1116/1.577894; ISRAELACHVILI JN, 1973, NATURE-PHYS SCI, V241, P148, DOI 10.1038/physci241148a0; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSTON GJ, 1991, TRIBOL T, V34, P187, DOI 10.1080/10402009108982026; JOYCE SA, 1992, PHYS REV LETT, V68, P2790, DOI 10.1103/PhysRevLett.68.2790; KARABORNI S, 1994, PHYS REV LETT, V73, P1668, DOI 10.1103/PhysRevLett.73.1668; LEGANT A, 1999, THESIS U HEIDELBERG; LIU GY, 1994, LANGMUIR, V10, P367, DOI 10.1021/la00014a006; Maboudian R, 1998, MRS BULL, V23, P47, DOI 10.1557/S0883769400030633; Shen YR, 1984, PRINCIPLES NONLINEAR; SIEPMANN JI, 1993, LANGMUIR, V9, P2351, DOI 10.1021/la00033a017; TUPPER KJ, 1994, LANGMUIR, V10, P2041, DOI 10.1021/la00019a002; TUPPER KJ, 1994, LANGMUIR, V10, P2335, DOI 10.1021/la00019a051	26	20	20	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					468	470		10.1126/science.287.5452.468	http://dx.doi.org/10.1126/science.287.5452.468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642544				2022-12-28	WOS:000084929900042
J	Schein, OD; Katz, J; Bass, EB; Tielsch, JM; Lubomski, LH; Feldman, MA; Petty, BG; Steinberg, EP				Schein, OD; Katz, J; Bass, EB; Tielsch, JM; Lubomski, LH; Feldman, MA; Petty, BG; Steinberg, EP		Study Medical Testing Cataract Sur	The value of routine preoperative medical testing before cataract surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Routine preoperative medical testing is commonly performed in patients scheduled to undergo cataract surgery, although the value of such testing is uncertain. We performed a study to determine whether routine testing helps reduce the incidence of intraoperative and postoperative medical complications. Methods We randomly assigned 19,557 elective cataract operations in 18,189 patients at nine centers to be preceded or not preceded by a standard battery of medical tests (electrocardiography, complete blood count, and measurement of serum levels of electrolytes, urea nitrogen, creatinine, and glucose), in addition to a history taking and physical examination. Adverse medical events and interventions on the day of surgery and during the seven days after surgery were recorded. Results Medical outcomes were assessed in 9408 patients who underwent 9626 cataract operations that were not preceded by routine testing and in 9411 patients who underwent 9624 operations that were preceded by routine testing. The most frequent medical events in both groups were treatment for hypertension and arrhythmia (principally bradycardia). The overall rate of complications (intraoperative and postoperative events combined) was the same in the two groups (31.3 events per 1000 operations). There were also no significant differences between the no-testing group and the testing group in the rates of intraoperative events (19.2 and 19.7, respectively, per 1000 operations) and postoperative events (12.6 and 12.1 per 1000 operations). Analyses stratified according to age, sex, race, physical status (according to the American Society of Anesthesiologists classification), and medical history revealed no benefit of routine testing. Conclusions Routine medical testing before cataract surgery does not measurably increase the safety of the surgery. (N Engl J Med 2000;342:168-75.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Med, Div Gen Internal Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Anesthesiol, Baltimore, MD USA; Johns Hopkins Univ, Dept Med, Div Clin Pharmacol, Baltimore, MD USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Covance Hlth Econ & Outcomes Serv, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Covance	Schein, OD (corresponding author), Johns Hopkins Hosp, 116 Wilmer Bldg,600 N Wolfe St, Baltimore, MD 21287 USA.			Bass, Eric/0000-0001-9106-527X; Katz, Joanne/0000-0002-5997-7823; Tielsch, James/0000-0002-1151-060X	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008331] Funding Source: NIH RePORTER; AHRQ HHS [R01-HSO-8331] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BASS EB, 1995, ARCH OPHTHALMOL-CHIC, V113, P1248, DOI 10.1001/archopht.1995.01100100036025; BRESLIN P P, 1973, International Ophthalmology Clinics, V13, P215, DOI 10.1097/00004397-197301320-00013; Cataract Management Guideline Panel, 1993, AHCPR PUBL; FISHER SJ, 1985, GERIATRIC CLIN N AM, V1, P339; GILVARRY A, 1982, T OPHTHAL SOC UK, V102, P502; HARDESTY DC, 1989, MED PERIOPERATIVE MA, P417; KAPLAN EB, 1985, JAMA-J AM MED ASSOC, V253, P3576, DOI 10.1001/jama.253.24.3576; Maltzman B A, 1981, J Med Soc N J, V78, P519; Marcello PW, 1996, SURG CLIN N AM, V76, P11, DOI 10.1016/S0039-6109(05)70418-7; McKibbin M, 1996, EYE, V10, P138, DOI 10.1038/eye.1996.25; NARR BJ, 1991, MAYO CLIN PROC, V66, P155, DOI 10.1016/S0025-6196(12)60487-X; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Pasternak LR, 1995, AMBULATORY ANESTHESI, P2; QUIGLEY HA, 1974, AM J OPHTHALMOL, V77, P517, DOI 10.1016/0002-9394(74)90465-6; ROIZEN MF, 1987, ANESTHESIOL CLIN N A, V5, P15; ROIZEN MF, 1994, ANESTHESIA, V1, P827; Schein OD, 1996, ARCH OPHTHALMOL-CHIC, V114, P1129, DOI 10.1001/archopht.1996.01100140331014; Velanovich V, 1996, J AM COLL SURGEONS, V183, P79; Walters G, 1997, EYE, V11, P847, DOI 10.1038/eye.1997.217	19	312	326	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					168	175		10.1056/NEJM200001203420304	http://dx.doi.org/10.1056/NEJM200001203420304			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639542				2022-12-28	WOS:000084851700004
J	Paunio, M; Heinonen, OP; Virtanen, M; Leinikki, P; Patja, A; Peltola, H				Paunio, M; Heinonen, OP; Virtanen, M; Leinikki, P; Patja, A; Peltola, H			Measles history and atopic diseases - A population-based cross-sectional study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINATION PROGRAM; ASTHMA; INFECTIONS; CHILDHOOD; RUBELLA; FINLAND; MUMPS; CHILDREN; SIZE	Context Many recent cross-sectional studies have suggested that lack of early exposure to communicable diseases, including measles, in affluent countries may have increased rates of atopic disease. Objective To study the association between natural measles infection and atopy, Design and Setting Cross-sectional nationwide study in Finland using data gathered between November 1, 1982, and June 30, 1986. Subjects A total of 547 910 individuals aged 14 months to 19 years who at the time of measles-mumps-rubella (MMR) vaccination had relevant information collected on the occurrence of measles and allergic rhinitis, eczema, and asthma. Main Outcome Measures Lifetime occurrence of atopic manifestations in subjects who had had measles compared with those who had not, expressed as age-specific and age-adjusted prevalence ratios. Results The age-adjusted prevalence ratio of atopic manifestations among those who had had measles (n = 20 690) compared with those who had not (n = 527 220) was 1.32 (95% confidence interval [CI], 1.27-1.36) for eczema, 1.41 (95% CI, 1.33-1.49) for rhinitis, and 1.67 (95% CI, 1.54-1.79) for asthma. The positive association between measles and atopy was evident at all ages, in both urban and rural dwellers, and among subjects with many or few contacts at home or in day care. Conclusions Based on our data, measles and atopy occur more frequently together than expected, which does not support the hypothesis that experiencing natural measles infection offers protection against atopic disease.	Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Assoc Local & Reg Author, Dept Hosp Serv, Helsinki, Finland; Natl Publ Hlth Inst, Dept Infect Dis, Helsinki, Finland; Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Paunio, M (corresponding author), Minist Social Affairs & Hlth, POB 267, Helsinki 00171, Finland.							Allen JE, 1997, IMMUNOL TODAY, V18, P387, DOI 10.1016/S0167-5699(97)01102-X; Bodner C, 1998, THORAX, V53, P28, DOI 10.1136/thx.53.1.28; Campbell DE, 1996, LANCET, V348, P825, DOI 10.1016/S0140-6736(05)65244-0; *CENTR STAT OFF FI, 1987, STAT YB FINL 1987; Cookson WOCM, 1997, SCIENCE, V275, P41, DOI 10.1126/science.275.5296.41; FOX JP, 1971, AM J EPIDEMIOL, V94, P179, DOI 10.1093/oxfordjournals.aje.a121310; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Hayney M S, 1998, Int J Infect Dis, V2, P143, DOI 10.1016/S1201-9712(98)90116-3; Holgate ST, 1997, NAT GENET, V15, P227, DOI 10.1038/ng0397-227; HOLT PG, 1994, LANCET, V344, P456, DOI 10.1016/S0140-6736(94)91776-0; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; MARTINEZ FD, 1994, THORAX, V49, P1189, DOI 10.1136/thx.49.12.1189; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; PAUNIO M, 1991, AM J EPIDEMIOL, V133, P1152, DOI 10.1093/oxfordjournals.aje.a115827; PELTOLA H, 1994, NEW ENGL J MED, V331, P1397, DOI 10.1056/NEJM199411243312101; PELTOLA H, 1986, LANCET, V1, P137; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Soothill JF, 1996, LANCET, V348, P825, DOI 10.1016/S0140-6736(05)65245-2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692	22	131	136	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					343	346		10.1001/jama.283.3.343	http://dx.doi.org/10.1001/jama.283.3.343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647796	Bronze			2022-12-28	WOS:000084732400025
J	Yuan, CS; Foss, JF; O'Connor, M; Osinski, J; Karrison, T; Moss, J; Roizen, MF				Yuan, CS; Foss, JF; O'Connor, M; Osinski, J; Karrison, T; Moss, J; Roizen, MF			Methylnaltrexone for reversal of constipation due to chronic methadone use - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUATERNARY NARCOTIC-ANTAGONISTS; MORPHINE-INDUCED DELAY; CECAL TRANSIT-TIME; ORAL NALOXONE; GASTROINTESTINAL PROPULSION; INTESTINAL TRANSIT; CANCER PAIN; SMALL-BOWEL; INHIBITION; SAFETY	Context Constipation is the most common chronic adverse effect of opioid pain medications in patients who require long-term opioid administration, such as patients with advanced cancer, but conventional measures for ameliorating constipation often are insufficient, Objective To evaluate the efficacy of methylnaltrexone, the first peripheral opioid receptor antagonist, in treating chronic methadone-induced constipation. Design Double-blind, randomized, placebo-controlled trial conducted between May 1997 and December 1998, Setting Clinical research center of a university hospital. Participants Twenty-two subjects (9 men and 13 women; mean [SD] age, 43.2 [5.5] years) enrolled iq a methadone maintenance program and having methadone-induced constipation. Main Outcome Measures Laxation response, oral-cecal transit time, and central opioid withdrawal symptoms were compared between the 2 groups. Results The 11 subjects in the placebo group showed no laxation response, and all 11 subjects in the intervention group had laxation response after intravenous methylnaltrexone administration (P<.001). The oral-cecal transit times at baseline for subjects in the methylnaltrexone and placebo groups averaged 132.3 and 126.8 minutes, respectively. The average (SD) change in the methylnaltrexone-treated group was -77.7 (37.2) minutes, significantly greater than the average change in the placebo group (-1.4 [12.0] minutes; P<.001), No opioid withdrawal was observed in any subject, acid no significant adverse effects were reported by the subjects during the study. Conclusions Our data demonstrate that intravenous methylnaltrexone can induce laxation and reverse slowing of oral cecal-transit time in subjects taking high opioid dosages, Low-dosage methylnaltrexone may have clinical utility in managing opioid-induced constipation.	Univ Chicago, Pritzker Sch Med, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Comm Clin Pharmacol, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Yuan, CS (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Anesthesia & Crit Care, 5841 S Maryland Ave,MC 4028, Chicago, IL 60637 USA.		Foss, Joseph F/B-8342-2008	Foss, Joseph F/0000-0002-4050-7151	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00055] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BASILISCO G, 1987, DIGEST DIS SCI, V32, P829, DOI 10.1007/BF01296704; BOND JH, 1975, J LAB CLIN MED, V85, P546; BROWN DR, 1985, NEUROPHARMACOLOGY, V24, P181, DOI 10.1016/0028-3908(85)90072-3; CAMERON JC, 1992, CANCER NURS, V15, P372; CULPEPPERMORGAN JA, 1992, CLIN PHARMACOL THER, V52, P90, DOI 10.1038/clpt.1992.106; DANIEL EE, 1959, GASTROENTEROLOGY, V36, P510; FERRETTI P, 1981, RES COMMUN SUBSTANCE, V2, P1; FIFIELD MY, 1991, AM J NURS, V91, P18, DOI 10.2307/3426463; Foss JF, 1997, J CLIN PHARMACOL, V37, P25, DOI 10.1177/009127009703700105; FRASER HF, 1961, J PHARMACOL EXP THER, V133, P371; GALLIGAN JJ, 1983, J PHARMACOL EXP THER, V226, P356; GLARE P, 1992, J PAIN SYMPTOM MANAG, V7, P369, DOI 10.1016/0885-3924(92)90092-V; GOWAN JD, 1988, CAN J ANAESTH, V35, P143, DOI 10.1007/BF03010654; Jovanovic BD, 1997, ANN EMERG MED, V30, P301, DOI 10.1016/S0196-0644(97)70165-3; KIM C, 1989, CHROMATOGRAPHIA, V28, P359, DOI 10.1007/BF02261014; MANARA L, 1985, ANNU REV PHARMACOL, V25, P249, DOI 10.1146/annurev.pa.25.040185.001341; MANARA L, 1986, J PHARMACOL EXP THER, V237, P945; Martin, 1977, DRUG ADDICTION, P197, DOI DOI 10.1007/978-3-642-66612-4_4; McCaffrey M, 1989, Nursing, V19, P166; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; OKEEFE EA, 1995, J GERONTOL A-BIOL, V50, P184; PARUP PG, 1998, SCAND J GASTROENTERO, V33, P28; PORTENOY RK, 1987, MED CLIN N AM, V71, P303, DOI 10.1016/S0025-7125(16)30872-0; READ NW, 1985, GUT, V26, P834, DOI 10.1136/gut.26.8.834; RUSSELL J, 1982, EUR J PHARMACOL, V78, P255, DOI 10.1016/0014-2999(82)90026-7; SCHUG SA, 1992, J PAIN SYMPTOM MANAG, V7, P259, DOI 10.1016/0885-3924(92)90059-Q; STEWART JJ, 1978, J PHARMACOL EXP THER, V205, P547; SYKES NP, 1991, LANCET, V337, P1475, DOI 10.1016/0140-6736(91)93162-3; TAVANI A, 1980, LIFE SCI, V27, P2211, DOI 10.1016/0024-3205(80)90386-0; VONDEROHE MR, 1992, MAYO CLIN PROC, V67, P1169, DOI 10.1016/S0025-6196(12)61147-1; WALSH TD, 1984, PAIN, V18, P1, DOI 10.1016/0304-3959(84)90121-0; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; Yuan CS, 1998, J CLIN PHARMACOL, V38, P931, DOI 10.1002/j.1552-4604.1998.tb04389.x; YUAN CS, 1995, EUR J PHARMACOL, V276, P107, DOI 10.1016/0014-2999(95)00018-G; Yuan CS, 1997, CLIN PHARMACOL THER, V61, P467, DOI 10.1016/S0009-9236(97)90197-1; Yuan CS, 1999, PAIN, V83, P631, DOI 10.1016/S0304-3959(99)00162-1; Yuan CS, 1996, CLIN PHARMACOL THER, V59, P469, DOI 10.1016/S0009-9236(96)90117-4	37	176	199	2	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					367	372		10.1001/jama.283.3.367	http://dx.doi.org/10.1001/jama.283.3.367			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	273WM	10647800				2022-12-28	WOS:000084732400029
J	Tateno, M; Nishida, Y; Adachi-Yamada, T				Tateno, M; Nishida, Y; Adachi-Yamada, T			Regulation of JNK by Src during Drosophila development	SCIENCE			English	Article							N-TERMINAL KINASE; SIGNAL-TRANSDUCTION PATHWAY; CELL SHEET MOVEMENT; TYROSINE KINASE; C-SRC; DORSAL CLOSURE; MORPHOGENESIS; EXPRESSION; ACTIVATION; PP60C-SRC	In Drosophila, the Jun amino-terminal kinase (JNK) homolog Basket (Bsk) is required for epidermal closure. Mutants for Src42A, a Drosophila c-src protooncogene homolog, are described. Src42A functions in epidermal closure during both embryogenesis and metamorphosis. The severity of the epidermal closure defect in the Src42A mutant depended on the amount of Bsk activity, and the amount of Bsk activity depended. on the amount of Src42A. Thus, activation of the Bsk pathway is required downstream of Src42A in epidermal closure. This work confirms mammalian studies that demonstrated a physiological link between Src and JNK.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Adachi-Yamada, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	adachi@bio.nagoya-u.ac.jp						BRAND AH, 1993, DEVELOPMENT, V118, P401; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; Dodson GS, 1998, DEVELOPMENT, V125, P2883; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Guarnieri DJ, 1998, MOL CELL, V1, P831, DOI 10.1016/S1097-2765(00)80082-9; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lu XY, 1999, DEV BIOL, V208, P233, DOI 10.1006/dbio.1999.9196; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; RiesgoEscovar JR, 1997, GENE DEV, V11, P1717, DOI 10.1101/gad.11.13.1717; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; RODIER JM, 1995, J CELL BIOL, V131, P761, DOI 10.1083/jcb.131.3.761; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Takahashi F, 1996, GENE DEV, V10, P1645, DOI 10.1101/gad.10.13.1645; TATENO M, UNPUB; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	36	113	114	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					324	327		10.1126/science.287.5451.324	http://dx.doi.org/10.1126/science.287.5451.324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634792				2022-12-28	WOS:000084769600047
J	Bloch, I; Hansch, TW; Esslinger, T				Bloch, I; Hansch, TW; Esslinger, T			Measurement of the spatial coherence of a trapped Bose gas at the phase transition	NATURE			English	Article							EINSTEIN CONDENSATION	The experimental realization of Bose-Einstein condensates of dilute gases(1-3) has allowed investigations of fundamental concepts in quantum mechanics at ultra-low temperatures, such as wave-like behaviour and interference phenomena, The formation of an interference pattern depends fundamentally on the phase coherence of a system; the latter may be quantified by the spatial correlation function. Phase coherence over a long; range(4-7) is the essential factor underlying Bose-Einstein condensation and related macroscopic quantum phenomena, such as superconductivity and superfluidity. Here we report a direct measurement of the phase coherence properties of a weakly interacting Bose gas of rubidium atoms. Effectively, we create a double slit for magnetically trapped atoms using a radio wave field with two frequency components. The correlation function of the system is determined by evaluating the interference pattern of two matter waves originating from the spatially separated 'slit' regions of the trapped gas. Above the critical temperature for Bose-Einstein condensation, the correlation function shows a rapid gaussian decay, as expected for a thermal gas. Below the critical temperature, the correlation function has a different shape: at slow decay towards a plateau is observed, indicating the long-range phase coherence of the condensate fraction.	Univ Munich, Sekt Phys, D-80799 Munich, Germany; Max Planck Inst Quantum Opt, D-85748 Garching, Germany	University of Munich; Max Planck Society	Esslinger, T (corresponding author), Univ Munich, Sekt Phys, Schellingstr 4-3, D-80799 Munich, Germany.	tie@mpq.mpg.de	Bloch, Immanuel/G-3174-2010; Esslinger, Tilman/M-9022-2016; Bloch, Immanuel/N-9169-2019	Bloch, Immanuel/0000-0002-0679-4759; Esslinger, Tilman/0000-0002-8333-107X; 				Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Band YB, 1999, PHYS REV A, V59, P3823, DOI 10.1103/PhysRevA.59.3823; BELIAEV ST, 1958, SOV PHYS JETP, V34, P417; Bloch I, 1999, PHYS REV LETT, V82, P3008, DOI 10.1103/PhysRevLett.82.3008; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Ensher JR, 1996, PHYS REV LETT, V77, P4984, DOI 10.1103/PhysRevLett.77.4984; Esslinger T, 1998, PHYS REV A, V58, pR2664, DOI 10.1103/PhysRevA.58.R2664; FETTER AL, 1972, ANN PHYS-NEW YORK, V70, P67, DOI 10.1016/0003-4916(72)90330-2; Flugge S., 1974, PRACTICAL QUANTUM ME, P101; Hagley EW, 1999, PHYS REV LETT, V83, P3112, DOI 10.1103/PhysRevLett.83.3112; Hall DS, 1998, PHYS REV LETT, V81, P1543, DOI 10.1103/PhysRevLett.81.1543; HUANG K, 1987, STAT MECH, P304; Ketterle W, 1997, PHYS REV A, V56, P3291, DOI 10.1103/PhysRevA.56.3291; Naraschewski M, 1999, PHYS REV A, V59, P4595, DOI 10.1103/PhysRevA.59.4595; PENROSE O, 1951, PHILOS MAG, V42, P1373; PENROSE O, 1956, PHYS REV, V104, P576, DOI 10.1103/PhysRev.104.576; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; YANG CN, 1962, REV MOD PHYS, V34, P694, DOI 10.1103/RevModPhys.34.694	22	243	247	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					166	170		10.1038/35003132	http://dx.doi.org/10.1038/35003132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646595				2022-12-28	WOS:000084835300046
J	Berry, M				Berry, M			Making waves in physics - Three wave singularities from the miraculous 1830s.	NATURE			English	Editorial Material									Univ Bristol, Dept Phys, Bristol BS8 1TL, Avon, England	University of Bristol	Berry, M (corresponding author), Univ Bristol, Dept Phys, Bristol BS8 1TL, Avon, England.								0	78	83	4	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					21	21		10.1038/47364	http://dx.doi.org/10.1038/47364			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638732	Bronze			2022-12-28	WOS:000084687400019
J	Nakagawa, T; Zhu, H; Morishima, N; Li, E; Xu, J; Yankner, BA; Yuan, JY				Nakagawa, T; Zhu, H; Morishima, N; Li, E; Xu, J; Yankner, BA; Yuan, JY			Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta	NATURE			English	Article							CELL-DEATH; ALZHEIMERS-DISEASE; PROTEASE; RECEPTOR; PROTEINS; COMPLEX; ICE	Apoptosis, or cellular suicide, is important for normal development and tissue homeostasis, but too much or too Little apoptosis can also cause disease(1,2). The family of cysteine proteases, the so-called caspases, are critical mediators of programmed cell death(3), and thus far 14 family members have been identified. Some of these, such as caspase-(8) (refs 4, 5), mediate signal transduction downstream of death receptors located on the plasma membrane. Others, such as caspase-9 (ref. 6), mediate apoptotic signals after mitochondrial damage. Stress in the endoplasmic reticulum (ER) can also result in apoptosis(7). Here we show that caspase-12 is localized to the ER and activated by ER stress, including disruption of ER calcium homeostasis and accumulation of excess proteins in ER, but not by membrane- or mitochondrial-targeted apoptotic signals. Mice that are deficient in caspase-12 are resistant to ER stress-induced apoptosis, but their cells undergo apoptosis in response to other death stimuli. Furthermore, we show that caspase-12-deficient cortical neurons are defective in apoptosis induced by amyloid-beta protein but not by staurosporine or trophic factor deprivation. Thus, caspase-12 mediates an ER-specific apoptosis pathway and may contribute to amyloid-beta neurotoxicity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; RIKEN, Inst Phys & Chem Res, Biodesign Res Grp, Wako, Saitama 3510198, Japan; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02119 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; RIKEN; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Morishima, Nobuhiro/D-3946-2017	Zhu, Hong/0000-0002-2575-4031; Nakagawa, Toshiyuki/0000-0001-8415-4119; Xu, Jin/0000-0001-6617-5311				Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Troy CM, 1996, J NEUROSCI, V16, P253; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; Walter J, 1996, MOL MED, V2, P673, DOI 10.1007/BF03401652; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Yan SD, 1997, NATURE, V389, P689; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	17	2776	3012	6	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					98	103		10.1038/47513	http://dx.doi.org/10.1038/47513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638761				2022-12-28	WOS:000084687400051
J	Botvinick, M; Nystrom, LE; Fissell, K; Carter, CS; Cohen, JD				Botvinick, M; Nystrom, LE; Fissell, K; Carter, CS; Cohen, JD			Conflict monitoring versus selection-for-action in anterior cingulate cortex	NATURE			English	Article							HUMAN-BRAIN; ACTIVATION; SYSTEM; PET	The anterior cingulate cortex (ACC), on the medial surface of the frontal lobes of the brain, is widely believed to be involved in the regulation of attention(1,2), Beyond this, however, its specific contribution to cognition remains uncertain, One influential theory has interpreted activation within the ACC as reflecting 'selection-for-action'(3-5), a set of processes that guide the selection of environmental objects as triggers of or targets for action. We have proposed an alternative hypothesis, in which the ACC serves not to exert top-down attentional control but instead to detect and signal the occurrence of conflicts in information processing(6-8). Here, to test this theory against the selection-for-action theory, we used functional magnetic resonance imaging to measure brain activation during performance of a task where, for a particular subset of trials, the strength of selection-for action is inversely related to the degree of response conflict. Activity within the ACC was greater during trials featuring high levels of conflict (and weak selection-for-action) than during trials with low levels of conflict (and strong selection-for-action), providing evidence in favour of the conflict-monitoring account of ACC function.	Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Botvinick, M (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.		Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026				Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Botvinick M. M., 1998, 981 CTR NEUR BAS COG; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CARTER CS, UNPUB P NATL ACAD SC; Casey BJ, 1998, J COGNITIVE NEUROSCI, V10, P108; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN JD, 1992, AM J PSYCHOL, V105, P239, DOI 10.2307/1423029; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Posner MI, 1998, ATTENTIVE BRAIN, P401; Sanders Andries, 1987, PERSPECTIVES PERCEPT, P395; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	20	1562	1607	1	116	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					179	181		10.1038/46035	http://dx.doi.org/10.1038/46035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256FZ	10647008				2022-12-28	WOS:000083716400049
J	Ramakrishna, BS; Venkataraman, S; Srinivasan, P; Dash, P; Young, GP; Binder, HJ				Ramakrishna, BS; Venkataraman, S; Srinivasan, P; Dash, P; Young, GP; Binder, HJ			Amylase-resistant starch plus oral rehydration solution for cholera.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHAIN FATTY-ACIDS; RAT DISTAL COLON; DIARRHEA; ABSORPTION; DYSFUNCTION; EFFICACY; THERAPY; IMPACT; SODIUM	Background: Although standard glucose-based oral rehydration therapy corrects the dehydration caused by cholera, it does not reduce the diarrhea. Short-chain fatty acids, which are produced in the colon from nonabsorbed carbohydrates, enhance sodium absorption. We conducted a study to determine the effects of an orally administered, nonabsorbed starch (i.e., one resistant to digestion by amylase) on fecal fluid loss and the duration of diarrhea in patients with cholera. Methods: We randomly assigned 48 adolescents and adults with cholera to treatment with standard oral rehydration therapy (16 patients), standard therapy and 50 g of rice flour per liter of oral rehydration solution (16 patients), or standard therapy and 50 g of high-amylose maize starch, an amylase-resistant starch, per liter of oral rehydration solution (16 patients). The primary end points were fecal weight (for every 12-hour period during the first 48 hours after enrollment) and the length of time to the first formed stool. Results: The mean (+/-SD) fecal weights in the periods 12 to 24 hours, 24 to 36 hours, and 36 to 48 hours after enrollment were significantly lower in the resistant-starch group (2206+/-1158 g, 1810+/-1018 g, and 985+/-668 g) than in the standard-therapy group (3251+/-766 g, 2621+/-1149 g, and 2498+/-1080 g; P=0.01, P=0.04, and P=0.001, respectively). From 36 to 48 hours after enrollment, fecal weight was also significantly lower with the resistant-starch therapy than with the rice-flour therapy (985+/-668 g vs. 1790+/-866 g, P=0.01). The mean duration of diarrhea was significantly shorter with the resistant-starch therapy (56.7+/-18.6 hours) than with standard therapy alone (90.9+/-29.8 hours, P=0.001) or the rice-flour therapy (70.8+/-20.2 hours, P=0.05). Fecal excretion of starch was higher with the resistant-starch therapy (32.6+/-30.4) than with the standard therapy (11.7+/-4.1 g, P=0.002) or the rice-flour therapy (15.1+/-8.4 g, P=0.01). Conclusions: The addition of a resistant starch to oral rehydration solution reduces fecal fluid loss and shortens the duration of diarrhea in adolescents and adults with cholera. (N Engl J Med 2000;342:308-13.) (C) 2000, Massachusetts Medical Society.	Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore 632004, Tamil Nadu, India; Flinders Univ S Australia, Adelaide, SA 5001, Australia; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Christian Medical College & Hospital (CMCH) Vellore; Flinders University South Australia; Yale University	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore 632004, Tamil Nadu, India.		Ramakrishna, Balakrishnan/D-6808-2015; Subramanian, Venkataraman/B-8274-2011	Ramakrishna, Balakrishnan/0000-0001-5090-9501; Young, Graeme/0000-0001-9458-8383; Subramanian, Venkataraman/0000-0003-3603-0861				[Anonymous], 1978, LANCET, V2, P300; BABANIYI OA, 1991, J TROP PEDIATRICS, V37, P57, DOI 10.1093/tropej/37.2.57; BEHRENS RH, 1993, T R SOC TROP MED S3, V87; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; BINDER HJ, 1989, GASTROENTEROLOGY, V96, P989, DOI 10.1016/0016-5085(89)91614-4; BINDER HJ, 1990, PFLUG ARCH EUR J PHY, V417, P365, DOI 10.1007/BF00370654; Binder HJ, 1998, GASTROENTEROLOGY, V115, P512, DOI 10.1016/S0016-5085(98)70237-9; Binder HJ, 1991, LARGE INTESTINE PHYS, P141; Brown I, 1996, NUTR REV, V54, pS115, DOI 10.1111/j.1753-4887.1996.tb03830.x; CARPENTER CCJ, 1992, J INFECT DIS, V166, P2, DOI 10.1093/infdis/166.1.2; CUMMINGS JH, 1987, AM J CLIN NUTR, V45, P1243, DOI 10.1093/ajcn/45.5.1243; Desjeux JF, 1997, BAILLIERE CLIN GASTR, V11, P509, DOI 10.1016/S0950-3528(97)90029-4; GORE SM, 1992, BMJ-BRIT MED J, V304, P287, DOI 10.1136/bmj.304.6822.287; GREENOUGH WB, 1993, J DIARRHOEAL DIS RES, V11, P1; HYDEN SA, 1955, LANTBRUKSHOGSK ANN, V22, P139; Krishnan S, 1999, DIGEST DIS SCI, V44, P1924, DOI 10.1023/A:1018871412748; MEEUWISSE GW, 1983, ACTA PAEDIATR SCAND, V72, P161, DOI 10.1111/j.1651-2227.1983.tb09689.x; MUIR JG, 1995, AM J CLIN NUTR, V61, P792, DOI 10.1093/ajcn/61.4.792; NATH SK, 1989, AM J PHYSIOL, V256, pG335, DOI 10.1152/ajpgi.1989.256.2.G335; PHILLIPS J, 1995, AM J CLIN NUTR, V61, P1; PIERRELOUIS JN, 1991, AM J PUBLIC HEALTH, V81, P1205, DOI 10.2105/AJPH.81.9.1205; PIZARRO D, 1992, NEW ENGL J MED, V326, P488; PIZARRO D, 1991, NEW ENGL J MED, V324, P517, DOI 10.1056/NEJM199102213240802; RAMAKRISHNA BS, 1990, DIGESTION, V45, P93, DOI 10.1159/000200229; RAMAKRISHNA BS, 1993, GUT, V34, P1215, DOI 10.1136/gut.34.9.1215; READ NW, 1982, LANCET, V2, P481; REIS EC, 1994, PEDIATRICS, V93, P708; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; SCHEPPACH W, 1988, SCAND J GASTROENTERO, V23, P755, DOI 10.3109/00365528809093945; SPEELMAN P, 1986, GASTROENTEROLOGY, V91, P1164, DOI 10.1016/S0016-5085(86)80012-9; Thillainayagam AV, 1998, GASTROENTEROLOGY, V114, P197, DOI 10.1016/S0016-5085(98)70647-X	31	157	176	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					308	313		10.1056/NEJM200002033420502	http://dx.doi.org/10.1056/NEJM200002033420502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655529				2022-12-28	WOS:000085070300002
J	Jiang, Y; Haxby, JV; Martin, A; Ungerleider, LG; Parasuraman, R				Jiang, Y; Haxby, JV; Martin, A; Ungerleider, LG; Parasuraman, R			Complementary neural mechanisms for tracking items in human working memory	SCIENCE			English	Article							PREFRONTAL CORTEX; RETRIEVAL; FMRI	Recognition of a specific visual target among equally familiar distracters requires neural mechanisms for tracking items in working memory. Event-related functional magnetic resonance imaging revealed evidence for two such mechanisms: (i) Enhanced neural responses, primarily in the frontal cortex, were associated with the target and were maintained across repetitions of the target. (ii) Reduced responses, primarily in the extrastriate visual cortex, were associated with stimulus repetition, regardless of whether the stimulus was a target or a distracter, These complementary neural mechanisms track the status of familiar items in working memory, allowing for the efficient recognition of a currently relevant object and rejection of irrelevant distracters.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA; Catholic Univ Amer, Cognit Sci Lab, Washington, DC 20064 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Catholic University of America	Jiang, Y (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.		martin, alex/B-6176-2009	JIANG, Yang/0000-0003-4589-0097	NIA NIH HHS [AG07569] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002035, ZIAMH002035, Z01MH002588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007569] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Clark VP, 1998, J NEUROPHYSIOL, V79, P3257, DOI 10.1152/jn.1998.79.6.3257; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DEMB JB, 1995, J NEUROSCI, V15, P5870; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; HAXBY JV, MAPPING MODELING HUM; MILLER EK, 1993, J NEUROSCI, V13, P1460; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Miller EK, 1996, J NEUROSCI, V16, P5154; Parasuraman R, 1998, ATTENTIVE BRAIN, P3; Schacter DL, 1998, PHILOS T ROY SOC B, V353, P1861, DOI 10.1098/rstb.1998.0338; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Suzuki WA, 1999, NEURON, V24, P295, DOI 10.1016/S0896-6273(00)80844-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	21	141	157	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					643	646		10.1126/science.287.5453.643	http://dx.doi.org/10.1126/science.287.5453.643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649996				2022-12-28	WOS:000084989400045
J	Studdert, DM; Brennan, TA				Studdert, DM; Brennan, TA			The problems with punitive damages in lawsuits against managed-care organizations.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									RAND Corp, Santa Monica, CA 90407 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health	Brennan, TA (corresponding author), Brigham & Womens Hosp, 75 Francis St,Clin 3 PBB, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537				ABRAHAM KS, 1989, J LEGAL STUD, V18, P415, DOI 10.1086/468153; Brennan T., 1996, NEW RULES REGULATION; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Cerminara KL, 1998, AM J LAW MED, V24, P7; CHIRBAMARTIN MA, 1994, HEALTH AFFAIR, V13, P142, DOI 10.1377/hlthaff.13.2.142; COFFEE JC, 1995, COLUMBIA LAW REV, V95, P1343, DOI 10.2307/1123132; DANIELS S, 1990, MINN LAW REV, V75, P1; DANIELS S, 1995, CIVIL JURIES POLITIC; Danzon PM, 1997, J LEGAL STUD, V26, P491, DOI 10.1086/468006; DEFRANCES CJ, 1995, NCJ15346 DEP JUST; ECKHOLM E, 1993, NEW YORK TIMES  0920, pA1; Eisenberg T, 1998, WISC LAW REV, P387; Eisenberg T, 1997, J LEGAL STUD, V26, P623, DOI 10.1086/468010; ELLIS DD, 1989, ALA L REV, V40, P975; FRANKLIN MA, 1987, CASES MAT TORT LAW A, P622; FREUDENHEIM M, 2000, NY TIMES        0906, pA1; Galanter M, 1998, WISC LAW REV, P1; GALANTER M, 1997, MARYLAND L REV, V55, P1093; Garber S, 1998, WISC LAW REV, P237; GRESENZ DR, 1999, IP184 RAND; GROSSO SM, 1998, POLICY REV, V9, P433; Hensler Deborah, 1993, BROOK L REV, V59, P961; HENSLER DR, 1995, DRU1014ICJ RAND; JEFFRIES JC, 1986, VA LAW REV, V72, P139, DOI 10.2307/1072993; KASSIRER JP, 1995, NEW ENGL J MED, V333, P50, DOI 10.1056/NEJM199507063330110; KELSO JC, 1999, JURY VERDICTS INSURA; KLEIN SA, 1999, AM MED NEWS     0208, P47; KLEIN SA, 1999, AM MED NEWS, V42, P29; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; MCGOVERN FE, 1986, U CHICAGO LAW REV, V53, P440, DOI 10.2307/1599647; MOLLER E, 1997, MR888ICJ RAND; PETERSON M, 1987, R3311ICJ RAND; Polinsky AM, 1998, HARVARD LAW REV, V111, P869, DOI 10.2307/1342009; RASTAD M, 1993, AM U L REV, V42, P1269; Rustad ML, 1998, WISC LAW REV, P15; SCHUCK PH, 1995, CORNELL LAW REV, V80, P941; Studdert DM, 1999, HEALTH AFFAIR, V18, P7, DOI 10.1377/hlthaff.18.6.7; WEILER PC, 1991, MED MALPRACTICE TRIA	39	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					280	284		10.1056/NEJM200001273420411	http://dx.doi.org/10.1056/NEJM200001273420411			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	277PB	10648773				2022-12-28	WOS:000084941000011
J	Antonelli, M; Conti, G; Bufi, M; Costa, MG; Lappa, A; Rocco, M; Gasparetto, A; Meduri, GU				Antonelli, M; Conti, G; Bufi, M; Costa, MG; Lappa, A; Rocco, M; Gasparetto, A; Meduri, GU			Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE-PRESSURE VENTILATION; MECHANICAL VENTILATION; FACE MASK; SUPPORT VENTILATION; PNEUMONIA; DEFINITIONS	Context Noninvasive ventilation (NIV) has been associated with lower rates of endotracheal intubation in populations of patients with acute respiratory failure. Objective To compare NIV with standard treatment using supplemental oxygen administration to avoid endotracheal intubation in recipients of solid organ transplantation with acute hypoxemic respiratory failure. Design and Setting Prospective randomized study conducted at a 14-bed, general intensive care unit of a university hospital. Patients Of 238 patients who underwent solid organ transplantation from December 1995 to October 1997, 51 were treated for acute respiratory failure. Of these, 40 were eligible and 20 were-randomized to each group. Intervention Noninvasive ventilation vs standard treatment with supplemental oxygen administration. Main Outcome Measures The need for endotracheal intubation and mechanical ventilation at any time during the study, complications not present on admission, duration of ventilatory assistance, length of hospital stay, and intensive care unit mortality. Results The 2 groups were similar at study entry. Within the first hour of treatment, 14 patients (70%) in the NIV group, and 5 patients (25%) in the standard treatment group improved their ratio of the PaO2 to the fraction of inspired oxygen (FIO2). Over time, a sustained improvement in PaO2 to FIO2 was noted in 12 patients (60%) in the NIV group, and in 5 patients (25%) randomized to standard treatment (P = .03). The use of NIV was associated with a significant reduction in the rate of endotracheal intubation (20% vs 70%, P = .002), rate of fatal complications (20% vs 50%, P = .05), length of stay in the intensive care unit by survivors (mean [SD] days, 5.5 [3] vs 9 [4]; P = .03), and intensive care unit mortality (20% vs 50%; P = .05), Hospital mortality did not differ. Conclusions These results indicate,that transplantation programs should consider NIV in the treatment of selected recipients of transplantation with acute respiratory failure.	Univ Cattolica Sacro Cuore, Ist Anestesiol & Rianimaz, I-00168 Rome, Italy; Univ Roma La Sapienza, Policlin Umberto I, Rome, Italy; Univ Tennessee, Dept Med, Div Pulm & Crit Care, Memphis Lung Res Program, Memphis, TN 38104 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; University Hospital Sapienza Rome; University of Tennessee System; University of Tennessee Health Science Center	Antonelli, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Anestesiol & Rianimaz, 1 Largo F Vito, I-00168 Rome, Italy.	max.antonelli@flashnet.it	Rocco, Monica/B-8407-2013; Costa, Maria Gabriella/J-4030-2012; Antonelli, Massimo/F-9848-2010; Antonelli, Massimo/K-9915-2016	Rocco, Monica/0000-0001-8380-3607; Costa, Maria Gabriella/0000-0002-8403-3541; Antonelli, Massimo/0000-0003-3007-1670				Ambrosino N, 1994, Monaldi Arch Chest Dis, V49, P311; Antonelli M, 1996, CHEST, V110, P724, DOI 10.1378/chest.110.3.724; ANTONELLI M, 1994, CHEST, V105, P224, DOI 10.1378/chest.105.1.224; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BROCHARD L, 1989, AM REV RESPIR DIS, V139, P513, DOI 10.1164/ajrccm/139.2.513; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Cochran W.G., 1967, STAT METHODS; GENTILE G, 1993, CHEST, V104, P371, DOI 10.1378/chest.104.2.371; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; HODSON ME, 1991, EUR RESPIR J, V4, P524; Keenan SP, 1997, CRIT CARE MED, V25, P1685, DOI 10.1097/00003246-199710000-00018; KILGER E, 1995, MED KLIN, V90, P26; Kraemer HC, 1987, MANY SUBJECTS STAT P; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Meduri GU, 1996, CHEST, V109, P179, DOI 10.1378/chest.109.1.179; MEDURI GU, 1989, CHEST, V95, P865, DOI 10.1378/chest.95.4.865; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221; MEDURI GU, 1992, CHEST, V102, P557; MEDURI GU, 1998, PHYSL BASIS VENTILAT, P921; Mermel L A, 1990, Semin Respir Infect, V5, P10; Nourdine K, 1999, INTENS CARE MED, V25, P567, DOI 10.1007/s001340050904; PENNOCK BE, 1991, CHEST, V100, P1371, DOI 10.1378/chest.100.5.1371; QUARANTA AJ, 1996, AM J RESP CRIT CARE, V153, pA608; Rocker GM, 1999, CHEST, V115, P173, DOI 10.1378/chest.115.1.173; Rubini F, 1994, Minerva Anestesiol, V60, P139; SWARNI A, 1991, EUR RESPIR J, V1, P188; WYSOCKI M, 1995, CHEST, V107, P761, DOI 10.1378/chest.107.3.761	30	472	506	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					235	241		10.1001/jama.283.2.235	http://dx.doi.org/10.1001/jama.283.2.235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634340	Bronze			2022-12-28	WOS:000084661400030
J	Shields, JA; Shields, CL; Tovilla-Canales, JL; Mercado, GV; Ehya, H				Shields, JA; Shields, CL; Tovilla-Canales, JL; Mercado, GV; Ehya, H			Breast carcinoma metastatic to the iris	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMORS		Thomas Jefferson Univ, Wills Eye Hosp, Oncol Serv, Philadelphia, PA 19107 USA; Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA	Jefferson University; Fox Chase Cancer Center	Shields, JA (corresponding author), Thomas Jefferson Univ, Wills Eye Hosp, Oncol Serv, 900 Walnut St, Philadelphia, PA 19107 USA.							CATALANO RA, 1990, JAMA-J AM MED ASSOC, V264, P1032; PAVLIN CJ, 1992, OPHTHALMOLOGY, V99, P1220; Shields CL, 1997, OPHTHALMOLOGY, V104, P1265, DOI 10.1016/S0161-6420(97)30148-1; SHIELDS JA, 1995, AM J OPHTHALMOL, V119, P422, DOI 10.1016/S0002-9394(14)71227-9; SHIELDS JA, 1993, OPHTHALMOLOGY, V100, P1677; SHIELDS JA, 1999, ATLAS INTRAOCULAR TU, P154	6	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					178	178		10.1001/jama.283.2.178	http://dx.doi.org/10.1001/jama.283.2.178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634323				2022-12-28	WOS:000084661400003
J	Morris, SC				Morris, SC			Evolution: Bringing molecules into the fold	CELL			English	Review							CAMBRIAN EXPLOSION; GENE; PHYLOGENY; RELATIVES; PRIMATES; CNIDARIA; HOMOLOGY; AFRICAN; SYSTEM; FAMILY		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.							Abouheif E, 1998, J MOL EVOL, V47, P394, DOI 10.1007/PL00006397; Adoutte A, 1999, TRENDS GENET, V15, P104, DOI 10.1016/S0168-9525(98)01671-0; Arendt D, 1999, DEVELOPMENT, V126, P2309; Balavoine G, 1998, AM ZOOL, V38, P843; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Barrow J., 1998, ANTHROPIC COSMOLOGIC; Benton MJ, 1999, BIOESSAYS, V21, P1043; Beschin A, 1999, NATURE, V400, P627, DOI 10.1038/23164; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; CavalierSmith T, 1996, CAN J ZOOL, V74, P2031, DOI 10.1139/z96-231; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Chiu J, 1999, MOL BIOL EVOL, V16, P826, DOI 10.1093/oxfordjournals.molbev.a026167; Cho YR, 1999, MOL BIOL EVOL, V16, P1155, DOI 10.1093/oxfordjournals.molbev.a026206; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Conway Morris S., 1998, CRUCIBLE CREATION BU; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Davidson DH, 1999, J EXP ZOOL, V285, P104, DOI 10.1002/(SICI)1097-010X(19990815)285:2<104::AID-JEZ2>3.0.CO;2-Z; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DENTON MJ, 1998, NATURES DESTINY LAWS; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Eizinger A, 1999, TRENDS GENET, V15, P197, DOI 10.1016/S0168-9525(99)01728-X; Eizinger A, 1997, SCIENCE, V278, P452, DOI 10.1126/science.278.5337.452; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; GILLESPIE JH, 1986, MOL BIOL EVOL, V3, P138; GINGERICH PD, 1986, MOL BIOL EVOL, V3, P205; Golubic S, 1995, LETHAIA, V28, P285, DOI 10.1111/j.1502-3931.1995.tb01817.x; Guo YX, 1997, J NEUROSCI, V17, P1761; Hanelt B, 1996, MOL BIOL EVOL, V13, P1187, DOI 10.1093/oxfordjournals.molbev.a025683; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holland ND, 1999, AM ZOOL, V39, P630; Hoshiyama D, 1998, J MOL EVOL, V47, P640, DOI 10.1007/PL00006421; Kawasaki M, 1996, BIOL BULL, V191, P103, DOI 10.2307/1543070; Kobayashi M, 1999, NATURE, V401, P762, DOI 10.1038/44513; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kupfermann H, 1999, J MOL EVOL, V48, P663, DOI 10.1007/PL00006510; Lacalli TC, 1996, PHILOS T ROY SOC B, V351, P243, DOI 10.1098/rstb.1996.0022; Lacalli TC, 1999, P ROY SOC B-BIOL SCI, V266, P1461, DOI 10.1098/rspb.1999.0801; Lawn RM, 1997, P NATL ACAD SCI USA, V94, P11992, DOI 10.1073/pnas.94.22.11992; Lee MSY, 1999, TRENDS ECOL EVOL, V14, P177, DOI 10.1016/S0169-5347(99)01603-1; Leys SP, 1999, J EXP BIOL, V202, P1139; Lynch M, 1999, EVOLUTION, V53, P319, DOI [10.2307/2640769, 10.1111/j.1558-5646.1999.tb03768.x]; Martin WF, 1996, BIOESSAYS, V18, P523, DOI 10.1002/bies.950180702; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Meffert LM, 1999, J EVOLUTION BIOL, V12, P859, DOI 10.1046/j.1420-9101.1999.00105.x; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Morris SC, 1998, AM ZOOL, V38, P867; Morris SC, 1998, BIOESSAYS, V20, P676, DOI 10.1002/(SICI)1521-1878(199808)20:8<676::AID-BIES11>3.0.CO;2-W; Morris SC, 1998, PHILOS T R SOC B, V353, P327, DOI 10.1098/rstb.1998.0213; Morris SC, 1998, CURR OPIN GENET DEV, V8, P662, DOI 10.1016/S0959-437X(98)80034-8; MULLER WEG, 1998, MOL EVOLUTION ORIGIN, P141; Nagy L, 1998, AM ZOOL, V38, P818; Noren M, 1997, NATURE, V390, P31, DOI 10.1038/36242; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.1111/j.1558-5646.1997.tb01461.x, 10.2307/2411190]; Ono K, 1999, J MOL EVOL, V48, P654, DOI 10.1007/PL00006509; Paul CRC, 1998, ADEQUACY OF THE FOSSIL RECORD, P111; Perovic S, 1999, CELL TISSUE RES, V296, P395, DOI 10.1007/s004410051299; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Peterson KJ, 1997, BIOESSAYS, V19, P623, DOI 10.1002/bies.950190713; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reuter M, 1998, TISSUE CELL, V30, P57, DOI 10.1016/S0040-8166(98)80006-2; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Schaecke Heike, 1994, Journal of Molecular Recognition, V7, P273, DOI 10.1002/jmr.300070406; Schierwater B, 1998, MOL PHYLOGENET EVOL, V9, P375, DOI 10.1006/mpev.1998.0489; Schwartz J, 1999, SUDDEN ORIGINS FOSSI; Sessions A, 1999, GENE DEV, V13, P1051, DOI 10.1101/gad.13.9.1051; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; Smith KM, 1999, DEV BIOL, V212, P392, DOI 10.1006/dbio.1999.9337; SYVANEN M, 1994, ANNU REV GENET, V28, P237, DOI 10.1146/annurev.ge.28.120194.001321; Teichmann SA, 1999, J MOL EVOL, V49, P98, DOI 10.1007/PL00006538; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Umesono Y, 1999, DEV GENES EVOL, V209, P31, DOI 10.1007/s004270050224; VACELET J, 1995, NATURE, V373, P333, DOI 10.1038/373333a0; Valentine JW, 1999, DEVELOPMENT, V126, P851; WALLACE A, 1999, EVOL DEV, V1, P62; Williams NA, 1998, MOL BIOL EVOL, V15, P600, DOI 10.1093/oxfordjournals.molbev.a025961; WISTOW G, 1993, TRENDS BIOCHEM SCI, V18, P301, DOI 10.1016/0968-0004(93)90041-K; Wray Gregory A., 1999, P189; Wu LH, 1998, DEVELOPMENT, V125, P2433	87	44	48	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					1	11		10.1016/S0092-8674(00)81679-7	http://dx.doi.org/10.1016/S0092-8674(00)81679-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647927	Bronze			2022-12-28	WOS:000084722600001
J	Kawai, N; Matsuzawa, T				Kawai, N; Matsuzawa, T			Cognition - Numerical memory span in a chimpanzee	NATURE			English	Article							PAN-TROGLODYTES		Kyoto Univ, Primate Res Inst, Aichi 4848506, Japan	Kyoto University	Kawai, N (corresponding author), Kyoto Univ, Primate Res Inst, Aichi 4848506, Japan.		Kawai, Nobuyuki/M-4902-2014	Kawai, Nobuyuki/0000-0003-0372-1703				Biro D, 1999, J COMP PSYCHOL, V113, P178, DOI 10.1037/0735-7036.113.2.178; Boysen ST, 1999, ANIM LEARN BEHAV, V27, P229, DOI 10.3758/BF03199679; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; MATSUZAWA T, 1991, PRIMATOLOGY TODAY, P317; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Murofushi K, 1997, JPN PSYCHOL RES, V39, P140, DOI 10.1111/1468-5884.00050; RUMBAUGH DM, 1987, J EXP PSYCHOL ANIM B, V13, P107, DOI 10.1037/0097-7403.13.2.107; Tomonaga M., 1993, PRIMATE RES, V9, P67; TOMONAGA M, IN PRESS ANIM COGN	10	125	129	2	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					39	40		10.1038/47405	http://dx.doi.org/10.1038/47405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273BM	10638743				2022-12-28	WOS:000084687400033
J	Williams, KA				Williams, KA			Three-dimensional structure of the ion-coupled transport protein NhaA	NATURE			English	Article							ELECTRON CRYSTALLOGRAPHY; 3-DIMENSIONAL STRUCTURE; NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; WATER CHANNEL; RESOLUTION; BACTERIORHODOPSIN; CRYOMICROSCOPY; CONFORMATION; AQUAPORIN-1	Ion-coupled membrane-transport proteins, or secondary transporters, comprise a diverse and abundant group of membrane proteins that are found in all organisms. These proteins facilitate solute accumulation and toxin removal against concentration gradients using energy supplied by ion gradients across membranes. NhaA is a Na+/H+ antiporter of relative molecular mass 42,000, which is found in the inner membrane of Escherichia coli, and which has been cloned and characterized(1,2). NhaA uses the H+ electrochemical gradient to expel Na+ from the cytoplasm, and functions primarily in the adaptation to high salinity at alkaline pH(1,2). Most secondary transporters, including NhaA(3), are predicted to have 12 transmembrane helices. Here we report the structure of NhaA, at 7 Angstrom resolution in the membrane plane and at 14 Angstrom vertical resolution, determined from two-dimensional crystals(4) using electron cryo-microscopy. The three-dimensional map of NhaA reveals 12 tilted, bilayer-spanning helices. A roughly linear arrangement of six helices is adjacent to a compact bundle of six helices, with the density for one helix in the bundle not continuous through the membrane. The molecular organization of NhaA represents a new membrane-protein structural motif and offers the first insights into the architecture of an ion-coupled transport protein.	Max Planck Inst Biophys, Dept Biol Struct, D-60528 Frankfurt, Germany	Max Planck Society	Williams, KA (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Heinrich Hoffmann Str 7, D-60528 Frankfurt, Germany.							Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; BLAKELY RD, 1994, J EXP BIOL, V196, P263; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1006/jmbi.1995.0176; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P899; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Padan E, 1999, NOVART FDN SYMP, V221, P183; Padan E., 1996, HDB BIOL PHYS, V2, P501; PERUSE E, 1999, SCIENCE, V285, P73; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Saier MH, 1998, FASEB J, V12, P265, DOI 10.1096/fasebj.12.3.265; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; SHAW PJ, 1981, MICRON, V12, P279, DOI 10.1016/0047-7206(81)90081-9; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; UNGER VM, 1995, BIOPHYS J, V68, P1776, DOI 10.1016/S0006-3495(95)80354-1; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WANG DN, 1991, J MOL BIOL, V217, P691, DOI 10.1016/0022-2836(91)90526-C; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Wright EM, 1998, AM J PHYSIOL-GASTR L, V275, P879; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	30	192	195	1	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					112	115		10.1038/47534	http://dx.doi.org/10.1038/47534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638764				2022-12-28	WOS:000084687400054
J	Henney, JE				Henney, JE			FDA's proposed strategy on reuse of single-use devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					46	46		10.1001/jama.283.1.46	http://dx.doi.org/10.1001/jama.283.1.46			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632269				2022-12-28	WOS:000084514400007
J	Bishop, DVM				Bishop, DVM			Cognition - An innate basis for language?	SCIENCE			English	Editorial Material									Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	dorothy.bishop@psy.ox.ac.uk		Bishop, Dorothy/0000-0002-2448-4033				Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Howlin P, 1998, J APPL RES INTELLECT, V11, P207, DOI 10.1111/j.1468-3148.1998.tb00062.x; Klein BP, 1999, DEV NEUROPSYCHOL, V16, P177, DOI 10.1207/S15326942DN1602_3; Mervis CB, 1999, DEV COGN NEUROSCI, P65; MERVIS CB, IN PRESS DEV NEUROPS; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355	6	19	19	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 17	1999	286	5448					2283	2284		10.1126/science.286.5448.2283	http://dx.doi.org/10.1126/science.286.5448.2283			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	266UK	10636789				2022-12-28	WOS:000084318500036
J	Linde, K; Berner, M				Linde, K; Berner, M			Commentary: Has hypericum found its place in antidepressant treatment?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, D-8000 Munich, Germany; Univ Freiburg, Dept Psychiat & Psychotherapy, D-79104 Freiburg, Germany	Technical University of Munich; University of Freiburg	Linde, K (corresponding author), Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, Ismaninger Str 22, D-8000 Munich, Germany.							Harrer G, 1999, ARZNEIMITTELFORSCH, V49, P289; Laakmann G, 1998, PHYTOMEDICINE, V5, P435, DOI 10.1016/S0944-7113(98)80039-1; LINDE K, 1999, COCHRANE LIB; Schrader E, 1998, HUM PSYCHOPHARM CLIN, V13, P163, DOI 10.1002/(SICI)1099-1077(199804)13:3<163::AID-HUP5>3.3.CO;2-9	4	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 11	1999	319	7224					1539	1539						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	265LK	10651472				2022-12-28	WOS:000084245600022
J	Weyhenmeyer, CE; Burns, SJ; Waber, HN; Aeschbach-Hertig, W; Kipfer, R; Loosli, HH; Matter, A				Weyhenmeyer, CE; Burns, SJ; Waber, HN; Aeschbach-Hertig, W; Kipfer, R; Loosli, HH; Matter, A			Cool glacial temperatures and changes in moisture source recorded in Oman groundwaters	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; INDIAN-OCEAN; LAST DEGLACIATION; YR BP; MAXIMUM; CLIMATE; CIRCULATION; DELTA-O-18; HOLOCENE; PALEOTEMPERATURES	Concentrations of atmospheric noble gases (neon, argon, krypton, and xenon) dissolved in groundwaters from northern Oman indicate that the average ground temperature during the Late Pleistocene (15,000 to 24,000 years before present) was 6.5 degrees +/- 0.6 degrees C Lower than that of today. Stable oxygen and hydrogen isotopic groundwater data show that the origin of atmospheric water vapor changed from a primarily southern, Indian Ocean source during the Late Pleistocene to a dominantly northern, Mediterranean source today. The reduced northern water vapor source is consistent with a drier Last Glacial Maximum through much of northern Africa and Arabia.	Univ Bern, Inst Geol, CH-3012 Bern, Switzerland; ETH, EAWAG, CH-8600 Dubendorf, Switzerland; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern	Weyhenmeyer, CE (corresponding author), Univ Bern, Inst Geol, CH-3012 Bern, Switzerland.		Burns, Stephen/H-9419-2013; Aeschbach, Werner/C-1026-2008	Aeschbach, Werner/0000-0003-0917-1239; Waber, Niklaus/0000-0003-4546-0249				Aeschbach-Hertig W, 1999, WATER RESOUR RES, V35, P2779, DOI 10.1029/1999WR900130; AESCHBACHHERTIG W, UNPUB; [Anonymous], 1998, IAEA VIENN S 1997; Ballentine CJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2315, DOI 10.1016/S0016-7037(99)00131-3; Bard E, 1999, SCIENCE, V284, P1133, DOI 10.1126/science.284.5417.1133; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Beck JW, 1997, NATURE, V385, P705, DOI 10.1038/385705a0; BROCCOLI AJ, 1987, CLIM DYNAM, V1, P87; BROECKER WS, 1986, QUATERNARY RES, V26, P121, DOI 10.1016/0033-5894(86)90087-6; Burns SJ, 1998, GEOLOGY, V26, P499, DOI 10.1130/0091-7613(1998)026<0499:SBPRFN>2.3.CO;2; Bush ABG, 1998, SCIENCE, V279, P1341, DOI 10.1126/science.279.5355.1341; BUSH MB, 1990, QUATERNARY RES, V34, P330, DOI 10.1016/0033-5894(90)90045-M; BUSH MB, 1992, ECOL MONOGR, V62, P251, DOI 10.2307/2937095; CLAPPERTON CM, 1993, PALAEOGEOGR PALAEOCL, V101, P189, DOI 10.1016/0031-0182(93)90012-8; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; DANSGAARD W, 1964, TELLUS, V16, P436; DUPLESSY JC, 1982, NATURE, V295, P494, DOI 10.1038/295494a0; Edmunds WM, 1999, J GEOL SOC LONDON, V156, P345, DOI 10.1144/gsjgs.156.2.0345; EDMUNDS WM, 1988, ISOTOPE TECHNIQUES S, P693; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Ganopolski A, 1998, NATURE, V391, P351, DOI 10.1038/34839; GASSE F, 1990, NATURE, V346, P141, DOI 10.1038/346141a0; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; HASTENRATH S, 1985, CLIMATE CIRCULATION; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; KUTZBACH JE, 1986, J ATMOS SCI, V43, P1726, DOI 10.1175/1520-0469(1986)043<1726:TIOCOP>2.0.CO;2; LEYDEN BW, 1993, GEOPHYS MONOGR, V78, P156; LIU KB, 1985, NATURE, V318, P556, DOI 10.1038/318556a0; MAZOR E, 1972, GEOCHIM COSMOCHIM AC, V36, P1321, DOI 10.1016/0016-7037(72)90065-8; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P339, DOI 10.1029/PA001i003p00339; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P43, DOI 10.1029/PA001i001p00043; Pedgley D. E., 1969, WEATHER, V24, P456; PEDGLEY DE, 1970, METEOROL MAG, V99, P29; Pierrehumbert RT, 1999, GEOPHYS RES LETT, V26, P1345, DOI 10.1029/1999GL900183; Plummer LN, 1994, 944169 US GEOL SURV; PRELL WL, 1980, QUATERNARY RES, V14, P309, DOI 10.1016/0033-5894(80)90014-9; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; ROSTEK F, 1993, NATURE, V364, P319, DOI 10.1038/364319a0; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; SCHNEIDER RR, 1995, PALEOCEANOGRAPHY, V10, P197, DOI 10.1029/94PA03308; SIKES EL, 1994, PALEOCEANOGRAPHY, V9, P31, DOI 10.1029/93PA02198; SIROCKO F, 1993, NATURE, V364, P322, DOI 10.1038/364322a0; SIROCKO F, 1991, QUATERNARY RES, V36, P72, DOI 10.1016/0033-5894(91)90018-Z; Stott LD, 1996, PALEOCEANOGRAPHY, V11, P37, DOI 10.1029/95PA03344; STREET FA, 1979, QUATERNARY RES, V12, P83, DOI 10.1016/0033-5894(79)90092-9; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Stute M., 1993, PROTEOM, P89, DOI [DOI 10.1016/J.CBD.2016.06.005, DOI 10.1029/GM078P0089]; SWART PK, 1993, GEOPHYS MONOGR, V78, P1; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; THUNELL R, 1994, QUATERNARY RES, V41, P255, DOI 10.1006/qres.1994.1029; VANCAMPO E, 1986, QUATERNARY RES, V26, P376, DOI 10.1016/0033-5894(86)90097-9; Webb RS, 1997, NATURE, V385, P695, DOI 10.1038/385695a0; WEBSTER PJ, 1978, QUATERNARY RES, V10, P279, DOI 10.1016/0033-5894(78)90024-8; WEYHENMEYER CE, UNPUB	57	119	120	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					842	845		10.1126/science.287.5454.842	http://dx.doi.org/10.1126/science.287.5454.842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657295				2022-12-28	WOS:000085136400042
J	Robzyk, K; Recht, L; Osley, MA				Robzyk, K; Recht, L; Osley, MA			Rad6-dependent ubiquitination of histone H2B in yeast	SCIENCE			English	Article							CONJUGATING ENZYME RAD6; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; CHROMATIN MODIFICATION; PROTEIN-DEGRADATION; CRYSTAL-STRUCTURE; GENE; MUTATIONS; TRANSCRIPTION; NUCLEOSOMES	Although ubiquitinated histones are present in substantial Levels in vertebrate cells, the roles they play in specific biological processes and the cellular factors that regulate this modification are not well characterized. Ubiquitinated H2B (uH2B) has been identified in the yeast Saccharomyces cerevisiae, and mutation of the conserved ubiquitination site is shown to confer defects in mitotic cell growth and meiosis. uH2B was not detected in rad6 mutants, which are defective for the ubiquitin-conjugating enzyme Ubc2, thus identifying Rad6 as the major cellular activity that ubiquitinates H2B in yeast.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Osley, MA (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.			Recht, Judith/0000-0003-3572-0457	NIGMS NIH HHS [GM40118, R01 GM040118] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040118] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; BARSOUM J, 1985, J BIOL CHEM, V260, P7688; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; CASSIERCHAUVAT C, 1991, MUTAT RES, V254, P247, DOI 10.1016/0921-8777(91)90063-U; Chen HY, 1998, J BIOL CHEM, V273, P13165, DOI 10.1074/jbc.273.21.13165; DAVIE JR, 1991, BIOCHEM CELL BIOL, V69, P66, DOI 10.1139/o91-009; DAVIE JR, 1990, BIOCHEMISTRY-US, V29, P4752, DOI 10.1021/bi00472a002; DAVIE JR, 1994, BIOCHEM BIOPH RES CO, V203, P344, DOI 10.1006/bbrc.1994.2188; Dor Y, 1996, MOL MICROBIOL, V21, P1197, DOI 10.1046/j.1365-2958.1996.671433.x; FINLEY D, 1992, MOL CELLULAR BIOL YE, V2, P539; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAAS AL, 1991, J BIOL CHEM, V266, P4104; HENSOLD JO, 1988, BLOOD, V71, P1153; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Huang HH, 1997, MOL CELL BIOL, V17, P6693, DOI 10.1128/MCB.17.11.6693; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; KANG XL, 1992, GENETICS, V130, P285; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; LIEBMAN SW, 1993, GENETICS, V133, P499; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MORRISON A, 1988, MOL CELL BIOL, V8, P1179, DOI 10.1128/MCB.8.3.1179; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; PICOLOGLOU S, 1990, MOL CELL BIOL, V10, P1017, DOI 10.1128/MCB.10.3.1017; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; RABOY B, 1994, EUR J BIOCHEM, V221, P247, DOI 10.1111/j.1432-1033.1994.tb18735.x; Recht J, 1999, EMBO J, V18, P229, DOI 10.1093/emboj/18.1.229; REYNOLDS P, 1990, EMBO J, V9, P1423, DOI 10.1002/j.1460-2075.1990.tb08258.x; ROBZYK K, UNPUB; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; SIEDE W, 1988, RADIAT ENVIRON BIOPH, V27, P277, DOI 10.1007/BF01209756; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Storchova Z, 1998, MOL GEN GENET, V258, P546, DOI 10.1007/s004380050766; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; SWERDLOW PS, 1990, MOL CELL BIOL, V10, P4905, DOI 10.1128/MCB.10.9.4905; VANHOLDE KE, 1988, CHROMATIN, P111; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Wolffe A., 1998, CHROMATIN STRUCTURE; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Worthylake DR, 1998, J BIOL CHEM, V273, P6271, DOI 10.1074/jbc.273.11.6271	47	503	521	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					501	504		10.1126/science.287.5452.501	http://dx.doi.org/10.1126/science.287.5452.501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642555				2022-12-28	WOS:000084929900053
J	Ebrahim, SH; Floyd, RL; Merritt, RK; Decoufle, P; Holtzman, D				Ebrahim, SH; Floyd, RL; Merritt, RK; Decoufle, P; Holtzman, D			Trends in pregnancy-related smoking rates in the United States, 1987-1996	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CESSATION; INTERVENTIONS; METAANALYSIS; PEOPLE	Context Rates of smoking are increasing among adolescents and young adults, but trends in smoking among pregnant women have not been studied, Objective To assess pregnancy-related variations in smoking behaviors and their determinants among women of childbearing age in the United States, Design Analysis of data collected between 1987-1996 from the Behavioral Risk Factor Surveillance System survey. Setting and Subjects A total of 187 302 (178 499 nonpregnant and 8803 pregnant) noninstitutionalized women aged 18 to 44 years from 33 states. Main Outcome Measures Prevalence rates of smoking initiation and current smoking, median number of cigarettes smoked, and adjusted odds ratios for smoking stratified by pregnancy status; prevalence rate ratio for current smoking comparing pregnant with nonpregnant women, Results The overall percentage of women who had ever initiated smoking decreased significantly from 44.1% in 1987 to 38.2% in 1996, During that 10-year period, the prevalence of current smoking also decreased significantly among both pregnant women (16.3% to 11.8%) and nonpregnant women (26.7% to 23.6%), Overall, pregnant women were about half (54%) as likely as nonpregnant women to be current smokers during 1987-1996. Over time, the median number of cigarettes smoked per day by pregnant smokers remained at 10, whereas among nonpregnant smokers it decreased from 19 to 15 (P<.05 for trend). in the same period, among young women (aged 18-20 years), prevalence rates of smoking initiation and current smoking increased slightly, Sociodemographic subgroups of women at increased risk for current smoking were the same for pregnant and nonpregnant women tie, those with a completed high school education or less, whites, and those who were unmarried). Conclusions In this analysis, the decline in smoking over time among pregnant women was primarily due to the overall decline in smoking initiation rates among women of childbearing age, not to an increased rate of smoking cessation related to pregnancy. To foster effective perinatal tobacco control, efforts are needed to further reduce the number of young women who begin smoking. Clinicians should query all pregnant women and women of childbearing age about smoking and provide cessation and relapse interventions to each smoker.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Ebrahim, SH (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30341 USA.							Appleton PL, 1998, BRIT J HEALTH PSYCH, V3, P361, DOI 10.1111/j.2044-8287.1998.tb00580.x; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1048; Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention, 1989, DHHS PUBL, V(CDC) 89-8411; Centers for Disease Control and Prevention, 1993, MMWR-MORBID MORTAL W, V42, P504; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P537; DiFranza JR, 1996, PEDIATRICS, V97, P560; DOLANMULLEN P, 1994, AM J OBSTET GYNECOL, V171, P1328, DOI 10.1016/0002-9378(94)90156-2; Evans WN, 1999, J PUBLIC ECON, V72, P135, DOI 10.1016/S0047-2727(98)00090-5; FERGUSSON DM, 1993, PEDIATRICS, V92, P815; FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541; Fiore MC, 1996, AHCPR PUBLICATION, V96-0692; Grant TM, 1996, AM J PUBLIC HEALTH, V86, P1816; HOLLIS JF, 1993, ANN INTERN MED, V118, P521, DOI 10.7326/0003-4819-118-7-199304010-00006; Hurt RD, 1999, B WORLD HEALTH ORGAN, V77, P367; Kendrick JS, 1996, AM J OBSTET GYNECOL, V175, P528; Klerman LV, 1999, J NURSE-MIDWIFERY, V44, P118, DOI 10.1016/S0091-2182(99)00031-2; LAW M, 1995, ARCH INTERN MED, V155, P1933, DOI 10.1001/archinte.155.18.1933; LECLERE FB, 1997, ADV DATA VITAL HLTH, V288; McBride CM, 1999, AM J PUBLIC HEALTH, V89, P706, DOI 10.2105/AJPH.89.5.706; *NCI, 1994, MONOGR NCI, V5, P1; OWEN L, 1999, SMOKING PREGNANCY SU; *PHS, 1991, DHHS PUBL; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; SHAH BV, 1996, SUDAAN COMP SOFTW VE; SILAGY C, 1994, LANCET, V343, P139, DOI 10.1016/S0140-6736(94)90933-4; U.S. Bureau of the Census, 1997, STAT ABSTR US 1997; *US DEP HHS, 1998, TARG TOB US NAT LEAD; *US DEP HHS, 1994, PREV TOB US YOUNG PE; Vartiainen E, 1998, AM J PUBLIC HEALTH, V88, P81, DOI 10.2105/AJPH.88.1.81; VENTURA SJ, 1997, REPORT FINAL NATALIT, P11; Wechsler H, 1998, JAMA-J AM MED ASSOC, V280, P1673, DOI 10.1001/jama.280.19.1673; [No title captured]	32	175	181	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					361	366		10.1001/jama.283.3.361	http://dx.doi.org/10.1001/jama.283.3.361			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	273WM	10647799	Bronze			2022-12-28	WOS:000084732400028
J	Forman, LM; Simmons, DA; Diamond, RH				Forman, LM; Simmons, DA; Diamond, RH			Hepatic failure in a patient taking rosiglitazone	ANNALS OF INTERNAL MEDICINE			English	Article							ISCHEMIC HEPATITIS; TROGLITAZONE; THIAZOLIDINEDIONES	Background: Rosiglitazone maleate is the second approved oral hypoglycemic agent of the thiazolidinedione class. The first, troglitazone, has been associated with liver failure, occasionally resulting in liver transplantation or death. There have been no reports to date of rosiglitazone-associated elevations in the alanine aminotransferase level or hepatotoxicity. Objective: To report the clinical characteristics of liver failure developing in a patient receiving rosiglitazone. Design: Case report. Setting: University hospital. Patient: 69-year-old man taking rosiglitazone, 4 mg/d. Intervention: Discontinuation of rosiglitazone therapy and treatment with lactulose, vitamin K, fresh frozen plasma, ventilatory assistance, and intensive care unit support. Measurements: Blood test monitoring, including toxicology screening, liver function tests, coagulation studies, serum chemistries, and complete blood counts. Results: After 21 days of rosiglitazone therapy, hepatic failure developed. Other causes of hepatic failure, such as viruses and toxins, were excluded, although it is possible that congestive heart failure was also a causative factor. The patient recovered fully with supportive care. Conclusion: Rosiglitazone may be associated with hepatic failure.	Hosp Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Diamond, RH (corresponding author), Hosp Univ Penn, Div Gastroenterol, 600 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.							Balfour JAB, 1999, DRUGS, V57, P921; Elcock FJ, 1999, DIABETES, V48, pA63; Fuchs S, 1998, J CLIN GASTROENTEROL, V26, P183, DOI 10.1097/00004836-199804000-00007; GIBSON PR, 1984, AUST NZ J MED, V14, P822, DOI 10.1111/j.1445-5994.1984.tb03780.x; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Herrine SK, 1999, ANN INTERN MED, V130, P163, DOI 10.7326/0003-4819-130-2-199901190-00021; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Neuschwander-Tetri BA, 1998, ANN INTERN MED, V129, P38, DOI 10.7326/0003-4819-129-1-199807010-00009; Plosker GL, 1999, DRUGS, V57, P409, DOI 10.2165/00003495-199957030-00014; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Salzman A, 1999, DIABETES, V48, pA95; SHIBUYA A, 1998, DIABETES CARE, V12, P21; Spencer CM, 1997, DRUGS, V54, P89, DOI 10.2165/00003495-199754010-00010; Vella A, 1998, ANN INTERN MED, V129, P1080, DOI 10.7326/0003-4819-129-12-199812150-00032; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314	16	155	160	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					118	121		10.7326/0003-4819-132-2-200001180-00005	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644272				2022-12-28	WOS:000084852300004
J	Topol, EJ; Mark, DB; Lincoff, AM; Cohen, E; Burton, J; Kleiman, N; Talley, D; Sapp, S; Booth, J; Cabot, CF; Anderson, KM; Califf, RM				Topol, EJ; Mark, DB; Lincoff, AM; Cohen, E; Burton, J; Kleiman, N; Talley, D; Sapp, S; Booth, J; Cabot, CF; Anderson, KM; Califf, RM		EPISTENT Investigators	Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY DISEASE; BALLOON ANGIOPLASTY; ANTIPLATELET THERAPY; IMPLANTATION; TICLOPIDINE; PLACEMENT; ASPIRIN; ANTICOAGULATION; INTERVENTIONS	Background We assessed in a randomised trial the long-term outcomes for potent adjunctive antiplatelet therapy given at the time of coronary stenting. Methods In 63 hospitals in the USA and Canada, 2399 patients were randomly assigned stenting with abciximab, stenting with placebo, or balloon angioplasty with abciximab. Standard adjunctive therapy with aspirin, ticlopidine, and heparin was used. The major outcomes of death and myocardial infarction were assessed at 1-year follow-up by intention to treat. We also investigated the 1-year cost-effectiveness of combined stenting and abciximab therapy. Findings At 1-year follow-up, eight (1.0%) of 794 patients in the stent plus abciximab group had died, compared with 19 (2.4%) of 809 in the stent plus placebo group (hazard ratio 0.43 [95% CI 0.19-0.97], p=0.037). The combined endpoint of death or large myocardial infarction occurred in 42 (5.3%) and 89 (11.0%), respectively (0.46 [0.32-0.67], p<0.001). By multivariate modelling, the factors independently associated with improved survival were assignment to stenting with abciximab (p=0.027) and greater preprocedural stenosis (p=0.002); those associated with worse survival were age greater than 70 years (p<0.001), previous heart failure (p=0.001), diabetes treated with insulin (p=0.02), and postprocedural occlusion (p<0.001). Relative to stenting plus placebo and balloon angioplasty plus abciximab, the incremental 1-year costs of stenting plus abciximab were US$581 and $932. The corresponding cost-effectiveness ratios were US$5291 and $6213 per added life-year. Interpretation Coronary stenting with abciximab, compared with stenting alone or balloon angioplasty with abciximab, is associated with improved survival and is an economically attractive therapy by conventional standards.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; Univ Manitoba, Winnipeg, MB, Canada; Baylor Coll Med, Houston, TX 77030 USA; Univ Arkansas, Little Rock, AR 72204 USA; Centocor Inc, Malvern, PA 19355 USA	Cleveland Clinic Foundation; Duke University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Baylor College of Medicine; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Topol, EJ (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.			Mark, Daniel/0000-0001-6340-8087; Topol, Eric/0000-0002-1478-4729				ABDELMEGUID AE, 1995, CIRCULATION, V91, P2733, DOI 10.1161/01.CIR.91.11.2733; Abdelmeguid AE, 1996, CIRCULATION, V94, P1528, DOI 10.1161/01.CIR.94.7.1528; Adgey AAJ, 1999, CLIN CARDIOL, V22, P257; Alderman EL, 1996, NEW ENGL J MED, V335, P217; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Brener SJ, 1998, CIRCULATION, V98, P734, DOI 10.1161/01.CIR.98.8.734; ELLIS SG, 1997, CIRCULATION, V96, P87; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Hall P, 1996, CIRCULATION, V93, P215, DOI 10.1161/01.CIR.93.2.215; Kong TQ, 1997, JAMA-J AM MED ASSOC, V277, P461, DOI 10.1001/jama.277.6.461; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lincoff A. M., 1997, Journal of the American College of Cardiology, V29, p240A; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1; MARK DB, 1994, ANN INTERN MED, V120, P111, DOI 10.7326/0003-4819-120-2-199401150-00003; Mark DB, 1996, CIRCULATION, V94, P629, DOI 10.1161/01.CIR.94.4.629; MARK DB, 1995, NEW ENGL J MED, V332, P1418, DOI 10.1056/NEJM199505253322106; MARK DB, 1999, TXB INTERVENTIONAL C, P889; MARK DB, IN PRESS CIRCULATION; Miller J. M., 1999, TXB INTERVENTIONAL C, P379; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; Ohman EM, 1997, JAMA-J AM MED ASSOC, V277, P495, DOI 10.1001/jama.277.6.495; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Simoons ML, 1997, LANCET, V349, P1429; Simoons ML, 1999, EUR HEART J, V20, P1112, DOI 10.1053/euhj.1999.1521; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 1998, NEW ENGL J MED, V339, P1702, DOI 10.1056/NEJM199812033392311; TOPOL EJ, 1993, NEW ENGL J MED, V329, P221, DOI 10.1056/NEJM199307223290401; Urban P, 1998, CIRCULATION, V98, P2126, DOI 10.1161/01.CIR.98.20.2126	34	263	269	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2019	2024		10.1016/S0140-6736(99)10018-7	http://dx.doi.org/10.1016/S0140-6736(99)10018-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636365				2022-12-28	WOS:000084183300008
J	Jeffery, SLA; Cubison, TCS; Greenaway, C; Gilbert, PM; Parkhouse, N				Jeffery, SLA; Cubison, TCS; Greenaway, C; Gilbert, PM; Parkhouse, N			Lesson of the week - Warming milk - a preventable cause of scalds in children	BRITISH MEDICAL JOURNAL			English	Review							BURNS		Queen Victoria Hosp, McIndoe Burn Ctr, E Grinstead RH19 3DZ, W Sussex, England		Jeffery, SLA (corresponding author), Queen Victoria Hosp, McIndoe Burn Ctr, E Grinstead RH19 3DZ, W Sussex, England.		Jeffery, Steve/A-5207-2013	Jeffery, Steve/0000-0001-6587-5412				COSTALOS C, 1979, ARCH DIS CHILD, V54, P899, DOI 10.1136/adc.54.11.899; Dixon JJ, 1997, BURNS, V23, P268, DOI 10.1016/S0305-4179(96)00127-1; GARLAND JS, 1986, CHEST, V90, P621, DOI 10.1378/chest.90.4.621; HIBBARD RA, 1987, PEDIATRICS, V82, P382; POWELL EC, 1993, PEDIATRICS, V91, P344; SANDO WC, 1984, J PEDIATR-US, V105, P864, DOI 10.1016/S0022-3476(84)80067-0; Siu V, 1987, Pediatr Emerg Care, V3, P99, DOI 10.1097/00006565-198706000-00010	7	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					235	235		10.1136/bmj.320.7229.235	http://dx.doi.org/10.1136/bmj.320.7229.235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642236	Green Published			2022-12-28	WOS:000085029600034
J	Beecham, L				Beecham, L			UK GPs will have to show they are fit to practise	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					136	136						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634720				2022-12-28	WOS:000084860300010
J	Veeken, H				Veeken, H			Lurigancho prison: Lima's "high school" for criminality	BRITISH MEDICAL JOURNAL			English	Article									Med Sans Frontieres, NL-1001 EA Amsterdam, Netherlands	Doctors Without Borders	Veeken, H (corresponding author), Med Sans Frontieres, POB 10014, NL-1001 EA Amsterdam, Netherlands.							GAUDALUPE JLP, 1994, THESIS FACULTAD TEOL	1	7	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					173	175		10.1136/bmj.320.7228.173	http://dx.doi.org/10.1136/bmj.320.7228.173			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634742	Green Published			2022-12-28	WOS:000084860300033
J	Neuzil, CE				Neuzil, CE			Osmotic generation of 'anomalous' fluid pressures in geological environments	NATURE			English	Article							PIERRE SHALE; MODEL; BASIN	Osmotic pressures are generated by differences in chemical potential of a solution across a membrane. But whether osmosis can have a significant effect on the pressure of fluids in geological environments has been controversial, because the membrane properties of geological media are poorly understood(1). 'Anomalous' pressures-large departures from hydrostatic pressure that are not explicable in terms of topographic or fluid-density effects-are widely found in geological settings, and are commonly considered to result from processes that alter the pore or fluid volurne(2), which in turn implies crustal changes happening at a rate too slow to observe directly. Yet if osmosis can explain some anomalies, there is no need to invoke such dynamic geological processes in those cases, Here I report results of a nine-year in situ measurement of fluid pressures and solute concentrations in shale that are consistent with the generation of large (up to 20 MPa) osmotic-pressure anomalies which could persist for tens of millions of years. Osmotic pressures of this magnitude and duration can explain many of the pressure anomalies observed in geological settings. They require, however,small shale porosity and large contrasts in the amount of dissolved solids in the pore waters-criteria that may help to distinguish between osmotic and crustal-dynamic origins of anomalous pressures.	US Geol Survey, Natl Ctr 431, Reston, VA 20192 USA	United States Department of the Interior; United States Geological Survey	Neuzil, CE (corresponding author), US Geol Survey, Natl Ctr 431, Reston, VA 20192 USA.			Neuzil, Chris/0000-0003-2022-4055				BACHU S, 1995, AAPG BULL, V79, P1159; BRESLER E, 1973, SOIL SCI SOC AM J, V37, P663, DOI 10.2136/sssaj1973.03615995003700050013x; Crank J., 1964, MATH DIFFUSION, V1956th; DOMENICO PA, 1990, PHYSICAL CHEM HYDROG; FRITZ SJ, 1986, CLAY CLAY MINER, V34, P214, DOI 10.1346/CCMN.1986.0340212; Hanor J.S., 1994, GEOFLUIDS ORIGIN MIG, V78, P151, DOI DOI 10.1144/GSL.SP.1994.078.01.13; HANSHAW BB, 1965, GEOL SOC AM BULL, V76, P1379, DOI 10.1130/0016-7606(1965)76[1379:OEAOF]2.0.CO;2; Ingebritsen SE, 1998, GEOL MAG, V136, P697, DOI [10.1017/S0016756899363329, DOI 10.1017/S0016756899363329]; Katsube T. J., 1998, SHALES MUDSTONES, VII, P69; MARINE IW, 1981, WATER RESOUR RES, V17, P73, DOI 10.1029/WR017i001p00073; Mitchell J. K., 1993, FUNDAMENTALS SOIL BE; NEUZIL CE, 1993, WATER RESOUR RES, V29, P2007, DOI 10.1029/93WR00406; NEUZIL CE, 1994, WATER RESOUR RES, V30, P145, DOI 10.1029/93WR02930; NICHOLS TC, 1986, CAN GEOTECH J, V23, P181, DOI 10.1139/t86-028; SCLATER JG, 1980, J GEOPHYS RES, V85, P3711, DOI 10.1029/JB085iB07p03711; SHAW DB, 1965, J SEDIMENT PETROL, V35, P213; [No title captured]	17	131	138	2	24	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					182	184		10.1038/35003174	http://dx.doi.org/10.1038/35003174			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646600				2022-12-28	WOS:000084835300051
J	Hanahan, D; Weinberg, RA				Hanahan, D; Weinberg, RA			The hallmarks of cancer	CELL			English	Review							FIBROBLAST GROWTH-FACTOR; CELL-ADHESION MOLECULES; SUPPRESSES TUMOR-GROWTH; TELOMERASE ACTIVITY; MATRIX METALLOPROTEINASES; TYROSINE KINASES; TRANSGENIC MICE; FACTOR-BETA; LIFE-SPAN; IN-VIVO		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Hormone Res Inst, San Francisco, CA 94143 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Hanahan, D (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.		damiani, chiara/R-4256-2016; mert, sevda/D-9524-2018; ravegnini, gloria/K-1330-2016; duan, chris/J-2484-2015	mert, sevda/0000-0002-0481-2829; ravegnini, gloria/0000-0002-7774-402X; 				Aplin AE, 1998, PHARMACOL REV, V50, P197; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; BERGERS G, 2000, IN PRESS CURR OPIN G; BISHOP JM, 1996, MOL ONCOLOGY; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Butt AJ, 1999, IMMUNOL CELL BIOL, V77, P256, DOI 10.1046/j.1440-1711.1999.00822.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Cordon-Cardo C, 1999, J EXP MED, V190, P1367, DOI 10.1084/jem.190.10.1367; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fedi P., 1997, CANC MED, P41; Fogar P, 1997, ANTICANCER RES, V17, P1227; Foley KP, 1999, BBA-REV CANCER, V1423, pM37, DOI 10.1016/S0304-419X(99)00012-8; FOLKMAN J, 1997, CANC MED, P181; FOULDS L, 1954, EXPT STUDY TUMOR PRO, V1; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Hayflick L, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1180; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Hynes RO, 1996, J CLIN INVEST, V98, P2193, DOI 10.1172/JCI119027; ISHIZAKI Y, 1995, MOL BIOL CELL, V6, P1443, DOI 10.1091/mbc.6.11.1443; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; JOHNSON JP, 1991, CANCER METAST REV, V10, P11, DOI 10.1007/BF00046840; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; Kaiser U, 1996, LEUKEMIA LYMPHOMA, V20, P389, DOI 10.3109/10428199609052420; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LOEB LA, 1991, CANCER RES, V51, P3075; Lotem J, 1996, LEUKEMIA, V10, P925; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olumi AF, 1999, CANCER RES, V59, P5002; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Rak J, 1995, CANCER METAST REV, V14, P263, DOI 10.1007/BF00690598; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; Rommel C, 1998, CURR OPIN GENET DEV, V8, P412, DOI 10.1016/S0959-437X(98)80111-1; Schutte M, 1996, CANCER RES, V56, P2527; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shibata MA, 1996, CANCER RES, V56, P2998; SINGH RK, 1995, P NATL ACAD SCI USA, V92, P4562, DOI 10.1073/pnas.92.10.4562; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; Volpert OV, 1997, ONCOGENE, V14, P1495, DOI 10.1038/sj.onc.1200977; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	102	20487	21606	145	5714	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2000	100	1					57	70		10.1016/S0092-8674(00)81683-9	http://dx.doi.org/10.1016/S0092-8674(00)81683-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	273TB	10647931	Bronze			2022-12-28	WOS:000084722600005
J	Rossi, A; Kapahi, P; Natoli, G; Takahashi, T; Chen, Y; Karin, M; Santoro, MG				Rossi, A; Kapahi, P; Natoli, G; Takahashi, T; Chen, Y; Karin, M; Santoro, MG			Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I kappa B kinase	NATURE			English	Article							TRANSCRIPTION FACTOR; ANTIVIRAL ACTIVITY; HUMAN-CELLS; ACTIVATION; GAMMA; IKK; MECHANISMS; EXPRESSION; COMPLEX; ALPHA	NF-kappa B is a critical activator of genes involved in inflammation and immunity(1,2). Pro-inflammatory cytokines activate the I kappa B kinase (IKK) complex that phosphorylates the NF-kappa B inhibitors, triggering their conjugation with ubiquitin and subsequent degradation(3,4). Freed NF-kappa B dimers translocate to the nucleus and induce target genes, including the one for cyclo-oxygenase 2 (COX2), which catalyses the synthesis of pro-inflammatory prostaglandins, in particular pGE(5,6). At late stages of inflammatory episodes, however, COX2 directs the synthesis of anti-inflammatory cyclopentenone prostaglandins, suggesting a role for these molecules in the resolution of inflammation(7). Cyclopentenone prostaglandins have been suggested to exert anti-inflammatory activity through the activation of peroxisome proliferator-activated receptor-gamma (refs 8, 9). Here we demonstrate a novel mechanism of antiinflammatory activity which is based on the direct inhibition and modification of the IKK beta subunit of IKK, As IKK beta is responsible for the activation of NF-kappa B by pro-inflammatory stimuli(10,11), our findings explain how cyclopentenone prostaglandins function and can be used to improve the utility of COX2 inhibitors.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Roma Tor Vergata, Dept Biol, Virol Lab, I-00133 Rome, Italy; Italian Natl Council Res, Inst Expt Med, I-00133 Rome, Italy	University of California System; University of California San Diego; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR)	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Natoli, gioacchino/ABB-8679-2020; Natoli, gioacchino/J-2100-2018	Santoro, Maria Gabriella/0000-0003-1432-4949; Natoli, Gioacchino/0000-0003-0711-2411; ROSSI, ANTONIO/0000-0003-0383-3828				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; CALDERWOOD SK, 1989, J CELL PHYSIOL, V141, P325, DOI 10.1002/jcp.1041410214; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FUKUSHIMA M, 1990, EICOSANOIDS, V3, P189; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Herschman HR, 1997, ADV EXP MED BIOL, V407, P61; Hirose S, 1998, J AM SOC NEPHROL, V9, P408; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; LEUNG DYM, 1988, J IMMUNOL, V140, P84; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; OFFENBACHER S, 1986, J PERIODONTAL RES, V21, P101, DOI 10.1111/j.1600-0765.1986.tb01443.x; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 1996, J BIOL CHEM, V271, P32192, DOI 10.1074/jbc.271.50.32192; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rozera C, 1996, J CLIN INVEST, V97, P1795, DOI 10.1172/JCI118609; SANTORO MG, 1980, SCIENCE, V209, P1032, DOI 10.1126/science.6157190; SANTORO MG, 1989, P NATL ACAD SCI USA, V86, P8407, DOI 10.1073/pnas.86.21.8407; Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; WANG CY, 1998, SCIENCE, V274, P786; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	30	1150	1231	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2000	403	6765					103	108		10.1038/47520	http://dx.doi.org/10.1038/47520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638762				2022-12-28	WOS:000084687400052
J	Morrison, I				Morrison, I			The future of physicians' time	ANNALS OF INTERNAL MEDICINE			English	Article								Physicians' lime is under assault in the current health care system. In particular, managed care payers are reducing compensation to physicians on a discounted fee-for service basis. More demanding consumers, complex new technologies, and increased managerial and administrative burdens are placing further constraints on physicians' time. As we look ahead, it seems likely that these pressures will intensify and transform the ways in which physicians spend their time. Physicians will play eight key roles in the future: clinical data collector, shaman, health advisor and wellness coach, knowledge navigator, proceduralist, diagnostician, physician manager, and quality assurance specialist. They will need to lead the redesign of these roles and define the ways in which they should spend their time in the health care system of the new millennium.	Inst Future, Menlo Pk, CA USA		Morrison, I (corresponding author), 1635 Bay Laurel Dr, Menlo Pk, CA 94025 USA.	seccurve@aol.com						*HARR INT, 1999, HARR POLL; MORRISON I, 2000, JOS-BAS HEA, P1; Wadland WC, 1999, J FAM PRACTICE, V48, P711	3	23	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					80	84		10.7326/0003-4819-132-1-200001040-00013	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627256				2022-12-28	WOS:000084518600012
J	Scannell, KA				Scannell, KA			Leave of absence	ANNALS OF INTERNAL MEDICINE			English	Article									Kaiser Permanente, Oakland, CA 94611 USA	Kaiser Permanente	Scannell, KA (corresponding author), Kaiser Permanente, 280 W MacArthur Blvd, Oakland, CA 94611 USA.								0	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					55	57		10.7326/0003-4819-132-1-200001040-00009	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627252				2022-12-28	WOS:000084518600008
J	Xu, GL; Bestor, TH; Bourc'his, D; Hsieh, CL; Tommerup, N; Bugge, M; Hulten, M; Qu, XY; Russo, JJ; Viegas-Pequignot, E				Xu, GL; Bestor, TH; Bourc'his, D; Hsieh, CL; Tommerup, N; Bugge, M; Hulten, M; Qu, XY; Russo, JJ; Viegas-Pequignot, E			Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene	NATURE			English	Article							ICF SYNDROME; METHYLATION PATTERN; HETEROCHROMATIN; HYPOMETHYLATION; FISH; SET	The recessive autosomal disorder known as ICF syndrome(1-3) (for immunodeficiency, centromere instability and facial anomalies; Mendelian Inheritance in Man number 242860) is characterized by variable reductions in serum immunoglobulin levels which cause most ICF patients to succumb to infectious diseases before adulthood. Mild facial anomalies include hypertelorism, low-set ears, epicanthal folds and macroglossia. The cytogenetic abnormalities in lymphocytes are exuberant: juxtacentromeric heterochromatin is greatly elongated and thread-like in metaphase chromosomes, which is associated with the formation of complex multiradiate chromosomes. The same juxtacentromeric regions are subject to persistent interphase self-associations and are extruded into nuclear blebs or micronuclei. Abnormalities are largely confined to tracts of classical satellites 2 and 3 at juxtacentromeric regions of chromosomes 1, 9 and 16. Classical satellite DNA is normally heavily methylated at cytosine residues, but in ICF syndrome it is almost completely unmethylated in all tissues(4) ICF syndrome is the only genetic disorder known to involve constitutive abnormalities of genomic methylation patterns. Here we show that five unrelated ICF patients have mutations in both alleles of the gene that encodes DNA methyltransferase 3B (refs 5, 6). Cytosine methylation is essential for the organization and stabilization of a specific type of heterochromatin, and this methylation appears to be carried out by an enzyme specialized for the purpose.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Hop Necker Enfants Malad, INSERM, U383, F-75743 Paris 15, France; Univ So Calif, Sch Med, Dept Urol, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ Copenhagen, Inst Med Biochem & Genet, Dept Med Genet, DK-2600 Glostrup, Denmark; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA	Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Southern California; University of Southern California; University of Copenhagen; University of Warwick; Columbia University	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.		Tommerup, Niels/T-8776-2017	Tommerup, Niels/0000-0003-2304-0112; Bourc'his, Deborah/0000-0001-9499-7291				Bestor TH, 1998, CIBA F SYMP, V214, P187; Bourc'his D, 1999, CYTOGENET CELL GENET, V84, P245, DOI 10.1159/000015269; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; HSIEH CL, IN PRESS MOL CELL BI; HULTEN M, 1978, CLIN GENET, V14, P294; JEANPIERRE M, 1994, ANN GENET-PARIS, V37, P163; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; LAUSTER R, 1989, J MOL BIOL, V206, P305, DOI 10.1016/0022-2836(89)90480-4; LUBIT BW, 1976, CELL, V9, P503, DOI 10.1016/0092-8674(76)90032-5; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; MARASCHIO P, 1992, ANN HUM GENET, V56, P273, DOI 10.1111/j.1469-1809.1992.tb01152.x; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; REYNAUD C, 1992, CANCER LETT, V61, P255, DOI 10.1016/0304-3835(92)90296-8; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; SCHUFFENHAUER S, 1995, HUM GENET, V96, P562, DOI 10.1007/BF00197412; Schulz WG, 1997, CHEM ENG NEWS, V75, P64, DOI 10.1021/cen-v075n018.p064; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Sumner AT, 1998, J MED GENET, V35, P833, DOI 10.1136/jmg.35.10.833; TIEPOLO L, 1978, CLIN GENET, V14, P313; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	29	880	921	1	39	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					187	191		10.1038/46052	http://dx.doi.org/10.1038/46052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647011				2022-12-28	WOS:000083716400052
J	Imagawa, A; Hanafusa, T; Miyagawa, J; Matsuzawa, Y				Imagawa, A; Hanafusa, T; Miyagawa, J; Matsuzawa, Y		Osaka IDDM Study Grp	A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; PANCREAS BIOPSY SPECIMENS; AUTOIMMUNE-DISEASE; INSULIN; HETEROGENEITY; RISK; IDDM	Background and Methods: Type 1 diabetes mellitus is now classified as autoimmune (type 1A) or idiopathic (type 1B), but little is known about the latter. We classified 56 consecutive Japanese adults with type 1 diabetes according to the presence or absence of glutamic acid decarboxylase antibodies (their presence is a marker of autoimmunity) and compared their clinical, serologic, and pathological characteristics. Results: We divided the patients into three groups: 36 patients with positive tests for serum glutamic acid decarboxylase antibodies, 9 with negative tests for serum glutamic acid decarboxylase antibodies and glycosylated hemoglobin values higher than 11.5 percent, and 11 with negative tests for serum glutamic acid decarboxylase antibodies and glycosylated hemoglobin values lower than 8.5 percent. In comparison with the first two groups, the third group had a shorter mean duration of symptoms of hyperglycemia (4.0 days), a higher mean plasma glucose concentration (773 mg per deciliter [43 mmol per liter]) in spite of lower glycosylated hemoglobin values, diminished urinary excretion of C peptide, a more severe metabolic disorder (with ketoacidosis), higher serum pancreatic enzyme concentrations, and an absence of islet-cell, IA-2, and insulin antibodies. Immunohistologic studies of pancreatic-biopsy specimens from three patients with negative tests for glutamic acid decarboxylase antibodies and low glycosylated hemoglobin values revealed T-lymphocyte-predominant infiltrates in the exocrine pancreas but no insulitis and no evidence of acute or chronic pancreatitis. Conclusions: Some patients with idiopathic type 1 diabetes have a nonautoimmune, fulminant disorder characterized by the absence of insulitis and of diabetes-related antibodies, a remarkably abrupt onset, and high serum pancreatic enzyme concentrations. (N Engl J Med 2000;342:301-7.) (C) 2000, Massachusetts Medical Society.	Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan	Osaka University	Imagawa, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, B5,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Christie MR, 1997, DIABETES CARE, V20, P965, DOI 10.2337/diacare.20.6.965; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; GAINES KL, 1986, DIABETOLOGIA, V29, P313, DOI 10.1007/BF00452069; Gavin JR, 1997, DIABETES CARE, V20, P1183; HANAFUSA T, 1990, DIABETOLOGIA, V33, P105, DOI 10.1007/BF00401048; HARTIG PC, 1983, J INFECTION, V6, P43, DOI 10.1016/S0163-4453(83)95566-4; Imagawa A, 1996, RES COMMUN MOL PATH, V92, P43; Imagawa A, 1995, DIABETES RES CLIN PR, V30, P79, DOI 10.1016/0168-8227(95)01159-5; Imagawa A, 1999, DIABETOLOGIA, V42, P574, DOI 10.1007/s001250051197; IMAGAWA A, 1995, J CLIN ENDOCR METAB, V80, P992; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; KAWASAKI E, 1995, J AUTOIMMUN, V8, P633, DOI 10.1006/jaut.1995.0047; KIMURA N, 1994, ARCH PATHOL LAB MED, V118, P864; LERNMARK A, 1995, VIRCHOWS ARCH, V425, P631; MYERS MA, 1995, DIABETES, V44, P1290, DOI 10.2337/diabetes.44.11.1290; POWELL M, 1997, J ENDOCRINOL S2, V155, pP27; SCHMIDLI RS, 1995, DIABETES, V44, P636, DOI 10.2337/diabetes.44.6.636; STIRLING GA, 1994, SYSTEMIC PATHOLOGY, V11, P621; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; WAKISAKA M, 1987, Journal of the Japan Diabetes Society, V30, P619; Yamada K, 1996, DIABETES CARE, V19, P671, DOI 10.2337/diacare.19.6.671a; Yasunaga S, 1996, TISSUE ANTIGENS, V47, P37, DOI 10.1111/j.1399-0039.1996.tb02512.x	26	437	561	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					301	307		10.1056/NEJM200002033420501	http://dx.doi.org/10.1056/NEJM200002033420501			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655528	Green Published, Bronze			2022-12-28	WOS:000085070300001
J	Smith, L				Smith, L			So who's teaching whom?	BRITISH MEDICAL JOURNAL			English	Editorial Material									VSO, London, England		Smith, L (corresponding author), VSO, London, England.								0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					323	323		10.1136/bmj.320.7230.323	http://dx.doi.org/10.1136/bmj.320.7230.323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650055	Green Published			2022-12-28	WOS:000085132700071
J	Alexander, JH; Sparapani, RA; Mahaffey, KW; Deckers, JW; Newby, LK; Ohman, EM; Corbalan, R; Chierchia, SL; Boland, JB; Simoons, ML; Califf, RM; Topol, EJ; Harrington, RA				Alexander, JH; Sparapani, RA; Mahaffey, KW; Deckers, JW; Newby, LK; Ohman, EM; Corbalan, R; Chierchia, SL; Boland, JB; Simoons, ML; Califf, RM; Topol, EJ; Harrington, RA		PURSUIT Steering Comm	Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC TROPONIN-T; PROGNOSTIC-SIGNIFICANCE; CK-MB; SIZE; ISOENZYME; ISCHEMIA; RELEASE; INTERVENTIONS; PHOSPHOKINASE	Context Controversy surrounds the diagnostic and prognostic importance of slightly elevated cardiac markers in patients with acute coronary syndromes without ST-segment elevation. Objectives To investigate the relationship between peak creatine kinase (CK)-MB level and outcome and to determine whether a threshold CK-MB level exists below which risk is not increased. Design and Setting Retrospective observational analysis of data from the international Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial, conducted from November 1995 to January 1997, Patients A total of 8250 patients with acute coronary sydromes without ST-segment elevation who had at least 1 CK-MB sample collected during their index hospitalization. Main Outcome Measure Mortality at 30 days and 6 months, was assessed by category of index-hospitalization peak CK-MB level (0-1, >1-2, >2-3, >3-5, >5-10, or >10 times the upper limit of normal). Multivariable logistic regression was used to determine the independent prognostic significance of peak CK-MB level after adjustment for baseline predictors of 30-day and 6-month mortality. Results Mortality at 30 days and 6 months increased from 1.8% and 4.0%, respectively, in patients with normal peak CK-MB levels, to 3.3% and 6.2% at peak CK-MB levels 1 to 2 times normal, to 5.1% and 7.5% at peak CK-MB levels 3 to 5 times normal, and to 8.3% and 11.0% at peak CK-MB levels greater than 10 times normal. Log-transformed peak CK-MB levels were predictive of adjusted 30-day and 6-month mortality (P<.001 for both). Conclusions Our data show that elevation of CK-MB level is strongly related to mortality in patients with acute coronary syndromes without ST-segment elevation, and that the increased risk begins with CK-MB levels just above normal. in the appropriate clinical context, even minor CK-MB elevations should be considered indicative of myocardial infarction.	Duke Clin Res Inst, Durham, NC 27715 USA; Catholic Univ Chile, Santiago, Chile; Univ Milan, Osped San Raffaele, I-20127 Milan, Italy; Hop Citadelle, Liege, Belgium; Cardialysis, Rotterdam, Netherlands; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Duke University; Pontificia Universidad Catolica de Chile; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Cardialysis; Cleveland Clinic Foundation	Alexander, JH (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.		Alexander, John/GVS-7271-2022	Alexander, John/0000-0002-1444-2462; Topol, Eric/0000-0002-1478-4729; Sparapani, Rodney/0000-0002-7780-6825				Abdelmeguid AE, 1996, CIRCULATION, V94, P1528, DOI 10.1161/01.CIR.94.7.1528; ADAMS JE, 1993, CIRCULATION, V88, P750, DOI 10.1161/01.CIR.88.2.750; Adgey AAJ, 1999, CLIN CARDIOL, V22, P257; AHMED SA, 1976, CIRCULATION, V54, P187, DOI 10.1161/01.CIR.54.2.187; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; BENHORIN J, 1990, J AM COLL CARDIOL, V15, P253, DOI 10.1016/S0735-1097(10)80043-9; BITTL JA, 1985, J BIOL CHEM, V260, P208; BLEIFELD W, 1977, CIRCULATION, V55, P303, DOI 10.1161/01.CIR.55.2.303; Boersma Eric, 1999, Journal of the American College of Cardiology, V33, p359A; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; CLYNE CA, 1989, AM HEART J, V118, P901, DOI 10.1016/0002-8703(89)90221-4; COHEN L, 1984, PRINCIPLES PRACTICE, P383; COX JR, 1976, CIRCULATION, V53, P150; Cutlip D. E., 1997, Journal of the American College of Cardiology, V29, p187A; FIORETTI P, 1985, EUR HEART J, V6, P473, DOI 10.1093/oxfordjournals.eurheartj.a061892; GELTMAN EM, 1979, AM J CARDIOL, V43, P370; GEWIRTZ H, 1979, CIRCULATION, V59, P707, DOI 10.1161/01.CIR.59.4.707; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HARRINGTON RA, 1995, J AM COLL CARDIOL, V25, P1693, DOI 10.1016/0735-1097(95)00091-H; HONG RA, 1986, AM HEART J, V111, P1041, DOI 10.1016/0002-8703(86)90004-9; Hudson Michael P., 1999, Journal of the American College of Cardiology, V33, p325A; Koch KC, 1999, J AM COLL CARDIOL, V33, P998, DOI 10.1016/S0735-1097(98)00659-7; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Kong TQ, 1997, JAMA-J AM MED ASSOC, V277, P461, DOI 10.1001/jama.277.6.461; KORNOWSKI R, 1993, AM J CARDIOL, V72, P883, DOI 10.1016/0002-9149(93)91100-V; MARMOR A, 1978, LANCET, V2, P812; MATHEY D, 1974, BRIT HEART J, V36, P271; MERCER DW, 1975, CLIN CHEM, V21, P1088; MUELLER HS, 1995, J AM COLL CARDIOL, V26, P900, DOI 10.1016/0735-1097(95)00270-1; NORRIS RM, 1975, CIRCULATION, V51, P614, DOI 10.1161/01.CIR.51.4.614; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; ROBERTS R, 1975, BRIT HEART J, V37, P1169; ROGERS WJ, 1977, CIRCULATION, V56, P199, DOI 10.1161/01.CIR.56.2.199; Savonitto Stefano, 1999, Journal of the American College of Cardiology, V33, p346A; SHELL WE, 1976, CIRCULATION, V53, P98; Simoons ML, 1999, EUR HEART J, V20, P1112, DOI 10.1053/euhj.1999.1521; SOBEL BE, 1972, CIRCULATION, V46, P640, DOI 10.1161/01.CIR.46.4.640; Stone Gregg W., 1999, Journal of the American College of Cardiology, V33, p80A; Tardiff BE, 1999, J AM COLL CARDIOL, V33, P88, DOI 10.1016/S0735-1097(98)00551-8; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1996, NEW ENGL J MED, V335, P775; van Domburg R. T., 1998, European Heart Journal, V19, P166; Wagner GS, 1982, ARCH INTERN MED, V140, P33; WHITE RD, 1985, AM J CARDIOL, V55, P1478, DOI 10.1016/0002-9149(85)90957-9; YUSUF S, 1987, AM J CARDIOL, V59, P245, DOI 10.1016/0002-9149(87)90793-4	46	88	93	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					347	353		10.1001/jama.283.3.347	http://dx.doi.org/10.1001/jama.283.3.347			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647797	Green Published, Bronze			2022-12-28	WOS:000084732400026
J	Carpenter, CCJ; Cooper, DA; Fischl, MA; Gatell, JM; Gazzard, BG; Hammer, SM; Hirsch, MS; Jacobsen, DM; Katzenstein, DA; Montaner, JSG; Richman, DD; Saag, MS; Schechter, M; Schooley, RT; Vella, S; Yeni, PG; Volberding, PA				Carpenter, CCJ; Cooper, DA; Fischl, MA; Gatell, JM; Gazzard, BG; Hammer, SM; Hirsch, MS; Jacobsen, DM; Katzenstein, DA; Montaner, JSG; Richman, DD; Saag, MS; Schechter, M; Schooley, RT; Vella, S; Yeni, PG; Volberding, PA			Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMMUNODEFICIENCY-VIRUS INFECTION; PLASMA VIRAL LOAD; CD4 CELL COUNTS; HIV-1 INFECTION; PHARMACOKINETIC INTERACTION; COMBINATION THERAPY; PROTEASE INHIBITORS; CUBIC MILLIMETER; INDINAVIR; NEVIRAPINE	Objective To update recommendations for antiretroviral therapy for adult human immunodeficiency virus type 1 (HIV-1) infection, based on new information and drugs that are available. Participants A 17-member international physician panel with antiretroviral research and HIV patient care experience initially convened by the International AIDS Society-USA in December 1995. Evidence Available clinical and basic science data including phase 3 controlled trials; data on clinical, virologic, and immunologic end points; research conference reports; HIV pathogenesis data; and panel expert opinion. Recommendations were limited to therapies available (US Food and Drug Administration approved) in 1999. Consensus Process The panel assesses new research reports and interim results and regularly meets to consider how the new data affect therapy recommendations. Recommendations are updated via full-panel consensus. Guidelines are presented as recommendations if the supporting evidence warrants routine use in the particular situation and as considerations if data are preliminary or incomplete but suggestive. Conclusions The availability of new antiretroviral drugs has expanded treatment choices. The importance of adherence, emerging long-term complications of therapy, recognition and management of antiretroviral failure, and new monitoring tools are addressed. Optimal care requires individualized management and ongoing attention to relevant scientific and clinical information in the field.	Brown Univ, Sch Med, Providence, RI 02912 USA; Univ New S Wales, Sydney, NSW, Australia; Univ Miami, Sch Med, Miami, FL USA; Univ Barcelona, Barcelona, Spain; Chelsea & Westminster Hosp, London, England; Columbia Univ, Coll Phys & Surg, New York, NY USA; Harvard Univ, Sch Med, Boston, MA USA; Int AIDS Soc USA, San Francisco, CA USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Univ Calif San Diego, San Diego, CA 92103 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; Univ Colorado, Sch Med, Denver, CO 80202 USA; AIDS Res Consortium Atlanta, Atlanta, GA USA; Ist Super Sanita, I-00161 Rome, Italy; Hop Bichat Claude Bernard, X Bichat Med Sch, F-75877 Paris 18, France; Univ Calif San Francisco, San Francisco, CA 94143 USA	Brown University; University of New South Wales Sydney; University of Miami; University of Barcelona; Imperial College London; Columbia University; Harvard University; Harvard Medical School; Stanford University; St. Paul's Hospital; University of Saskatchewan; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Universidade Federal do Rio de Janeiro; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Istituto Superiore di Sanita (ISS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco	Carpenter, CCJ (corresponding author), Brown Univ, Miriam Hosp, Sch Med, 164 Summit Ave, Providence, RI 02906 USA.	Charles_Carpenter@brown.edu	VELLA, STEFANO/ABI-3368-2020; VELLA, STEFANO/V-8440-2019; Vella, Stefano/GZM-0519-2022; Gatell, Jose M/ABC-3607-2020	VELLA, STEFANO/0000-0003-2347-5984; katzenstein, david/0000-0002-8593-4560				ACOSTA EP, 1999, 6 C RETR OPP INF JAN; AITKHALED M, 1999, 6 C RETR OPP INF JAN; ANASTOS K, 1999, 6 C RETR OPP INF JAN; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1996, Lancet, V348, P283; AUTRAN B, 1999, 6 C RETR OPP INF JAN; Baxter J, 1999, ANTIVIR THER S, V4, P43; Brambilla D, 1999, AIDS, V13, P2269, DOI 10.1097/00002030-199911120-00009; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; BURGER DM, 1999, 6 C RETR OPP INF JAN; BUSS N, 1998, 5 C RETR OPP INF FEB; CALL S, 1999, 39 INT C ANT AG CHEM; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; CHEESEMAN SH, 1993, ANTIMICROB AGENTS CH, V37, P178, DOI 10.1128/AAC.37.2.178; CLEVENBERGH P, 1999, ANTIVIR THER S, V4, P42; COAKLEY E, IN PRESS AIDS; COX SR, 1998, 5 C RETR OPP INF FEB; DEEKS S, 1999, 6 C RETR OPP INF JAN; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; DEMETER L, 1998, 5 C RETR OPP INF FEB; DESCAMPS D, 1999, 6 C RETR OPP INF JAN; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; *DUP PHARM CO, 1998, EF PACK INS; ERON J, 1999, 6 C RETR OPP INF JAN; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FERRY JJ, 1997, 4 C RETR OPP INF JAN; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FISCHL M, 1999, 6 C RETR OPP INF JAN; FISKE WD, 1998, 5 C RETR OPP INF FEB; FISKE WD, 1997, 37 INT C ANT AG CHEM; FISKE WD, 1997, 4 C RETR OPP INF JAN; FLEXNER C, 1998, 12 WORLD AIDS C JUN; GALLANT JE, 1999, 6 C RETR OPP INF JAN; GARRAFFO R, 1999, ANTIVIR THER S, V4, P75; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Gunthard HF, 1999, J VIROL, V73, P9404; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hecht F M, 1998, AIDS Clin Care, V10, P57; Hengel RL, 1997, LANCET, V350, P1596, DOI 10.1016/S0140-6736(05)64011-1; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; HOLDER DJ, 1999, 6 C RETR OPP INF JAN; Hsu A, 1998, ANTIMICROB AGENTS CH, V42, P2784, DOI 10.1128/AAC.42.11.2784; KATLAMA C, 1999, 6 C RETR OPP INF JAN; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; KRAVCIK S, 1997, 4 C RETR OPP INF JAN; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; LYLES R, 1999, 6 C RETR OPP INF JAN; MANION DJ, 1999, 6 C RETR OPP INF JAN; MARKOWITZ M, 1999, 39 INT C ANT AG CHEM; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; MCCREA J, 1997, 4 C RETR OPP INF JAN; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Miller MD, 1999, J INFECT DIS, V179, P92, DOI 10.1086/314560; MILLER V, 1999, 6 C RETR OPP INF JAN; MILLER V, IN PRESS ANTIVIRAL T; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; MURPHY R, 1997, 4 C RETR OPP INF JAN; Murphy RL, 1999, J INFECT DIS, V179, P808, DOI 10.1086/314668; MURPHY RL, 1999, 39 INT C ANT AG CHEM; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PATERSON D, 1999, 6 C RETR OPP INF JAN; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Phillips P, 1999, J ACQ IMMUN DEF SYND, V20, P122, DOI 10.1097/00042560-199902010-00003; Plana M, 1998, LANCET, V352, P1194, DOI 10.1016/S0140-6736(05)60532-6; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; RACE E, 1999, ANTIVIR THER S, V4, P80; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; ROSS L, 1999, ANTIVIR THER S, V4, P79; RUIZ L, 1999, 6 C RETR OPP INF JAN; Saag M., 1997, 37 INT C ANT AG CHEM; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; SAAH AJ, 1999, 6 C RETR OPP INF JAN; SADLER B, 1998, 12 WORLD AIDS C JUN; SAHAL J, 1997, 4 C RETR OPP INF JAN; SARGENT S, 1998, 5 C RETR OPP INF FEB; Schechter M, 1999, AIDS, V13, P97, DOI 10.1097/00002030-199901140-00013; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; SHELTON M, 1997, 37 INT C ANT AG CHEM; Skowron G, 1998, AIDS, V12, P1243, DOI 10.1097/00002030-199810000-00017; SLATER L, 1999, 6 C RETR OPP INF JAN; SQUIRES K, 1999, 6 C RETR OPP INF JAN; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; STASZEWSKI S, 1999, 39 INT C ANT AG CHEM; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Sullivan AK, 1997, AIDS, V11, P938; Tebas P, 1999, AIDS, V13, pF23, DOI 10.1097/00002030-199902040-00002; *US DHHS, 1998, MMWR-MORBID MORTAL W, V47, P42; Vergis E, 1998, ANTIVIR THER, V3, P1; WATHEN L, 1998, ANTIVIR THER S, V3, P95; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; YUEN G, 1997, 4 C RETR OPP INF JAN; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	112	851	887	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					381	390		10.1001/jama.283.3.381	http://dx.doi.org/10.1001/jama.283.3.381			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647802				2022-12-28	WOS:000084732400031
J	Graham, W; Smith, P; Kamal, A; Fitzmaurice, A; Smith, N; Hamilton, N				Graham, W; Smith, P; Kamal, A; Fitzmaurice, A; Smith, N; Hamilton, N			Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests	BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSIS	Objective To compare the effectiveness of touch screen system with information leaflet for providing women with information on prenatal tests. Design Randomised controlled trial; participants allocated to intervention group (given access to touch screen and leaflet information) or control group (leaflet information only). Setting Antenatal clinic in university teaching hospital. Subjects 875 women booking antenatal care. Interventions All participants received a leaflet providing information on prenatal tests. Women in the intervention arm also had access to touch screen information system in antenatal clinic. Main outcome measures Women's informed decision making on prenatal testing as measured by their uptake of and understanding of the purpose of specific tests; their satisfaction with information provided; and their levels of anxiety. Results All women in the trial had a good baseline knowledge of prenatal tests. Women in the intervention group did not show any greater understanding of the purpose of the tests than control women. However, uptake of detailed anomaly scans was significantly higher in intervention group lan the control group (94% (351/375)v 87% (310/358), P = 0.0014). Levels of anxiety among nulliparous women in intervention group declined significantly over time (P < 0.001). Conclusions The touch screen seemed to convey no benefit over well prepared leaflets in improving understanding of prenatal tests among the pregnant women. It did, however, seem to reduce levels of anxiety and may be most effective for providing information to selected women who have a relevant adverse history or abnormal results from tests in their current pregnancy.	Aberdeen Matern Hosp, Dept Obstet & Gynecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland; Univ Aberdeen, Fac Med & Med Sci, Comp Assisted Learning Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Graham, W (corresponding author), Aberdeen Matern Hosp, Dept Obstet & Gynecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland.			Graham, Wendy/0000-0003-1473-5342				ASTBURY J, 1980, J PSYCHOSOM RES, V24, P9, DOI 10.1016/0022-3999(80)90069-0; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; DALTON ME, 1993, NEW ENGL J MED, V328, P114; Department of Health, 1991, PATIENTS CHARTER; Dezateux C, 1998, LANCET, V352, P24; GREEN J, 1992, OBSTETRICS 1990S CUR, P65; Hundley V, 1998, MIDWIFERY, V14, P118, DOI 10.1016/S0266-6138(98)90009-2; MARTEAU TM, 1988, J PSYCHOSOM RES, V32, P403, DOI 10.1016/0022-3999(88)90023-2; MARTEAU TM, 1992, PUBLIC HEALTH, V106, P131, DOI 10.1016/S0033-3506(05)80390-7; MIEDZYBRODZKA ZH, 1995, BRIT MED J, V310, P353, DOI 10.1136/bmj.310.6976.353; MORUSIS MJ, 1994, SPSS 6 1 REFERENCE M; Oliver S, 1996, BMJ-BRIT MED J, V313, P1251, DOI 10.1136/bmj.313.7067.1251a; PECKHAM M, 1991, LANCET, V338, P367, DOI 10.1016/0140-6736(91)90494-A; REID M, 1988, EUR J OBSTET GYN R B, V28, P79; RUSSEL CH, 1998, HLTH B, V56, P631; SMITH AP, 1996, DIPLOMATE, V3, P175; Spielberger C., 1983, STAI MANUAL; THORNTON JG, 1995, BMJ-BRIT MED J, V311, P1127, DOI 10.1136/bmj.311.7013.1127; WALLACE C, 1996, UNPUB DEV TOUCHSCREE	19	62	61	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					155	159		10.1136/bmj.320.7228.155	http://dx.doi.org/10.1136/bmj.320.7228.155			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	276DL	10634736	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000084860300026
J	Wright, J				Wright, J			Far,far away	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					195	195		10.1136/bmj.320.7228.195	http://dx.doi.org/10.1136/bmj.320.7228.195			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634764	Green Published			2022-12-28	WOS:000084860300068
J	Haschke, JM; Allen, TH; Morales, LA				Haschke, JM; Allen, TH; Morales, LA			Reaction of plutonium dioxide with water: Formation and properties of PuO2+x	SCIENCE			English	Article								Results show that PuO2-x, a high-composition (x less than or equal to 0.27) phase containing Pu(VI), is the stable binary oxide in air, This nonstoichiometric oxide forms by reaction of dioxide with water and by water-catalyzed reaction of dioxide with oxygen. The PuO2 + H2O reaction rate is 0.27 nanomoles per meter squared per hour at 25 degrees C; the activation energy at 25 degrees to 350 degrees C is 39 kilojoules per mole. Slow kinetics and a Low Lattice parameter-composition dependence for fluorite-related PuO2+x are consistent with a failure to observe the phase in earlier studies. Perplexing aspects of plutonium oxide chemistry can now be explained.	Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Haschke, JM (corresponding author), 11003 Willow Bend Dr, Waco, TX 76712 USA.							BAKER MM, 1966, T FARADAY SOC, V62, P252; Bondietti E.A., 1976, ACS SYM SER, V35, P47; BREWER L, 1953, CHEM REV, V52, P1, DOI 10.1021/cr60161a001; CLEVELAND JM, 1979, CHEM PLUTONIUM, P291; Colmenares C.A., 1975, PROG SOLID STATE CH, V9, P139; GARDNER ER, 1965, J INORG NUCL CHEM, V27, P541, DOI 10.1016/0022-1902(65)80259-7; Haschke J. M., 1983, RFP3416; Haschke J.M., 1998, ENCY ENV ANAL REMEDI, V6, P3740; Haschke JM, 1997, J ALLOY COMPD, V252, P148, DOI 10.1016/S0925-8388(96)02627-8; Haschke JM, 1996, J ALLOY COMPD, V243, P23, DOI 10.1016/S0925-8388(96)02328-6; HASCHKE JM, 1992, TRANSURANIUM ELEMENTS, P416; HASCHKE JM, 1999, LA13537MS LOS AL NAT; HOLLEY CE, 1958, 2ND P UN INT C PEAC, V6, P215; KATZ JJ, 1949, J AM CHEM SOC, V71, P2106, DOI 10.1021/ja01174a056; Kersting AB, 1999, NATURE, V397, P56, DOI 10.1038/16231; MARQUART R, 1983, J LESS-COMMON MET, V91, P119, DOI 10.1016/0022-5088(83)90101-7; Morales L.A., 1999, LA13597MS LOS AL NAT; MORALES LA, UNPUB; SACKMAN JF, 1961, PLUTONIUM 1960, P222; STAKEBAKE JL, 1993, J ALLOY COMPD, V202, P251, DOI 10.1016/0925-8388(93)90547-Z; WABER JT, 1980, PLUTONIUM HDB, P145; WEIGEL F, 1986, CHEM ACTINIDE ELEMEN, V1, P680; WESTRUM EF, 1949, NATL NUCL ENERGY SER, V4, P936	23	216	218	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					285	287		10.1126/science.287.5451.285	http://dx.doi.org/10.1126/science.287.5451.285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634778				2022-12-28	WOS:000084769600033
J	Le Naour, F; Rubinstein, E; Jasmin, C; Prenant, M; Boucheix, C				Le Naour, F; Rubinstein, E; Jasmin, C; Prenant, M; Boucheix, C			Severely reduced female fertility in CD9-deficient mice	SCIENCE			English	Article							INTEGRIN COMPLEXES; ZONA-PELLUCIDA; MOUSE OOCYTES; CELL-SURFACE; CD9 ANTIGEN; HB-EGF; GENE; EXPRESSION; PROTEINS; LOCALIZATION	CD9 is a widely expressed cell surface molecule that belongs to the tetraspanin superfamily of proteins. The tetraspanins CD9, KAI-1/CD82, and CD63 are involved in metastasis suppression, an effect that may be related to their association with beta 1 integrins. Knockout mice lacking CD9 were created to evaluate the physiological importance of CD9. CD9(-/-) females displayed a severe reduction of fertility. Oocytes were ovulated but were not successfully fertilized because sperm did not fuse with the oocytes from CD9(-/-) females. Thus, CD9 appears to be essential for sperm-egg fusion, a process involving the CD9-associated integrin alpha 6 beta 1.	Hop Paul Brousse, INSERM, U 268, F-94800 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boucheix, C (corresponding author), Hop Paul Brousse, INSERM, U 268, F-94800 Villejuif, France.	boucheix@infoblogen.fr	Rubinstein, Eric/B-4650-2019	Rubinstein, Eric/0000-0001-7623-9665; Boucheix, Claude/0000-0003-4184-7008				ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; BOUCHEIX C, 1991, J BIOL CHEM, V266, P117; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Capmany G, 1998, MOL HUM REPROD, V4, P951, DOI 10.1093/molehr/4.10.951; CONOVER JC, 1988, J REPROD FERTIL, V82, P681, DOI 10.1530/jrf.0.0820681; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; EVANS JP, 1995, MOL REPROD DEV, V40, P211, DOI 10.1002/mrd.1080400210; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; Hogan B, 1994, MANIPULATING MOUSE E; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KUBIAK JZ, 1992, J CELL SCI, V102, P457; Lagaudriere-Gesbert C, 1997, CELL IMMUNOL, V182, P105, DOI 10.1006/cimm.1997.1223; LANZA F, 1991, J BIOL CHEM, V266, P10638; LeNaour F, 1997, LEUKEMIA, V11, P1290, DOI 10.1038/sj.leu.2400721; LeNaour F, 1996, ONCOGENE, V13, P481; LENAOUR F, UNPUB; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Monget P, 1999, M S-MED SCI, V15, P141, DOI 10.4267/10608/1304; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; RADFORD KJ, 1995, INT J CANCER, V62, P631, DOI 10.1002/ijc.2910620523; Rankin T, 1996, DEVELOPMENT, V122, P2903; RUBINSTEIN E, 1994, EUR J IMMUNOL, V24, P3005, DOI 10.1002/eji.1830241213; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; TARONE G, 1993, DEVELOPMENT, V117, P1369; Zuccotti M, 1998, DEV BIOL, V200, P27, DOI 10.1006/dbio.1998.8923	30	508	523	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					319	321		10.1126/science.287.5451.319	http://dx.doi.org/10.1126/science.287.5451.319			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634790				2022-12-28	WOS:000084769600045
J	Li, JX; Wang, XQ; Watson, MB; Assmann, SM				Li, JX; Wang, XQ; Watson, MB; Assmann, SM			Regulation of abscisic acid-induced stomatal closure and anion channels by guard cell AAPK kinase	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; PROTEIN-KINASE; ARABIDOPSIS-THALIANA; CALCIUM; PHOSPHATASE; RESPONSES; BLOCKERS; PLANTS; GENE; ABI1	Abscisic acid (ABA) stimulates stomatal closure and thus supports water conservation by plants during drought. Mass spectrometry-generated peptide sequence information was used to clone a Vicia faba complementary DNA, AAPK, encoding a guard cell-specific ABA-activated serine-threonine protein kinase.(AAPK). Expression in transformed guard cells of AAPK altered by one amino acid (lysine 43 to alanine 43) renders stomata insensitive to ABA-induced closure by eliminating ABA activation of plasma membrane anion channels. This information should allow cell-specific, targeted biotechnological manipulation of crop water status.	Penn State Univ, Mueller Lab 208, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Assmann, SM (corresponding author), Penn State Univ, Mueller Lab 208, Dept Biol, University Pk, PA 16802 USA.			Wang, Xi-Qing/0000-0003-4477-9557				ANDERBERG RJ, 1992, P NATL ACAD SCI USA, V89, P10183, DOI 10.1073/pnas.89.21.10183; ASSMANN SM, 1993, ANNU REV CELL BIOL, V9, P345, DOI 10.1146/annurev.cb.09.110193.002021; Assmann SM, 1998, J EXP BOT, V49, P163, DOI 10.1093/jexbot/49.319.163; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; DAVIES WJ, 1991, ABSCISIC ACID PHYSIO; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holappa LD, 1997, PLANT MOL BIOL, V33, P935, DOI 10.1023/A:1005720203535; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P22; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li JX, 1996, PLANT CELL, V8, P2359, DOI 10.1105/tpc.8.12.2359; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; LOO JA, 1995, BIOCONJUGATE CHEM, V6, P644, DOI 10.1021/bc00036a600; LOVEYS BR, 1984, NEW PHYTOL, V98, P563, DOI 10.1111/j.1469-8137.1984.tb04149.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Mori IC, 1997, PLANT PHYSIOL, V113, P833, DOI 10.1104/pp.113.3.833; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; SCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9535, DOI 10.1073/pnas.92.21.9535; SCHROEDER JI, 1993, PLANT CELL, V5, P1831, DOI 10.1105/tpc.5.12.1831; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; SCHWARTZ A, 1995, PLANT PHYSIOL, V109, P651, DOI 10.1104/pp.109.2.651; Schwarz M, 1998, FEBS LETT, V428, P177, DOI 10.1016/S0014-5793(98)00526-2; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Wang XQ, 1998, PLANT PHYSIOL, V118, P1421, DOI 10.1104/pp.118.4.1421; WANG YH, 1993, ARCH BIOCHEM BIOPHYS, V304, P496, DOI 10.1006/abbi.1993.1381	34	340	398	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					300	303		10.1126/science.287.5451.300	http://dx.doi.org/10.1126/science.287.5451.300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634783				2022-12-28	WOS:000084769600038
J	Daynard, RA; Bates, C; Francey, N				Daynard, RA; Bates, C; Francey, N			Tobacco litigation worldwide	BRITISH MEDICAL JOURNAL			English	Article									Northeastern Univ, Sch Law, Boston, MA 02116 USA; Act Smoking & Hlth, London EC2A 4HW, England; Wentworth Chambers, Sydney, NSW 2000, Australia	Northeastern University	Daynard, RA (corresponding author), Northeastern Univ, Sch Law, 400 Huntington Ave, Boston, MA 02116 USA.			Bates, Clive/0000-0002-4106-7119					0	28	29	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 8	2000	320	7227					111	113		10.1136/bmj.320.7227.111	http://dx.doi.org/10.1136/bmj.320.7227.111			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274CR	10625272	Green Published			2022-12-28	WOS:000084746600025
J	McCarty, JG				McCarty, JG			Methane combustion - Durable catalysts for cleaner air	NATURE			English	Editorial Material									Catalysis Combust Syst Inc, Mt View, CA 94043 USA		McCarty, JG (corresponding author), Catalysis Combust Syst Inc, 430 Ferguson Dr Bldg 3, Mt View, CA 94043 USA.							Arai H, 1991, CATAL TODAY, V10, P81, DOI 10.1016/0920-5861(91)80076-L; Berzelius JJ., 1836, ANN CHIM PHYS, V61, P146; DallaBetta RA, 1997, CATAL TODAY, V35, P129, DOI 10.1016/S0920-5861(96)00139-3; DAVY H, 1817, PHIL T R SOC LOND, V107, P45; PFEFFERLE WC, 1978, J ENERGY, V2, P142, DOI 10.2514/3.47964; Zarur AJ, 2000, NATURE, V403, P65, DOI 10.1038/47450	6	55	57	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					35	36		10.1038/47388	http://dx.doi.org/10.1038/47388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638739				2022-12-28	WOS:000084687400029
J	Henney, JE				Henney, JE			Injunction affecting Abbott's in vitro test devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					46	46		10.1001/jama.283.1.46	http://dx.doi.org/10.1001/jama.283.1.46			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632269				2022-12-28	WOS:000084514400005
J	Schiffman, M; Herrero, R; Hildesheim, A; Sherman, ME; Bratti, M; Wacholder, S; Alfaro, M; Hutchinson, M; Morales, J; Greenberg, MD; Lorincz, AT				Schiffman, M; Herrero, R; Hildesheim, A; Sherman, ME; Bratti, M; Wacholder, S; Alfaro, M; Hutchinson, M; Morales, J; Greenberg, MD; Lorincz, AT			HPV DNA testing in cervical cancer screening - Results from women in a high-risk province of Costa Rica	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN PAPILLOMAVIRUS INFECTION; ATYPICAL SQUAMOUS CELLS; INTRAEPITHELIAL NEOPLASIA; UNDETERMINED SIGNIFICANCE; TYPE-16; TRIAGE	Context Human papillomaviruses (HPVs) are known to cause most cervical cancer worldwide, but the utility of HPV DNA testing in cervical cancer prevention has not been determined. Objective To provide comprehensive data on the screening performance of HPV testing for the most common carcinogenic types, at different levels of analytic sensitivity. Design Laboratory analysis conducted during 1993-1995, using 3 cytologic techniques and cervicography, followed by colposcopic examination of women with any abnormal cervical finding, to detect all high-grade intraepithelial lesions and cancer (reference standard of clinically significant disease). The HPV testing was performed subsequently with masking regarding clinical findings. Setting Guanacaste Province, Costa Rica, a region with a high age-adjusted incidence of cervical cancer. Participants Of 11742 randomly selected women, 8554 nonpregnant, sexually active women without hysterectomies underwent initial HPV DNA testing using the original Hybrid Capture Tube test; a stratified subsample of 1119 specimens was retested using the more analytically sensitive second generation assay, the Hybrid Capture II test. Main Outcome Measures Receiver operating characteristic analysis of detection of cervical high-grade intraepithelial lesions and cancer by HPV DNA testing based on different cut points of positivity. Results An analytic sensitivity of 1.0 pg/mL using the second generation assay would have permitted detection of 88.4% of 138 high-grade lesions and cancers (all 12 cancers were HPV-positive), with colposcopic referral of 12.3% of women. Papanicolaou testing using atypical squamous cells of undetermined significance as a cut point for referral resulted in 77.7% sensitivity and 94.2% specificity, with 6.9% referred. Specificity of the second generation assay for positivity for high-grade lesions and cancer was 89.0%, with 33.8% of remaining HPV DNA-positive subjects having low-grade or equivocal microscopically evident lesions. The higher detection threshold of 10 pg/mL used with the original assay had a sensitivity of 74.8% and a specificity of 93.4%, Lower levels of detection with the second generation assay (<1 pg/mL) proved clinically nonspecific without gains in diagnostic sensitivity, Conclusions In this study population, a cut point of 1.0 pg/mL using the second generation assay permitted sensitive detection of cervical high-grade lesions and cancer, yielding an apparently optimal trade-off between high sensitivity and reasonable specificity for this test. The test will perform best in settings in which sensitive detection of high-grade lesions and cancer is paramount. Because HPV prevalence varies by population, HPV testing positive predictive value for detection of high-grade lesions and cancer will vary accordingly, with implications for utility relative to other cervical cancer screening methods.	NCI, Interdisciplinary Studies Sect, Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Int Agcy Res Canc, F-69372 Lyon, France; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Costa Rican Social Secur Adm, San Jose, Costa Rica; Brown Univ, Women & Infants Hosp, Providence, RI USA; Omnia, Blue Bell, PA USA; Digene Corp, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); Johns Hopkins University; Johns Hopkins Medicine; Brown University; Women & Infants Hospital Rhode Island	Schiffman, M (corresponding author), NCI, Interdisciplinary Studies Sect, Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Room 7066,6120 Execut Blvd, Rockville, MD 20852 USA.	schiffmm@exchange.nih.gov	Schiffman, Mark/B-9766-2015		NATIONAL CANCER INSTITUTE [Z01CP010124, ZIACP010124] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*ALTS GROUP, IN PRESS J NATL CANC; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BRINTON LA, 1989, INT J CANCER, V44, P199, DOI 10.1002/ijc.2910440202; Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; Cox JT, 1998, J FAM PRACTICE, V46, P121; COX JT, 1995, AM J OBSTET GYNECOL, V172, P946, DOI 10.1016/0002-9378(95)90026-8; Crum CP, 1998, AM J PATHOL, V153, P1667, DOI 10.1016/S0002-9440(10)65679-9; CUZICK J, 1994, BRIT J CANCER, V69, P167, DOI 10.1038/bjc.1994.28; FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485; Herrero R, 1993, Bull Pan Am Health Organ, V27, P15; HERRERO R, 1997, PAN AM J PUBLIC HLTH, V1, P362; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; Hutchinson ML, 1999, CANCER CYTOPATHOL, V87, P48, DOI 10.1002/(SICI)1097-0142(19990425)87:2&lt;48::AID-CNCR2&gt;3.0.CO;2-D; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; JOHNSON MA, 1990, J GEN VIROL, V71, P1473, DOI 10.1099/0022-1317-71-7-1473; Kaufman RH, 1997, AM J OBSTET GYNECOL, V177, P930, DOI 10.1016/S0002-9378(97)70296-5; KIVIAT NB, 1990, AM J CLIN PATHOL, V94, P561, DOI 10.1093/ajcp/94.5.561; LORINCZ A, 1996, PAPILLOMAVIRUS REPOR, V7, P1; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Peyton CL, 1998, J CLIN MICROBIOL, V36, P3248, DOI 10.1128/JCM.36.11.3248-3254.1998; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; SCHIFFMAN MH, 1992, EPIDEMIOLOGY HUMAN P, P169; SCHIFFMAN MH, 1994, EARLY DETECTION CANC, P265; SCHIFFMAN MH, 1997, VIRAL INFECT HUMANS, P983; Schneider A, 1996, AM J OBSTET GYNECOL, V174, P1534, DOI 10.1016/S0002-9378(96)70602-6; Schneider DL, 1999, AM J OBSTET GYNECOL, V180, P290, DOI 10.1016/S0002-9378(99)70202-4; Sherman ME, 1998, CANCER CYTOPATHOL, V84, P273; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wingo PA, 1998, CANCER-AM CANCER SOC, V82, P1197, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0; ZWEIG MH, 1993, CLIN CHEM, V39, P561	31	405	430	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					87	93		10.1001/jama.283.1.87	http://dx.doi.org/10.1001/jama.283.1.87			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632285	Bronze			2022-12-28	WOS:000084514400030
J	Ludmerer, KM				Ludmerer, KM			Time and medical education	ANNALS OF INTERNAL MEDICINE			English	Article							AMBULATORY-CARE SETTINGS; RESIDENTS	An indispensable ingredient of good medical education is the presence of enough time to allow educational objectives to be met. The length of study needs to be sufficient for learners to acquire the necessary factual, reasoning, judgmental, and behavioral skills. For medical education to be conducted at the highest level, learners also need sufficient contact time with patients, and faculty need enough time to teach in a thoughtful, Socratic fashion. As the 21st century approaches, time is disappearing from the process of teaching and learning medicine, with disturbing implications for the quality of education. Medical educators in the future must work as hard to defend the availability of sufficient time as they do to acquire new buildings and research funds.	Washington Univ, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Ludmerer, KM (corresponding author), Washington Univ, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.							CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; DELBANCO TL, 1986, ANN INTERN MED, V105, P961, DOI 10.7326/0003-4819-105-6-961; FELTOVICH J, 1989, ACAD MED, V64, P36, DOI 10.1097/00001888-198901000-00015; FLEXNER A, 1930, U AM ENGLISH GERMAN, P92; FLEXNER A, 1925, MED ED COMP STUDY A, P148; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; Jones DR, 1996, ACAD MED, V71, P820, DOI 10.1097/00001888-199608000-00008; KREVANS JR, 1989, MED DYING ANGELS, P40; LITZELMAN DK, 1995, ACAD MED, V70, P448, DOI 10.1097/00001888-199505000-00049; Ludmerer K., 1999, TIME HEAL AM MED ED; Ludmerer Kenneth M., 1985, LEARNING HEAL DEV AM; MANGAN KS, 1996, CHRONICLE HIGHE 0726, V26, pA18; *MGMA AAMC, 1996, ACAD MED, V71, P161; SCHLESINGER LS, 1995, ACAD MED, V70, P561, DOI 10.1097/00001888-199507000-00002; SOULE MH, 1940, COMMUNICATION   0430; TAYLOR CA, 1991, ACAD MED, V66, P121, DOI 10.1097/00001888-199102000-00018	16	23	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					25	28		10.7326/0003-4819-132-1-200001040-00005	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627247				2022-12-28	WOS:000084518600004
J	Auerbach, AD; Hamel, MB; Davis, RB; Connors, AF; Regueiro, C; Desbiens, N; Goldman, L; Califf, RM; Dawson, NV; Wenger, N; Vidaillet, H; Phillips, RS				Auerbach, AD; Hamel, MB; Davis, RB; Connors, AF; Regueiro, C; Desbiens, N; Goldman, L; Califf, RM; Dawson, NV; Wenger, N; Vidaillet, H; Phillips, RS		SUPPORT Investigators	Resource use and survival of patients hospitalized with congestive heart failure: Differences in care by specialty of the attending physician	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	20th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 01-03, 1997	WASHINGTON, D.C.	Soc Gen Internal Med			ACUTE MYOCARDIAL-INFARCTION; MEDICAL OUTCOMES; PROPENSITY SCORE; MORTALITY; CARDIOLOGISTS; MANAGEMENT; PROGNOSIS; SUPPORT; DISEASE; DYSFUNCTION	Background: Previous studies suggest that specialty care is more costly but may produce improved outcomes for patients with acute cardiac illnesses. Objective: To determine whether patients with congestive heart failure who are cared for by cardiologists experienced differences in costs, care patterns, and survival compared with patients of generalists. Design: Prospective cohort study. Setting: 5 U.S. teaching hospitals between 1989 and 1994, Patients: 1298 patients hospitalized with an exacerbation of congestive heart failure. Measurements: Hospital costs; average daily Therapeutic Intervention Scoring System (TISS) score; and survival censored at 30, 180, and 365 days and 31 December 1994. Results: Compared with patients of generalists, patients of cardiologists were younger (mean age, 63.3 and 71.4 years; P < 0.001) and had lower Acute Physiology Scores at the time of admission (35.1 and 36.7; P < 0.001) but were more likely to have a history of ventricular arrhythmias (21.0% and 10.2%; P < 0.001). At 6 months, 201 (27%) patients of cardiologists and 149 (27%) patients of generalists had died. After adjustment for sociodemographic characteristics and severity of illness, patients of cardiologists incurred costs that were 42.9% (95% CI, 27.8% to 59.8%) higher and average daily TISS scores that were 2.83 points (CI, 1.96 to 3.68 points) higher than those of patients of generalists. Patients of cardiologists were more likely,to undergo right-heart catheterization (adjusted odds ratio, 2.9 [CI, 1.7 to 4.9]) or cardiac catheterization (adjusted:odds ratio, 3.9 [CI, 2.4 to 6.2]) and had higher odds for transfer to an intensive care unit and electrocardiographic monitoring. Adjusted survival did not differ significantly between groups at 30 days; however, there was a trend toward improved survival among patients of cardiologists at 1 year (adjusted relative hazard, 0.82 [Cl, 0.65 to 1.04])and at maximum follow-up (adjusted relative hazard, 0.80 [CI, 0.66 to 0.96]). Conclusions: In this observational study of patients hospitalized with congestive heart failure, cardiologist care was associated with greater costs and resource use and no difference in survival at 30 days of follow-up. Whether the trend toward better survival at longer follow-up represents differences in care or unadjusted illness severity is uncertain.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Univ Tennessee, Coll Med, Chattanooga, TN USA; Duke Univ, Med Ctr, Durham, NC USA; Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA; Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA; Allegheny Gen Hosp, Pittsburgh, PA 15212 USA	University of California System; University of California San Francisco; University of Virginia; University of Tennessee System; University of Tennessee Health Science Center; Duke University; Case Western Reserve University; MetroHealth System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Marshfield Clinic; Allegheny General Hospital	Auerbach, AD (corresponding author), Univ Calif San Francisco, Dept Med, Box 0120, San Francisco, CA 94143 USA.			Connors, Alfred F./0000-0001-7123-3360				Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; BAKER DW, 1994, JAMA-J AM MED ASSOC, V272, P1528, DOI 10.1001/jama.272.19.1528; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; COHEN JJ, 1993, NEW ENGL J MED, V329, P1810, DOI 10.1056/NEJM199312093292412; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; Doval HC, 1996, CIRCULATION, V94, P3198, DOI 10.1161/01.CIR.94.12.3198; EDWARDS BS, 1992, MAYO CLIN PROC, V67, P485, DOI 10.1016/S0025-6196(12)60400-5; Goldman L, 1996, NEW ENGL J MED, V335, P1918, DOI 10.1056/NEJM199612193352510; GOLDMAN S, 1993, CIRCULATION, V87, P24; GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Harjai KJ, 1998, AM J CARDIOL, V82, P82, DOI 10.1016/S0002-9149(98)00234-3; HUGHES CV, 1993, CIRCULATION, V87, P111; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; KARLSON BW, 1992, CARDIOLOGY, V81, P134, DOI 10.1159/000175788; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; KRELLING B, 1990, J CLIN EPIDEMIOL, V43, P55; LEE TH, 1988, ANN INTERN MED, V108, P887, DOI 10.7326/0003-4819-108-6-887; LEIER CV, 1994, AM HEART J, V128, P564, DOI 10.1016/0002-8703(94)90633-5; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; LYNN J, 1990, J CLIN EPIDEMIOL, V43, pS1, DOI 10.1016/0895-4356(90)90211-7; MURPHY DJ, 1990, J CLIN EPIDEMIOL, V43, pS11, DOI 10.1016/0895-4356(90)90213-9; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PARAMESHWAR J, 1992, AM HEART J, V123, P421, DOI 10.1016/0002-8703(92)90656-G; POLLACK MM, 1988, CRIT CARE MED, V16, P11, DOI 10.1097/00003246-198801000-00003; Regueiro CR, 1998, AM J MED, V105, P366, DOI 10.1016/S0002-9343(98)00290-3; Reis SE, 1997, J AM COLL CARDIOL, V30, P733, DOI 10.1016/S0735-1097(97)00214-3; Rickenbacher PR, 1996, J AM COLL CARDIOL, V27, P1192, DOI 10.1016/0735-1097(95)00587-0; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SCHREIBER TL, 1995, J AM COLL CARDIOL, V26, P577, DOI 10.1016/0735-1097(95)00214-O; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; STRAUSS MJ, 1986, MED CARE, V24, P915, DOI 10.1097/00005650-198610000-00005; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; VanDenBerg MP, 1997, HEART, V77, P309, DOI 10.1136/hrt.77.4.309; VANDENBROEK SAJ, 1992, AM J CARDIOL, V70, P359, DOI 10.1016/0002-9149(92)90619-A; WARD MM, 1993, ARCH INTERN MED, V153, P2229, DOI 10.1001/archinte.153.19.2229; Willison DJ, 1998, ARCH INTERN MED, V158, P1778, DOI 10.1001/archinte.158.16.1778	45	105	106	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					191	200		10.7326/0003-4819-132-3-200002010-00004	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	276XE	10651599				2022-12-28	WOS:000084903000003
J	Hahn, BH; Shaw, GM; De Cock, KM; Sharp, PM				Hahn, BH; Shaw, GM; De Cock, KM; Sharp, PM			AIDS - AIDS as a zoonosis: Scientific and public health implications	SCIENCE			English	Review							SIMIAN IMMUNODEFICIENCY VIRUS; AFRICAN-GREEN MONKEYS; CROSS-SPECIES TRANSMISSION; WILD-CAPTURED CHIMPANZEE; HIV-1 GROUP-O; PHYLOGENETIC ANALYSIS; SEQUENCE-ANALYSIS; TANTALUS MONKEYS; MACAQUE MONKEYS; INFECTION	Evidence of simian immunodeficiency virus (SIV) infection has been reported for 26 different species of African nonhuman primates. Two of these viruses, SIVcpz from chimpanzees and SIVsm from sooty mangabeys, are the cause of acquired immunodeficiency syndrome (AIDS) in humans. Together, they have been transmitted to humans on at least seven occasions. The implications of human infection by a diverse set of SIVs and of exposure to a plethora of additional human immunodeficiency virus-related viruses are discussed.	Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Howard Hughes Med Inst, Birmingham, AL 35294 USA; Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NH7 2UH, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; University of Nottingham	Hahn, BH (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Sharp, Paul/Y-3787-2019; Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887	NIAID NIH HHS [N01 AI 35338, R01 AI 40951, R01 AI 44596] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044596, R01AI040951] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI J, 1994, MOLPHY VERSION 2 2; ALLAN JS, 1991, J VIROL, V65, P2816, DOI 10.1128/JVI.65.6.2816-2828.1991; Beer BE, 1999, J VIROL, V73, P7734, DOI 10.1128/JVI.73.9.7734-7744.1999; BEER BE, IN PRESS J VIROL; BibolletRuche F, 1996, J GEN VIROL, V77, P773, DOI 10.1099/0022-1317-77-4-773; BIBOLLETRUCHE F, 2000, 7 C RETR OPP INF SAN; Buve A, 1995, AIDS, V9 Suppl A, pS103; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P678; *CDCP, 1999, SURV HLTH CAR WORK H; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P814; Centers for Disease Control, 1994, MORBIDITY MORTALITY, V43, P1; CHAKRABARTI L, 1987, NATURE, V328, P543, DOI 10.1038/328543a0; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Chen ZW, 1996, J VIROL, V70, P3617, DOI 10.1128/JVI.70.6.3617-3627.1996; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Clewley JP, 1998, J VIROL, V72, P10305, DOI 10.1128/JVI.72.12.10305-10309.1998; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Curtis Tom, 1992, ROLLING STONE, P108; DANIEL MD, 1987, J GEN VIROL, V68, P3183, DOI 10.1099/0022-1317-68-12-3183; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; deCock KM, 1996, REV EPIDEMIOL SANTE, V44, P511; Delaporte E, 1996, AIDS, V10, P903, DOI 10.1097/00002030-199607000-00014; DELASSUS S, 1991, J VIROL, V65, P225, DOI 10.1128/JVI.65.1.225-231.1991; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; DJOMAND G, 1994, AIDS, V8, P843, DOI 10.1097/00002030-199406000-00019; Dutrillaux B., 1988, P150; FOMSGAARD A, 1991, VIROLOGY, V182, P397, DOI 10.1016/0042-6822(91)90689-9; FUKASAWA M, 1988, NATURE, V333, P457, DOI 10.1038/333457a0; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gao F., UNPUB; Gautier J.-P., 1988, P194; GeorgesCourbot MC, 1998, J VIROL, V72, P600, DOI 10.1128/JVI.72.1.600-608.1998; GOULD P, 1993, SLOW PLAQUE GEOGRAPH; Gurtler LG, 1996, ARCH VIROL, P195; HIRSCH VM, 1993, VIROLOGY, V197, P426, DOI 10.1006/viro.1993.1606; HIRSCH VM, 1993, J VIROL, V67, P1517, DOI 10.1128/JVI.67.3.1517-1528.1993; Hirsch VM, 1999, J VIROL, V73, P1036, DOI 10.1128/JVI.73.2.1036-1045.1999; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; Holmes Eddie C., 1996, P169; Hooper Edward, 1999, RIVER JOURNEY SOURCE; HRDY DB, 1987, REV INFECT DIS, V9, P1109; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; JANSSENS W, 1994, AIDS RES HUM RETROV, V10, P1191, DOI 10.1089/aid.1994.10.1191; JIN MJ, 1994, EMBO J, V13, P2935, DOI 10.1002/j.1460-2075.1994.tb06588.x; JIN MJ, 1994, J VIROL, V68, P8454, DOI 10.1128/JVI.68.12.8454-8460.1994; Jonassen TO, 1997, VIROLOGY, V231, P43, DOI 10.1006/viro.1997.8510; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KHABBAZ RF, 1994, NEW ENGL J MED, V330, P172, DOI 10.1056/NEJM199401203300304; Kingdon J., 1988, PRIMATE RAD EVOLUTIO, P160; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; KORBER B, UNPUB; KUIKEN CL, 1994, AIDS S1, V8, pS73; Lederberg J., 1992, I MED US COMMITTEE; LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295; LI WH, 1988, MOL BIOL EVOL, V5, P313; *LOS AL NAT LAB, 1998, HUM RETR AIDS 1998 C; LOWENSTINE LJ, 1986, INT J CANCER, V38, P563, DOI 10.1002/ijc.2910380417; Mauclere P, 1997, AIDS, V11, P445, DOI 10.1097/00002030-199704000-00007; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; MULLER MC, 1993, J VIROL, V67, P1227; MURPHEYCORB M, 1986, NATURE, V321, P435, DOI 10.1038/321435a0; Nerrienet E, 1998, AIDS RES HUM RETROV, V14, P785, DOI 10.1089/aid.1998.14.785; NICOL I, 1989, J MED PRIMATOL, V18, P227; NKENGASONG JN, 1994, AIDS, V8, P1405, DOI 10.1097/00002030-199410000-00006; Osterhaus ADME, 1999, VIROLOGY, V260, P116, DOI 10.1006/viro.1999.9794; Peeters M, 1997, AIDS, V11, P493, DOI 10.1097/00002030-199704000-00013; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; PEETERS M, 1992, AIDS, V6, P447, DOI 10.1097/00002030-199205000-00002; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; SANTIAGO M, 2000, 7 C RETR OPP INF SAN; Sharp P.M., 1994, AIDS S1, V8, pS27; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Sharp PM, 2000, BIOCHEM SOC T, V28, P275, DOI 10.1042/bst0280275; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; SIMON F, 1999, 6 C RETR OPP INF CHI; SIMON F, UNPUB; SONNET J, 1987, SCAND J INFECT DIS, V19, P511, DOI 10.3109/00365548709032415; SOUQUIERE S, 2000, 7 C RETR OPP INF SAN; Stricker RB, 1997, MED HYPOTHESES, V48, P193, DOI 10.1016/S0306-9877(97)90288-7; Takehisa J, 1998, VIROLOGY, V245, P1, DOI 10.1006/viro.1998.9141; Takehisa J, 1999, J VIROL, V73, P6810, DOI 10.1128/JVI.73.8.6810-6820.1999; TSUJIMOTO H, 1989, NATURE, V341, P539, DOI 10.1038/341539a0; *UNAIDS, 1999, AIDS EP UPD DEC 1999; *US DEP HHS, 1998, PREV EM INF DIS STRA; van der Loeff MFS, 1999, AIDS, V13, pS69; van Rensburg EJ, 1998, J GEN VIROL, V79, P1809, DOI 10.1099/0022-1317-79-7-1809; VandenHaesevelde MM, 1996, VIROLOGY, V221, P346, DOI 10.1006/viro.1996.0384; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; VERDRAGER J, 1995, B SOC PATHOL EXOT, V88, P54; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	95	776	801	0	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					607	614		10.1126/science.287.5453.607	http://dx.doi.org/10.1126/science.287.5453.607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649986				2022-12-28	WOS:000084989400035
J	Watson, RDS; Gibbs, CR; Lip, GYH				Watson, RDS; Gibbs, CR; Lip, GYH			ABC of heart failure - Clinical features and complications	BRITISH MEDICAL JOURNAL			English	Review									City Hosp, Univ Dept Med, Birmingham, W Midlands, England; City Hosp, Dept Cardiol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Watson, RDS (corresponding author), City Hosp, Univ Dept Med, Birmingham, W Midlands, England.							CLELAND JG, 1995, EUR HEART J, V16, P741; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; GRADMAN A, 1989, J AM COLL CARDIOL, V14, P564, DOI 10.1016/0735-1097(89)90093-4; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; RODEHEFFER RJ, 1993, MAYO CLIN PROC, V68, P1143, DOI 10.1016/S0025-6196(12)60063-9; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429	6	65	72	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					236	239		10.1136/bmj.320.7229.236	http://dx.doi.org/10.1136/bmj.320.7229.236			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642237	Green Published			2022-12-28	WOS:000085029600035
J	Yamey, G				Yamey, G			Lord Winston attacks Labour's health policy	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					205	205						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642215				2022-12-28	WOS:000085029600011
J	Beecham, L				Beecham, L			Juniors to discuss training and development	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					191	191						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634757				2022-12-28	WOS:000084860300067
J	Bader, B; Kuhn, K; Owen, DJ; Waldmann, H; Wittinghofer, A; Kuhlmann, J				Bader, B; Kuhn, K; Owen, DJ; Waldmann, H; Wittinghofer, A; Kuhlmann, J			Bioorganic synthesis of lipid-modified proteins for the study of signal transduction	NATURE			English	Article							RAS LIPOPEPTIDES; BINDING-SITE; PRENYLATION; VESICLES; EXPRESSION; MEMBRANES; P21(RAS); DOMAIN; ESTER	Biological membranes define the boundaries of the cellular compartments in higher eukaryotes and are active in many processes such as signal transduction and vesicular transport. Although post-translational lipid modification of numerous proteins in signal transduction is crucial for biological function(1), analysis of protein-protein interactions has mainly focused on recombinant proteins in solution under defined in vitro conditions. Here we present a new strategy for the synthesis of such lipid-modified proteins. It involves the bacterial expression of a carboxy-terminally truncated non-lipidated protein, the chemical synthesis of differently lipidated peptides representing the C terminus of the proteins, and their covalent coupling. Our technique is demonstrated using Ras constructs, which exhibit properties very similar to fully processed Ras, but can be produced in high yields and are open for selective modifications. These constructs are operative in biophysical and cellular assay systems, showing specific recognition of effecters by Ras lipoproteins inserted into the membrane surface of biosensors and transforming activity of oncogenic variants aft er microinjection into cultured cells.	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; Univ Dortmund, D-44227 Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.		Waldmann, Herbert/B-7406-2017	Waldmann, Herbert/0000-0002-9606-7247; Owen, David/0000-0002-9165-1540; Bader, Benjamin/0000-0002-5299-396X				BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Gelb MH, 1997, SCIENCE, V275, P1750, DOI 10.1126/science.275.5307.1750; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Nagele E, 1998, J AM CHEM SOC, V120, P6889, DOI 10.1021/ja9805627; PAGE MJ, 1989, J BIOL CHEM, V264, P19147; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Schelhaas M, 1999, CHEM-EUR J, V5, P1239, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1239::AID-CHEM1239>3.0.CO;2-N; Schelhaas M, 1996, ANGEW CHEM INT EDIT, V35, P106, DOI 10.1002/anie.199601061; Schmidt G, 1996, ONCOGENE, V12, P87; Schmittberger T, 1998, CHEM COMMUN, P937, DOI 10.1039/a708749g; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Siddiqui AA, 1998, J BIOL CHEM, V273, P3712, DOI 10.1074/jbc.273.6.3712; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Waddick KG, 1998, BIOCHEM PHARMACOL, V56, P1411, DOI 10.1016/S0006-2952(98)00211-1; Willumsen BM, 1996, ONCOGENE, V13, P1901; Wittinghofer A, 1998, BIOL CHEM, V379, P933	21	134	145	1	29	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					223	226		10.1038/35003249	http://dx.doi.org/10.1038/35003249			4	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646611				2022-12-28	WOS:000084835300062
J	Chiang, YPJ; Kole, HK; Brown, K; Naramura, M; Fukuhara, S; Hu, RJ; Jang, IK; Gutkind, JS; Shevach, E; Gu, H				Chiang, YPJ; Kole, HK; Brown, K; Naramura, M; Fukuhara, S; Hu, RJ; Jang, IK; Gutkind, JS; Shevach, E; Gu, H			Cbl-b regulates the CD28 dependence of T-cell activation	NATURE			English	Article							RECEPTOR TRANSGENIC MICE; SIGNAL-TRANSDUCTION; C-CBL; ANTIGEN RECEPTORS; DEFICIENT MICE; VAV; PROTOONCOGENE; THYMOCYTES; RESPONSES; PRODUCT	Whereas co-stimulation of the T-cell antigen receptor (TCR) and CD28 triggers T-cell activation, stimulation of the TCR alone may result in an anergic state or T-cell deletion, both possible mechanisms of tolerance induction(1,2), Here we show that T cells that are deficient in the adaptor molecule Cbl-b, (ref. 3) do not require CD28 engagement for interleukin-2 production, and that the Cbl-b-null mutation (Cbl-b(-/-)) fully res;tores T-cell-dependent antibody responses in CD28(-/-) mice. The main TCR signalling pathways, such as tyrosine kinases Zap-70 and Lck, Ras/mitogen-activated kinases, phospholipase C gamma-1 and Ca2+ mobilization, were not affected in Cbl-b(-/-) T cells. In contrast, the activation of Vav, a guanine nucleotide exchange factor for Rac1/Rho/CDC42, was significantly enhanced. Our findings indicate that Cbl-b may influence the CD28 dependence of T-cell activation by selectively suppressing TCR-mediated Vav activation, Mice deficient in Cbl-b are highly susceptible to experimental autoimmune encephalomyelitis, suggesting that the dysregulation of signalling pathways modulated by Cbl-b may also contribute to human autoimmune diseases such as multiple sclerosis.	NIAID, Immunol Lab, NIH, Rockville, MD 20852 USA; NIH, Bethesda, MD 20892 USA; NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gu, H (corresponding author), NIAID, Immunol Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.		Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Naramura, Mayumi/0000-0003-3658-0767; Jang, Ihn Kyung/0000-0001-8899-7930	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zhang ZH, 1999, CURR BIOL, V9, P203, DOI 10.1016/S0960-9822(99)80090-6	26	465	488	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					216	220		10.1038/35003235	http://dx.doi.org/10.1038/35003235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646609				2022-12-28	WOS:000084835300060
J	Felz, MW; Smith, CD; Swift, TR				Felz, MW; Smith, CD; Swift, TR			A six-year-old girl with tick paralysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Med Coll Georgia, Dept Family Med, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Felz, MW (corresponding author), Med Coll Georgia, Dept Family Med, HB 4032, Augusta, GA 30912 USA.	mfelz@mail.mcg.edu						ABBOTT KH, 1943, MAYO CLIN P, V18, P59; ALEXANDER RM, 1955, JAMA-J AM MED ASSOC, V149, P931; Bassoe P, 1924, ARCH NEURO PSYCHIATR, V11, P564, DOI 10.1001/archneurpsyc.1924.02190350070006; BEACH MW, 1941, J S CAROLINA M A, V37, P323; Bruno R, 1998, J Emerg Nurs, V24, P13, DOI 10.1016/S0099-1767(98)90161-1; CHERINGTON M, 1968, NEW ENGL J MED, V278, P95, DOI 10.1056/NEJM196801112780207; Cleland JB, 1912, AUSTRALAS MED GAZ, V32, P295; Cleland JB, 1912, AUSTRALAS MED GAZ, V32, P269; COSTA JA, 1952, AMA AM J DIS CHILD, V83, P336, DOI 10.1001/archpedi.1952.02040070082011; DEBUSK FL, 1972, PEDIATRICS, V50, P328; DeSanctis AG, 1943, J AMER MED ASSOC, V122, P86, DOI 10.1001/jama.1943.72840190001006; ESPLIN DW, 1960, SCIENCE, V132, P958, DOI 10.1126/science.132.3432.958; Felz MW, 1998, PATIENT CARE, V32, P172; GIBBES JH, 1938, JAMA-J AM MED ASSOC, V111, P1008; GIBSON JJ, 1966, CAN MED ASSOC J, V94, P1319; GOTHE R, 1979, J MED ENTOMOL, V16, P357, DOI 10.1093/jmedent/16.5.357; GrattanSmith PJ, 1997, BRAIN, V120, P1975, DOI 10.1093/brain/120.11.1975; GREGSON JD, 1973, CANADIAN DEP AGR MON, V9, P5; Hadwen Seymour, 1913, Parasitology Cambridge, V6, DOI 10.1017/S0031182000003127; HALLER JS, 1972, AM J DIS CHILD, V124, P915, DOI 10.1001/archpedi.1972.02110180117018; Jones H R Jr, 1995, Curr Opin Pediatr, V7, P663; KAIRE GH, 1966, TOXICON, V4, P91, DOI 10.1016/0041-0101(66)90003-1; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; MORRIS HH, 1977, SOUTHERN MED J, V70, P121, DOI 10.1097/00007611-197701000-00056; Mulherin PA, 1940, J PEDIATR-US, V16, P86, DOI 10.1016/S0022-3476(40)80045-0; MURNAGHAN MF, 1960, CAN J BIOCHEM PHYS, V38, P287; MURNAGHAN MF, 1960, SCIENCE, V131, P418, DOI 10.1126/science.131.3398.418; NUTTALL G. H. F., 1914, Parasitology, V7, P95, DOI 10.1017/S0031182000006326; PEARN J, 1977, J NEUROL SCI, V34, P37, DOI 10.1016/0022-510X(77)90089-2; RANSMEIER JC, 1949, J PEDIATR-US, V34, P299, DOI 10.1016/S0022-3476(49)80084-9; ROSE I, 1956, NATURE, V178, P95, DOI 10.1038/178095a0; ROSE I, 1954, CAN MED ASSOC J, V70, P175; STANBURY JB, 1945, MEDICINE, V24, P219, DOI 10.1097/00005792-194509000-00001; SWIFT TR, 1975, NEUROLOGY, V25, P1130, DOI 10.1212/WNL.25.12.1130; TEMPLE IU, 1912, MED SENTINEL, V20, P507; Todd JL, 1912, CAN MED ASSOC J, V2, P1118; Zanga J R, 1979, Va Med, V106, P443; 1996, MMWR MORB MORTAL WKL, V45, P325	38	51	55	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					90	94		10.1056/NEJM200001133420204	http://dx.doi.org/10.1056/NEJM200001133420204			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631277				2022-12-28	WOS:000084723900004
J	Fricke, H; Hissmann, K; Schauer, J; Erdmann, M; Moosa, MK; Plante, R				Fricke, H; Hissmann, K; Schauer, J; Erdmann, M; Moosa, MK; Plante, R			Conservation - Biogeography of the Indonesian coelacanths	NATURE			English	Article							HOME		Max Planck Inst Verhaltensphysiol, D-82319 Seewiesen, Germany; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Indonesian Inst Sci, Jakarta 11048, Indonesia; Ctr Oceanol Marseille, Marine Endoume Stn, F-13007 Marseille, France	Max Planck Society; University of California System; University of California Berkeley; Indonesian Institute of Sciences	Fricke, H (corresponding author), Max Planck Inst Verhaltensphysiol, D-82319 Seewiesen, Germany.							Erdmann MV, 1998, NATURE, V395, P335, DOI 10.1038/26376; Forey P, 1998, NATURE, V395, P319, DOI 10.1038/26328; FRICKE H, 1994, MAR BIOL, V120, P171, DOI 10.1007/BF00349676; FRICKE HW, IN PRESS MAR BIOL; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Pouyaud L, 1999, CR ACAD SCI III-VIE, V322, P261, DOI 10.1016/S0764-4469(99)80061-4	7	21	24	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					38	38		10.1038/47400	http://dx.doi.org/10.1038/47400			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638741	Bronze			2022-12-28	WOS:000084687400031
J	Loitman, JE				Loitman, JE			Pain management: Beyond pharmacology to acupuncture and hypnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brown Univ, Sch Med, Providence, RI 02912 USA	Brown University	Loitman, JE (corresponding author), Brown Univ, Sch Med, Providence, RI 02912 USA.							Blumberg D L, 1995, Altern Ther Health Med, V1, P31; BROSE W, 1992, AM PSYCHIAT PRESS TX; Crock RD, 1999, ALTERN THER HEALTH M, V5, P61; Elder NC, 1997, ARCH FAM MED, V6, P181, DOI 10.1001/archfami.6.2.181; Freeman J W, 1997, S D J Med, V50, P65; KELLERMAN J, 1983, J ADOLESC HLTH CARE, V4, P35; LEWIT K, 1979, PAIN, V6, P83, DOI 10.1016/0304-3959(79)90142-8; MELZACK R, 1977, PAIN, V3, P3, DOI 10.1016/0304-3959(77)90032-X; Montbriand MJ, 1998, CANCER NURS, V21, P36, DOI 10.1097/00002820-199802000-00005; MORGAN AH, 1973, INT J CLIN EXP HYP, V21, P78, DOI 10.1080/00207147308409308; National Institutes of Health, 1995, INT BEH REL APPR TRE, P1; *NIH, 1997, NIH CONS DEV C AC; Pomeranz B, 1996, J Altern Complement Med, V2, P53, DOI 10.1089/acm.1996.2.53; PORTENOY RK, 1992, LANCET, V339, P1026, DOI 10.1016/0140-6736(92)90545-E; Reston, 1971, NY TIMES, P1; Reston J, 1971, NY TIMES, V1, P6; Ulett GA, 1998, SOUTHERN MED J, V91, P1115, DOI 10.1097/00007611-199812000-00004	17	3	4	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					118	119		10.1001/jama.283.1.118	http://dx.doi.org/10.1001/jama.283.1.118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632295				2022-12-28	WOS:000084514400040
J	Clever, LH				Clever, LH			Some things have not changed	ANNALS OF INTERNAL MEDICINE			English	Article							MANAGED CARE; MORTALITY; MEDICINE; SURGERY; VOLUME	The profession of medicine faces unprecedented pressures that jeopardize physicians' ability to care for patients. This is the perfect time for physicians to look back at the history of medicine; examine our own personal journeys; and reflect on our ideals, commitments, and accomplishments. To be effective leaders for medicine and health, physicians must work together. We must be vigilant about threats to high standards, research, education, and ethics and seize opportunities for improvement. We need to ensure that relationships with patients, students and housestaff, and other colleagues are marked by trust and healing. The days, years, and careers that we spend caring for others are most sustainable and satisfying if we also care for ourselves and our families, Many elements are required for physicians to maintain the lifegiving capabilities of our profession. Principles and thought combined with action have carried and buoyed medicine throughout time. This must not change.	Calif Pacific Med Ctr, San Francisco, CA 94120 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	California Pacific Medical Center; University of California System; University of California San Francisco	Clever, LH (corresponding author), Calif Pacific Med Ctr, S513F Box 7999, San Francisco, CA 94120 USA.							[Anonymous], 1983, LANCET, V1, P1273; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bloche MG, 1999, JAMA-J AM MED ASSOC, V281, P268, DOI 10.1001/jama.281.3.268; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; BRANDEIS LD, 1914, BUSINESS PROFESSION, P2; BRECHT B, 1961, GALILEO 7 PLAYS B BR, P399; Campbell EG, 1997, JAMA-J AM MED ASSOC, V278, P222, DOI 10.1001/jama.278.3.222; Cutter Irving Samuel, 1964, SHORT HIST MIDWIFERY; Feldman DS, 1998, ARCH INTERN MED, V158, P1626, DOI 10.1001/archinte.158.15.1626; Fitzgerald FT, 1999, ANN INTERN MED, V130, P70, DOI 10.7326/0003-4819-130-1-199901050-00015; FOA RP, 1986, PHAROS           SUM, P22; Grisso JA, 1998, ANN INTERN MED, V129, P916, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00025; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HIPPOCRATES, 1939, GENUINE WORK HIPPOCR, P29; Johnson T, 1998, NEW ENGL J MED, V339, P87, DOI 10.1056/NEJM199807093390206; Kassirer JP, 1998, NEW ENGL J MED, V339, P397, DOI 10.1056/NEJM199808063390608; KLAIDMAN S, 1998, STANFORD, V26, P72; Lee RV, 2000, ANN INTERN MED, V132, P71, DOI 10.7326/0003-4819-132-1-200001040-00012; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; Moy E, 1997, JAMA-J AM MED ASSOC, V278, P217, DOI 10.1001/jama.278.3.217; *NAT COUNT CTR, 1997, ANN REP C FOR EC COL, P2; *NAT CTR HIV STD T, 1999, WORLD TB DAY OPP REC, V1, P9; *NY CIT HLTH DEP, 1916, ANN REP DEP HLTH CIT, P25; Pare A, 1969, 10 BOOKS SURG MAGAZI; RAMAZZINI B, 1964, DIS WORKERS, P253; RAMAZZINI B, 1964, DIS WORKERS, P153; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Upshaw CB, 1999, ANN INTERN MED, V130, P58, DOI 10.7326/0003-4819-130-1-199901050-00011; WALPERT B, 1998, ACP ASIM OBSERVER, V18, P10; Zalewski D, 1997, LINGUA FRANCA, V7, P61	30	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					85	89		10.7326/0003-4819-132-1-200001040-00014	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627257				2022-12-28	WOS:000084518600013
J	Shay, JW; Wright, WE				Shay, JW; Wright, WE			Molecular biology - Mutant dyskerin ends relationship with telomerase	SCIENCE			English	Editorial Material							DYSKERATOSIS		Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shay, JW (corresponding author), Univ Texas, SW Med Ctr, Dallas, TX 75390 USA.		Shay, Jerry W/F-7878-2011					Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Dokal I, 1999, J PEDIAT HEMATOL ONC, V21, P344, DOI 10.1097/00043426-199909000-00002; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Luzzatto L, 1998, NAT GENET, V19, P6, DOI 10.1038/ng0598-6; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Price CM, 1999, CURR OPIN GENET DEV, V9, P218, DOI 10.1016/S0959-437X(99)80032-X	10	26	26	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	1999	286	5448					2284	2285		10.1126/science.286.5448.2284	http://dx.doi.org/10.1126/science.286.5448.2284			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266UK	10636790				2022-12-28	WOS:000084318500037
J	Ernst, E				Ernst, E			Second thoughts about safety of St John's wort	LANCET			English	Editorial Material									Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England	University of Exeter	Ernst, E (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England.							AJOHNE A, 1999, JAHR KLIN PHARM BERL; BON S, 1999, SCHWEITZER APOTHEKER, V16, P535; Brevoort P., 1998, HerbalGram, P33; ERESHEFSKY B, 1999, P 39 ANN M NEW CLIN; GEWERTZ N, P 39 ANN M NEW CLIN; Harrison P, 1998, CAN MED ASSOC J, V158, P637; Lantz MS, 1999, J GERIATR PSYCH NEUR, V12, P7, DOI 10.1177/089198879901200103; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; Martin TG, 1996, ANN EMERG MED, V28, P520, DOI 10.1016/S0196-0644(96)70116-6; MAURER A, 1999, EUR J CLIN PHARMACOL, V55, pA22; Muller WE, 1997, PHARMACOPSYCHIATRY, V30, P102, DOI 10.1055/s-2007-979528; Nebel A, 1999, ANN PHARMACOTHER, V33, P502, DOI 10.1345/aph.18252; Rey JM, 1998, MED J AUSTRALIA, V169, P583, DOI 10.5694/j.1326-5377.1998.tb123424.x; ROBY CA, 1999, P 39 ANN M NEW CLIN; Stevinson C, 1999, CNS DRUGS, V11, P125, DOI 10.2165/00023210-199911020-00004	15	221	229	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	1999	354	9195					2014	2016		10.1016/S0140-6736(99)00418-3	http://dx.doi.org/10.1016/S0140-6736(99)00418-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636361				2022-12-28	WOS:000084183300004
J	Manikoth, P; Subramanyan, R; Menon, S; Al Khusaiby, SM				Manikoth, P; Subramanyan, R; Menon, S; Al Khusaiby, SM			A child with cardiac arrhythmia and convulsions	LANCET			English	Article									Royal Hosp, Dept Paediat, Seeb 111, Oman	The Royal Hospital, Sultanate of Oman	Manikoth, P (corresponding author), Royal Hosp, Dept Paediat, POB 1331, Seeb 111, Oman.			Manikoth, Prakash/0000-0002-9406-5678				ANDERSON A, 1996, CRITICAL CARE INFANT, P605; ASHER R, 1951, LANCET, V260, P339; FROMMER DA, 1987, JAMA-J AM MED ASSOC, V257, P521, DOI 10.1001/jama.257.4.521; MEADOW R, 1977, LANCET, V2, P343; MEADOW R, 1993, ABC CHILD ABUSE, P43	5	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	1999	354	9195					2046	2046		10.1016/S0140-6736(99)09449-0	http://dx.doi.org/10.1016/S0140-6736(99)09449-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636371				2022-12-28	WOS:000084183300014
J	Rosing, J; Middeldorp, S; Curvers, J; Thomassen, MCLGD; Nicolaes, GAF; Meijers, JCM; Bouma, BN; Buller, HR; Prins, MH; Tans, G				Rosing, J; Middeldorp, S; Curvers, J; Thomassen, MCLGD; Nicolaes, GAF; Meijers, JCM; Bouma, BN; Buller, HR; Prins, MH; Tans, G			Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study	LANCET			English	Article							POOR ANTICOAGULANT RESPONSE; VENOUS THROMBOEMBOLISM; BLOOD-COAGULATION; RISK; THROMBOSIS; THROMBOPHILIA; PROGESTAGEN; CONTROVERSY; GENERATION; VARIABLES	Background We have reported previously that, compared with use of second-generation oral contraceptives, the use of third-generation oral contraceptives is associated with increased resistance to the anticoagulant action of activated protein C (APC). Owing to the cross-sectional design of that study, these observations may have been subject to unknown bias or uncontrolled effects of the menstrual cycle. We aimed to overcome these sources of bias by doing a cycle-controlled randomised cross-over trial. Methods The response to APC in plasma was assessed in 33 women who received two consecutive cycles of a second-generation oral contraceptive (150 mu g levonorgestrel and 30 mu g ethinyloestradiol) or a third-generation oral contraceptive (150 mu g desogestrel and 30 mu g ethinyloestradiol), and who switched preparations after two pill-free cycles. Normalised APC sensitivity ratios were calculated by measurement of the effect of APC on thrombin generation in the plasma of these women and in pooled plasma from 90 controls. Findings Of the 33 women,five were excluded because not all required plasma samples were available. in the remaining 28 women, the normalised APC sensitivity ratio increased during treatment with both preparations. Compared with levonorgestrel, desogestrel-containing oral-contraceptive treatment caused a highly significant (p<0.0001) additional increase in normalised APC sensitivity ratio (0.51 [95% CI 0.37-0.66]). Normalised APC sensitivity ratios during oral-contraceptive treatment correlated with the values before oral-contraceptive use. Interpretation Oral-contraceptive treatment diminishes the efficacy with which APC down-regulates in-vitro thrombin formation. This phenomenon, designated as acquired APC resistance, is more pronounced in women using desogestrel-containing oral contraceptives than in women using levonorgestrel-containing preparations. Whether acquired APC resistance induced by oral contraceptives explains the increased risk of venous thromboembolism in oral-contraceptive users remains to be established.	Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Utrecht Hosp, Dept Haematol, Thrombosis & Haemostasis Lab, NL-3508 GA Utrecht, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Rosing, J (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, POB 616, NL-6200 MD Maastricht, Netherlands.	j.rosing@bioch.unimaas.nl	Middeldorp, Saskia/ABI-8197-2020; Nicolaes, Gerry A.F./A-8421-2016; Meijers, J.C.M./S-5981-2019	Middeldorp, Saskia/0000-0002-1006-6420; Nicolaes, Gerry A.F./0000-0002-2482-0412; Meijers, J.C.M./0000-0002-4198-6780; Thomassen, Stella/0000-0002-9686-6364				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Clark P, 1999, LANCET, V353, P292, DOI 10.1016/S0140-6736(05)74935-7; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; de Visser MCH, 1999, BLOOD, V93, P1271, DOI 10.1182/blood.V93.4.1271.404k22_1271_1276; FARLEY TMM, 1995, LANCET, V346, P1582; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Heinemann LAJ, 1998, CONTRACEPTION, V58, P321, DOI 10.1016/S0010-7824(98)00111-5; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kluft C, 1997, THROMB HAEMOSTASIS, V78, P315; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; Lowe GDO, 1997, LANCET, V349, P1623, DOI 10.1016/S0140-6736(05)61660-1; MEIJERS JCM, 1999, THROMB HAEMOSTASIS, V82, P436; Middeldorp S, 1999, THROMB HAEMOSTASIS, P551; Mishell DR, 1998, AM J OBSTET GYNECOL, V179, pS37, DOI 10.1053/ob.1998.v179.a91999; Nicolaes GAF, 1997, BLOOD COAGUL FIBRIN, V8, P28, DOI 10.1097/00001721-199701000-00006; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Rosing J, 1997, BRIT J HAEMATOL, V97, P233, DOI 10.1046/j.1365-2141.1997.192707.x; Rosing J, 1998, SEMIN THROMB HEMOST, V24, P329, DOI 10.1055/s-2007-996021; Schramm W, 1997, BRIT J HAEMATOL, V98, P491; Spitzer WO, 1998, AM J OBSTET GYNECOL, V179, pS43, DOI 10.1053/ob.1998.v179.a93059; Spitzer WO, 1997, HUM REPROD, V12, P2347, DOI 10.1093/humrep/12.11.2347; Spitzer WO, 1996, BRIT MED J, V312, P83; STADEL BV, 1981, NEW ENGL J MED, V305, P612, DOI 10.1056/NEJM198109103051104; Tans G, 1999, THROMB HAEMOSTASIS, P202; Vandenbroucke JP, 1997, AM J OBSTET GYNECOL, V177, P887, DOI 10.1016/S0002-9378(97)70289-8; Vandenbroucke JP, 1997, LANCET, V349, P1113, DOI 10.1016/S0140-6736(05)63015-2; Walker AM, 1998, CONTRACEPTION, V57, P169, DOI 10.1016/S0010-7824(98)00014-6; Winkler UH, 1998, AM J OBSTET GYNECOL, V179, pS51, DOI 10.1053/ob.1998.v179.a92633; Winkler UH, 1998, CONTRACEPTION, V57, P203, DOI 10.1016/S0010-7824(98)00020-1	32	212	216	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	1999	354	9195					2036	2040		10.1016/S0140-6736(99)06092-4	http://dx.doi.org/10.1016/S0140-6736(99)06092-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636369				2022-12-28	WOS:000084183300012
J	Wolfe, J; Grier, HE; Klar, N; Levin, SB; Ellenbogen, JM; Salem-Schatz, S; Emanuel, EJ; Weeks, JC				Wolfe, J; Grier, HE; Klar, N; Levin, SB; Ellenbogen, JM; Salem-Schatz, S; Emanuel, EJ; Weeks, JC			Symptoms and suffering at the end of life in children with cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PALLIATIVE CARE; FAMILY MEMBERS; PAIN	Background: Cancer is the second leading cause of death in children, after accidents. Little is known, however, about the symptoms and suffering at the end of life in children with cancer. Methods: In 1997 and 1998, we interviewed the parents of children who had died of cancer between 1990 and 1997 and who were cared for at Children's Hospital in Boston, the Dana-Farber Cancer Institute, or both. Additional data were obtained by reviewing medical records. Results: Of 165 eligible parents, we interviewed 103 (62 percent), 98 by telephone and 5 in person. The interviews were conducted a mean (+/-SD) of 3.1+/-1.6 years after the death of the child. Almost 80 percent died of progressive disease, and the rest died of treatment-related complications. Forty-nine percent of the children died in the hospital; nearly half of these deaths occurred in the intensive care unit. According to the parents, 89 percent of the children suffered "a lot'' or "a great deal'' from at least one symptom in their last month of life, most commonly pain, fatigue, or dyspnea. Of the children who were treated for specific symptoms, treatment was successful in 27 percent of those with pain and 16 percent of those with dyspnea. On the basis of a review of the medical records, parents were significantly more likely than physicians to report that their child had fatigue, poor appetite, constipation, and diarrhea. Suffering from pain was more likely in children whose parents reported that the physician was not actively involved in providing end-of-life care (odds ratio, 2.6; 95 percent confidence interval, 1.0 to 6.7). Conclusions: Children who die of cancer receive aggressive treatment at the end of life. Many have substantial suffering in the last month of life, and attempts to control their symptoms are often unsuccessful. Greater attention must be paid to palliative care for children who are dying of cancer. (N Engl J Med 2000;342:326-33.) (C) 2000, Massachusetts Medical Society.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA	Weeks, JC (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.	joanne_wolfe@dfci.harvard.edu	Harding, Richard/G-9729-2012		AHRQ HHS [5 T32 HS00063] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000063] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; ARMITAGE JO, 1994, NEW ENGL J MED, V330, P827, DOI 10.1056/NEJM199403243301206; BORTIN MM, 1993, BONE MARROW TRANSPL, V12, P97; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COLLINS JJ, 1995, J PEDIATR-US, V126, P653, DOI 10.1016/S0022-3476(95)70370-5; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Fainsinger R, 1991, J Palliat Care, V7, P5; FIELD MJ, 1997, APPROACHING DEATH IM, V17, P437; Frager G, 1996, J PALLIATIVE CARE, V12, P9; Goldman A, 1998, BRIT MED J, V316, P49, DOI 10.1136/bmj.316.7124.49; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; KANE RL, 1984, LANCET, V1, P890; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; MAUER AM, 1987, AM J PEDIAT HEMATOL, V9, P58; Monti M, 1996, J PAIN SYMPTOM MANAG, V12, P18, DOI 10.1016/0885-3924(96)00044-9; Power David, 1993, Palliative Medicine, V7, P213, DOI 10.1177/026921639300700308; Robinson WM, 1997, PEDIATRICS, V100, P205, DOI 10.1542/peds.100.2.205; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th; Sanders J, 1997, PEDIATRICS, V99, P139; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Sirkia K, 1998, J PAIN SYMPTOM MANAG, V15, P220, DOI 10.1016/S0885-3924(98)00366-2; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; 1991, JAMA, V275, P1232	28	758	770	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					326	333		10.1056/NEJM200002033420506	http://dx.doi.org/10.1056/NEJM200002033420506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655532				2022-12-28	WOS:000085070300006
J	[Anonymous]				[Anonymous]			GPs given advice on primary care trusts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2000	320	7229					255	255						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642251				2022-12-28	WOS:000085029600067
J	Strewler, GJ				Strewler, GJ			Mechanisms of disease - The physiology of parathyroid hormone-related protein	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SMOOTH-MUSCLE CELLS; PLACENTAL CALCIUM-TRANSPORT; ENDOCHONDRAL BONE-FORMATION; MAMMARY-GLAND DEVELOPMENT; PTH-RELATED PROTEIN; PEPTIDE GENE; BLOMSTRAND-CHONDRODYSPLASIA; PTH/PTHRP RECEPTOR; INACTIVATING MUTATION; INDIAN HEDGEHOG		Vet Affairs Boston Hlth Care Syst, Dept Med, W Roxbury, MA USA; Harvard Med Sch, Boston, MA USA	Harvard University; Harvard Medical School	Strewler, GJ (corresponding author), Vet Affairs Boston Hlth Care Syst, Dept Med, W Roxbury, MA USA.							ABBAS SK, 1989, Q J EXP PHYSIOL CMS, V74, P549, DOI 10.1113/expphysiol.1989.sp003303; Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; BRAUDE S, 1991, LANCET, V337, P140, DOI 10.1016/0140-6736(91)90802-V; Brines ML, 1999, NEUROSCI LETT, V274, P13, DOI 10.1016/S0304-3940(99)00664-3; Broadus Arthur E., 1994, P259; BUDAYR AA, 1989, P NATL ACAD SCI USA, V86, P7183, DOI 10.1073/pnas.86.18.7183; CARE AD, 1986, PLACENTA, V7, P417, DOI 10.1016/S0143-4004(86)80029-7; CARE AD, 1990, EXP PHYSIOL, V75, P605, DOI 10.1113/expphysiol.1990.sp003437; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Cornish J, 1997, ENDOCRINOLOGY, V138, P1299, DOI 10.1210/en.138.3.1299; DEFTOS LJ, 1993, J CLIN INVEST, V92, P727, DOI 10.1172/JCI116643; FENTON AJ, 1991, ENDOCRINOLOGY, V129, P1762, DOI 10.1210/endo-129-4-1762; FERGUSON JE, 1992, P NATL ACAD SCI USA, V89, P8384, DOI 10.1073/pnas.89.17.8384; Foley J, 1998, J INVEST DERMATOL, V111, P1122, DOI 10.1046/j.1523-1747.1998.00428.x; FUKAYAMA S, 1995, P NATL ACAD SCI USA, V92, P10182, DOI 10.1073/pnas.92.22.10182; GAICH G, 1993, ENDOCRINOLOGY, V132, P1402, DOI 10.1210/en.132.3.1402; GRILL V, 1992, CLIN ENDOCRINOL, V37, P405, DOI 10.1111/j.1365-2265.1992.tb02350.x; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hara M, 1997, CIRCULATION, V96, P3704; HENDERSON J, 1990, ENDOCRINOLOGY, V127, P1310, DOI 10.1210/endo-127-3-1310; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; HOLICK MF, 1994, P NATL ACAD SCI USA, V91, P8014, DOI 10.1073/pnas.91.17.8014; Holt EH, 1996, J BIOL CHEM, V271, P28105, DOI 10.1074/jbc.271.45.28105; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Kovacs CS, 1996, P NATL ACAD SCI USA, V93, P15233, DOI 10.1073/pnas.93.26.15233; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; KUKREJA SC, 1988, J CLIN INVEST, V82, P1798, DOI 10.1172/JCI113794; Lam MHC, 1999, J BIOL CHEM, V274, P18559, DOI 10.1074/jbc.274.26.18559; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEPRE F, 1993, NEW ENGL J MED, V328, P666, DOI 10.1056/NEJM199303043280917; Li HS, 1995, LAB INVEST, V73, P864; Maeda S, 1999, ENDOCRINOLOGY, V140, P1815, DOI 10.1210/en.140.4.1815; Massfelder T, 1996, ENDOCRINOLOGY, V137, P3151, DOI 10.1210/en.137.8.3151; Massfelder T, 1997, P NATL ACAD SCI USA, V94, P13630, DOI 10.1073/pnas.94.25.13630; Mather KJ, 1999, J CLIN ENDOCR METAB, V84, P424, DOI 10.1210/jc.84.2.424; NAKAYAMA T, 1994, BIOCHEM BIOPH RES CO, V200, P1028, DOI 10.1006/bbrc.1994.1553; NICKOLS GA, 1989, ENDOCRINOLOGY, V125, P834, DOI 10.1210/endo-125-2-834; OGINO K, 1995, ENDOCRINOLOGY, V136, P3024, DOI 10.1210/en.136.7.3024; ORLOFF JJ, 1992, AM J PHYSIOL, V262, pE599, DOI 10.1152/ajpendo.1992.262.5.E599; ORLOFF JJ, 1994, ENDOCR REV, V15, P40, DOI 10.1210/er.15.1.40; Ozeki S, 1996, ARTERIOSCL THROM VAS, V16, P565, DOI 10.1161/01.ATV.16.4.565; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; PIROLA CJ, 1993, J BIOL CHEM, V268, P1987; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Sowers MF, 1996, JAMA-J AM MED ASSOC, V276, P549, DOI 10.1001/jama.276.7.549; STREWLER GJ, 1990, WESTERN J MED, V153, P635; Strewler Gordon J., 1994, P311; TAKAHASHI K, 1995, BIOCHEM BIOPH RES CO, V208, P447, DOI 10.1006/bbrc.1995.1358; THIEDE MA, 1990, P NATL ACAD SCI USA, V87, P6969, DOI 10.1073/pnas.87.18.6969; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WEIR EC, 1990, P NATL ACAD SCI USA, V87, P108, DOI 10.1073/pnas.87.1.108; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; WYSOLMERSKI JJ, 1995, DEVELOPMENT, V121, P3539; WYSOLMERSKI JJ, 1994, ANNU REV MED, V45, P189, DOI 10.1146/annurev.med.45.1.189; WYSOLMERSKI JJ, 1994, P NATL ACAD SCI USA, V91, P1133, DOI 10.1073/pnas.91.3.1133; YAMAMOTO M, 1992, P NATL ACAD SCI USA, V89, P5326, DOI 10.1073/pnas.89.12.5326; Yamamoto S, 1997, ENDOCRINOLOGY, V138, P2066, DOI 10.1210/en.138.5.2066; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zhang P, 1998, J CLIN ENDOCR METAB, V83, P3365, DOI 10.1210/jc.83.9.3373	66	283	300	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					177	185		10.1056/NEJM200001203420306	http://dx.doi.org/10.1056/NEJM200001203420306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639544				2022-12-28	WOS:000084851700006
J	Yusuf, S; Sleight, P; Pogue, J; Bosch, J; Davies, R; Dagenais, G				Yusuf, S; Sleight, P; Pogue, J; Bosch, J; Davies, R; Dagenais, G		Heart Outcomes Prevent Evaluat Study	Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; RANDOMIZED TRIALS; BLOOD-PRESSURE; MORTALITY; MORBIDITY	Background Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dysfunction, whether or not they have heart failure. We assessed the role of an angiotensin-converting-enzyme inhibitor, ramipril, in patients who were at high risk for cardiovascular events but who did not have left ventricular dysfunction or heart failure. Methods A total of 9297 high-risk patients (55 years of age or older) who had evidence of vascular disease or diabetes plus one other cardiovascular risk factor and who were not known to have a low ejection fraction or heart failure were randomly assigned to receive ramipril (10 mg once per day orally) or matching placebo for a mean of five years. The primary outcome was a composite of myocardial infarction, stroke, or death from cardiovascular causes. The trial was a two-by-two factorial study evaluating both ramipril and vitamin E. The effects of vitamin E are reported in a companion paper. Results A total of 651 patients who were assigned to receive ramipril (14.0 percent) reached the primary end point, as compared with 826 patients who were assigned to receive placebo (17.8 percent) (relative risk, 0.78; 95 percent confidence interval, 0.70 to 0.86; P<0.001). Treatment with ramipril reduced the rates of death from cardiovascular causes (6.1 percent, as compared with 8.1 percent in the placebo group; relative risk, 0.74; P<0.001), myocardial infarction (9.9 percent vs. 12.3 percent; relative risk, 0.80; P<0.001), stroke (3.4 percent vs. 4.9 percent; relative risk, 0.68; P<0.001), death from any cause (10.4 percent vs. 12.2 percent; relative risk, 0.84; P=0.005), revascularization procedures (16.0 percent vs. 18.3 percent; relative risk, 0.85; P=0.002), cardiac arrest (0.8 percent vs. 1.3 percent; relative risk, 0.63; P=0.03), heart failure (9.0 percent vs. 11.5 percent; relative risk, 0.77; P<0.001), and complications related to diabetes (6.4 percent vs. 7.6 percent; relative risk, 0.84; P=0.03). Conclusions Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure. (N Engl J Med 2000;342:145-53.) (C) 2000, Massachusetts Medical Society.	Hamilton Gen Hosp, Canadian Cardiovasc Collaborat Project Off, Hamilton, ON L8L 2X2, Canada	McMaster University	Yusuf, S (corresponding author), Hamilton Gen Hosp, Canadian Cardiovasc Collaborat Project Off, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	hope@ccc.mcmaster.ca	Lehmann, Roger/B-9120-2015; Hramiak, Irene/G-3305-2011; Zinman, Bernard/E-7266-2013; Arnold, Malcolm/G-2869-2011; Bosch, Jacqueline/AAP-6910-2021; McManus, Ruth/G-3938-2011	Lehmann, Roger/0000-0002-3681-4431; Bosch, Jacqueline/0000-0001-6292-4207; Yusuf, Salim/0000-0003-4776-5601; MOLINARI, GIUSEPPE/0000-0002-8603-8098				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; BALL SG, 1993, LANCET, V342, P821; Carlsson PO, 1998, DIABETOLOGIA, V41, P127, DOI 10.1007/s001250050880; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GARG R, 1995, JAMA-J AM MED ASSOC, V274, P462; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Law M., 1998, EVIDENCE BASED CARDI, P191; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; Mindlen F, 1996, CAN J CARDIOL, V12, P127; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; SCHIEFFER B, IN PRESS CIRCULATION; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; YUSUF S, 1992, LANCET, V340, P1173, DOI 10.1016/0140-6736(92)92889-N; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]	25	6499	6775	5	476	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					145	153						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639539				2022-12-28	WOS:000084851700001
J	Lee, BG; Griscom, SB; Lee, JS; Choi, HJ; Koh, CH; Luoma, SN; Fisher, NS				Lee, BG; Griscom, SB; Lee, JS; Choi, HJ; Koh, CH; Luoma, SN; Fisher, NS			Influences of dietary uptake and reactive sulfides on metal bioavailability from aquatic sediments	SCIENCE			English	Article							ACID-VOLATILE SULFIDE; POTAMOCORBULA-AMURENSIS; MARINE BIVALVES; ASSIMILATION; TOXICITY; ENVIRONMENTS; CADMIUM; MODEL	Understanding how animals are exposed to the Large repository of metal pollutants in aquatic sediments is complicated and is important in regulatory decisions. Experiments with four types of invertebrates showed that feeding behavior and dietary uptake control bioaccumulation of cadmium, silver, nickel, and zinc. Metal concentrations in animal tissue correlated with metal concentrations extracted from sediments, but not with metal in porewater, across a range of reactive sulfide concentrations, from 0.5 to 30 micromoles per gram. These results contradict the notion that metal bioavailability in sediments is controlled by geochemical equilibration of metals between porewater and reactive sulfides, a proposed basis for regulatory criteria for metals.	US Geol Survey, Div Water Resources, Menlo Pk, CA 94025 USA; SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Seoul Natl Univ, Dept Oceanog, Seoul 151742, South Korea	United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Seoul National University (SNU)	Lee, BG (corresponding author), US Geol Survey, Div Water Resources, Mail Stop 465,345 Middlefield Rd, Menlo Pk, CA 94025 USA.	bglee@usgs.gov						Ankley GT, 1996, ENVIRON TOXICOL CHEM, V15, P2056, DOI 10.1002/etc.5620151202; Berry WJ, 1999, ENVIRON TOXICOL CHEM, V18, P40, DOI 10.1897/1551-5028(1999)018<0040:PTOSSW>2.3.CO;2; Berry WJ, 1996, ENVIRON TOXICOL CHEM, V15, P2067, DOI 10.1002/etc.5620151203; BROWN CL, 1995, MAR ECOL PROG SER, V124, P129, DOI 10.3354/meps124129; DECHO AW, 1994, MAR ECOL PROG SER, V108, P133, DOI 10.3354/meps108133; Decho AW, 1996, LIMNOL OCEANOGR, V41, P568, DOI 10.4319/lo.1996.41.3.0568; DiToro DM, 1996, ENVIRON TOXICOL CHEM, V15, P2168, DOI 10.1002/etc.5620151212; DITORO DM, 1990, ENVIRON TOXICOL CHEM, V9, P1487; FISHER NS, 1991, MAR ECOL PROG SER, V70, P157, DOI 10.3354/meps070157; Griscom SB, 2000, ENVIRON SCI TECHNOL, V34, P91, DOI 10.1021/es981309+; HORNBERGER MI, 1999, 9955 US GEOL SURV; Luoma SN, 1997, SETAC SP P, P211; LUOMA SN, 1995, MAR POLLUT BULL, V31, P44, DOI 10.1016/0025-326X(95)00081-W; MARSH HW, 1987, J EDUC MEAS, V24, P1; MAYER LM, 1995, LIMNOL OCEANOGR, V40, P511, DOI 10.4319/lo.1995.40.3.0511; Mayer LM, 1997, J MAR RES, V55, P785, DOI 10.1357/0022240973224247; MEYER JS, 1994, BIOAVAILABILITY PHYS, P155; MORSE JW, 1994, MAR CHEM, V46, P1, DOI 10.1016/0304-4203(94)90040-X; MYER JS, 1994, BIOAVAILABILITY PHYS, P155; Reinfelder JR, 1998, SCI TOTAL ENVIRON, V219, P117, DOI 10.1016/S0048-9697(98)00225-3; SCHOONEN MAA, 1991, GEOCHIM COSMOCHIM AC, V55, P1505, DOI 10.1016/0016-7037(91)90123-M; Wang WX, 1996, LIMNOL OCEANOGR, V41, P197, DOI 10.4319/lo.1996.41.2.0197; Wang WX, 1999, MAR ECOL PROG SER, V178, P281, DOI 10.3354/meps178281	23	201	216	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					282	284		10.1126/science.287.5451.282	http://dx.doi.org/10.1126/science.287.5451.282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634777				2022-12-28	WOS:000084769600032
J	McGaugh, JL				McGaugh, JL			Neuroscience - Memory - a century of consolidation	SCIENCE			English	Review							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; GYRUS IN-VIVO; BASOLATERAL AMYGDALA; RETROGRADE-AMNESIA; NOREPINEPHRINE RELEASE; INHIBITORY AVOIDANCE; ANTEROGRADE AMNESIA; PROTEIN-SYNTHESIS; EMOTIONAL EVENTS	The memory consolidation hypothesis proposed 100 years ago by Muller and Pilzecker continues to guide memory research. The hypothesis that new memories consolidate slowly over time has stimulated studies revealing the hormonal and neural influences regulating memory consolidation, as well as molecular and cellular mechanisms. This review examines the progress made over the century in understanding the time-dependent processes that create our lasting memories.	Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	McGaugh, JL (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA.	jlmcgaug@uci.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH012526, R56MH012526, R01MH012526] Funding Source: NIH RePORTER; NIMH NIH HHS [MH12526] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; AGRANOFF BERNARD W., 1966, BRAIN RES, V1, P303, DOI 10.1016/0006-8993(66)90095-3; ALLOWAY TM, 1967, SCIENCE, V158, P1066, DOI 10.1126/science.158.3804.1066; Barros DM, 1999, NEUROBIOL LEARN MEM, V71, P94, DOI 10.1006/nlme.1998.3830; BERMUDEZRATTONI F, 1991, P NATL ACAD SCI USA, V88, P5379, DOI 10.1073/pnas.88.12.5379; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bjordahl TS, 1998, BEHAV NEUROSCI, V112, P467, DOI 10.1037/0735-7044.112.3.467; Burnham WH, 1903, AM J PSYCHOL, V14, P382; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; CHO YH, 1993, J NEUROSCI, V13, P1759; Christianson S. A., 1992, HDB EMOTION MEMORY C; COLLEY PA, 1990, J NEUROSCI, V10, P3353; DEKLOET ER, 1988, NEUROENDOCRINOLOGY, V47, P109, DOI 10.1159/000124900; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; Escobar ML, 1998, BRAIN RES, V779, P314, DOI 10.1016/S0006-8993(97)01175-X; Ferry B, 1999, NEUROBIOL LEARN MEM, V72, P8, DOI 10.1006/nlme.1998.3904; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Galvan V. V., 1998, Society for Neuroscience Abstracts, V24, P1422; Galvez R, 1996, NEUROBIOL LEARN MEM, V66, P253, DOI 10.1006/nlme.1996.0067; GERARD RW, 1949, AM J PSYCHIAT, V106, P161, DOI 10.1176/ajp.106.3.161; GLICKMAN SE, 1961, PSYCHOL BULL, V58, P218, DOI 10.1037/h0044212; GOLD PE, 1975, BEHAV BIOL, V13, P145, DOI 10.1016/S0091-6773(75)91784-8; Gold PE, 1975, SHORT TERM MEMORY, P355; GOLD PE, 1988, CELLULAR MECHANISMS, P329; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hatfield T, 1999, NEUROBIOL LEARN MEM, V71, P232, DOI 10.1006/nlme.1998.3875; Hatfield T, 1999, BRAIN RES, V835, P340, DOI 10.1016/S0006-8993(99)01566-8; Hebb Donald O., 1949, ORG BEHAV; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; HUANG YY, 1992, NEUROSCIENCE, V49, P819, DOI 10.1016/0306-4522(92)90359-A; IKEGAYA Y, 1995, BRAIN RES, V671, P351, DOI 10.1016/0006-8993(94)01403-5; Ikegaya Y, 1997, NEUROREPORT, V8, P3143, DOI 10.1097/00001756-199709290-00027; IKEGAYA Y, 1995, NEUROSCI RES, V22, P203, DOI 10.1016/0168-0102(95)00894-7; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; JERUSALINSKY D, 1994, BEHAV NEURAL BIOL, V61, P107, DOI 10.1016/S0163-1047(05)80063-9; Jones MW, 1999, J NEUROSCI, V19, part. no.; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lechner HA, 1999, LEARN MEMORY, V6, P77; LIANG KC, 1986, BRAIN RES, V368, P125, DOI 10.1016/0006-8993(86)91049-8; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDougall W., 1901, MIND, V10, P388; McGaugh J. L., 1989, PSYCHOENDOCRINOLOGY, P305; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MCGAUGH JL, 1989, BRAIN RES BULL, V23, P339, DOI 10.1016/0361-9230(89)90220-7; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; MCGAUGH JL, 1973, ANNU REV PHARMACOL, V13, P229, DOI 10.1146/annurev.pa.13.040173.001305; MCGAUGH JL, 1968, RECENT ADV LEARNING, P13; MCGAUGH JL, 1972, MEMORY CONSOLIDATION; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Milner B., 1966, AMNESIA, P109; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; MULLER U, 1996, NEURON, V16, P1249; Murphy KJ, 1998, NEUROBIOL LEARN MEM, V70, P73, DOI 10.1006/nlme.1998.3839; NIELSON KA, 1994, BEHAV NEURAL BIOL, V62, P190, DOI 10.1016/S0163-1047(05)80017-2; PACKARD MG, 1995, NEUROBEHAVIORAL PLASTICITY, P149; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; PACKARD MG, 1989, J NEUROSCI, V9, P1465; PACKARD MG, 1991, BEHAV NEUROSCI, V105, P295, DOI 10.1037/0735-7044.105.2.295; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; POLSTER MR, 1991, J COGNITIVE NEUROSCI, V3, P95, DOI 10.1162/jocn.1991.3.2.95; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; REIDEL G, 1999, NAT NEUROSCI, V3, P898; Ribot T. A., 1882, DIS MEMORY; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 1999, P NATL ACAD SCI USA, V96, P11642, DOI 10.1073/pnas.96.20.11642; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Roozendaal B, 1996, INT CONGR SER, V1108, P39; Roullet P, 1997, NEUROREPORT, V8, P1907, DOI 10.1097/00001756-199705260-00023; ROUTTENBERG A, IN PRESS 4 DECADES M; SANDI C, 1994, BRAIN RES, V647, P106, DOI 10.1016/0006-8993(94)91404-4; Schafe GE, 1999, LEARN MEMORY, V6, P97; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; SOETENS E, 1995, PSYCHOPHARMACOLOGY, V119, P155, DOI 10.1007/BF02246156; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR., 1999, MEMORY MIND MOL; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Tully T, 1997, P NATL ACAD SCI USA, V94, P4239, DOI 10.1073/pnas.94.9.4239; TYLER TJ, 1986, BEHAV NEUROSCI, V100, P147; van Stegeren AH, 1998, PSYCHOPHARMACOLOGY, V138, P305, DOI 10.1007/s002130050675; Weinberger NM, 1998, TRENDS COGN SCI, V2, P271, DOI 10.1016/S1364-6613(98)01200-5; Weinberger Norman M., 1995, P1071; Weingartner H., 1984, MEMORY CONSOLIDATION; Williams CL, 1998, BEHAV NEUROSCI, V112, P1414, DOI 10.1037/0735-7044.112.6.1414; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	101	2893	2978	17	532	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					248	251		10.1126/science.287.5451.248	http://dx.doi.org/10.1126/science.287.5451.248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	274ML	10634773				2022-12-28	WOS:000084769600027
J	Bear, G				Bear, G			Deep ice and DNA languages	NATURE			English	Article																			0	0	0	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					141	141		10.1038/35003068	http://dx.doi.org/10.1038/35003068			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646579	Bronze			2022-12-28	WOS:000084835300027
J	Bryant, P; Nunes, T; Snaith, R				Bryant, P; Nunes, T; Snaith, R			Orthography - Children learn an untaught rule of spelling	NATURE			English	Article									Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ London, Inst Educ, Dept Child Dev & Learning, London WC1H OAL, England; Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England	University of Oxford; University of London; University of Surrey	Bryant, P (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	peter.bryant@psy.ox.ac.uk						CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Nunes T, 1997, DEV PSYCHOL, V33, P637, DOI 10.1037/0012-1649.33.4.637; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; TAFT M, 1991, READING MENT LEXICON; [No title captured]	6	17	17	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					157	158		10.1038/35003114	http://dx.doi.org/10.1038/35003114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275TB	10646591				2022-12-28	WOS:000084835300042
J	Luck, A; Pearson, S; Maddern, G; Hewett, P				Luck, A; Pearson, S; Maddern, G; Hewett, P			Effects of video information on precolonoscopy anxiety and knowledge: a randomised trial	LANCET			English	Article							INFORMED CONSENT; PREOPERATIVE ANXIETY; DAYCASE ANESTHESIA; STRESS; CATHETERIZATION	Background The provision of information before medical or surgical procedures should improve knowledge and allay anxiety about the pending procedure. This trial aimed to assess the value of an information video in this process, Methods Patients scheduled to undergo colonoscopy were approached about 1 week before the procedure. All patients; were given an information leaflet about colonoscopy, and: completed a Spielberger state anxiety inventory (STAI) questionnaire to assess baseline anxiety. The patients were then randomly assigned to watch or not watch the information video. Immediately before colonoscopy, all patients completed a second anxiety questionnaire and a knowledge questionnaire. Findings 198 patients were screened. 31 declined to participate and 17 were unable to complete the forms. Of the remaining 150 patients, 72 were assigned the video, and 78 no video, The groups were similar with regard to age, sex, educational attainment, and initial anxiety score. Female patients had higher baseline anxiety than male patients (mean STAI 46.3 [95% CI 44.9-47.7] vs 36.9 [35.5-38.3]; difference 9.4 [7.8-12.2], p=0.0008). Patients who had not had a previous colonoscopy had higher baseline anxiety scores than those who had prior experience of the procedure (46.9 [45.4-48.5] vs 36.3 [34.7-37.9]; difference 10.6 [7.5-13.8], p=0.0008). Patients who watched the video were significantly less anxious before colonoscopy than those who did not. The former also scored more highly in the knowledge questionnaire than the latter with regard to the purpose of the procedure, procedural details, and potential complications of colonoscopy. Interpretation An information video increases knowledge and decreases anxiety in patients preparing for colonoscopy.	Queen Elizabeth Hosp, Div Surg, Woodville S, SA, Australia		Luck, A (corresponding author), Concord Hosp, Colorectal Surg Unit, Ward 130, Concord, NSW 2139, Australia.		Hewett, PJ/AAT-9350-2020	Pearson, Sue/0000-0001-6592-6494; Maddern, Guy/0000-0003-2064-181X; Hewett, Peter/0000-0002-8135-1317				*AUSTR GASTR I, 1997, PAT ED VID SER COL; Black I, 1997, MAYO CLIN P, V52, P106; CASSILETH BR, 1980, NEW ENGL J MED, V302, P896, DOI 10.1056/NEJM198004173021605; Cohen D, 1983, J Biocommun, V10, P19; ELSASS P, 1987, ACTA ANAESTH SCAND, V31, P579, DOI 10.1111/j.1399-6576.1987.tb02624.x; FELL D, 1985, BRIT J ANAESTH, V57, P770, DOI 10.1093/bja/57.8.770; Fisher I, 1981, AM J HUM GENET, V33, P987; GOLDMANN L, 1988, ANAESTHESIA, V43, P466, DOI 10.1111/j.1365-2044.1988.tb06633.x; HERRMANN KS, 1989, EUR HEART J, V10, P753, DOI 10.1093/oxfordjournals.eurheartj.a059560; Johnston Marie, 1993, Annals of Behavioral Medicine, V15, P245; KERRIGAN DD, 1993, BRIT MED J, V306, P298, DOI 10.1136/bmj.306.6873.298; KULIK JA, 1987, HEALTH PSYCHOL, V6, P525, DOI 10.1037/0278-6133.6.6.525; MACKENZIE JW, 1989, ANAESTHESIA, V44, P437, DOI 10.1111/j.1365-2044.1989.tb11349.x; MALE CG, 1981, BRIT J ANAESTH, V53, P663; Marteau TM, 1996, BRIT J HEALTH PSYCH, V1, P181, DOI 10.1111/j.2044-8287.1996.tb00501.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MILLER SM, 1983, J PERS SOC PSYCHOL, V45, P223, DOI 10.1037/0022-3514.45.1.223; OLVER IN, 1995, MED J AUSTRALIA, V162, P82, DOI 10.5694/j.1326-5377.1995.tb138439.x; SORG BA, 1992, J RES PERS, V26, P235, DOI 10.1016/0092-6566(92)90041-2; SPIELBERGER CD, 1970, MANUAL STATE TRAIT A; Stanley BM, 1998, AUST NZ J SURG, V68, P788, DOI 10.1111/j.1445-2197.1998.tb04678.x; UZARK K, 1982, PEDIATR CARDIOL, V3, P287, DOI 10.1007/BF02427029; WALLACE LM, 1986, BRIT J CLIN PSYCHOL, V25, P111, DOI 10.1111/j.2044-8260.1986.tb00679.x; WILLIAMS OA, 1993, J ROY SOC MED, V86, P328	24	192	193	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2032	2035		10.1016/S0140-6736(98)10495-6	http://dx.doi.org/10.1016/S0140-6736(98)10495-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	264LG	10636368				2022-12-28	WOS:000084183300011
J	King, GL; Suzuma, K				King, GL; Suzuma, K			Pigment-epithelium-derived factor - A key coordinator of retinal neuronal and vascular functions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR		Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.	King, GL (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.							AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Casey R, 1997, AM J OPHTHALMOL, V124, P521, DOI 10.1016/S0002-9394(14)70868-2; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526	5	59	68	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2000	342	5					349	351		10.1056/NEJM200002033420511	http://dx.doi.org/10.1056/NEJM200002033420511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279XL	10655537				2022-12-28	WOS:000085070300011
J	Berger, A				Berger, A			Scientists discover how helicobacter survives gastric acid	BRITISH MEDICAL JOURNAL			English	News Item																		MELCHERS K, 2000, SCIENCE, V287, P482	1	4	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					268	268		10.1136/bmj.320.7230.268	http://dx.doi.org/10.1136/bmj.320.7230.268			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650011	Green Published			2022-12-28	WOS:000085132700008
J	Ramchandani, P; Wiggs, L; Webb, V; Stores, G				Ramchandani, P; Wiggs, L; Webb, V; Stores, G			A systematic review of treatments for settling problems and night waking in young children	BRITISH MEDICAL JOURNAL			English	Article							INFANT SLEEP DISTURBANCE; TRIMEPRAZINE; DISRUPTIONS; EXTINCTION; TRIAL	Objectives To assess the efficacy of treatments for settling problems and night waking in young children. Design A systematic review of randomised controlled trials of interventions for settling problems and night waking in young children. Setting Electronic bibliographic databases and references on identified papers, hand searches, and personal contact with specialists. Subjects Children aged 5 years or less who had established settling problems or night waking. Interventions Interventions had to be described and a placebo, waiting list, or another intervention needed to have been used as a comparison. Interventions comprised drug trials or non-drug trials. Main outcome measures Number of wakes at night, time to settle, or number of nights in which these problems occurred. Results Drugs seemed to be effective in treating night caking in the short term, but long term efficacy nas questionable. In contrast, specific behavioural interventions showed both short term efficacy and possible longer term effects for dealing with settling problems and night waking. Conclusions Given the prevalence and persistence of childhood sleep problems and the effects they can have on children and families, treatments that offer long lasting benefits are appealing and these are likely to be behavioural interventions.	Florence Nightingale House, Aylesbury HP21 8AL, Bucks, England; Univ Oxford, Pk Hosp Children, Sect Child & Adolescent Psychiat, Oxford OX3 7LQ, England	University of Oxford	Ramchandani, P (corresponding author), Sue Nicholls Ctr, Child & Family Psychiat Serv, Manor House, Aylesbury HP21 8AL, Bucks, England.		Ramchandani, Paul/O-5340-2014	Ramchandani, Paul/0000-0003-3646-2410	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS LA, 1989, PEDIATRICS, V84, P756; Anders TF, 1997, J AM ACAD CHILD PSY, V36, P9, DOI 10.1097/00004583-199701000-00012; BAX MCO, 1980, BRIT MED J, V141, P1177; Chavin W, 1980, Health Visit, V53, P477; DOUGLA SJ, 1984, MY CHILD WONT SLEEP; Ferber Richard, 1985, SOLVE YOUR CHILDS SL; FRANCE KG, 1991, J DEV BEHAV PEDIATR, V12, P308; FRANCE KG, 1993, CLIN PSYCHOL REV, V13, P635, DOI 10.1016/0272-7358(93)90030-P; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KERR S, 1994, CHILD CARE HLTH DEV, V20, P379, DOI 10.1111/j.1365-2214.1994.tb00400.x; MONTANARI G, 1992, PHARMACOL RES, V25, P83, DOI 10.1016/1043-6618(92)90551-L; OUNSTED MK, 1977, DEV MED CHILD NEUROL, V19, P446, DOI 10.1111/j.1469-8749.1977.tb07937.x; PAUL DH, 1982, ADV COMP PHYSIOL BIO, V8, P111; Pritchard A. A., 1988, EARLY CHILD DEV CARE, V34, P227, DOI DOI 10.1080/0300443880340117; RICHMAN N, 1985, J CHILD PSYCHOL PSYC, V26, P591, DOI 10.1111/j.1469-7610.1985.tb01643.x; RICHMAN N, 1975, J CHILD PSYCHOL PSYC, V16, P277, DOI 10.1111/j.1469-7610.1975.tb00362.x; RICHMAN N, 1981, J AM ACAD CHILD PSY, V20, P281, DOI 10.1016/S0002-7138(09)60989-4; RICKERT VI, 1988, PEDIATRICS, V81, P203; SCOTT G, 1990, J CHILD PSYCHOL PSYC, V31, P551, DOI 10.1111/j.1469-7610.1990.tb00797.x; SEYMOUR FW, 1989, J CHILD PSYCHOL PSYC, V30, P913, DOI 10.1111/j.1469-7610.1989.tb00293.x; SIMONOFF EA, 1987, ARCH DIS CHILD, V62, P253, DOI 10.1136/adc.62.3.253; Stores G, 1996, J CHILD PSYCHOL PSYC, V37, P907, DOI 10.1111/j.1469-7610.1996.tb01489.x; Szyndler J, 1992, Health Visit, V65, P277; ZUCKERMAN B, 1987, PEDIATRICS, V80, P664	24	106	110	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					209	213		10.1136/bmj.320.7229.209	http://dx.doi.org/10.1136/bmj.320.7229.209			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	279DR	10642226	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000085029600021
J	Shannon, M				Shannon, M			Primary care - Ingestion of toxic substances by children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WHOLE-BOWEL IRRIGATION; POISON-CONTROL-CENTERS; IPECAC-INDUCED EMESIS; EXPOSURE-SURVEILLANCE-SYSTEM; ACTIVATED-CHARCOAL; GASTRIC LAVAGE; PEDIATRIC INGESTIONS; EFFICACY; SORBITOL; OVERDOSE		Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; Childrens Hosp, Program Clin Toxicol, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; Massachusetts Poison Control Ctr, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Shannon, M (corresponding author), Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	shannon@al.tch.harvard.edu						ALBERTSON TE, 1989, ANN EMERG MED, V18, P56, DOI 10.1016/S0196-0644(89)80314-2; *AM AC CLIN TOX, 1997, J TOXICOL-CLIN TOXIC, V35, P753; *AM AC CLIN TOX EU, 1997, J TOXICOL-CLIN TOXIC, V35, P721; *AM AC CLIN TOX EU, 1997, CLIN TOXICOL, V35, P711; *AM AC CLIN TOX EU, 1997, J TOXICOL-CLIN TOXIC, V35, P743; ANDREWS PLR, 1992, BRIT J ANAESTH, V69, pS2, DOI 10.1093/bja/69.supplement_1.2S; Arnold TC, 1999, J TOXICOL-CLIN TOXIC, V37, P9, DOI 10.1081/CLT-100102402; AUERBACH PS, 1986, ANN EMERG MED, V15, P692, DOI 10.1016/S0196-0644(86)80427-9; Belson MG, 1999, AM J EMERG MED, V17, P221, DOI 10.1016/S0735-6757(99)90109-2; BOND GR, 1993, ANN EMERG MED, V22, P1403, DOI 10.1016/S0196-0644(05)81986-9; CHAFEEBAHAMON C, 1983, PEDIATRICS, V72, P164; Clausen MR, 1997, DRUGS, V53, P930, DOI 10.2165/00003495-199753060-00003; DERLET RW, 1986, WESTERN J MED, V145, P493; DILLON EC, 1989, ANN EMERG MED, V18, P547, DOI 10.1016/S0196-0644(89)80841-8; EISEN TF, 1991, ANN EMERG MED, V20, P143, DOI 10.1016/S0196-0644(05)81212-0; FARLEY TA, 1986, J PEDIATR-US, V109, P719, DOI 10.1016/S0022-3476(86)80250-5; GRBCICH PA, 1987, J PEDIATR-US, V110, P970, DOI 10.1016/S0022-3476(87)80427-4; HARCHELROAD F, 1990, VET HUM TOXICOL, V32, P156; HARRIS CR, 1993, ANN EMERG MED, V22, P1470, DOI 10.1016/S0196-0644(05)81998-5; HILL RE, 1982, MED J AUSTRALIA, V1, P387; Izzo AA, 1998, TRENDS PHARMACOL SCI, V19, P403, DOI 10.1016/S0165-6147(98)01249-8; JAMES LP, 1995, PEDIATRICS, V96, P235; JUSTINIANI FR, 1985, CHEST, V87, P404, DOI 10.1378/chest.87.3.404; Kaczorowski JM, 1996, ANN EMERG MED, V27, P258, DOI 10.1016/S0196-0644(96)70334-7; KELLER RE, 1990, ANN EMERG MED, V19, P654, DOI 10.1016/S0196-0644(05)82470-9; KIRSHENBAUM LA, 1989, CLIN PHARMACOL THER, V46, P264, DOI 10.1038/clpt.1989.137; KNIGHT KM, 1987, SOUTHERN MED J, V80, P786, DOI 10.1097/00007611-198706000-00031; KORNBERG AE, 1991, ANN EMERG MED, V20, P648, DOI 10.1016/S0196-0644(05)82385-6; Krenzelok E, 1997, J TOXICOL-CLIN TOXIC, V35, P695; Krenzelok E. P., 1997, J TOXICOL-CLIN TOXIC, V35, P699; KRENZELOK EP, 1987, CLIN PHARMACY, V6, P715; KULIG K, 1985, ANN EMERG MED, V14, P562, DOI 10.1016/S0196-0644(85)80780-0; LANPHEAR W F, 1986, Journal of Emergency Medicine, V4, P43, DOI 10.1016/0736-4679(86)90111-3; Lee AGL, 1998, J THORAC CARDIOV SUR, V115, P822, DOI 10.1016/S0022-5223(98)70362-9; LEVY G, 1982, NEW ENGL J MED, V307, P676, DOI 10.1056/NEJM198209093071109; LITOVITZ T, 1992, PEDIATRICS, V89, P999; Litovitz TL, 1999, AM J EMERG MED, V17, P435, DOI 10.1016/S0735-6757(99)90254-1; Litovitz TL, 1997, AM J EMERG MED, V15, P447, DOI 10.1016/S0735-6757(97)90193-5; Litovitz TL, 1996, AM J EMERG MED, V14, P487, DOI 10.1016/S0735-6757(96)90160-6; Litovitz TL, 1998, AM J EMERG MED, V16, P443, DOI 10.1016/S0735-6757(98)90000-6; MCCORD MM, 1987, J PEDIATR-US, V111, P307, DOI 10.1016/S0022-3476(87)80096-3; MERIGIAN KS, 1990, AM J EMERG MED, V8, P479, DOI 10.1016/0735-6757(90)90146-Q; Murray K F, 1998, Pediatr Rev, V19, P337, DOI 10.1542/pir.19-10-337; NEUVONEN PJ, 1995, ANN EMERG MED, V25, P570; OLKKOLA KT, 1985, BRIT J CLIN PHARMACO, V19, P767, DOI 10.1111/j.1365-2125.1985.tb02712.x; POND SM, 1995, MED J AUSTRALIA, V163, P345, DOI 10.5694/j.1326-5377.1995.tb124625.x; Roberts JR, 1997, ACAD EMERG MED, V4, P167, DOI 10.1111/j.1553-2712.1997.tb03735.x; Rodgers GB, 1996, JAMA-J AM MED ASSOC, V275, P1661, DOI 10.1001/jama.275.21.1661; RUMACK B, 1999, POISINDEX SYSTEM; SAETTA JP, 1991, J ROY SOC MED, V84, P35, DOI 10.1177/014107689108400113; Saincher A, 1997, J TOXICOL-CLIN TOXIC, V35, P609, DOI 10.3109/15563659709001241; SMITH SW, 1991, ANN EMERG MED, V20, P536, DOI 10.1016/S0196-0644(05)81610-5; SUE YJ, 1994, ANN EMERG MED, V24, P709, DOI 10.1016/S0196-0644(94)70283-7; TANDBERG D, 1986, AM J EMERG MED, V4, P205, DOI 10.1016/0735-6757(86)90066-5; TENENBEIN M, 1987, J PEDIATR-US, V111, P142, DOI 10.1016/S0022-3476(87)80365-7; TENENBEIN M, 1988, MED TOXICOL ADV DRUG, V3, P77, DOI 10.1007/BF03259934; WOLOWODIUK OJ, 1984, ANN EMERG MED, V13, P1148, DOI 10.1016/S0196-0644(84)80341-8; WOOLF AD, 1998, CLIN MANAGEMENT POIS, P300	58	81	87	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					186	191		10.1056/NEJM200001203420307	http://dx.doi.org/10.1056/NEJM200001203420307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639545				2022-12-28	WOS:000084851700007
J	Katayama, Y; Mizutani, T; Utsumi, W; Shimomura, O; Yamakata, M; Funakoshi, K				Katayama, Y; Mizutani, T; Utsumi, W; Shimomura, O; Yamakata, M; Funakoshi, K			A first-order liquid-liquid phase transition in phosphorus	NATURE			English	Article							HIGH-PRESSURE; BLACK PHOSPHORUS; AMORPHOUS PHASES; TEMPERATURE; WATER; DIFFRACTION; METALS	First-order structural phase transitions are common in crystalline solids, whereas first-order liquid-liquid phase transitions (that is, transitions between two distinct liquid forms with different density and entropy) are exceedingly rare in pure substances(1-4), Bur recent theoretical and experimental studies have shown evidence for such a transition in several materials, including supercooled water(5-8) and liquid carbon(9,10). Her we report an in sit X-ray diffraction observation of a liquid-liquid transition in phosphorus, involving an abrupt, pressure-induced structural change between two distinct liquid forms. In addition to a known form of liquid phosphorus-a molecular liquid comprising tetrahedral P-4 molecules-we have found a polymeric form at pressures above 1 Cpa, Changing the pressure results in a reversible transformation from the low-pressure molecular form into the high-pressure polymeric form. The transformation is sharp and rapid, occurring within a few minutes over a pressure range of less than 0.02 Gpa. During the transformation, the two forms of liquid coexist, These features are strongly suggestive of a first-order liquid-liquid phase transition.	Japan Atom Energy Res Inst, Dept Synchrotron Radiat Res, Sayo, Hyogo 6795148, Japan; Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Japan Atomic Energy Agency; Japan Synchrotron Radiation Research Institute	Katayama, Y (corresponding author), Japan Atom Energy Res Inst, Dept Synchrotron Radiat Res, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.							AASLAND S, 1994, NATURE, V369, P633, DOI 10.1038/369633a0; AKAHAMA Y, 1987, PHYS LETT A, V122, P129, DOI 10.1016/0375-9601(87)90790-0; Brazhkin VV, 1997, HIGH PRESSURE RES, V15, P267, DOI 10.1080/08957959708240477; CLARKE JH, 1981, MOL PHYS, V42, P861, DOI 10.1080/00268978100100671; Donohue J., 1974, STRUCTURE ELEMENTS, P231; Elliott SR, 1985, J PHYS C SOLID STATE, V8, P349; ENDO S, 1982, JPN J APPL PHYS 2, V21, pL482, DOI 10.1143/JJAP.21.L482; FUNAKOSHI K, UNPUB ACTA CRYSTA A; Glosli JN, 1999, PHYS REV LETT, V82, P4659, DOI 10.1103/PhysRevLett.82.4659; Harrington S, 1997, PHYS REV LETT, V78, P2409, DOI 10.1103/PhysRevLett.78.2409; HOHL D, 1992, PHYS REV B, V45, P8995, DOI 10.1103/PhysRevB.45.8995; HOHL D, 1994, PHYS REV B, V50, P17047, DOI 10.1103/PhysRevB.50.17047; Katayama Y, 1998, J SYNCHROTRON RADIAT, V5, P1023, DOI 10.1107/S0909049597015239; Katayama Y, 1998, J NON-CRYST SOLIDS, V232, P93, DOI 10.1016/S0022-3093(98)00485-2; KIKEGAWA T, 1987, J APPL CRYSTALLOGR, V20, P406, DOI 10.1107/S0021889887086394; MISAWA M, 1990, J CHEM PHYS, V93, P6774, DOI 10.1063/1.458946; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; PECK DR, 1971, MELLORS COMPREHEN S3, V8, P149; PONYATOVSKY EG, 1992, MATER SCI REP, V8, P147, DOI 10.1016/0920-2307(92)90007-N; Poole PH, 1997, SCIENCE, V275, P322, DOI 10.1126/science.275.5298.322; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; RAPOPORT E, 1967, J CHEM PHYS, V46, P2891, DOI 10.1063/1.1841150; Togaya M, 1997, PHYS REV LETT, V79, P2474, DOI 10.1103/PhysRevLett.79.2474; TSUJI K, 1989, REV SCI INSTRUM, V60, P2425, DOI 10.1063/1.1140736; TSUJI K, 1990, J NON-CRYST SOLIDS, V117, P27, DOI 10.1016/0022-3093(90)90872-J; WINTER R, 1990, J PHYS-CONDENS MAT, V2, P8427, DOI 10.1088/0953-8984/2/42/019; Young D. A., 1991, PHASE DIAGRAM ELEMEN; Zhao YS, 1997, HIGH PRESSURE RES, V15, P369, DOI 10.1080/08957959708240481	30	714	729	2	254	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					170	173		10.1038/35003143	http://dx.doi.org/10.1038/35003143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646596				2022-12-28	WOS:000084835300047
J	Liu, QH; Wang, LM; Frutos, AG; Condon, AE; Corn, RM; Smith, LM				Liu, QH; Wang, LM; Frutos, AG; Condon, AE; Corn, RM; Smith, LM			DNA computing on surfaces	NATURE			English	Article							COMBINATORIAL TECHNOLOGIES; DRUG DISCOVERY; AMPLIFICATION; HYBRIDIZATION; COMPUTATION; BETAINE; ARRAYS; DESIGN; GOLD	DNA computing was proposed(1) as a means of solving a class of intractable computational problems in which the computing time can grow exponentially with problem size (the 'NP-complete' or non-deterministic polynomial time complete problems). The principle of the technique has been demonstrated experimentally for a simple example of the hamiltonian path problem(2) (in this case, finding an airline flight path between several cities, such that each city is visited only once(3)). DNA computational approaches to the solution of other problems have also been investigated(4-9). One technique(10-13) involves the immobilization and manipulation of combinatorial mixtures of DNA on a support. A set of DNA molecules encoding all candidate solutions to the computational problem of interest is synthesized and attached to the surface. Successive cycles of hybridization operations and exonuclease digestion are used to identify and eliminate those members of the set that are not solutions. Upon completion of all the multistep cycles, the solution to the computational problem is identified using a polymerase chain reaction to amplify the remaining molecules, which are then hybridized to an addressed array. The advantages of this approach are its scalability and potential to be automated (the use of solid-phase formats simplifies the complex repetitive chemical processes, as has been demonstrated in DNA and protein synthesis(14)). Here we report the use of this method to solve a NP-complete problem. We consider a small example of the satisfiability problem (SAT)(2), in which the values of a set of boolean variables satisfying certain logical constraints are determined.	Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Smith, LM (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.			Corn, Robert/0000-0002-4756-2161				Adleman LM, 1998, SCI AM, V279, P54, DOI 10.1038/scientificamerican0898-54; ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; BONEH D, 1999, DIMACS SERIES DISCRE, V44, P163; CAI W, 1997, P 1 ANN INT C COMP M; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Farrell RE, 1997, IMMUNOL INVEST, V26, P3, DOI 10.3109/08820139709048910; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Frutos AG, 1997, NUCLEIC ACIDS RES, V25, P4748, DOI 10.1093/nar/25.23.4748; Frutos AG, 1998, J AM CHEM SOC, V120, P10277, DOI 10.1021/ja982030w; GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001; Garey M.R., 1979, COMPUTERS INTRACTABI; GILLMOR SD, UNPUB LANGMUIR; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; Guarnieri F, 1996, SCIENCE, V273, P220, DOI 10.1126/science.273.5272.220; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Jordan CE, 1997, ANAL CHEM, V69, P4939, DOI 10.1021/ac9709763; Karp RM, 1999, RANDOM STRUCT ALGOR, V15, P450, DOI 10.1002/(SICI)1098-2418(199910/12)15:3/4<450::AID-RSA12>3.0.CO;2-2; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Lyamichev V, 1999, NAT BIOTECHNOL, V17, P292, DOI 10.1038/7044; MORIMOTO N, 1997, P DIMACS DNA BASED C, V3, P83; OGIHARA M, 1996, 629 TR U ROCH DEP CO; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Pippenger N., 1990, P S PURE MATH, V50, P311; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; SCHONING U, 1999, P 40 ANN IEEE S FDN, P410; Seeman NC, 1998, NANOTECHNOLOGY, V9, P257, DOI 10.1088/0957-4484/9/3/018; SMITH LM, 1988, ANAL CHEM, V60, pA381, DOI 10.1021/ac00157a001; Smith LM, 1998, J COMPUT BIOL, V5, P255, DOI 10.1089/cmb.1998.5.255; Voss KO, 1998, ANAL CHEM, V70, P3818, DOI 10.1021/ac980067t; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; YOSHIDA H, 1999, PRELIMINARY P DIMACS, V5, P9	33	404	510	4	90	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					175	179		10.1038/35003155	http://dx.doi.org/10.1038/35003155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646598				2022-12-28	WOS:000084835300049
J	[Anonymous]				[Anonymous]			Private vs public genomics?	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					117	117						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646564				2022-12-28	WOS:000084835300001
J	Abrahm, JL				Abrahm, JL			The role of the clinician in palliative medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Abrahm, JL (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							Abrahm JL, 1999, ANN INTERN MED, V131, P37, DOI 10.7326/0003-4819-131-1-199907060-00009; Buckman R., 1992, BREAK BAD NEWS GUIDE; *WHO, 1990, WHO TECHN REP SER, V804	3	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					116	116		10.1001/jama.283.1.116	http://dx.doi.org/10.1001/jama.283.1.116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632293	Bronze			2022-12-28	WOS:000084514400038
J	Lee, RV				Lee, RV			Doctoring to the music of time	ANNALS OF INTERNAL MEDICINE			English	Article								What patients believe about time has much to do with their notion of health and medicine. Synchrony of time sense between physician and patient shapes the objectives and the content of care and compliance; asynchrony leads to frustration and failure. Traditional time is circular, a regular repetition of events and ideas. Traditional time is driven by the environment in that planets, stars, and spirits appear to control the cycles of nature. There is no apocalypse, no salvation or damnation; rather, there is a continuous cycle of reincarnation that can be stopped or escaped only by extraordinary action. Traditional time leads to a static, stable world. In this view, changes are transient because things that were will be again; progress is fiction, a conceit of the proud. Renaissance notions of the perfectibility of humankind, the importance of individuality, and the possibility of progress originated with a sense of time as a straight line leading to "an end of time" and apocalypse, rather than a circle. The present Christian calendar is the product of 16th-century attempts to unify the calendrical expectations for the apocalypse held by diverse Christian sects and to rectify the discrepancies between the old calendar timing of Christian holy days and the natural seasonal cycles. Millenarian and scientific time have a future; traditional time is, in a sense, timeless.	SUNY Buffalo, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, RV (corresponding author), 7664 E Quaker Rd, Orchard Pk, NY 14127 USA.							[Anonymous], ECCLESIASTES, V1, P27; Aveni A.F., 1989, EMPIRES TIME CALENDA; CROSBY AW, 1997, MEASURE REALITY QUAN, P3; DOHRNVANROSSUM G, 1996, HIST HOUR CLOCKS MOD, P1; DONDEN Y, 1986, HLTH BALANCE INTRO T, P5; FABREGA H, 1997, EVOLUTION SICKNESS H, P1; Gould Stephen Jay, 1987, TIMES ARROW TIMES CY; Herlihy David, 1997, BLACK DEATH TRANSFOR, P17; HUANG R, 1988, CHINA MACRO HIST, P1; LANDES DS, 1983, REVOLUTION TIME CLOC, P1; LANGLAND W, 1959, PIERS PLOWMAN; Lee R V, 1994, Pharos Alpha Omega Alpha Honor Med Soc, V57, P35; LEE RV, 1984, AM J MED, V77, P972, DOI 10.1016/0002-9343(84)90171-2; LEE RV, 1988, OBSTET GYNECOL, V71, P643; Leslie Charles, 1992, PATHASIAN MED KNOW, P177; Mattern SP, 1999, B HIST MED, V73, P1, DOI 10.1353/bhm.1999.0038; McNeill William H., 1995, KEEPING TOGETHER TIM, P1; PETRARCA F, 1982, LETT FAMILIAR MATTER, V9; REDFIELD R, 1953, PRIMITIVE WORLD ITS, P1; RESTON J, 1998, LAST APOXALYPSE EURO, P11; SIGERIST HE, 1961, HIST MED, V2, P137; Sobel Dava., 2016, GLASS UNIVERSE LADIE; Thorndike L., 1966, HIST MAGIC EXPT SCI, P386; Unschuld P, 1992, PATHS ASIAN MED KNOW, P44; WONG KC, 1932, HIST CHINESE MED CHR; ZIMMERMAN F, 1987, JUNGLE AROMA MEATS E, P20; 1975, TIBETAN BOOK DEAD, P3	27	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2000	132	1					11	17		10.7326/0003-4819-132-1-200001040-00003	http://dx.doi.org/10.7326/0003-4819-132-1-200001040-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270CV	10627245				2022-12-28	WOS:000084518600002
J	Dunton, CJ; Berd, D				Dunton, CJ; Berd, D			Vulvar melanoma, biologically different from other cutaneous melanomas	LANCET			English	Editorial Material							MALIGNANT-MELANOMA		Thomas Jefferson Univ Hosp, Div Gynecol Oncol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ Hosp, Div Med Oncol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Dunton, CJ (corresponding author), Thomas Jefferson Univ Hosp, Div Gynecol Oncol, Philadelphia, PA 19107 USA.							BACCHI CE, 1992, GYNECOL ONCOL, V46, P216, DOI 10.1016/0090-8258(92)90258-K; Berd D, 1997, J CLIN ONCOL, V15, P2359, DOI 10.1200/JCO.1997.15.6.2359; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Cagir B, 1999, DIS COLON RECTUM, V42, P1203, DOI 10.1007/BF02238576; CHUNG AF, 1975, OBSTET GYNECOL, V45, P638, DOI 10.1097/00006250-197506000-00008; CLARK WH, 1969, CANCER RES, V29, P705; DAVIDSON T, 1987, BRIT J OBSTET GYNAEC, V94, P473, DOI 10.1111/j.1471-0528.1987.tb03128.x; LOOK KY, 1993, CANCER, V72, P143, DOI 10.1002/1097-0142(19930701)72:1<143::AID-CNCR2820720127>3.0.CO;2-M; MASTRANGELO MJ, 1979, HUMAN MALIGNANT MELA; PIURA B, 1992, J SURG ONCOL, V50, P234, DOI 10.1002/jso.2930500408; Ragnarsson-Olding BK, 1999, CANCER, V86, P1285, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1285::AID-CNCR25>3.0.CO;2-P; Ragnarsson-Olding BK, 1999, CANCER, V86, P1273, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1273::AID-CNCR24>3.0.CO;2-Z; ROGO K O, 1991, European Journal of Gynaecological Oncology, V12, P113; ROSE PG, 1988, AM J OBSTET GYNECOL, V159, P52, DOI 10.1016/0002-9378(88)90493-0; TASSERON EWK, 1992, GYNECOL ONCOL, V46, P170, DOI 10.1016/0090-8258(92)90250-M; TRIMBLE EL, 1992, GYNECOL ONCOL, V45, P254, DOI 10.1016/0090-8258(92)90300-8	16	19	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 11	1999	354	9195					2013	2014		10.1016/S0140-6736(99)00390-6	http://dx.doi.org/10.1016/S0140-6736(99)00390-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636360				2022-12-28	WOS:000084183300003
J	Evans, C; Chalmers, J; Capewell, S; Redpath, A; Finlayson, A; Boyd, J; Pell, J; McMurray, J; Macintyre, K; Graham, L				Evans, C; Chalmers, J; Capewell, S; Redpath, A; Finlayson, A; Boyd, J; Pell, J; McMurray, J; Macintyre, K; Graham, L			"I don't like Mondays" - day of the week of coronary heart disease deaths in Scotland: study of routinely collected data	BRITISH MEDICAL JOURNAL			English	Article									Natl Hlth Serv Scotland, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Glasgow Royal Infirm, Dept Cardiol, Glasgow G31 2ER, Lanark, Scotland; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G12 8QQ, Lanark, Scotland	NHS National Services Scotland; University of Glasgow; University of Glasgow; University of Glasgow	Chalmers, J (corresponding author), Natl Hlth Serv Scotland, Informat & Stat Div, Trin Pk House, Edinburgh EH5 3SQ, Midlothian, Scotland.		mcmurray, John/B-2467-2013; Macintyre, Kate/J-7174-2014	mcmurray, John/0000-0002-6317-3975; Macintyre, Kate/0000-0003-2741-0467; Pell, Jill/0000-0002-8898-7035; Boyd, James/0000-0002-8925-8811				Chen Z, 1998, CAN J EXP PSYCHOL, V52, P7, DOI 10.1037/h0087274; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; Peters Robert W., 1996, Cardiology Clinics, V14, P185; WILLICH SN, 1994, CIRCULATION, V90, P87, DOI 10.1161/01.CIR.90.1.87	4	57	60	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					218	219		10.1136/bmj.320.7229.218	http://dx.doi.org/10.1136/bmj.320.7229.218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642230	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000085029600024
J	Xu, CG; Mao, DL; Holers, VM; Palanca, B; Cheng, AM; Molina, H				Xu, CG; Mao, DL; Holers, VM; Palanca, B; Cheng, AM; Molina, H			A critical role for murine complement regulator Crry in fetomaternal tolerance	SCIENCE			English	Article							DECAY-ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; PREFERENTIAL EXPRESSION; IMMUNE-RESPONSE; PREGNANCY; RECEPTOR; HOMOLOG; CELLS; ACTIVATION; DISTINCT	Complement is a component of natural immunity. Its regulation is needed to protect tissues from inflammation, but mice with a disrupted gene for the complement regulator decay accelerating factor were normal. Mice that were deficient in another murine complement regulator, Crry, were generated to investigate its role in vivo. Survival of Crry(-/-) embryos was compromised because of complement deposition and concomitant placenta inflammation. Complement activation at the fetomaternal interface caused the fetal Loss because breeding to C3(-/-) mice rescued Crry(-/-) mice from lethality. Thus, the regulation of complement is critical in fetal control of maternal processes that mediate tissue damage.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Vet Adm Med Ctr, St Louis, MO 63106 USA	Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Molina, H (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	hmolina@imgate.wustl.edu	Palanca, Ben Julian/AAW-4006-2021	Palanca, Ben Julian/0000-0001-7535-5701	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040576, R01AI044912] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI44912-01, R01 AI40576-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBAS AK, 1997, CELLULAR MOL IMMUNOL, P294; BILLINGTON WD, 1992, BAILLIERE CLIN OB GY, V6, P417, DOI 10.1016/S0950-3552(05)80004-5; BOOM B W, 1991, Journal of Dermatological Science, V2, P308, DOI 10.1016/0923-1811(91)90055-3; BULMER JN, 1992, BAILLIERE CLIN OB GY, V6, P461, DOI 10.1016/S0950-3552(05)80006-9; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; HOGAN B, 1986, MANIPULATING MOUSE E, P152; HOLERS VM, 1992, IMMUNOL TODAY, V13, P231; HOLMES CH, 1992, BAILLIERE CLIN OB GY, V6, P439, DOI 10.1016/S0950-3552(05)80005-7; HOLMES CH, 1990, J IMMUNOL, V144, P3099; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; ITOH J, 1991, CLIN EXP IMMUNOL, V83, P364; KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151; KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A; KURTZ CB, 1989, J IMMUNOL, V143, P2058; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LI B, 1993, J IMMUNOL, V151, P4295; LUBLIN DM, 1990, CURR TOP MICROBIOL, V153, P123; MOLINA H, 1992, J EXP MED, V175, P121, DOI 10.1084/jem.175.1.121; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; ROONEY IA, 1993, IMMUNOL RES, V12, P276, DOI 10.1007/BF02918258; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Suny XJ, 1999, P NATL ACAD SCI USA, V96, P628, DOI 10.1073/pnas.96.2.628; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; WEIGLE WO, 1983, SPRINGER SEMIN IMMUN, V6, P173; WONG WW, 1985, J IMMUNOL, V134, P4048; Xu C., UNPUB	26	396	415	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					498	501		10.1126/science.287.5452.498	http://dx.doi.org/10.1126/science.287.5452.498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642554				2022-12-28	WOS:000084929900052
J	Al-Salman, J; Arjomand, H; Kemp, DG; Mittal, M				Al-Salman, J; Arjomand, H; Kemp, DG; Mittal, M			Hepatocellular injury in a patient receiving rosiglitazone - A case report	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATIC-FAILURE; TROGLITAZONE; HEPATOTOXICITY	Background: Rosiglitazone maleate (Avandia, SmithKline Beecham, Philadelphia, Pennsylvania) is a new oral hypoglycemic agent approved for the treatment of type 2 diabetes. It acts primarily by increasing insulin sensitivity. In controlled trials, there has been no evidence of rosiglitazone-induced hepatocellular injury. Objective: To report a case of hepatocellular injury in a patient receiving rosiglitazone, Design: Case report. Setting: Community teaching hospital. Patient: 61-year-old man receiving rosiglitazone, 4 mg/d for 2 weeks. Intervention: Discontinuation of rosiglitazone therapy. Measurements: Clinical evaluation and assessment of liver function test results were done daily during hospitalization and periodically after discharge. The outpatient record was also reviewed. Results: After receiving rosiglitazone for 2 weeks, the patient presented with anorexia, vomiting, and abdominal pain. Liver function tests revealed severe hepatocellular injury. Discontinuation of rosiglitazone therapy led to rapid improvement of liver function and resolution of symptoms. Conclusion: Rosiglitazone may be associated with hepatocellular injury. We believe that patients receiving rosiglitazone should have liver enzyme levels monitored earlier and more frequently than initially recommended.	MCP Hahnemann Univ, Div Gastroenterol, Easton Hosp, Easton, PA 18042 USA	Drexel University	Mittal, M (corresponding author), MCP Hahnemann Univ, Div Gastroenterol, Easton Hosp, 250 S 21st St, Easton, PA 18042 USA.	bhudson@mail.acponline.org	Mohammed, Jasim/AAH-6360-2021	Mohammed, Jasim/0000-0001-5542-6445				Berger S, 1998, DIABETES, V47, pA18; Bernstein D, 1998, CRIT CARE CLIN, V14, P181, DOI 10.1016/S0749-0704(05)70391-2; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Neuschwander-Tetri BA, 1998, ANN INTERN MED, V129, P38, DOI 10.7326/0003-4819-129-1-199807010-00009; Salzman A, 1999, DIABETES, V48, pA95; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; [No title captured]	9	134	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					121	124		10.7326/0003-4819-132-2-200001180-00006	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644273				2022-12-28	WOS:000084852300005
J	Lyons, RA; Delahunty, AM; Heaven, M; McCabe, M; Allen, H; Nash, P				Lyons, RA; Delahunty, AM; Heaven, M; McCabe, M; Allen, H; Nash, P			Incidence of childhood fractures in affluent and deprived areas: population based study	BRITISH MEDICAL JOURNAL			English	Article									Univ Wales, Coll Med, Welsh Combined Ctr Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Iechyd Morgannwg Hlth, Dept Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Morriston Hosp, Dept Accid & Emergency, Swansea SA6 6NL, W Glam, Wales; Neath Gen Hosp, Local Accid Ctr, Neath SA11 2LQ, Wales	Morriston Hospital	Lyons, RA (corresponding author), Univ Wales, Coll Med, Welsh Combined Ctr Publ Hlth, Swansea SA1 1LT, W Glam, Wales.		Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X				[Anonymous], 1980, REPORT WORKING GROUP; Lyons R A, 1999, Inj Prev, V5, P129; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; Morrison A, 1999, BRIT MED J, V318, P567, DOI 10.1136/bmj.318.7183.567; Williams JM, 1997, SOC SCI MED, V44, P1881, DOI 10.1016/S0277-9536(96)00297-3	5	54	54	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					149	149		10.1136/bmj.320.7228.149	http://dx.doi.org/10.1136/bmj.320.7228.149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634734	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000084860300024
J	Wingren, C; Crowley, MP; Degano, M; Chien, YH; Wilson, IA				Wingren, C; Crowley, MP; Degano, M; Chien, YH; Wilson, IA			Crystal structure of a gamma delta T cell receptor ligand T22: A truncated MHC-like fold	SCIENCE			English	Article							HISTOCOMPATIBILITY COMPLEX-MOLECULES; 2.4 ANGSTROM RESOLUTION; NEONATAL FC RECEPTOR; CLASS-I; 3-DIMENSIONAL STRUCTURE; ANTIGEN PRESENTATION; VIRAL PEPTIDES; BINDING-SITE; RECOGNITION; PROGRAM	Murine T10 and T22 are highly related nonclassical major histocompatibility complex (MHC) class Ib proteins that bind to certain gamma delta T cell receptors (TCRs) in the absence of other components. The crystal structure of T22(b) at 3.1 angstroms reveals similarities to MHC class I molecules, but one side of the normal peptide-binding groove is severely truncated, which allows direct access to the beta-sheet floor. Potential gamma delta TCR-binding sites can be inferred from functional mapping of T10 and T22 point mutants and allelic variants. Thus, T22 represents an unusual variant of the MHC-like fold and indicates that gamma delta and alpha beta TCRs interact differently with their respective MHC ligands.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Scripps Research Institute; Scripps Research Institute; Stanford University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Degano, Massimo/K-4669-2018	Degano, Massimo/0000-0002-0787-1883	NCI NIH HHS [CA58896] Funding Source: Medline; NIAID NIH HHS [AI33431] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033431] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achour A, 1998, IMMUNITY, V9, P199, DOI 10.1016/S1074-7613(00)80602-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Boismenu R, 1997, CURR OPIN IMMUNOL, V9, P57, DOI 10.1016/S0952-7915(97)80159-8; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Hampl J, 1999, J IMMUNOL, V163, P288; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; Jones EY, 1998, IMMUNOL REV, V163, P121, DOI 10.1111/j.1600-065X.1998.tb01191.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mazza G, 1998, IMMUNOL REV, V163, P187, DOI 10.1111/j.1600-065X.1998.tb01197.x; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MORIWAKI S, 1993, P NATL ACAD SCI USA, V90, P11396, DOI 10.1073/pnas.90.23.11396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parham P, 1996, TRENDS BIOCHEM SCI, V21, P427, DOI 10.1016/S0968-0004(96)10053-0; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Shields MJ, 1998, MOL IMMUNOL, V35, P919, DOI 10.1016/S0161-5890(98)00083-2; SILVER ML, 1991, NATURE, V350, P619, DOI 10.1038/350619a0; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; STROYNOWSKI I, 1994, CURR OPIN IMMUNOL, V6, P38, DOI 10.1016/0952-7915(94)90031-0; TEITELL M, 1994, CRIT REV IMMUNOL, V14, P1; VELLIEUX FMD, DEMON PROGRAM SUITE; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WEINTRAUB BC, 1994, J IMMUNOL, V153, P3051; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	72	55	55	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					310	314		10.1126/science.287.5451.310	http://dx.doi.org/10.1126/science.287.5451.310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634787				2022-12-28	WOS:000084769600042
J	Bauer, J; Chen, KH; Hiltbunner, A; Wehrli, E; Eugster, M; Schnell, D; Kessler, F				Bauer, J; Chen, KH; Hiltbunner, A; Wehrli, E; Eugster, M; Schnell, D; Kessler, F			The major protein import receptor of plastids is essential for chloroplast biogenesis	NATURE			English	Article							INNER ENVELOPE MEMBRANE; ARABIDOPSIS; COMPONENT; APPARATUS; MACHINERY; INSERTION; IDENTIFICATION; TRANSLOCATION; EXPRESSION; NUCLEAR	Light triggers the developmental programme in plants that leads to the production of photosynthetically active chloroplasts from non-photosynthetic proplastids(1). During this chloroplast biogenesis, the photosynthetic apparatus is rapidly assembled, mostly from nuclear-encoded imported proteins(2-4), which are synthesized in the cytosol as precursors with cleavable amino-terminal targeting sequences called transit sequences. Protein translocon complexes at the outer (Toc complex)(5-7) and inner (Tic complex)(6,8,9) envelope membranes recognize these transit sequences, leading to the precursors being imported. The Toc complex in the pea consists of three major components, Toc75, Toc34 and Toc159 (formerly termed ToC86)(6,7,10,11). Toc159, Which is an integral membrane GTPase(12), functions as a transit-sequence recepto(5-7,13). Here we show that Arabidopsis thaliana Toc159 (atToc159) is essential for the biogenesis of chloroplasts. In an Arabidopsis mutant (ppi2) that lacks atToc159, photosynthetic proteins that are normally abundant are transcriptionally repressed, and are found in much smaller amounts in the plastids, although ppi2 does not affect either the expression or the import of less abundant non-photosynthetic plastid proteins. These findings indicate that atToc159 is required for the quantitative import of photosynthetic proteins. Two proteins that are related to atToc159 (atToc120 and atToc132) probably help to maintain basal protein import in ppi2, and so constitute components of alternative, atToc159-independent import pathways.	Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; Swiss Fed Inst Technol, Inst Biochem, Lab Electronmicroscopy 1, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Rutgers State University Newark; Rutgers State University New Brunswick; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schnell, D (corresponding author), Swiss Fed Inst Technol, Inst Plant Sci, Univ Str 2, CH-8092 Zurich, Switzerland.		Kessler, Felix Henrique/AAO-1722-2020	Hiltbrunner, Andreas/0000-0003-0438-5297; Kessler, Felix/0000-0001-6409-5043				Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bolter B, 1998, FEBS LETT, V441, P59, DOI 10.1016/S0014-5793(98)01525-7; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; CHEN K, IN PRESS PLANT PHYS; Chen XJ, 1999, TRENDS CELL BIOL, V9, P222, DOI 10.1016/S0962-8924(99)01554-8; DAHLIN C, 1991, PLANT CELL, V3, P1131, DOI 10.1105/tpc.3.10.1131; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; HIRSCH S, 1994, SCIENCE, V266, P1989, DOI 10.1126/science.7801125; Jarvis P, 1998, SCIENCE, V282, P100, DOI 10.1126/science.282.5386.100; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; LI HM, 1995, PLANT CELL, V7, P1599, DOI 10.1105/tpc.7.10.1599; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Lubeck J, 1996, EMBO J, V15, P4230, DOI 10.1002/j.1460-2075.1996.tb00797.x; MA Y, 1996, J CELL BIOL, V134, P1; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; MICHEL M, 1991, J MICROSC-OXFORD, V163, P3, DOI 10.1111/j.1365-2818.1991.tb03155.x; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; SEEDORF M, 1995, PLANT J, V7, P401, DOI 10.1046/j.1365-313X.1995.7030401.x; Soll J, 1998, PLANT MOL BIOL, V38, P191, DOI 10.1023/A:1006034020192; Surpin M, 1997, ESSAYS BIOCHEM, V32, P113; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x	27	284	313	3	39	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2000	403	6766					203	207		10.1038/35003214	http://dx.doi.org/10.1038/35003214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646606	Green Submitted			2022-12-28	WOS:000084835300057
J	Yeghiazarians, Y; Braunstein, JB; Askari, A; Stone, PH				Yeghiazarians, Y; Braunstein, JB; Askari, A; Stone, PH			Medical progress: Unstable angina pectoris	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-ARTERY DISEASE; ACUTE MYOCARDIAL-INFARCTION; MOLECULAR-WEIGHT HEPARIN; C-REACTIVE PROTEIN; LATE CLINICAL OUTCOMES; TIMI-III REGISTRY; ATHEROSCLEROTIC PLAQUES; TROPONIN-T; UNFRACTIONATED HEPARIN; TISSUE FACTOR		Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Stone, PH (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Dept Med, 75 Francis St, Boston, MA 02115 USA.	pstone@rics.bwh.harvard.edu						Alderman EL, 1996, NEW ENGL J MED, V335, P217; ALISON HW, 1978, AM J CARDIOL, V41, P204, DOI 10.1016/0002-9149(78)90157-1; ALPERT JS, 1985, J AM COLL CARDIOL, V5, P617, DOI 10.1016/S0735-1097(85)80385-5; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609, DOI 10.1016/S0735-1097(85)80384-3; AMBROSE JA, 1986, J AM COLL CARDIOL, V7, P472, DOI 10.1016/S0735-1097(86)80455-7; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; AMBROSE JA, 1994, CIRCULATION, V90, P69, DOI 10.1161/01.CIR.90.1.69; Anand SS, 1998, CIRCULATION, V98, P1064, DOI 10.1161/01.CIR.98.11.1064; [Anonymous], 1994, Circulation, V89, P1545; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1998, J AM COLL CARDIOL, V31, P326, DOI 10.1016/S0735-1097(97)00485-3; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BALSANO F, 1990, CIRCULATION, V82, P17, DOI 10.1161/01.CIR.82.1.17; BAR FW, 1992, CIRCULATION, V86, P131, DOI 10.1161/01.CIR.86.1.131; Bassenge E, 1998, J CLIN INVEST, V102, P67, DOI 10.1172/JCI977; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; BENTIVOGLIO LG, 1994, J AM COLL CARDIOL, V24, P1195, DOI 10.1016/0735-1097(94)90098-1; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boden WE, 1998, NEW ENGL J MED, V339, P1091; Bovill EG, 1997, AM J CARDIOL, V79, P391, DOI 10.1016/S0002-9149(96)00773-4; Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Braunwald E, 1994, AHCPR PUBLICATION, V94-0602, P1; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Cannon CP, 1997, J AM COLL CARDIOL, V30, P133, DOI 10.1016/S0735-1097(97)00160-5; Cannon CP, 1997, AM J CARDIOL, V79, P253, DOI 10.1016/S0002-9149(97)00743-1; *CAPTURE INV, 1997, LANCET, V350, P1429; *CAPTURE INV, 1997, LANCET, V350, P744; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chauhan A, 1998, CATHETER CARDIO DIAG, V43, P11; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; COHEN M, 1994, CIRCULATION, V89, P81, DOI 10.1161/01.CIR.89.1.81; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; CURFMAN GD, 1993, NEW ENGL J MED, V329, P1730, DOI 10.1056/NEJM199312023292310; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Eisenberg, 1995, J Thromb Thrombolysis, V1, P237, DOI 10.1007/BF01060733; Eisenberg MJ, 1996, ARCH INTERN MED, V156, P1506, DOI 10.1001/archinte.156.14.1506; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FERNANDEZORTIZ A, 1994, J AM COLL CARDIOL, V23, P1562, DOI 10.1016/0735-1097(94)90657-2; Ferrari Roberto, 1996, American Journal of Cardiology, V77, p22D, DOI 10.1016/S0002-9149(96)00304-9; *FIBR THER TRIAL C, 1994, LANCET, V343, P742; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fishbein MC, 1996, CIRCULATION, V94, P2662, DOI 10.1161/01.CIR.94.10.2662; FITZGERALD DJ, 1984, CIRCULATION, V70, P297, DOI 10.1161/01.CIR.70.2.297; FLUGELMAN MY, 1993, CIRCULATION, V88, P2493, DOI 10.1161/01.CIR.88.6.2493; Fuster V, 1997, LANCET, V350, P389; FUSTER V, 1988, CIRCULATION, V77, P1213, DOI 10.1161/01.CIR.77.6.1213; FUSTER V, 1975, BRIT HEART J, V37, P1250; FUSTER V, 1995, CIRCULATION, V91, P256; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gibson CM, 1998, J AM COLL CARDIOL, V32, P28, DOI 10.1016/S0735-1097(98)00192-2; GORGELS APM, 1993, AM J CARDIOL, V72, P999, DOI 10.1016/0002-9149(93)90852-4; GOTTLIEB SO, 1986, CIRCULATION, V73, P331, DOI 10.1161/01.CIR.73.2.331; GRAVES E, 1998, NATL HOSP DISCHAR 13; Grip L, 1997, EUR HEART J, V18, P1416; GURFINKEL EP, 1995, J AM COLL CARDIOL, V26, P313, DOI 10.1016/0735-1097(95)80001-W; HAINES DE, 1983, AM J CARDIOL, V52, P14, DOI 10.1016/0002-9149(83)90061-9; Hall P, 1996, CIRCULATION, V93, P215, DOI 10.1161/01.CIR.93.2.215; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Hanrath P, 1997, CIRCULATION, V96, P1445; HANSEN JF, 1990, AM J CARDIOL, V66, P779; HELD PH, 1989, BMJ-BRIT MED J, V299, P1187, DOI 10.1136/bmj.299.6709.1187; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Hillis WS, 1997, AM J CARDIOL, V80, pE51, DOI 10.1016/S0002-9149(97)00491-8; Jain D, 1997, J AM COLL CARDIOL, V30, P421, DOI 10.1016/S0735-1097(97)00164-2; Klein LW, 1997, AM J CARDIOL, V79, P259, DOI 10.1016/S0002-9149(96)00744-8; Klein W, 1997, CIRCULATION, V96, P61; Klein W, 1997, AM J CARDIOL, V80, pE30, DOI 10.1016/S0002-9149(97)00487-6; KLEIN W, 1998, CIRCULATION, V97, P413; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lincoff AM, 1999, CIRCULATION, V99, P1951, DOI 10.1161/01.CIR.99.15.1951; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; LUBSEN J, 1987, AM J CARDIOL, V60, pA18; LUCHI RJ, 1987, NEW ENGL J MED, V316, P977, DOI 10.1056/NEJM198704163161603; Madan M, 1998, CIRCULATION, V98, P2629, DOI 10.1161/01.CIR.98.23.2629; Madan M, 1998, CAN J CARDIOL, V14, P1109; MADSEN JK, 1988, BRIT HEART J, V59, P184; Marzocchi A, 1997, AM J CARDIOL, V79, P1314, DOI 10.1016/S0002-9149(97)00131-8; MEREDITH IT, 1993, CIRCULATION, V87, P56; Moreno PR, 1996, CIRCULATION, V94, P3090, DOI 10.1161/01.CIR.94.12.3090; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; MOSS AJ, 1988, NEW ENGL J MED, V319, P385; Moussa I, 1999, CIRCULATION, V99, P2364, DOI 10.1161/01.CIR.99.18.2364; Munzel T, 1996, Am J Cardiol, V77, p24C, DOI 10.1016/S0002-9149(96)00185-3; MYLER RK, 1990, CIRCULATION, V82, P88; NOBUYOSHI M, 1991, J AM COLL CARDIOL, V18, P904, DOI 10.1016/0735-1097(91)90745-U; Oler A, 1996, JAMA-J AM MED ASSOC, V276, P811, DOI 10.1001/jama.276.10.811; Patrono C, 1997, AM J CARDIOL, V80, pE17, DOI 10.1016/S0002-9149(97)00484-0; Pettijohn TL, 1997, AM J CARDIOL, V80, P510, DOI 10.1016/S0002-9149(97)00405-0; *PLAT REC INH ISCH, 1998, NEW ENGL J MED, V339, P415; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; PRISANT LM, 1994, POSTGRAD MED, V96, P88, DOI 10.1080/00325481.1994.11945876; RICHARDSON PD, 1989, LANCET, V2, P941; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1998, CIRCULATION, V97, P425; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Savonitto S, 1999, JAMA-J AM MED ASSOC, V281, P707, DOI 10.1001/jama.281.8.707; SCLAROVSKY S, 1986, AM HEART J, V112, P459, DOI 10.1016/0002-8703(86)90506-5; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; Shimada K, 1998, CATHETER CARDIO DIAG, V43, P381, DOI 10.1002/(SICI)1097-0304(199804)43:4<381::AID-CCD4>3.0.CO;2-4; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; Stone PH, 1999, EUR HEART J, V20, P1084, DOI 10.1053/euhj.1998.1480; STONE PH, 1991, UNSTABLE ANGINA PECT, P105; STRATMANN HG, 1995, AM HEART J, V130, P734, DOI 10.1016/0002-8703(95)90071-3; STRATMANN HG, 1995, AM J CARDIOL, V76, P236, DOI 10.1016/S0002-9149(99)80072-1; Swahn E, 1997, AM J CARDIOL, V80, pE25, DOI 10.1016/S0002-9149(97)00486-4; Tcheng JE, 1997, LANCET, V349, P1422; TELFORD AM, 1981, LANCET, V1, P1225; THADANI U, 1994, CARDIOVASC DRUG THER, V8, P719, DOI 10.1007/BF00877118; Theroux P, 1998, CIRCULATION, V97, P1195, DOI 10.1161/01.CIR.97.12.1195; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; THEROUX P, 1985, J AM COLL CARDIOL, V5, P717, DOI 10.1016/S0735-1097(85)80400-9; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; TOPOL EJ, 1994, LANCET, V343, P881, DOI 10.1016/S0140-6736(94)90007-8; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Wallentin L, 1996, LANCET, V347, P561; Wallentin L, 1999, LANCET, V354, P701; WALLENTIN L, 1990, LANCET, V336, P827; WALLENTIN LC, 1991, J AM COLL CARDIOL, V18, P1587, DOI 10.1016/0735-1097(91)90489-V; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WATANABE T, 1991, CIRC RES, V69, P370, DOI 10.1161/01.RES.69.2.370; Weitz JI, 1997, NEW ENGL J MED, V337, P1567; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WIECZOREK I, 1994, BRIT HEART J, V72, P436; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; Williams MJA, 1997, J AM COLL CARDIOL, V30, P364, DOI 10.1016/S0735-1097(97)00153-8; Yusuf S, 1999, LANCET, V353, P429; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259; Zaacks SM, 1999, J AM COLL CARDIOL, V33, P107, DOI 10.1016/S0735-1097(98)00553-1	145	146	155	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					101	114		10.1056/NEJM200001133420207	http://dx.doi.org/10.1056/NEJM200001133420207			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631280				2022-12-28	WOS:000084723900007
J	Pope, C; Ziebland, S; Mays, N				Pope, C; Ziebland, S; Mays, N			Qualitative research in health care - Analysing qualitative data (Reprinted from Qualitative Research in Health Care)	BMJ-BRITISH MEDICAL JOURNAL			English	Reprint									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Oxford, Inst Hlth Sci, Imperial Canc Res Fund, Gen Practice Res Grp, Oxford OX3 7LS, England; The Treasury, Social Policy Branch, Wellington, New Zealand	University of Bristol; University of Oxford	Pope, C (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	c.pope@bristol.ac.uk	Samaan, M. Constantine/R-1456-2017	Samaan, M. Constantine/0000-0002-6403-4715; Ziebland, Sue/0000-0002-6496-4859; Pope, Catherine/0000-0002-8935-6702				Armstrong D, 1997, SOCIOLOGY, V31, P597, DOI 10.1177/0038038597031003015; BECKER H, 1982, FIELD RES SOURCEBOOK; Becker HS, 1971, SOCIOLOGICAL WORK; BLOOR M, 1978, SOCIOLOGY, V12, P545, DOI 10.1177/003803857801200307; Dey I., 1993, QUALITATIVE DATA ANA; Dingwall R, 1998, J Health Serv Res Policy, V3, P167; Fielding N., 1993, RES SOCIAL LIFE, P155; Glaser B.G., 1965, AWARENESS DYING; LEE RM, 1995, COMPUTER AIDED QUALI; Mays, QUALITATIVE RES HLTH; Miles M.B., 1994, ANAL DONNEES QUALITA, V2nd; MUHR T, 1997, ATLAS TI WINDOWS; PERRY S, 1994, LIVING MULTIPLE SCLE; RICHARDS T, 1994, QSR NUD STAR IST VER; Ritchie J, 1993, ANAL QUALITATIVE DAT, P173, DOI DOI 10.1016/J.JPSYCHORES.2008.12.001; Seidel John., 1995, COMPUTER AIDED QUALI; Waitzkin H., 1991, POLITICS MED ENCOUNT; Willis, 1992, RES HLTH CARE DESIGN, P189	18	3914	3947	4	275	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2000	320	7227					114	116		10.1136/bmj.320.7227.114	http://dx.doi.org/10.1136/bmj.320.7227.114			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274CR	10625273	Green Published			2022-12-28	WOS:000084746600026
J	Strang, J; Witton, J; Hall, W				Strang, J; Witton, J; Hall, W			Improving the quality of the cannabis debate: defining the different domains	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MARIJUANA; SCHIZOPHRENIA; DEPENDENCE; PATTERNS; SMOKERS; TOBACCO; ILLNESS; ABUSE		Kings Coll London, Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England; Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia	University of London; King's College London; University of New South Wales Sydney	Strang, J (corresponding author), Kings Coll London, Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.	j.strang@iop.kcl.ac.uk	Strang, John/H-5460-2011; Hall, Wayne D/A-3283-2008	Strang, John/0000-0002-5413-2725; Hall, Wayne D/0000-0003-1984-0096				Abrams DI, 1998, J PSYCHOACTIVE DRUGS, V30, P163; ALBERY I, 1998, J SUBSTANCE MISUSE, V3, P140; ALLEBECK P, 1993, ACTA PSYCHIAT SCAND, V88, P21, DOI 10.1111/j.1600-0447.1993.tb03408.x; ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; *BRIT MED ASS, 1997, MIS DRUGS; CHESHER G, 1995, EFFECTS DRUGS OTHER, P67; DEQUARDO JR, 1994, J PSYCHIAT RES, V28, P267, DOI 10.1016/0022-3956(94)90010-8; DONNELLY N, 1995, AUST J PUBLIC HEALTH, V19, P281; Fergusson DM, 1997, ADDICTION, V92, P279; Fligiel SEG, 1997, CHEST, V112, P319, DOI 10.1378/chest.112.2.319; Hall W, 1998, ADDICTION, V93, P1461; Hall W, 1997, ADDICTION, V92, P1109; Hall W, 1998, DRUG ALCOHOL REV, V17, P433, DOI 10.1080/09595239800187271; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; Hall W, 1994, NATL DRUG STRATEGY M, V25; HAWKS RL, 1985, JAMA-J AM MED ASSOC, V254, P2618; *HL SEL COMM SCI T, 1998, CANN SCI MED EV; *HOM OFF, 1999, DRUG SEIZ OFF STAT U; JOHNSTON LD, 1998, NATL SURVEY RESULTS; Joy JE, 1999, MARIJUANA MED ASSESS; Kandel DB, 1992, VULNERABILITY DRUG A; Kovasznay B, 1997, SCHIZOPHRENIA BULL, V23, P195, DOI 10.1093/schbul/23.2.195; LINSZEN DH, 1994, ARCH GEN PSYCHIAT, V51, P273; MacCoun R, 1997, SCIENCE, V278, P47, DOI 10.1126/science.278.5335.47; MATHERS DC, 1992, BRIT J PSYCHIAT, V161, P648, DOI 10.1192/bjp.161.5.648; NEGRETE JC, 1986, PSYCHOL MED, V16, P515, DOI 10.1017/S0033291700010278; RAMSAY M, 1997, DRUG MISUSE DECLARED; Reuband K-H., 1995, EUROPEAN ADDICTION R, V1, P32, DOI [10.1159/000259066, DOI 10.1159/000259066]; REUTER P, 1999, P INT CANN PSYCH C M; Robson P, 1998, BRIT MED J, V316, P1034; Roth MD, 1998, AM J RESP CRIT CARE, V157, P928, DOI 10.1164/ajrccm.157.3.9701026; RUSSELL MAH, 1995, ADV PHAR SC, P233; SCHNEIDER U, 1998, PHARMACOPSYCHIATRY, V2, P110; SINGLE E W, 1989, Journal of Public Health Policy, V10, P456, DOI 10.2307/3342518; SODERSTROM CA, 1995, ACCIDENT ANAL PREV, V27, P131, DOI 10.1016/0001-4575(94)00043-L; STEPHENS RS, 1994, J CONSULT CLIN PSYCH, V62, P92, DOI 10.1037/0022-006X.62.1.92; STEPHENS RS, 1993, J CONSULT CLIN PSYCH, V61, P1100, DOI 10.1037/0022-006X.61.6.1100; Swift W, 1998, ADDICTION, V93, P1681, DOI 10.1046/j.1360-0443.1998.931116816.x; Swift W, 1998, ADDICTION, V93, P1149, DOI 10.1046/j.1360-0443.1998.93811493.x; Thomas H, 1996, DRUG ALCOHOL DEPEN, V42, P201, DOI 10.1016/S0376-8716(96)01277-X; Tomaszewski C, 1996, J TOXICOL-CLIN TOXIC, V34, P37, DOI 10.3109/15563659609020231	42	38	39	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2000	320	7227					108	110		10.1136/bmj.320.7227.108	http://dx.doi.org/10.1136/bmj.320.7227.108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274CR	10625271	Green Published			2022-12-28	WOS:000084746600024
J	Baumler, AJ; Hargis, BM; Tsolis, RM				Baumler, AJ; Hargis, BM; Tsolis, RM			Epidemiology - Tracing the origins of Salmonella outbreaks	SCIENCE			English	Editorial Material							UNITED-STATES; ENTERITIDIS INFECTIONS; LAYER FLOCKS; EGGS; PREVALENCE; CHICKENS; MICE		Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Microbiol & Immunol, College Stn, TX 77843 USA; Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Baumler, AJ (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Microbiol & Immunol, 407 Reynolds Med Bldg, College Stn, TX 77843 USA.		Baumler, Andreas J/H-2301-2011	Baumler, Andreas J/0000-0001-9152-7809; Tsolis, Renee/0000-0001-9131-6657				Anderson RM, 1995, PARASITOLOGY, V111, pS15, DOI 10.1017/S003118200007579X; Angulo FJ, 1998, J AM VET MED ASSOC, V213, P1729; ASERKOFF B, 1970, AM J EPIDEMIOL, V92, P13, DOI 10.1093/oxfordjournals.aje.a121175; BARROW PA, 1992, AVIAN DIS, V36, P227, DOI 10.2307/1591495; BARROW PA, 1992, EPIDEMIOL INFECT, V109, P361, DOI 10.1017/S0950268800050354; BLAXLAND J. D., 1958, Veterinary Record, V70, P374; BULLIS KL, 1977, AVIAN DIS, V21, P422, DOI 10.2307/1589326; COLLINS FM, 1966, J EXP MED, V124, P601, DOI 10.1084/jem.124.4.601; COOPER GL, 1989, VET REC, V125, P567; EBEL ED, 1992, AVIAN DIS, V36, P646, DOI 10.2307/1591760; Edwards PR, 1943, J INFECT DIS, V72, P58, DOI 10.1093/infdis/72.1.58; GALBRAITH N S, 1961, Vet Rec, V73, P1296; GuardPetter J, 1997, APPL ENVIRON MICROB, V63, P1588, DOI 10.1128/AEM.63.4.1588-1593.1997; HENZLER DJ, 1992, AVIAN DIS, V36, P625, DOI 10.2307/1591757; HENZLER DJ, 1994, AVIAN DIS, V38, P37, DOI 10.2307/1591834; HEPNER E, 1980, PUBLIC HEALTH, V94, P337, DOI 10.1016/S0033-3506(80)80136-3; Hinz KH, 1996, J VET MED B, V43, P23, DOI 10.1111/j.1439-0450.1996.tb00284.x; Hormaeche CE, 1996, VACCINE, V14, P251, DOI 10.1016/0264-410X(95)00249-Z; Jones FS, 1913, J MED RES, V27, P481; KRABISCH P, 1980, BERL MUNCH TIERARZTL, V93, P232; LEE JA, 1974, J HYG-CAMBRIDGE, V72, P185, DOI 10.1017/S0022172400023391; MCCOY JH, 1975, J HYG-CAMBRIDGE, V74, P271, DOI 10.1017/S0022172400024347; MISHU B, 1994, J INFECT DIS, V169, P547, DOI 10.1093/infdis/169.3.547; Pignato S, 1996, ZBL BAKT-INT J MED M, V283, P399, DOI 10.1016/S0934-8840(96)80075-2; POPPE C, 1991, EPIDEMIOL INFECT, V106, P259, DOI 10.1017/S0950268800048408; RODRIGUE DC, 1990, EPIDEMIOL INFECT, V105, P21, DOI 10.1017/S0950268800047609; RYDER RW, 1976, J INFECT DIS, V133, P483, DOI 10.1093/infdis/133.4.483; SATO G, 1970, JPN J VET RES, V18, P47; Scuderi G, 1996, EPIDEMIOL INFECT, V116, P257, DOI 10.1017/S0950268800052559; Sojka W. J., 1970, Veterinary Bulletin, V40, P515; SOJKA WJ, 1975, VET REC, V96, P280; STLOUIS ME, 1988, JAMA-J AM MED ASSOC, V259, P2103, DOI 10.1001/jama.259.14.2103; THRELFALL EJ, 1992, J CLIN PATHOL, V45, P34, DOI 10.1136/jcp.45.1.34; WILSON JE, 1967, BRIT VET J, V123, P139, DOI 10.1016/S0007-1935(17)40052-2; 1982, MORBID MORTAL WKLY R, V31, P613; 1982, NATL POULTRY IMPROVE	36	185	195	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 7	2000	287	5450					50	52		10.1126/science.287.5450.50	http://dx.doi.org/10.1126/science.287.5450.50			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	271DG	10644222				2022-12-28	WOS:000084578400028
J	Ellerbroek, B; Rigaut, F				Ellerbroek, B; Rigaut, F			Optics adapt to the whole sky	NATURE			English	Editorial Material									Gemini Observ, Hilo, HI 96720 USA		Ellerbroek, B (corresponding author), Gemini Observ, 670 N Aohoku Pl, Hilo, HI 96720 USA.		Rigaut, Francois/R-6116-2019	Rigaut, Francois/0000-0003-3490-7121				BECKERS JM, 1989, P SOC PHOTO-OPT INS, V1114, P215, DOI 10.1117/12.960826; DAVIES R, IN PRESS EXP ASTRON; FOY R, 1985, ASTRON ASTROPHYS, V152, pL29; Gilmozzi R, 1998, P SOC PHOTO-OPT INS, V3352, P778, DOI 10.1117/12.319284; HAPPER W, 1994, J OPT SOC AM A, V11, P263, DOI 10.1364/JOSAA.11.000263; Ragazzoni R, 2000, NATURE, V403, P54, DOI 10.1038/47425; RIGAUT F, 1992, ASTRON ASTROPHYS, V261, P677; RIMMELE T, 1999, NOAO NEWSLETTER, V57	8	23	23	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					25	26		10.1038/47369	http://dx.doi.org/10.1038/47369			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638733				2022-12-28	WOS:000084687400022
J	Henney, JE				Henney, JE			New drug for stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					46	46		10.1001/jama.283.1.46	http://dx.doi.org/10.1001/jama.283.1.46			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	270AZ	10632269				2022-12-28	WOS:000084514400006
J	Henry, SH; Bosch, FX; Troxell, TC; Bolger, PM				Henry, SH; Bosch, FX; Troxell, TC; Bolger, PM			Public health - Reducing liver cancer - Global control of aflatoxin	SCIENCE			English	Article							HEPATITIS-B VACCINATION; METABOLISM; RISK; B-1		US FDA, Ctr Food Safety & Appl Nutr, Washington, DC 20204 USA; Inst Catala Oncol, Unitat Epidemiol, Barcelona, Spain	US Food & Drug Administration (FDA); Catalan Institute of Oncology	Henry, SH (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Washington, DC 20204 USA.	SHenry@bangate.fda.gov; X.Bosch@ico.scs.es	JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012	JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412				[Anonymous], 1998, WHO FOOD ADDITIVES S; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Brechot C, 1998, J HEPATOL, V29, P173, DOI 10.1016/S0168-8278(98)80001-9; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; EATON DL, 1994, TOXICOLOGY AFLATOXIN; Ferlay JIARC, 1998, GLOBOCAN 1 CANC INCI; Food and Agriculture Organization (FAO), 1997, WORLDW REG MYC 1995; GORELICK NJ, 1990, RISK ANAL, V10, P539, DOI 10.1111/j.1539-6924.1990.tb00538.x; Groopman, 1994, TOXICOLOGY AFLATOXIN, P3; Guengerich FP, 1996, ENVIRON HEALTH PERSP, V104, P557, DOI 10.2307/3432823; HALL AJ, 1994, TOXICOLOGY AFLATOXIN; Lee MS, 1998, INT J EPIDEMIOL, V27, P316, DOI 10.1093/ije/27.2.316; MASSEY TE, 1995, P SOC EXP BIOL MED, V208, P213, DOI 10.3181/00379727-208-43852A; MCLEAN M, 1995, PHARMACOL THERAPEUT, V65, P163, DOI 10.1016/0163-7258(94)00054-7; MILLER DM, 1994, TOXICOLOGY AFLATOXIN, P347, DOI DOI 10.1016/B978-0-12-228255-3.50021-0; ROEBUCK BD, 1994, TOXICOLOGY AFLATOXIN, P27; VANEGMOND HP, 1999, 3 JOINT FAO WHO UNEP; Wilson D.M., 1994, TOXICOLOGY AFLATOXIN, P309; 1999, AGR RES, V47	19	160	174	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 24	1999	286	5449					2453	2454		10.1126/science.286.5449.2453	http://dx.doi.org/10.1126/science.286.5449.2453			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268RQ	10636808				2022-12-28	WOS:000084429700026
J	Bird, A				Bird, A			Molecular biology - DNA methylation de novo	SCIENCE			English	Editorial Material							ICF SYNDROME; METHYLTRANSFERASES; DIFFERENTIATION; CLONING; PATTERN; CELLS		Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.			Bird, Adrian/0000-0002-8600-0372				BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Lei H, 1996, DEVELOPMENT, V122, P3195; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; VIEGASPEQUIGNOT E, 1976, HUM GENET, V34, P247, DOI 10.1007/BF00295287; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	15	80	92	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 17	1999	286	5448					2287	2288		10.1126/science.286.5448.2287	http://dx.doi.org/10.1126/science.286.5448.2287			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266UK	10636791				2022-12-28	WOS:000084318500040
J	Pahlow, M; Riebesell, U				Pahlow, M; Riebesell, U			Temporal trends in deep ocean Redfield ratios	SCIENCE			English	Article							EQUATORIAL PACIFIC-OCEAN; NORTH-ATLANTIC; NUTRIENT LIMITATION; IRON; NITROGEN; PHYTOPLANKTON; PRODUCTIVITY; NITRATE; OXYGEN; GROWTH	The Redfield ratio [carbon:nitrogen:phosphorus (C:N:P)] of particle flux to the deep ocean is a key factor in marine biogeochemical cycling. Changes in oceanic carbon sequestration have been Linked to variations in the Redfield ratio on geological time scales, but this ratio generally is assumed to be constant with time in the modern ocean. However, deep-water Redfield ratios in the northern hemisphere show evidence for temporal trends over the past five decades. The North Atlantic Ocean exhibits a rising N:P ratio, which may be related to increased deposition of atmospheric nitrous oxides from anthropogenic N emissions. In the North Pacific Ocean, increasing C:N and C:P ratios are accompanied by rising remineralization rates, which suggests intensified export production. Stronger export of carbon in this region may be due to enhanced bioavailability of aeolian iron. These findings imply that the biological part of the marine carbon cycle currently is not in steady state.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Pahlow, M (corresponding author), Alfred Wegener Inst Polar & Marine Res, POB 120161, D-27515 Bremerhaven, Germany.		Pahlow, Markus/AAC-4919-2020; Riebesell, Ulf/AAC-9717-2020					ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Bacon S, 1998, NATURE, V394, P871, DOI 10.1038/29736; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; BROECKER WS, 1985, J GEOPHYS RES-OCEANS, V90, P6925, DOI 10.1029/JC090iC04p06925; BROECKER WS, 1980, DEEP-SEA RES, V27, P591, DOI 10.1016/0198-0149(80)90076-X; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; DOERING PH, 1995, MAR ECOL PROG SER, V124, P271, DOI 10.3354/meps124271; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Duce R.A., 1986, ROLE AIR SEA EXCHANG, P497, DOI DOI 10.1007/978-94-009-4738-2_; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; FANNING KA, 1992, J GEOPHYS RES-OCEANS, V97, P5693, DOI 10.1029/92JC00007; FANNING KA, 1989, NATURE, V339, P460, DOI 10.1038/339460a0; GRASSHOFF K, 1968, REPORT INTERCALIBRAT; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HAGER SW, 1972, LIMNOL OCEANOGR, V17, P931, DOI 10.4319/lo.1972.17.6.0931; HECKY RE, 1993, LIMNOL OCEANOGR, V38, P709, DOI 10.4319/lo.1993.38.4.0709; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; KNAP A, 1986, NATURE, V320, P158, DOI 10.1038/320158a0; LOGAN JA, 1983, J GEOPHYS RES-OCEANS, V88, P785, DOI 10.1029/JC088iC15p10785; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; LONGHURST AR, 1991, LIMNOL OCEANOGR, V36, P1507, DOI 10.4319/lo.1991.36.8.1507; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1988, DEEP-SEA RES, V35, P177, DOI 10.1016/0198-0149(88)90035-0; MOREL FMM, 1991, LIMNOL OCEANOGR, V36, P1742, DOI 10.4319/lo.1991.36.8.1742; PRICE NM, 1991, DEEP-SEA RES, V38, P1361, DOI 10.1016/0198-0149(91)90011-4; Redfield A.C., 1963, SEA IDEA OBSERV, V2; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; SAKSHAUG E, 1977, J EXP MAR BIOL ECOL, V29, P1, DOI 10.1016/0022-0981(77)90118-6; SARMIENTO JL, 1990, J GEOPHYS RES-OCEANS, V95, P18303, DOI 10.1029/JC095iC10p18303; WATSON AJ, 1985, DEEP-SEA RES, V32, P1023, DOI 10.1016/0198-0149(85)90060-3; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; YENTSCH CS, 1990, J PLANKTON RES, V12, P717, DOI 10.1093/plankt/12.4.717; Young RW, 1991, GLOBAL BIOGEOCHEM CY, V5, P119, DOI 10.1029/91GB00927; Zhu Z. D., 1993, Desertification Control Bulletin, P27; ZHUANG G, 1990, J GEOPHYS RES-OCEANS, V95, P16207, DOI 10.1029/JC095iC09p16207; ZHUANG GS, 1992, NATURE, V355, P537, DOI 10.1038/355537a0	38	87	92	5	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					831	833		10.1126/science.287.5454.831	http://dx.doi.org/10.1126/science.287.5454.831			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657291	Green Submitted			2022-12-28	WOS:000085136400038
J	Rivera, VM; Wang, XR; Wardwell, S; Courage, NL; Volchuk, A; Keenan, T; Holt, DA; Gilman, M; Orci, L; Cerasoli, F; Rothman, JE; Clackson, T				Rivera, VM; Wang, XR; Wardwell, S; Courage, NL; Volchuk, A; Keenan, T; Holt, DA; Gilman, M; Orci, L; Cerasoli, F; Rothman, JE; Clackson, T			Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum	SCIENCE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; INTRAMUSCULAR INJECTION; GENE-EXPRESSION; MAMMALIAN-CELLS; SKELETAL-MUSCLE; MICE; INSULIN; BINDING; ERYTHROPOIETIN; TRANSDUCTION	A system for direct pharmacologic control of protein secretion was developed to allow rapid and pulsatile delivery of therapeutic proteins. A protein was engineered so that it accumulated as aggregates in the endoplasmic reticulum. Secretion was then stimulated by a synthetic small-molecule drug that induces protein disaggregation. Rapid and transient secretion of growth hormone and insulin was achieved in vitro and in vivo. A regulated pulse of insulin secretion resulted in a transient correction of serum glucose concentrations in a mouse model of hyperglycemia. This approach may make gene therapy a viable method for delivery of polypeptides that require rapid and regulated delivery.	ARIAD Pharmaceut Inc, Gene Therapeut, Cambridge, MA 02139 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Univ Geneva, Sch Med, Dept Morphol, CH-1211 Geneva, Switzerland	Takeda Pharmaceutical Company Ltd; Takeda Oncology; Memorial Sloan Kettering Cancer Center; University of Geneva	Rivera, VM (corresponding author), ARIAD Pharmaceut Inc, Gene Therapeut, 26 Landsdowne St, Cambridge, MA 02139 USA.			Rivera, Victor/0000-0002-7258-3001				ATTAR RM, 1992, MOL CELL BIOL, V12, P2432, DOI 10.1128/MCB.12.5.2432; BELL GI, 1979, NATURE, V282, P525, DOI 10.1038/282525a0; Bohl D, 1998, BLOOD, V92, P1512, DOI 10.1182/blood.V92.5.1512.417k43_1512_1517; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; CLACKSON T, UNPUB; Denault JB, 1996, FEBS LETT, V379, P113, DOI 10.1016/0014-5793(95)01487-X; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GROSKREUTZ DJ, 1994, J BIOL CHEM, V269, P6241; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; HOLT DA, UNPUB; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Li FQ, 1996, J CELL BIOL, V135, P1043, DOI 10.1083/jcb.135.4.1043; MARTIAL JA, 1979, SCIENCE, V205, P602, DOI 10.1126/science.377496; Murphy JE, 1997, P NATL ACAD SCI USA, V94, P13921, DOI 10.1073/pnas.94.25.13921; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; ORCI L, 1982, DIABETES, V31, P538, DOI 10.2337/diab.31.6.538; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Rendahl KG, 1998, NAT BIOTECHNOL, V16, P757, DOI 10.1038/nbt0898-757; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rivera VM, 1999, P NATL ACAD SCI USA, V96, P8657, DOI 10.1073/pnas.96.15.8657; RIVERA VM, UNPUB; RONNE H, 1983, J CELL BIOL, V96, P907, DOI 10.1083/jcb.96.3.907; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Spencer DM, 1996, TRENDS GENET, V12, P181, DOI 10.1016/0168-9525(96)10013-5; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876; VOLCHUK A, 1995, J BIOL CHEM, V270, P8233, DOI 10.1074/jbc.270.14.8233; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; WARDWELL S, UNPUB; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Ye XH, 1999, SCIENCE, V283, P88, DOI 10.1126/science.283.5398.88	37	253	283	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					826	830		10.1126/science.287.5454.826	http://dx.doi.org/10.1126/science.287.5454.826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10657290				2022-12-28	WOS:000085136400037
J	Deyle, GD; Henderson, NE; Matekel, RL; Ryder, MG; Garber, MB; Allison, SC				Deyle, GD; Henderson, NE; Matekel, RL; Ryder, MG; Garber, MB; Allison, SC			Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							OSTEO-ARTHRITIS; PROGRAM; CAPACITY; MUSCLE; REHABILITATION; FLEXIBILITY; CRITERIA; PATIENT; WOMAC; HIP	Background: Few investigations include both subjective and objective measurements of the effectiveness of treatments for osteoarthritis of the knee. Beneficial interventions may decrease the disability associated with osteoarthritis and the need for more invasive treatments. Objective: To evaluate the effectiveness of physical therapy for osteoarthritis of the knee, applied by experienced physical therapists with formal training in manual therapy. Design: Randomized, controlled clinical trial. Setting: Outpatient physical therapy department of a large military medical center. Patients: 83 patients with osteoarthritis of the knee who were randomly assigned to receive treatment (n = 42; 15 men and 27 women [mean age, 60 +/- 11 years]) or placebo (n = 41; 19 men and 22 women [mean age, 62 +/- 10 years]). Intervention: The treatment group received manual therapy, applied to the knee as well as to the lumbar spine, hip, and ankle as required, and performed a standardized knee exercise program in the clinic and at home. The placebo group had subtherapeutic ultrasound to the knee at an intensity of 0.1 W/cm(2) with a 10% pulsed mode. Both groups were treated at the clinic twice weekly for 4 weeks. Measurements: Distance walked in 6 minutes and sum of the function, pain, and stiffness subscores of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). A tester who was blinded to group assignment made group comparisons at the initial visit (before initiation of treatment), 4 weeks, 8 weeks, and 1 year. Results: Clinically and statistically significant improvements in 6-minute walk distance and WOMAC score at 4 weeks and 8 weeks were seen in the treatment group but not the placebo group. By 8 weeks, average 6-minute walk distances had improved by 13.1% and WOMAC scores had improved by 55.8% over baseline values in the treatment group (P < 0.05). After controlling for potential confounding variables, the average distance walked in 6 minutes at 8 weeks among patients in the treatment group was 170 m (95% CI, 71 to 270 m) more than that in the placebo group and the average WOMAC scores were 599 mm higher (95% CI, 197 to 1002 mm). At 1 year, patients in the treatment group had clinically and statistically significant gains over baseline WOMAC scores and walking distance; 20% of patients in the placebo group and 5% of patients in the treatment group had undergone knee arthroplasty. Conclusions: A combination of manual physical therapy and supervised exercise yields functional benefits for patients with osteoarthritis of the knee and may delay or prevent the need for surgical intervention.	Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA; Baylor Univ, USA, Ft Sam Houston, TX 78234 USA; Madigan Army Med Ctr, Tacoma, WA 98431 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army; Baylor University; Madigan Army Medical Center	Deyle, GD (corresponding author), Brooke Army Med Ctr, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	gail.deyle@amedd.army.mil						ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ALTMAN RD, 1991, J RHEUMATOL, V18, P10; ALTMAN RD, 1987, J RHEUMATOL, V14, P3; BANDY WD, 1994, PHYS THER, V74, P845, DOI 10.1093/ptj/74.9.845; BANG MD, 2000, IN PRESS J ORTHOP SP; BARR S, 1994, J RHEUMATOL, V21, P2106; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bellamy N, 1995, WOMAC OSTEOARTHRITIS; DALY MP, 1993, CLIN GERIATR MED, V9, P783, DOI 10.1016/S0749-0690(18)30377-X; DINUBILE NA, 1991, CLIN SPORT MED, V10, P33; ETTINGER WH, 1994, MED SCI SPORT EXER, V26, P1435; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; EVJENTH O, 1988, MUSCLE STRETCHING MA, V1; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; FISHER NM, 1993, ARCH PHYS MED REHAB, V74, P840, DOI 10.1016/0003-9993(93)90011-X; FISHER NM, 1994, AM J PHYS MED REHAB, V73, P413, DOI 10.1097/00002060-199411000-00006; FISHER NM, 1993, ARCH PHYS MED REHAB, V74, P1319, DOI 10.1016/0003-9993(93)90087-Q; FISHER NM, 1994, ARCH PHYS MED REHAB, V75, P792; FISHER NM, 1991, ARCH PHYS MED REHAB, V72, P365; Greenman P., 1996, PRINCIPLES MANUAL ME; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HICKS JE, 1989, J MUSCULOSKEL MED, V6, P40; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; LANE NE, 1993, RHEUM DIS CLIN N AM, V19, P617; Maitland G., 1991, PERIPHERAL MANIPULAT; MAITLAND GD, 1985, VERTEBRAL MANIPULATI; Mangione KK, 1996, PHYS THER, V76, P387; MCNEIL JM, 1994, JAMA-J AM MED ASSOC, V272, P1735; NESHER G, 1994, CLIN GERIATR MED, V10, P659, DOI 10.1016/S0749-0690(18)30322-7; PANUSH RS, 1994, BAILLIERE CLIN RHEUM, V8, P79, DOI 10.1016/S0950-3579(05)80226-2; PANUSH RS, 1994, SOUTH MED J, V87, pS74; PINALS RS, 1992, CLIN THER, V14, P336; PRENTICE WE, 1992, J SPORT REHABIL, V1, P249; PUETT DW, 1994, ANN INTERN MED, V121, P133, DOI 10.7326/0003-4819-121-2-199407150-00010; TICHENOR CI, 1998, ORTHOPAEDIC MANUAL P; WALLIN D, 1985, AM J SPORT MED, V13, P263, DOI 10.1177/036354658501300409; YTTERBERG SR, 1994, BAILLIERE CLIN RHEUM, V8, P161, DOI 10.1016/S0950-3579(05)80230-4; Zachazewski J. E., 1996, ATHLETIC INJURIES RE	40	438	450	1	75	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2000	132	3					173	181		10.7326/0003-4819-132-3-200002010-00002	http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276XE	10651597				2022-12-28	WOS:000084903000001
J	Kremer, C; Duffy, S; Moroney, M				Kremer, C; Duffy, S; Moroney, M			Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							ANESTHESIA; RECOVERY; WELL	Objective To compare outpatient hysteroscopy with day case hysteroscopy in terms of patient satisfaction and acceptability. Setting Gynaecology clinic of a teaching hospital. Participants 100 women. Design and interventions Patients were randomly allocated to outpatient hysteroscopy or day case hysteroscopy provided they had no preference for either procedure. Main outcome measures Satisfaction rate, requirements for postoperative analgesia, speed of recovery, time away from home, and time off work. Results The outpatient group recovered preoperative fitness more quickly than the day case group (2 days (range 1-2.7) versus 3 days (2-4), P < 0.05). After the procedure, the outpatient group were also fully mobile more quickly than the day case group (0 minutes (0-5) versus 105 minutes (80-120), P < 0.001). Requirements for postoperative analgesia were similar in both groups. Overall, 78% of patients considered that the pain from outpatient hysteroscopy was less than that usually experienced during menstruation. Patient satisfaction was similar in both groups (83.6% in the outpatient group versus 77.0% in the day case group). Conclusions Outpatient hysteroscopy and day case hysteroscopy were equally acceptable to patients. Patients recovered significantly more quickly from outpatient hysteroscopy than from day case hysteroscopy.	St James Univ Hosp, Dept Obstet & Gynaecol, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Duffy, S (corresponding author), St James Univ Hosp, Dept Obstet & Gynaecol, Leeds LS9 7TF, W Yorkshire, England.							DEJONG P, 1990, BRIT J OBSTET GYNAEC, V97, P299; DOWNES E, 1993, EUR J OBSTET GYN R B, V48, P37, DOI 10.1016/0028-2243(93)90051-D; Finikiotis G, 1990, Aust N Z J Obstet Gynaecol, V30, P89; GOLDRATH MH, 1985, AM J OBSTET GYNECOL, V152, P220, DOI 10.1016/S0002-9378(85)80026-0; HAMOU J, 1982, CURR PROB OBST GYN F, V6, P6; JAMISON NR, 1993, POSTOPERATIVE PAIN M, P119; Kremer C, 1998, BRIT J OBSTET GYNAEC, V105, P672, DOI 10.1111/j.1471-0528.1998.tb10185.x; La Sala G B, 1986, Acta Eur Fertil, V17, P369; LIN BL, 1990, J REPROD MED, V35, P685; Nagele F, 1996, OBSTET GYNECOL, V88, P87, DOI 10.1016/0029-7844(96)00108-1; SANDERS LD, 1991, ANAESTHESIA, V46, P451, DOI 10.1111/j.1365-2044.1991.tb11681.x; STEWARD DJ, 1975, CAN ANAESTH SOC J, V22, P111, DOI 10.1007/BF03004827; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	13	115	119	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					279	282		10.1136/bmj.320.7230.279	http://dx.doi.org/10.1136/bmj.320.7230.279			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650023	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000085132700019
J	Briggs, A; Gray, A				Briggs, A; Gray, A			Economics notes - Using cost effectiveness information	BRITISH MEDICAL JOURNAL			English	Article							GUIDELINES; ADOPTION		Univ Oxford, Inst Hlth Sci, Hlth Econ Res Ctr, Oxford OX3 7LF, England	University of Oxford	Briggs, A (corresponding author), Univ Oxford, Inst Hlth Sci, Hlth Econ Res Ctr, Oxford OX3 7LF, England.			Briggs, Andrew/0000-0002-0777-1997				GAFNI A, 1993, CAN MED ASSOC J, V148, P913; Gerard K, 1993, Health Econ, V2, P59, DOI 10.1002/hec.4730020108; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Palmer S, 1999, BRIT MED J, V318, P1551, DOI 10.1136/bmj.318.7197.1551; Pharoah PDP, 1996, BMJ-BRIT MED J, V312, P1443, DOI 10.1136/bmj.312.7044.1443; WILLIAMS A, 1985, BRIT MED J, V291, P326, DOI 10.1136/bmj.291.6491.326	6	42	42	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					246	246		10.1136/bmj.320.7229.246	http://dx.doi.org/10.1136/bmj.320.7229.246			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642242	Green Published			2022-12-28	WOS:000085029600038
J	Lundgren, O; Peregrin, AT; Persson, K; Kordasti, S; Uhnoo, I; Svensson, L				Lundgren, O; Peregrin, AT; Persson, K; Kordasti, S; Uhnoo, I; Svensson, L			Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea	SCIENCE			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; INFECTED MOUSE INTESTINE; CHOLERA SECRETION; MURINE ROTAVIRUS; MICE; PATHOGENESIS; INVOLVEMENT; TRANSPORT; BLOCKADE; CHILDREN	The mechanism underlying the intestinal fluid loss in rotavirus diarrhea, which often afflicts children in developing countries, is not known. One hypothesis is that the rotavirus evokes intestinal fluid and electrolyte secretion by activation of the nervous system in the intestinal wall, the enteric nervous system (ENS). Four different drugs that inhibit ENS functions were used to obtain experimental evidence for this hypothesis in mice in vitro and in vivo, The involvement of the ENS in rotavirus diarrhea indicates potential sites of action for drugs in the treatment of the disease.	Univ Gothenburg, Dept Physiol, S-40530 Gothenburg, Sweden; Univ Uppsala Hosp, Dept Med Sci, Infect Dis Sect, S-75185 Uppsala, Sweden; Swedish Inst Infect Dis Control, Dept Virol, S-17182 Solna, Sweden	University of Gothenburg; Uppsala University; Uppsala University Hospital; Swedish Institute for Infectious Disease Control	Lundgren, O (corresponding author), Univ Gothenburg, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden.		svensson, lennart/K-6163-2019					Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; BRUNSSON I, 1987, ACTA PHYSIOL SCAND, V131, P609, DOI 10.1111/j.1748-1716.1987.tb08282.x; BRUNSSON I, 1987, ACTA PHYSIOL SCAND, V130, P633, DOI 10.1111/j.1748-1716.1987.tb08186.x; CASSUTO J, 1981, SCAND J GASTROENTERO, V16, P377, DOI 10.3109/00365528109181984; CASSUTO J, 1982, ACTA PHYSIOL SCAND, V114, P573, DOI 10.1111/j.1748-1716.1982.tb07026.x; CASSUTO J, 1982, SCAND J GASTROENTERO, V17, P695, DOI 10.3109/00365528209181081; CASTAGLIUOLO I, 1994, GASTROENTEROLOGY, V107, P657, DOI 10.1016/0016-5085(94)90112-0; COELHO KIR, 1981, ULTRASTRUCT PATHOL, V2, P59, DOI 10.3109/01913128109031504; COOPER H, 1966, GASTROENTEROLOGY, V50, P1; DAVIDSON GP, 1979, ACTA PAEDIATR SCAND, V68, P181, DOI 10.1111/j.1651-2227.1979.tb04986.x; DAVIDSON GP, 1975, J CLIN PATHOL, V28, P263, DOI 10.1136/jcp.28.4.263; EKLUND S, 1988, ACTA PHYSIOL SCAND, V133, P551, DOI 10.1111/j.1748-1716.1988.tb08440.x; Hille B., 1992, IONIC CHANNELS EXCIT; JODAL M, 1993, GUT, V34, P1526, DOI 10.1136/gut.34.11.1526; JODAL M, 1995, REGULATORY MECH GAST, P99; KOHLER VT, 1990, KINDERARZTL PRAX, V58, P323; LITTLE LM, 1982, INFECT IMMUN, V38, P755, DOI 10.1128/IAI.38.2.755-763.1982; LUNDGREN O, UNPUB; MATHIAS JR, 1989, HDB PHYSL GASTROINTE, V1, P1153; OFFIT PA, 1984, J VIROL, V51, P233, DOI 10.1128/JVI.51.1.233-236.1984; OSBORNE MP, 1991, J PEDIATR GASTR NUTR, V12, P111, DOI 10.1097/00005176-199101000-00021; OSBORNE MP, 1988, J PEDIATR GASTR NUTR, V7, P236, DOI 10.1097/00005176-198803000-00014; Peregrin AT, 1997, ACTA PHYSIOL SCAND, V160, P379, DOI 10.1046/j.1365-201X.1997.00173.x; Ruggeri FM, 1998, J VIROL, V72, P2708, DOI 10.1128/JVI.72.4.2708-2714.1998; SJOQVIST A, 1988, ACTA PHYSIOL SCAND, V133, P289, DOI 10.1111/j.1748-1716.1988.tb08410.x; SPENCER AJ, 1990, J PEDIATR GASTR NUTR, V10, P516, DOI 10.1097/00005176-199005000-00016; STARKEY WG, 1986, J GEN VIROL, V67, P2625, DOI 10.1099/0022-1317-67-12-2625; STARKEY WG, 1990, J PEDIATR GASTR NUTR, V11, P254, DOI 10.1097/00005176-199008000-00016; STEPHEN J, 1989, P 9 BSG SK F INT WOR; SVENSSON L, 1991, J VIROL, V65, P4190, DOI 10.1128/JVI.65.8.4190-4197.1991; Weclewicz K, 1998, BRAIN RES BULL, V46, P353, DOI 10.1016/S0361-9230(98)00013-6; 1999, WHO WEEKLY EPIDEMIOL, P33	32	178	191	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2000	287	5452					491	495		10.1126/science.287.5452.491	http://dx.doi.org/10.1126/science.287.5452.491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642552				2022-12-28	WOS:000084929900050
J	Stathopoulos, C; Li, T; Longman, R; Vothknecht, UC; Becker, HD; Ibba, M; Soll, D				Stathopoulos, C; Li, T; Longman, R; Vothknecht, UC; Becker, HD; Ibba, M; Soll, D			One polypeptide with two aminoacyl-tRNA synthetase activities	SCIENCE			English	Article							TRANSFER-RNA SYNTHETASES; COMPLETE GENOME SEQUENCE; PARTITION; CODE	The genome sequences of certain archaea do not contain recognizable cysteinyl-transfer RNA (tRNA) synthetases, which are essential for messenger RNA-encoded protein synthesis. However, a single cysteinyl-tRNA synthetase activity was detected and purified from one such organism, Methanococcus jannaschii. The amino-terminal sequence of this protein corresponded to the predicted sequence of prolyl-tRNA synthetase. Biochemical and genetic analyses indicated that this archaeal form of prolyl-tRNA synthetase can synthesize both cysteinyl-tRNA(Cys) and prolyl-tRNA(Pro). The ability of one enzyme to provide two aminoacyl-tRNAs for protein synthesis raises questions about concepts of substrate specificity in protein synthesis and may provide insights into the evolutionary origins of this process.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Copenhagen, Panum Inst, Ctr Biomol Recognit, Dept Med Biochem & Genet,Lab B, DK-2200 Copenhagen N, Denmark	Yale University; Yale University; Yale University; University of Copenhagen	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114,266 Whitney Ave, New Haven, CT 06520 USA.	soll@trna.chem.yale.edu	Vothknecht, Ute C/F-4678-2014	Vothknecht, Ute C/0000-0002-8930-0127; Becker, Hubert/0000-0002-4102-7520; Stathopoulos, Constantinos/0000-0002-5699-4118				BOHMAN K, 1979, MOL GEN GENET, V176, P53, DOI 10.1007/BF00334295; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; BUSIELLO V, 1979, BIOCHIM BIOPHYS ACTA, V564, P311, DOI 10.1016/0005-2787(79)90228-4; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; CURNOW AW, UNPUB; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Delarue M, 1995, J MOL EVOL, V41, P703; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Hamann CS, 1999, J BACTERIOL, V181, P5880, DOI 10.1128/JB.181.18.5880-5884.1999; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ibba M, 1997, TRENDS BIOCHEM SCI, V22, P39, DOI 10.1016/S0968-0004(96)20033-7; Jakubowski H, 1999, BIOCHEMISTRY-US, V38, P8088, DOI 10.1021/bi990629i; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Jakubowski H, 1997, BIOCHEMISTRY-US, V36, P11077, DOI 10.1021/bi970589n; Kim HS, 1998, J BACTERIOL, V180, P6446, DOI 10.1128/JB.180.24.6446-6449.1998; LACEY JC, 1999, CHEMTRACTS, V12, P398; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; NAGEL GM, 1995, J MOL EVOL, V40, P487; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; PEARSON RL, 1971, BIOCHIM BIOPHYS ACTA, V228, P770, DOI 10.1016/0005-2787(71)90748-9; Reeve JN, 1999, J BACTERIOL, V181, P3613, DOI 10.1128/JB.181.12.3613-3617.1999; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Springer M, 1998, COLD SPRING HARBOR M, P377; Stehlin C, 1998, BIOCHEMISTRY-US, V37, P8605, DOI 10.1021/bi980364s; WHITFELD PR, 1953, NATURE, V171, P1151, DOI 10.1038/1711151a0; WOESE CR, 1966, COLD SPRING HARB SYM, V31, P723, DOI 10.1101/SQB.1966.031.01.093; Wolf YI, 1999, GENOME RES, V9, P689	28	65	71	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					479	482		10.1126/science.287.5452.479	http://dx.doi.org/10.1126/science.287.5452.479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642548				2022-12-28	WOS:000084929900046
J	Seeff, LB; Miller, RN; Rabkin, CS; Buskell-Bales, Z; Straley-Eason, KD; Smoak, BL; Johnson, LD; Lee, SR; Kaplan, EL				Seeff, LB; Miller, RN; Rabkin, CS; Buskell-Bales, Z; Straley-Eason, KD; Smoak, BL; Johnson, LD; Lee, SR; Kaplan, EL			45-year follow-up of hepatitis C virus infection in healthy young adults	ANNALS OF INTERNAL MEDICINE			English	Article							NON-B-HEPATITIS; POST-TRANSFUSION HEPATITIS; VOLUNTEER BLOOD-DONORS; NON-A; HEPATOCELLULAR-CARCINOMA; POSTTRANSFUSION HEPATITIS; ALANINE AMINOTRANSFERASE; ANTIBODIES; PREVALENCE; EPIDEMIOLOGY	Background: The sequelae during the first two decades after acute hepatitis C virus (HCV) infection have been well studied, but the outcome thereafter is unknown. Objective: To conduct an extended study of the natural history of HCV infection by using archived serum specimens originally collected between 1948 and 1954. Design: Retrospective cohort study. Setting: A university, a Veterans Affairs medical center, and a medical follow-up agency that had access to the serum specimens and accompanying demographic and medical records. Participants: 8568 military recruits who were evaluated for group A streptococcal infection and acute rheumatic fever between 1948 and 1954. Blood samples were taken from the recruits and, after testing, were stored frozen for almost 45 years. Measurements: The presence of antibodies to HCV was determined by enzyme-linked immunoassay, supplementary recombinant immunoblot assay, and polymerase chain reaction for HCV RNA. Morbidity and mortality were also assessed. Results: Of 8568 persons, 17 (0.2%) had positive results on enzyme-linked immunosorbent assay and recombinant immunoblot assay. The rate was 1.8% among the African-American persons and 0.1% among the white persons in the total sample (relative risk, 25.9 [95% CI, 8.4 to 80.01]). During the 45-year follow-up, liver disease occurred in 205 of the 17 HCV-positive persons (11.8%) and 205 of the 8551 HCV-negative persons (2.4%) (ethnicity-adjusted relative risk, 3.56 [CI, 0.94 to 13.52]). Seven of the 17 HCV-positive persons (41 %) and 2226 of the 8551 HCV-negative persons (26%) had died by December 1996 (ethnicity-adjusted relative risk, 1.48 [CI, 0.8 to 2.61]). Of persons who were HCV-positive, 1 (5.9%) died of liver disease 42 years after the original phlebotomy, 5 (29%) died of non-liver-related disease a median of 37 years after the original phlebotomy, and 1 (5.9%) died of unknown causes. One hundred nineteen HCV-negative persons (1.4%) died of liver disease. Conclusions: The rate of HCV infection from 1948 to 1954 among a sample of military recruits parallels that among present-day military recruits and volunteer blood donors. During 45 years of follow-up, HCV-positive persons had low liver-related morbidity and mortality rates. This suggests that healthy HCV-positive persons may be at less risk for progressive liver disease than is currently thought.	Vet Affairs Med Ctr, Washington, DC 20422 USA; Georgetown Univ, Sch Med, Inst Med, Washington, DC USA; Walter Reed Army Inst Res, Washington, DC USA; NCI, NIH, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; Ortho Clin Diagnost, Raritan, NJ USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities	Seeff, LB (corresponding author), NIDDKD, NIH, Room 9A-18,31 Ctr Dr, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [Z01CP005782, ZIACP005782] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; ALTER HJ, 1978, P 2 S VIR HEP U CALF, P359; BRUIX J, 1989, LANCET, V2, P1004; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COLOMBO M, 1989, LANCET, V2, P1006; CUCCHERINI B, 1983, J LAB CLIN MED, V102, P370; DAVIS GL, 1994, HEPATOLOGY, V19, P1337, DOI 10.1002/hep.1840190603; DEAN AG, 1995, WORD PROCESSING DATA; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; DIENSTAG JL, 1983, GASTROENTEROLOGY, V85, P439; DITTMANN S, 1991, J HEPATOL, V13, P323, DOI 10.1016/0168-8278(91)90076-N; ELSERAG HB, 1999, RISING INCIDENCE HEP, V340, P745; HYAMS KC, 1992, MIL MED, V157, P579, DOI 10.1093/milmed/157.11.579; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; KNODELL RG, 1976, LANCET, V1, P557; KORETZ RL, 1993, ANN INTERN MED, V119, P110, DOI 10.7326/0003-4819-119-2-199307150-00003; MCQUILLAN GM, 1997, P IC TRIENN INT S VI, P267; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; MOYER LA, 1989, AM J EPIDEMIOL, V130, P1024, DOI 10.1093/oxfordjournals.aje.a115403; NISHIOKA K, 1991, CANCER, V67, P429, DOI 10.1002/1097-0142(19910115)67:2<429::AID-CNCR2820670218>3.0.CO;2-#; Page WF, 1996, ANN EPIDEMIOL, V6, P102, DOI 10.1016/1047-2797(95)00126-3; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; RLES LA, 1998, ANN CAC REV 1973 199; SEEFF LB, 1977, GASTROENTEROLOGY, V72, P111; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; SEEFF LB, 1978, P 2 S VIR HEP U CALF, P371; SHAKIL AO, 1995, ANN INTERN MED, V123, P330, DOI 10.7326/0003-4819-123-5-199509010-00002; STUYVER L, 1993, J GEN VIROL, V74, P1093, DOI 10.1099/0022-1317-74-6-1093; TAKAHASHI M, 1993, AM J GASTROENTEROL, V88, P240; TAKANO S, 1995, HEPATOLOGY, V21, P650; THOMAS RJ, 1988, REV INFECT DIS, V10, P125; TOBLER LH, 1994, TRANSFUSION, V34, P130, DOI 10.1046/j.1537-2995.1994.34294143940.x; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; UYTTENDAELE S, 1994, VOX SANG, V66, P122, DOI 10.1111/j.1423-0410.1994.tb00293.x; YANO M, 1993, GUT, V34, pS13, DOI 10.1136/gut.34.2_Suppl.S13	42	272	282	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					105	111		10.7326/0003-4819-132-2-200001180-00003	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	10644270				2022-12-28	WOS:000084852300002
J	Ciment, J				Ciment, J			Procedures on dying patients are wrong, study concludes	BRITISH MEDICAL JOURNAL			English	News Item																		Kaldjian LC, 1999, NEW ENGL J MED, V341, P2088, DOI 10.1056/NEJM199912303412711	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					137	137		10.1136/bmj.320.7228.137	http://dx.doi.org/10.1136/bmj.320.7228.137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634722	Green Published			2022-12-28	WOS:000084860300011
J	Diffey, B				Diffey, B			Has the sun protection factor had its day?	BRITISH MEDICAL JOURNAL			English	Article							SUNSCREEN APPLICATION		Newcastle Gen Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle General Hospital	Diffey, B (corresponding author), Newcastle Gen Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.							[Anonymous], 1978, FED REGISTER, V43, P38206; BECHTHOMSEN N, 1993, PHOTODERMATOL PHOTO, V9, P242; *BRIT STAND I, 1998, 7914 BS; CIE Standard, 1998, S007E1998 CIE; COX NH, 1992, BRIT J DERMATOL, V126, P315, DOI 10.1111/j.1365-2133.1992.tb00671.x; Diffey BL, 1996, BMJ-BRIT MED J, V313, P942; Dixon H., 1997, SUNSMART EVALUATION, P70; GARMYN MA, 1986, PHOTODERMATOLOGY, V3, P104; GIES HP, 1996, ENV UV RAD RISK SKIN, P213; Gottlieb A., 1997, SUNSCREENS DEV EVALU, P583; Hawk J.L.M., 1999, PHOTODERMATOLOGY, P5; *HLTH ED AUTH, 1996, SUNSCR CONS; La Vecchia C, 1999, EUR J CANCER PREV, V8, P267; LOCKANDERSEN J, 1998, LANDMARKS PHOTOBIOLO, P315; MARKS R, 1995, ARCH DERMATOL, V131, P462; Rhodes LE, 1996, J SOC COSMET CHEM, V47, P109; ROY C, 1996, CANC FORUM, V20, P173; STENBERG C, 1985, ARCH DERMATOL, V121, P1400, DOI 10.1001/archderm.121.11.1400; Stokes R, 1997, PHOTODERMATOL PHOTO, V13, P186, DOI 10.1111/j.1600-0781.1997.tb00227.x; WEINSTOCK MA, 1992, J CLIN EPIDEMIOL, V45, P547, DOI 10.1016/0895-4356(92)90104-U	20	39	42	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					176	177		10.1136/bmj.320.7228.176	http://dx.doi.org/10.1136/bmj.320.7228.176			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634743	Green Published			2022-12-28	WOS:000084860300034
J	Eccleshall, SC; Townend, JN				Eccleshall, SC; Townend, JN			Unstable angina due to spontaneous coronary-artery dissection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									N Staffordshire Hosp Ctr, Stoke On Trent ST4 6QG, Staffs, England; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England	Keele University; University of Birmingham	Eccleshall, SC (corresponding author), N Staffordshire Hosp Ctr, Stoke On Trent ST4 6QG, Staffs, England.			Townend, Jonathan/0000-0002-5881-5806					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2000	342	2					95	95		10.1056/NEJM200001133420205	http://dx.doi.org/10.1056/NEJM200001133420205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273TQ	10631278				2022-12-28	WOS:000084723900005
J	Fisher, AT; Becker, K				Fisher, AT; Becker, K			Channelized fluid flow in oceanic crust reconciles heat-flow and permeability data	NATURE			English	Article							HYDROTHERMAL CIRCULATION; RIDGE; CONVECTION; SEDIMENT; ATLANTIC; FLUXES; FLANK; AGE	Hydrothermal fluid circulation within the sea floor profoundly influences the physical, chemical and biological state of the crust and the oceans. Circulation within ridge flanks (in crust more than 1 Myr old) results in greater heat loss(1-3) and fluid flux(4) than that at ridge crests and persists for millions of years, thereby altering the composition of the crust and overlying ocean(5,6). Fluid flow in oceanic crust is, however, limited by the extent and nature of the rock's permeability(7). Here we demonstrate that the global data set of borehole permeability measurements in uppermost oceanic crust(7-9) defines a trend with age that is consistent with changes in seismic velocity(10,11). This trend-which indicates that fluid flow should be greatly reduced in crust older than a few million years-would appear to be inconsistent with heat-flow observations, which on average indicate significant advective heat loss in crust up to 65 Myr old(3). But our calculations, based on a lateral flow model, suggest that regional-scale permeabilities are much higher than have been measured in boreholes. These results can be reconciled if most of the fluid flow in the upper crust is channelized through a small volume of rock, influencing the geometry of convection and the nature of fluid-rock interaction.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, Miami, FL 33145 USA	University of California System; University of California Santa Cruz; University of Miami	Fisher, AT (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA.		Fisher, Andrew/A-1113-2016					Alt J.C., 1995, GEOPHYS MONOGRAPH AM, V91, P85; BAKER PA, 1991, EARTH PLANET SC LETT, V105, P522, DOI 10.1016/0012-821X(91)90189-O; BECKER K, 1983, J GEOPHYS RES, V88, P3447, DOI 10.1029/JB088iB04p03447; BECKER K, IN PRESS J GEOPHYS R; BRUNS TR, 1994, P OCEAN DRILLING PRO, V135, P805; Carlson RL, 1998, J GEOPHYS RES-SOL EA, V103, P7069, DOI 10.1029/97JB03577; DAVIS E, 1998, EOS, V79, pF377; DAVIS E, 1998, EOS, V79, P367; Davis EE, 1997, EARTH PLANET SC LETT, V146, P137, DOI 10.1016/S0012-821X(96)00212-9; Davis EE, 1999, J GEOPHYS RES-SOL EA, V104, P17675, DOI 10.1029/1999JB900124; DAVIS EE, 1989, NATURE, V342, P533, DOI 10.1038/342533a0; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; EMBLEY RW, 1983, J GEOPHYS RES, V88, P1067, DOI 10.1029/JB088iB02p01067; Fisher AT, 1997, GEOPHYS RES LETT, V24, P1311, DOI 10.1029/97GL01286; Fisher AT, 1998, REV GEOPHYS, V36, P143, DOI 10.1029/97RG02916; GILLIS KM, 1988, GEOLOGY, V16, P262, DOI 10.1130/0091-7613(1988)016<0262:DOAZIT>2.3.CO;2; Gillis KM, 1997, J GEOPHYS RES-SOL EA, V102, P10133, DOI 10.1029/96JB03909; Grevemeyer I, 1999, J GEOPHYS RES-SOL EA, V104, P5069, DOI 10.1029/1998JB900096; HOLMES ML, 1993, GEOPHYS RES LETT, V20, P1871, DOI 10.1029/93GL00909; JACOBSON RS, 1992, REV GEOPHYS, V30, P23, DOI 10.1029/91RG02811; LANGSETH MG, 1992, GEOPHYS RES LETT, V19, P517, DOI 10.1029/92GL00079; LANGSETH MG, 1981, J GEOPHYS RES, V86, P805, DOI 10.1029/JB086iB11p10805; MATTHEWS M, 1984, INIT REPTS DSDP B, V78, P717; MOTTL MJ, 1994, GEOCHIM COSMOCHIM AC, V58, P2225, DOI 10.1016/0016-7037(94)90007-8; NOEL M, 1988, EARTH PLANET SC LETT, V90, P77, DOI 10.1016/0012-821X(88)90113-6; SCLATER JG, 1980, REV GEOPHYS, V18, P269, DOI 10.1029/RG018i001p00269; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; STEINBERG RH, 1994, SEM OPHTALM, V5, P99; Tsang CF, 1998, REV GEOPHYS, V36, P275, DOI 10.1029/97RG03319; Wang KL, 1996, J GEOPHYS RES-SOL EA, V101, P11483, DOI 10.1029/96JB00641	31	155	158	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					71	74		10.1038/47463	http://dx.doi.org/10.1038/47463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638753				2022-12-28	WOS:000084687400043
J	Kraft, GH				Kraft, GH			Rehabilitation still the only way to improve function in multiple sclerosis	LANCET			English	Editorial Material							COGNITIVE DYSFUNCTION; IMPACT		Univ Washington, MS Ctr, Dept Rehabil Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kraft, GH (corresponding author), Univ Washington, MS Ctr, Dept Rehabil Med, Seattle, WA 98195 USA.							Freeman JA, 1997, ANN NEUROL, V42, P236, DOI 10.1002/ana.410420216; Freeman JA, 1999, NEUROLOGY, V52, P50, DOI 10.1212/WNL.52.1.50; Heide AC, 1998, AM J NEURORADIOL, V19, P1047; Kraft G H, 1998, J Spinal Cord Med, V21, P117; KRAFT GH, 1996, VETERANS AFFAIRS REH, V33, P329; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Petajan JH, 1996, ANN NEUROL, V39, P432, DOI 10.1002/ana.410390405; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Rumrill Jr P. D., 1996, EMPLOYMENT ISSUES MU; Schwartz L, 1999, AM J PHYS MED REHAB, V78, P525, DOI 10.1097/00002060-199911000-00006; Solari A, 1999, NEUROLOGY, V52, P57, DOI 10.1212/WNL.52.1.57; Stolz W, 1994, CHRONIC DIS DISABILI, P3; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502	15	61	61	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 11	1999	354	9195					2016	2017		10.1016/S0140-6736(99)90035-1	http://dx.doi.org/10.1016/S0140-6736(99)90035-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264LG	10636362				2022-12-28	WOS:000084183300005
J	Gershon, D				Gershon, D			Improving the plight of the physician-scientist in the US	NATURE			English	Article							CLINICAL INVESTIGATOR		Nat Med, London, England		Gershon, D (corresponding author), Nat Med, London, England.							Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; Institute of Medicine, 1994, CAR CLIN RES OBST OP; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; Rosenberg LE, 1999, SCIENCE, V283, P331, DOI 10.1126/science.283.5400.331; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303	5	8	9	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					215	216		10.1038/46100	http://dx.doi.org/10.1038/46100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647018				2022-12-28	WOS:000083716400059
J	Gold, J; Bennett, PJ; Sekuler, AB				Gold, J; Bennett, PJ; Sekuler, AB			Signal but not noise changes with perceptual learning	NATURE			English	Article							TEMPORAL CORTEX; VISUAL-CORTEX; DISCRIMINATION; PLASTICITY; REPRESENTATION; EFFICIENCY; MONKEYS; IMPROVEMENT; ORIENTATION; HYPERACUITY	Perceptual discrimination improves with practice. This 'perceptual learning' is often specific to the stimuli presented during training(1-5): indicating that practice may alter the response characteristics of cortical sensory neurons(6,7). Although much is known about how learning modifies cortical circuits(8), it remains unclear how these changes relate to behaviour. Different theories assume that practice improves discrimination by enhancing the signal(1,9,10) diminishing internal noise(11,12) or both(13). Here, to distinguish among these alternatives, we fashioned sets of faces and textures whose signal strength could be varied, and we trained observers to identify these patterns embedded in noise. Performance increased by up to 400% across several sessions over several days. Comparisons of human performance to that of an ideal discriminator showed that learning increased the efficiency with which observers encoded task-relevant information. Observer response consistency, measured by a double-pass technique in which identical stimuli are shown twice in each experimental session(14,15), did not change during training, showing that learning had no effect on internal noise. These results indicate that perceptual learning may enhance signal strength, and provide important constraints for theories of learning.	Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada	University of Toronto	Bennett, PJ (corresponding author), Univ Toronto, Dept Psychol, 100 St George St, Toronto, ON M5S 3G3, Canada.							BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; BURGESS AE, 1988, J OPT SOC AM A, V5, P617, DOI 10.1364/JOSAA.5.000617; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; LEGGE GE, 1987, J OPT SOC AM A, V4, P391, DOI 10.1364/JOSAA.4.000391; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Mackintosh N. J, 1983, CONDITIONING ASS LEA; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; MCLAREN I, 1988, PARALLEL DISTRIBUTED, P102; McLaren I. P. L., 1994, CAUSAL MECHANIMS BEH, P377, DOI [10. 1017/ CBO9780511565120. 018, DOI 10.1017/CB09780511565120.018, 10.1017/CB09780511565120.018]; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Pelli D. G., 1990, VISION CODING EFFICI, P3; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; TJAN BS, 1995, VISION RES, V35, P3053, DOI 10.1016/0042-6989(95)00070-G; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VANMEETEREN A, 1981, VISION RES, V21, P765, DOI 10.1016/0042-6989(81)90174-7; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; WEISS Y, 1993, NEURAL COMPUT, V5, P695, DOI 10.1162/neco.1993.5.5.695; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	30	243	248	1	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					176	178		10.1038/46027	http://dx.doi.org/10.1038/46027			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647007				2022-12-28	WOS:000083716400048
J	Baines, DL; Parry, DJ				Baines, DL; Parry, DJ			Analysis of the ability of the new needs adjustment formula to improve the setting of weighted capitation prescribing budgets in English general practice	BRITISH MEDICAL JOURNAL			English	Article							ASTRO-PU; CENSUS; AGE; SEX		Univ Birmingham, Hlth Econ Facil, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham	Baines, DL (corresponding author), Univ Birmingham, Hlth Econ Facil, Hlth Serv Management Ctr, Pk House, Birmingham B15 2RT, W Midlands, England.		Baines, Darrin/ABI-5893-2020	Baines, Darrin/0000-0001-9502-4678				*AUD COMM, 1994, PRESCR IMPR MOR RAT; Baines D, 1998, J CLIN PHARM THER, V23, P229, DOI 10.1046/j.1365-2710.1998.00157.x; CARRHILL R, 1998, LOCALLY BASED RESOUR; Culyer AJ., 1976, NEED NATL HLTH SERVI; DAY P, 1991, BRIT MED J, V303, P168, DOI 10.1136/bmj.303.6795.168; *DEP HLTH, 1997, CM3807; *DEP HLTH, 1989, WORK PAT; Greenhalgh T, 1998, BRIT MED J, V316, P750, DOI 10.1136/bmj.316.7133.750; LLOYD D, 1998, PRESCRIBER       APR, V5, P33; LLOYD DCE, 1997, BRIT J MED EC, V11, P81; Majeed A, 1998, BRIT MED J, V316, P748, DOI 10.1136/bmj.316.7133.748; Majeed A, 1996, BRIT MED J, V313, P1274; MAJEED FA, 1995, BRIT MED J, V310, P1511, DOI 10.1136/bmj.310.6993.1511; MAJEED FA, 1995, BRIT MED J, V310, P1373, DOI 10.1136/bmj.310.6991.1373; Maxwell M, 1998, BRIT J GEN PRACT, V48, P1467; NEWDICK C, 1998, BRIT MED J, V17, P1361; *NHS EX, 1999, REP ADV COMM RES ALL; Popper K, 1957, POVERTY HIST; RICE N, 1999, DERIVATION NEEDS BAS; ROBERTS SJ, 1993, BRIT MED J, V307, P485, DOI 10.1136/bmj.307.6902.485; SEARLE JR, 1964, PHILOS REV, V73, P43, DOI 10.2307/2183201; SLEATOR DJD, 1993, BRIT J GEN PRACT, V43, P102; Smith PC, 1999, BRIT MED J, V318, P776, DOI 10.1136/bmj.318.7186.776; Whynes DK, 1996, BRIT MED J, V312, P488, DOI 10.1136/bmj.312.7029.488	24	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					288	290		10.1136/bmj.320.7230.288	http://dx.doi.org/10.1136/bmj.320.7230.288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650027	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085132700024
J	Bong, JL; Lucke, TW; Douglas, WS				Bong, JL; Lucke, TW; Douglas, WS			Drug points - Lichenoid drug eruption with proton pump inhibitors	BRITISH MEDICAL JOURNAL			English	Article									Monklands Hosp, Dept Dermatol, Airdrie ML6 0JS, Scotland	Monklands Hospital	Bong, JL (corresponding author), Monklands Hosp, Dept Dermatol, Airdrie ML6 0JS, Scotland.							COLINJONES DG, 1993, ALIMENT PHARM THERAP, V7, P56; *COMM SAF MED, 1991, CURR PROBL, V31; *GISED, 1996, DERMATOLOGY, V193, P11	3	28	29	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 29	2000	320	7230					283	283		10.1136/bmj.320.7230.283	http://dx.doi.org/10.1136/bmj.320.7230.283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280ZB	10650025	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000085132700021
J	Yu, MF; Lourie, O; Dyer, MJ; Moloni, K; Kelly, TF; Ruoff, RS				Yu, MF; Lourie, O; Dyer, MJ; Moloni, K; Kelly, TF; Ruoff, RS			Strength and breaking mechanism of multiwalled carbon nanotubes under tensile load	SCIENCE			English	Article								The tensile strengths of individual multiwalled carbon nanotubes (MWCNTs) were measured with a "nanostressing stage" located within a scanning electron microscope. The tensile-loading experiment was prepared and observed entirely within the microscope and was recorded on video. The MWCNTs broke in the outermost Layer ("sword-in-sheath" failure), and the tensile strength of this Layer ranged from 11 to 63 gigapascals for the set of 19 MWCNTs that were Loaded. Analysis of the stress-strain curves for individual MWCNTs indicated that the Young's modulus E of the outermost Layer varied from 270 to 950 gigapascals, Transmission electron microscopic examination of the broken nanotube fragments revealed a variety of structures, such as a nanotube ribbon, a wave pattern, and partial radial collapse.	Washington Univ, Dept Phys, St Louis, MO 63130 USA; Zyvex LLC, Richardson, TX 75081 USA; Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA	Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Ruoff, RS (corresponding author), Washington Univ, Dept Phys, CB 1105, St Louis, MO 63130 USA.	ruoff@wuphys.wustl.edu	Ruoff, Rodney/ABE-6532-2020; Yu, Min-Feng/C-2809-2012; Ruoff, Rodney S/B-7605-2009	Ruoff, Rodney/0000-0002-6599-6764; Ruoff, Rodney S/0000-0002-6599-6764; Kelly, Thomas/0000-0002-2775-1854				BACON R, 1960, J APPL PHYS, V31, P283, DOI 10.1063/1.1735559; CHOPRA NG, 1995, NATURE, V377, P135, DOI 10.1038/377135a0; Dresselhaus M. S., 1988, GRAPHITE FIBERS FILA, V5; FUJII T, 1991, J VAC SCI TECHNOL B, V9, P666, DOI 10.1116/1.585483; KELLY BT, 1981, PHYSICS GRAPHITE; KOOPS HWP, 1994, JPN J APPL PHYS 1, V33, P7099, DOI 10.1143/JJAP.33.7099; Krishnan A, 1998, PHYS REV B, V58, P14013, DOI 10.1103/PhysRevB.58.14013; LEVITT AP, 1970, WHISKER TECHNOLOGY; Lourie O, 1998, PHYS REV LETT, V81, P1638, DOI 10.1103/PhysRevLett.81.1638; Lu JP, 1997, J PHYS CHEM SOLIDS, V58, P1649, DOI 10.1016/S0022-3697(97)00045-0; Meyers M.A., 1994, DYNAMIC BEHAV MAT; Nardelli MB, 1998, PHYS REV LETT, V81, P4656, DOI 10.1103/PhysRevLett.81.4656; Nardelli MB, 1998, PHYS REV B, V57, pR4277, DOI 10.1103/PhysRevB.57.R4277; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; RUOFF RS, 1993, NATURE, V364, P514, DOI 10.1038/364514a0; RUOFF RS, 1995, CARBON, V33, P925, DOI 10.1016/0008-6223(95)00021-5; Salvetat JP, 1999, ADV MATER, V11, P161, DOI 10.1002/(SICI)1521-4095(199902)11:2<161::AID-ADMA161>3.0.CO;2-J; SOULE DE, 1968, J APPL PHYS, V39, P5122, DOI 10.1063/1.1655933; TIBBETTS GG, 1987, J PHYS D APPL PHYS, V20, P292, DOI 10.1088/0022-3727/20/3/008; Wagner HD, 1998, APPL PHYS LETT, V72, P188, DOI 10.1063/1.120680; Walters DA, 1999, APPL PHYS LETT, V74, P3803, DOI 10.1063/1.124185; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Yakobson BI, 1996, PHYS REV LETT, V76, P2511, DOI 10.1103/PhysRevLett.76.2511; Yakobson BI, 1997, COMP MATER SCI, V8, P341, DOI 10.1016/S0927-0256(97)00047-5; Yakobson BI, 1998, APPL PHYS LETT, V72, P918, DOI 10.1063/1.120873; YAKOBSON BI, 1997, FULLERENES RECENT AD, V5, P549; Yu M. S., UNPUB; Yu MF, 1999, NANOTECHNOLOGY, V10, P244, DOI 10.1088/0957-4484/10/3/304; Zhang PH, 1998, PHYS REV LETT, V81, P5346, DOI 10.1103/PhysRevLett.81.5346	29	4082	4241	38	1154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					637	640		10.1126/science.287.5453.637	http://dx.doi.org/10.1126/science.287.5453.637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649994				2022-12-28	WOS:000084989400043
J	Nielsen, OW; Hansen, JF; Hilden, J; Larsen, CT; Svanegaard, J				Nielsen, OW; Hansen, JF; Hilden, J; Larsen, CT; Svanegaard, J			Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests	BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; EJECTION FRACTION; HEART-FAILURE; NATRIURETIC PEPTIDES; ECHOCARDIOGRAPHY; POPULATION; SURVIVAL	Objectives To assess the probability of left ventricular systolic dysfunction without echocardiography in patients from general practice. Design Cross sectional study using multivariate regression models to examine the relation between clinical variables and left ventricular systolic dysfunction as determined by echocardiography. Setting Three general practices in Copenhagen. Subjects 2158 patients aged >40 years were screened by questionnaires and case record reviews; 357 patients with past or present signs or symptoms of heart disease were identified, of whom 126 were eligible for and consented to examination. Main outcome measures Clinical variables that were significantly (P < 0.05) related to ejection fraction less than or equal to 0.45 and their predictive value for left ventricular systolic dysfunction. Results 15 patients (12%) had left ventricular systolic dysfunction. The prevalence was significantly related to three questions: does the electrocardiogram have Q waves, left bundle branch block, or ST-T segment changes? (P = 0.012); is resting supine heart rate greater than the simultaneous diastolic blood pressure? (P = 0.002); and is plasma N-terminal atrial natriuretic peptide >0.8 nmol/l? (P = 0.040)? Only one of 60 patients with a normal electrocardiogram had systolic dysfunction (2%, 95% confidence interval 0% to 9%) regardless of response to the other two questions. The risk of dysfunction was appreciable in patients with a ces answer to two or three questions (50%, 27% to 73%). Conclusions A normal electrocardiogram implies a low risk of left ventricular systolic dysfunction. Patients can be identified for echocardiography on the basis of an abnormal electrocardiogram combined with increased natriuretic peptide concentration or a heart rate greater than diastolic blood pressure, or both.	Univ Copenhagen, Hvidovre Hosp, Cardiovasc Dept, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Panum Inst, Dept Biostat, DK-2200 Copenhagen, Denmark; Odense Univ Hosp, Dept Clin Biochem, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Nielsen, OW (corresponding author), Univ Copenhagen, Hvidovre Hosp, Cardiovasc Dept, DK-2650 Hvidovre, Denmark.		Nielsen, Olav Wendelboe/S-4390-2016	Nielsen, Olav Wendelboe/0000-0003-3532-9431				BERNING J, 1992, CARDIOLOGY, V80, P257, DOI 10.1159/000175011; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Davie AP, 1996, BRIT MED J, V312, P222; Gillespie ND, 1997, BMJ-BRIT MED J, V314, P936, DOI 10.1136/bmj.314.7085.936; KOBER L, 1994, EUR HEART J, V15, P1616; Lechat P, 1999, LANCET, V353, P9; McClure SJ, 1998, BRIT MED J, V317, P516; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; MCDONAGH TA, 1997, EUR HEART J S, V19, P597; MCNAMARA RF, 1988, AM J CARDIOL, V62, P192, DOI 10.1016/0002-9149(88)90210-X; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Mosterd A, 1997, AM J CARDIOL, V79, P103, DOI 10.1016/S0002-9149(96)00691-1; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; RIHAL CS, 1995, AM J CARDIOL, V75, P220, DOI 10.1016/0002-9149(95)80023-L; ROSE GA, 1960, CIRCULATION, V21, P137; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SILVER MT, 1994, ANN INTERN MED, V121, P750, DOI 10.7326/0003-4819-121-10-199411150-00004; Wendelboe O., 1998, European Heart Journal, V19, P249; Willenheimer RB, 1997, SCAND CARDIOVASC J, V31, P9, DOI 10.3109/14017439709058063; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	24	59	60	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					220	224		10.1136/bmj.320.7229.220	http://dx.doi.org/10.1136/bmj.320.7229.220			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642232	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000085029600026
J	Younkin, TR; Conner, EF; Henderson, JI; Friedrich, SK; Grubbs, RH; Bansleben, DA				Younkin, TR; Conner, EF; Henderson, JI; Friedrich, SK; Grubbs, RH; Bansleben, DA			Neutral, single-component nickel (II) polyolefin catalysts that tolerate heteroatoms	SCIENCE			English	Article							ETHYLENE HOMOPOLYMERIZATION; POLYMERIZATION; METHYLALUMOXANE	More than half of the 170 million metric tons of polymers produced each year are polyolefins. Current technology uses highly active cationic catalysts, which suffer from an inability to tolerate heteroatoms such as oxygen, nitrogen, and sulfur, These systems require scrupulously clean starting materials and activating cocatalysts. A family of catalysts has been developed whose members are tolerant of both heteroatoms and Less pure starting materials. These heteroatom-tolerant neutral late transition metal complexes are in fact highly active systems that produce high-molecular-weight polyethylene, polymerize functionalized olefins, and require no cocatalyst.	CALTECH, Arnold & Mabel Beckman Labs Chem Synthesis, Pasadena, CA 91125 USA	California Institute of Technology	Grubbs, RH (corresponding author), CALTECH, Arnold & Mabel Beckman Labs Chem Synthesis, Pasadena, CA 91125 USA.		grubbs, robert h/D-4293-2009	grubbs, robert h/0000-0002-0057-7817				BOOR J, 1979, ZIEGLERNATTA CATALYS; Britovsek GJP, 1999, ANGEW CHEM INT EDIT, V38, P428, DOI 10.1002/(SICI)1521-3773(19990215)38:4<428::AID-ANIE428>3.0.CO;2-3; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; EWEN JA, 1984, J AM CHEM SOC, V106, P6355, DOI 10.1021/ja00333a041; FISCHER EO, 1952, ANGEW CHEM-GER EDIT, V64, P620; GURAM AS, 1996, COMPREHENSIVE ORGANO, P589; ITA P, 1999, WORLD POLYETHYLENE, V1138; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; JOHNSON LK, 1998, CHEM ABSTR 149362J, V129; KAMINSKY W, 1985, ANGEW CHEM INT EDIT, V24, P507, DOI 10.1002/anie.198505071; KASCHUBE W, 1988, J ORGANOMET CHEM, V355, P525, DOI 10.1016/0022-328X(88)89050-8; KEIM W, 1978, ANGEW CHEM INT EDIT, V17, P466, DOI 10.1002/anie.197804661; KLABUNDE U, 1987, J MOL CATAL, V41, P123, DOI 10.1016/0304-5102(87)80023-8; KLABUNDE U, 1987, J ORGANOMET CHEM, V334, P141, DOI 10.1016/0022-328X(87)80045-1; KLABUNDE U, 1987, J POLYM SCI POL CHEM, V25, P1989, DOI 10.1002/pola.1987.080250719; LEVOWITZ IL, 1999, MOD PLAST ENCY, V75, pB3; LI RT, 1997, THESIS CALTECH PASAD; Sanford MS, 1998, ORGANOMETALLICS, V17, P5384, DOI 10.1021/om980683f; SINN H, 1980, ANGEW CHEM INT EDIT, V19, P390, DOI 10.1002/anie.198003901; Sinn H., 1980, ADV ORGANOMET CHEM, V18, P99; Starzewski KAO, 1999, ANGEW CHEM INT EDIT, V38, P2439; Togni A., 1998, METALLOCENES SYNTHES; Wang CM, 1998, ORGANOMETALLICS, V17, P3149, DOI 10.1021/om980176y; WILD FRWP, 1982, J ORGANOMET CHEM, V232, P233; WILKINSON G, 1954, J AM CHEM SOC, V76, P4281, DOI 10.1021/ja01646a008; YANG XM, 1991, J AM CHEM SOC, V113, P3623, DOI 10.1021/ja00009a076	26	1034	1112	3	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2000	287	5452					460	462		10.1126/science.287.5452.460	http://dx.doi.org/10.1126/science.287.5452.460			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277JF	10642541				2022-12-28	WOS:000084929900039
J	Yusuf, S; Dagenais, G; Pogue, J; Bosch, J; Sleight, P				Yusuf, S; Dagenais, G; Pogue, J; Bosch, J; Sleight, P		Heart Outcomes Prevent Evaluat Study	Vitamin E supplementation and cardiovascular events in high-risk patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; LOW-DENSITY LIPOPROTEIN; MYOCARDIAL-INFARCTION; ANTIOXIDANT VITAMINS; BETA-CAROTENE; ALPHA-TOCOPHEROL; E CONSUMPTION; ATHEROSCLEROSIS; TRIAL; PROGRESSION	Background Observational and experimental studies suggest that the amount of vitamin E ingested in food and in supplements is associated with a lower risk of coronary heart disease and atherosclerosis. Methods We enrolled a total of 2545 women and 6996 men 55 years of age or older who were at high risk for cardiovascular events because they had cardiovascular disease or diabetes in addition to one other risk factor. These patients were randomly assigned according to a two-by-two factorial design to receive either 400 IU of vitamin E daily from natural sources or matching placebo and either an angiotensin-converting-enzyme inhibitor (ramipril) or matching placebo for a mean of 4.5 years (the results of the comparison of ramipril and placebo are reported in a companion article). The primary outcome was a composite of myocardial infarction, stroke, and death from cardiovascular causes. The secondary outcomes included unstable angina, congestive heart failure, revascularization or amputation, death from any cause, complications of diabetes, and cancer. Results A total of 772 of the 4761 patients assigned to vitamin E (16.2 percent) and 739 of the 4780 assigned to placebo (15.5 percent) had a primary outcome event (relative risk, 1.05; 95 percent confidence interval, 0.95 to 1.16; P=0.33). There were no significant differences in the numbers of deaths from cardiovascular causes (342 of those assigned to vitamin E vs. 328 of those assigned to placebo; relative risk, 1.05; 95 percent confidence interval, 0.90 to 1.22), myocardial infarction (532 vs. 524; relative risk, 1.02; 95 percent confidence interval, 0.90 to 1.15), or stroke (209 vs. 180; relative risk, 1.17; 95 percent confidence interval, 0.95 to 1.42). There were also no significant differences in the incidence of secondary cardiovascular outcomes or in death from any cause. There were no significant adverse effects of vitamin E. Conclusions In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years has no apparent effect on cardiovascular outcomes. (N Engl J Med 2000;342:154-60.) (C) 2000, Massachusetts Medical Society.	Hamilton Gen Hosp, Canadian Cardiovasc Collaborat Project Off, Hamilton, ON L8L 2X2, Canada	McMaster University	Yusuf, S (corresponding author), Hamilton Gen Hosp, Canadian Cardiovasc Collaborat Project Off, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.		Lehmann, Roger/B-9120-2015; Hramiak, Irene/G-3305-2011; Bosch, Jacqueline/AAP-6910-2021; McManus, Ruth/G-3938-2011; Zinman, Bernard/E-7266-2013	Lehmann, Roger/0000-0002-3681-4431; Bosch, Jacqueline/0000-0001-6292-4207; Yusuf, Salim/0000-0003-4776-5601				BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; Gaziano J. Michael, 1995, Annals of Epidemiology, V5, P255, DOI 10.1016/1047-2797(94)00090-G; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hercberg S, 1998, INT J VITAM NUTR RES, V68, P3; HODIS HN, 1995, JAMA-J AM MED ASSOC, V273, P1849, DOI 10.1001/jama.273.23.1849; JHA P, 1995, ANN INTERN MED, V123, P860, DOI 10.7326/0003-4819-123-11-199512010-00009; Klipstein-Grobusch K, 1999, AM J CLIN NUTR, V69, P261; KNEKT P, 1994, AM J EPIDEMIOL, V139, P1180, DOI 10.1093/oxfordjournals.aje.a116964; Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803; Lonn EM, 1996, AM J CARDIOL, V78, P914, DOI 10.1016/S0002-9149(96)00467-5; Meade T, 1999, EUR HEART J, V20, P725; Mindlen F, 1996, CAN J CARDIOL, V12, P127; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Upston JM, 1999, FASEB J, V13, P977, DOI 10.1096/fasebj.13.9.977; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VERLANGIERI AJ, 1992, J AM COLL NUTR, V11, P131; Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668; WILLIAMS RJ, 1992, ATHEROSCLEROSIS, V94, P153, DOI 10.1016/0021-9150(92)90240-H; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145	28	1412	1474	1	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					154	160		10.1056/nejm200001203420302	http://dx.doi.org/10.1056/nejm200001203420302			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639540	Bronze			2022-12-28	WOS:000084851700002
J	Stanford, JL; Feng, ZD; Hamilton, AS; Gilliland, FD; Stephenson, RA; Eley, JW; Albertsen, PC; Harlan, LC; Potosky, AL				Stanford, JL; Feng, ZD; Hamilton, AS; Gilliland, FD; Stephenson, RA; Eley, JW; Albertsen, PC; Harlan, LC; Potosky, AL			Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer - The prostate cancer outcomes study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; EXPERIENCE; THERAPY; MEN	Context Patients with prostate cancer and their physicians need knowledge of treatment options and their potential complications, but limited data on complications are available in unselected population-based cohorts of patients. Objective To measure changes in urinary and sexual function in men who have undergone radical prostatectomy for clinically localized prostate cancer. Design The Prostate Cancer Outcomes Study, a population-based longitudinal cohort study with up to 24 months of follow-up. Setting Population-based cancer registries in 6 geographic regions of the United States. Participants A total of 1291 black, white, and Hispanic men aged 39 to 79 years who were diagnosed as having primary prostate cancer between October 1, 1994, and October 31, 1995, and who underwent radical prostatectomy within 6 months of diagnosis for clinically localized disease. Main Outcome Measures Distribution of and change in urinary and sexual function measures reported by patients at baseline and 6, 12, and 24 months after diagnosis. Results At 18 or more months following radical prostatectomy, 8.4% of men were incontinent and 59.9% were impotent. Among men who were potent before surgery, the proportion of men reporting impotence at 18 or more months after surgery varied according to whether the procedure was nerve sparing (65.6% of non-nerve-sparing, 58.6% of unilateral, and 56.0% of bilateral nerve-sparing). At 18 or more months after surgery, 41.9% reported that their sexual performance was a moderate-to-large problem. Both sexual and urinary function varied by age (39.0% of men aged <60 years vs 15.3%-21.7% of older men were potent at greater than or equal to 18 months [P<.001]; 13.8% of men aged 75-79 years vs 0.7%-3.6% of younger men experienced the highest level of incontinence at greater than or equal to 18 months [P =.03]), and sexual function also varied by race (38.4% of black men reported firm erections at greater than or equal to 18 months vs 25.9% of Hispanic and 21.3% of white men; P =.001), Conclusions Our study suggests that radical prostatectomy is associated with significant erectile dysfunction and some decline in urinary function. These results may be particularly helpful to community-based physicians and their patients with prostate cancer who face difficult treatment decisions.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; Univ New Mexico, Hlth Sci Ctr, New Mexico Tumor Registry, Albuquerque, NM USA; Univ Utah, Sch Med, Utah Canc Registry, Salt Lake City, UT USA; Univ Utah, Sch Med, Div Urol, Salt Lake City, UT USA; Emory Univ, Rollins Sch Publ Hlth, Georgia Ctr Canc Stat, Atlanta, GA USA; Univ Connecticut, Hlth Sci Ctr, Div Urol, Farmington, CT USA; NCI, Div Canc Prevent & Control, Bethesda, MD 20892 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Southern California; University of New Mexico; University of New Mexico's Health Sciences Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Emory University; Rollins School Public Health; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stanford, JL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MW 814, Seattle, WA 98109 USA.	jstanfor@fhcrc.org			NCI NIH HHS [N01-PC-67007, N01-PC-67010, N01-PC-67009] Funding Source: Medline; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067010, N01PC067007, N01PC067009] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences)		BRASLIS KG, 1995, BRIT J UROL, V75, P48, DOI 10.1111/j.1464-410X.1995.tb07231.x; Catalona WJ, 1999, J UROLOGY, V162, P433, DOI 10.1016/S0022-5347(05)68578-3; FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E; FOWLER FJ, 1995, UROLOGY, V45, P1007, DOI 10.1016/S0090-4295(99)80122-8; JONLER M, 1994, BRIT J UROL, V74, P352, DOI 10.1111/j.1464-410X.1994.tb16626.x; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LEANDRI P, 1992, J UROLOGY, V147, P883, DOI 10.1016/S0022-5347(17)37412-8; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIM AJ, 1995, J UROLOGY, V154, P1420, DOI 10.1016/S0022-5347(01)66881-2; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Litwin MS, 1998, J UROLOGY, V159, P1988, DOI 10.1016/S0022-5347(01)63222-1; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; MURPHY GP, 1994, J UROLOGY, V152, P1817, DOI 10.1016/S0022-5347(17)32392-3; OSOBA D, 1994, J CLIN ONCOL, V12, P608, DOI 10.1200/JCO.1994.12.3.608; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; *RES TRIANGL I, 1997, SUDAAN COMP PROGR RE; STANFORD JL, 1999, NIH PUBLICATION; STEINER MS, 1991, J UROLOGY, V145, P512, DOI 10.1016/S0022-5347(17)38382-9; Talcott JA, 1998, J CLIN ONCOL, V16, P275, DOI 10.1200/JCO.1998.16.1.275; Talcott JA, 1997, J NATL CANCER I, V89, P1117, DOI 10.1093/jnci/89.15.1117	20	824	851	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2000	283	3					354	360		10.1001/jama.283.3.354	http://dx.doi.org/10.1001/jama.283.3.354			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273WM	10647798	Bronze			2022-12-28	WOS:000084732400027
J	Beecham, L				Beecham, L			GPs' questions on supporting doctors, protecting patients	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	2000	320	7228					191	191						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276DL	10634757				2022-12-28	WOS:000084860300064
J	Huey, RB; Gilchrist, GW; Carlson, ML; Berrigan, D; Serra, L				Huey, RB; Gilchrist, GW; Carlson, ML; Berrigan, D; Serra, L			Rapid evolution of a geographic cline in size in an introduced fly	SCIENCE			English	Article							DROSOPHILA-SUBOBSCURA; NATURAL-POPULATIONS; MATHEMATICAL ARTIFACT; SMOOTH CURVE; ADULT SIZE; COLONIZATION; ECTOTHERMS; DIFFERENTIATION; MELANOGASTER; TEMPERATURE	The introduction and rapid spread of Drosophila subobscura in the New-World two decades ago provide an opportunity to determine the predictability and rate of evolution of a geographic cline. In ancestral Old World populations, wing length increases clinally with latitude, in North American populations, no wing length cline was detected one decade after the introduction. After two decades, however, a cline has evolved and largely converged on the ancestral cline. The rate of morphological evolution on a continental scale is very fast, relative even to rates measured within local populations. Nevertheless, different wing sections dominate the New versus Old World clines. Thus, the evolution of geographic variation in wing length has been predictable, but the means by which the cline is achieved is contingent.	Univ Washington, Dept Zool, Seattle, WA 98195 USA; Univ Barcelona, Dept Genet, Barcelona 08071, Spain	University of Washington; University of Washington Seattle; University of Barcelona	Huey, RB (corresponding author), Univ Washington, Dept Zool, Box 351800, Seattle, WA 98195 USA.	hueyrb@u.washington.edu	Huey, Raymond/F-1597-2010; Berrigan, David/AAF-1576-2020	Huey, Raymond/0000-0002-4962-8670				ANDERSON WW, 1966, GENET RES, V7, P255, DOI 10.1017/S0016672300009666; [Anonymous], 1861, ORIGIN SPECIES MEANS; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; AYALA FJ, 1989, GENOME, V31, P246, DOI 10.1139/g89-042; Baker H. G., 1965, GENETICS COLONIZING; BECKENBACH AT, 1986, AM MIDL NAT, V115, P10, DOI 10.2307/2425832; BRNCIC D, 1981, GENETICA, V56, P3; Brncic D, 1980, DROSOPHILA INF SERV, V55, P20; Brncic D, 1995, GENETICS NATURAL POP, P154; BUDNIK M, 1991, HEREDITY, V67, P29, DOI 10.1038/hdy.1991.61; Carroll SP, 1997, EVOLUTION, V51, P1182, DOI [10.1111/j.1558-5646.1997.tb03966.x, 10.2307/2411048]; CAVICCHI S, 1985, GENETICS, V109, P665; DAVID JR, 1975, NATURE, V257, P588, DOI 10.1038/257588a0; Endler J.A., 1986, Monographs in Population Biology, pviii; Ewald PW, 1994, EVOLUTION INFECT DIS; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; GINGERICH PD, 1984, SCIENCE, V226, P995, DOI 10.1126/science.226.4677.995; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1984, SCIENCE, V226, P994, DOI 10.1126/science.6505682; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; JAMES AC, 1995, GENETICS, V140, P659; JOHNSTON RF, 1964, SCIENCE, V144, P548, DOI 10.1126/science.144.3618.548; Karan D, 1998, GENET RES, V71, P31, DOI 10.1017/S0016672397003054; LENSKI RE, 1988, EVOLUTION, V42, P425, DOI 10.1111/j.1558-5646.1988.tb04149.x; LONG AD, 1995, HEREDITY, V74, P569, DOI 10.1038/hdy.1995.81; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; MISRA RK, 1964, GENET RES, V5, P240, DOI 10.1017/S0016672300001208; MITTON JB, 1997, SELECTION NATURAL PO; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Parsons P, 1983, EVOLUTIONARY BIOL CO; Partridge L, 1997, EVOLUTION, V51, P632, DOI 10.1111/j.1558-5646.1997.tb02454.x; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI 10.1111/j.1558-5646.1994.tb05311.x; Partridge L, 1996, ANIMALS TEMPERATURE, P265; PEGUEROLES G, 1995, EVOL ECOL, V9, P453, DOI 10.1007/BF01237767; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; PREVOSTI A, 1955, COLD SPRING HARB SYM, V20, P294, DOI 10.1101/SQB.1955.020.01.028; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; SIBLY RM, 1994, FUNCT ECOL, V8, P486, DOI 10.2307/2390073; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; WILLIAMS CK, 1989, J ANIM ECOL, V58, P495, DOI 10.2307/4844	47	574	609	1	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					308	309		10.1126/science.287.5451.308	http://dx.doi.org/10.1126/science.287.5451.308			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634786				2022-12-28	WOS:000084769600041
J	Kegel, WK; van Blaaderen, A				Kegel, WK; van Blaaderen, A			Direct observation of dynamical heterogeneities in colloidal hard-sphere suspensions	SCIENCE			English	Article							DIGITAL VIDEO MICROSCOPY; GLASS-TRANSITION; DISPERSIONS; LATTICES; SYSTEMS; LIQUID; MEDIA	The real-space dynamics in a model system of colloidal hard spheres was studied by means of time-resolved fluorescence confocal scanning microscopy. Direct experimental evidence for the presence of dynamical heterogeneities in a dense liquid was obtained from an analysis of particle trajectories in two-dimensional slices of the bulk sample. These heterogeneities manifest themselves as a non-Gaussian probability distribution of particle displacements and also affect the onset of long-time diffusive behavior.	Univ Utrecht, Debye Inst, Vant Hoff Lab Phys & Colloid Chem, NL-3584 CH Utrecht, Netherlands; FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	Utrecht University; AMOLF	Kegel, WK (corresponding author), Univ Utrecht, Debye Inst, Vant Hoff Lab Phys & Colloid Chem, Padualaan 8, NL-3584 CH Utrecht, Netherlands.		van Blaaderen, Alfons/ABB-1370-2020; van Blaaderen, Alfons/B-6304-2009; Kegel, Willem K/H-4084-2016	van Blaaderen, Alfons/0000-0003-3090-2753; van Blaaderen, Alfons/0000-0003-3090-2753; 				ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; ANTL L, 1986, COLLOID SURFACE, V17, P67, DOI 10.1016/0166-6622(86)80187-1; Bongers J, 1998, J CHEM PHYS, V108, P9937, DOI 10.1063/1.476433; CICERONE MT, 1995, J CHEM PHYS, V103, P5684, DOI 10.1063/1.470551; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Debenedetti P. G., 1996, METASTABLE LIQUIDS; Dhont J K G, 1996, INTRO DYNAMICS COLLO, P327; Doliwa B, 1998, PHYS REV LETT, V80, P4915, DOI 10.1103/PhysRevLett.80.4915; Fuchs M, 1998, PHYS REV E, V58, P3384, DOI 10.1103/PhysRevE.58.3384; Hansen J.-P., 2013, THEORY SIMPLE LIQUID, V4th; HURLEY MM, 1995, PHYS REV E, V52, P1694, DOI 10.1103/PhysRevE.52.1694; Kasper A, 1998, LANGMUIR, V14, P5004, DOI 10.1021/la971089y; Kob W, 1997, PHYS REV LETT, V79, P2827, DOI 10.1103/PhysRevLett.79.2827; MORTENSEN TC, 1998, SLOW DYNAMICS COMPLE, P3; NIJBOER BRA, 1966, PHYSICA, V32, P415, DOI 10.1016/0031-8914(66)90068-1; PATHMAMANOHARAN C, 1989, COLLOID POLYM SCI, V267, P448, DOI 10.1007/BF01410191; Poon W, 1996, PHYS WORLD, V9, P27, DOI 10.1088/2058-7058/9/4/23; PUSEY PN, 1986, NATURE, V320, P340, DOI 10.1038/320340a0; SCHAERTL W, 1994, J STAT PHYS, V77, P1007, DOI 10.1007/BF02183148; SCHMIDT-ROHR K, 1991, PHYS REV LETT, V66, P3020, DOI 10.1103/PhysRevLett.66.3020; Sillescu H, 1999, J NON-CRYST SOLIDS, V243, P81, DOI 10.1016/S0022-3093(98)00831-X; Truskett TM, 1998, PHYS REV E, V58, P3083, DOI 10.1103/PhysRevE.58.3083; VANBLAADEREN A, 1995, SCIENCE, V270, P1177, DOI 10.1126/science.270.5239.1177; VANBLAADEREN A, 1992, LANGMUIR, V8, P2921, DOI 10.1021/la00048a013; VANBLAADEREN A, UNPUB; VANMEGEN W, 1993, NATURE, V362, P616, DOI 10.1038/362616a0	26	703	713	5	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2000	287	5451					290	293		10.1126/science.287.5451.290	http://dx.doi.org/10.1126/science.287.5451.290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634780				2022-12-28	WOS:000084769600035
J	Miyado, K; Yamada, G; Yamada, S; Hasuwa, H; Nakamura, Y; Ryu, F; Suzuki, K; Kosai, K; Inoue, K; Ogura, A; Okabe, M; Mekada, E				Miyado, K; Yamada, G; Yamada, S; Hasuwa, H; Nakamura, Y; Ryu, F; Suzuki, K; Kosai, K; Inoue, K; Ogura, A; Okabe, M; Mekada, E			Requirement of CD9 on the egg plasma membrane for fertilization	SCIENCE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; CELL-SURFACE; IN-VITRO; BINDING; PROTEIN; EXPRESSION; MOTILITY; INTEGRINS	CD9 is an integral membrane protein associated with integrins and other membrane proteins, Mice lacking CD9 were produced by homologous recombination. Both male and female CD9(-/-) mice were born healthy and grew normally, However, the litter size from CD9(-/-) females was less than 2% of that of the wild type. In vitro fertilization experiments indicated that the cause of this infertility was due to;the failure of sperm-egg fusion. When sperm were injected into oocytes with assisted microfertilization techniques, however, the fertilized eggs developed to term. These results indicate that CD9 has a crucial role in sperm-egg fusion.	Kurume Univ, Inst Life Sci, Fukuoka 8390861, Japan; Kurume Univ, Res Ctr Innovat Canc Therapy, Fukuoka 8300011, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; Program Promot Basic Res Act Innovat Biosci, Tokyo 1050001, Japan; St Marys Hosp, Fukuoka 8300047, Japan; Natl Inst Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan; Osaka Univ, Genome Informat Res Ctr, Osaka 5650861, Japan	Kurume University; Kurume University; Kumamoto University; National Institute of Infectious Diseases (NIID); Osaka University	Mekada, E (corresponding author), Kurume Univ, Inst Life Sci, Fukuoka 8390861, Japan.	emekada@lsi.kurume-u.ac.jp	MIYADO, KENJI/E-6568-2013; Hasuwa, Hidetoshi/B-1083-2009; Ogura, Atsuo/J-3916-2014; Okabe, Masaru/B-6917-2015	Ogura, Atsuo/0000-0003-0447-1988; Miyado, Kenji/0000-0002-8339-6738; Yamada, Gen/0000-0001-6160-2660; Okabe, Masaru/0000-0002-0803-9044; Mekada, Eisuke/0000-0001-8858-4781				ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; ANTON ES, 1995, J NEUROSCI, V15, P584; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Bigler D, 1997, TRENDS CELL BIOL, V7, P220, DOI 10.1016/S0962-8924(97)01058-1; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chen H, 1999, CHEM BIOL, V6, P1, DOI 10.1016/S1074-5521(99)80015-5; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Evans JP, 1998, BIOL REPROD, V59, P145, DOI 10.1095/biolreprod59.1.145; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; HADJIARGYROU M, 1995, J NEUROSCI, V15, P574; HAYAKAWA S, 1983, J BIOL CHEM, V258, P4311; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HIGASHIYAMA M, 1995, CANCER RES, V55, P6040; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; IWAMOTO R, 1991, J BIOL CHEM, V266, P20463; KERSEY JH, 1981, J EXP MED, V153, P726, DOI 10.1084/jem.153.3.726; Loffler S, 1997, J VIROL, V71, P42; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MIYADO K, UNPUB; Myles DG, 1997, BIOL REPROD, V56, P320, DOI 10.1095/biolreprod56.2.320; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; Nakamura Y, 1996, AM J PATHOL, V149, P575; NEWMAN RA, 1982, BIOCHIM BIOPHYS ACTA, V701, P318, DOI 10.1016/0167-4838(82)90234-5; SHAW ARE, 1995, J BIOL CHEM, V270, P24092, DOI 10.1074/jbc.270.41.24092; Snell WJ, 1996, CELL, V85, P629, DOI 10.1016/S0092-8674(00)81230-1; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; WASSARMAN PM, 1987, SCIENCE, V235, P553, DOI 10.1126/science.3027891; Yanagimachi R., 1994, P189; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	31	523	554	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2000	287	5451					321	324		10.1126/science.287.5451.321	http://dx.doi.org/10.1126/science.287.5451.321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ML	10634791				2022-12-28	WOS:000084769600046
J	Smith, O				Smith, O			Nota bene: Aging - Sensing old age	SCIENCE			English	Editorial Material																		Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694	2	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 7	2000	287	5450					54	54		10.1126/science.287.5450.54	http://dx.doi.org/10.1126/science.287.5450.54			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	271DG	10644225				2022-12-28	WOS:000084578400031
J	Orlove, BS; Chiang, JCH; Cane, MA				Orlove, BS; Chiang, JCH; Cane, MA			Forecasting Andean rainfall and crop yield from the influence of El Nino on Pleiades visibility	NATURE			English	Article							SOUTHERN OSCILLATION; SAGE-II; CLOUD	Farmers in drought-prone regions of Andean South America have historically made observations of changes in the apparent brightness of stars in the Pleiades around the time of the southern winter solstice in order to forecast interannual variations in summer rainfall and in autumn harvests. They moderate the effect of reduced rainfall by adjusting the planting dates of potatoes, their most important crop(1). Here we use data on cloud cover and water vapour from satellite imagery, agronomic data from the Andean altiplano and an index of El Nino variability to analyse this forecasting method. We find that poor visibility of the Pleiades in June-caused by an increase in subvisual high cirrus clouds-is indicative of an El Nino year, which is usually linked to reduced rainfall during the growing season several months later. Our results suggest that this centuries-old method? of seasonal rainfall forecasting may be based on a simple indicator of El Nino variability.	Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Davis; Columbia University	Orlove, BS (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.		Chiang, John/A-9421-2010; Chiang, John/AAK-6169-2021; Cane, Mark/I-8086-2012; Orlove, Ben/I-6327-2015	Orlove, Ben/0000-0003-0489-4219; Cane, Mark/0000-0001-5408-2388				ACEITUNO P, 1988, MON WEATHER REV, V116, P505, DOI 10.1175/1520-0493(1988)116<0505:OTFOTS>2.0.CO;2; Ballon Aguirre E., 1992, VOCABULARIO RAZONADO; Bauer Brian S., 1995, ASTRONOMY EMPIRE ANC; BEST EM, 1953, ARCH PERUANOS FOLKLO, V1, P160; Beukema H.P., 1990, INTRO POTATO PRODUCT; CAMINO A, 1981, RUNAKUNAP KAWSAYNINK, V1, P261; Carter William, 1982, IRPA CHICO INDIVIDUO; DEARRIAGA PJ, 1968, EXTIRPATION IDOLATRY; FRISANCHO AR, 1995, AM J PHYS ANTHROPOL, V96, P431, DOI 10.1002/ajpa.1330960408; GOLAND C, 1992, 4 U N CAR DEP ANTHR; GRILLO FERNANDEZ Eduardo, 1994, CRIANZA ANDINA CHACR; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KENT GS, 1995, J CLIMATE, V8, P2577, DOI 10.1175/1520-0442(1995)008<2577:STRVIT>2.0.CO;2; KOLATA A, 1996, VALLEY SPIRITS JOURN; KRAFT KE, 1995, THESIS U FLORIDA; LIAO XH, 1995, J GEOPHYS RES-ATMOS, V100, P1121, DOI 10.1029/94JD02429; LIRA JA, 1946, FARMACOPEA TRADICION; MACKERRON DKL, 1988, POTATO RES, V31, P269, DOI 10.1007/BF02365535; MAMANI M, 1988, RAICES AM MUNDO AYMA, P75; MISHKIN B, 1940, J AM FOLKLORE, V53, P225; ORLOVE BS, 1979, ANTHROPOL QUART, V52, P86, DOI 10.2307/3317259; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; Salomon Frank, 1991, HUAROCHIRI MANUSCRIP; SANTILLAN F. DE., 1950, TRES RELACIONES ANTI; Schaefer B.E., 1993, VISTAS ASTRON, V36, P311, DOI DOI 10.1016/0083-6656(93)90113-X; THOMPSON LG, 1984, SCIENCE, V226, P50, DOI 10.1126/science.226.4670.50; Urton Gary, 1981, CROSSROADS EARTH SKY; Yampara Huarachi Simon, 1992, COSMOVISION AYMARA, P143; Zimmerer K. S., 1996, CHANGING FORTUNES BI, DOI 10.1525/9780520917033; 1919, REV HIST, V6, P180	30	118	125	1	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2000	403	6765					68	71		10.1038/47456	http://dx.doi.org/10.1038/47456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273BM	10638752				2022-12-28	WOS:000084687400042
J	Rongo, C; Kaplan, JM				Rongo, C; Kaplan, JM			CaMKII regulates the density of central glutamatergic synapses in vivo	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROTEIN-KINASE-II; RECEPTOR; PHOSPHORYLATION; LOCALIZATION; SUBUNIT; MUTANTS; NEURONS	Synaptic connections undergo a dynamic process of stabilization or elimination during development, and this process is thought to be critical in memory and learning and in establishing the specificity of synaptic connections(1). The type II calcium- and calmodulin-dependent protein kinase (CaMKII) has been proposed to be pivotal in regulating synaptic strength(2-4) and in maturation of synapses during developments. Here we describe how CaMKII regulates the formation of central glutamatergic synapses in Caenorhabditis elegans, During larval development, the density of ventral nerve cord synapses containing the GLR-1 glutamate receptor is held constant despite marked changes in neurite length. The coupling of synapse number to neurite length requires both CaMKII and voltage-gated calcium channels. CaMKII regulates GLR-1 by at least two distinct mechanisms: regulating transport of GLR-1 from cell bodies to neurites; and regulating the addition or maintenance of GLR-1 to postsynaptic elements.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kaplan, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, LSA 361, Berkeley, CA 94720 USA.							Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; FONG YL, 1989, J BIOL CHEM, V264, P16759; HART A, 1993, NATURE, V378, P82; Hebb Donald O., 1949, ORG BEHAV; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Nonet ML, 1998, J NEUROSCI, V18, P70; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Riddle DL, 1997, C ELEGANS; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	27	153	168	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 11	1999	402	6758					195	199		10.1038/46065	http://dx.doi.org/10.1038/46065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256FZ	10647013				2022-12-28	WOS:000083716400054
J	Tang, L; Shah, S; Chung, L; Carney, J; Katz, L; Khosla, C; Julien, B				Tang, L; Shah, S; Chung, L; Carney, J; Katz, L; Khosla, C; Julien, B			Cloning and heterologous expression of the epothilone gene cluster	SCIENCE			English	Article							ENGINEERED BIOSYNTHESIS; POLYKETIDES	The polyketide epothilone is a potential anticancer agent that stabilizes microtubules in a similar manner to Taxol. The gene cluster responsible for epothilone biosynthesis in the myxobacterium Sorangium cellulosum was cloned and completely sequenced. It encodes six multifunctional proteins composed of a loading module, one nonribosomal peptide synthetase module, eight polyketide synthase modules, and a P450 epoxidase that converts desoxyepothilone into epothilone. Concomitant expression of these genes in the actinomycete Streptomyces coelicolor produced epothilones A and B. Streptomyces coelicolor is more amenable to strain improvement and grows about 10-fold as rapidly as the natural producer, so this heterologous expression system portends a plentiful supply of this important agent.	KOSAN Biosci, Hayward, CA 94545 USA	Bristol-Myers Squibb; Kosan Biosciences, Inc.	Julien, B (corresponding author), KOSAN Biosci, 3832 Bay Ctr Pl, Hayward, CA 94545 USA.			Carney, John/0000-0002-0461-8890; Khosla, Chaitan/0000-0001-6529-495X	NATIONAL CANCER INSTITUTE [R43CA079228] Funding Source: NIH RePORTER; NCI NIH HHS [1 R43 CA79228-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balog A, 1996, ANGEW CHEM INT EDIT, V35, P2801, DOI 10.1002/anie.199628011; BEDFORD DJ, 1995, J BACTERIOL, V177, P4544, DOI 10.1128/jb.177.15.4544-4548.1995; Betlach MC, 1998, BIOCHEMISTRY-US, V37, P14937, DOI 10.1021/bi981699c; BOLLAG DM, 1995, CANCER RES, V55, P2325; CASPERS P, 1994, CELL MOL BIOL, V40, P635; Chou TC, 1998, P NATL ACAD SCI USA, V95, P15798, DOI 10.1073/pnas.95.26.15798; Chou TC, 1998, P NATL ACAD SCI USA, V95, P9642, DOI 10.1073/pnas.95.16.9642; FU H, 1994, J AM CHEM SOC, V116, P4166, DOI 10.1021/ja00089a003; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; Hendrickson L, 1999, CHEM BIOL, V6, P429, DOI 10.1016/S1074-5521(99)80061-1; Hopwood D.A., 1985, GENETIC MANIPULATION; KAO CM, 1994, SCIENCE, V265, P509, DOI 10.1126/science.8036492; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Nicolaou KC, 1997, ANGEW CHEM INT EDIT, V36, P2097, DOI 10.1002/anie.199720971; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Su DS, 1997, ANGEW CHEM INT EDIT, V36, P2093, DOI 10.1002/anie.199720931; Tang L., UNPUB; Xue Q, 1999, P NATL ACAD SCI USA, V96, P11740, DOI 10.1073/pnas.96.21.11740; YANG Z, 1995, ANGEW CHEM INT EDIT, V35, P2399; Yu TW, 1998, J AM CHEM SOC, V120, P7749, DOI 10.1021/ja9803658	25	339	401	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2000	287	5453					640	642		10.1126/science.287.5453.640	http://dx.doi.org/10.1126/science.287.5453.640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10649995				2022-12-28	WOS:000084989400044
J	Brickner, ME; Hillis, LD; Lange, RA				Brickner, ME; Hillis, LD; Lange, RA			Congenital heart disease in adults: First of two parts	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ATRIAL SEPTAL-DEFECT; BALLOON PULMONARY VALVULOPLASTY; PATENT DUCTUS-ARTERIOSUS; 2ND NATURAL-HISTORY; TERM FOLLOW-UP; CARDIOVASCULAR ANOMALIES; BACTERIAL-ENDOCARDITIS; PERCUTANEOUS CLOSURE; SURGICAL-CORRECTION; AORTIC-STENOSIS		Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, 5323 Harry Hine Blvd, Dallas, TX 75235 USA.		Lange, Richard/AAM-9594-2021					ADAMS CW, 1965, DIS CHEST, V48, P357, DOI 10.1378/chest.48.4.357; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; BASSON CT, 1994, NEW ENGL J MED, V330, P1627; BELLTHOMSON J, 1980, ANN THORAC SURG, V30, P80, DOI 10.1016/S0003-4975(10)61209-X; BOEHRER JD, 1992, AM HEART J, V124, P448, DOI 10.1016/0002-8703(92)90612-Y; CAMPBELL M, 1970, BRIT HEART J, V32, P633; CAMPBELL M, 1955, BRIT HEART J, V17, P511; CAMPBELL M, 1968, BRIT HEART J, V30, P4; CAMPBELL M, 1970, BRIT HEART J, V32, P820; Carabello BA, 1997, NEW ENGL J MED, V337, P507; Chen CR, 1996, NEW ENGL J MED, V335, P21, DOI 10.1056/NEJM199607043350104; COGGIN CJ, 1970, CAN MED ASSOC J, V102, P718; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; CRAIG RJ, 1968, CIRCULATION, V37, P805, DOI 10.1161/01.CIR.37.5.805; Dajani AS, 1997, JAMA-J AM MED ASSOC, V277, P1794, DOI 10.1001/jama.277.22.1794; Espino-Vela J, 1968, Circulation, V38, P45; FAWZY ME, 1990, CATHETER CARDIO DIAG, V21, P77, DOI 10.1002/ccd.1810210204; FELDT RH, 1971, MAYO CLIN PROC, V46, P794; FISHER RG, 1986, J AM COLL CARDIOL, V8, P280, DOI 10.1016/S0735-1097(86)80040-7; Friedman WF, 1995, MOSS ADAMS HEART DIS, P1087; Gatzoulis MA, 1999, NEW ENGL J MED, V340, P839, DOI 10.1056/NEJM199903183401103; GERSONY WM, 1993, CIRCULATION, V87, P121; Graham Jr TP, 1995, MOSS ADAMS HEART DIS, P724; HAYES CJ, 1993, CIRCULATION, V87, P28; HOLT M, 1960, BRIT HEART J, V22, P236; JOHN S, 1981, J THORAC CARDIOV SUR, V82, P314; KAPLAN S, 1998, CONGENITAL HEART DIS, P189; KAUL UA, 1993, AM HEART J, V126, P1152, DOI 10.1016/0002-8703(93)90668-Y; Kelly D T, 1979, Cardiovasc Clin, V10, P321; KIDD L, 1993, CIRCULATION, V87, P38; KIRKLIN JW, 1993, CARDIAC SURG MORPHOL, V2, P1263; KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801; Lambert V, 1997, ARCH MAL COEUR VAISS, V90, P245; LEACHMAN RD, 1976, AM J CARDIOL, V38, P167, DOI 10.1016/0002-9149(76)90144-2; LUND JT, 1991, EUR J CARDIO-THORAC, V5, P566, DOI 10.1016/1010-7940(91)90220-E; LYNCH HT, 1978, AM J DIS CHILD, V132, P600, DOI 10.1001/archpedi.1978.02120310064013; MARKMAN P, 1965, Q J MED, V34, P409; MATTILA S, 1979, SCAND J THORAC CARD, V13, P21, DOI 10.3109/14017437909101781; MAZZANTI L, 1988, HELV PAEDIATR ACTA, V43, P25; MOODIE DS, 1994, CURR OPIN CARDIOL, V9, P137, DOI 10.1097/00001573-199401000-00017; MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401; Neumayer U, 1998, EUR HEART J, V19, P1573, DOI 10.1053/euhj.1998.1083; OHTSUKA S, 1987, CLIN CARDIOL, V10, P537, DOI 10.1002/clc.4960100916; OTOOLE JD, 1977, CIRCULATION, V56, P1047, DOI 10.1161/01.CIR.56.6.1047; PEARL W, 1977, CHEST, V71, P677, DOI 10.1378/chest.71.5.677; PEASE WE, 1976, CIRCULATION, V53, P759, DOI 10.1161/01.CIR.53.5.759; PERLOFF JK, 1984, AM J CARDIOL, V53, P388, DOI 10.1016/0002-9149(84)90486-7; Perloff JK, 1998, CONGENITAL HEART DIS; PIERONI DR, 1993, CIRCULATION, V87, P80; Rickers C, 1998, HEART, V80, P517, DOI 10.1136/hrt.80.5.517; Sadr-Ameli MA, 1998, AM J CARDIOL, V82, P398, DOI 10.1016/S0002-9149(98)00302-6; SHADDY RE, 1993, CIRCULATION, V87, P793, DOI 10.1161/01.CIR.87.3.793; SHUB C, 1983, J AM COLL CARDIOL, V2, P127, DOI 10.1016/S0735-1097(83)80385-4; STEELE PM, 1987, CIRCULATION, V76, P1037, DOI 10.1161/01.CIR.76.5.1037; SUBRAMANIAN R, 1984, MAYO CLIN PROC, V59, P683, DOI 10.1016/S0025-6196(12)62057-6; TAKENAKA K, 1991, AM J CARDIOL, V68, P691, DOI 10.1016/0002-9149(91)90371-Q; Teupe CHJ, 1997, AM J CARDIOL, V80, P240, DOI 10.1016/S0002-9149(97)00334-2; Valdes-Cruz LM, 1999, ECHOCARDIOGRAPHIC DI, P199; VANPRAAGH S, 1994, AM HEART J, V128, P365, DOI 10.1016/0002-8703(94)90491-X; WEIDMAN WH, 1977, CIRCULATION, V56, P78; ZALZSTEIN E, 1991, PEDIATR CARDIOL, V12, P219, DOI 10.1007/BF02310569	61	347	364	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2000	342	4					256	263		10.1056/NEJM200001273420407	http://dx.doi.org/10.1056/NEJM200001273420407			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	277PB	10648769				2022-12-28	WOS:000084941000007
J	Betjes, MGH				Betjes, MGH			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Betjes, MGH (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.			Betjes, Michiel/0000-0001-9435-6208					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2000	342	3					176	176		10.1056/NEJM200001203420305	http://dx.doi.org/10.1056/NEJM200001203420305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZT	10639543				2022-12-28	WOS:000084851700005
J	Freire-de-Lima, CG; Nascimento, DO; Soares, MBP; Bozza, PT; Castro-Faria-Neto, HC; de Mello, FG; DosReis, GA; Lopes, MF				Freire-de-Lima, CG; Nascimento, DO; Soares, MBP; Bozza, PT; Castro-Faria-Neto, HC; de Mello, FG; DosReis, GA; Lopes, MF			Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages	NATURE			English	Article							FACTOR-BETA; TGF-BETA; VITRONECTIN RECEPTOR; CRUZI; ACTIVATION; DECARBOXYLASE; IDENTIFICATION; INVOLVEMENT; LYMPHOCYTES; INHIBITION	After apoptosis, phagocytes prevent inflammation and tissue damage by the uptake and removal of dead cells(1). In addition, apoptotic cells evoke an anti-inflammatory response through macrophages(2,3). We have previously shown that there is intense lymphocyte apoptosis in an experimental model of Chagas' disease(4), a debilitating cardiac illness caused by the protozoan Trypanosoma cruzi. Here we show that the interaction of apoptotic, but not necrotic T lymphocytes with macrophages infected with I: cruzi fuels parasite growth in a manner dependent on prostaglandins, transforming growth factor-beta (TGF-beta) and polyamine biosynthesis. We show that the vitronectin receptor is critical, in both apoptotic-cell cytoadherence and the induction of prostaglandin E-2/TGF-beta release and ornithine decarboxylase activity in macrophages. A single injection of apoptotic cells in infected mice increases parasitaemia, whereas treatment with cyclooxygenase inhibitors almost completely ablates it in vivo. These results suggest that continual lymphocyte apoptosis and phagocytosis of apoptotic cells by macrophages have a role in parasite persistence in the host, and that cyclooxygenase inhibitors have potential therapeutic application in the control of parasite replication and spread in Chagas' disease.	Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944970 Rio De Janeiro, Brazil; Fiocruz MS, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil; Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	DosReis, GA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944970 Rio De Janeiro, Brazil.	gdosreis@biof.ufrj.br; mlopes@niaid.nih.gov	Soares, Milena B. P./O-3771-2018; NASCIMENTO, DANIELLE/ABE-1057-2020; Bozza, Patricia T./AAE-2933-2021; Lopes, Marcela Freitas/E-2201-2012; de Lima, Celio Geraldo Freire/A-9057-2012; Bozza, Patricia T./AAM-4537-2021	NASCIMENTO, DANIELLE/0000-0001-8946-6998; Lopes, Marcela Freitas/0000-0002-4508-0505; Bozza, Patricia T./0000-0001-8349-9529; DosReis, George/0000-0002-8924-4727; Soares, Milena/0000-0001-7549-2992				BOUTARD V, 1995, J IMMUNOL, V155, P2077; CELENTANO AM, 1995, PROSTAGLANDINS, V49, P141, DOI 10.1016/0090-6980(95)00002-R; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Corraliza IM, 1997, BBA-GEN SUBJECTS, V1334, P123, DOI 10.1016/S0304-4165(96)00081-5; De Mello F G, 1976, J Neurochem, V27, P847; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FUTAKI N, 1993, J PHARM PHARMACOL, V45, P753, DOI 10.1111/j.2042-7158.1993.tb07103.x; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; HUNTER KJ, 1994, EUR J BIOCHEM, V226, P1019, DOI 10.1111/j.1432-1033.1994.t01-1-01019.x; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; KIERSZENBAUM F, 1987, P NATL ACAD SCI USA, V84, P4278, DOI 10.1073/pnas.84.12.4278; LOPES MF, 1995, J IMMUNOL, V154, P744; MAMONT PS, 1976, P NATL ACAD SCI USA, V73, P1626, DOI 10.1073/pnas.73.5.1626; MAXFIELD SR, 1989, J EXP MED, V169, P2173, DOI 10.1084/jem.169.6.2173; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Nunes MP, 1998, J IMMUNOL, V160, P1313; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PROSSER EH, 1998, ARCH BIOCHEM BIOPHYS, V260, P218; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Soares MBP, 1997, INFECT IMMUN, V65, P2837, DOI 10.1128/IAI.65.7.2837-2845.1997; STURMER AM, 1992, J IMMUNOL METHODS, V146, P105, DOI 10.1016/0022-1759(92)90053-V; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; YOKOYAMA WM, 1988, J IMMUNOL, V141, P369	29	349	358	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2000	403	6766					199	203		10.1038/35003208	http://dx.doi.org/10.1038/35003208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275TB	10646605	Green Published			2022-12-28	WOS:000084835300056
J	Macintyre, AG; Christopher, GW; Eitzen, E; Gum, R; Weir, S; DeAtley, C; Tonat, K; Barbera, JA				Macintyre, AG; Christopher, GW; Eitzen, E; Gum, R; Weir, S; DeAtley, C; Tonat, K; Barbera, JA			Weapons of mass destruction events with contaminated casualties - Effective planning for health care facilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIOLOGICAL WARFARE; MISSILE ATTACKS; GULF-WAR; DECONTAMINATION; MANAGEMENT; INJURIES; EXPOSURE; VICTIMS; ISRAEL	Biological and chemical terrorism is a growing concern for the emergency preparedness community. While health care facilities (HCFs) are an essential component of the emergency response system, at present they are poorly prepared for such incidents. The greatest challenge for HCFs may be the sudden presentation of large numbers of contaminated individuals. Guidelines for managing contaminated patients have been based on traditional hazardous material response or military experience, neither of which is directly applicable to the civilian HCF. We discuss HCF planning for terrorist events that expose large numbers of people to contamination. Key elements of an effective HCF response plan include prompt recognition of the incident, staff and facility protection, patient decontamination and triage, medical therapy, and coordination with external emergency response and public health agencies. Controversial aspects include the optimal choice of personal protective equipment, establishment of patient decontamination procedures, the role of chemical and biological agent detectors, and potential environmental impacts on water treatment systems. These and other areas require further investigation to improve response strategies.	George Washington Univ, Med Ctr, Inst Crisis Disaster & Risk Management, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Dept Emergency Med, Washington, DC 20037 USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; USA, Ctr Hlth Promot & Prevent Med Europe, Landstuhl Army Reg Med Ctr, Landstuhl, Germany; US PHS, Off Emergency Preparedness, Rockville, MD USA	George Washington University; George Washington University; Landstuhl Regional Medical Center; United States Public Health Service	Macintyre, AG (corresponding author), 2140 Penn Ave NW, Washington, DC 20037 USA.			Christopher, George/0000-0001-7471-4610				*ASS PROF INF CONT, 1999, BIOT READ PLAN TEMPL; Barbera Joseph A., 1996, Emergency Medicine Clinics of North America, V14, P399, DOI 10.1016/S0733-8627(05)70258-3; BINDER S, 1989, AM J PUBLIC HEALTH, V79, P1042, DOI 10.2105/AJPH.79.8.1042; Birenzvige Amnon, 1992, TR413 US ARM CHEM RE; BLEICH A, 1991, ISRAEL J MED SCI, V27, P673; BORAK J, 1991, HAZARDOUS MAT EXPOSU, P145; Burgess JL, 1999, ANN EMERG MED, V34, P205, DOI 10.1016/S0196-0644(99)70230-1; CANCIO LC, 1993, MIL MED, V158, P1; CARMELI A, 1991, ISRAEL J MED SCI, V27, P677; CARNES SA, 1989, JAMA-J AM MED ASSOC, V262, P653, DOI 10.1001/jama.262.5.653; *CDCP, 1995, FED REGISTER, V60, P33307; CHRISTEN H, 1998, EMS INCIDENT MANAGEM, P1; Cone D C, 1997, Prehosp Emerg Care, V1, P85, DOI 10.1080/10903129708958794; COX RD, 1994, ANN EMERG MED, V23, P761, DOI 10.1016/S0196-0644(94)70312-4; *DISTR COL HOSP AS, 1996, HOSP MUT AID EM PREP; *DOM PREP PROGR DE, 1997, TECHN HOSP PROV COUR; Eitzen E, 1998, MED MANAGEMENT BIOL, V3rd; ELSANADI N, 1993, J PREHOSP DISASTER M, V8, P337; FEHR S, 1995, WASHINGTON POST 1107, pB3; FLAN, 1993, IMK; FLANAGIN A, 1996, JAMA-J AM MED ASSOC, V275, P1714; Franz D.R., 1997, MED ASPECTS CHEM BIO, Vfirst, P197; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; FULLERTON CS, 1994, MIL MED, V159, P524, DOI 10.1093/milmed/159.7.524; GOLD MB, 1994, DRUG CHEM TOXICOL, V17, P499, DOI 10.3109/01480549409014314; GONG E, 1996, SEATTLE TIMES   0711, pB1; GRAHAM B, 1998, WASHINGTON POST 1003, pA9; Graham Bradley, 1998, WASHINGTON POST 0521, pA1; Hall H. Irene, 1994, Morbidity and Mortality Weekly Report, V43, P1; HAUER JM, 1998, US CAP POL BOARD FEB; HAYNES V, 1998, CHICAGO TRIBU E 0222, V98, P30; *HAZ MAT DQE, 1998, HZIMAT DQE NEWS, V6, P2; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HOROWITZ S, 1997, WASHINGTON POST 0429, pB2; Hurst C., 1997, TXB MILITARY MED MED, P351; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; KARSENTY E, 1991, ISRAEL J MED SCI, V27, P603; Keim M, 1999, ANN EMERG MED, V34, P177, DOI 10.1016/S0196-0644(99)70227-1; LANDESMAN L, 1993, J PREHOSP DISASTER M, V8, P39; Levitin Howard W., 1996, Emergency Medicine Clinics of North America, V14, P327, DOI 10.1016/S0733-8627(05)70254-6; LILLIBRIDGE SR, 1995, REPORT AM MED DELEGA; LONDORF D, 1995, J PREHOSP DISASTER M, V10, P184; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; MCCLAIN D, 1997, TXB MILITARY MED, P539; Merritt N L, 1989, J Emerg Nurs, V15, P463; *MMWR, 1999, MMWR-MORBID MORTAL W, V48, P69; NOLL G, 1995, HAZARDOUS MAT, P285; NOZAKI H, 1995, LANCET, V345, P980; Nozaki H, 1995, INTENS CARE MED, V21, P1032, DOI 10.1007/BF01700667; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; *PPE, 1999, CHEM BIOL TERR RES D, P35; *PPE, 1999, CHEM BIOL TERR RES D, P41; Rivkind A, 1997, ANN EMERG MED, V30, P513; SHAPIRA Y, 1991, ISRAEL J MED SCI, V27, P616; SIDELL FR, 1990, POSTGRAD MED, V88, P70, DOI 10.1080/00325481.1990.11716446; SOROKIN E, 1997, FAIRFAX J       0502, pA11; Stokes JW, 1997, MIL PSYCHOL, V9, P395, DOI 10.1207/s15327876mp0904_8; SULLIVAN F, 1998, EMERG MED REP, V19, P21; Sullivan J.B., 1992, J OCCUPAT ENV MED, V34, P365; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; *US ARM MED RES I, 1995, MED MAN CHEM CAS HDB; *US ARM MED RES I, 1996, MED MAN BIOL CAS HDB; *US ARM SOLD BIOL, 1999, BIOL WARF IMPR RESP; *US DEP HHS, 1996, HLTH MED SERV SUPP P; *US DEP HHS, 1992, MAN HAZ MAT INC; *US PHS, 1997, METR MED STRIK TEAM; WALDRON RL, 1981, AM J ROENTGENOL, V136, P977, DOI 10.2214/ajr.136.5.977; Woolf AD, 1997, AM J EMERG MED, V15, P62, DOI 10.1016/S0735-6757(97)90051-6; [No title captured]; 1990, TREATMENT CHEM AGENT	71	101	103	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2000	283	2					242	249		10.1001/jama.283.2.242	http://dx.doi.org/10.1001/jama.283.2.242			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272QA	10634341				2022-12-28	WOS:000084661400031
J	Sheridan, RL; Hinson, MI; Liang, MH; Nackel, AF; Schoenfeld, DA; Ryan, CM; Mulligan, JL; Tompkins, RG				Sheridan, RL; Hinson, MI; Liang, MH; Nackel, AF; Schoenfeld, DA; Ryan, CM; Mulligan, JL; Tompkins, RG			Long-term outcome of children surviving massive burns	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SF-36 HEALTH SURVEY; THERMAL-INJURY; FULL-THICKNESS; BODY-SURFACE; VALIDITY; QUALITY; LIFE; MORTALITY; EXCISION; DETERMINANTS	Context Major advances in treatment of burn injuries in the last 20 years have made it possible to save the lives of children with massive burns, but whether their survival comes at the cost of impaired quality of life is unknown. Objective To investigate the long-term quality of life in children who have survived massive burns. Design and Setting Retrospective, cross-sectional study conducted in a regional pediatric burn center. Patients Eighty subjects who were younger than 18 years at the time of injury, who survived massive burns involving greater than or equal to 70% of the body surface, and who were admitted to the burn center between 1969 and 1992 were evaluated an average (SD) of 14.7 (6.0) years after injury. Main Outcome Measures Short Form 36 (SF-36) scores of the 60 patients aged at least 14 years were compared with national norms and the impact of clinical variables on individual domain scores was assessed. Results The SF-36 domain scores of the study patients, who had survived massive burns at a mean (SD) age of 8.8 (5.5) years, were generally similar to the normal population). However, 15% and 20% of the burn patients had scores in the physical functioning and physical role domains, respectively, that were more than 2 SDs below the relevant norm, indicating that a few patients had continuing serious physical disability. Better functional status of the family predicted a higher score in physical role (P = .04). The child's early reintegration with preburn activities predicted higher scores in general health (P = .03), physical functioning (P = .003), and physical role (P = .01). Children followed up consistently in the multidisciplinary burn clinic for 2 years had higher physical functioning (P = .04). Conclusions In this study, while some children surviving severe burns had lingering physical disability, most had a satisfying quality of life. Comprehensive burn care that included experienced multidisciplinary aftercare played an important role in recovery.	Massachusetts Gen Hosp, Burn Serv, Boston, MA 02114 USA; Shriners Burns Hosp Children, Boston, MA USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Tompkins, RG (corresponding author), Massachusetts Gen Hosp, Burn Serv, GRB1302,55 Fruit St, Boston, MA 02114 USA.			Ryan, Colleen/0000-0002-6455-936X	NIGMS NIH HHS [GM P50-21700, GM T32-07035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007035, P50GM021700] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaronson N K, 1988, Oncology (Williston Park), V2, P69; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Anderson C, 1996, STROKE, V27, P1812, DOI 10.1161/01.STR.27.10.1812; BLAKENEY P, 1990, Journal of Burn Care and Rehabilitation, V11, P472, DOI 10.1097/00004630-199009000-00018; BROWNE G, 1985, BURNS, V12, P28, DOI 10.1016/0305-4179(85)90180-9; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; BURKE JF, 1976, SURG CLIN N AM, V56, P477; Byrne C, 1986, J Burn Care Rehabil, V7, P247, DOI 10.1097/00004630-198605000-00011; EYLES P, 1984, BURNS, V10, P427, DOI 10.1016/0305-4179(84)90084-6; Fratianne R B, 1992, J Burn Care Rehabil, V13, P600, DOI 10.1097/00004630-199209000-00018; HERNDON DN, 1986, J TRAUMA, V26, P609, DOI 10.1097/00005373-198607000-00004; HERNDON DN, 1987, J TRAUMA, V27, P208, DOI 10.1097/00005373-198702000-00020; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; PERNEGER TV, 1995, J CLIN EPIDEMIOL, V48, P1051, DOI 10.1016/0895-4356(94)00227-H; PINNEGAR MD, 1986, BURNS, V12, P508, DOI 10.1016/0305-4179(86)90079-3; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; SAWYER MG, 1983, BURNS, V9, P205, DOI 10.1016/0305-4179(83)90040-2; Sheridan R L, 1994, J Intensive Care Med, V9, P6; Sheridan R L, 1998, Curr Probl Pediatr, V28, P105, DOI 10.1016/S0045-9380(98)80021-2; Sheridan R L, 1998, Curr Probl Pediatr, V28, P139, DOI 10.1016/S0045-9380(98)80061-3; SHERIDAN RL, 1995, J TRAUMA, V38, P48, DOI 10.1097/00005373-199501000-00014; STODDARD FJ, 1989, J AM ACAD CHILD PSY, V28, P589, DOI 10.1097/00004583-198907000-00020; Stoll T, 1997, J RHEUMATOL, V24, P1608; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; TOMPKINS RG, 1988, ANN SURG, V208, P577, DOI 10.1097/00000658-198811000-00006; VANDAM F, 1986, B CANCER, V73, P607; Warden Glenn D., 1993, Journal of Burn Care and Rehabilitation, V14, P581, DOI 10.1097/00004630-199311000-00001; WARE JE, 1993, SF 36 HLTH SURVEY MA, V3, P4; Wolf SE, 1997, ANN SURG, V225, P554, DOI 10.1097/00000658-199705000-00012; WRIGHT L, 1974, PEDIATR RES, V8, P931, DOI 10.1203/00006450-197412000-00003; [No title captured]	32	188	193	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2000	283	1					69	73		10.1001/jama.283.1.69	http://dx.doi.org/10.1001/jama.283.1.69			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	270AZ	10632282	Bronze			2022-12-28	WOS:000084514400027
J	Mitchell, E				Mitchell, E			Commentary: Cot death-the story so far	BRITISH MEDICAL JOURNAL			English	Editorial Material							SLEEPING POSITION		Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Auckland 1, New Zealand	University of Auckland	Mitchell, E (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Postbag 92019, Auckland 1, New Zealand.							Fleming PJ, 1999, ARCH DIS CHILD, V81, P112, DOI 10.1136/adc.81.2.112; L'Hoir MP, 1998, EUR J PEDIATR, V157, P681, DOI 10.1007/s004310050911; MITCHELL EA, 1999, INT CONSULTATION ENV, P105; NELSON EAS, 1989, LANCET, V1, P199; Scragg RKR, 1998, ANN MED, V30, P345, DOI 10.3109/07853899809029933	5	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 4	1999	319	7223					1461	1462						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263MV	10644147				2022-12-28	WOS:000084129200017
J	Markovic, SN; Inwards, DJ; Frigas, EA; Phyliky, RP				Markovic, SN; Inwards, DJ; Frigas, EA; Phyliky, RP			Acquired C1 esterase inhibitor deficiency	ANNALS OF INTERNAL MEDICINE			English	Review							HEREDITARY ANGIONEUROTIC EDEMA; C1-ESTERASE INHIBITOR; C1-INHIBITOR DEFICIENCY; RECURRENT ANGIOEDEMA; TRANEXAMIC ACID; THERAPY; PARAPROTEINEMIA; CONCENTRATE; PROPHYLAXIS; ANTIBODIES	Acquired C1 esterase inhibitor deficiency is a rare condition associated with autoimmune or low-grade lymphoproliferative disorders. Adults or elderly patients are most commonly affected. The diagnosis is suspected when patients present with recurrent angioedema and low serum levels of C4 with normal levels of C3. Low levels of Clq and low C1 esterase inhibitor activity confirm the diagnosis. In this paper, we summarize experience with 22 cases of acquired C1 esterase inhibitor deficiency in the context of a review of the published literature on diagnosis and treatment of this condition.	Mayo Clin & Mayo Fdn, Dept Internal Med, Div Hematol, Rochester, MN 55901 USA	Mayo Clinic	Markovic, SN (corresponding author), Mayo Clin & Mayo Fdn, Dept Internal Med, Div Hematol, 200 1st St SW, Rochester, MN 55901 USA.							ALSENZ J, 1989, BEHRING I MITT, V84, P165; Bauernschmitt R, 1998, INTENS CARE MED, V24, P635, DOI 10.1007/s001340050629; BORK K, 1989, J ALLERGY CLIN IMMUN, V83, P677, DOI 10.1016/0091-6749(89)90082-1; Caldwell JR, 1972, CLIN IMMUNOL IMMUNOP, V1, P39; CASALI P, 1978, ACTA HAEMATOL-BASEL, V59, P277, DOI 10.1159/000207773; CICARDI M, 1985, Complement, V2, P133; CICARDI M, 1993, AM J MED, V95, P169, DOI 10.1016/0002-9343(93)90257-P; COHEN SH, 1978, J ALLERGY CLIN IMMUN, V62, P217, DOI 10.1016/0091-6749(78)90210-5; COLMAN RW, 1976, ANN INTERN MED, V85, P399, DOI 10.7326/0003-4819-85-3-399; CUGNO M, 1994, J ALLERGY CLIN IMMUN, V93, P870, DOI 10.1016/0091-6749(94)90380-8; Davis A E 3rd, 1989, Immunodefic Rev, V1, P207; DAY NK, 1976, CLIN EXP IMMUNOL, V26, P189; DERMER A, 1993, HEMATOLOGICA, V78, P408; DONALDSON VH, 1992, J LAB CLIN MED, V119, P397; Farkas H, 1999, Z GASTROENTEROL, V37, P513; FRANK MM, 1972, NEW ENGL J MED, V286, P808, DOI 10.1056/NEJM197204132861503; FRIGAS E, 1989, MAYO CLIN PROC, V64, P1269, DOI 10.1016/S0025-6196(12)61290-7; Gerencer M, 1997, AIDS RES HUM RETROV, V13, P813, DOI 10.1089/aid.1997.13.813; GORDON EH, 1983, ANN ALLERGY, V51, P349; HEDA GD, 1990, BLOOD, V75, P2401; JAFFE CJ, 1975, J ALLERGY CLIN IMMUN, V55, P386, DOI 10.1016/0091-6749(75)90077-9; JONES RR, 1979, BRIT J DERMATOL, V101, P711, DOI 10.1111/j.1365-2133.1979.tb05652.x; MASSA MC, 1982, J AM ACAD DERMATOL, V7, P255, DOI 10.1016/S0190-9622(82)70115-X; MATHUR R, 1993, POSTGRAD MED J, V69, P646, DOI 10.1136/pgmj.69.814.646; NILSEN A, 1980, ACTA MED SCAND, V207, P123; OLTVAI ZN, 1991, LAB INVEST, V65, P381; Osler W, 1888, AM J MED SCI, V95, P362; PASCUAL M, 1987, AM J MED, V83, P959, DOI 10.1016/0002-9343(87)90659-0; PASQUALI JL, 1984, INT ARCH ALLER A IMM, V74, P284, DOI 10.1159/000233560; QUINCKE H, 1882, DERMATOLOGIE, V1, P129; SHEFFER AL, 1972, NEW ENGL J MED, V287, P452, DOI 10.1056/NEJM197208312870907; WASSERFALLEN JB, 1995, J ALLERGY CLIN IMMUN, V95, P124, DOI 10.1016/S0091-6749(95)70160-5	32	110	115	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2000	132	2					144	150		10.7326/0003-4819-132-2-200001180-00009	http://dx.doi.org/10.7326/0003-4819-132-2-200001180-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275ZZ	11085856				2022-12-28	WOS:000084852300008
J	Markovic, SN; Inwards, DJ; Phyliky, RP				Markovic, SN; Inwards, DJ; Phyliky, RP			Acquired C1 esterase inhibitor deficiency - In Response	ANNALS OF INTERNAL MEDICINE			English	Letter									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Markovic, SN (corresponding author), Mayo Clin, Rochester, MN 55905 USA.								0	110	115	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2000	133	10					839	839		10.7326/0003-4819-133-10-200011210-00025	http://dx.doi.org/10.7326/0003-4819-133-10-200011210-00025			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374AA	11085856				2022-12-28	WOS:000165321200017
J	Sheldon, T				Sheldon, T			EU law makes Netherlands reconsider its health system	BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					206	206						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642219				2022-12-28	WOS:000085029600014
J	Ferriman, A				Ferriman, A			Blair promises to raise spending on NHS to European average	BRITISH MEDICAL JOURNAL			English	News Item																			0	27	27	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 22	2000	320	7229					205	205		10.1136/bmj.320.7229.205	http://dx.doi.org/10.1136/bmj.320.7229.205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279DR	10642214	Green Published			2022-12-28	WOS:000085029600010
